Citrus Sinensis ID: 006703
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 634 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | yes | no | 0.947 | 0.732 | 0.572 | 0.0 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.386 | 0.262 | 0.611 | 2e-87 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.406 | 0.200 | 0.433 | 4e-57 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.384 | 0.380 | 0.467 | 9e-57 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.384 | 0.353 | 0.463 | 2e-55 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.451 | 0.381 | 0.394 | 8e-54 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.392 | 0.271 | 0.435 | 4e-52 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.408 | 0.511 | 0.420 | 2e-50 | |
| Q54RB7 | 527 | Dual specificity protein | no | no | 0.441 | 0.531 | 0.392 | 1e-49 | |
| Q54U31 | 744 | Dual specificity protein | no | no | 0.405 | 0.345 | 0.429 | 2e-49 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 696 bits (1797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/666 (57%), Positives = 463/666 (69%), Gaps = 65/666 (9%)
Query: 18 WAQQTEESYQLQLAMALRLSSQAASADDPHFLA----LSSCDRHTDSAETVSHRFWVNGC 73
WAQQTEESYQLQLA+ALRLSS+A ADDP+FL S+ SAETVSHRFWVNGC
Sbjct: 161 WAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESALRTSPSSAETVSHRFWVNGC 220
Query: 74 LSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKSS 133
LSY+D++ DGFY+++G+DPY W++ + ++G IP +SL+AVD + S++ I++D+ S
Sbjct: 221 LSYYDKVPDGFYMMNGLDPYIWTLCIDLHESGRIPSIESLRAVDSGVDSSLEAIIVDRRS 280
Query: 134 DPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKD 193
DP KELHNRV + C IT +E V QLA L+CN MGG E+E W EC + LK+
Sbjct: 281 DPAFKELHNRVHDISCSCITTKEVVDQLAKLICNRMGGPVIMGEDELVPMWKECIDGLKE 340
Query: 194 CLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDR 253
VV+PIGSLSVGLC HRALLFKVLAD+I+LPCRIAKGCKYC RDDA+SCLV+ G DR
Sbjct: 341 IF-KVVVPIGSLSVGLCRHRALLFKVLADIIDLPCRIAKGCKYCNRDDAASCLVRFGLDR 399
Query: 254 EYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSP 313
EYLVDL+ PG L +PDS LN +S+ +SSPL PR K VE + R LAK YF D+ S
Sbjct: 400 EYLVDLVGKPGHLWEPDSLLNGPSSISISSPLRFPRPKPVEPAVDFRLLAKQYFSDSQS- 458
Query: 314 KFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSG--------PSTHVID 365
+L DP+ D + ++F R N + D +N G P +++
Sbjct: 459 -LNLVFDPASD--DMGF-----SMFHRQYDNPGGENDALAENGGGSLPPSANMPPQNMMR 510
Query: 366 SSNFIK-------------------------------------------GSFGTVYHAEW 382
+SN I+ GSFGTV+ AEW
Sbjct: 511 ASNQIEAAPMNAPPISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW 570
Query: 383 RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442
SDVAVKIL+EQ+FH +R EFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEYLSR
Sbjct: 571 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 630
Query: 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 502
GSLY+LLH AR +DER RL+MAYDVAKGMNYLH R PPIVHRDLKSPNLLVD YTV
Sbjct: 631 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTV 690
Query: 503 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP 562
KVCDFGLSR K +T++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+P
Sbjct: 691 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 750
Query: 563 WRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622
W N P+QV++AVGFK +RLEIP+N+NP VAA+IE CW EP RPSF +IM+ L+ +
Sbjct: 751 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 810
Query: 623 SSVCQP 628
S+V P
Sbjct: 811 SAVPPP 816
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 151/247 (61%), Positives = 186/247 (75%), Gaps = 2/247 (0%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
GS+G VYHA+W ++VAVK ++Q+F EF EV IM+ LRHPN+V +GAVT PP
Sbjct: 678 GSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPP 737
Query: 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491
NLSIVTE+L RGSLY++LH P + + DER R+ MA DVA GMN LH P IVHRDLK+
Sbjct: 738 NLSIVTEFLPRGSLYRILHRPKSHI--DERRRIKMALDVAMGMNCLHTSTPTIVHRDLKT 795
Query: 492 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 551
PNLLVD+ + VKV DFGLSR K NT++SSK+ AGTPEWMAPEVLR +PSNEK DV+SFGV
Sbjct: 796 PNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGV 855
Query: 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 611
ILWEL TL+ PWR P QV+ AVGF+ RRLEIPK ++P+V +I CW +P +RPSF
Sbjct: 856 ILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFA 915
Query: 612 SIMETLQ 618
+ E L+
Sbjct: 916 QLTEVLK 922
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (568), Expect = 4e-57, Method: Compositional matrix adjust.
Identities = 114/263 (43%), Positives = 163/263 (61%), Gaps = 5/263 (1%)
Query: 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 418
P + + + +G +G V+ WR ++VAVK+L + + +EV ++ LRHP
Sbjct: 847 PLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKLRHP 906
Query: 419 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 478
NIVL MGA TEP + IVTEYLSRGSL +L D + +D LRL + +D A+GM YLH
Sbjct: 907 NIVLFMGACTEPSSPCIVTEYLSRGSLANILL--DESIEMDWGLRLQLGFDCARGMTYLH 964
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 538
R P I+HRDLK+ NLLVD ++ VKV DFGL+ K +T+ +KT GT W+APEVL E+
Sbjct: 965 SRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEVLAEE 1022
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598
EK+DV+S+ ++LWEL+T P+ QV+ ++ +G RL +P P AAL+
Sbjct: 1023 GYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYAALMNR 1081
Query: 599 CWAEEPEIRPSFPSIMETLQQFL 621
CW +P RPSFP I+ ++ +
Sbjct: 1082 CWETDPTHRPSFPEILPIMEGMI 1104
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 116/248 (46%), Positives = 151/248 (60%), Gaps = 4/248 (1%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
KG++G VY WR S VAVK L +E+ KEF RE+ +MK LRHPN++ +G+ P
Sbjct: 382 KGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNVIQFLGSCLIP 441
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
P++ I TEY+ RGSLY +LH D + + L + M D AKG+ YLH P I+HRDLK
Sbjct: 442 PDICICTEYMPRGSLYSILH--DQALQLQWSLLIKMMIDAAKGVIYLHNSTPVILHRDLK 499
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
S NLLVD + VKV DFGLS + ++ TA GTP W +PEVLR EK+DV+SFG
Sbjct: 500 SHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTEKADVYSFG 557
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 610
+ILWE T Q P+ P QVI AVG +G R +P+N P L+ C E P RP+
Sbjct: 558 IILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDCLNENPSHRPTM 617
Query: 611 PSIMETLQ 618
+E L+
Sbjct: 618 EQCLERLE 625
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (554), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 115/248 (46%), Positives = 149/248 (60%), Gaps = 4/248 (1%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
KG+FG VY WR S VAVK L +E+ KEF RE+ +MK LRHPN++ +G+
Sbjct: 399 KGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNVIQFLGSCLIS 458
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
P++ I TEY+ RGSLY +LH + ++ + L M D AKG+ YLH P I+HRDLK
Sbjct: 459 PDICICTEYMPRGSLYSILH--NEKIKISWSLVKRMMIDAAKGIIYLHGSTPVILHRDLK 516
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
S NLLVD + VKV DFGLS + ++ TA GTP W +PEVLR EK+DV+SFG
Sbjct: 517 SHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTEKADVYSFG 574
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 610
+ILWE T Q P+ P QVI AVG +G R PK P L++ C E P RP+
Sbjct: 575 IILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKDCLNENPSQRPTM 634
Query: 611 PSIMETLQ 618
+E L+
Sbjct: 635 EQCLEILE 642
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 8e-54, Method: Compositional matrix adjust.
Identities = 123/312 (39%), Positives = 174/312 (55%), Gaps = 26/312 (8%)
Query: 311 HSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFI 370
H+ ++DD + DYK LF+ +++ ++ +QN G
Sbjct: 458 HALPIGINDDERSPLLKTDYK----TLFEIKPIDIS---EIVVQNRIG------------ 498
Query: 371 KGSFGTVYHAEWRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
+GS V+ WR VA+K + E ED E +E IM LRHPNI +G
Sbjct: 499 RGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELAQEATIMSQLRHPNICQFLGTCNN 558
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
PP + IV EY+ GSLY++LH D + +D +MA D+AKGMNYLH P ++HRDL
Sbjct: 559 PPEILIVMEYMPLGSLYRILH--DPSISLDWPRMKSMALDIAKGMNYLHCCDPIVIHRDL 616
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA---AGTPEWMAPEVLREDPSNEKSDV 546
KS NLLVD Y VK+ DFGLS ++ ++ KTA GTP W APEVLR DP EK+DV
Sbjct: 617 KSHNLLVDEHYRVKISDFGLS-TRFKKHLDKKTAMTPVGTPCWTAPEVLRNDPYTEKADV 675
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
FSF ++LWE++T + P++ Q++ +VG R +P V+ LI CW+E+P+
Sbjct: 676 FSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFTRLITECWSEDPQQ 735
Query: 607 RPSFPSIMETLQ 618
RPSF I++ L+
Sbjct: 736 RPSFQEIVKRLE 747
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 111/255 (43%), Positives = 156/255 (61%), Gaps = 6/255 (2%)
Query: 366 SSNFIKGSFGTVYHAEWRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
SS +G+FG VY WR S VA+K I I ++ + +EF +E+ I+ LRHPNIVLLM
Sbjct: 665 SSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLM 724
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
A T PPNL +TEYL GSLY LH ++ ++ +L +A +A+GMNYLH +
Sbjct: 725 AACTAPPNLCFITEYLPGGSLYDALH--SKKIKMNMQLYKKLAIQIAQGMNYLHLSG--V 780
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
+HRD+KS NLL+D VK+CDFGLS+ K + +K + G+P WM+PE+L + EK
Sbjct: 781 IHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTK-SIGSPIWMSPELLMGEDYTEKV 839
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
DV++FG+ILWEL T + P+ Q+ AV K R IP ++ LI+ CW ++P
Sbjct: 840 DVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDP 899
Query: 605 EIRPSFPSIMETLQQ 619
RPSF I+ L +
Sbjct: 900 LKRPSFTEILNLLNE 914
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 200 bits (509), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 111/264 (42%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
GSFG VY R VAVK+L +Q F F +EV +M + HPNI L MGA T P
Sbjct: 33 GSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKEVHLMSKIYHPNICLFMGACTIPG 92
Query: 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491
IVTE + +G+L LLH D ++ + LR+ MA D A G+N+LH+ P VHRD+KS
Sbjct: 93 RCVIVTELVPKGNLETLLH--DQKIQLPLYLRMRMARDAALGINWLHESNPVFVHRDIKS 150
Query: 492 PNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
NLLVD VK+CDFGLS + K +A GTP +MAPEV+ NE SDV+SF
Sbjct: 151 SNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEVMMFKEFNESSDVYSF 210
Query: 550 GVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G++LWE++T ++P+ + + AV K R IP + + LIE CW +EP RP
Sbjct: 211 GIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDCLDSLRRLIEKCWDKEPISRP 270
Query: 609 SFPSIMETLQQFLMSSVCQPLSAQ 632
SF I+ L ++ + L+ +
Sbjct: 271 SFKEIISALDHVIIDAAISDLNGR 294
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 117/298 (39%), Positives = 167/298 (56%), Gaps = 18/298 (6%)
Query: 345 VTADRDLQMQN----------PSGPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIE 394
+ A +D+Q+Q P T + S GSFGTVY R DVAVK++++
Sbjct: 17 IKARKDIQIQQAQSASDILGPPEISETEITTESILGDGSFGTVYKGRCRLKDVAVKVMLK 76
Query: 395 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA 454
Q + +F +EVAIM + HPNIVL +GA T P ++ L +G+L LL P
Sbjct: 77 Q-VDQKTLTDFRKEVAIMSKIFHPNIVLFLGACTSTPGKLMICTELMKGNLESLLLDPMV 135
Query: 455 RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK- 513
++ + R+R MA D A G+ +LH P +HRDLK+ NLLVD+ TVKVCDFGLS+ K
Sbjct: 136 KLPLITRMR--MAKDAALGVLWLHSSNPVFIHRDLKTSNLLVDANLTVKVCDFGLSQIKQ 193
Query: 514 --PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW-RNSTPSQ 570
N A GTP WMAPEVL+ NEK+DV+SFG++LW++ T Q+ + +
Sbjct: 194 RGENLKDGQDGAKGTPLWMAPEVLQGRLFNEKADVYSFGLVLWQIFTRQELFPEFDNFFK 253
Query: 571 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 628
++A+ K R IP + + LI+ CW PE+RPSF I+ L++ ++ C P
Sbjct: 254 FVAAICEKQLRPSIPDDCPKSLKELIQKCWDPNPEVRPSFEGIVSELEEIII-DCCIP 310
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 112/261 (42%), Positives = 153/261 (58%), Gaps = 4/261 (1%)
Query: 364 IDSSNFI-KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 422
ID ++F+ +GSFG+VY + R +VAVKI +Q+ F EV IM + HPN+VL
Sbjct: 277 IDRTDFLGQGSFGSVYKGKCRGQEVAVKIPRKQKLSLYELTSFRHEVKIMSKIFHPNVVL 336
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+GA T+ + IVTE L + L KLLH + R+ MA D A GMN+LH
Sbjct: 337 FLGACTQSGKMQIVTE-LCQTDLEKLLHNDRTKKEFSLFRRMQMAKDAALGMNWLHGITR 395
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
IVH DLK+ NLLVD VKV DFG S+ K K A GTP WMAPEV+ +P NE
Sbjct: 396 -IVHNDLKTANLLVDINLRVKVTDFGFSQIKEGEEFQDKAAKGTPLWMAPEVMMGNPYNE 454
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
K+DV+SFG+ILWE++T + P+ + + +A+ + R IP + P + LI+TCW
Sbjct: 455 KADVYSFGIILWEILTKEAPYSHHKDYDIFFNAICNEKERPPIPADTLPSLRHLIQTCWD 514
Query: 602 EEPEIRPSFPSIMETLQQFLM 622
P+ RPSF I+ L + L+
Sbjct: 515 HNPQNRPSFSEILFRLNEILI 535
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 634 | ||||||
| 224100665 | 668 | serine/threonine protein kinase 3, CTR3 | 0.966 | 0.917 | 0.612 | 0.0 | |
| 224068980 | 821 | serine/threonine protein kinase 1, CTR1 | 0.974 | 0.752 | 0.588 | 0.0 | |
| 114229339 | 809 | ethylene control element [Malus x domest | 0.970 | 0.760 | 0.588 | 0.0 | |
| 224138778 | 813 | serine/threonine protein kinase 2, CTR2 | 0.963 | 0.751 | 0.590 | 0.0 | |
| 114229343 | 843 | ethylene control element variant [Malus | 0.971 | 0.730 | 0.566 | 0.0 | |
| 114229341 | 843 | ethylene control element variant [Malus | 0.971 | 0.730 | 0.566 | 0.0 | |
| 237857405 | 843 | serine/threonine protein kinase [Prunus | 0.963 | 0.724 | 0.572 | 0.0 | |
| 297740063 | 745 | unnamed protein product [Vitis vinifera] | 0.984 | 0.837 | 0.569 | 0.0 | |
| 350535513 | 837 | CTR1-like protein kinase [Solanum lycope | 0.966 | 0.732 | 0.578 | 0.0 | |
| 357439961 | 713 | Serine/threonine protein kinase 1 CTR1 [ | 0.958 | 0.852 | 0.545 | 0.0 |
| >gi|224100665|ref|XP_002311967.1| serine/threonine protein kinase 3, CTR3 [Populus trichocarpa] gi|222851787|gb|EEE89334.1| serine/threonine protein kinase 3, CTR3 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/665 (61%), Positives = 477/665 (71%), Gaps = 52/665 (7%)
Query: 13 APCKSWAQQTEESYQLQLAMALRLSSQAASADDPHFLALSSCDRHTD-----SAETVSHR 67
A KS A+QTEESYQLQLA+ALRLSSQAASA+DP+FL SS D S E++SHR
Sbjct: 9 ATIKSRAKQTEESYQLQLALALRLSSQAASANDPYFLDFSSSDNTKRGLPPYSPESLSHR 68
Query: 68 FWVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVI 127
FWV+G LSYFDRI DGFY+IHG+DPYTWSI + R +P ++SLKAV N+LSI V+
Sbjct: 69 FWVSGSLSYFDRIPDGFYVIHGLDPYTWSISADSR----VPSFESLKAV---NDLSIGVV 121
Query: 128 LIDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEE-FDKQWSE 186
LID+ DP LKE+HNRV+ L T E+ V LA +VCN MGG E++ F + W E
Sbjct: 122 LIDRFRDPGLKEVHNRVIGLSSSLSTTEDVVKHLAIVVCNLMGGVVLNEDDNAFAECWKE 181
Query: 187 CAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCL 246
C E +K SVVLPIGSLS+GLCVHRALLFKVLAD INLPCRI KGCKYCRRD SSCL
Sbjct: 182 CTEVMKRRFRSVVLPIGSLSIGLCVHRALLFKVLADSINLPCRIVKGCKYCRRDVVSSCL 241
Query: 247 VQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLY 306
VQ+G DREY VDLL +PG LS+PDSSLN ++S+ VSSPL HPRFK+ +T E+ R+LAKLY
Sbjct: 242 VQVGNDREYFVDLLRNPGALSQPDSSLNCSSSILVSSPLSHPRFKSNQTTEDFRTLAKLY 301
Query: 307 FIDNHSPKFDLDDDPSGTAIDQDYK------PDPQALFQRASWNVTAD------------ 348
F+D+ D+ SGT ID+D K D + L +S N
Sbjct: 302 FLDSQPLNLVFDNSSSGTTIDEDDKFISRLGKDKKNLLPTSSNNRDTSLSSSVLPVRQKY 361
Query: 349 RDLQMQNPSGPSTHVI---------------------DSSNFIKGSFGTVYHAEWRNSDV 387
D + NP +T+ + D+ GSFGTVYHA+WR SDV
Sbjct: 362 TDPVVSNPKRVATNNLLFMELNQSIPICQLCEISFMKDTDKCFSGSFGTVYHADWRGSDV 421
Query: 388 AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYK 447
AVKIL EQEFH +RF+EFL EVAIMK LRHPNIVL MGAVT+PPNLSIV EYLSRGSL+K
Sbjct: 422 AVKILEEQEFHAERFEEFLSEVAIMKRLRHPNIVLFMGAVTQPPNLSIVMEYLSRGSLHK 481
Query: 448 LLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 507
LLH+ DA ++DER RLNMAYDVAKGMNYLHQ RPPIVHRDLKS NLLVDSTYTVK+CDF
Sbjct: 482 LLHMNDAASILDERRRLNMAYDVAKGMNYLHQFRPPIVHRDLKSLNLLVDSTYTVKICDF 541
Query: 508 GLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 567
GLSRSK TYISS AAG PEWMAPEVLR + SNEKSDV+SFGVILWEL+TLQ+PWRN
Sbjct: 542 GLSRSKAKTYISSTNAAGRPEWMAPEVLRNERSNEKSDVYSFGVILWELMTLQQPWRNLK 601
Query: 568 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627
+Q+I AVGF G+RLEIP +VNP VAALI+ C EP RP F IMETLQ+ + +S+
Sbjct: 602 QAQIIEAVGFMGQRLEIPSSVNPSVAALIDVCLDNEPSKRPPFSYIMETLQELINNSISH 661
Query: 628 PLSAQ 632
P++AQ
Sbjct: 662 PVAAQ 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224068980|ref|XP_002326245.1| serine/threonine protein kinase 1, CTR1 [Populus trichocarpa] gi|222833438|gb|EEE71915.1| serine/threonine protein kinase 1, CTR1 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1941), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/678 (58%), Positives = 476/678 (70%), Gaps = 60/678 (8%)
Query: 9 GNEMAPCKSWAQQTEESYQLQLAMALRLSSQAASADDPHFL-------ALSSCDRHTDSA 61
N + KSWAQQTEESYQLQLA+ALRLSS+A ADDPHFL AL S ++S
Sbjct: 137 ANNGSSGKSWAQQTEESYQLQLALALRLSSEATCADDPHFLDPVPDESALRSST--SNSP 194
Query: 62 ETVSHRFWVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNN 121
E +SHRFWVNGCLSYF++I DGFYLIHGMDPY W++ T+ +D G IP +SLK+VDP +
Sbjct: 195 EALSHRFWVNGCLSYFNKIPDGFYLIHGMDPYVWTVCTDLQDNGRIPSIESLKSVDPNAD 254
Query: 122 LSIKVILIDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFD 181
S++V+LID+ SDPNLKEL NRV + C IT +E V QLA LVCN MGG S E++F
Sbjct: 255 SSMEVVLIDRRSDPNLKELQNRVHGISCSSITTKEVVDQLAKLVCNRMGGPASRGEDDFI 314
Query: 182 KQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDD 241
W EC+++LKDCL S+V+PIGSLS+GLC HRALLFKVLAD I+LPCRIAKGCKYC+RDD
Sbjct: 315 SIWKECSDNLKDCLESIVVPIGSLSIGLCRHRALLFKVLADTIDLPCRIAKGCKYCKRDD 374
Query: 242 ASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRS 301
SSCLV+ G DREYLVDL+ PG L +PDS LN +S+ +SSPL PR K+ E+ + R
Sbjct: 375 GSSCLVRFGLDREYLVDLVGRPGFLCEPDSLLNGPSSISISSPLRFPRIKSTESTVDFRQ 434
Query: 302 LAKLYFIDNHSPKFDLDDDPSGTAIDQDYK------------------------------ 331
LAK YF+D S DD +GT D +
Sbjct: 435 LAKQYFLDCQSLNLVFDDASTGTVHDGEAPGFSMYPKKTDRTDSEISNHVQLPSNSNEIS 494
Query: 332 -----------------PDPQALF----QRASWNVTADRDLQMQNPSGPSTHVIDSSNFI 370
P ++F Q S + + L ++ P ++
Sbjct: 495 QLPLPQKVSRISNHVQLPSKDSMFSEGSQLLSGKTSKELSLDAEDSDIPWNDLVLKERIG 554
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
GSFGTV+ A+W SDVAVKIL+EQ+FH DRFKEFLREVAIMK LRHPNIVL MGAVT+P
Sbjct: 555 AGSFGTVHRADWHGSDVAVKILMEQDFHADRFKEFLREVAIMKRLRHPNIVLFMGAVTQP 614
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
PNLSIVTEYLSRGSLY+LL AR V+DER RLNMAYDVAKGMNYLH+R PPIVHRDLK
Sbjct: 615 PNLSIVTEYLSRGSLYRLLRKSGAREVLDERRRLNMAYDVAKGMNYLHKRNPPIVHRDLK 674
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
SPNLLVD YTVKVCDFGLSR K NT++SSK+AAGTPEWMAPEVLR++ SNEKSDV+SFG
Sbjct: 675 SPNLLVDKKYTVKVCDFGLSRFKANTFLSSKSAAGTPEWMAPEVLRDELSNEKSDVYSFG 734
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 610
VILWEL TLQ+PW N +QV++AVGFKG+RLEIP+++NP VAALIE CWA EP RPSF
Sbjct: 735 VILWELATLQQPWSNLNAAQVVAAVGFKGKRLEIPRDLNPHVAALIEACWANEPWKRPSF 794
Query: 611 PSIMETLQQFLMSSVCQP 628
SIM++L+ + QP
Sbjct: 795 ASIMDSLRSLIKPPTPQP 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229339|gb|ABI58288.1| ethylene control element [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/666 (58%), Positives = 479/666 (71%), Gaps = 51/666 (7%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL---ALSSCDRHTDSAETVSHRFWVNG 72
KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL S R + S + VSHRFWVNG
Sbjct: 139 KSWAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESASRTSGSVDAVSHRFWVNG 198
Query: 73 CLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKS 132
CLSYFD++ DGFYLIHG+D Y W++ T+ ++ G IP +SL++VDP SI+V+LID+
Sbjct: 199 CLSYFDKVPDGFYLIHGIDQYVWTVCTDLQENGRIPSIESLRSVDPGIGSSIEVVLIDRR 258
Query: 133 SDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLK 192
SDP+LKEL NRVL++ C I +E V LA LVC+ MGG++S E+E W E ++ LK
Sbjct: 259 SDPSLKELQNRVLTISCTCINTKEIVDHLAKLVCSRMGGSSSVGEDEILSIWRESSDDLK 318
Query: 193 DCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD 252
DCL SVV+PIGSLSVGLC HRALLFKVLAD I+LPCRIAKGC+YC RDDASSCLV+ G D
Sbjct: 319 DCLGSVVVPIGSLSVGLCRHRALLFKVLADTIDLPCRIAKGCQYCTRDDASSCLVRFGLD 378
Query: 253 REYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHS 312
REYLVDL+ +PG L +PDS LN +S+ +SSPL PR K VE + R LAK YF D S
Sbjct: 379 REYLVDLIANPGYLREPDSLLNGPSSISISSPLRFPRLKPVEPTIDFRLLAKQYFSDCQS 438
Query: 313 PKFDLDDDPSGTAIDQDYKPDPQALFQRASW------NVTADRDLQMQNP------SGPS 360
D+ P+G+A+D+D P+ ++++ N++ D + P GP
Sbjct: 439 LNLVFDEAPAGSAVDED-NIHPKKFDRKSTEGKNLISNLSGDTSAHAKIPRTSGHRDGPR 497
Query: 361 THVIDSSNFIKG-----------------------------------SFGTVYHAEWRNS 385
I S F++G SFGTV+ A+W S
Sbjct: 498 VDTITGSRFVEGVQLVPSKPSRELGFDIEDLDIPWSELIIKERIGAGSFGTVHRADWHGS 557
Query: 386 DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445
DVAVKIL+EQ+FH +RFKEFL EV IMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSL
Sbjct: 558 DVAVKILMEQDFHAERFKEFLSEVTIMKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSL 617
Query: 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505
Y+LLH AR +DER RL+MAYDVAKGMNYLH+R+PPIVHRDLKSPNLLVD YTVKVC
Sbjct: 618 YRLLHKAGAREALDERRRLSMAYDVAKGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVC 677
Query: 506 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 565
DFGLSR K NT++SSK+AAGTPEWMAPEVLR++PSNEKSD++SFGVILWEL T+Q+PW N
Sbjct: 678 DFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATMQQPWGN 737
Query: 566 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625
P+QV++AVGFK +RLEIP+++NP VAA+IE CWA EP RPSF SIM++L + + V
Sbjct: 738 LNPAQVVAAVGFKNKRLEIPRDLNPNVAAIIEACWANEPWKRPSFASIMDSLTPLIKAPV 797
Query: 626 CQPLSA 631
QP A
Sbjct: 798 AQPSRA 803
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138778|ref|XP_002322899.1| serine/threonine protein kinase 2, CTR2 [Populus trichocarpa] gi|222867529|gb|EEF04660.1| serine/threonine protein kinase 2, CTR2 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/669 (59%), Positives = 477/669 (71%), Gaps = 58/669 (8%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL-------ALSSCDRHTDSAETVSHRF 68
KSWAQQT+ESYQLQLA+ALRLSS+A ADDP+FL AL S ++S E +SHRF
Sbjct: 138 KSWAQQTQESYQLQLALALRLSSEATCADDPNFLDSVPAESALRSST--SNSPEALSHRF 195
Query: 69 WVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVIL 128
WV+GCLSY D+I DGFYLIHGMDPY W++ T+ ++ G IP +SLK+VDP + S++V+L
Sbjct: 196 WVSGCLSYLDKIPDGFYLIHGMDPYVWTVCTDSQENGRIPSIESLKSVDPNADSSMEVVL 255
Query: 129 IDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECA 188
ID+ SDP LKEL NRV + C +T +E V QLA LVCN MGG+ S E++F W EC+
Sbjct: 256 IDQRSDPCLKELQNRVHGISCSCVTTKEVVDQLAKLVCNRMGGSASRREDDFVSIWKECS 315
Query: 189 EHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQ 248
+ LKDCL SVV+PIGSLS GLC HRALLFKVLAD I+LPCRIAKGCKYC+RDDASSCLVQ
Sbjct: 316 DDLKDCLGSVVVPIGSLSSGLCSHRALLFKVLADTIDLPCRIAKGCKYCKRDDASSCLVQ 375
Query: 249 IGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFI 308
DREYLVDL+ PG L +PDS LN +S+ +SSPL PR K+VE + RSLA+ YF+
Sbjct: 376 FELDREYLVDLVGMPGCLCEPDSLLNGPSSISISSPLRFPRIKSVEPTVDFRSLAEQYFL 435
Query: 309 DNHSPKFDLDDDPSGTAI-----DQDYKP--------------------------DPQAL 337
D S F DD + + D+ Y P D + L
Sbjct: 436 DCQSLNFVFDDASAEITLYPKTKDKAYNPSQNAKQSMNEVRDPIPLKKIPPVVRRDIRPL 495
Query: 338 FQRASWNVTADRD------------------LQMQNPSGPSTHVIDSSNFIKGSFGTVYH 379
+ V A +D L +++ P + ++ GSFGTV+
Sbjct: 496 ISLSDQRVDASKDSISEGSQLVSGKTSKELSLDVEDLDIPWSDLVLKERIGAGSFGTVHR 555
Query: 380 AEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439
A+W SDVAVKIL+EQ+FH +RFKEFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEY
Sbjct: 556 ADWHGSDVAVKILMEQDFHAERFKEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 615
Query: 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499
LSRGSLY+LLH AR V+DER RL+MAYDVAKGMNYLH+ PPIVHRDLKSPNLLVD
Sbjct: 616 LSRGSLYRLLHKSGAREVLDERRRLSMAYDVAKGMNYLHKHNPPIVHRDLKSPNLLVDKK 675
Query: 500 YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 559
YTVKVCDFGLSR K NT++SSK+AAGTPEWMAPEVL ++PSNEKSDV+SFGVILWEL TL
Sbjct: 676 YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLCDEPSNEKSDVYSFGVILWELATL 735
Query: 560 QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619
Q+PW N P+QV++AVGFKG+RLEIP+++NP V ALIE+CWA EP RPSF S+ME+L+
Sbjct: 736 QQPWSNLNPAQVVAAVGFKGKRLEIPRDLNPQVVALIESCWANEPWKRPSFTSVMESLRS 795
Query: 620 FLMSSVCQP 628
+ QP
Sbjct: 796 LIKPPTPQP 804
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229343|gb|ABI58290.1| ethylene control element variant [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/699 (56%), Positives = 481/699 (68%), Gaps = 83/699 (11%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL---ALSSCDRHTDSAETVSHRFWVNG 72
KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL S R + S + VSHRFWVNG
Sbjct: 139 KSWAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESASRTSGSVDAVSHRFWVNG 198
Query: 73 CLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKS 132
CLSYFD++ DGFYLIHG+D Y W++ T+ ++ G IP +SL++VDP SI+V+LID+
Sbjct: 199 CLSYFDKVPDGFYLIHGIDQYVWTVCTDLQENGRIPSIESLRSVDPGIGSSIEVVLIDRR 258
Query: 133 SDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLK 192
SDP+LKEL NRVL++ C I +E V LA LVC+ MGG++S E+E W E ++ LK
Sbjct: 259 SDPSLKELQNRVLTISCTCINTKEIVDHLAKLVCSRMGGSSSVGEDEILSIWRESSDDLK 318
Query: 193 DCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD 252
DCL SVV+PIGSLSVGLC HRALLFKVLAD I+LPCRIAKGC+YC RDDASSCLV+ G D
Sbjct: 319 DCLGSVVVPIGSLSVGLCRHRALLFKVLADTIDLPCRIAKGCQYCTRDDASSCLVRFGLD 378
Query: 253 REYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHS 312
REYLVDL+ +PG L +PDS LN +S+ +SSPL PR K VE + R LAK YF D S
Sbjct: 379 REYLVDLIANPGYLREPDSLLNGPSSISISSPLRFPRLKPVEPTIDFRLLAKQYFSDCQS 438
Query: 313 PKFDLDDDPSGTAIDQD---------YKPDPQALFQRASWNVTA----------DRDLQM 353
D+ P+G+A+D+D + + L S + +A DR+ Q+
Sbjct: 439 LNLVFDEAPAGSAVDEDNIHPKKFDRKSTEGKNLISNLSGDTSAHAKIPRTSGDDRNPQL 498
Query: 354 QNP--------------------------SGPSTHVIDSSNFIK---------------- 371
NP GP I S F++
Sbjct: 499 FNPLQNILHTPPMVNDPIPLKCMPPVGHRDGPRVDTITGSRFVEGVQLVPSKPSRELGFD 558
Query: 372 -------------------GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIM 412
GSFGTV+ A+W SDVAVKIL+EQ+FH +RFKEFL EV IM
Sbjct: 559 IEDLDIPWSELIIKERIGAGSFGTVHRADWHGSDVAVKILMEQDFHAERFKEFLSEVTIM 618
Query: 413 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 472
K LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH AR +DER RL+MAYDVAK
Sbjct: 619 KRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVAK 678
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 532
GMNYLH+R+PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT++SSK+AAGTPEWMAP
Sbjct: 679 GMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 738
Query: 533 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592
EVLR++PSNEKSD++SFGVILWEL T+Q+PW N P+QV++AVGFK +RLEIP+++NP V
Sbjct: 739 EVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPNV 798
Query: 593 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 631
AA+IE CWA EP RPSF SIM++L + + V QP A
Sbjct: 799 AAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRA 837
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229341|gb|ABI58289.1| ethylene control element variant [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/699 (56%), Positives = 481/699 (68%), Gaps = 83/699 (11%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL---ALSSCDRHTDSAETVSHRFWVNG 72
KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL S R + S + VSHRFWVNG
Sbjct: 139 KSWAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESASRTSGSVDAVSHRFWVNG 198
Query: 73 CLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKS 132
CLSYFD++ DGFYLIHG+D Y W++ T+ ++ G IP +SL++VDP SI+V+LID+
Sbjct: 199 CLSYFDKVPDGFYLIHGIDQYVWTVCTDLQENGRIPSIESLRSVDPGIGSSIEVVLIDRR 258
Query: 133 SDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLK 192
SDP+LKEL NRVL++ C I +E V LA LVC+ MGG++S E+E W E ++ LK
Sbjct: 259 SDPSLKELQNRVLTISCTCINTKEIVDHLAKLVCSRMGGSSSVGEDEILSIWRESSDDLK 318
Query: 193 DCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD 252
DCL SVV+PIGSLSVGLC HRALLFKVLAD I+LPCRIAKGC+YC RDDASSCLV+ G D
Sbjct: 319 DCLGSVVVPIGSLSVGLCRHRALLFKVLADTIDLPCRIAKGCQYCTRDDASSCLVRFGLD 378
Query: 253 REYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHS 312
REYLVDL+ +PG L +PDS LN +S+ +SSPL PR K VE + R LAK YF D S
Sbjct: 379 REYLVDLIANPGYLREPDSLLNGPSSISISSPLRFPRLKPVEPTIDFRLLAKQYFSDCQS 438
Query: 313 PKFDLDDDPSGTAIDQD---------YKPDPQALFQRASWNVTA----------DRDLQM 353
D+ P+G+A+D+D + + L S + +A DR+ Q+
Sbjct: 439 LNLVFDEAPAGSAVDEDNIHPKKFDRKSTEGKNLISNLSGDTSAHAKIPRTSGDDRNPQL 498
Query: 354 QNP--------------------------SGPSTHVIDSSNFIK---------------- 371
NP GP I S F++
Sbjct: 499 FNPLQNILHTPPMVNDPIPLKCMPPVGHRDGPRVDTITDSRFVEGVQLVPSKPSRELGFD 558
Query: 372 -------------------GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIM 412
GSFGTV+ A+W SDVAVKIL+EQ+FH +RFKEFL EV IM
Sbjct: 559 IEDLDIPWSELIIKERIGAGSFGTVHRADWHGSDVAVKILMEQDFHAERFKEFLSEVTIM 618
Query: 413 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 472
K LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH AR +DER RL+MAYDVAK
Sbjct: 619 KRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDERRRLSMAYDVAK 678
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 532
GMNYLH+R+PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT++SSK+AAGTPEWMAP
Sbjct: 679 GMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAP 738
Query: 533 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592
EVLR++PSNEKSD++SFGVILWEL T+Q+PW N P+QV++AVGFK +RLEIP+++NP V
Sbjct: 739 EVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPNV 798
Query: 593 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 631
AA+IE CWA EP RPSF SIM++L + + V QP A
Sbjct: 799 AAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRA 837
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|237857405|gb|ACR23642.1| serine/threonine protein kinase [Prunus persica] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1890), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/700 (57%), Positives = 478/700 (68%), Gaps = 89/700 (12%)
Query: 18 WAQQTEESYQLQLAMALRLSSQAASADDPHFLALS---SCDRHTDSAETVSHRFWVNGCL 74
WAQQTEESYQLQLA+ALRLSS+A DDP+FL L S R + S + VSHRFWVNGCL
Sbjct: 135 WAQQTEESYQLQLALALRLSSEATCTDDPNFLDLVPDVSSSRSSGSVDAVSHRFWVNGCL 194
Query: 75 SYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKSSD 134
SYFD + DGFYLIHG+DPY W++ T+ ++ G IP +SL++VDP SI+V+LID+ SD
Sbjct: 195 SYFDIVPDGFYLIHGIDPYVWTVCTDMQENGRIPSIESLRSVDPGIGSSIEVVLIDRRSD 254
Query: 135 PNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKDC 194
P+LKEL NRV SL C IT +E V QLA LVCN MGG+ S E+EF W E ++ LKDC
Sbjct: 255 PSLKELQNRVFSLSCTCITTKEIVDQLAKLVCNRMGGSASVGEDEFVPIWRESSDDLKDC 314
Query: 195 LNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDRE 254
L SVV+PIGSLSVGLC HRALLFKVLAD I+L CRIAKGCKYC RDDASSCLV+ G DRE
Sbjct: 315 LGSVVVPIGSLSVGLCRHRALLFKVLADRIDLSCRIAKGCKYCTRDDASSCLVRFGLDRE 374
Query: 255 YLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPK 314
YLVDL+ +PG L +PDS LN +S+ +SSPL PR K VE + RSLAK YF D S
Sbjct: 375 YLVDLIANPGYLCEPDSLLNGPSSISISSPLRFPRLKPVEPTIDFRSLAKQYFSDCQSLN 434
Query: 315 FDLDDDPSGTAIDQDYKP-------------------------DPQALFQRASWNVTADR 349
D+ +G+A+D+D K D +++ + S DR
Sbjct: 435 LVFDEASAGSAVDEDNKEFSMYPKQLDRKITEGNNLLLVSSLNDNTSMYAKVSQPSFEDR 494
Query: 350 DLQMQNPSGPSTHV-----------------------IDS---SNFIKG----------- 372
+ Q+ NPS H +D+ S F++G
Sbjct: 495 NPQLFNPSQNIVHTPGMVKDPIPLKRIPPIGHRDVSRVDTTKGSRFVEGVQLVPSKPSKE 554
Query: 373 ------------------------SFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLRE 408
SFGTV+ A+W SDVAVKIL+EQ+FH +RFKEFLRE
Sbjct: 555 LTFDIEDLDIPWNDLVLKDRIGAGSFGTVHRADWHGSDVAVKILMEQDFHAERFKEFLRE 614
Query: 409 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 468
V IMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH P A +DE+ RLNMAY
Sbjct: 615 VTIMKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKPGAMEALDEKRRLNMAY 674
Query: 469 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE 528
DVAKGMNYLH+R PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT++SSK+AAGTPE
Sbjct: 675 DVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPE 734
Query: 529 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588
WMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N P+QV++AVGFK +RLEIP+++
Sbjct: 735 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKNKRLEIPRDL 794
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 628
NP VA++IE CWA EP RPSF SIME+L + QP
Sbjct: 795 NPQVASIIEACWANEPWKRPSFASIMESLMPLIKPPATQP 834
|
Source: Prunus persica Species: Prunus persica Genus: Prunus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740063|emb|CBI30245.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/685 (56%), Positives = 481/685 (70%), Gaps = 61/685 (8%)
Query: 7 GVGNEMAPCKSWAQQTEESYQLQLAMALRLSSQAASADDPHFL-------ALSSCDRHTD 59
G G+ + KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL A S
Sbjct: 56 GTGDSSS-SKSWAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDDSASRSLSSSGS 114
Query: 60 SAETVSHRFWVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPC 119
S E +SHRFWV+GCLSYFD++ DGFYLIHGMDPY W++ + R+ G IP +SLK +P
Sbjct: 115 SVEAMSHRFWVSGCLSYFDKVPDGFYLIHGMDPYVWTVCNDLRENGRIPSIESLKHAEPS 174
Query: 120 NNLSIKVILIDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEE 179
+ I+V+LID+ +DP LKEL N+V + C +T +E V QLA LVCN MGG ST E++
Sbjct: 175 ADSPIEVVLIDRRTDPTLKELQNKVHGISCSCMTTKEVVDQLAKLVCNCMGGAASTGEDD 234
Query: 180 FDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRR 239
F W EC++ KDCL S+V+PIGSLS GLC HRALLFKVLAD I+L CRIAKGCKYC R
Sbjct: 235 FVSIWRECSDDQKDCLGSIVVPIGSLSFGLCRHRALLFKVLADTIDLRCRIAKGCKYCTR 294
Query: 240 DDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENI 299
DDASSCLV++GPDRE+LVDL+ PG L +PDS LN AS+ +SSPL PR K VET +
Sbjct: 295 DDASSCLVRVGPDREFLVDLVGKPGCLCEPDSLLNGPASISISSPLRFPRSKPVETNIDF 354
Query: 300 RSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPD-------------------------- 333
RSLAK YF + S +D G +D+ D
Sbjct: 355 RSLAKQYFSECQSLNLVFEDTSVGVIVDEADGGDSMYPKKFDRKCTDRTHLVPISRNRGE 414
Query: 334 -PQ-ALFQRASWNVTAD------RDLQMQN-----PSGPSTHV--------IDSSNFI-- 370
PQ + + +W +D +D++ + P+ P + I S+ +
Sbjct: 415 TPQLPMPPKVAWPTLSDLRGDTIKDMRFTDGGQLYPNKPCKELSLDVEDLDIPWSDLVLK 474
Query: 371 ----KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
GSFGTV+ A+W SDVAVK+L+EQ+FH +RFKEFLREV+IMK LRHPNIVL MGA
Sbjct: 475 ERIGAGSFGTVHRADWNGSDVAVKVLMEQDFHAERFKEFLREVSIMKRLRHPNIVLFMGA 534
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
VT+PPNLSIVTEYLSRGSLY+LLH P AR ++DER RL+MAYDVAKGMNYLH+R PPIVH
Sbjct: 535 VTQPPNLSIVTEYLSRGSLYRLLHKPGAREMLDERRRLSMAYDVAKGMNYLHKRNPPIVH 594
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLKSPNLLVD YTVKVCDFGLSR K NT++SSK+AAGTPEWMAPEVLR++ SNEKSD+
Sbjct: 595 RDLKSPNLLVDKKYTVKVCDFGLSRFKANTFLSSKSAAGTPEWMAPEVLRDEASNEKSDI 654
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
+SFG+ILWEL TLQ+PW N P+QV++AVGFKG+RLEIP+++NP VA++IE CWA EP
Sbjct: 655 YSFGIILWELATLQQPWSNLNPAQVVAAVGFKGKRLEIPRDLNPQVASIIEACWANEPWK 714
Query: 607 RPSFPSIMETLQQFLMSSVCQPLSA 631
RPSF +IME+L+ + QP+ A
Sbjct: 715 RPSFFNIMESLKPLIKPPTPQPVRA 739
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350535513|ref|NP_001234454.1| CTR1-like protein kinase [Solanum lycopersicum] gi|40781628|gb|AAR89820.1| CTR1-like protein kinase [Solanum lycopersicum] gi|40781634|gb|AAR89823.1| CTR1-like protein kinase [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/678 (57%), Positives = 477/678 (70%), Gaps = 65/678 (9%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL------ALSSCDRHTDSAETVSHRFW 69
KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL + S SAET+SHRFW
Sbjct: 149 KSWAQQTEESYQLQLALALRLSSEATCADDPNFLDHVPDESASRASASAASAETLSHRFW 208
Query: 70 VNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILI 129
VNGCLSYFD++ DGFYLIHGMDPY W + ++ ++ +P +S++AVDP S++VILI
Sbjct: 209 VNGCLSYFDKVPDGFYLIHGMDPYVWIVCSDLQENARVPSIESMRAVDPSVVPSVEVILI 268
Query: 130 DKSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAE 189
D+ +DP+LKEL NR+ SL T +E V QLA LVC+HMGG TS E+E W EC+
Sbjct: 269 DRRTDPSLKELQNRIHSLSPTCGTTKEVVDQLAQLVCSHMGGATSAGEDELVPLWKECSY 328
Query: 190 HLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQI 249
LKDCL S VLPIGSLSVGLC HRALLFKVLAD I LPCRIAKGCKYC R DASSCLV+
Sbjct: 329 ELKDCLGSTVLPIGSLSVGLCRHRALLFKVLADAIGLPCRIAKGCKYCNRADASSCLVRF 388
Query: 250 GPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYF-- 307
GPDREYLVDL+ PG L +PDSSLN +S+ +SSPL PRF+ VE + RSLAK YF
Sbjct: 389 GPDREYLVDLIGSPGCLCEPDSSLNGPSSISISSPLRFPRFREVEPTTDFRSLAKQYFSD 448
Query: 308 ----------------IDNHSPKFDLDDDPSGTAID----------------QDYKP--- 332
+D + + D ++ +A+ +D P
Sbjct: 449 CQSLNLVFEESSAGAAVDGDAGQTDRNNIERNSAVTGPSNRDEVSRLPVPAIRDMAPVKY 508
Query: 333 ------------DPQAL------FQRASW----NVTADRDLQMQNPSGPSTHVIDSSNFI 370
DP+ + +R S ++ D L++++ P ++
Sbjct: 509 VRPVLHGDTQLSDPRDIGNDMRFLERGSQLVPSKISRDIALEIEDFDIPWEDLVLKERIG 568
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
GSFGTV+ A+W SDVAVKIL+EQ+FH +RFKEFLREVAIMK LRHPNIVL MGAVT+
Sbjct: 569 AGSFGTVHRADWNGSDVAVKILMEQDFHAERFKEFLREVAIMKRLRHPNIVLFMGAVTQR 628
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
PNLSIVTEYLSRGSLY+LLH P AR V+DER RL+MAYDVAKGMNYLH+R PPIVHRDLK
Sbjct: 629 PNLSIVTEYLSRGSLYRLLHKPGAREVLDERRRLSMAYDVAKGMNYLHKRNPPIVHRDLK 688
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
SPNLLVD YTVKVCDFGLSR K NT++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFG
Sbjct: 689 SPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 748
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 610
VILWEL TLQ+PW N P+QV++AVGFKG+RL+IP+++ P VA++IE CWA+EP RPSF
Sbjct: 749 VILWELATLQQPWSNLNPAQVVAAVGFKGKRLDIPRDLTPQVASIIEACWAKEPWKRPSF 808
Query: 611 PSIMETLQQFLMSSVCQP 628
+IM+ L+ + V P
Sbjct: 809 AAIMDMLRPLIKPPVTPP 826
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357439961|ref|XP_003590258.1| Serine/threonine protein kinase 1 CTR1 [Medicago truncatula] gi|355479306|gb|AES60509.1| Serine/threonine protein kinase 1 CTR1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1840), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/678 (54%), Positives = 464/678 (68%), Gaps = 70/678 (10%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPH-FLALSSCDRHTDSAETVS------HRF 68
KSWA+QTEESYQLQLA+ALR+SS +AS+ + FL L S + S+ + HRF
Sbjct: 35 KSWAKQTEESYQLQLALALRISSHSASSAQSNRFLDLESTSSPSPSSSSSDSPQSLSHRF 94
Query: 69 WVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVIL 128
WVNGCL Y D++LDGFYLIHGMD YTW+I T+ ++ G+IP ++SL +V PC+N S+ V+
Sbjct: 95 WVNGCLQYSDKVLDGFYLIHGMDAYTWTISTDMQNVGMIPSFESLMSVKPCDNSSVVVVA 154
Query: 129 IDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECA 188
IDKS DP L+EL + VLSL + IT ++A QLANLVC+ MGG +S +EE +W EC+
Sbjct: 155 IDKSRDPALRELQSGVLSLSSNWITIKDATDQLANLVCSRMGGGSS-DEENLGARWKECS 213
Query: 189 EHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQ 248
+ LK CL ++LPIGSL VGLCVHRALLFKVLADLINLPCRIAKGCKYCR+D +SC+VQ
Sbjct: 214 DILKSCLQCIILPIGSLPVGLCVHRALLFKVLADLINLPCRIAKGCKYCRKDTGASCIVQ 273
Query: 249 IGPDR---------------------------------EYLVDLLEDPGVLSKPDSSLNR 275
G DR EY++DL+ PG +PDSS+N
Sbjct: 274 FGSDRVPRDILGKDLDKQDVCIAYFKYMYEEATTSVRTEYMIDLVGRPGDTCQPDSSVNS 333
Query: 276 TASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQD------ 329
+S+ + SPL HPRFK VET E +++A+LYF+DN + D GT +D
Sbjct: 334 ASSMLIPSPLCHPRFKPVETAEYTKTMAQLYFLDNQALHLVFDTTSGGTVDCRDNVDLQQ 393
Query: 330 -----------------YKP--DPQALFQRASWNV----TADRDLQMQNPSGPSTHVIDS 366
+ P + F A+ +V + + DL+ ++ P + +I
Sbjct: 394 TEMFGANYAGGNNHIGAFSPGTEEHVSFNEANQSVVNYSSHEVDLEEEDLDIPWSELILK 453
Query: 367 SNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
N GSFGTV A+WR SDVAVKIL Q F +RF+EFL+EV +MK LRHPNIVLLMGA
Sbjct: 454 ENIGTGSFGTVLRADWRGSDVAVKILKVQGFDSERFEEFLKEVTLMKRLRHPNIVLLMGA 513
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
V +PP LSIVTEYLSRGSLY+ L +P + E+ RL+MAYDVA GMNYLHQ +PPIVH
Sbjct: 514 VIQPPKLSIVTEYLSRGSLYEFLQMPGVGSSISEKRRLSMAYDVASGMNYLHQMKPPIVH 573
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLKSPNLLVD +YTVKVCDFGLSR+K NTY+SSKTAAGTPEWMAPEV++ + SNEK DV
Sbjct: 574 RDLKSPNLLVDDSYTVKVCDFGLSRTKANTYLSSKTAAGTPEWMAPEVIKGELSNEKCDV 633
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
FSFGVILWEL+TLQ+PWR PSQV++AV F G+RLEIP++VNP VAALIE CW+ EP
Sbjct: 634 FSFGVILWELVTLQQPWRQLNPSQVVAAVAFMGKRLEIPRHVNPQVAALIELCWSTEPRR 693
Query: 607 RPSFPSIMETLQQFLMSS 624
RPSF IM+ LQQ + ++
Sbjct: 694 RPSFSYIMKCLQQIIANA 711
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 634 | ||||||
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.405 | 0.313 | 0.743 | 9.8e-196 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.388 | 0.238 | 0.608 | 3.1e-122 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.388 | 0.279 | 0.604 | 1.8e-118 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.388 | 0.247 | 0.608 | 9.7e-118 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.454 | 0.308 | 0.533 | 2.6e-117 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.388 | 0.321 | 0.562 | 2.2e-73 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.388 | 0.318 | 0.544 | 6.7e-72 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.359 | 0.339 | 0.582 | 1.1e-69 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.276 | 0.210 | 0.557 | 1.3e-69 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.386 | 0.332 | 0.518 | 1.7e-68 |
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 9.8e-196, Sum P(2) = 9.8e-196
Identities = 191/257 (74%), Positives = 219/257 (85%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
GSFGTV+ AEW SDVAVKIL+EQ+FH +R EFLREVAIMK LRHPNIVL MGAVT+PP
Sbjct: 560 GSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 619
Query: 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491
NLSIVTEYLSRGSLY+LLH AR +DER RL+MAYDVAKGMNYLH R PPIVHRDLKS
Sbjct: 620 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKS 679
Query: 492 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 551
PNLLVD YTVKVCDFGLSR K +T++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGV
Sbjct: 680 PNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 739
Query: 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 611
ILWEL TLQ+PW N P+QV++AVGFK +RLEIP+N+NP VAA+IE CW EP RPSF
Sbjct: 740 ILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFA 799
Query: 612 SIMETLQQFLMSSVCQP 628
+IM+ L+ + S+V P
Sbjct: 800 TIMDLLRPLIKSAVPPP 816
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 801 (287.0 bits), Expect = 3.1e-122, Sum P(3) = 3.1e-122
Identities = 151/248 (60%), Positives = 188/248 (75%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
GS+G VY +W ++VAVK ++Q+ + +EF EV IMK LRHPNIVL MGAVT PP
Sbjct: 757 GSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLRHPNIVLFMGAVTRPP 816
Query: 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491
NLSIVTE+L RGSLY+L+H P+ ++ DER RL MA D A+GMNYLH P IVHRDLKS
Sbjct: 817 NLSIVTEFLPRGSLYRLIHRPNNQL--DERRRLRMALDAARGMNYLHSCNPMIVHRDLKS 874
Query: 492 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 551
PNLLVD + VKVCDFGLSR K +TY+SSK+ AGT EWMAPEVLR +P++EK DV+S+GV
Sbjct: 875 PNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLRNEPADEKCDVYSYGV 934
Query: 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 611
ILWEL TLQ+PW P QV+ AVGF+ RRL+IP V+P +A LI CW + ++RPSF
Sbjct: 935 ILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLISKCWQTDSKLRPSFA 994
Query: 612 SIMETLQQ 619
IM +L++
Sbjct: 995 EIMASLKR 1002
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 1.8e-118, Sum P(2) = 1.8e-118
Identities = 150/248 (60%), Positives = 189/248 (76%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
GS+G VY AEW ++VAVK ++Q+F D +F E+ IM LRHPN+VL MGAVT PP
Sbjct: 618 GSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLRLRHPNVVLFMGAVTRPP 677
Query: 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491
N SI+TE+L RGSLY+LLH P+ ++ DE+ R+ MA DVAKGMNYLH P +VHRDLKS
Sbjct: 678 NFSILTEFLPRGSLYRLLHRPNHQL--DEKRRMRMALDVAKGMNYLHTSHPTVVHRDLKS 735
Query: 492 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 551
PNLLVD + VKVCDFGLSR K +TY+SSK+ AGTPEWMAPEVLR +P+NEK DV+SFGV
Sbjct: 736 PNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPEVLRNEPANEKCDVYSFGV 795
Query: 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 611
ILWEL T + PW+ P QV+ AVGF+ RRLEIP +++ VA +I CW EP +RPSF
Sbjct: 796 ILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVAQIIRECWQTEPHLRPSFT 855
Query: 612 SIMETLQQ 619
+M++L++
Sbjct: 856 QLMQSLKR 863
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
Identities = 151/248 (60%), Positives = 189/248 (76%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
GS+G VY +W + VAVK I+Q+ + +EF EV +M+ LRHPNIVL MGAVT PP
Sbjct: 724 GSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRRLRHPNIVLFMGAVTRPP 783
Query: 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491
NLSIVTE+L RGSLY+L+H P+ ++ DER RL MA D A+GMNYLH P IVHRDLKS
Sbjct: 784 NLSIVTEFLPRGSLYRLIHRPNNQL--DERKRLRMALDAARGMNYLHSCNPVIVHRDLKS 841
Query: 492 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 551
PNLLVD + VKVCDFGLSR K +TY+SSK+ AGT EWMAPEVLR +P++EK DV+S+GV
Sbjct: 842 PNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEVLRNEPADEKCDVYSYGV 901
Query: 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 611
ILWEL TLQ+PW P QV+ AVGF+ RRL+IP+ V+P +A +I CW +P +RPSF
Sbjct: 902 ILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIADIIRKCWQTDPRLRPSFG 961
Query: 612 SIMETLQQ 619
IM++L+Q
Sbjct: 962 EIMDSLKQ 969
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 2.6e-117, Sum P(2) = 2.6e-117
Identities = 161/302 (53%), Positives = 206/302 (68%)
Query: 318 DDDPSGTAIDQ-DYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGSFGT 376
D + + +++D Y+ DPQ L D D + P ++ + GS+G
Sbjct: 634 DHESTSSSLDSTSYRNDPQVL----------D-DADVGECEIPWNDLVIAERIGLGSYGE 682
Query: 377 VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436
VYHA+W ++VAVK ++Q+F EF EV IM+ LRHPN+V +GAVT PPNLSIV
Sbjct: 683 VYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIV 742
Query: 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496
TE+L RGSLY++LH P + + DER R+ MA DVA GMN LH P IVHRDLK+PNLLV
Sbjct: 743 TEFLPRGSLYRILHRPKSHI--DERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLV 800
Query: 497 DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWEL 556
D+ + VKV DFGLSR K NT++SSK+ AGTPEWMAPEVLR +PSNEK DV+SFGVILWEL
Sbjct: 801 DNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 860
Query: 557 ITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616
TL+ PWR P QV+ AVGF+ RRLEIPK ++P+V +I CW +P +RPSF + E
Sbjct: 861 ATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEV 920
Query: 617 LQ 618
L+
Sbjct: 921 LK 922
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
Identities = 140/249 (56%), Positives = 184/249 (73%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
+GS GTVYH W SDVAVK+ +QE+ E+ F +EV++MK LRHPN++L MGAV P
Sbjct: 495 QGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKRLRHPNVLLFMGAVASP 554
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
L IVTE+L RGSL++LL +++ D R R++MA D+A+GMNYLH PPI+HRDLK
Sbjct: 555 QRLCIVTEFLPRGSLFRLLQRNKSKL--DLRRRIHMASDIARGMNYLHHCSPPIIHRDLK 612
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
S NLLVD +TVKV DFGLSR K TY+++ GTP+WMAPEVLR + ++EKSDV+SFG
Sbjct: 613 SSNLLVDRNWTVKVADFGLSRIKHETYLTTN-GRGTPQWMAPEVLRNEAADEKSDVYSFG 671
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 610
V+LWEL+T + PW N QVI AVGF +RLE+PK+V+P AL+E+CW EP+ RPSF
Sbjct: 672 VVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQWIALMESCWHSEPQCRPSF 731
Query: 611 PSIMETLQQ 619
+M+ L++
Sbjct: 732 QELMDKLRE 740
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
Identities = 135/248 (54%), Positives = 183/248 (73%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
+GS GTVYH W SDVAVK+ +QE+ + + F +EV +MK LRHPN++L MGAVT P
Sbjct: 502 QGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSP 561
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
L IV+E+L RGSL++LL +++ D R R++MA D+A+GMNYLH PPI+HRDLK
Sbjct: 562 QRLCIVSEFLPRGSLFRLLQKSTSKL--DWRRRIHMALDIARGMNYLHHCSPPIIHRDLK 619
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
S NLLVD +TVKV DFGLSR K TY++SK+ GTP+WMAPEVLR + ++EKSD++SFG
Sbjct: 620 SSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFG 679
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 610
V+LWEL T + PW QVI AVGF +RLEIPK+++P +L+E+CW + ++RP+F
Sbjct: 680 VVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDPRWISLMESCWHSDTKLRPTF 739
Query: 611 PSIMETLQ 618
+M+ L+
Sbjct: 740 QELMDKLR 747
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 706 (253.6 bits), Expect = 1.1e-69, P = 1.1e-69
Identities = 134/230 (58%), Positives = 172/230 (74%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
+GS GTVYH W SDVAVK+ +QE+ E K F +EV++MK LRHPN++L MGAVT P
Sbjct: 442 RGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIKSFEKEVSLMKRLRHPNVLLFMGAVTSP 501
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
L IV+E++ RGSL++LL +++ D R R+NMA D+A+GMNYLH PPI+HRDLK
Sbjct: 502 QRLCIVSEFVPRGSLFRLLQRSMSKL--DWRRRINMALDIARGMNYLHCCSPPIIHRDLK 559
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
S NLLVD +TVKV DFGLSR K TY++SK+ GTP+WMAPEVLR + ++EKSD++SFG
Sbjct: 560 SSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFG 619
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
V+LWEL T + PW N QVI AVGF +RLEIPK+ +P +LIE+CW
Sbjct: 620 VVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIPKDTDPDWISLIESCW 669
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 1.3e-69, Sum P(2) = 1.3e-69
Identities = 102/183 (55%), Positives = 130/183 (71%)
Query: 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA--KGMNYLHQRRPPIVHRDLKSPNLLV 496
Y S SL +LL++ V L + + Y A +GMNYLH PPI+HRDLKS NLLV
Sbjct: 630 YYSLDSLIQLLYL------VYNMLHIFLTYFFAQARGMNYLHHCTPPIIHRDLKSSNLLV 683
Query: 497 DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWEL 556
D +TVKV DFGLSR K TY+++KT GTP+WMAPEVLR + ++EKSDV+SFGVILWEL
Sbjct: 684 DKNWTVKVADFGLSRIKHETYLTTKTGRGTPQWMAPEVLRNEAADEKSDVYSFGVILWEL 743
Query: 557 ITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616
+T + PW + QVI AVGF +RLE+PKNV+P +L+E+CW EP+ RPSF IME
Sbjct: 744 VTEKIPWESLNAMQVIGAVGFMNQRLEVPKNVDPQWISLMESCWHSEPQDRPSFQEIMEK 803
Query: 617 LQQ 619
L++
Sbjct: 804 LRE 806
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 695 (249.7 bits), Expect = 1.7e-68, P = 1.7e-68
Identities = 128/247 (51%), Positives = 173/247 (70%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
+GSF V+ W SDVA+K+ + +++ E +E+ IMK LRHPN++L MGAV
Sbjct: 476 RGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKLRHPNVLLFMGAVCTE 535
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
+I+ EY+ RGSL+K+LH + +D++ RL MA DVA+GMNYLH+R PPIVHRDLK
Sbjct: 536 EKSAIIMEYMPRGSLFKILH--NTNQPLDKKRRLRMALDVARGMNYLHRRNPPIVHRDLK 593
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
S NLLVD + VKV DFGLS+ K T++S+K+ GTP+WMAPEVLR +PSNEK DVFSFG
Sbjct: 594 SSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLRSEPSNEKCDVFSFG 653
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 610
VILWEL+T PW QV+ VGF RRL++P+ +NP +A++I+ CW +P RPSF
Sbjct: 654 VILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPRIASIIQDCWQTDPAKRPSF 713
Query: 611 PSIMETL 617
++ +
Sbjct: 714 EELISQM 720
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q05609 | CTR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5720 | 0.9479 | 0.7320 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 634 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 6e-90 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-81 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-79 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-79 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-75 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-65 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-62 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-53 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-52 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-52 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-50 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-48 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-47 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-47 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-47 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-47 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-47 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-46 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-46 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-43 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-43 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-42 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-42 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-42 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-41 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-41 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-40 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-40 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-39 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-39 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-38 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-38 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-38 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-37 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-37 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-37 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-37 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-37 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-37 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-36 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-36 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-36 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-36 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-36 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-36 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-36 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-35 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-35 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-35 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-35 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-34 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-34 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-34 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-33 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-33 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-33 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-33 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-33 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-33 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-32 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-32 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-32 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-31 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-31 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-31 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-31 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-30 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-30 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-30 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-29 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-29 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-29 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-29 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-29 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-28 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-28 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-27 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-26 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-24 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-24 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-23 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-23 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-23 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-23 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-22 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-22 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-20 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-19 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 6e-90
Identities = 105/210 (50%), Positives = 133/210 (63%), Gaps = 10/210 (4%)
Query: 59 DSAETVSHRFWVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDP 118
SAE +SHR+WV GCLSY D+I DGFY I+GMDP + ++ G IP + L+AV P
Sbjct: 2 SSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDL-----KEFGRIPSLEDLQAVPP 56
Query: 119 CNNLSIKVILIDKSSDPNLKELHNRVLSLLCDRITA-EEAVHQLANLVCNHMGGTTSTEE 177
+ S +V+L+D+ +DP LKEL L+ T V +LA LV +HMGG E
Sbjct: 57 -GDSSFEVVLVDRRTDPKLKELEQLARCLVSGCGTNTAALVQKLAGLVSDHMGGPVKDAE 115
Query: 178 EEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYC 237
+ W EC+ LK+ NS V+P+GSL +GLC HRALLFKVLAD I LPCR+ KGCKYC
Sbjct: 116 SMLAR-WKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYC 172
Query: 238 RRDDASSCLVQIGPDREYLVDLLEDPGVLS 267
DD +S LV+ REYLVDL+ PG L
Sbjct: 173 GSDDDASNLVKFDDGREYLVDLMGAPGTLI 202
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 256 bits (657), Expect = 3e-81
Identities = 102/256 (39%), Positives = 140/256 (54%), Gaps = 15/256 (5%)
Query: 371 KGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G+FG VY + VAVK L E E+R +EFL E +IMK L HPNIV L+
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-EEFLEEASIMKKLSHPNIVRLL 67
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
G T+ L IVTEY+ G L L ++ + + L MA +AKGM YL +
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESKN--F 123
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNE 542
VHRDL + N LV VK+ DFGLSR Y + P +WMAPE L++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 543 KSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
KSDV+SFGV+LWE+ TL ++P+ + +V+ + G RL P+N + L+ CWA
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYELMLQCWA 242
Query: 602 EEPEIRPSFPSIMETL 617
+PE RP+F ++E L
Sbjct: 243 YDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 1e-79
Identities = 99/255 (38%), Positives = 137/255 (53%), Gaps = 14/255 (5%)
Query: 371 KGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G+FG VY + + +VAVK L E + +EFLRE IM+ L HPN+V L+
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-EEFLREARIMRKLDHPNVVKLL 67
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
G TE L IV EY+ G L L R + L+ A +A+GM YL +
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEYLESKN--F 123
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEVLREDPSNEK 543
+HRDL + N LV VK+ DFGLSR + Y + WMAPE L+E K
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+SFGV+LWE+ TL ++P+ + +V+ + G RL P N P + L+ CWAE
Sbjct: 184 SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYDLMLQCWAE 242
Query: 603 EPEIRPSFPSIMETL 617
+PE RP+F ++E L
Sbjct: 243 DPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 3e-79
Identities = 101/255 (39%), Positives = 137/255 (53%), Gaps = 13/255 (5%)
Query: 371 KGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G+FG VY + +VAVK L E + +EFLRE IM+ L HPNIV L+
Sbjct: 9 EGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-EEFLREARIMRKLDHPNIVKLL 67
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
G TE L IV EY+ G L L + L+ A +A+GM YL +
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN--F 124
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEVLREDPSNEK 543
+HRDL + N LV VK+ DFGLSR + Y K WMAPE L+E K
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK 184
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+SFGV+LWE+ TL ++P+ + ++V+ + KG RL P N P + L+ CWAE
Sbjct: 185 SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYKLMLQCWAE 243
Query: 603 EPEIRPSFPSIMETL 617
+PE RP+F ++E L
Sbjct: 244 DPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 1e-75
Identities = 99/262 (37%), Positives = 141/262 (53%), Gaps = 18/262 (6%)
Query: 371 KGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
+G+FG VY + + +VAVK L E E+R K+FL+E +MK L HPN+V L+G
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-KDFLKEARVMKKLGHPNVVRLLG 63
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLL------HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
TE L +V EY+ G L L + + + L+ A +AKGM YL
Sbjct: 64 VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLRE 537
++ VHRDL + N LV VK+ DFGLSR + Y KT P WMAPE L++
Sbjct: 124 KK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD 181
Query: 538 DPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596
KSDV+SFGV+LWE+ TL P+ + +V+ + KG RL P+ + L+
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDELYELM 240
Query: 597 ETCWAEEPEIRPSFPSIMETLQ 618
+CW +PE RP+F ++E L+
Sbjct: 241 LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 2e-65
Identities = 83/249 (33%), Positives = 126/249 (50%), Gaps = 11/249 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+GSFG VY A + + VA+K++ +++ +DR + LRE+ I+K L+HPNIV L
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR-ERILREIKILKKLKHPNIVRLYDVFE 67
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ L +V EY G L+ LL R + E + + YLH + IVHRD
Sbjct: 68 DEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSKG--IVHRD 122
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
LK N+L+D VK+ DFGL+R T GTPE+MAPEVL + D++S
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFVGTPEYMAPEVLLGKGYGKAVDIWS 181
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEI 606
GVIL+EL+T + P+ + K + P +++P LI ++PE
Sbjct: 182 LGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEK 241
Query: 607 RPSFPSIME 615
R + ++
Sbjct: 242 RLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 4e-65
Identities = 88/255 (34%), Positives = 133/255 (52%), Gaps = 17/255 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GSFGTVY A+ + + VAVKIL ++ + + RE+ I++ L HPNIV L+ A
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFE 68
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ +L +V EY G L+ L + E +A + +G+ YLH I+HRD
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRD 123
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVF 547
LK N+L+D VK+ DFGL++ + S T GTP +MAPEVL + K DV+
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 548 SFGVILWELITLQKPWRNS---TPSQVISAVGFKGRRLEIPK----NVNPMVAALIETCW 600
S GVIL+EL+T + P+ Q+I + G LE + + + LI+ C
Sbjct: 184 SLGVILYELLTGKPPFSGENILDQLQLIRRI--LGPPLEFDEPKWSSGSEEAKDLIKKCL 241
Query: 601 AEEPEIRPSFPSIME 615
++P RP+ I++
Sbjct: 242 NKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 4e-62
Identities = 92/251 (36%), Positives = 125/251 (49%), Gaps = 42/251 (16%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G FGTVY A + + VA+KI I++E +E LRE+ I+K L HPNIV L G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKI-IKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ +L +V EY GSL LL + + E L + + +G+ YLH I+HRD
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSN--GIIHRD 117
Query: 489 LKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDV 546
LK N+L+DS VK+ DFGLS+ + KT GTP +MAPEVL +EKSD+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
+S GVIL+EL L+ LI ++PE
Sbjct: 178 WSLGVILYELPELKD---------------------------------LIRKMLQKDPEK 204
Query: 607 RPSFPSIMETL 617
RPS I+E L
Sbjct: 205 RPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 3e-53
Identities = 93/255 (36%), Positives = 129/255 (50%), Gaps = 14/255 (5%)
Query: 372 GSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
GSFG V EW S VAVK L + + D +FL+E AIM L H N++ L G
Sbjct: 6 GSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGV 64
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
V P L +VTE GSL L + L + A +A GM YL +R +H
Sbjct: 65 VLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYAVQIANGMRYLESKR--FIH 120
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAPEVLREDPSNEK 543
RDL + N+L+ S VK+ DFGL R+ P Y+ + W APE LR +
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA 180
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+ FGV LWE+ T ++PW + SQ++ + +G RLE P+ + ++ CWA
Sbjct: 181 SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAH 240
Query: 603 EPEIRPSFPSIMETL 617
P RP+F ++ E L
Sbjct: 241 NPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 5e-52
Identities = 91/253 (35%), Positives = 134/253 (52%), Gaps = 14/253 (5%)
Query: 372 GSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G FG V+ W + VAVK L + FL+E IMK LRH +V L +E
Sbjct: 17 GQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
+ IVTEY+S+GSL L + + + +L ++MA +A+GM YL R +HRDL
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMAAQIAEGMAYLESRN--YIHRDLA 130
Query: 491 SPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
+ N+LV K+ DFGL+R + + Y + + A +W APE KSDV+SF
Sbjct: 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF 190
Query: 550 GVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G++L E++T + P+ T +V+ V +G R+ P N + L+ CW ++PE RP
Sbjct: 191 GILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERP 249
Query: 609 SFPSIMETLQQFL 621
+F E LQ FL
Sbjct: 250 TF----EYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 5e-52
Identities = 96/263 (36%), Positives = 137/263 (52%), Gaps = 11/263 (4%)
Query: 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 418
S + + KG FG V ++R VAVK L + + FL E ++M LRHP
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHP 60
Query: 419 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 478
N+V L+G V + L IVTEY+++GSL L R V+ +L A DV +GM YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 538
++ VHRDL + N+LV KV DFGL++ S K +W APE LRE
Sbjct: 120 EKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREK 174
Query: 539 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
+ KSDV+SFG++LWE+ + + P+ V+ V KG R+E P+ P V +++
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMK 233
Query: 598 TCWAEEPEIRPSFPSIMETLQQF 620
CW +P RP+F + E L
Sbjct: 234 DCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 6e-52
Identities = 81/252 (32%), Positives = 126/252 (50%), Gaps = 24/252 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA-V 427
+GSFG+VY A +++ +AVK + E+ + RE+ I+ L+HPNIV G+
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSER 69
Query: 428 TEPPN-LSIVTEYLSRGSL------YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
E N L+I EY+S GSL + L P R + +G+ YLH
Sbjct: 70 DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY---------TRQILEGLAYLHSN 120
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLRED 538
IVHRD+K N+LVDS VK+ DFG ++ + + + GTP WMAPEV+R +
Sbjct: 121 G--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
+D++S G + E+ T + PW P + +G G EIP++++ +
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 598 TCWAEEPEIRPS 609
C +P+ RP+
Sbjct: 239 KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 5e-50
Identities = 91/249 (36%), Positives = 133/249 (53%), Gaps = 11/249 (4%)
Query: 372 GSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G FG V+ +WR DVA+K++ E ED +F+ E +M L HPN+V L G T+
Sbjct: 15 GQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
+ IVTEY++ G L L + + + L+M DV + M YL +HRDL
Sbjct: 72 RPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSDVCEAMEYL--ESNGFIHRDLA 127
Query: 491 SPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
+ N LV VKV DFGL+R + Y SS+ +W PEV + KSDV+SF
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSF 187
Query: 550 GVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
GV++WE+ + K P+ + S+V+ +V G RL PK V ++ +CW E+PE RP
Sbjct: 188 GVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRP 246
Query: 609 SFPSIMETL 617
+F ++ L
Sbjct: 247 AFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 4e-48
Identities = 95/251 (37%), Positives = 136/251 (54%), Gaps = 11/251 (4%)
Query: 372 GSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G +G VY W+ + VAVK L E +EFL+E A+MK ++HPN+V L+G T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P I+TE+++ G+L L + R V+ + L MA ++ M YL ++ +HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDL 130
Query: 490 KSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+ N LV + VKV DFGLSR +TY + A +W APE L + + KSDV++
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 190
Query: 549 FGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FGV+LWE+ T P+ SQV + KG R+E P+ P V L+ CW P R
Sbjct: 191 FGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVYELMRACWQWNPSDR 249
Query: 608 PSFPSIMETLQ 618
PSF I + +
Sbjct: 250 PSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 91/266 (34%), Positives = 141/266 (53%), Gaps = 23/266 (8%)
Query: 371 KGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+GSFG VY + + VA+K + E +R EFL E ++MK ++V L
Sbjct: 16 QGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLNEASVMKEFNCHHVVRL 74
Query: 424 MGAV-TEPPNLSIVTEYLSRGSLYKLL--HIPDARV-----VVDERLRLNMAYDVAKGMN 475
+G V T P L +V E +++G L L P+A + + MA ++A GM
Sbjct: 75 LGVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 476 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT-P-EWMAPE 533
YL ++ VHRDL + N +V TVK+ DFG++R T K G P WMAPE
Sbjct: 134 YLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191
Query: 534 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592
L++ KSDV+SFGV+LWE+ TL ++P++ + +V+ V G L++P+N +
Sbjct: 192 SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPDKL 250
Query: 593 AALIETCWAEEPEIRPSFPSIMETLQ 618
L+ CW P++RP+F I+ +L+
Sbjct: 251 LELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 88/254 (34%), Positives = 134/254 (52%), Gaps = 14/254 (5%)
Query: 372 GSFGTVYHAEWRNS-DVAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V+ W+N VA+KIL + + +F +EV +K LRH +++ L +
Sbjct: 17 GYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ---DFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+ I+TE + +GSL L P+ +V+ L ++MA VA+GM YL ++ +HRDL
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-IDMACQVAEGMAYLEEQN--SIHRDL 130
Query: 490 KSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVF 547
+ N+LV KV DFGL+R K + Y+SS P +W APE + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK--IPYKWTAPEAASHGTFSTKSDVW 188
Query: 548 SFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
SFG++L+E+ T Q P+ +V + G R+ P + ++ CWA EPE
Sbjct: 189 SFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLECWAAEPED 247
Query: 607 RPSFPSIMETLQQF 620
RPSF ++ E L
Sbjct: 248 RPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 91/258 (35%), Positives = 134/258 (51%), Gaps = 14/258 (5%)
Query: 372 GSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG V + DVA+K L + R +FL E +IM HPNI+ L G
Sbjct: 15 GEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPNIIRLEGV 73
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
VT+ + I+TEY+ GSL K L D + V +L + M +A GM YL + VH
Sbjct: 74 VTKSRPVMIITEYMENGSLDKFLRENDGKFTV-GQL-VGMLRGIASGMKYLSEMN--YVH 129
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-TP-EWMAPEVLREDPSNEKS 544
RDL + N+LV+S KV DFGLSR ++ + T G P W APE + S
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSAS 189
Query: 545 DVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
DV+SFG+++WE+++ ++P+ + + VI AV G RL P + + L+ CW ++
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALYQLMLDCWQKD 248
Query: 604 PEIRPSFPSIMETLQQFL 621
RP+F I+ TL + +
Sbjct: 249 RNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 87/261 (33%), Positives = 134/261 (51%), Gaps = 25/261 (9%)
Query: 372 GSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G+FG+V + VAVK L ++ + KEFLRE ++M L HP IV L+G
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRLIG- 63
Query: 427 VTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
V + L +V E G L K L IP + + +A+ VA GM YL +
Sbjct: 64 VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-------KELAHQVAMGMAYLESKH- 115
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTP-EWMAPEVLREDP 539
VHRDL + N+L+ + + K+ DFG+SR+ + Y + TA P +W APE +
Sbjct: 116 -FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 540 SNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598
+ KSDV+S+GV LWE + KP+ ++VI+ + G RL P+ + +++ +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLS 233
Query: 599 CWAEEPEIRPSFPSIMETLQQ 619
CW PE RP+F + T ++
Sbjct: 234 CWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 8e-47
Identities = 89/252 (35%), Positives = 126/252 (50%), Gaps = 10/252 (3%)
Query: 371 KGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
KG+FG VY + N++VAVK + + K FL+E I+K HPNIV L+G +
Sbjct: 5 KGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGVCVQ 63
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+ IV E + GSL L R+ V + L M+ D A GM YL + +HRDL
Sbjct: 64 KQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKN--CIHRDL 119
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVF 547
+ N LV +K+ DFG+SR + Y S P +W APE L +SDV+
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 548 SFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
S+G++LWE +L P+ + Q + G R+ P+ + L+ CWA +PE
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238
Query: 607 RPSFPSIMETLQ 618
RPSF I LQ
Sbjct: 239 RPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 1e-46
Identities = 95/257 (36%), Positives = 137/257 (53%), Gaps = 15/257 (5%)
Query: 369 FIK----GSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
F+K G FG V + +WR DVA+K++ E ED EF+ E +M L H +V L
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQL 64
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
G T+ + IVTEY+S G L L R + L M DV +GM YL ++
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE--MCKDVCEGMAYLESKQ-- 120
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLREDPSNE 542
+HRDL + N LVD VKV DFGLSR + Y SS + W PEVL +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 543 KSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
KSDV++FGV++WE+ +L K P+ S+ + V +G RL P + V A++ +CW
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSCWH 239
Query: 602 EEPEIRPSFPSIMETLQ 618
E+ E RP+F ++ +++
Sbjct: 240 EKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 5e-46
Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 20/261 (7%)
Query: 372 GSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G+FGTVY W VA+K+L E+ + KE L E +M + HP++V L+G
Sbjct: 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA-NKEILDEAYVMASVDHPHVVRLLG 76
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ + ++T+ + G L L ++ + + + + LN +AKGM+YL ++R +V
Sbjct: 77 -ICLSSQVQLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LV 131
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP-EWMAPEVLREDPSN 541
HRDL + N+LV + VK+ DFGL++ Y + P +WMA E +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA--EGGKVPIKWMALESILHRIYT 189
Query: 542 EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
KSDV+S+GV +WEL+T KP+ P+ I + KG RL P V ++ CW
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCW 248
Query: 601 AEEPEIRPSFPSIMETLQQFL 621
+ E RP+F ++ +
Sbjct: 249 MIDAESRPTFKELINEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 5e-46
Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 24/251 (9%)
Query: 371 KGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEF-LREVAIMKGLRHPNIVLLMGA 426
KGSFG VY R SD +K I+ ++ +E L EV I+K L HPNI+ +
Sbjct: 10 KGSFGKVYLVR-RKSDGKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 427 VTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAYDVAKGMNYLH 478
E L IV EY G L + + P+ ++ L+ + + YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-------LDWFVQLCLALKYLH 120
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 538
R+ I+HRD+K N+ + S VK+ DFG+S+ +T +KT GTP +++PE+ +
Sbjct: 121 SRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598
P N KSD++S G +L+EL TL+ P+ ++ + KG+ IP + + L+ +
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-LKGQYPPIPSQYSSELRNLVSS 237
Query: 599 CWAEEPEIRPS 609
++PE RPS
Sbjct: 238 LLQKDPEERPS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 6e-46
Identities = 90/250 (36%), Positives = 134/250 (53%), Gaps = 11/250 (4%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V+ +WR VA+K + E E+ +F+ E +M L HP +V L G T+
Sbjct: 14 SGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
L IVTE++ G L L + + + + L+M DV +GM YL R +HRDL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYL--ERNSFIHRDL 126
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+ N LV ST VKV DFG++R + Y SS A +W PEV + KSDV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 549 FGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FGV++WE+ T K P+ + +V+ + +G RL PK + V ++ +CW E+PE R
Sbjct: 187 FGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCWHEKPEGR 245
Query: 608 PSFPSIMETL 617
P+F ++ +
Sbjct: 246 PTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 8e-45
Identities = 82/247 (33%), Positives = 129/247 (52%), Gaps = 20/247 (8%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KG FG VY A + + VA+K++ + +++ ++ + E+ I+K +HPNIV G+
Sbjct: 10 KGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLHQRRPPIV 485
+ L IV E+ S GSL LL + E +AY ++ KG+ YLH I+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLK--STNQTLTES---QIAYVCKELLKGLEYLHSNG--II 120
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
HRD+K+ N+L+ S VK+ DFGLS +T + T GTP WMAPEV+ P + K+D
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMAPEVINGKPYDYKAD 179
Query: 546 VFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
++S G+ EL + P+ P + I+ G G L P+ + ++ C +
Sbjct: 180 IWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG--LRNPEKWSDEFKDFLKKCLQK 237
Query: 603 EPEIRPS 609
PE RP+
Sbjct: 238 NPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 92/251 (36%), Positives = 133/251 (52%), Gaps = 16/251 (6%)
Query: 372 GSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G FG V+ W N+ VAVK L K+FL E IMK LRHP ++ L T
Sbjct: 17 GQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
+ IVTE + GSL + L R + +L ++MA VA GM YL + +HRDL
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-IDMAAQVASGMAYLEAQN--YIHRDLA 130
Query: 491 SPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFS 548
+ N+LV KV DFGL+R K + Y ++ A P +W APE + + KSDV+S
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 549 FGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG++L E++T + P+ T ++V+ V +G R+ P + ++ CW E+P+ R
Sbjct: 190 FGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDIMLDCWKEDPDDR 248
Query: 608 PSFPSIMETLQ 618
P+F ETLQ
Sbjct: 249 PTF----ETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 5e-43
Identities = 90/275 (32%), Positives = 130/275 (47%), Gaps = 32/275 (11%)
Query: 371 KGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G FG V + VAVK L E +F RE+ I++ L H NIV
Sbjct: 14 EGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVKYK 72
Query: 425 GAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
G +P +L ++ EYL GSL L R ++ + L + + KGM+YL +R
Sbjct: 73 GVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGSQR- 129
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTP-EWMAPEVLREDP 539
+HRDL + N+LV+S VK+ DFGL++ P Y K +P W APE LR
Sbjct: 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK---------------GRRLEI 584
+ SDV+SFGV L+EL T P S P++ + +G G RL
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDP-SQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619
P + V L++ CW EP+ RPSF ++ + +
Sbjct: 248 PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 90/251 (35%), Positives = 133/251 (52%), Gaps = 13/251 (5%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA-VTE 429
KG FG V ++R + VAVK + ++ + FL E ++M LRH N+V L+G V E
Sbjct: 16 KGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
L IVTEY+++GSL L R V+ L + DV + M YL VHRDL
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDL 128
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
+ N+LV KV DFGL++ +T + K +W APE LRE + KSDV+SF
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSF 185
Query: 550 GVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G++LWE+ + + P+ V+ V KG +++ P P+V +++ CW + RP
Sbjct: 186 GILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQCWHLDAATRP 244
Query: 609 SFPSIMETLQQ 619
SF + E L+
Sbjct: 245 SFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 4e-42
Identities = 91/250 (36%), Positives = 133/250 (53%), Gaps = 13/250 (5%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
+G FG V E+ VAVK I+ + + FL E A+M L H N+V L+G +
Sbjct: 16 EGEFGAVLQGEYTGQKVAVKN-IKCDVTA---QAFLEETAVMTKLHHKNLVRLLGVILHN 71
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
L IV E +S+G+L L R +V L + DVA+GM YL ++ +VHRDL
Sbjct: 72 -GLYIVMELMSKGNLVNFLR-TRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLA 127
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
+ N+LV KV DFGL+R +SK +W APE L+ + KSDV+S+G
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKFSSKSDVWSYG 184
Query: 551 VILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 609
V+LWE+ + + P+ + +V V KG R+E P+ V L+ +CW EP+ RPS
Sbjct: 185 VLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCWETEPKKRPS 243
Query: 610 FPSIMETLQQ 619
F + E L++
Sbjct: 244 FHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-42
Identities = 91/263 (34%), Positives = 135/263 (51%), Gaps = 15/263 (5%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
KG FG VYH +SD AVK L E+ ++FL+E IMK HPN++ L+G
Sbjct: 5 KGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVLSLLG 63
Query: 426 AVTEPPNLS-IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+V Y+ G L + V + + + VAKGM YL ++
Sbjct: 64 ICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASKK--F 119
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP-EWMAPEVLREDPS 540
VHRDL + N ++D ++TVKV DFGL+R K + + T A P +WMA E L+
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
KSDV+SFGV+LWEL+T P S I+ +GRRL P+ + ++ +CW
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW 239
Query: 601 AEEPEIRPSFPSIMETLQQFLMS 623
+PE+RP+F ++ ++Q +
Sbjct: 240 HPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 76/241 (31%), Positives = 126/241 (52%), Gaps = 11/241 (4%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
GS+G+VY A + + VA+K++ ED +E ++E++I+K P IV G+ +
Sbjct: 14 GSYGSVYKAIHKETGQVVAIKVV---PVEED-LQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+L IV EY GS+ ++ I + E + Y KG+ YLH + +HRD+
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDI 125
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
K+ N+L++ K+ DFG+S +T T GTP WMAPEV++E N K+D++S
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSL 185
Query: 550 GVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G+ E+ + P+ + P + I + K L P+ +P ++ C ++PE RP
Sbjct: 186 GITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245
Query: 609 S 609
S
Sbjct: 246 S 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 92/273 (33%), Positives = 139/273 (50%), Gaps = 26/273 (9%)
Query: 372 GSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 423
G+FG V AE D VAVK+L + E + + E+ +MK + +H NI+ L
Sbjct: 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 81
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHI---------PDARVVVDERLRL----NMAYDV 470
+G T+ L +V EY + G+L L PD +E L + AY V
Sbjct: 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQV 141
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT-P-E 528
A+GM +L ++ +HRDL + N+LV + +K+ DFGL+R + KT G P +
Sbjct: 142 ARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK 199
Query: 529 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588
WMAPE L + +SDV+SFGV+LWE+ TL P + + + +G R+E P+N
Sbjct: 200 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNC 259
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ L+ CW E P RP+F ++E L + L
Sbjct: 260 TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 6e-41
Identities = 86/252 (34%), Positives = 138/252 (54%), Gaps = 11/252 (4%)
Query: 372 GSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G FG V+ + + VA+K L + + FL E +MK L+HP +V L VT+
Sbjct: 17 GQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
P + I+TEY+ GSL L P+ + +L ++MA +A+GM ++ ++ +HRDL+
Sbjct: 74 P-IYIITEYMENGSLVDFLKTPEGIKLTINKL-IDMAAQIAEGMAFIERKN--YIHRDLR 129
Query: 491 SPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
+ N+LV T K+ DFGL+R + N Y + + A +W APE + KSDV+SF
Sbjct: 130 AANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 189
Query: 550 GVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G++L E++T + P+ T +VI + +G R+ P N + L+ CW E+PE RP
Sbjct: 190 GILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYELMRLCWKEKPEERP 248
Query: 609 SFPSIMETLQQF 620
+F + L+ F
Sbjct: 249 TFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 70/245 (28%), Positives = 129/245 (52%), Gaps = 16/245 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+FG VY + VA+K + ++ E+ K ++E+ ++K L+HPNIV +G++
Sbjct: 10 RGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE 69
Query: 429 EPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+L I+ EY GSL +++ P E L Y V +G+ YLH++ +
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKFGPFP-------ESLVAVYVYQVLQGLAYLHEQG--V 120
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
+HRD+K+ N+L VK+ DFG++ + + GTP WMAPEV+ ++ S
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
D++S G + EL+T P+ + P + + + +P+ ++P + + C+ ++P
Sbjct: 181 DIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKDP 239
Query: 605 EIRPS 609
+RP+
Sbjct: 240 NLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 92/269 (34%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 372 GSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
G+FG V+ E + VAVK L E ++ R K+F RE ++ +H NIV
Sbjct: 16 GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR-KDFEREAELLTNFQHENIVKFY 74
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR---------LNMAYDVAKG 473
G TE +V EY+ G L K L H PDA + L +A +A G
Sbjct: 75 GVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASG 134
Query: 474 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMA 531
M YL + VHRDL + N LV VK+ DFG+SR T Y P WM
Sbjct: 135 MVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMP 192
Query: 532 PEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNP 590
PE + +SDV+SFGV+LWE+ T K PW + +VI + +GR L+ P+
Sbjct: 193 PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QGRLLQRPRTCPS 251
Query: 591 MVAALIETCWAEEPEIRPSFPSIMETLQQ 619
V ++ CW +P+ R + I E LQ+
Sbjct: 252 EVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 4e-40
Identities = 88/249 (35%), Positives = 126/249 (50%), Gaps = 11/249 (4%)
Query: 372 GSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G FG V+ W VA+K + E E+ F E E +M L HP +V L G TE
Sbjct: 15 GQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYGVCTER 71
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
+ +V E++ G L L R + L M DV +GM YL ++HRDL
Sbjct: 72 SPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLA 127
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSF 549
+ N LV VKV DFG++R + +S T P +W +PEV + KSDV+SF
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187
Query: 550 GVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
GV++WE+ + K P+ N + S+V+ + G RL P+ + V L++ CW E PE RP
Sbjct: 188 GVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELMQHCWKERPEDRP 246
Query: 609 SFPSIMETL 617
SF ++ L
Sbjct: 247 SFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 75/245 (30%), Positives = 122/245 (49%), Gaps = 14/245 (5%)
Query: 372 GSFGTVYHAEWRNSD---VAVK---ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
GSFG+VY D AVK + + + ++ K+ +E+A++ L+HPNIV +G
Sbjct: 11 GSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG 69
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
E NL I E + GSL KLL + E + + G+ YLH R V
Sbjct: 70 TEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLHDRN--TV 124
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-REDPSNEKS 544
HRD+K N+LVD+ VK+ DFG+++ + + +K+ G+P WMAPEV+ ++ +
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
D++S G + E+ T + PW + +G IP +++ I C +P
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243
Query: 605 EIRPS 609
+RP+
Sbjct: 244 SLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 2e-39
Identities = 90/253 (35%), Positives = 131/253 (51%), Gaps = 11/253 (4%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+FG V+ R N+ VAVK E D +FL+E I+K HPNIV L+G T
Sbjct: 5 RGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 63
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ + IV E + G L R+ V E ++ M + A GM YL + +HRD
Sbjct: 64 QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ--MVENAAAGMEYLESKH--CIHRD 119
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTP-EWMAPEVLREDPSNEKSDV 546
L + N LV +K+ DFG+SR + + Y S+ P +W APE L + +SDV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 547 FSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 605
+SFG++LWE +L P+ N + Q A+ +G RL P+ V L+E CW +P
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYDPG 238
Query: 606 IRPSFPSIMETLQ 618
RPSF ++ + LQ
Sbjct: 239 QRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 96/254 (37%), Positives = 135/254 (53%), Gaps = 15/254 (5%)
Query: 371 KGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V+ W N+ VAVK L + FL E IMK LRH +V L V+E
Sbjct: 16 NGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P + IVTEY+S+GSL L + R + L ++MA VA GM Y+ R +HRDL
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMAYIE--RMNYIHRDL 128
Query: 490 KSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+S N+LV K+ DFGL+R + N Y + + A +W APE KSDV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 549 FGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG++L EL+T + P+ +V+ V +G R+ P++ + L+ CW ++PE R
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHELMLQCWKKDPEER 247
Query: 608 PSFPSIMETLQQFL 621
P+F E LQ FL
Sbjct: 248 PTF----EYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 100/281 (35%), Positives = 140/281 (49%), Gaps = 43/281 (15%)
Query: 368 NFI-KGSFGTVYHAEWRNSD--------VAVKIL----IEQEFHEDRFKEFLREVAIMKG 414
NF+ G+FG VY + VAVK L +QE KEFL+E +M
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-----KEFLKEAHLMSN 55
Query: 415 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV---------VVDERLRLN 465
HPNIV L+G I+ E + G L L ++ DARV + + L+
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDL--LSYLRDARVERFGPPLLTLKE---LLD 110
Query: 466 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-----DSTYTVKVCDFGLSRS-KPNTYIS 519
+ DVAKG YL Q +HRDL + N LV D+ VK+ DFGL+R + Y
Sbjct: 111 ICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 520 SKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 577
+ P WMAPE L + +SDV+SFGV++WE++TL Q+P+ +V+ V
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228
Query: 578 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618
G RL+ P+N + L+ CWA++P RP+F I E LQ
Sbjct: 229 GG-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 90/254 (35%), Positives = 123/254 (48%), Gaps = 27/254 (10%)
Query: 387 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446
VAVK+L R ++FL+EV I+ L PNI L+G T P L ++ EY+ G L
Sbjct: 49 VAVKVLRPDASDNAR-EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 447 KLL--HIPDARVVVDERLRL------NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS 498
+ L H+ + + L MA +A GM YL VHRDL + N LV
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGK 165
Query: 499 TYTVKVCDFGLSRSKPNTYIS--SKTAAGTP---EWMAPEVLREDPSNEKSDVFSFGVIL 553
YT+K+ DFG+SR N Y S + P WMA E + KSDV++FGV L
Sbjct: 166 NYTIKIADFGMSR---NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222
Query: 554 WELITL--QKPWRNSTPSQVISAVGFKGRR------LEIPKNVNPMVAALIETCWAEEPE 605
WE++TL ++P+ + T QVI G R L P N + L+ CW + E
Sbjct: 223 WEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE 282
Query: 606 IRPSFPSIMETLQQ 619
RP+F I LQ+
Sbjct: 283 DRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 6e-38
Identities = 75/253 (29%), Positives = 126/253 (49%), Gaps = 32/253 (12%)
Query: 371 KGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G+ G VY A R +VA+K + + + + + E+ IMK +HPNIV +
Sbjct: 29 EGASGEVYKATDRATGKEVAIKKMRLRK----QNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN---MAY---DVAKGMNYLHQRR 481
L +V EY+ GSL ++ +R+N +AY +V +G+ YLH +
Sbjct: 85 LVGDELWVVMEYMDGGSL--------TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISSKTAAGTPEWMAPEVLRE 537
++HRD+KS N+L+ +VK+ DFG L++ K + GTP WMAPEV++
Sbjct: 137 --VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVGTPYWMAPEVIKR 190
Query: 538 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALI 596
K D++S G++ E+ + P+ P + + + KG L+ P+ +P +
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250
Query: 597 ETCWAEEPEIRPS 609
C ++PE RPS
Sbjct: 251 NKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 91/259 (35%), Positives = 130/259 (50%), Gaps = 18/259 (6%)
Query: 372 GSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG VY + + + VAVK R K FL+E IM+ HP+IV L+G
Sbjct: 17 GQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVKLIGV 75
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+TE P + IV E G L L + + + L L +Y ++ + YL +R VH
Sbjct: 76 ITENP-VWIVMELAPLGELRSYLQVNKYSLDL-ASLIL-YSYQLSTALAYLESKR--FVH 130
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP-EWMAPEVLREDPSNEK 543
RD+ + N+LV S VK+ DFGLSR + Y +SK P +WMAPE +
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK--LPIKWMAPESINFRRFTSA 188
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+ FGV +WE++ L KP++ + VI + G RL +P N P + +L+ CWA
Sbjct: 189 SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAY 247
Query: 603 EPEIRPSFPSIMETLQQFL 621
+P RP F + L L
Sbjct: 248 DPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 85/252 (33%), Positives = 140/252 (55%), Gaps = 10/252 (3%)
Query: 372 GSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G FG V+ + NS VAVK L + FL E +MK L+H +V L VT+
Sbjct: 17 GQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
+ I+TEY+++GSL L + V+ +L ++ + +A+GM Y+ ++ +HRDL+
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIERKN--YIHRDLR 130
Query: 491 SPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
+ N+LV + K+ DFGL+R + N Y + + A +W APE + KSDV+SF
Sbjct: 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190
Query: 550 GVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G++L+E++T K P+ + S V+SA+ +G R+ +N + +++TCW E+ E RP
Sbjct: 191 GILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELYDIMKTCWKEKAEERP 249
Query: 609 SFPSIMETLQQF 620
+F + L F
Sbjct: 250 TFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-37
Identities = 92/271 (33%), Positives = 141/271 (52%), Gaps = 21/271 (7%)
Query: 371 KGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+GSFG VY R+ + VAVK + E +R EFL E ++MKG ++V L
Sbjct: 16 QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVVRL 74
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERLRLNMAYDVAKGMNY 476
+G V++ +V E ++ G L L P+A R + + MA ++A GM Y
Sbjct: 75 LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 134
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG--TPEWMAPEV 534
L+ ++ VHRDL + N +V +TVK+ DFG++R T K G WMAPE
Sbjct: 135 LNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
L++ SD++SFGV+LWE+ +L ++P++ + QV+ V G L+ P N V
Sbjct: 193 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDGGYLDQPDNCPERVT 251
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
L+ CW P++RP+F I+ L+ L S
Sbjct: 252 DLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 82/264 (31%), Positives = 129/264 (48%), Gaps = 21/264 (7%)
Query: 372 GSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 423
G+FG V A VAVK+L H + + E+ IM L H NIV L
Sbjct: 46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNL 104
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+GA T + ++TEY G L L + L+ +Y VAKGM +L +
Sbjct: 105 LGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAFLASKN-- 161
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSN 541
+HRDL + N+L+ VK+CDFGL+R + Y+ A +WMAPE +
Sbjct: 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT 221
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK----GRRLEIPKNVNPMVAALIE 597
+SDV+S+G++LWE+ +L N P + + +K G R+ P++ + +++
Sbjct: 222 FESDVWSYGILLWEIFSLGS---NPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK 278
Query: 598 TCWAEEPEIRPSFPSIMETLQQFL 621
TCW +P RP+F I++ + + L
Sbjct: 279 TCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 84/257 (32%), Positives = 138/257 (53%), Gaps = 15/257 (5%)
Query: 372 GSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
G+FG V Y + DVA+K+L + R E +RE IM L +P IV ++G V
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRMIG-V 63
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
E L +V E S G L K L + V + L + V+ GM YL + VHR
Sbjct: 64 CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSMGMKYLEGKN--FVHR 119
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKS 544
DL + N+L+ + + K+ DFGLS++ ++Y +++A P +W APE + + +S
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 545 DVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
DV+S+G+ +WE + QKP++ +V+S + +G+RL+ P P + AL++ CW +
Sbjct: 180 DVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIYK 238
Query: 604 PEIRPSFPSIMETLQQF 620
E RP+F + E ++ +
Sbjct: 239 WEDRPNFAKVEERMRTY 255
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 9e-37
Identities = 87/266 (32%), Positives = 137/266 (51%), Gaps = 14/266 (5%)
Query: 363 VIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 422
VI + F + G + R VA+K L + + E + ++FL E +IM HPNI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
L G VT+ + I+TE++ G+L L D + V + + M +A GM YL +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYLSEMN- 126
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAGTPEWMAPEVLR 536
VHRDL + N+LV+S KV DFGLSR S P TY SS W APE +
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSSLGGKIPIRWTAPEAIA 184
Query: 537 EDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595
SDV+S+G+++WE+++ ++P+ + + VI+A+ + RL P + + L
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQL 243
Query: 596 IETCWAEEPEIRPSFPSIMETLQQFL 621
+ CW ++ RP F I+ TL + +
Sbjct: 244 MLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 80/274 (29%), Positives = 137/274 (50%), Gaps = 18/274 (6%)
Query: 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAI 411
P +++ + + +G FG V+ A+ + + V VK L + + E+ EF RE+ +
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDM 61
Query: 412 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE------RLRLN 465
+ L H N+V L+G E ++ EY G L + L ++ + + ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 466 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAA 524
+ +A GM++L R VHRDL + N LV S VKV LS+ N+ Y + A
Sbjct: 122 LCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLE 583
W+APE ++ED + KSDV+SFGV++WE+ T + P+ + +V++ + L
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239
Query: 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 617
+P+ + L+ CWA P+ RPSF ++ L
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 79/250 (31%), Positives = 121/250 (48%), Gaps = 27/250 (10%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KGSFG VY A + N VA+K+ I+ E ED ++ +E+ + R P I G+
Sbjct: 11 KGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL 69
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ L I+ EY GS LL +DE + +V G+ YLH+ +HRD
Sbjct: 70 KGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYLHEEGK--IHRD 123
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+K+ N+L+ VK+ DFG+S +T T GTP WMAPEV+++ +EK+D++S
Sbjct: 124 IKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWS 183
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---------LIETC 599
G+ EL + P + P +V+ IPKN P + + C
Sbjct: 184 LGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEGNKFSKPFKDFVSLC 234
Query: 600 WAEEPEIRPS 609
++P+ RPS
Sbjct: 235 LNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 79/268 (29%), Positives = 127/268 (47%), Gaps = 20/268 (7%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
+G FG+V + D VAVK + +EFL E A MK HPN++ L+G
Sbjct: 9 EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIG 68
Query: 426 ------AVTEPPNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNY 476
++ + P ++ ++ G L+ L + + + L D+A GM Y
Sbjct: 69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY 128
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTP-EWMAPEV 534
L R +HRDL + N ++ TV V DFGLS+ + Y A P +W+A E
Sbjct: 129 LSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
L + KSDV++FGV +WE+ T Q P+ ++ + G RL+ P++ +
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQPEDCLDELY 245
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQQFL 621
L+ +CW +P+ RP+F + E L+ L
Sbjct: 246 DLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 80/259 (30%), Positives = 128/259 (49%), Gaps = 15/259 (5%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLLMG 425
KGSFGTV R SD KIL+ +E E + EV I++ L+HPNIV
Sbjct: 10 KGSFGTVRKVR-RKSDG--KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 426 AVTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+ + N L IV EY G L +L+ R ++E + + + H R
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 483 P---IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 539
P ++HRDLK N+ +D+ VK+ DFGL++ + +KT GTP +M+PE L
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS 186
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
+EKSD++S G +++EL L P+ Q+ S + +G+ IP + + +I++
Sbjct: 187 YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSELNEVIKSM 245
Query: 600 WAEEPEIRPSFPSIMETLQ 618
+P+ RPS +++
Sbjct: 246 LNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 82/263 (31%), Positives = 138/263 (52%), Gaps = 30/263 (11%)
Query: 387 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446
VAVK+L E ++ L E ++K + HP+++ L GA ++ L ++ EY GSL
Sbjct: 33 VAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 91
Query: 447 KLLHI----------------------PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
L PD R + L ++ A+ +++GM YL + + +
Sbjct: 92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDL-ISFAWQISRGMQYLAEMK--L 148
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
VHRDL + N+LV +K+ DFGLSR + ++Y+ +WMA E L +
Sbjct: 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208
Query: 543 KSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
+SDV+SFGV+LWE++TL P+ P ++ + + G R+E P+N + + L+ TCW
Sbjct: 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK-TGYRMERPENCSEEMYNLMLTCWK 267
Query: 602 EEPEIRPSFPSIMETLQQFLMSS 624
+EP+ RP+F I + L++ ++ S
Sbjct: 268 QEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 5e-36
Identities = 89/265 (33%), Positives = 124/265 (46%), Gaps = 21/265 (7%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
G+FG VY +R D VAVK L E +D +FL E IM H NIV L
Sbjct: 16 HGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE-SDFLMEALIMSKFNHQNIVRL 74
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LNMAYDVAKGMNYLHQ 479
+G E I+ E ++ G L L R L L A DVAKG YL +
Sbjct: 75 IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE 134
Query: 480 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEV 534
+HRD+ + N L+ K+ DFG++R + + Y A +WM PE
Sbjct: 135 NH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA 192
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
+ K+DV+SFGV+LWE+ +L P+ T +V+ V G RL+ PK V
Sbjct: 193 FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGGGRLDPPKGCPGPVY 251
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQ 618
++ CW PE RP+F +I+E +Q
Sbjct: 252 RIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 6e-36
Identities = 81/264 (30%), Positives = 131/264 (49%), Gaps = 19/264 (7%)
Query: 372 GSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G+FG +++ + +V VK + + E + L+E ++ GL H NI+ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 426 AVTEPPNLSIVTE-YLSRGSLYKLLHIP-----DARVVVDERLRLNMAYDVAKGMNYLHQ 479
E V Y++ G+L L + + + ++MA +A GM+YLH+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLRE 537
R ++H+D+ + N ++D VK+ D LSR P Y P +WMA E L
Sbjct: 136 RG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 538 DPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596
+ SDV+SFGV+LWEL+TL Q P+ P + ++A G RL P N + A++
Sbjct: 194 KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQPINCPDELFAVM 252
Query: 597 ETCWAEEPEIRPSFPSIMETLQQF 620
CWA +PE RPSF +++ L F
Sbjct: 253 ACCWALDPEERPSFSQLVQCLTDF 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 7e-36
Identities = 94/287 (32%), Positives = 133/287 (46%), Gaps = 36/287 (12%)
Query: 362 HVIDSSNFIKGSFGTV----YHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL 415
H+ KG+FG+V Y N+ VAVK L Q + ++F RE+ I+K L
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSL 62
Query: 416 RHPNIVLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 473
+H NIV G NL +V EYL GSL L R+ D R L A + KG
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL--DHRKLLLYASQICKG 120
Query: 474 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WM 530
M YL +R VHRDL + N+LV+S VK+ DFGL++ P Y + +P W
Sbjct: 121 MEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 531 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGF------------ 577
APE L E + SDV+SFGV+L+EL T ++ +P + +G
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSD--KSCSPPAEFMRMMGNDKQGQMIVYHLI 236
Query: 578 ----KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620
RL P + A+++ CW +P RPSF + ++
Sbjct: 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 95/270 (35%), Positives = 133/270 (49%), Gaps = 27/270 (10%)
Query: 371 KGSFGTVYHAEWRN----SD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+FG V+ AE N D VAVK L +E E ++F RE ++ L+H +IV
Sbjct: 15 EGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR----------LNMAYDVA 471
G TE L +V EY+ G L + L H PDA+++ L +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 472 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EW 529
GM YL VHRDL + N LV VK+ DFG+SR +T Y P W
Sbjct: 133 SGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 530 MAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNV 588
M PE + +SD++SFGV+LWE+ T K PW + ++ I + +GR LE P+
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-QGRELERPRTC 249
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQ 618
P V A+++ CW EP+ R I LQ
Sbjct: 250 PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 20/250 (8%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G VY A + VA+K++ + D F+ +E++++K RHPNIV G+
Sbjct: 13 SGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 429 EPPNLSIVTEYLSRGSL---YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
L IV EY GSL Y++ P + E + + KG+ YLH+ +
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGP-----LSELQIAYVCRETLKGLAYLHETG--KI 123
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL---REDPSNE 542
HRD+K N+L+ VK+ DFG+S T K+ GTP WMAPEV R+ +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDG 183
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIETC 599
K D+++ G+ EL LQ P + P + IS F +L+ + +P+ I+ C
Sbjct: 184 KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKC 243
Query: 600 WAEEPEIRPS 609
++P+ RP+
Sbjct: 244 LTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 21/266 (7%)
Query: 371 KGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+GSFG VY + + VA+K + E +R EFL E ++MK ++V L
Sbjct: 16 QGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHHVVRL 74
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERL-----RLNMAYDVAKGMNY 476
+G V++ ++ E ++RG L L P+ + + MA ++A GM Y
Sbjct: 75 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAY 134
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG--TPEWMAPEV 534
L+ + VHRDL + N +V +TVK+ DFG++R T K G WM+PE
Sbjct: 135 LNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 192
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
L++ SDV+SFGV+LWE+ TL ++P++ + QV+ V +G L+ P N M+
Sbjct: 193 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEGGLLDKPDNCPDMLF 251
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQQ 619
L+ CW P++RPSF I+ ++++
Sbjct: 252 ELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 84/259 (32%), Positives = 129/259 (49%), Gaps = 15/259 (5%)
Query: 372 GSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG V+ + VA+K L + + E + ++FL E +IM H NI+ L G
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGV 74
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
VT+ I+TEY+ G+L K L D + + M +A GM YL VH
Sbjct: 75 VTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ--LVGMLRGIAAGMKYLSDMN--YVH 130
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP---EWMAPEVLREDPSNEK 543
RDL + N+LV+S KV DFGLSR + + T +G W APE +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+SFG+++WE+++ ++P+ + + +V+ A+ G RL P + V L+ CW +
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAVYQLMLQCWQQ 249
Query: 603 EPEIRPSFPSIMETLQQFL 621
+ RP F I+ L + L
Sbjct: 250 DRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 9e-35
Identities = 86/253 (33%), Positives = 135/253 (53%), Gaps = 11/253 (4%)
Query: 371 KGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
+G FG V+ W + VA+K L + FL+E IMK LRH +V L V+E
Sbjct: 16 QGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P + IVTE++ +GSL L D + + +L ++MA +A GM Y+ R +HRDL
Sbjct: 73 EP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYI--ERMNYIHRDL 128
Query: 490 KSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
++ N+LV K+ DFGL+R + N Y + + A +W APE KSDV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 549 FGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG++L EL+T + P+ +V+ V +G R+ P+ + L++ CW ++P+ R
Sbjct: 189 FGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHELMKLCWKKDPDER 247
Query: 608 PSFPSIMETLQQF 620
P+F I L+ +
Sbjct: 248 PTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 85/259 (32%), Positives = 129/259 (49%), Gaps = 15/259 (5%)
Query: 372 GSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG V R VA+K L + + E + ++FL E +IM HPNI+ L G
Sbjct: 15 GEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGV 73
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
VT+ + IVTEY+ GSL L D + V + + M +A GM YL VH
Sbjct: 74 VTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYLSDM--GYVH 129
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
RDL + N+LV+S KV DFGLSR P +++ W APE +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+G+++WE+++ ++P+ + VI A+ +G RL P + + L+ CW +
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQK 248
Query: 603 EPEIRPSFPSIMETLQQFL 621
+ RP F I+ L + +
Sbjct: 249 DRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 78/250 (31%), Positives = 117/250 (46%), Gaps = 14/250 (5%)
Query: 371 KGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+ VY A N VA+K I+ E + E +EV M HPN+V +
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV 69
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L +V YLS GSL ++ R +DE + + +V KG+ YLH +HRD
Sbjct: 70 VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRD 127
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRS----KPNTYISSKTAAGTPEWMAPEVLREDPS-NEK 543
+K+ N+L+ +VK+ DFG+S S T KT GTP WMAPEV+ + + K
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA---LIETC 599
+D++SFG+ EL T P+ P +V+ LE + + +I C
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLC 247
Query: 600 WAEEPEIRPS 609
++P RP+
Sbjct: 248 LQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 2e-34
Identities = 93/254 (36%), Positives = 133/254 (52%), Gaps = 15/254 (5%)
Query: 371 KGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
+G FG V+ W + VA+K L + FL+E +MK LRH +V L V+E
Sbjct: 16 QGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P + IVTEY+S+GSL L + + +L ++MA +A GM Y+ R VHRDL
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYV--ERMNYVHRDL 128
Query: 490 KSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
++ N+LV KV DFGL+R + N Y + + A +W APE KSDV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 549 FGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG++L EL T + P+ +V+ V +G R+ P + L+ CW +EPE R
Sbjct: 189 FGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEER 247
Query: 608 PSFPSIMETLQQFL 621
P+F E LQ FL
Sbjct: 248 PTF----EYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 88/278 (31%), Positives = 143/278 (51%), Gaps = 28/278 (10%)
Query: 371 KGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 420
+G FG V AE + VAVK+L + +D + + E+ +MK + +H NI
Sbjct: 22 EGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-LADLISEMELMKLIGKHKNI 80
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL---------HIPDARVVVDERLR----LNMA 467
+ L+G T+ L ++ EY ++G+L + L + D V +E+L ++ A
Sbjct: 81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-- 525
Y VA+GM YL RR +HRDL + N+LV +K+ DFGL+R + KT+ G
Sbjct: 141 YQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198
Query: 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 585
+WMAPE L + +SDV+SFG+++WE+ TL P + + + +G R++ P
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP 258
Query: 586 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
N + L+ CW P RP+F ++E L + L +
Sbjct: 259 SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 82/261 (31%), Positives = 128/261 (49%), Gaps = 23/261 (8%)
Query: 372 GSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
G+FGTV Y + VAVKIL E LRE +M+ L +P IV ++G +
Sbjct: 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-I 64
Query: 428 TEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
E + +V E G L K L H+ + + + + V+ GM YL +
Sbjct: 65 CEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-------ELVHQVSMGMKYLEETN-- 115
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP-EWMAPEVLREDPS 540
VHRDL + N+L+ + + K+ DFGLS+ Y +KT P +W APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 541 NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
+ KSDV+SFGV++WE + QKP++ ++V + G R+E P+ P + L++ C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLC 234
Query: 600 WAEEPEIRPSFPSIMETLQQF 620
W + RP F + L+ +
Sbjct: 235 WTYGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 5e-34
Identities = 78/233 (33%), Positives = 118/233 (50%), Gaps = 15/233 (6%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHP-NIVLLMGAVT 428
+GSFG VY A VA+K+L ++ + + E FLRE+ I+ L HP NIV L
Sbjct: 10 EGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ 68
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ +L +V EY+ GSL LL + + E L + + + YLH + I+HRD
Sbjct: 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRD 126
Query: 489 LKSPNLLVDSTYT-VKVCDFGLSRSKPNTYISS------KTAAGTPEWMAPEVLR---ED 538
+K N+L+D VK+ DFGL++ P+ +S T+ GTP +MAPEVL
Sbjct: 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591
++ SD++S G+ L+EL+T P+ S S L P +P+
Sbjct: 187 YASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 9e-34
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 22/197 (11%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
G++G VY A + + VA+K I ++ E E+ LRE++++K L+HPNIV L+ +
Sbjct: 10 GTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVI 67
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L +V EY L K L + L ++ Y + +G+ Y H R I+HR
Sbjct: 68 HTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHR 122
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLREDPSNE 542
DLK N+L++ +K+ DFGL+R T E W APE+L
Sbjct: 123 DLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEILLGSKHYS 177
Query: 543 KS-DVFSFGVILWELIT 558
+ D++S G I E+IT
Sbjct: 178 TAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 84/258 (32%), Positives = 137/258 (53%), Gaps = 21/258 (8%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILI---EQEFHEDRFKEFL----REVAIMKGLRHPNIVL 422
GSFG+VY +S +AVK + +DR + L RE+A++K L+H NIV
Sbjct: 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+G+ + +L+I EY+ GS+ LL+ A +E L N + KG+NYLH R
Sbjct: 71 YLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHNRG- 126
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE------WMAPEVLR 536
I+HRD+K N+LVD+ +K+ DFG+S+ +S+KT P WMAPEV++
Sbjct: 127 -IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 537 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596
+ K+D++S G ++ E++T + P+ + T Q I +G EIP N++ +
Sbjct: 186 QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP-EIPSNISSEAIDFL 244
Query: 597 ETCWAEEPEIRPSFPSIM 614
E + + RP+ ++
Sbjct: 245 EKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 89/276 (32%), Positives = 140/276 (50%), Gaps = 28/276 (10%)
Query: 371 KGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 420
+G FG V AE D VAVK+L + +D + + E+ +MK + +H NI
Sbjct: 25 EGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNI 83
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP---------DARVVVDERLR----LNMA 467
+ L+GA T+ L ++ EY S+G+L + L D V DE++ ++
Sbjct: 84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-- 525
Y VA+GM YL ++ +HRDL + N+LV +K+ DFGL+R N KT G
Sbjct: 144 YQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 585
+WMAPE L + +SDV+SFGV++WE+ TL P + + + +G R++ P
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 261
Query: 586 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
N + ++ CW P RP+F ++E L + L
Sbjct: 262 ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 96/318 (30%), Positives = 154/318 (48%), Gaps = 45/318 (14%)
Query: 337 LFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEW---------RNSDV 387
L + W V DR L + P G +G FG V AE R + V
Sbjct: 7 LPEDPRWEVPRDR-LVLGKPLG------------EGCFGQVVMAEAIGLDKEKPNRVTKV 53
Query: 388 AVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446
AVK+L + + E + + E+ +MK + +H NI+ L+GA T+ L ++ EY S+G+L
Sbjct: 54 AVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 447 KLL---------------HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491
+ L +P+ ++ + + + AY VA+GM YL ++ +HRDL +
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLV--SCAYQVARGMEYLASKK--CIHRDLAA 168
Query: 492 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG--TPEWMAPEVLREDPSNEKSDVFSF 549
N+LV +K+ DFGL+R + KT G +WMAPE L + +SDV+SF
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 550 GVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 609
GV+LWE+ TL P + + + +G R++ P N + ++ CW P RP+
Sbjct: 229 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 288
Query: 610 FPSIMETLQQFLMSSVCQ 627
F ++E L + L + Q
Sbjct: 289 FKQLVEDLDRILALTSNQ 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 95/270 (35%), Positives = 134/270 (49%), Gaps = 28/270 (10%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+FG V+ AE N VAVK L + K+F RE ++ L+H +IV
Sbjct: 15 EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIVKF 72
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMAYDV 470
G + L +V EY+ G L K L H PDA ++VD + R L++A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-E 528
A GM YL + VHRDL + N LV + VK+ DFG+SR +T Y P
Sbjct: 133 ASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 529 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 587
WM PE + +SDV+SFGVILWE+ T K PW + ++VI + +GR LE P+
Sbjct: 191 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-QGRVLERPRV 249
Query: 588 VNPMVAALIETCWAEEPEIRPSFPSIMETL 617
V ++ CW EP+ R + I + L
Sbjct: 250 CPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 86/265 (32%), Positives = 135/265 (50%), Gaps = 20/265 (7%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
KG FG+V A+ ++ D VAVK+L F +EFLRE A MK HPN++ L+G
Sbjct: 9 KGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIG 68
Query: 426 ------AVTEPPNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNY 476
A P ++ ++ G L+ L I + + + + D+A GM Y
Sbjct: 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEY 128
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEV 534
L + +HRDL + N +++ TV V DFGLS+ Y A+ P +W+A E
Sbjct: 129 LSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
L ++ SDV++FGV +WE++T Q P+ S++ + + KG RL+ P + V
Sbjct: 187 LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQPPDCLEDVY 245
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQ 618
L+ CW+ EP+ RPSF + + L+
Sbjct: 246 ELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 84/250 (33%), Positives = 124/250 (49%), Gaps = 9/250 (3%)
Query: 371 KGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
KG+FG V+ ++ + VAVK E E + K FL E I+K HPNIV L+G T+
Sbjct: 5 KGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGVCTQ 63
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+ IV E + G L + + ++ A D A GM YL + +HRDL
Sbjct: 64 RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESKN--CIHRDL 119
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFS 548
+ N LV +K+ DFG+SR + + SS P +W APE L + +SDV+S
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179
Query: 549 FGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
+G++LWE +L P+ T Q V KG R+ P+ V +++ CW +PE R
Sbjct: 180 YGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238
Query: 608 PSFPSIMETL 617
P F + + L
Sbjct: 239 PKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 93/273 (34%), Positives = 141/273 (51%), Gaps = 30/273 (10%)
Query: 371 KGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 425
+G+FG V A + D A+K + E +D ++F E+ ++ L HPNI+ L+G
Sbjct: 17 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLG 75
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VDERLRLNMAYDV 470
A L + EY G+L L +RV+ + + L+ A DV
Sbjct: 76 ACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EW 529
A+GM+YL Q++ +HRDL + N+LV Y K+ DFGLSR + Y+ KT P W
Sbjct: 134 ARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVK-KTMGRLPVRW 189
Query: 530 MAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNV 588
MA E L SDV+S+GV+LWE+++L P+ T +++ + +G RLE P N
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 248
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ V L+ CW E+P RPSF I+ +L + L
Sbjct: 249 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 91/266 (34%), Positives = 132/266 (49%), Gaps = 29/266 (10%)
Query: 372 GSFGTVYHAE-----WRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMG 425
G+FG VY E R S +V I +E E +EF +E +M L+HPNIV L+G
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMAYDVAK 472
T+ ++ EYL+ G L++ L + P + V + L++A +A
Sbjct: 76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWM 530
GM YL VHRDL + N LV TVK+ DFGLSR Y ++ + P WM
Sbjct: 136 GMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWM 193
Query: 531 APEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPSQVISAVGFKGRR-LEIPKN 587
PE + +SD++SFGV+LWE+ + LQ P+ + +VI + + R+ L P++
Sbjct: 194 PPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ-PYYGFSNQEVIEMI--RSRQLLPCPED 250
Query: 588 VNPMVAALIETCWAEEPEIRPSFPSI 613
V AL+ CW E P RP F I
Sbjct: 251 CPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 76/259 (29%), Positives = 125/259 (48%), Gaps = 27/259 (10%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQ--------EFHEDRFKEFLR----EVAIMKGLRHP 418
KG++G VY A N + ++Q H+ R K+ ++ E+ +K L H
Sbjct: 11 KGTYGRVYLA--LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 419 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 478
NIV +G T LSI EY+ GS+ L +E+L V +G+ YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLH 125
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLR 536
+ I+HRDLK+ NLLVD+ K+ DFG+S+ + Y + + + G+ WMAPEV+
Sbjct: 126 SKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 537 EDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK----NVNP 590
+ K D++S G ++ E+ ++PW + + +G K IP N++P
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSP 243
Query: 591 MVAALIETCWAEEPEIRPS 609
+ + C+ P+ RP+
Sbjct: 244 VALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 93/278 (33%), Positives = 134/278 (48%), Gaps = 33/278 (11%)
Query: 371 KGSFGTVYHAEW-------RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+FG V+ A + VAVK+L E E D +F RE A+M HPNIV L
Sbjct: 15 QGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDHPNIVKL 73
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLH-------------IPDARVVVDERLRLN----- 465
+G + ++ EY++ G L + L AR L L+
Sbjct: 74 LGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133
Query: 466 -MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKT 522
+A VA GM YL +R+ VHRDL + N LV VK+ DFGLSR+ + Y +S+
Sbjct: 134 CIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 581
A WM PE + + +SDV+++GV+LWE+ + +P+ +VI V G
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR-DGNV 250
Query: 582 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619
L P N + L+ CW++ P RPSF SI LQ+
Sbjct: 251 LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 82/252 (32%), Positives = 138/252 (54%), Gaps = 11/252 (4%)
Query: 372 GSFGTVYHAEW-RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G FG V+ A + +++ VAVK + + FL E +MK L+H +V L VT+
Sbjct: 17 GQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
P + I+TE++++GSL L + +L ++ + +A+GM ++ QR +HRDL+
Sbjct: 74 P-IYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFIEQRN--YIHRDLR 129
Query: 491 SPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
+ N+LV ++ K+ DFGL+R + N Y + + A +W APE + KSDV+SF
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189
Query: 550 GVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G++L E++T + P+ + +VI A+ +G R+ P+N + ++ CW PE RP
Sbjct: 190 GILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERP 248
Query: 609 SFPSIMETLQQF 620
+F I L F
Sbjct: 249 TFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 73/258 (28%), Positives = 126/258 (48%), Gaps = 20/258 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG++G V+ A+ +++ A+K++ + + +++ + L E I+ + P +V L +
Sbjct: 3 KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
NL +V EYL G L LL + +DE + ++ + YLH I+HR
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGS---LDEDVARIYIAEIVLALEYLHSNG--IIHR 117
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSR--------SKPNTYISSKTAAGTPEWMAPEVLREDP 539
DLK N+L+DS +K+ DFGLS+ + + K GTP+++APEV+
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--LIE 597
++ D +S G IL+E + P+ TP ++ + ++E P++V A LI
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIEWPEDVEVSDEAIDLIS 235
Query: 598 TCWAEEPEIRPSFPSIME 615
+PE R SI E
Sbjct: 236 KLLVPDPEKRLGAKSIEE 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 65/202 (32%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 371 KGSFGTVYHAE--WRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG F VY A VA+K + I + ++ L+E+ ++K L HPN++ + +
Sbjct: 12 KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF 71
Query: 428 TEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
E L+IV E G L +++ H + ++ ER + + ++H +R I+H
Sbjct: 72 IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMH 129
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMAPEVLREDPSN 541
RD+K N+ + +T VK+ D GL R + SSKT A GTP +M+PE + E+ N
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 542 EKSDVFSFGVILWELITLQKPW 563
KSD++S G +L+E+ LQ P+
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 94/274 (34%), Positives = 136/274 (49%), Gaps = 25/274 (9%)
Query: 371 KGSFGTVYHAEWRN----SD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+FG V+ AE N D VAVK L ++ ++ K+F RE ++ L+H +IV
Sbjct: 15 EGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVD--------ERLRLNMAYDVAKG 473
G E L +V EY+ G L K L H PDA ++ + + L++A +A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 474 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMA 531
M YL + VHRDL + N LV VK+ DFG+SR +T Y P WM
Sbjct: 133 MVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190
Query: 532 PEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNP 590
PE + +SDV+S GV+LWE+ T K PW + ++VI + +GR L+ P+
Sbjct: 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRVLQRPRTCPK 249
Query: 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
V L+ CW EP +R + I LQ +S
Sbjct: 250 EVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 67/241 (27%), Positives = 125/241 (51%), Gaps = 8/241 (3%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIE---QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KGSFG V+ R +D V + + + + +E + E ++ L I+ +
Sbjct: 10 KGSFGVVFKVV-RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF 68
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ L+IV EY G L+KLL + R + ++++ + G+ +LH ++ I+HR
Sbjct: 69 LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-WRFFIQILLGLAHLHSKK--ILHR 125
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+KS NL +D+ VK+ D G+++ + + T GTP +++PE+ + P NEKSDV+
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVW 185
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
+ GV+L+E T + P+ + +I + +G + + + +A LI+ C ++ R
Sbjct: 186 ALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
Query: 608 P 608
P
Sbjct: 245 P 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 90/276 (32%), Positives = 141/276 (51%), Gaps = 28/276 (10%)
Query: 371 KGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 420
+G FG V AE D VAVK+L + +D + + E+ +MK + +H NI
Sbjct: 22 EGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHKNI 80
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP---------DARVVVDERLR----LNMA 467
+ L+GA T+ L ++ EY S+G+L + L D + +E+L ++ A
Sbjct: 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA 140
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-- 525
Y VA+GM YL ++ +HRDL + N+LV +K+ DFGL+R N KT G
Sbjct: 141 YQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 585
+WMAPE L + +SDV+SFGV+LWE+ TL P + + + +G R++ P
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 258
Query: 586 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
N + ++ CW P RP+F ++E L + L
Sbjct: 259 ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 74/266 (27%), Positives = 128/266 (48%), Gaps = 32/266 (12%)
Query: 372 GSFGTVYHAEWRNSDV------AVKILIEQEF----HEDRFKEFLREVAIMKGLRHPNIV 421
G+F + Y A DV AVK + E+ + +E+ +M L HP+I+
Sbjct: 11 GAFSSCYQAR----DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
++GA E + ++ E+++ GS+ LL A E + +N + +G++YLH+ +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHENQ 123
Query: 482 PPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYISSK-----TAAGTPEWMAPEVL 535
I+HRD+K NLL+DST +++ DFG + ++ + GT +MAPEVL
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 536 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGRRLEIPKNVNPMV 592
R + DV+S G ++ E+ T + PW S +I + IP++++P +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 593 AALIETCWAEEPEIRPSFPSIMETLQ 618
+ C +PE R P E L+
Sbjct: 241 RDVTLRCLELQPEDR---PPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 91/273 (33%), Positives = 135/273 (49%), Gaps = 30/273 (10%)
Query: 371 KGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 425
+G+FG V A + + A+K+L E D ++F E+ ++ L HPNI+ L+G
Sbjct: 12 EGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLG 70
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VDERLRLNMAYDV 470
A L I EY G+L L +RV+ + + L A DV
Sbjct: 71 ACENRGYLYIAIEYAPYGNLLDFLR--KSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EW 529
A GM YL +++ +HRDL + N+LV K+ DFGLSR + Y+ KT P W
Sbjct: 129 ATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSRGE-EVYVK-KTMGRLPVRW 184
Query: 530 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 588
MA E L KSDV+SFGV+LWE+++L P+ T +++ + +G R+E P+N
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRMEKPRNC 243
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ V L+ CW + P RP F I L + L
Sbjct: 244 DDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 71/251 (28%), Positives = 116/251 (46%), Gaps = 16/251 (6%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
KGSFG V +++ A+K+L I + + E I+ + HP IV L
Sbjct: 3 KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT---ERNILSRINHPFIVKLH 59
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
A L +V EY G L+ H+ +ER R A ++ + YLH I
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFS--HLSKEGRFSEERARFYAA-EIVLALEYLHSLG--I 114
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
++RDLK N+L+D+ +K+ DFGL++ + + T GTPE++APEVL +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
D +S GV+L+E++T + P+ ++ + L P+ ++P LI ++P
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQKDP 232
Query: 605 EIRPSFPSIME 615
R E
Sbjct: 233 TKRLGSGGAEE 243
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 75/248 (30%), Positives = 121/248 (48%), Gaps = 15/248 (6%)
Query: 371 KGSFGTVY--HAEWRNSDVAVK-ILIEQEFHEDR--FKEFLREVAIMKGLRHPNIVLLMG 425
+G+FG VY + ++AVK + + + E + E+ ++K L+H IV G
Sbjct: 12 QGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG 71
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ + LSI EY+ GS+ L A + E + + +G+ YLH IV
Sbjct: 72 CLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSNM--IV 126
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS----KTAAGTPEWMAPEVLREDPSN 541
HRD+K N+L DS VK+ DFG S+ + T SS K+ GTP WM+PEV+ +
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASK-RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
K+DV+S G + E++T + PW I + + ++P +V+P + +
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 602 EEPEIRPS 609
E + RPS
Sbjct: 246 ENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 88/276 (31%), Positives = 138/276 (50%), Gaps = 34/276 (12%)
Query: 371 KGSFGTV--YHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G FG V Y + N VAVK L ++E + + +E+ I+K L H NIV
Sbjct: 14 EGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVKYK 72
Query: 425 GAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
G +E L ++ EY+ GSL L P ++ + + L A + +GM YLH +
Sbjct: 73 GCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLF--AQQICEGMAYLHSQH- 127
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVLREDP 539
+HRDL + N+L+D+ VK+ DFGL+++ P + Y + +P W A E L+E+
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF---------------KGRRLEI 584
+ SDV+SFGV L+EL+T + S P + +G +G RL
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQ-SPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC 245
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620
PKN V L++ CW E + RP+F S++ L++
Sbjct: 246 PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 4e-31
Identities = 90/272 (33%), Positives = 138/272 (50%), Gaps = 28/272 (10%)
Query: 371 KGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 425
+G+FG V A + D A+K + E +D ++F E+ ++ L HPNI+ L+G
Sbjct: 5 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLG 63
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VDERLRLNMAYDV 470
A L + EY G+L L +RV+ + + L+ A DV
Sbjct: 64 ACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 530
A+GM+YL Q++ +HRDL + N+LV Y K+ DFGLSR + Y+ WM
Sbjct: 122 ARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKTMGRLPVRWM 178
Query: 531 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589
A E L SDV+S+GV+LWE+++L P+ T +++ + +G RLE P N +
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCD 237
Query: 590 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
V L+ CW E+P RPSF I+ +L + L
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 73/261 (27%), Positives = 136/261 (52%), Gaps = 32/261 (12%)
Query: 372 GSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G+FG VY A+ + + + A KI+ + E+ ++F+ E+ I+ +HPNIV L A
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
L I+ E+ G+L ++ + R + + ++R + + +N+LH + ++HRDL
Sbjct: 74 ENKLWILIEFCDGGALDSIM-LELERGLTEPQIRYVC-RQMLEALNFLHSHK--VIHRDL 129
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----REDPSNEKS 544
K+ N+L+ VK+ DFG+S +T T GTP WMAPEV+ +++P + K+
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---------- 594
D++S G+ L EL ++ P P +V+ L+I K+ P +
Sbjct: 190 DIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEPPTLDQPSKWSSSFND 240
Query: 595 LIETCWAEEPEIRPSFPSIME 615
+++C ++P+ RP+ +++
Sbjct: 241 FLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 85/250 (34%), Positives = 125/250 (50%), Gaps = 14/250 (5%)
Query: 372 GSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G+FGTVY W VA+KIL E + EF+ E IM + HP++V L+G
Sbjct: 18 GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALIMASMDHPHLVRLLG 76
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
V P + +VT+ + G L +H + + + +L LN +AKGM YL +RR +V
Sbjct: 77 -VCLSPTIQLVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGMMYLEERR--LV 131
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDPSNEK 543
HRDL + N+LV S VK+ DFGL+R G +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
SDV+S+GV +WEL+T + P++ I + KG RL P V ++ CW +
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMID 251
Query: 604 PEIRPSFPSI 613
+ RP F +
Sbjct: 252 ADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 37/275 (13%)
Query: 372 GSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM 424
GSF TV A+ + N + A+KIL + +E K E ++ L HP I+ L
Sbjct: 12 GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV---KYVKIEKEVLTRLNGHPGIIKLY 68
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ NL V EY G L + + +DE+ A ++ + YLH + I
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG--I 123
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNT----------------YISSKTAA 524
+HRDLK N+L+D +K+ DFG L + +
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 584
GT E+++PE+L E P+ + SD+++ G I+++++T + P+R S +
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI--LKLEYSF 241
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619
P N P LIE +P+ R + L+
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 27/252 (10%)
Query: 371 KGSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVLLM 424
+G++G VY H VA+KI I + +D + REVA++ LR PNI
Sbjct: 11 RGAYGAVYRGKHVP-TGRVVALKI-INLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYDVAKGMNYLHQ 479
G+ + P L I+ EY GS+ L+ V++ E L VA + Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-------VA--LKYIH- 118
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 539
+ ++HRD+K+ N+LV +T VK+CDFG++ T GTP WMAPEV+ E
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 540 S-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-FKGRRLEIPKNVNPMVAALIE 597
+ K+D++S G+ ++E+ T P+ + + + + K RLE + ++ +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREFVA 236
Query: 598 TCWAEEPEIRPS 609
C EEP+ R S
Sbjct: 237 ACLDEEPKERLS 248
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 81/263 (30%), Positives = 128/263 (48%), Gaps = 33/263 (12%)
Query: 367 SNFI-KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 421
N I G+FG VY A N D +AVK + Q+ KE E+ +++ L+HPN+V
Sbjct: 5 GNKIGGGTFGKVYTA--VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLH---IPDARVVVDERLRLNMAYDVA--KGMNY 476
G + I EY S G+L +LL I D V+ Y + +G+ Y
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI--------RVYTLQLLEGLAY 114
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYI---SSKTAAGTPEWMAP 532
LH IVHRD+K N+ +D +K+ DFG + + K NT ++ AGTP +MAP
Sbjct: 115 LHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 533 EVLREDPSNEK---SDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKN- 587
EV+ +D++S G ++ E+ T ++PW Q++ VG G + IP +
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSL 231
Query: 588 -VNPMVAALIETCWAEEPEIRPS 609
++P ++ C +P+ RP+
Sbjct: 232 QLSPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 66/248 (26%), Positives = 132/248 (53%), Gaps = 8/248 (3%)
Query: 371 KGSFG--TVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KG+FG T+Y +S V K + E ++ L E+ I+ L+HPNI+
Sbjct: 10 KGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM 69
Query: 429 EPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ L I EY + G+LY K++ + +E + L + + ++Y+H+ I+HR
Sbjct: 70 DDNTLLIEMEYANGGTLYDKIVRQKGQ--LFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+K+ N+ + +K+ DFG+S+ + Y ++T GTP +M+PE+ + N KSD++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
+ G +L+EL+TL++ + + P ++ + +G + + + +L+ + ++PE R
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQDPEKR 244
Query: 608 PSFPSIME 615
P+ +++
Sbjct: 245 PTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 86/252 (34%), Positives = 125/252 (49%), Gaps = 23/252 (9%)
Query: 387 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446
VAVK+L E R +FL+E+ IM L+ PNI+ L+ L ++TEY+ G L
Sbjct: 49 VAVKMLREDANKNAR-NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 447 KLL---------HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 497
+ L D + L MA +A GM YL VHRDL + N LV
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLI-FMATQIASGMKYLSSLN--FVHRDLATRNCLVG 164
Query: 498 STYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWE 555
YT+K+ DFG+SR+ + Y A WM+ E + SDV++FGV LWE
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 556 LITL--QKPWRNSTPSQVISAVG--FK--GRRLEIPK-NVNP-MVAALIETCWAEEPEIR 607
++TL ++P+ + QVI G F+ GR++ +PK + P + L+ +CW + R
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKER 284
Query: 608 PSFPSIMETLQQ 619
PSF I TL +
Sbjct: 285 PSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 24/254 (9%)
Query: 371 KGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
KGSFG VY + R +V +I+ E ED ++ +E+ ++ P I G+ +
Sbjct: 14 KGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK 73
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
L I+ EYL GS LL P ++E + ++ KG++YLH R +HRD+
Sbjct: 74 GTKLWIIMEYLGGGSALDLLK-PGP---LEETYIATILREILKGLDYLHSERK--IHRDI 127
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
K+ N+L+ VK+ DFG++ +T I T GTP WMAPEV+++ + K+D++S
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187
Query: 550 GVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--------LIETCWA 601
G+ EL + P + P +V+ IPKN P + +E C
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYSKPFKEFVEACLN 238
Query: 602 EEPEIRPSFPSIME 615
++P RP+ +++
Sbjct: 239 KDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 85/260 (32%), Positives = 127/260 (48%), Gaps = 34/260 (13%)
Query: 387 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446
VAVK+L + + +FL+E+ IM L++PNI+ L+G L ++TEY+ G L
Sbjct: 47 VAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 447 KLL-------------HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 493
+ L +IP V L MA +A GM YL VHRDL + N
Sbjct: 106 QFLSQREIESTFTHANNIPS----VSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159
Query: 494 LLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGV 551
LV + YT+K+ DFG+SR+ Y + A P WMA E + SDV++FGV
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 552 ILWELITL--QKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPM----VAALIETCWAEE 603
LWE+ TL ++P+ + QVI G F+ + +I + P+ V L+ CW+ +
Sbjct: 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRD 279
Query: 604 PEIRPSFPSIMETLQQFLMS 623
+ RP+F + FL
Sbjct: 280 IKDRPTF----NKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 89/276 (32%), Positives = 134/276 (48%), Gaps = 30/276 (10%)
Query: 371 KGSFGTV----YHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G FG V Y E N+ VAVK L + E + + +E+ I++ L H NIV
Sbjct: 14 EGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYK 72
Query: 425 GAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
G TE I + E+L GSL + L P + ++ + +L A + KGM+YL R+
Sbjct: 73 GICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ- 129
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPE-WMAPEVLREDP 539
VHRDL + N+LV+S + VK+ DFGL+++ Y + K +P W APE L +
Sbjct: 130 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 540 SNEKSDVFSFGVILWELIT--------------LQKPWRNSTPSQVISAVGFKGRRLEIP 585
SDV+SFGV L+EL+T + P + V +G+RL P
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP 248
Query: 586 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
N V L+ CW +P R +F +++E + L
Sbjct: 249 PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 74/253 (29%), Positives = 128/253 (50%), Gaps = 20/253 (7%)
Query: 371 KGSFGTVYHAEWRNSD--------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 422
KGS+G+VY + R SD V + + ++E + + E+ I+ + HPNI+
Sbjct: 10 KGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKEREDA-----VNEIRILASVNHPNIIS 63
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRR 481
A + L IV EY G L K + R ++ E+ + + +G+ LH+++
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 541
I+HRDLKS N+L+ + VK+ D G+S+ +KT GTP +MAPEV + P +
Sbjct: 124 --ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKTQIGTPHYMAPEVWKGRPYS 179
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
KSD++S G +L+E+ T P+ + + V +G+ IP + + I +
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPIPPIYSQDLQNFIRSMLQ 238
Query: 602 EEPEIRPSFPSIM 614
+P++RP+ I+
Sbjct: 239 VKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 77/267 (28%), Positives = 129/267 (48%), Gaps = 19/267 (7%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
+G FG+V + D VAVK + ++FL E MK HPN++ L+G
Sbjct: 9 EGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGV 68
Query: 427 VTEP------PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYL 477
+ P+ ++ ++ G L+ L + D + ++ + D+A GM YL
Sbjct: 69 CLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL 128
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVL 535
+ +HRDL + N +++ V V DFGLS+ N Y + A +W+A E L
Sbjct: 129 SSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186
Query: 536 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594
+ KSDV+SFGV +WE+ T Q P+ S++ + +G RL+ P + + +
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPPDCLDGLYS 245
Query: 595 LIETCWAEEPEIRPSFPSIMETLQQFL 621
L+ +CW P+ RPSF ++ L++ L
Sbjct: 246 LMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 76/249 (30%), Positives = 133/249 (53%), Gaps = 9/249 (3%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIVLLMGAV 427
+GSFG +Y A+ + SD ++ E + + KE +EV ++ ++HPNIV +
Sbjct: 10 EGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF 68
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
E L IV EY G L K ++ V+ E L+ ++ G+ ++H R+ I+HR
Sbjct: 69 QENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK--ILHR 125
Query: 488 DLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
D+KS N+ + V K+ DFG++R ++ + T GTP +++PE+ + P N K+D+
Sbjct: 126 DIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDI 185
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
+S G +L+EL TL+ P+ + Q++ + +G I N + + +LI + P
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQLFKVSPRD 244
Query: 607 RPSFPSIME 615
RPS SI++
Sbjct: 245 RPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 68/201 (33%), Positives = 108/201 (53%), Gaps = 26/201 (12%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFH--EDRFKEFLREV-AIMKGLRHPNIVLLMGA 426
G+FG+VY A + + VA+K + ++F+ E+ LREV ++ K HPNIV L
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMN--LREVKSLRKLNEHPNIVKLKEV 66
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
E L V EY+ G+LY+L+ + + +R ++ Y + +G+ ++H + H
Sbjct: 67 FRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH--KHGFFH 122
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSR---SKP--NTYISSKTAAGTPEWM-APEVLREDPS 540
RDLK NLLV VK+ DFGL+R S+P Y+S++ W APE+L S
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-------WYRAPEILLRSTS 175
Query: 541 -NEKSDVFSFGVILWELITLQ 560
+ D+++ G I+ EL TL+
Sbjct: 176 YSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 72/199 (36%), Positives = 110/199 (55%), Gaps = 8/199 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+ G V R + +AVK I E +E K+ LRE+ I+ P IV GA
Sbjct: 11 AGNSGVVSKVLHRPTGKIMAVKT-IRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY 69
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
++SI EY+ GSL K+L + + + ER+ +A V KG+ YLH++ I+HRD
Sbjct: 70 NNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKHK-IIHRD 126
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+K N+LV+S +K+CDFG+S N+ +KT GT +MAPE ++ + + KSD++S
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQGNDYSVKSDIWS 184
Query: 549 FGVILWELITLQKPWRNST 567
G+ L EL T + P+
Sbjct: 185 LGLSLIELATGRFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 71/237 (29%), Positives = 116/237 (48%), Gaps = 8/237 (3%)
Query: 387 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446
VA+ L + R + FL E + H NIV L G +T + IVTEY+S G+L
Sbjct: 36 VAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 447 KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 506
L + ++V + + M +A GM YL + VH+ L + +LV+S K+
Sbjct: 95 SFLRKHEGQLVAGQ--LMGMLPGLASGMKYLSEM--GYVHKGLAAHKVLVNSDLVCKISG 150
Query: 507 FG-LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWR 564
F L K ++ + W APE ++ + SDV+SFG+++WE+++ ++P+
Sbjct: 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210
Query: 565 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ + VI AV G RL P+N ++ L+ CW +E RP F I L + +
Sbjct: 211 DMSGQDVIKAVE-DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 71/248 (28%), Positives = 129/248 (52%), Gaps = 8/248 (3%)
Query: 371 KGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+GSFG + + V +I I + ++R +E +EVA++ ++HPNIV +
Sbjct: 10 EGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQYQESF 68
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
E NL IV +Y G LYK ++ V+ E L+ + + ++H R+ I+HR
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK--ILHR 125
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+KS N+ + T+K+ DFG++R +T ++T GTP +++PE+ P N KSD++
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIW 185
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
+ G +L+E+ TL+ + ++ + +G + + + + L+ + P R
Sbjct: 186 ALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRNPRDR 244
Query: 608 PSFPSIME 615
PS SI+E
Sbjct: 245 PSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 82/255 (32%), Positives = 128/255 (50%), Gaps = 16/255 (6%)
Query: 372 GSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G+FGTVY W VA+K+L E + KE L E +M G+ P + L+G
Sbjct: 18 GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYVCRLLG 76
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ + +VT+ + G L L ++ + + + + LN +AKGM+YL + R +V
Sbjct: 77 -ICLTSTVQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LV 131
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
HRDL + N+LV S VK+ DFGL+R T + +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+GV +WEL+T KP+ + P++ I + KG RL P V ++ CW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPY-DGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 603 EPEIRPSFPSIMETL 617
+ E RP F +++
Sbjct: 251 DSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 79/250 (31%), Positives = 125/250 (50%), Gaps = 20/250 (8%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDR-----FKEFLREVAIMKGLRHPNIVLLMGA 426
G FGTV+ W ++KI + + +DR F+E + M L H IV L+G
Sbjct: 18 GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLG- 76
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+ +L +VT+ GSL L H+ R +D + LN +AKGM YL + R +VH
Sbjct: 77 ICPGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVH 132
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTYISSKTAAGTPEWMAPEVLREDPSN 541
R+L + N+L+ S V++ DFG++ K Y KT +WMA E +
Sbjct: 133 RNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI---KWMALESILFGRYT 189
Query: 542 EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
+SDV+S+GV +WE+++ +P+ P +V + KG RL P+ V ++ CW
Sbjct: 190 HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTIDVYMVMVKCW 248
Query: 601 AEEPEIRPSF 610
+ +RP+F
Sbjct: 249 MIDENVRPTF 258
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 81/248 (32%), Positives = 127/248 (51%), Gaps = 16/248 (6%)
Query: 372 GSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G+FGTVY W VA+K L E + KE L E +M + +P++ L+G
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLG 76
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ + ++T+ + G L L ++ + + + + LN +AKGMNYL +RR +V
Sbjct: 77 -ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LV 131
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-TP-EWMAPEVLREDPSNEK 543
HRDL + N+LV + VK+ DFGL++ G P +WMA E + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+GV +WEL+T KP+ + P+ IS++ KG RL P V ++ CW
Sbjct: 192 SDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 603 EPEIRPSF 610
+ + RP F
Sbjct: 251 DADSRPKF 258
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 74/254 (29%), Positives = 122/254 (48%), Gaps = 24/254 (9%)
Query: 371 KGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
KGSFG V+ + R V +I+ E ED ++ +E+ ++ P + G+ +
Sbjct: 14 KGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
L I+ EYL GS LL DE M ++ KG++YLH + +HRD+
Sbjct: 74 GTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHSEKK--IHRDI 127
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
K+ N+L+ VK+ DFG++ +T I T GTP WMAPEV+++ + K+D++S
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187
Query: 550 GVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--------LIETCWA 601
G+ EL + P + P +V+ IPKN P + I+ C
Sbjct: 188 GITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKPFKEFIDACLN 238
Query: 602 EEPEIRPSFPSIME 615
++P RP+ +++
Sbjct: 239 KDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 75/254 (29%), Positives = 123/254 (48%), Gaps = 24/254 (9%)
Query: 371 KGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
KGSFG V+ + R V +I+ E ED ++ +E+ ++ P + G+ +
Sbjct: 14 KGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
L I+ EYL GS LL P +DE + ++ KG++YLH + +HRD+
Sbjct: 74 DTKLWIIMEYLGGGSALDLLE-PGP---LDETQIATILREILKGLDYLHSEKK--IHRDI 127
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
K+ N+L+ VK+ DFG++ +T I T GTP WMAPEV+++ + K+D++S
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187
Query: 550 GVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--------LIETCWA 601
G+ EL + P P +V+ IPKN P + +E C
Sbjct: 188 GITAIELAKGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKPLKEFVEACLN 238
Query: 602 EEPEIRPSFPSIME 615
+EP RP+ +++
Sbjct: 239 KEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 79/251 (31%), Positives = 128/251 (50%), Gaps = 21/251 (8%)
Query: 387 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446
VA+K L + + ++ EF +E ++M L HPNIV L+G VT+ + ++ EYL++G L+
Sbjct: 37 VAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLH 95
Query: 447 KLLHI--PDARV------------VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 492
+ L + P + V +D L++A +A GM YL VH+DL +
Sbjct: 96 EFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAAR 153
Query: 493 NLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFG 550
N+L+ VK+ D GLSR Y + + P WM PE + + SD++SFG
Sbjct: 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFG 213
Query: 551 VILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 609
V+LWE+ + +P+ + +VI V K + L ++ P + +L+ CW E P RP
Sbjct: 214 VVLWEIFSFGLQPYYGFSNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPR 272
Query: 610 FPSIMETLQQF 620
F I L+ +
Sbjct: 273 FKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 72/252 (28%), Positives = 127/252 (50%), Gaps = 18/252 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+FG V+ + V +K + ++ +D E ++K L HPNI+
Sbjct: 10 RGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL 69
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
E L IV EY G+L + + ++DE L+ + ++++H + I+HRD
Sbjct: 70 EDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRD 126
Query: 489 LKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAA----GTPEWMAPEVLREDPSNEK 543
LK+ N+L+D V K+ DFG+S+ +SSK+ A GTP +++PE+ P N+K
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 544 SDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SD+++ G +L+EL +L++ + + P+ V+ + G I +P + LI +
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIM--SGTFAPISDRYSPDLRQLILSMLNL 239
Query: 603 EPEIRPSFPSIM 614
+P RP IM
Sbjct: 240 DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 18/197 (9%)
Query: 372 GSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAVTE 429
G++G VY A + + V I I+ F + K LRE+ ++K L HPNI+ L+
Sbjct: 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH 69
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+L +V E++ LYKL I D + + E L + Y + +G+ + H I+HRDL
Sbjct: 70 KGDLYLVFEFMDT-DLYKL--IKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDL 124
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLREDPS-NEK 543
K NLL+++ +K+ DFGL+RS S T W APE+L D +
Sbjct: 125 KPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 544 SDVFSFGVILWELITLQ 560
D++S G I EL++ +
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 90/299 (30%), Positives = 132/299 (44%), Gaps = 47/299 (15%)
Query: 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD------------------VAVKILIEQEFHED 400
P H++ +G FG V+ E N VAVKIL
Sbjct: 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA 62
Query: 401 RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---HIPDAR-- 455
R +FL+EV I+ L+ PNI+ L+G + L ++TEY+ G L + L H+ D
Sbjct: 63 R-NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 456 -----------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 504
+ L++A +A GM YL VHRDL + N LV T+K+
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKI 179
Query: 505 CDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL--Q 560
DFG+SR+ Y + A P WMA E + SDV++FGV LWE++ L +
Sbjct: 180 ADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239
Query: 561 KPWRNSTPSQVISAVG--FKGRRLEI----PKNVNPMVAALIETCWAEEPEIRPSFPSI 613
+P+ T QVI G F+ + ++ P + L+ CW+ + RPSF I
Sbjct: 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 77/246 (31%), Positives = 126/246 (51%), Gaps = 12/246 (4%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILI-EQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMGAVT 428
KG++G VY A R+ V+I I E + R+ + L E+A+ L+H NIV +G+ +
Sbjct: 18 KGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
E I E + GSL LL + +E+ + + +G+ YLH + IVHRD
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRD 133
Query: 489 LKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS--NEKS 544
+K N+LV+ TY+ VK+ DFG S+ ++T GT ++MAPEV+ + P +
Sbjct: 134 IKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 545 DVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
D++S G + E+ T + P+ P + VG EIP++++ I C+ +
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD 252
Query: 604 PEIRPS 609
P+ R S
Sbjct: 253 PDKRAS 258
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 21/226 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVLLMGA 426
KG+FG+VY A+ R++ A+K+L + + +++ E AIM P + L +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 427 VTEPPNLSIVTEYLSRG---SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
L +V EYL+ G SL K L + E +V G+ LHQR
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRG-- 117
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
I+HRD+K NLL+D T +K+ DFGLSR N + K GTP+++APE + ++
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLEN-KKFVGTPDYLAPETILGVGDDKM 173
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589
SD +S G +++E + P+ TP V + RR+ P+ V
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LSRRINWPEEVK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 69/255 (27%), Positives = 116/255 (45%), Gaps = 25/255 (9%)
Query: 371 KGSFGTVYHAEWRNSD-VAVKILI----EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
KG++GTVY +AVK + E +++ EV ++K L+H NIV +G
Sbjct: 10 KGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ +SI E++ GS+ +L+ E + + G+ YLH +V
Sbjct: 70 TCLDDNTISIFMEFVPGGSISSILNRFGPLP---EPVFCKYTKQILDGVAYLHNNC--VV 124
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSR---------SKPNTYISSKTAAGTPEWMAPEVLR 536
HRD+K N+++ +K+ DFG +R + N K+ GTP WMAPEV+
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML---KSMHGTPYWMAPEVIN 181
Query: 537 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAA 594
E KSD++S G ++E+ T + P + + +G R L +P + +
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAAID 240
Query: 595 LIETCWAEEPEIRPS 609
+ +C + RPS
Sbjct: 241 FVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 75/248 (30%), Positives = 124/248 (50%), Gaps = 9/248 (3%)
Query: 371 KGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KGS+G V H V K+ + +R K +E ++ L+HPNIV +
Sbjct: 10 KGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESW 68
Query: 428 T-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
E L IV + G LY L +++ E + +A + YLH++ I+H
Sbjct: 69 EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLP-ENQVVEWFVQIAMALQYLHEKH--ILH 125
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK+ N+ + T +KV D G++R N + T GTP +M+PE+ P N KSDV
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
++ G ++E+ TL+ + + ++ + +G+ +PK+ +P + LI T ++ PE
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSKRPEK 244
Query: 607 RPSFPSIM 614
RPS SI+
Sbjct: 245 RPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 73/250 (29%), Positives = 119/250 (47%), Gaps = 22/250 (8%)
Query: 371 KGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
+GS G VY + A+K + ++ F K+ LRE+ ++ P +V GA
Sbjct: 11 QGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 428 TEPPNLSIVTEYLSRGSL----YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+ +SIV EY+ GSL K+ IP E + +A + KG++YLH +R
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIP-------EPVLAYIARQILKGLDYLHTKRH- 120
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
I+HRD+K NLL++S VK+ DFG+S+ NT T GT +M+PE ++ + +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 544 SDVFSFGVILWELIT----LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
+D++S G+ L E P + S + + L + +P I C
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP-AEEFSPEFRDFISAC 239
Query: 600 WAEEPEIRPS 609
++P+ RPS
Sbjct: 240 LQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 29/279 (10%)
Query: 368 NFIK---GSFGTVYHAEWRNSD--VAVKI--LIEQEFHEDRFKEFLREVAIMKGLRHPNI 420
NF+K GS G V A +++ VAVK L +Q+ E F E V IM+ +HPNI
Sbjct: 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE----VVIMRDYQHPNI 78
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
V + + L +V E+L G+L ++ ++E + V K +++LH +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISSKTAAGTPEWMAPEVLR 536
++HRD+KS ++L+ S VK+ DFG +S+ P K+ GTP WMAPEV+
Sbjct: 135 G--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR----RKSLVGTPYWMAPEVIS 188
Query: 537 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GFKGRRLEIPKNVNPMVAAL 595
P + D++S G+++ E++ + P+ N P Q + + +L+ V+P + +
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSF 248
Query: 596 IETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 634
++ +P R + E L ++ P S PL
Sbjct: 249 LDRMLVRDPAQR---ATAAELLNHPFLAKAGPPSSIVPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 60/165 (36%), Positives = 90/165 (54%), Gaps = 11/165 (6%)
Query: 403 KEFLREVAIMKGLRHPNIVLLMGAVTEPP--NLSIVTEYLSRGSL---YKLLHIPDARVV 457
K+ LRE+ I K + P IV GA + ++ I EY GSL YK + R+
Sbjct: 44 KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI- 102
Query: 458 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517
E++ +A V KG++YLH R+ I+HRD+K N+L+ VK+CDFG+S N+
Sbjct: 103 -GEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159
Query: 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP 562
+ T GT +MAPE ++ P + SDV+S G+ L E+ + P
Sbjct: 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 24/257 (9%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
G+FG VY A+ + + + + E+ ++++ E+ I+ HP IV L+GA
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82
Query: 432 NLSIVTEYLSRGS-------LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
L I+ E+ G+ L + L P +V+ + L + + YLH + I
Sbjct: 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---------EALQYLHSMK--I 131
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-----LREDP 539
+HRDLK+ N+L+ +K+ DFG+S T + GTP WMAPEV +++ P
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-FKGRRLEIPKNVNPMVAALIET 598
+ K+D++S G+ L E+ ++ P P +V+ + + L P + ++T
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKT 251
Query: 599 CWAEEPEIRPSFPSIME 615
+ PE RPS ++E
Sbjct: 252 ALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 54/158 (34%), Positives = 89/158 (56%), Gaps = 5/158 (3%)
Query: 467 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAA 524
++ VA+GM +L R+ +HRDL + N+L+ VK+CDFGL+R K Y+ +A
Sbjct: 180 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 583
+WMAPE + + +SDV+SFGV+LWE+ +L P+ ++ G R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
P+N P + ++ CW +P+ RP+F +++E L L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 18/257 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG+FG V + R++ A+K + +Q+ E + L E I++ L HP +V L +
Sbjct: 10 KGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF 69
Query: 428 TEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+ N+ +V + L G L Y H+ +E+++ + ++ + YLH + I+H
Sbjct: 70 QDEENMYLVVDLLLGGDLRY---HLSQKVKFSEEQVKFWIC-EIVLALEYLHSKG--IIH 123
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
RD+K N+L+D V + DF ++ P+T +S +GTP +MAPEVL + D
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLCRQGYSVAVD 181
Query: 546 VFSFGVILWELITLQKPWRN--STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
+S GV +E + ++P+R T I A + + P + I +
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADVLYPATWSTEAIDAINKLLERD 240
Query: 604 PEIRPSFPSIMETLQQF 620
P+ R ++ L+
Sbjct: 241 PQKRLGDN--LKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL----------IEQEFHEDRFKEFLREVAIMKGLRHP 418
KGSFG V AE + +D AVK+L +E E R +HP
Sbjct: 5 KGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--------KHP 56
Query: 419 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 478
+ L L V EY++ G L + HI + + R R A ++ G+ +LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARF-YAAEIVLGLQFLH 113
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 538
+R I++RDLK N+L+DS +K+ DFG+ + +++ T GTP+++APE+L
Sbjct: 114 ERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 539 PSNEKSDVFSFGVILWELITLQKP 562
P D ++ GV+L+E++ Q P
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 72/234 (30%), Positives = 117/234 (50%), Gaps = 32/234 (13%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
G+FG VY A+ + + V + E+ ++++ E+ I+ HPNIV L+ A
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75
Query: 432 NLSIVTEYLSRGS-------LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
NL I+ E+ + G+ L + L P RVV + L + +NYLH+ + I
Sbjct: 76 NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL---------EALNYLHENK--I 124
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----REDP 539
+HRDLK+ N+L +K+ DFG+S T + GTP WMAPEV+ ++ P
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
+ K+DV+S G+ L E+ ++ P P +V+ L+I K+ P +A
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPTLA 229
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 75/254 (29%), Positives = 116/254 (45%), Gaps = 51/254 (20%)
Query: 368 NFIK----GSFGTVYHAEWRNSD--VAVKIL-----IE--QEFHEDRFKEFLREVAIMKG 414
FIK GSFG V + S A+KIL ++ Q H L E I++
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH------VLNEKRILQS 57
Query: 415 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------IPDARVVVDERLRLNMAY 468
+RHP +V L G+ + NL +V EY+ G L+ L P AR +
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-------- 109
Query: 469 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTP 527
V + YLH IV+RDLK NLL+DS +K+ DFG + R K TY T GTP
Sbjct: 110 -VVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTP 162
Query: 528 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLE 583
E++APE++ + D ++ G++++E++ P+ + P +++ ++
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG------KVR 216
Query: 584 IPKNVNPMVAALIE 597
P +P LI
Sbjct: 217 FPSFFSPDAKDLIR 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 68/247 (27%), Positives = 127/247 (51%), Gaps = 9/247 (3%)
Query: 371 KGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+GSFG + NSD +I + + ++ +E ++ ++HPNIV +
Sbjct: 10 EGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA--VEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+L IV EY G L + + + ++ ++ + L + G+ ++H++R ++HR
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQMCLGVQHIHEKR--VLHR 124
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+KS N+ + VK+ DFG +R + + T GTP ++ PE+ P N KSD++
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIW 184
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
S G IL+EL TL+ P++ ++ +I V +G +P + + + +LI+ + P R
Sbjct: 185 SLGCILYELCTLKHPFQANSWKNLILKV-CQGSYKPLPSHYSYELRSLIKQMFKRNPRSR 243
Query: 608 PSFPSIM 614
PS +I+
Sbjct: 244 PSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 41/263 (15%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR-----------EVAIMK-GLRHPN 419
G+FG VY +N+ + L E H F + R EV I+K LRHPN
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAYDVA 471
IV E L IV + + L + + R+ N+ +
Sbjct: 71 IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-------WNIFVQMV 123
Query: 472 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWM 530
+ YLH+ + IVHRDL N+++ V + DFGL++ K P + ++S GT +
Sbjct: 124 LALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILYS 180
Query: 531 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRN----STPSQVISAVGFKGRRLEIPK 586
PE+++ +P EK+DV++FG IL+++ TLQ P+ + S ++++ AV +P+
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-----YEPLPE 235
Query: 587 NV-NPMVAALIETCWAEEPEIRP 608
+ + V +I +C + E RP
Sbjct: 236 GMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 70/262 (26%), Positives = 131/262 (50%), Gaps = 22/262 (8%)
Query: 371 KGSFGTVYHAE--WRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G F VY A VA+K + I + ++ ++E+ ++K L HPN++ + +
Sbjct: 12 RGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF 71
Query: 428 TEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
E L+IV E G L +++ + + ++ ER + + ++H RR ++H
Sbjct: 72 IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMH 129
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMAPEVLREDPSN 541
RD+K N+ + +T VK+ D GL R + SSKT A GTP +M+PE + E+ N
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP----KNVNPMVAALIE 597
KSD++S G +L+E+ LQ P+ + + ++ K + + P ++ + + L+
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242
Query: 598 TCWAEEPEIRPSFPSIMETLQQ 619
C +P+ RP + + +Q
Sbjct: 243 MCIYPDPDQRPDIGYVHQIAKQ 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 70/251 (27%), Positives = 122/251 (48%), Gaps = 22/251 (8%)
Query: 371 KGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G F VY A V V K+ I + ++E+ ++K L HPN++ +
Sbjct: 12 RGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 71
Query: 428 TEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
E L+IV E G L +++ H + ++ E+ + + ++H RR ++H
Sbjct: 72 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMH 129
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMAPEVLREDPSN 541
RD+K N+ + +T VK+ D GL R + SSKT A GTP +M+PE + E+ N
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP----KNVNPMVAALIE 597
KSD++S G +L+E+ LQ P+ + + ++ K + + P + + + L+
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQLVN 242
Query: 598 TCWAEEPEIRP 608
C +PE RP
Sbjct: 243 MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 75/266 (28%), Positives = 132/266 (49%), Gaps = 19/266 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAV--KILIEQ-EFHEDRFKEFL-REVAIMKGLRHPNIVLLMGA 426
+G+ GTV+ A DVA ++ I+Q + KE + E+ +MK L++PNIV + +
Sbjct: 29 QGASGTVFTA----IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L +V EYL+ GSL ++ +DE + + + + +LH + ++H
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RD+KS N+L+ +VK+ DFG T GTP WMAPEV+ K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPE 605
+S G++ E++ + P+ N P + + + G L+ P+ ++P+ + C + E
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 606 IRPSFPSIMETLQQFLMSSVCQPLSA 631
R S +++ FL + +PLS+
Sbjct: 259 KRGSAKELLQ--HPFL--KLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 85/324 (26%), Positives = 138/324 (42%), Gaps = 73/324 (22%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 422
+G+FG V A + VAVK+L E + +K + E+ I+ + H N+V
Sbjct: 17 RGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-YKALMTELKILIHIGHHLNVVN 75
Query: 423 LMGAVTEP--PNLSIV--------TEYL-SRGSLYKLLHIPDAR-----VVVDERLRLN- 465
L+GA T+P P + IV + YL S+ + R ++ RL+
Sbjct: 76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDS 135
Query: 466 ------------------------------------------MAYDVAKGMNYLHQRRPP 483
++ VA+GM +L R+
Sbjct: 136 VSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK-- 193
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSN 541
+HRDL + N+L+ VK+CDFGL+R K Y+ A +WMAPE + +
Sbjct: 194 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYT 253
Query: 542 EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
+SDV+SFGV+LWE+ +L P+ + +G R+ P+ P + +++ CW
Sbjct: 254 TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCW 313
Query: 601 AEEPEIRPSFPSIMETLQQFLMSS 624
PE RP+F ++E L L +
Sbjct: 314 HNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 73/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREV-------AIMKGLRHPNIVLL 423
+G+FG VY ++D ++ ++Q + +E +EV ++K LRH IV
Sbjct: 12 RGAFGEVYLC--YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 424 MGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
G + +P LSI EY+ GS+ L A + E + + +G++YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEVLRED 538
IVHRD+K N+L DS VK+ DFG S+ +S K+ GTP WM+PEV+ +
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598
K+DV+S + E++T + PW I + + + +P V+ ++
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQ 244
Query: 599 CWAEEPEIRPSF 610
+ EE + RP+
Sbjct: 245 IFVEE-KRRPTA 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 69/240 (28%), Positives = 120/240 (50%), Gaps = 10/240 (4%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG+FG V + + A+KIL E +D + E +++ RHP + L A
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L V EY + G L+ H+ RV +ER R A ++ + YLH R +V+R
Sbjct: 65 QTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSRD--VVYR 119
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+K NL++D +K+ DFGL + + + KT GTPE++APEVL ++ D +
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
GV+++E++ + P+ N ++ + + R P+ ++P +L+ ++P+ R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 20/271 (7%)
Query: 360 STHVIDSSNFIKGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREV-AIMKGLR 416
+ + D +G+FGTV + S AVK I E K L ++ +M+
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK-RIRSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 417 HPNIVLLMGAVTEPPNLSIVTEY--LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 474
P IV GA+ + I E +S YK ++ + V+ E + +A K +
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKAL 120
Query: 475 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 534
NYL + I+HRD+K N+L+D +K+CDFG+S ++ ++ A P +MAPE
Sbjct: 121 NYL-KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPE- 177
Query: 535 LREDPSNE-----KSDVFSFGVILWELITLQKPWR--NSTPSQVISAVGFKGRRL--EIP 585
R DPS +SDV+S G+ L+E+ T + P+ NS Q+ V L
Sbjct: 178 -RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236
Query: 586 KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616
+ +P I C ++ RP + ++E
Sbjct: 237 REFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 68/240 (28%), Positives = 121/240 (50%), Gaps = 10/240 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG+FG V + S A+KIL ++ +D L E ++K RHP + L +
Sbjct: 5 KGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF 64
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L V EY++ G L+ H+ RV ++R R A ++ ++YLH + IV+R
Sbjct: 65 QTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSGK--IVYR 119
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DLK NL++D +K+ DFGL + + KT GTPE++APEVL ++ D +
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
GV+++E++ + P+ N ++ + + ++ P+ ++ +L+ ++P R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 14/255 (5%)
Query: 371 KGSFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
KG++G+VY R + V + + I E E +F + + E+ I+ P IV GA
Sbjct: 11 KGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+ + EY+ GSL KL A + E + + Y V KG+ +L + I+HRD+
Sbjct: 71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-IIHRDV 129
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAAGTPEWMAPEVLREDPSNE------ 542
K N+LV+ VK+CDFG+S N S +KT G +MAPE ++ N+
Sbjct: 130 KPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTV 186
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALIETCW 600
+SDV+S G+ + E+ + P+ T + + + + G +P + + C
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCL 246
Query: 601 AEEPEIRPSFPSIME 615
+ P RP++ ++E
Sbjct: 247 NKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 71/269 (26%), Positives = 127/269 (47%), Gaps = 28/269 (10%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIVLLMGAV 427
G FG V E ++++++ E FL+EV + L HPN++ +G
Sbjct: 5 NGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC 64
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVV----DERLRLNMAYDVAKGMNYLHQRRPP 483
E +V E+ G L L R +V + + MA +VA G+ +LHQ
Sbjct: 65 IESIPYLLVLEFCPLGDLKNYLR--SNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLREDPSN 541
+H DL N + + +VK+ D+GL+ + P Y +K P W+APE++ +
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180
Query: 542 -------EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK-NVNPMV 592
+KS+++S GV +WEL T +P+ + + QV+ V + + +++PK ++
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLDLKY 239
Query: 593 A----ALIETCWAEEPEIRPSFPSIMETL 617
+ +++ CW +PE RP+ + E L
Sbjct: 240 SDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 67/240 (27%), Positives = 122/240 (50%), Gaps = 9/240 (3%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG+FG V + + + A+KIL ++ +D L E +++ RHP + L +
Sbjct: 5 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 64
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L V EY + G L+ H+ RV ++R R A ++ ++YLH + +V+R
Sbjct: 65 QTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN-VVYR 120
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DLK NL++D +K+ DFGL + + KT GTPE++APEVL ++ D +
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
GV+++E++ + P+ N ++ + + R P+ ++P +L+ ++P+ R
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 70/249 (28%), Positives = 118/249 (47%), Gaps = 23/249 (9%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLLMGAVT 428
G+ GTVY R + A+K++ HED + + RE+ I++ + HPN+V
Sbjct: 85 GAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFD 142
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ ++ E++ GSL + + DE+ ++A + G+ YLH+R IVHRD
Sbjct: 143 HNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRD 193
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK----- 543
+K NLL++S VK+ DFG+SR T ++ GT +M+PE + D ++
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA 253
Query: 544 SDVFSFGVILWELITLQKPW---RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
D++S GV + E + P+ R + ++ A+ + E P + I C
Sbjct: 254 GDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAPATASREFRHFISCCL 312
Query: 601 AEEPEIRPS 609
EP R S
Sbjct: 313 QREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 12/252 (4%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLR---EVAIMKGLRHPNIVLLMG 425
KGSFGTVY + + + +K+L E E E ++ E ++ L HP IV
Sbjct: 10 KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHA 69
Query: 426 AVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ E I+TEY L KL + + E + G++Y+HQRR I
Sbjct: 70 SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--I 127
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
+HRDLK+ N+ + + +K+ DFG+SR + + T GTP +M+PE L+ + KS
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKS 186
Query: 545 DVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
D++S G IL+E+ L + S V+ V +G +P+ + + +++++ ++
Sbjct: 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV--EGPTPSLPETYSRQLNSIMQSMLNKD 244
Query: 604 PEIRPSFPSIME 615
P +RPS I+
Sbjct: 245 PSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-23
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 5/161 (3%)
Query: 467 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAA 524
++ VAKGM +L R+ +HRDL + N+L+ VK+CDFGL+R K Y+ A
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 583
+WMAPE + + +SDV+SFGV+LWE+ +L P+ + +G R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
P P + + CW EP RP+F ++E L L ++
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 7e-23
Identities = 70/207 (33%), Positives = 113/207 (54%), Gaps = 13/207 (6%)
Query: 371 KGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIVLLM 424
KGSFG V A+ R SD AVK+L ++ + + + + R V ++K L+HP +V L
Sbjct: 5 KGSFGKVLLAK-RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGLH 62
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ L V +Y++ G L+ H+ R ++ R R A +VA + YLH I
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVASAIGYLHSLN--I 117
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
++RDLK N+L+DS V + DFGL + ++ T GTPE++APEVLR++P +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQV 571
D + G +L+E++ P+ + SQ+
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 74/266 (27%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAV--KILIEQEFHEDRFKEFL--REVAIMKGLRHPNIVLLMGA 426
+G+ GTVY A DVA ++ I+Q + + K+ L E+ +M+ +HPNIV + +
Sbjct: 29 QGASGTVYTA----IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L +V EYL+ GSL ++ +DE + + + + +LH + ++H
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ--VIH 138
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RD+KS N+L+ +VK+ DFG T GTP WMAPEV+ K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPE 605
+S G++ E++ + P+ N P + + + G L+ P+ ++ + + C + E
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 258
Query: 606 IRPSFPSIMETLQQFLMSSVCQPLSA 631
R S +++ FL + +PLS+
Sbjct: 259 KRGSAKELLQ--HPFL--KIAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 36/209 (17%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLLM 424
G++ VY A + + VA+K + E E K+ LRE+ +++ L+HPNI+ L+
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEA--KDGINFTALREIKLLQELKHPNIIGLL 68
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA------KGMNYLH 478
N+++V E++ L K++ D+ + L A + +G+ YLH
Sbjct: 69 DVFGHKSNINLVFEFME-TDLEKVIK--------DKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLR 536
I+HRDLK NLL+ S +K+ DFGL+RS PN ++ + T + APE+L
Sbjct: 120 SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELLF 175
Query: 537 EDPSNEKS---DVFSFGVILWELITLQKP 562
+ D++S G I EL+ L+ P
Sbjct: 176 G--ARHYGVGVDMWSVGCIFAELL-LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 80/279 (28%), Positives = 125/279 (44%), Gaps = 57/279 (20%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA- 426
+G++G VY A + + VA+KI + ED +E E I++ HPNI GA
Sbjct: 16 EGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 427 -----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM-AY---DVAKGMNYL 477
L +V E GS+ L+ + +RL+ AY + +G+ YL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK---GKRLKEEWIAYILRETLRGLAYL 129
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAGTPEWMA 531
H+ + ++HRD+K N+L+ VK+ DFG+S + NT+I GTP WMA
Sbjct: 130 HENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------GTPYWMA 181
Query: 532 PEVLREDPSNE-----KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 586
PEV+ D + +SDV+S G+ EL + P + P + + FK IP+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK-----IPR 232
Query: 587 NVNPMVAA----------LIETCWAEEPEIRPSFPSIME 615
N P + + I C + E RP ++E
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 27/201 (13%)
Query: 372 GSFGTVYHAEWRNSD----VAVK-ILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLLMG 425
G++G VY A RN VA+K I +E E ++ F +RE+ +++ LRHPNIV L
Sbjct: 10 GTYGQVYKA--RNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 426 AVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
VT SI V EY+ L LL P+ + + + +G+ YLH
Sbjct: 66 IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY--MKQLLEGLQYLHSNG-- 120
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLR-E 537
I+HRD+K N+L+++ +K+ DFGL+R Y +A T W PE+L
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRPPELLLGA 176
Query: 538 DPSNEKSDVFSFGVILWELIT 558
+ D++S G IL EL
Sbjct: 177 TRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-22
Identities = 54/165 (32%), Positives = 89/165 (53%), Gaps = 13/165 (7%)
Query: 464 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 521
L+ Y VA+GM +L + VHRDL + N+L+ VK+CDFGL+R + Y+S
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 522 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK-- 578
+ +WMAPE + ++ SDV+S+G++LWE+ +L P+ P ++ + +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY----PGMIVDSTFYNKI 353
Query: 579 --GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
G R+ P + V ++ CW EPE RPSF + + ++ L
Sbjct: 354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 73/264 (27%), Positives = 125/264 (47%), Gaps = 37/264 (14%)
Query: 372 GSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMGAVT 428
G+ G VY ++ + AVK + E+ K L ++ + +K P IV G
Sbjct: 26 GTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSHDCPYIVKCYGYFI 84
Query: 429 EPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
++ I E +S L KLL IP E + M + K ++YL ++
Sbjct: 85 TDSDVFICMELMST-CLDKLLKRIQGPIP-------EDILGKMTVAIVKALHYLKEKHG- 135
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLREDP 539
++HRD+K N+L+D++ VK+CDFG+S SK T +AG +MAPE R DP
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-----RSAGCAAYMAPE--RIDP 188
Query: 540 SNEK------SDVFSFGVILWELITLQKPWRN-STPSQVISAV-GFKGRRLEIPKNVNPM 591
+ +DV+S G+ L EL T Q P++N T +V++ + + L + +P
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248
Query: 592 VAALIETCWAEEPEIRPSFPSIME 615
+ ++ C ++ RP + +++
Sbjct: 249 FCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 20/251 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-------IMKGLRHPNIVLL 423
+G+FG VY ++D ++ ++Q + E +EV ++K L H IV
Sbjct: 12 QGAFGRVYLC--YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 424 MGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
G + +P LSI E++ GS+ L A + E + + +G++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSNM 126
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEVLRED 538
IVHRD+K N+L DS VK+ DFG S+ +S K+ GTP WM+PEV+ +
Sbjct: 127 --IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598
K+D++S G + E++T + PW I + + +P +V+ ++
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKR 244
Query: 599 CWAEEPEIRPS 609
+ E ++RPS
Sbjct: 245 IFVEA-KLRPS 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G +G V+ A+ +++ VA+K + + + + + L E I+ + +V L+ A
Sbjct: 11 QGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ L + EY+ G LL+ + V+ ++ R MA ++ LH+ +HR
Sbjct: 71 QDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFE-AVDALHEL--GYIHR 125
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DLK N L+D++ +K+ DFGLS+ + + G+P++MAPEVLR + D +
Sbjct: 126 DLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYW 182
Query: 548 SFGVILWELITLQKPWRNSTPSQV 571
S G +L+E + P+ STP++
Sbjct: 183 SLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-22
Identities = 53/165 (32%), Positives = 91/165 (55%), Gaps = 13/165 (7%)
Query: 464 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSK 521
L+ +Y VAKGM++L + +HRDL + N+L+ K+CDFGL+R N Y+
Sbjct: 217 LSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 522 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK-- 578
A +WMAPE + +SDV+S+G++LWE+ +L P+ P + + +K
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGMPVDSKFYKMI 330
Query: 579 --GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
G R+ P+ + ++++CW +P RP+F I++ ++Q L
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 19/266 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAV--KILIEQ-EFHEDRFKEFL-REVAIMKGLRHPNIVLLMGA 426
+G+ GTVY A DVA ++ I Q + KE + E+ +M+ ++PNIV + +
Sbjct: 30 QGASGTVYTA----MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L +V EYL+ GSL ++ +DE + + + + +LH + ++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ--VIH 139
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RD+KS N+L+ +VK+ DFG T GTP WMAPEV+ K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPE 605
+S G++ E+I + P+ N P + + + G L+ P+ ++ + + C + E
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 606 IRPSFPSIMETLQQFLMSSVCQPLSA 631
R S +++ QFL + +PLS+
Sbjct: 260 KRGSAKELLQ--HQFL--KIAKPLSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 19/254 (7%)
Query: 372 GSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G++G VY A N+ ++A +I+ E ED F +E+ +MK +H NIV G+
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLHQRRPPIVHR 487
L I E+ GSL + H V +AY + +G+ YLH + +HR
Sbjct: 79 DKLWICMEFCGGGSLQDIYH------VTGPLSESQIAYVSRETLQGLYYLHSKGK--MHR 130
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL---REDPSNEKS 544
D+K N+L+ VK+ DFG+S T K+ GTP WMAPEV R+ N+
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
D+++ G+ EL LQ P + P + +++ F+ +L+ + ++
Sbjct: 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALT 250
Query: 602 EEPEIRPSFPSIME 615
+ P+ RP+ +++
Sbjct: 251 KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-22
Identities = 55/162 (33%), Positives = 88/162 (54%), Gaps = 7/162 (4%)
Query: 464 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 521
+ +Y VA GM +L + VHRDL + N+L+ VK+CDFGL+R + + YIS
Sbjct: 242 VGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG 299
Query: 522 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKG 579
+ +WMAPE + + SDV+SFG++LWE+ TL P Q +A+ +G
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK-RG 358
Query: 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
R+ P + + + +++ CW E+ EIRP F ++ + L
Sbjct: 359 YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 21/197 (10%)
Query: 372 GSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
G++G V RN VA+K E E ED K LREV +++ LRH NIV L A
Sbjct: 12 GAYGVVLKC--RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF 69
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARV--VVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
L +V EY+ R LL + +A + + +R + + + + + Y H I+
Sbjct: 70 RRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYI-WQLLQAIAYCHSHN--II 122
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
HRD+K N+LV + +K+CDFG +R ++P + ++ A T + APE+L D +
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA--TRWYRAPELLVGDTNYG 180
Query: 543 KS-DVFSFGVILWELIT 558
K DV++ G I+ EL+
Sbjct: 181 KPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 79/272 (29%), Positives = 127/272 (46%), Gaps = 31/272 (11%)
Query: 374 FGTVYHAEW-------RNSDVAVKILIEQEFHEDRFKEFLREVAIMKG-LRHPNIVLLMG 425
FG VY + VA+K L ++ E +E + A+M+ L+HPNIV L+G
Sbjct: 18 FGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLG 75
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHI--PDARV-------VVDERLR----LNMAYDVAK 472
VT+ LS++ Y S L++ L + P + V V L +++ +A
Sbjct: 76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAA 135
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWM 530
GM +L +VH+DL + N+LV VK+ D GL R + Y + WM
Sbjct: 136 GMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM 193
Query: 531 APEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRR-LEIPKNV 588
+PE + + SD++S+GV+LWE+ + +P+ + VI + + R+ L P +
Sbjct: 194 SPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI--RNRQVLPCPDDC 251
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620
V L+ CW E P RP F I L+ +
Sbjct: 252 PAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 19/275 (6%)
Query: 367 SNFIK---GSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNI 420
+FIK GS G V A +++ VAVK + + + + +E L EV IM+ H N+
Sbjct: 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
V + + L +V E+L G+L ++ ++E + V + ++YLH +
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ 137
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
++HRD+KS ++L+ S +K+ DFG K+ GTP WMAPEV+ P
Sbjct: 138 --GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETC 599
+ D++S G+++ E+I + P+ N P Q + + R++ V+ ++ ++
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255
Query: 600 WAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 634
EP R + E LQ + P PL
Sbjct: 256 LVREPSQR---ATAQELLQHPFLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 69/264 (26%), Positives = 131/264 (49%), Gaps = 15/264 (5%)
Query: 371 KGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+ GTVY A +VA+K + Q+ + + + + E+ +M+ ++PNIV + +
Sbjct: 29 QGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L +V EYL+ GSL ++ +DE + + + +++LH + ++HRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQ--VIHRD 140
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+KS N+L+ +VK+ DFG T GTP WMAPEV+ K D++S
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPEIR 607
G++ E++ + P+ N P + + + G L+ P+ ++ + + C + + R
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260
Query: 608 PSFPSIMETLQQFLMSSVCQPLSA 631
S +++ FL + +PLS+
Sbjct: 261 GSAKELLQ--HPFL--KLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 16/213 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL----REVAIMKGLRHPNIVLLM 424
+G FG V AE++ + A+K L + + E L R RHP +V L
Sbjct: 9 RGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLF 68
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
++ V EY + G L ++HI V E + A V G+ YLH+ + I
Sbjct: 69 ACFQTEDHVCFVMEYAAGGDL--MMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK--I 122
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPSNE 542
V+RDLK NLL+D+ VK+ DFGL K +T+ GTPE++APEVL E
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 575
D + GV+++E++ + P+ +V ++
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 4e-21
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 371 KGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G V A + VA+K + K LRE+ +++ LRH NI+ L+ +
Sbjct: 10 SGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL-DIL 68
Query: 429 EPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
PP+ IVTE + L+K++ P + + D+ ++ + Y + +G+ YLH
Sbjct: 69 RPPSPEDFNDVYIVTELM-ETDLHKVIKSP--QPLTDDHIQYFL-YQILRGLKYLH--SA 122
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLRE 537
++HRDLK N+LV+S +K+CDFGL+R + T W APE+L
Sbjct: 123 NVIHRDLKPSNILVNSNCDLKICDFGLARG--VDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 538 DPSNEKS-DVFSFGVILWELITLQKP 562
K+ D++S G I EL+T +KP
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLT-RKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 31/207 (14%)
Query: 371 KGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G++G VY + + V KI +E E E +RE++++K L+HPNIV L +
Sbjct: 10 EGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVL 68
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ L ++ E+LS L K L +D L + Y + +G+ + H RR ++HR
Sbjct: 69 MQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHR 125
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----------WMAPEVLR 536
DLK NLL+D+ +K+ DFGL+R A G P + APEVL
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLAR-----------AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 537 EDPS-NEKSDVFSFGVILWELITLQKP 562
P + D++S G I E+ T +KP
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 70/233 (30%), Positives = 118/233 (50%), Gaps = 15/233 (6%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVA----IMKGLRHPNIVLLM 424
KGSFG V A+ + AVK+L Q+ + KE +A ++K ++HP +V L
Sbjct: 5 KGSFGKVLLAKHKADGKFYAVKVL--QKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ L V +Y++ G L+ H+ R + R R A ++A + YLH I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELF--FHLQRERSFPEPRARF-YAAEIASALGYLHSLN--I 117
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
++RDLK N+L+DS V + DFGL + ++ T GTPE++APEVLR+ P +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
D + G +L+E++ P+ + +++ + K L + N++ L+E
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 34/207 (16%)
Query: 372 GSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G VY A + VA+K I +E E E +RE++++K L HPNIV L+ V
Sbjct: 10 GTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVH 68
Query: 429 EPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L +V E+L L K + P +D L + Y + +G+ Y H R ++HR
Sbjct: 69 SENKLYLVFEFLDL-DLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHR 123
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----------WM-APEVLR 536
DLK NLL+D +K+ DFGL+R A G P W APE+L
Sbjct: 124 DLKPQNLLIDREGALKLADFGLAR-----------AFGVPVRTYTHEVVTLWYRAPEILL 172
Query: 537 EDPSNEKS-DVFSFGVILWELITLQKP 562
D++S G I E++ ++P
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 54/163 (33%), Positives = 87/163 (53%), Gaps = 10/163 (6%)
Query: 403 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDE 460
K+ LRE+ IM R P IV GA N+ + E++ GSL ++ P ++ +
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK 107
Query: 461 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520
+A V +G+ YL+ I+HRD+K N+LV+S +K+CDFG+S N+ +
Sbjct: 108 -----IAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--A 159
Query: 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 563
T GT +M+PE ++ KSDV+S G+ + EL + P+
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-21
Identities = 50/164 (30%), Positives = 97/164 (59%), Gaps = 8/164 (4%)
Query: 474 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWM 530
++++H + ++HRD+KS N+L+ S VK+ DFG S+ T +S +T GTP ++
Sbjct: 156 VHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYYV 212
Query: 531 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590
APE+ R P ++K+D+FS GV+L+EL+TL++P+ +V+ GR +P +++P
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-LAGRYDPLPPSISP 271
Query: 591 MVAALIETCWAEEPEIRPSFPSIMET-LQQFLMSSVCQPLSAQP 633
+ ++ + +P+ RPS ++ + + +S + + + QP
Sbjct: 272 EMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQP 315
|
Length = 496 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 408 EVAIMKGLRHPNIVLLMGAVTE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 465
E+ ++K L+H IV G + + L+I EY+ GS+ L A + E +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRK 110
Query: 466 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KT 522
+ +GM+YLH IVHRD+K N+L DS VK+ DFG S+ +S ++
Sbjct: 111 YTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 582
GTP WM+PEV+ + K+DV+S G + E++T + PW I + +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP 228
Query: 583 EIPKNVNPMVAALIETCWAEEPEIRPS 609
++P +++ + + E RPS
Sbjct: 229 QLPSHISEHARDFLGCIFVEARH-RPS 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 71/260 (27%), Positives = 131/260 (50%), Gaps = 26/260 (10%)
Query: 368 NFIK---GSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 421
N+IK GS G V A ++S VAVK++ + + + +E L EV IM+ +H N+V
Sbjct: 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVV 81
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
+ + L ++ E+L G+L ++ ++ ++E + V + + YLH +
Sbjct: 82 EMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQ- 136
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 541
++HRD+KS ++L+ VK+ DFG K+ GTP WMAPEV+ P
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP---KN---VNPMVAAL 595
+ D++S G+++ E++ + P+ + +P Q + K R P KN ++P++
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSPPPKLKNAHKISPVLRDF 250
Query: 596 IETCWAEEPEIRPSFPSIME 615
+E EP+ R + +++
Sbjct: 251 LERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 71/248 (28%), Positives = 118/248 (47%), Gaps = 31/248 (12%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GSFG V A+ + + A+K L ++E + + +E +I+ L HP IV +M +
Sbjct: 29 GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK--------GMNYLHQR 480
+ + + E++ G L+ L R DVAK YLH +
Sbjct: 89 DENRVYFLLEFVVGGELFTHL-----------RKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTPEWMAPEVLREDP 539
I++RDLK NLL+D+ VKV DFG ++ P+ T+ T GTPE++APEV++
Sbjct: 138 D--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYLAPEVIQSKG 191
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
+ D ++ GV+L+E I P+ + TP ++ + G RL+ P + L++
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-LAG-RLKFPNWFDGRARDLVKGL 249
Query: 600 WAEEPEIR 607
+ R
Sbjct: 250 LQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 71/245 (28%), Positives = 116/245 (47%), Gaps = 19/245 (7%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIVLLMG 425
KGSFG V AE + N A+K L + ED E R V + HP + L
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLTHLFC 63
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+L V EYL+ G L + HI + + R R A ++ G+ +LH++ I+
Sbjct: 64 TFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARF-YAAEIICGLQFLHKKG--II 118
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
+RDLK N+L+D +K+ DFG+ + N + T GTP+++APE+L+ NE D
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVD 178
Query: 546 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI---PKNVNPMVAALIETCWAE 602
+SFGV+L+E++ Q P+ ++ F + P+ ++ + +
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRPHFPRWISKEAKDCLSKLFER 233
Query: 603 EPEIR 607
+P R
Sbjct: 234 DPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 78/292 (26%), Positives = 138/292 (47%), Gaps = 23/292 (7%)
Query: 351 LQMQ-NPSGPSTHVIDSSNFIK---GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE 404
LQM +P P T++ NFIK GS G V A ++S VAVK + + + + +E
Sbjct: 9 LQMVVDPGDPRTYL---DNFIKIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRE 62
Query: 405 FL-REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 463
L EV IM+ +H N+V + + L +V E+L G+L ++ ++E
Sbjct: 63 LLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQI 118
Query: 464 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 523
+ V K ++ LH + ++HRD+KS ++L+ VK+ DFG K+
Sbjct: 119 AAVCLAVLKALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176
Query: 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRL 582
GTP WMAPE++ P + D++S G+++ E++ + P+ N P + + + +L
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL 236
Query: 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 634
+ V+P + ++ +P R + E L+ ++ P PL
Sbjct: 237 KNLHKVSPSLKGFLDRLLVRDPAQR---ATAAELLKHPFLAKAGPPSCIVPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 65/237 (27%), Positives = 116/237 (48%), Gaps = 27/237 (11%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-------IEQEFHEDRFKEFLREVAIMKGLRHPNIV 421
G+FG V+ R S+ A+K++ ++QE H K L+EV HP I+
Sbjct: 11 TGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV------SHPFII 64
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
L + L ++ EY+ G L+ L L A ++ + YLH +
Sbjct: 65 RLFWTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE 121
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPS 540
IV+RDLK N+L+D +K+ DFG ++ + T+ T GTPE++APEV++
Sbjct: 122 --IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAPEVIQSKGH 175
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
N+ D ++ G++++E++ P+ + P + + G +LE P++++ LI+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-LAG-KLEFPRHLDLYAKDLIK 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 74/252 (29%), Positives = 118/252 (46%), Gaps = 27/252 (10%)
Query: 372 GSFGTVYHAEWRNSDV----AVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G++G VY A RN AVKI+ +E D F +E+ ++K +H NIV G+
Sbjct: 20 GTYGDVYKA--RNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLHQRRPP 483
L I EY GSL + H V L +AY + +G+ YLH +
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYH------VTGPLSELQIAYVCRETLQGLAYLHSKGK- 127
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS--- 540
+HRD+K N+L+ VK+ DFG++ T K+ GTP WMAPEV + +
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEIPKNVNPMVAALIE 597
N+ D+++ G+ EL LQ P + P + ++S F+ +L+ + ++
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246
Query: 598 TCWAEEPEIRPS 609
+ P+ RP+
Sbjct: 247 ISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 66/232 (28%), Positives = 120/232 (51%), Gaps = 13/232 (5%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIVLLMG 425
KGSFG V A + + AVK+L ++ + + ++ + R V ++K ++HP +V L
Sbjct: 5 KGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGLHF 63
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ L V +Y++ G L+ H+ R ++ R R A ++A + YLH IV
Sbjct: 64 SFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARF-YAAEIASALGYLHSLN--IV 118
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
+RDLK N+L+DS + + DFGL + ++ T GTPE++APEVL + P + D
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVD 178
Query: 546 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
+ G +L+E++ P+ + +++ + + L++ N+ L+E
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 66/240 (27%), Positives = 120/240 (50%), Gaps = 10/240 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG+FG V + + A+KIL ++ +D L E +++ RHP + L +
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF 64
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L V EY + G L+ H+ RV ++R R A ++ + YLH +V+R
Sbjct: 65 QTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLHSCD--VVYR 119
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DLK NL++D +K+ DFGL + + + KT GTPE++APEVL ++ D +
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
GV+++E++ + P+ N ++ + + + P+ ++P +L+ ++P+ R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 70/244 (28%), Positives = 116/244 (47%), Gaps = 17/244 (6%)
Query: 372 GSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMGAVT 428
G FG V + ++ + A+K + ++ E +E + E I++ HP IV L
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ + ++ EY G L+ +L R + DE V YLH R I++RD
Sbjct: 64 DKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRD 118
Query: 489 LKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
LK NLL+DS VK+ DFG ++ S T+ T GTPE++APE++ + D
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPEYVAPEIILNKGYDFSVD 174
Query: 546 VFSFGVILWELITLQKPWRNS--TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
+S G++L+EL+T + P+ P ++ + + +LE P ++ LI+
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234
Query: 604 PEIR 607
PE R
Sbjct: 235 PEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 51/164 (31%), Positives = 91/164 (55%), Gaps = 11/164 (6%)
Query: 464 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSK 521
L + VA+GM++L + +HRD+ + N+L+ K+CDFGL+R N Y+
Sbjct: 215 LRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 522 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--- 578
A +WMAPE + + +SDV+S+G++LWE+ +L K + P ++++ +K
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK---SPYPGILVNSKFYKMVK 329
Query: 579 -GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
G ++ P P + ++++ CW EP RP+F I + +Q+ L
Sbjct: 330 RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+ G V+ A+ R + VA+K + + + LRE+ ++ +HP +V L+
Sbjct: 10 EGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP 69
Query: 429 EPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+V EY+ L ++L +P+A+V + + M + KG+ Y+H
Sbjct: 70 HGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQV----KSYMRM---LLKGVAYMHANG-- 119
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL----RED 538
I+HRDLK NLL+ + +K+ DFGL+R T + APE+L + D
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 539 PSNEKSDVFSFGVILWELI 557
P D+++ G I EL+
Sbjct: 180 PG---VDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 26/260 (10%)
Query: 371 KGSFGTVYHAE----WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG V E + + V VK L +++ K FL E + L+H N++ +G
Sbjct: 5 NGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQCLGQ 63
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
TE +V E+ G L L + D MA ++A G+ +LH+
Sbjct: 64 CTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--F 121
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEVLREDPSN- 541
+H DL N L+ + TVK+ D+GLS + K + Y++ W+APE++ E N
Sbjct: 122 IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL 181
Query: 542 ------EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594
++S+V+S GV +WEL L +P+R+ + QV++ + ++L++PK + +
Sbjct: 182 LVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQLKLPKPRLKLPLS 240
Query: 595 -----LIETCWAEEPEIRPS 609
+++ CW +PE RPS
Sbjct: 241 DRWYEVMQFCWL-QPEQRPS 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 371 KGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEF-LREVAIMKGLR---HPNIVLL 423
+G++GTVY A N+ VA+K + + E+ LRE+A++K L HPNIV L
Sbjct: 9 EGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 424 MGAVTEPPN-----LSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 477
+ P L++V E++ + + Y L P + ++ + +G+++L
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATY-LSKCPKP--GLPPETIKDLMRQLLRGVDFL 123
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-AP 532
H R IVHRDLK N+LV S VK+ DFGL+R I S A T W AP
Sbjct: 124 HSHR--IVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTSVVVTLWYRAP 175
Query: 533 EVLREDPSNEKSDVFSFGVILWELITLQ 560
EVL + D++S G I EL +
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 13/193 (6%)
Query: 371 KGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIVLLM 424
KGSFG V A+ R D AVK+L ++ + ++ + R V ++K ++HP +V L
Sbjct: 5 KGSFGKVLLAK-RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGLH 62
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ L V ++++ G L+ H+ R + R R A ++A + YLH I
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHSIN--I 117
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
V+RDLK N+L+DS V + DFGL + ++ T GTPE++APEV+R+ P +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 545 DVFSFGVILWELI 557
D + G +L+E++
Sbjct: 178 DWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 63/278 (22%), Positives = 126/278 (45%), Gaps = 31/278 (11%)
Query: 360 STHVIDSSNFI---KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK---EFLREVAIMK 413
+ ID + + ++Y + N +V ++ ++FH+ E+ ++
Sbjct: 16 ESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTF--KKFHKGHKVLIDITENEIKNLR 73
Query: 414 GLRHPNIVLLMG----AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 469
+ NI+ + G V + P LS++ EY +RG L ++L D + + +L+MA D
Sbjct: 74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAID 130
Query: 470 VAKGMNYLHQ--RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 527
KG+ L++ +P +++L S + LV Y +K+ GL + I S
Sbjct: 131 CCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEK------ILSSPPFKNV 181
Query: 528 EWMA---PEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 582
+M ++L + K D++S GV+LWE+ T + P+ N T ++ + K L
Sbjct: 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241
Query: 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620
++P + + ++E C + + RP+ I+ L +
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 60/204 (29%), Positives = 107/204 (52%), Gaps = 13/204 (6%)
Query: 368 NFI----KGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMK-GLRHPN 419
NF+ KGSFG V AE + +D A+KIL + +D + + E ++ + P
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
+ L L V EY++ G L + HI E + A ++A G+ +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKF-KEPHAVFYAAEIAIGLFFLHS 119
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 539
+ I++RDLK N+++D+ +K+ DFG+ + +++T GTP+++APE++ P
Sbjct: 120 K--GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP 177
Query: 540 SNEKSDVFSFGVILWELITLQKPW 563
+ D ++FGV+L+E++ Q P+
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMK-GLRHPNIVLLMGA 426
KGSFG V AE + +D A+K+L + +D + E I+ +HP + L
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC 64
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L V EY++ G L + I +R + R R A +V + +LH+ +++
Sbjct: 65 FQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRH--GVIY 119
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK N+L+D+ K+ DFG+ + +++ T GTP+++APE+L+E D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 547 FSFGVILWELITLQKPW 563
++ GV+++E++ Q P+
Sbjct: 180 WALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 12/193 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+GS+G V + + + VA+K +E E + K +RE+ ++K LRH N+V L+
Sbjct: 11 EGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR 70
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L +V E++ L L P+ +DE + + +G+ + H I+HRD
Sbjct: 71 RKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN--IIHRD 125
Query: 489 LKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS-D 545
+K N+LV + VK+CDFG +R + P + A T + APE+L D ++ D
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYGRAVD 183
Query: 546 VFSFGVILWELIT 558
+++ G ++ E++T
Sbjct: 184 IWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 372 GSFGTVYHAEWRNSD----VAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNIVLLMG 425
GS+G V+ RN + VA+K +E E +D K LRE+ ++K L+HPN+V L+
Sbjct: 12 GSYGVVFKC--RNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV-VDERLRLNMAYDVAKGMNYLHQRRPPI 484
L +V EY + +L+ + V E L + + + +N+ H+
Sbjct: 68 VFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--C 121
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPS-N 541
+HRD+K N+L+ +K+CDFG +R + P + A T + APE+L D
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA--TRWYRAPELLVGDTQYG 179
Query: 542 EKSDVFSFGVILWELITLQKPW 563
DV++ G + EL+T Q W
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLW 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 69/231 (29%), Positives = 119/231 (51%), Gaps = 26/231 (11%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRH----------P 418
KG+FG VY +++ A+K+L ++E + EVA G R+ P
Sbjct: 3 KGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDESP 56
Query: 419 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 478
IV L + +L +VT+Y+S G L+ H+ ++R + +A ++ + +LH
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELF--WHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 538
+ IV+RDLK N+L+D+T + +CDFGLS++ ++ T GT E++APEVL ++
Sbjct: 114 KYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 539 PSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588
K D +S GV+++E+ P+ Q+ + F ++ PKNV
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNV 220
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 65/194 (33%), Positives = 99/194 (51%), Gaps = 14/194 (7%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G+ GTVY A + +AVK+ I + + K+ + E+ I+ P I+ GA
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKV-IPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV 70
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+SI TE++ GSL IP E + +A V KG+ YL + I+HRD+
Sbjct: 71 ENRISICTEFMDGGSLDVYRKIP-------EHVLGRIAVAVVKGLTYLWSLK--ILHRDV 121
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
K N+LV++ VK+CDFG+S N+ +KT GT +MAPE + + SDV+S
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQYGIHSDVWSL 179
Query: 550 GVILWELITLQKPW 563
G+ EL + P+
Sbjct: 180 GISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 42/271 (15%)
Query: 371 KGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 427
KG++G VY + S AVKIL + D +E E I++ L HPN+V G
Sbjct: 32 KGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 428 TEPPNLS-----IVTEYLSRGS---LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
+ L +V E + GS L K L I R+ DE + + Y G+ +LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL--DEAMISYILYGALLGLQHLHN 146
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL---- 535
R I+HRD+K N+L+ + VK+ DFG+S +T + T+ GTP WMAPEV+
Sbjct: 147 NR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 536 REDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV-- 592
+ D S + + DV+S G+ EL P + P + + +IP+N P +
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---------FKIPRNPPPTLLH 255
Query: 593 --------AALIETCWAEEPEIRPSFPSIME 615
I C ++ E RPS ++E
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 66/243 (27%), Positives = 123/243 (50%), Gaps = 15/243 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIVLLMG 425
KGSFG V AE + +D A+KIL + +D E + V + G + P + L
Sbjct: 10 KGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQLHS 68
Query: 426 AVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
L V EY++ G L Y++ + + E + A ++A G+ +LH + I
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK----EPHAVFYAAEIAIGLFFLHSK--GI 122
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
++RDLK N+++DS +K+ DFG+ + +++KT GTP+++APE++ P +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
D ++FGV+L+E++ Q P+ ++ ++ + PK+++ A+ + + P
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTKHP 240
Query: 605 EIR 607
R
Sbjct: 241 GKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 6e-18
Identities = 70/267 (26%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT 428
G++G VY + A+K++ + D +E +E+ ++K H NI GA
Sbjct: 17 GTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 429 E--PPNLS----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+ PP + +V E+ GS+ L+ + +E + + ++ +G+++LHQ +
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQHK- 131
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR--EDPS 540
++HRD+K N+L+ VK+ DFG+S T T GTP WMAPEV+ E+P
Sbjct: 132 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190
Query: 541 ---NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA---- 593
+ KSD++S G+ E+ P + P + + IP+N P +
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRLKSKKW 241
Query: 594 -----ALIETCWAEEPEIRPSFPSIME 615
+ IE+C + RP+ +M+
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-18
Identities = 65/245 (26%), Positives = 125/245 (51%), Gaps = 20/245 (8%)
Query: 383 RNSDVAVKILIE-QEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440
R SD K++ + +++R + R E+ + H IV L ++ EY
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147
Query: 441 SRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLHQRRPPIVHRDLKSPNL 494
S G L K + + + E L + Y + ++ +H R+ ++HRDLKS N+
Sbjct: 148 SGGDLNKQI-----KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANI 200
Query: 495 LVDSTYTVKVCDFGLSRSKPNTYISSKTAA---GTPEWMAPEVLREDPSNEKSDVFSFGV 551
+ T +K+ DFG S+ ++ +S A+ GTP ++APE+ ++K+D++S GV
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDS-VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 611
IL+EL+TL +P++ + +++ V + G+ P V+ + AL++ ++ P +RP+
Sbjct: 260 ILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQ 318
Query: 612 SIMET 616
++ T
Sbjct: 319 QLLHT 323
|
Length = 478 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 68/247 (27%), Positives = 125/247 (50%), Gaps = 22/247 (8%)
Query: 371 KGSFGTVYHA-EWRNSDV----AVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLM 424
+GSFG V+ + D A+K+L + DR + + E I+ + HP IV L
Sbjct: 6 QGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIVKLH 64
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
A L ++ ++L G L+ L + +E ++ +A ++A +++LH I
Sbjct: 65 YAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLH--SLGI 119
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
++RDLK N+L+D +K+ DFGLS+ + + + GT E+MAPEV+ + +
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179
Query: 545 DVFSFGVILWELITLQKPW----RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
D +SFGV+++E++T P+ R T + ++ A +L +P+ ++P +L+ +
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA------KLGMPQFLSPEAQSLLRALF 233
Query: 601 AEEPEIR 607
P R
Sbjct: 234 KRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVLLM 424
KG FG V + + + K+ ++ + R K+ L E I++ + IV L
Sbjct: 3 KGGFGEVCACQVKATG---KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
A +L +V ++ G L ++ + R A + G+ +LHQRR I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQRR--I 116
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLS-----RSKPNTYISSKTAAGTPEWMAPEVLREDP 539
V+RDLK N+L+D V++ D GL+ K AGTP +MAPEVL+ +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR------AGTPGYMAPEVLQGEV 170
Query: 540 SNEKSDVFSFGVILWELITLQKPWR 564
+ D F+ G L+E+I + P+R
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 371 KGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G++ TVY R VA+K I ++ E E +RE+++MK L+H NIV L +
Sbjct: 10 EGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L +V EY+ L K + R +D + Y + KG+ + H+ R ++HR
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHR 124
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKS- 544
DLK NLL++ +K+ DFGL+R+ P S++ T + AP+VL + S
Sbjct: 125 DLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYSTSI 182
Query: 545 DVFSFGVILWELIT 558
D++S G I+ E+IT
Sbjct: 183 DIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 70/258 (27%), Positives = 124/258 (48%), Gaps = 21/258 (8%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMGAV 427
+G++G V + +AVK I + K L ++ I M+ + P V GA+
Sbjct: 11 RGAYGVVDKMRHVPTGTIMAVK-RIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69
Query: 428 TEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
++ I E + SL K + D + + E + +A + K + YLH + ++H
Sbjct: 70 FREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-VIH 127
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA-AGTPEWMAPEVLREDPSNE--- 542
RD+K N+L++ VK+CDFG+S ++ +KT AG +MAPE R +P
Sbjct: 128 RDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPE--RINPELNQKG 183
Query: 543 ---KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKN-VNPMVAALIE 597
KSDV+S G+ + EL T + P+ + TP Q + V + ++P +P +
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEPSPQLPAEKFSPEFQDFVN 242
Query: 598 TCWAEEPEIRPSFPSIME 615
C + + RP++P +++
Sbjct: 243 KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVLLMGA 426
KGSFG V+ AE + ++ A+K L + D E + + + HP + L
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
NL V EYL+ G L + HI R A ++ G+ +LH + IV+
Sbjct: 65 FQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATF-YAAEIICGLQFLHSK--GIVY 119
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK N+L+D+ +K+ DFG+ + + T GTP+++APE+L N D
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 547 FSFGVILWELITLQKPW 563
+SFGV+L+E++ Q P+
Sbjct: 180 WSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLR-HPNIVLLMGA 426
KGSFG V A + S AVK+L + +D + + E I+ R HP + L
Sbjct: 5 KGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC 64
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
P L V E+++ G L + HI +R + R R A ++ + +LH + I++
Sbjct: 65 FQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAA-EITSALMFLHDK--GIIY 119
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK N+L+D K+ DFG+ + ++ T GTP+++APE+L+E D
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAV 575
++ GV+L+E++ P+ + A+
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 60/248 (24%), Positives = 131/248 (52%), Gaps = 16/248 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLMGA 426
+GS+ V + ++ A+K++ ++ ++D ++++ + + HP +V L
Sbjct: 5 RGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 64
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L V EY++ G L + H+ R + +E R A +++ +NYLH+R I++
Sbjct: 65 FQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER--GIIY 119
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK N+L+DS +K+ D+G+ + ++ T GTP ++APE+LR + D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 547 FSFGVILWELITLQKPW----RNSTPSQVISAVGFK---GRRLEIPKNVNPMVAALIETC 599
++ GV+++E++ + P+ + P Q F+ +++ IP++++ A+++++
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239
Query: 600 WAEEPEIR 607
++P+ R
Sbjct: 240 LNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 372 GSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLLMGAV 427
G+FG VY A + V KIL+ E +D F LRE+ I+K L+HPN+V L+
Sbjct: 19 GTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNVVPLIDMA 76
Query: 428 TEPPNLS--------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
E P+ S +VT Y+ L LL P V + E + +G+NYLH+
Sbjct: 77 VERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHE 133
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS------KPNTYISSKTAAGTP----EW 529
I+HRD+K+ N+L+D+ +K+ DFGL+R P T T W
Sbjct: 134 NH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW 191
Query: 530 M-APE-VLREDPSNEKSDVFSFGVILWELITLQKP 562
PE +L E D++ G + E+ T ++P
Sbjct: 192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 33/202 (16%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GS+ TVY + + VA+K I +E E E +RE +++K L+H NIV L +
Sbjct: 16 GSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIH 73
Query: 429 EPPNLSIVTEYLSRG-SLY-----KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
L++V EYL Y L + + R+ + + LR G+ Y HQRR
Sbjct: 74 TKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR---------GLAYCHQRR- 123
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG---TPEWMAPEVLREDP 539
++HRDLK NLL+ +K+ DFGL+R+K + SKT + T + P+VL
Sbjct: 124 -VLHRDLKPQNLLISERGELKLADFGLARAKS---VPSKTYSNEVVTLWYRPPDVLLG-- 177
Query: 540 SNEKS---DVFSFGVILWELIT 558
S E S D++ G I +E+ T
Sbjct: 178 STEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 18/194 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++G V + + VA+K + E +E+ + LRE+ +++ L+ NIV L A
Sbjct: 11 EGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR 70
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L +V EY+ + L L +P+ V E++R + Y + K +++ H+ IVHRD
Sbjct: 71 RRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVR-SYIYQLIKAIHWCHKND--IVHRD 125
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA------PEVLREDPSNE 542
+K NLL+ +K+CDFG +R+ +S + A E++A PE+L P +
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARN-----LSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 543 KSDVFSFGVILWEL 556
D++S G IL EL
Sbjct: 181 AVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 387 VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV-LLMGAVTEPPNLSIVTEYLSRGS 444
VA+K+L + E + F RE A+ L HPNIV LL P L V EY+ +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 445 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYT 501
L ++L D + E RL M V + H + IVHRDLK N++V
Sbjct: 66 LREVLA-ADGALPAGETGRL-ML-QVLDALACAHNQ--GIVHRDLKPQNIMVSQTGVRPH 120
Query: 502 VKVCDFGLSRSKPNTYISSKTAA-------GTPEWMAPEVLREDPSNEKSDVFSFGVILW 554
KV DFG+ P + GTP + APE LR +P SD++++G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 555 ELITLQKPWRNSTPSQVI 572
E +T Q+ + ++ ++++
Sbjct: 181 ECLTGQRVVQGASVAEIL 198
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 38/269 (14%)
Query: 371 KGSFGTVY--HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGA- 426
KG++G V+ + S AVKIL H D +E E I+K L HPN+V G
Sbjct: 28 KGTYGKVFKVLNKKNGSKAAVKIL--DPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 427 ----VTEPPNLSIVTEYLSRGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMNYLHQRR 481
V L +V E + GS+ L+ R ++E + + ++ G+ +LH +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR----- 536
+HRD+K N+L+ + VK+ DFG+S +T + T+ GTP WMAPEV+
Sbjct: 145 --TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202
Query: 537 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA-- 594
+ + + DV+S G+ EL P + P + + +IP+N P +
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIPRNPPPTLHQPE 253
Query: 595 --------LIETCWAEEPEIRPSFPSIME 615
I C ++ E RP+ +++
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 37/255 (14%)
Query: 372 GSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GSFG VY A + R ++V K+ + +++++ ++EV ++ LRHPN + G
Sbjct: 26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+V EY GS +L + + E + + +G+ YLH +HRD
Sbjct: 86 REHTAWLVMEY-CLGSASDILEVHKKPLQEVEIAAI--CHGALQGLAYLHSHE--RIHRD 140
Query: 489 LKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV---LREDPSNEK 543
+K+ N+L+ TVK+ DFG + S N+++ GTP WMAPEV + E + K
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQYDGK 194
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--------- 594
DV+S G+ EL + P N +SA+ I +N +P +++
Sbjct: 195 VDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNDSPTLSSNDWSDYFRN 245
Query: 595 LIETCWAEEPEIRPS 609
+++C + P+ RPS
Sbjct: 246 FVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 69/251 (27%), Positives = 117/251 (46%), Gaps = 18/251 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVLLM 424
KG FG V + R + K+ ++ ++ R K+ + E I+ + IV L
Sbjct: 3 KGGFGEVSACQMRATG---KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 425 GAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
A +L +V ++ G L Y + ++ + E + G+ +LHQRR
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
I++RDLK N+L+D+ V++ D GL+ + +K AGTP +MAPE+L+ + +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE----IPKNVNPMVAALIETC 599
D F+ GV L+E+I + P+R + + K R L P +P + E
Sbjct: 178 VDYFALGVTLYEMIAARGPFR--ARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 600 WAEEPEIRPSF 610
A++PE R F
Sbjct: 236 LAKDPEKRLGF 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 49/274 (17%)
Query: 372 GSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G+FG V A + +VA+K +++ K RE+ ++K LRH NI+ L
Sbjct: 21 GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS 80
Query: 430 P-PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
P ++ VTE L L++LL +R + + ++ Y + +G+ Y+H +VHRD
Sbjct: 81 PLEDIYFVTELLGT-DLHRLL---TSRPLEKQFIQY-FLYQILRGLKYVHS--AGVVHRD 133
Query: 489 LKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEV-LREDPSNEKS 544
LK N+L++ +K+CDFGL+R + Y+S T + APE+ L + +
Sbjct: 134 LKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TRYYRAPEIMLTWQKYDVEV 187
Query: 545 DVFSFGVILWELITLQK--PWRN-------------STPSQVISAVGFKG---------R 580
D++S G I E++ + P ++ + P VI+ + + +
Sbjct: 188 DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPK 247
Query: 581 RLEIP-----KNVNPMVAALIETCWAEEPEIRPS 609
R +P KN +P L+E +P+ R S
Sbjct: 248 REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS 281
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-17
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 406 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 465
L E +++ + HP+++ + + +V + LY L + +D+ L +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIE 163
Query: 466 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 522
+ +G+ YLH +R I+HRD+K+ N+ ++ V + D G ++ P
Sbjct: 164 KQ--ILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----G 215
Query: 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 569
AGT E APEVL D N K+D++S G++L+E++ PS
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 37/255 (14%)
Query: 372 GSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GSFG VY A + RNS+V K+ + +++++ ++EV ++ LRHPN + G
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+V EY GS LL + + + E + + +G+ YLH ++HRD
Sbjct: 86 REHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRD 140
Query: 489 LKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV---LREDPSNEK 543
+K+ N+L+ VK+ DFG + + N ++ GTP WMAPEV + E + K
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQYDGK 194
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--------- 594
DV+S G+ EL + P N +SA+ I +N +P + +
Sbjct: 195 VDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNESPALQSGHWSEYFRN 245
Query: 595 LIETCWAEEPEIRPS 609
+++C + P+ RP+
Sbjct: 246 FVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 49/231 (21%)
Query: 368 NFI-KGSFGTVYHAEWRNSD--VAVK----ILIEQEFHEDRFK--------EFLREVAIM 412
+ +G++G V A + VA+K I I + +DR LRE+ IM
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 413 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---- 468
++H NI+ L+ E +++V + ++ D + VVD ++RL +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS----------DLKKVVDRKIRLTESQVKCI 124
Query: 469 --DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG- 525
+ G+N LH+ +HRDL N+ ++S K+ DFGL+R S +
Sbjct: 125 LLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 526 --------TPE-----WMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKP 562
T + + APE+L + + D++S G I EL+T KP
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKP 232
|
Length = 335 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 69/270 (25%), Positives = 114/270 (42%), Gaps = 41/270 (15%)
Query: 372 GSFGTVYHAEWRNS----------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 421
G+F +Y R +V+V + + H D F ++M L H ++V
Sbjct: 6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLV 64
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
L G N+ +V EY+ G L LH + V +L++A +A ++YL ++
Sbjct: 65 KLYGVCVRDENI-MVEEYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 482 PPIVHRDLKSPNLLV-----DSTYT--VKVCDFG-----LSRSKPNTYISSKTAAGTPEW 529
+VH ++ N+LV + Y +K+ D G LSR + I W
Sbjct: 122 --LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP---------W 170
Query: 530 MAPEVLREDPSNEKS--DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 587
+APE +R ++ D +SFG L E+ + + ++ S RL +P
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDC 230
Query: 588 VNPMVAALIETCWAEEPEIRPSFPSIMETL 617
+A LI CW +P RPSF +I+ L
Sbjct: 231 --AELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 66/197 (33%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 371 KGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G++G VY A R N +A+K I +EQE E +RE++++K ++H NIV L V
Sbjct: 12 EGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVV 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L +V EYL + PD + RL Y + +G+ Y H R ++HR
Sbjct: 71 HSEKRLYLVFEYLDLDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR--VLHR 126
Query: 488 DLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSD 545
DLK NLL+D T +K+ DFGL+R+ + T + APE+L + D
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVD 186
Query: 546 VFSFGVILWELITLQKP 562
++S G I E++ QKP
Sbjct: 187 IWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 62/241 (25%), Positives = 121/241 (50%), Gaps = 11/241 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVLLMGA 426
KGSFG V AE + +D A+KIL + +D E + + + + P + L
Sbjct: 10 KGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC 69
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L V EY++ G L + HI E + A +++ G+ +LH+R I++
Sbjct: 70 FQTVDRLYFVMEYVNGGDL--MYHIQQVGKF-KEPQAVFYAAEISVGLFFLHRR--GIIY 124
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK N+++DS +K+ DFG+ + ++++T GTP+++APE++ P + D
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
+++GV+L+E++ Q P+ ++ ++ + PK+++ ++ + + P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTKHPSK 242
Query: 607 R 607
R
Sbjct: 243 R 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 75/256 (29%), Positives = 125/256 (48%), Gaps = 39/256 (15%)
Query: 372 GSFGTVYHA--EWRNSDVAVKILIE--QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
GSFG VY A N VAVK + ++ +E ++++ ++EV ++ L+HPN + G
Sbjct: 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYKGCY 90
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ +V EY GS LL + + + E + + +G+ YLH ++HR
Sbjct: 91 LKEHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--MIHR 145
Query: 488 DLKSPNLLVDSTYTVKVCDFG-LSRSKP-NTYISSKTAAGTPEWMAPEV---LREDPSNE 542
D+K+ N+L+ VK+ DFG S+S P N+++ GTP WMAPEV + E +
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQYDG 199
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA-------- 594
K DV+S G+ EL + P N +SA+ I +N +P + +
Sbjct: 200 KVDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNDSPTLQSNEWTDSFR 250
Query: 595 -LIETCWAEEPEIRPS 609
++ C + P+ RP+
Sbjct: 251 GFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 50/164 (30%), Positives = 85/164 (51%), Gaps = 22/164 (13%)
Query: 403 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVV 458
+ +RE+ ++ P IV GA +SI E++ GSL ++L IP
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------ 97
Query: 459 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKP 514
E + ++ V +G+ YL ++ I+HRD+K N+LV+S +K+CDFG+S S
Sbjct: 98 -ENILGKISIAVLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155
Query: 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 558
N+++ GT +M+PE L+ +SD++S G+ L E+
Sbjct: 156 NSFV------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 371 KGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGA 426
+G+FG V+ A+K+L + + + +R E I+ P IV L +
Sbjct: 11 RGAFGEVWLV-RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS 69
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+ +L +V EY+ G L LL D V +E R +A V ++ +H+ +H
Sbjct: 70 FQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVL-ALDSVHKLG--FIH 124
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLS-----------------------------RSKPNTY 517
RD+K N+L+D+ +K+ DFGL R
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 570
+ + + GTP+++APEVLR P + D +S GVIL+E++ P+ + T +
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 63/192 (32%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+GS+ TVY + + + VA+K++ QE F +RE +++KGL+H NIVLL +
Sbjct: 15 EGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLHDIIH 73
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L++V EY+ + P + +L L + + +G++Y+HQR I+HRD
Sbjct: 74 TKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIHQRY--ILHRD 128
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS---D 545
LK NLL+ T +K+ DFGL+R+K + T + P+VL S E S D
Sbjct: 129 LKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYSTCLD 186
Query: 546 VFSFGVILWELI 557
++ G I E+I
Sbjct: 187 MWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 60/197 (30%), Positives = 106/197 (53%), Gaps = 17/197 (8%)
Query: 372 GSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G+ G V + + S + + LI E + +RE+ ++ P IV GA
Sbjct: 16 GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-RLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+SI E++ GSL ++L +A+ + +E L ++++A V +G+ YL ++ I+HRD+
Sbjct: 76 GEISICMEHMDGGSLDQVLK--EAKRIPEEILGKVSIA--VLRGLAYLREKHQ-IMHRDV 130
Query: 490 KSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
K N+LV+S +K+CDFG+S S N+++ GT +M+PE L+ + +SD
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSD 184
Query: 546 VFSFGVILWELITLQKP 562
++S G+ L EL + P
Sbjct: 185 IWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 73/284 (25%), Positives = 116/284 (40%), Gaps = 61/284 (21%)
Query: 387 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446
V V+I + E+ K EV + RHPNI+ T L +++ +++ GS
Sbjct: 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 447 KLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 504
LL + P+ + E L N+ + +G+NYLHQ +HR++K+ ++L+ V +
Sbjct: 88 SLLKTYFPEG---MSEALIGNILFGALRGLNYLHQN--GYIHRNIKASHILISGDGLVSL 142
Query: 505 CDFGLSRSKPNTYISSKTAAGTPE-------WMAPEVLREDPS--NEKSDVFSFGVILWE 555
S +K P+ W++PE+LR+D N KSD++S G+ E
Sbjct: 143 SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202
Query: 556 LIT--------------LQK-------PWRNSTPSQ-----------VISAVG------- 576
L T LQK P +T V S +G
Sbjct: 203 LATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262
Query: 577 ----FKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIM 614
RL P K +P L+E C ++PE RPS S++
Sbjct: 263 MTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G++G V A + VA+K L K RE+ ++K + H N++ L+ T
Sbjct: 26 GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP 85
Query: 430 PPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+L +VT + L ++ + + D+ ++ + Y + +G+ Y+H
Sbjct: 86 ASSLEDFQDVYLVTHLMGA-DLNNIVKC---QKLSDDHIQF-LVYQILRGLKYIHSAG-- 138
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEV-LREDP 539
I+HRDLK N+ V+ +K+ DFGL+R + Y+ T + APE+ L
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV------ATRWYRAPEIMLNWMH 192
Query: 540 SNEKSDVFSFGVILWELIT 558
N+ D++S G I+ EL+T
Sbjct: 193 YNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 69/261 (26%), Positives = 125/261 (47%), Gaps = 37/261 (14%)
Query: 372 GSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GSFG VY A + R ++V K+ + +++++ ++EV ++ ++HPN + G
Sbjct: 36 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+V EY GS LL + + + E + + +G+ YLH ++HRD
Sbjct: 96 REHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRD 150
Query: 489 LKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV---LREDPSNEK 543
+K+ N+L+ VK+ DFG + S N+++ GTP WMAPEV + E + K
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAMDEGQYDGK 204
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--------- 594
DV+S G+ EL + P N +SA+ I +N +P + +
Sbjct: 205 VDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNESPTLQSNEWSDYFRN 255
Query: 595 LIETCWAEEPEIRPSFPSIME 615
+++C + P+ RP+ +++
Sbjct: 256 FVDSCLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 52/197 (26%), Positives = 107/197 (54%), Gaps = 9/197 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMK-GLRHPNIVLLMGA 426
+GS+ V E + + A+K++ ++ ++D ++++ E + + HP +V L
Sbjct: 5 RGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSC 64
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L V E++S G L + H+ R + +E R A +++ +N+LH+R I++
Sbjct: 65 FQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNFLHER--GIIY 119
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK N+L+D+ +K+ D+G+ + ++ T GTP ++APE+LR + D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 547 FSFGVILWELITLQKPW 563
++ GV+++E++ + P+
Sbjct: 180 WALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 38/267 (14%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT 428
G++G VY + A+K++ + ED +E E+ ++K H NI GA
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 429 E--PP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+ PP L +V E+ GS+ L+ + ++ + + ++ +G+ +LH +
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLHAHK- 141
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL--REDPS 540
++HRD+K N+L+ VK+ DFG+S T T GTP WMAPEV+ E+P
Sbjct: 142 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200
Query: 541 ---NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--- 594
+ +SD++S G+ E+ P + P + + IP+N P + +
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPPPKLKSKKW 251
Query: 595 ------LIETCWAEEPEIRPSFPSIME 615
IE C + RPS +++
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 27/224 (12%)
Query: 372 GSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G VY H E R KI + ++ ++ E I+ +P +V + +
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+L +V EY+ G LL A V + R+ A V + YLH IVHRD
Sbjct: 72 TKRHLCMVMEYVEGGDCATLLKNIGALPV--DMARMYFAETVL-ALEYLHNY--GIVHRD 126
Query: 489 LKSPNLLVDSTYTVKVCDFGLSR-----SKPNTY----------ISSKTAAGTPEWMAPE 533
LK NLL+ S +K+ DFGLS+ N Y K GTPE++APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 534 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVIS 573
V+ + D ++ G+IL+E + P+ TP QVIS
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 7/200 (3%)
Query: 408 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 467
E I++ ++HP IV L+ A L ++ EYLS G L+ +H+ + +++ ++
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLS 107
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 527
+++ + +LHQ+ I++RDLK N+L+D+ VK+ DFGL + + + T GT
Sbjct: 108 -EISLALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164
Query: 528 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 587
E+MAPE+L + D +S G ++++++T P+ + I + KG +L +P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-LKG-KLNLPPY 222
Query: 588 VNPMVAALIETCWAEEPEIR 607
+ P L++ P R
Sbjct: 223 LTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++ TVY + +D VA+K I E E +REV+++K L+H NIV L +
Sbjct: 16 EGTYATVYKGRSKLTDNLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH 74
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+L++V EYL + L ++ + + +L L + + +G+NY H+R+ ++HRD
Sbjct: 75 TEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL---FQLLRGLNYCHRRK--VLHRD 129
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG--TPEWMAPE--VLREDPSNEKS 544
LK NLL++ +K+ DFGL+R+K I +KT + W P +L + +
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKS---IPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 545 DVFSFGVILWELITLQKPWRNST 567
D++ G I +E+ T + + ST
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 36/206 (17%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVT 428
G+F V A+ R + A+K + + F LRE+ ++ L HPNI+ L+ +
Sbjct: 10 GTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLF 68
Query: 429 EPPN--LSIVTEYLSRGSLYKLL-----HIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
+ L++V E L +LY+L+ +P+ RV + Y + K ++++H R
Sbjct: 69 DRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRV-------KSYMYQLLKSLDHMH--R 118
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM-APEVL 535
I HRD+K N+L+ +K+ DFG R P T YIS++ W APE L
Sbjct: 119 NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTR-------WYRAPECL 170
Query: 536 REDPS-NEKSDVFSFGVILWELITLQ 560
D K D+++ G + +E+++L
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 17/222 (7%)
Query: 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL 415
G +T ++ +GS+ TVY R + VA+K+ I + E +RE +++KGL
Sbjct: 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKV-ISMKTEEGVPFTAIREASLLKGL 60
Query: 416 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475
+H NIVLL + L+ V EY+ ++ P + +RL M + + +G+
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFM-FQLLRGLA 117
Query: 476 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK--PNTYISSKTAAGTPEWMAPE 533
Y+H + I+HRDLK NLL+ +K+ DFGL+R+K P+ SS+ T + P+
Sbjct: 118 YIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 534 VL--REDPSNEKSDVFSFGVILWELITLQK--PWRNSTPSQV 571
VL D S+ D++ G I E++ Q P + Q+
Sbjct: 174 VLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 51/197 (25%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLMGA 426
+GS+ V + +D A+K++ ++ H+D ++++ + + +P +V L
Sbjct: 5 RGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC 64
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L +V EY++ G L + H+ R + +E R A ++ +N+LH+R I++
Sbjct: 65 FQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHER--GIIY 119
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK N+L+D+ +K+ D+G+ + ++ T GTP ++APE+LR + D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 547 FSFGVILWELITLQKPW 563
++ GV+++E++ + P+
Sbjct: 180 WALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 15/196 (7%)
Query: 372 GSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
G+ G V+ + S + + LI E + +RE+ ++ P IV GA
Sbjct: 16 GNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
+SI E++ GSL ++L + E++ ++ V KG+ YL ++ I+HRD+K
Sbjct: 76 GEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMHRDVK 131
Query: 491 SPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
N+LV+S +K+CDFG+S S N+++ GT +M+PE L+ + +SD+
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDI 185
Query: 547 FSFGVILWELITLQKP 562
+S G+ L E+ + P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 367 SNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
F + + N+ VAVK + ++ K +E+ + L+HPNI+ + +
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 427 VTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
L +V+ ++ GS LL H P+ + E + DV ++Y+H +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALDYIHSKG--F 122
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRS-------KPNTYISSKTAAGTPEWMAPEVLRE 537
+HR +K+ ++L+ V + S S + + K++ W++PEVL++
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 538 DPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQ 570
+ NEKSD++S G+ EL P+++ +Q
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 371 KGSFGTVYHA-EWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLM 424
+G++G V+ A + +N VA+K + Q E +REVA+++ L HPN+V L
Sbjct: 11 EGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 70
Query: 425 GAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
T L++V E++ + L +P+ V E ++ +M + + +G+++LH
Sbjct: 71 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT-ETIK-DMMFQLLRGLDFLHS 128
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 539
R +VHRDLK N+LV S+ +K+ DFGL+R + T + APEVL +
Sbjct: 129 HR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSS 185
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNST 567
D++S G I E+ + +R S+
Sbjct: 186 YATPVDLWSVGCIFAEMFRRKPLFRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 32/203 (15%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLL 423
G++G VY A S VA+K + ++ E ++ LRE+ ++ LRHPNIV L
Sbjct: 18 GTYGIVYRARDTTSGEIVALKKVRMDNE------RDGIPISSLREITLLLNLRHPNIVEL 71
Query: 424 MGAVTEPPNLSI--VTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKGMNY 476
V SI V EY + L LL +++V + + +G+ Y
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC-------LMLQLLRGLQY 123
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 536
LH+ I+HRDLK NLL+ +K+ DFGL+R+ T + APE+L
Sbjct: 124 LHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 537 EDPSNEKS-DVFSFGVILWELIT 558
+ + D+++ G IL EL+
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 31/206 (15%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPNIV-- 421
G++G VY A + + VA+K + +E+E KE F LRE+ I+ L+HPNIV
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKE------KEGFPITSLREINILLKLQHPNIVTV 69
Query: 422 --LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
+++G+ + + +V EY+ L L+ + E + + G+ +LH
Sbjct: 70 KEVVVGSNLD--KIYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGVAHLHD 124
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLRE 537
I+HRDLK+ NLL+++ +K+CDFGL+R P + T + APE+L
Sbjct: 125 NW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPELLLG 180
Query: 538 DPS-NEKSDVFSFGVILWELITLQKP 562
+ D++S G I EL+T +KP
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLT-KKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 13/192 (6%)
Query: 405 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-R 463
F E I+ P I L A + NL +V EY G L LL+ + + DE + +
Sbjct: 48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DEDMAQ 105
Query: 464 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKT 522
+A ++ ++ +HQ VHRD+K N+L+D T +K+ DFG + R N ++SK
Sbjct: 106 FYLA-ELVLAIHSVHQM--GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL 162
Query: 523 AAGTPEWMAPEVLREDPSNEKS------DVFSFGVILWELITLQKPWRNSTPSQVISAVG 576
GTP+++APEVL + K D +S GVI +E+I + P+ T ++ + +
Sbjct: 163 PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
Query: 577 FKGRRLEIPKNV 588
R L+ P++
Sbjct: 223 NFQRFLKFPEDP 234
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 416 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475
R P +V L A L ++ +Y++ G L+ H+ + +R+ +A ++ ++
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFT--HLYQREHFTESEVRVYIA-EIVLALD 119
Query: 476 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 534
+LHQ I++RD+K N+L+DS V + DFGLS+ + + GT E+MAPEV
Sbjct: 120 HLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 535 LREDPS--NEKSDVFSFGVILWELITLQKPW 563
+R ++ D +S GV+ +EL+T P+
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++ TV+ + ++ VA+K I E E +REV+++K L+H NIV L +
Sbjct: 15 EGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH 73
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L++V EYL L + + + + ++ + + + +G++Y H+R+ I+HRD
Sbjct: 74 TERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM---FQLLRGLSYCHKRK--ILHRD 128
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS---D 545
LK NLL++ +K+ DFGL+R+K + T + P+VL S E S D
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYSTPID 186
Query: 546 VFSFGVILWELIT 558
++ G IL+E+ T
Sbjct: 187 MWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 371 KGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G++G VY A + + V KI ++ E E +RE++++K L HPNIV L+ +
Sbjct: 10 EGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVI 68
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRRPPIV 485
L +V E+L + L K + DA + L L +Y + +G+ + H R ++
Sbjct: 69 HTENKLYLVFEFLHQ-DLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VL 122
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS- 544
HRDLK NLL+++ +K+ DFGL+R+ + T + APE+L +
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 545 DVFSFGVILWELIT 558
D++S G I E++T
Sbjct: 183 DIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-14
Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 403 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 462
K FLRE I L HP IV + ++ + Y+ +L LL + + + L
Sbjct: 47 KRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL 106
Query: 463 R--------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK- 513
L++ + + + Y+H + ++HRDLK N+L+ V + D+G + K
Sbjct: 107 AEKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164
Query: 514 -------------PNTYISSKTA----AGTPEWMAPEVLREDPSNEKSDVFSFGVILWEL 556
N SS T GTP++MAPE L P++E +D+++ GVIL+++
Sbjct: 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
Query: 557 ITLQKPWRN 565
+TL P+R
Sbjct: 225 LTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGA 426
G++GTVY A +S VA+K + Q + +REVA++K L HPNIV LM
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70
Query: 427 VT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
+++V E++ + L +P + E ++ ++ +G+++LH
Sbjct: 71 CATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPA-ETIK-DLMRQFLRGLDFLHANC 128
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----WMAPEVLR 536
IVHRDLK N+LV S VK+ DFGL+R I S A TP + APEVL
Sbjct: 129 --IVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPEVLL 180
Query: 537 EDPSNEKSDVFSFGVILWELITLQKP 562
+ D++S G I E+ +KP
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 368 NFIK----GSFGTVYHAEWRNSD---VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPN 419
NFI+ GSFG V A ++N D VA+K + + + + E I+ + HP
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
V L G+ + L +V E++ G + L + R D + A + YL
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPND--VGCFYAAQIVLIFEYLQS 149
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLRED 538
IV+RDLK NLL+D +K+ DFG ++ TY T GTPE++APE+L
Sbjct: 150 LN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTPEYIAPEILLNV 203
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTP 568
+ +D ++ G+ ++E++ P+ + P
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 57/191 (29%), Positives = 101/191 (52%), Gaps = 13/191 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++ TV+ + ++ VA+K I E E +REV+++K L+H NIV L V
Sbjct: 16 EGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH 74
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+L++V EYL + + + + + ++ L Y + +G+ Y H+R+ ++HRD
Sbjct: 75 TDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---YQILRGLAYCHRRK--VLHRD 129
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS---D 545
LK NLL++ +K+ DFGL+R+K + T + P+VL S+E S D
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--SSEYSTQID 187
Query: 546 VFSFGVILWEL 556
++ G I +E+
Sbjct: 188 MWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 52/243 (21%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF-----------LREVAIMKGLRHPNI 420
G++G VY A+ +N + I++ FK RE+A+++ L+H N+
Sbjct: 11 GTYGRVYKAKRKNGKDGKEYAIKK------FKGDKEQYTGISQSACREIALLRELKHENV 64
Query: 421 VLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYDVAKG 473
V L+ E + S+ + +Y + + L I RV + + ++ + + G
Sbjct: 65 VSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 474 MNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSR---SKPNTYISSKTAAGT 526
++YLH ++HRDLK N+LV VK+ D GL+R + T
Sbjct: 121 VHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 527 PEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 585
+ APE+L K+ D+++ G I EL+TL+ FKGR +I
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI--------------FKGREAKIK 224
Query: 586 KNV 588
K+
Sbjct: 225 KSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 33/173 (19%)
Query: 407 REVAIMKGLR-HPNIVLLMGAVTEPPN---LSIVTEYLS-------RGSLYKLLHIPDAR 455
RE+ ++ L HPNIV L+ V + N + +V EY+ R ++ + +H R
Sbjct: 55 REIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK---R 110
Query: 456 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515
++ Y + K + Y+H ++HRDLK N+L++S VK+ DFGL+RS
Sbjct: 111 YIM---------YQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 516 TYISSKTAAGT----PEWM-APEVLREDPSNEKS-DVFSFGVILWELITLQKP 562
+ + T W APE+L K D++S G IL E++ L KP
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML-LGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 371 KGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVLLMGA 426
KGSFG V AE + AVK L + D E + + + +P + L
Sbjct: 5 KGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT 64
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+L V E+L+ G L + HI D + D A ++ G+ +LH + I++
Sbjct: 65 FQTKEHLFFVMEFLNGGDL--MFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG--IIY 119
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPEVLREDPSNEKS 544
RDLK N+++D +K+ DFG+ K N + ++ T GTP+++APE+L+
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 585
D +SFGV+L+E++ Q P+ ++ F+ R++ P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 66/242 (27%), Positives = 116/242 (47%), Gaps = 29/242 (11%)
Query: 371 KGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLREVAIMKGLRH----PNIVL 422
+G FG VY R +D A+K L ++ + + IM L P IV
Sbjct: 4 RGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+ A P L + + ++ G L+ H+ V ++ +R A ++ G+ ++H R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF- 117
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAPEVLRED 538
+V+RDLK N+L+D V++ D GL S+ KP+ + GT +MAPEVL++
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQKG 170
Query: 539 PSNEKS-DVFSFGVILWELITLQKPWRN--STPSQVISAVGFKGRRLEIPKNVNPMVAAL 595
+ + S D FS G +L++L+ P+R + I + +E+P + +P + +L
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-VNVELPDSFSPELKSL 229
Query: 596 IE 597
+E
Sbjct: 230 LE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 46/148 (31%), Positives = 77/148 (52%), Gaps = 15/148 (10%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++GTV+ A+ R + VA+K + + E LRE+ ++K L+H NIV L +
Sbjct: 10 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH 69
Query: 429 EPPNLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
L++V EY + L K D +V + M + + KG+ + H +
Sbjct: 70 SDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIV-----KSFM-FQLLKGLAFCHSHN--V 120
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRS 512
+HRDLK NLL++ +K+ DFGL+R+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 15/163 (9%)
Query: 403 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARV 456
K RE+ ++ +H N++ + + +PP++ +VTE L + L+K++ P
Sbjct: 44 KRVFRELKMLCFFKHDNVLSALD-ILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQP-- 99
Query: 457 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN 515
+ + +++ Y + +G+ YLH I+HRD+K NLLV+S +K+CDFGL+R +P+
Sbjct: 100 LSSDHVKV-FLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156
Query: 516 TYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELI 557
T + APE+L D++S G I EL+
Sbjct: 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 53/181 (29%), Positives = 92/181 (50%), Gaps = 15/181 (8%)
Query: 383 RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442
+VA+K L + K RE+ +MK + H NI+ L+ T +L +
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD---- 95
Query: 443 GSLYKLLHIPDARV--VVDERL---RLN-MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496
+Y ++ + DA + V+ L R++ + Y + G+ +LH I+HRDLK N++V
Sbjct: 96 --VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVV 151
Query: 497 DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWEL 556
S T+K+ DFGL+R+ +++ + T + APEV+ E D++S G I+ E+
Sbjct: 152 KSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
Query: 557 I 557
I
Sbjct: 211 I 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 27/241 (11%)
Query: 371 KGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLREVAIMKGLRH----PNIVL 422
+G FG VY R +D A+K L ++ + + IM L P IV
Sbjct: 4 RGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+ A P LS + + ++ G L+ H+ V + +R A ++ G+ ++H R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF- 117
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAPEVLRED 538
+V+RDLK N+L+D V++ D GL S+ KP+ + GT +MAPEVL++
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQKG 170
Query: 539 PSNEKS-DVFSFGVILWELITLQKPWR-NSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596
+ + S D FS G +L++L+ P+R + T + +E+P + +P + +L+
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 230
Query: 597 E 597
E
Sbjct: 231 E 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 44/215 (20%)
Query: 371 KGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPNIVL 422
+G+FG V+ A + + VA+K +L+E E KE F LRE+ I++ L+H N+V
Sbjct: 22 QGTFGEVFKARHKKTKQIVALKKVLMENE------KEGFPITALREIKILQLLKHENVVN 75
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLY-----------KLLHIPDARVVVDERLRLNMAYDVA 471
L+ +GS Y LL + + + E + + +
Sbjct: 76 LIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKMLL 129
Query: 472 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-------SKPNTYISSKTAA 524
G+ Y+H R I+HRD+K+ N+L+ +K+ DFGL+R SKPN Y +++
Sbjct: 130 NGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY-TNRVV- 185
Query: 525 GTPEWMAPEVLREDPS-NEKSDVFSFGVILWELIT 558
T + PE+L + D++ G I+ E+ T
Sbjct: 186 -TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 64/230 (27%), Positives = 115/230 (50%), Gaps = 36/230 (15%)
Query: 404 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARVVV 458
EFL++ + L+HPNI+ +G E +V EY G L L H ++++++
Sbjct: 41 EFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL 100
Query: 459 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL--SRSKPNT 516
+R MA ++A G+ ++H+ +H DL N + S TVKV D+G+ SR K +
Sbjct: 101 LQR----MACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED- 153
Query: 517 YISSKTAAGTP-EWMAPEVLRE-------DPSNEKSDVFSFGVILWELI-TLQKPWRNST 567
YI ++ P W+APE++ E + S+V++ GV LWEL +P+ + +
Sbjct: 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213
Query: 568 PSQVISAVGFKGRRLEIPKNVNPMVA--------ALIETCWAEEPEIRPS 609
+V++ V K +++++ K P + +++ CW PE R +
Sbjct: 214 DREVLNHV-IKDQQVKLFK---PQLELPYSERWYEVLQFCWL-SPEKRAT 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 60/266 (22%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 371 KGSFGTVY---------HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 421
+G+F ++ + E ++V +K+L + H + + F ++M L H ++V
Sbjct: 5 QGTFTKIFKGIRREVGDYGELHKTEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
L G +V EY+ GSL ++ + +++ +L +A +A +++L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLD--TYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 482 PPIVHRDLKSPNLLV-----DSTYT---VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 533
+ H ++ + N+L+ T +K+ D G+S T + + W+ PE
Sbjct: 121 --LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVPPE 174
Query: 534 VLREDPS-NEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591
+ + + +D +SFG LWE+ + KP + + F R ++P
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---FYEDRHQLPAPKWTE 231
Query: 592 VAALIETCWAEEPEIRPSFPSIMETL 617
+A LI C EP+ RPSF +I+ L
Sbjct: 232 LANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMG 425
+G++G V A + VA+K + + K LRE+ +++ R H NI L
Sbjct: 10 QGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLY- 68
Query: 426 AVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMA------YDVAKGMNYLH 478
++ IV LY+ L D ++ L A Y + G+ Y+H
Sbjct: 69 ------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS------KPNTYISSKTAAGTPEWMAP 532
++HRDLK NLLV++ +K+CDFGL+R + +++ A T + AP
Sbjct: 123 SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA--TRWYRAP 178
Query: 533 EVLREDPSNEKS-DVFSFGVILWELITLQKP 562
E++ S K+ DV+S G IL EL+ KP
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGR-KP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 51/178 (28%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 386 DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445
+VA+K L ++ K RE+ +MK + H NI+ L+ T +L + +
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD------V 104
Query: 446 YKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499
Y ++ + DA + ++ L+ + Y + G+ +LH I+HRDLK N++V S
Sbjct: 105 YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSD 162
Query: 500 YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 557
T+K+ DFGL+R+ +++ + T + APEV+ E D++S G I+ E+I
Sbjct: 163 CTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 8/196 (4%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KGSFG V R++ + ++ H L E ++ + P IV L +
Sbjct: 3 KGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF 62
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
P L +V +++ G L+ H+ R R A ++ + LH+ +++R
Sbjct: 63 QSPEKLYLVLAFINGGELFH--HLQREGRFDLSRARFYTA-ELLCALENLHKFN--VIYR 117
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DLK N+L+D + +CDFGL + + T GTPE++APE+L + D +
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 548 SFGVILWELITLQKPW 563
+ GV+L+E++T P+
Sbjct: 178 TLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 386 DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT------EPPNLSIVTEY 439
+VAVK L ++ K RE+ ++K + H NI+ L+ T E ++ +V E
Sbjct: 48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME- 106
Query: 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499
L +L +++H+ +D + Y + G+ +LH I+HRDLK N++V S
Sbjct: 107 LMDANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSD 159
Query: 500 YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 557
T+K+ DFGL+R+ ++ + T + APEV+ E D++S G I+ EL+
Sbjct: 160 CTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 15/180 (8%)
Query: 384 NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443
+ +VA+K L ++ K RE+ +MK + H NI+ L+ T +L +
Sbjct: 42 DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD----- 96
Query: 444 SLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 497
+Y ++ + DA + ++ L+ + Y + G+ +LH I+HRDLK N++V
Sbjct: 97 -VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVK 153
Query: 498 STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 557
S T+K+ DFGL+R+ +++ + T + APEV+ E D++S G I+ E++
Sbjct: 154 SDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 349 RDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL 406
R LQM+ VI +G+FG V ++S A+K+L + E + F
Sbjct: 36 RKLQMKAEDYDVVKVIG-----RGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 407 -REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 465
E IM P +V L A + L +V EY+ G L L+ D V E+
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKF 146
Query: 466 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAA 524
+V ++ +H ++HRD+K N+L+D +K+ DFG T + TA
Sbjct: 147 YTAEVVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 525 GTPEWMAPEVLREDPSN----EKSDVFSFGVILWELITLQKPW 563
GTP++++PEVL+ + + D +S GV L+E++ P+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVLLM 424
KG FG V + +N+ K+ ++ + R K+ L E I++ + P IV L
Sbjct: 3 KGGFGEVCAVQVKNTG---KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 425 GAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
A +L +V ++ G L Y + ++ ++ ++ + + G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
IV+RD+K N+L+D ++ D GL+ + + AGT +MAPE+L+E+P +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYP 174
Query: 544 SDVFSFGVILWELITLQKPWRN 565
D F+ G ++E++ + P+++
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 46/163 (28%), Positives = 86/163 (52%), Gaps = 18/163 (11%)
Query: 406 LREVAIMKGLRHPNIVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVD 459
LRE+ I++ +H NI+ ++ + PP+ IV E + LYKL+ + + +
Sbjct: 51 LREIKILRRFKHENIIGIL-DIIRPPSFESFNDVYIVQELMET-DLYKLIK---TQHLSN 105
Query: 460 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519
+ ++ Y + +G+ Y+H ++HRDLK NLL+++ +K+CDFGL+R +
Sbjct: 106 DHIQY-FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 520 SKTAA---GTPEWMAPEVLREDPSNEKS-DVFSFGVILWELIT 558
+ T + APE++ K+ D++S G IL E+++
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVLLM 424
KG FG V + R + K+ ++ + R K+ L E I++ + +V L
Sbjct: 10 KGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 425 GAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
A L +V ++ G L + + H+ +A +E + A ++ G+ LHQ R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF--EEGRAVFYAAEICCGLEDLHQER-- 122
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
IV+RDLK N+L+D +++ D GL+ P + K GT +MAPEV++ +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 544 SDVFSFGVILWELITLQKPWR 564
D ++ G +L+E+I Q P++
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNIVLLMGA 426
+G++G V A+ N VA+K I F ++R K LRE+ +++ L H N++ +
Sbjct: 15 RGAYGIVCSAKNSETNEKVAIK-KIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 427 VTEPPNLSIVTEYLSRGSLYKL----LH--IPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
+ P + Y+ Y+L LH I ++ + D+ + Y + +G+ Y+H
Sbjct: 73 MPPPHREAFNDVYIV----YELMDTDLHQIIRSSQTLSDDHCQY-FLYQLLRGLKYIHSA 127
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
++HRDLK NLL+++ +K+CDFGL+R+ T + APE+L
Sbjct: 128 N--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185
Query: 541 NEKS-DVFSFGVILWELITLQKP 562
+ DV+S G I EL+ +KP
Sbjct: 186 YTTAIDVWSVGCIFAELLG-RKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 62/247 (25%), Positives = 108/247 (43%), Gaps = 58/247 (23%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGAV 427
+G+FG V + +++ A+K L + E E +R E I+ +P +V L +
Sbjct: 11 RGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPD------ARVVVDERLRLNMAYDVAKGMNYLHQRR 481
+ L ++ EYL G + LL D R + E + +A D + Y
Sbjct: 71 QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI---LAIDSIHKLGY----- 122
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGL----------------SRSKPNTYI------- 518
+HRD+K NLL+D+ +K+ DFGL S + P+ ++
Sbjct: 123 ---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 519 SSK---------------TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 563
SSK + GTP+++APEV + N++ D +S GVI++E++ P+
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
Query: 564 RNSTPSQ 570
+ P +
Sbjct: 240 CSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 405 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---HIPD--ARVVVD 459
F E IM IV L A + L +V EY+ G L L+ IP+ AR
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTA 149
Query: 460 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYI 518
E + +A D M + +HRD+K N+L+D + +K+ DFG + N +
Sbjct: 150 E---VVLALDAIHSMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198
Query: 519 SSKTAAGTPEWMAPEVLREDPSN----EKSDVFSFGVILWELITLQKPW 563
TA GTP++++PEVL+ + + D +S GV L+E++ P+
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG G V+ + + A+K+L ++E + ++ K L E I+ L HP + L +
Sbjct: 11 KGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L +V +Y G L++LL + + +E R A +V + YLH IV+R
Sbjct: 71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLL--GIVYR 127
Query: 488 DLKSPNLLVDSTYTVKVCDFGLS------------------RSKPNTYISSKTAA----- 524
DLK N+L+ + + + DF LS R I S+T +
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 525 ------GTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 557
GT E++APEV+ D D ++ G++L+E++
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 39/211 (18%)
Query: 418 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 477
P +V L A L ++ +Y+S G ++ H+ ++ +R ++ + +L
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFT--HLYQRDNFSEDEVRFYSG-EIILALEHL 121
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTYISSKTAAGTPEWMAP 532
H + IV+RD+K N+L+DS V + DFGLS+ K TY + GT E+MAP
Sbjct: 122 H--KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY----SFCGTIEYMAP 175
Query: 533 EVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591
E++R + K+ D +S G++++EL+T P+ LE +N
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPF-----------------TLEGERNTQSE 218
Query: 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLM 622
V+ I C P FPS + Q L+
Sbjct: 219 VSRRILKC-------DPPFPSFIGPEAQDLL 242
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 27/200 (13%)
Query: 372 GSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAVT 428
G++GTV A R + VA+K L + F + F K RE+ ++K ++H N++ L+ T
Sbjct: 26 GAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT 84
Query: 429 EPPNLSIVTEYL--------SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
+L ++ G L K + + R+ + Y + KG+ Y+H
Sbjct: 85 PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIHA- 136
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM-APEV-LRED 538
I+HRDLK NL V+ +K+ DFGL+R S T W APEV L
Sbjct: 137 -AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEVILNWM 191
Query: 539 PSNEKSDVFSFGVILWELIT 558
+ D++S G I+ E++T
Sbjct: 192 HYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 27/201 (13%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEP 430
GSFG VY A D + K+ I++ + ++K RE+ IMK L H NI+ L TE
Sbjct: 77 GSFGVVYEAIC--IDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTEC 132
Query: 431 PN-------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
L++V E++ + + H + L +Y + + + Y+H +
Sbjct: 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-- 190
Query: 484 IVHRDLKSPNLLVD-STYTVKVCDFG-----LSRSKPNTYISSKTAAGTPEWMAPEV-LR 536
I HRDLK NLL+D +T+T+K+CDFG L+ + +YI S+ + APE+ L
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF------YRAPELMLG 244
Query: 537 EDPSNEKSDVFSFGVILWELI 557
D++S G I+ E+I
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 30/233 (12%)
Query: 370 IKGSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-IMKGLRHPNIVLLMG 425
I G FG V H + V KI+ + F+ V +MK +PN + L
Sbjct: 25 IDGKFGKVSVLKHKPTQKLFV-QKIIKAKNFNAIEPM-----VHQLMKD--NPNFIKLYY 76
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+VT ++ +Y+ G L+ LL + E + + + +N LH+ I+
Sbjct: 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALNDLHKHN--II 131
Query: 486 HRDLKSPNLLVD-STYTVKVCDFGLSRSK--PNTYISSKTAAGTPEWMAPEVLREDPSNE 542
H D+K N+L D + + +CD+GL + P+ Y GT ++ +PE ++ +
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY------DGTLDYFSPEKIKGHNYDV 185
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---RLEIPKNVNPMV 592
D ++ GV+ +EL+T + P++ + + R +L KNV+
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKED-EDEELDLESLLKRQQKKLPFIKNVSKNA 237
|
Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 46/291 (15%)
Query: 371 KGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGA 426
+G++G VY A +N+ V K +E + E LRE+++++ L IV L+
Sbjct: 11 EGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDV 69
Query: 427 V-----TEPPNLSIVTEYLSRG------SLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475
P+L +V EYL S + P + + + Y + KG+
Sbjct: 70 EHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-----LPAKTIKSFMYQLLKGVA 124
Query: 476 YLHQRRPPIVHRDLKSPNLLVDSTYTV-KVCDFGLSR--SKPNTYISSKTAAGTPEWM-A 531
+ H+ ++HRDLK NLLVD + K+ D GL R S P + S T W A
Sbjct: 125 HCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP---VKSYTHEIVTLWYRA 179
Query: 532 PEVLREDPSNEKS-DVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN 589
PEVL D++S G I E+ Q + +S Q++ G E V
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE---QVW 236
Query: 590 PMVAALIETCWAEEPEIRP-----SFPSI----METLQQFLMSSVCQPLSA 631
P V+ L + W E P+ +P + P + ++ LQ+ L + +SA
Sbjct: 237 PGVSKLRD--WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 19/223 (8%)
Query: 349 RDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL 406
RDL+M+ VI +G+FG V +++ A+K+L + E + F
Sbjct: 36 RDLRMKAEDYEVVKVIG-----RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 90
Query: 407 -REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 465
E IM P +V L A + L +V EY+ G L L+ D V E+
Sbjct: 91 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARF 146
Query: 466 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAA 524
+V ++ +H +HRD+K N+L+D + +K+ DFG + + TA
Sbjct: 147 YTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 525 GTPEWMAPEVLREDPSN----EKSDVFSFGVILWELITLQKPW 563
GTP++++PEVL+ + + D +S GV L+E++ P+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 24/198 (12%)
Query: 372 GSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G+V A + VA+K L + F + F K RE+ ++K ++H N++ L+ T
Sbjct: 26 GAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84
Query: 429 EPP------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+ +V Y+ + L K++ P + +++++ + Y + G+ Y+H
Sbjct: 85 SAVSGDEFQDFYLVMPYM-QTDLQKIMGHP----LSEDKVQY-LVYQMLCGLKYIH--SA 136
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM-APEV-LREDPS 540
I+HRDLK NL V+ +K+ DFGL+R + T W APEV L
Sbjct: 137 GIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILNWMHY 192
Query: 541 NEKSDVFSFGVILWELIT 558
N+ D++S G I+ E++T
Sbjct: 193 NQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 62/243 (25%), Positives = 110/243 (45%), Gaps = 43/243 (17%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGAV 427
+G+FG V + +++ A+KIL + + E +R E I+ +V + +
Sbjct: 11 RGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ NL ++ E+L G + LL D + +E + +A V ++ +HQ +HR
Sbjct: 71 QDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVL-AIDSIHQL--GFIHR 125
Query: 488 DLKSPNLLVDSTYTVKVCDFGL------------------------------SRSKPNTY 517
D+K NLL+DS VK+ DFGL S+ K T+
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185
Query: 518 ISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI 572
++ + GTP+++APEV + N+ D +S GVI++E++ P+ + TP +
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 573 SAV 575
V
Sbjct: 246 KKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 48/220 (21%)
Query: 371 KGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVL 422
+G++G VY A +++ VA+K + ++ E KE +RE+ I++ L H NIV
Sbjct: 17 EGTYGQVYKARDKDTGELVALKKVRLDNE------KEGFPITAIREIKILRQLNHRNIVN 70
Query: 423 LMGAVT----------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 472
L VT + +V EY+ L LL V E + + +
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLE--SGLVHFSEDHIKSFMKQLLE 127
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAGT 526
G+NY H++ +HRD+K N+L+++ +K+ DFGL+R S+P T T
Sbjct: 128 GLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT-----NKVIT 180
Query: 527 PEWMAPEVL----REDPSNEKSDVFSFGVILWELITLQKP 562
+ PE+L R P+ DV+S G IL EL T +KP
Sbjct: 181 LWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 60/227 (26%), Positives = 109/227 (48%), Gaps = 13/227 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G+FG V + +N+D A+KIL + E F E ++ + I L A
Sbjct: 11 RGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ NL +V +Y G L LL + R+ D R +A ++ ++ +HQ VHR
Sbjct: 71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA-EMVIAIDSVHQLH--YVHR 126
Query: 488 DLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLR--EDPSNE-- 542
D+K N+L+D +++ DFG + + + S A GTP++++PE+L+ ED +
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYG 186
Query: 543 -KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588
+ D +S GV ++E++ + P+ + + + R + P V
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 403 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI---VTEYLSRGSLYKLLHIPDARVVVD 459
K LRE+ I++ +H NI+ + + P V L L+ ++H + + +
Sbjct: 49 KRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH--SDQPLTE 106
Query: 460 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNT 516
E +R + Y + +G+ Y+H ++HRDLK NLLV+ +++ DFG++R S P
Sbjct: 107 EHIRYFL-YQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 517 YISSKTAAGTPEWM-APEVLREDPS-NEKSDVFSFGVILWELI 557
+ T W APE+L P D++S G I E++
Sbjct: 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 49/281 (17%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KGS+G V A ++ VA+K + + H LRE+ +++ LRHP+IV + +
Sbjct: 10 KGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK-HIM 68
Query: 429 EPPN------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
PP+ + +V E L L++++ D + E + + Y + + + Y+H
Sbjct: 69 LPPSRREFKDIYVVFE-LMESDLHQVIKANDD--LTPEHHQFFL-YQLLRALKYIHTAN- 123
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN---TYISSKTAAGTPEWMAPEVLREDP 539
+ HRDLK N+L ++ +K+CDFGL+R N T I T + APE+
Sbjct: 124 -VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 182
Query: 540 SNEKS--DVFSFGVILWELITLQK--PWRN-------------STPSQVISAVG-FKGRR 581
S D++S G I E++T + P +N + + IS V K RR
Sbjct: 183 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARR 242
Query: 582 --------LEIP-----KNVNPMVAALIETCWAEEPEIRPS 609
+P N +P+ L+E A +P+ RP+
Sbjct: 243 YLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/243 (25%), Positives = 110/243 (45%), Gaps = 43/243 (17%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGAV 427
+G+FG V + +++ A+KIL + + E +R E I+ +V + +
Sbjct: 11 RGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ NL ++ E+L G + LL D + +E + +A V ++ +HQ +HR
Sbjct: 71 QDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVL-AIDAIHQL--GFIHR 125
Query: 488 DLKSPNLLVDSTYTVKVCDFGL------------------------------SRSKPNTY 517
D+K NLL+D+ VK+ DFGL S+ K T+
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185
Query: 518 ISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI 572
++ + GTP+++APEV + N+ D +S GVI++E++ P+ + TP +
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 573 SAV 575
V
Sbjct: 246 RKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 398 HEDRFKEFLREVAIMKGLRHPNIVLLMGA-VTEPPNLSIVTEYLSRGSLYKLLHIPDARV 456
H D F ++M + H ++ + G V N+ +V E++ G L L RV
Sbjct: 56 HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENI-MVEEFVEHGPLDVCLRKEKGRV 114
Query: 457 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-------DSTYTVKVCDFGL 509
V ++ +A +A ++YL + +VH ++ + N+L+ ++ +K+ D G+
Sbjct: 115 PVA--WKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170
Query: 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWEL-ITLQKPWRNST 567
S T +S + W+APE + S + +D +SFG L E+ + P + T
Sbjct: 171 SF----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226
Query: 568 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 617
PS+ F ++ +P+ +A LI C EP RPSF +I+ L
Sbjct: 227 PSE---KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 408 EVAIMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 466
E I++ + HP+I+ L G T I+ Y + LY L + D L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICD---ILAI 187
Query: 467 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKT 522
V + + YLH+ R I+HRD+K+ N+ ++ V + DFG + N Y
Sbjct: 188 ERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG--- 242
Query: 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ 560
AGT APE+L DP D++S G++L+E+ T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 49/206 (23%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 408 EVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 466
E +++ +R P +V L A L ++ +Y++ G L+ H+ ++ +++
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT--HLSQRERFKEQEVQIYS 111
Query: 467 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAAG 525
++ + +LH + I++RD+K N+L+DS V + DFGLS+ + + + G
Sbjct: 112 G-EIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168
Query: 526 TPEWMAPEVLR-EDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 583
T E+MAP+++R D ++K+ D +S GV+++EL+T P+ + + + + E
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228
Query: 584 --IPKNVNPMVAALIETCWAEEPEIR 607
P+ ++ + +I+ ++P+ R
Sbjct: 229 PPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 37/214 (17%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQE---------FHEDRFKEFLREVAIMKGLRHPN 419
+G+FG V + +N+ A+KIL + E F E+R +V ++ G R
Sbjct: 11 RGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREER------DV-LVNGDRRW- 62
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY----DVAKGMN 475
I L A + NL +V +Y G L LL ++RL +MA ++ ++
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLS------KFEDRLPEDMARFYLAEMVLAID 116
Query: 476 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEV 534
+HQ VHRD+K N+L+D +++ DFG R + + S A GTP++++PE+
Sbjct: 117 SVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 535 LR--EDPSNE---KSDVFSFGVILWELITLQKPW 563
L+ ED + D +S GV ++E++ + P+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G+FG VY +N+ AVK++ + + +++ + E + + P IV L ++
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
N+ +V EYL G + LLHI DE + + +VA ++YLH R I+HR
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH--RHGIIHR 128
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 532
DLK N+L+ + +K+ DFGLS+ N ++ TP P
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVLLM 424
KG FG V + R + K+ ++ + R K+ L E I++ + +V L
Sbjct: 10 KGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 425 GAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
A L +V ++ G L + + ++ + DE + A ++ G+ LH+ R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF--DEERAVFYAAEITCGLEDLHRER-- 122
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
IV+RDLK N+L+D +++ D GL+ P + + GT +MAPEV++ +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 544 SDVFSFGVILWELITLQKPWR 564
D + G +++E+I + P+R
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 78/322 (24%), Positives = 130/322 (40%), Gaps = 49/322 (15%)
Query: 294 ETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDL-Q 352
E + ++ + + D D G + D + D A + S ++ +
Sbjct: 20 EAIFSLTGGTDTSDSKDTTGDKFDDCDELGDSDDVTHATDYDADEESLSPQTDVCQEPCE 79
Query: 353 MQNPSGPSTHVIDSSNFIK----GSFGTVY----HAEWRNSDVAVKILIEQEFHEDRFKE 404
+ S P++ V N + GS G V+ H + + V VK + K
Sbjct: 80 TTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KT 132
Query: 405 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD--ERL 462
RE+ I+K + H I+ L+ A + +V YK D VD L
Sbjct: 133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK------YKC----DLFTYVDRSGPL 182
Query: 463 RLNMAYDVAKGM----NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG------LSRS 512
L A + + + YLH R I+HRD+K+ N+ +D + DFG
Sbjct: 183 PLEQAITIQRRLLEALAYLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240
Query: 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWEL----ITLQKPWRNSTP 568
P Y +GT E +PE+L DP K+D++S G++L+E+ +TL S+
Sbjct: 241 TPQCY----GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
Query: 569 SQVISAV-GFKGRRLEIPKNVN 589
SQ+ S + + LE P+N +
Sbjct: 297 SQLRSIIRCMQVHPLEFPQNGS 318
|
Length = 392 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 403 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARV 456
K RE+ ++K ++H N++ L+ T +L +VT + L +I +
Sbjct: 61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQK 116
Query: 457 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516
+ D+ ++ + Y + +G+ Y+H I+HRDLK NL V+ +K+ DFGL+R +T
Sbjct: 117 LTDDHVQF-LIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HT 170
Query: 517 YISSKTAAGTPEWMAPEV-LREDPSNEKSDVFSFGVILWELIT 558
T + APE+ L N+ D++S G I+ EL+T
Sbjct: 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV-----LLM 424
GS G V+ A + D VAVK ++ + K LRE+ I++ L H NIV L
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVYEVLGP 73
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLHQR 480
++ +TE S + + + A V+ L A Y + +G+ Y+H
Sbjct: 74 SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA 133
Query: 481 RPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSK---TAAGTPEWM-APEVL 535
++HRDLK N+ +++ +K+ DFGL+R Y S K + +W +P +L
Sbjct: 134 N--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY-SHKGYLSEGLVTKWYRSPRLL 190
Query: 536 REDPSN--EKSDVFSFGVILWELIT 558
P+N + D+++ G I E++T
Sbjct: 191 LS-PNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVLLM 424
KG FG V + R + K+ + + R K+ L E I++ + +V L
Sbjct: 10 KGGFGEVCACQVRATG---KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
A L +V ++ G L HI + +E L A ++ G+ LH+
Sbjct: 67 YAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEILCGLEDLHREN-- 122
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
V+RDLK N+L+D +++ D GL+ P S + GT +MAPEVL
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 544 SDVFSFGVILWELITLQKPWR 564
D + G +++E+I Q P+R
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 32/236 (13%)
Query: 408 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 467
E+A M L+HPNIV L+G ++ EY+ +L ++L R + ER R +A
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWER-RRKIA 786
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSP-NLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT 526
+AK + +LH R P V SP +++D + S P + +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-----LSLPGLLCTDTKCFIS 841
Query: 527 PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------ 580
++APE EKSD++ FG+IL EL+T + P V ++ R
Sbjct: 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDC 899
Query: 581 ----------RLEIPKNVNPMVAA--LIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
R ++ N N +V L C A +P RP +++TL+ SS
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 19/195 (9%)
Query: 372 GSFGTV---YHAEWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G++G+V Y R VAVK L + H R RE+ ++K ++H N++ L+
Sbjct: 26 GAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHARRT---YRELRLLKHMKHENVIGLLD 81
Query: 426 AVTEPPNLSIVTE-YLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
T ++ E YL + L +I + + DE ++ + Y + +G+ Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLRGLKYIHS--AG 138
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDPSNE 542
I+HRDLK N+ V+ +++ DFGL+R + T + APE+ L N+
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VATRWYRAPEIMLNWMHYNQ 195
Query: 543 KSDVFSFGVILWELI 557
D++S G I+ EL+
Sbjct: 196 TVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 459 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518
DE+ + A ++ G+ L + R IV+RDLK N+L+D +++ D GL+ P
Sbjct: 100 DEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156
Query: 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 564
+ + GT +MAPEV+ + D + G +++E+I Q P+R
Sbjct: 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 6e-09
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 51/274 (18%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V+ + + + K + + E + + EV +M+ L+H NIV +
Sbjct: 24 GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83
Query: 430 PPN--LSIVTEYLSRGSL-------YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
N L I+ E+ G L YK+ + +VD +L A + Y H
Sbjct: 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA------LAYCHNL 137
Query: 481 R-----PPIVHRDLKSPNLLVDSTY-----------------TVKVCDFGLSRSKPNTYI 518
+ ++HRDLK N+ + + K+ DFGLS+ N I
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---NIGI 194
Query: 519 SS--KTAAGTPEWMAPEVLREDPS--NEKSDVFSFGVILWELITLQKPWRNSTP-SQVIS 573
S + GTP + +PE+L + ++KSD+++ G I++EL + + P+ + SQ+IS
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254
Query: 574 AVGFKGRRLEI---PKNVNPMVAALIETCWAEEP 604
+ +G L I K +N ++ L+ E P
Sbjct: 255 ELK-RGPDLPIKGKSKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 58/232 (25%), Positives = 110/232 (47%), Gaps = 23/232 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G+FG V + ++++ A+KIL + E F E ++ I L A
Sbjct: 11 RGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY----DVAKGMNYLHQRRPP 483
+ L +V +Y G L LL ++RL +MA ++ ++ +HQ
Sbjct: 71 QDENYLYLVMDYYVGGDLLTLLS------KFEDRLPEDMARFYIAEMVLAIHSIHQLH-- 122
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFG--LSRSKPNTYISSKTAAGTPEWMAPEVLR--EDP 539
VHRD+K N+L+D +++ DFG L ++ T + S A GTP++++PE+L+ ED
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDG 181
Query: 540 SNE---KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588
+ + D +S GV ++E++ + P+ + + + R + P ++
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 398 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 457
H D F ++M+ + H +IVLL G +V E++ G L +H V
Sbjct: 44 HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDV 101
Query: 458 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-----DSTYT--VKVCDFGLS 510
+ + +A +A ++YL + +VH ++ + N+L+ D +K+ D G+
Sbjct: 102 LTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI- 158
Query: 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK--SDVFSFGVILWEL-ITLQKPWRNST 567
P T +S + W+APE + ED N +D +SFG LWE+ + P ++ T
Sbjct: 159 ---PITVLSRQECVERIPWIAPECV-EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214
Query: 568 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 614
+ F + + +A L+ C +P RP F +IM
Sbjct: 215 ---LAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 60/256 (23%), Positives = 99/256 (38%), Gaps = 73/256 (28%)
Query: 372 GSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLR--EVAIMKGLR-------HP 418
G+FG V R D A+K L R + L + A +K R +
Sbjct: 12 GAFGEVCLV--RKVDTNALYAMKTL--------RKADVLMRNQAAHVKAERDILAEADNE 61
Query: 419 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-RLNMAYDVAKGMNYL 477
+V L + + NL V +Y+ G + LL + +E L R +A ++ + +
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIA-ELTCAIESV 117
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----------------------SRSKPN 515
H + +HRD+K N+L+D +K+ DFGL S
Sbjct: 118 H--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 516 TY---------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILW 554
+ + + GTP ++APEVL + D +S GVIL+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 555 ELITLQKPWRNSTPSQ 570
E++ Q P+ TP++
Sbjct: 236 EMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 27/160 (16%)
Query: 408 EVAIMKGLRHPNIVLLM-----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 462
E +++ L HP ++ L+ G +T ++ +Y R LY L AR+
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLT----CLVLPKY--RSDLYTYL---GARLRPLGLA 260
Query: 463 RLN-MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL------SRSKPN 515
++ +A + ++Y+H I+HRD+K+ N+LV+ + + DFG S S P
Sbjct: 261 QVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWE 555
Y AGT + APEVL DP D++S G++++E
Sbjct: 319 HY----GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 52/235 (22%), Positives = 103/235 (43%), Gaps = 30/235 (12%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
+G++G VY A+ ++ + ++Q RE+A+++ L+HPN++ L
Sbjct: 11 RGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH 70
Query: 431 PNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRL------NMAYDVAKGMNYLHQRRPP 483
+ + + + L+ ++ A + ++L ++ Y + G++YLH
Sbjct: 71 SDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-- 128
Query: 484 IVHRDLKSPNLLV----DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWM-APEVLR 536
++HRDLK N+LV VK+ D G +R + P ++ W APE+L
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 537 EDPSNEKS-DVFSFGVILWELITLQ-------------KPWRNSTPSQVISAVGF 577
K+ D+++ G I EL+T + P+ + ++ S +GF
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 68/241 (28%)
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPD--ARVVVDERLRLNMAYDVAKG 473
+V L + + NL V +Y+ G + LL P+ AR + E L +A +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAE---LTLAIESVHK 119
Query: 474 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-------------- 519
M + +HRD+K N+L+D +K+ DFGL T+ S
Sbjct: 120 MGF--------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 520 ---------------------------------SKTAAGTPEWMAPEVLREDPSNEKSDV 546
+ + GTP ++APEVL + D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV--NPMVAALIET--CWAE 602
+S GVIL+E++ Q P+ TP++ V L IP V +P LI C AE
Sbjct: 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291
Query: 603 E 603
E
Sbjct: 292 E 292
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 68/256 (26%), Positives = 113/256 (44%), Gaps = 46/256 (17%)
Query: 376 TVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGAVTEPPNL 433
TV A ++ + V + I E + FL+ E+ + K HPNIV L
Sbjct: 15 TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74
Query: 434 SIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAY---DVAKGMNYLHQRRPPIVHRD 488
+VT +++ GS L+ H D L +AY V K ++Y+H VHR
Sbjct: 75 WVVTSFMAYGSAKDLICTHFMDGMS------ELAIAYILQGVLKALDYIHHM--GYVHRS 126
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-----------SKTAAGTPEWMAPEVLRE 537
+K+ ++L+ + KV GL RS + I+ K + W++PEVL++
Sbjct: 127 VKASHILI--SVDGKVYLSGL-RSN-LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ 182
Query: 538 DPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595
+ + KSD++S G+ EL P+++ +Q+ LE +N V L
Sbjct: 183 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---------LLE---KLNGTVPCL 230
Query: 596 IETCW--AEEPEIRPS 609
++T AEE ++PS
Sbjct: 231 LDTTTIPAEELTMKPS 246
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
+G++G VY A+ ++ ++Q RE+A+++ L+HPN++ L
Sbjct: 11 RGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH 70
Query: 431 PNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRL------NMAYDVAKGMNYLHQRRPP 483
+ + + + L+ ++ A + ++L ++ Y + G++YLH
Sbjct: 71 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 128
Query: 484 IVHRDLKSPNLLV----DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWM-APEVLR 536
++HRDLK N+LV VK+ D G +R + P ++ W APE+L
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 537 EDPSNEKS-DVFSFGVILWELIT 558
K+ D+++ G I EL+T
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 50/202 (24%), Positives = 78/202 (38%), Gaps = 64/202 (31%)
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPD--ARVVVDERLRLNMAYDVAKG 473
+V L + + NL V +Y+ G + LL P+ AR + E L A +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE---LTCAVESVHK 119
Query: 474 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL------------------------ 509
M + +HRD+K N+L+D +K+ DFGL
Sbjct: 120 MGF--------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 510 ---------------SRSKPNTYISSK--------TAAGTPEWMAPEVLREDPSNEKSDV 546
R KP +++ + GTP ++APEVL + D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 547 FSFGVILWELITLQKPWRNSTP 568
+S GVIL+E++ Q P+ TP
Sbjct: 232 WSVGVILYEMLVGQPPFLAQTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 51/235 (21%), Positives = 98/235 (41%), Gaps = 55/235 (23%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG+FG V + +++ A+K L++ E F +D+ E ++ P +V L +
Sbjct: 11 KGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF 70
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ L ++ E+L G L +L D ++ R MA + + +H + +HR
Sbjct: 71 QDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMA-ECVLAIEAVH--KLGFIHR 125
Query: 488 DLKSPNLLVDSTYTVKVCDFGLS------------------------------------- 510
D+K N+L+D +K+ DFGLS
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 511 -----RSKPNTYISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWE 555
+ + T+ ++ + GTP+++APE+ + ++ D +S G I++E
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 32/154 (20%), Positives = 63/154 (40%), Gaps = 33/154 (21%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR------EVAIMK-----GLRHPN 419
KG+ +Y ++ +K + + + E +R E ++ G+ P
Sbjct: 4 KGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTP- 62
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
+V + +P N +IV EY + + V++E + ++ + + LH
Sbjct: 63 VVYDV----DPDNKTIVMEY---------IEGKPLKDVIEEG-NDELLREIGRLVGKLH- 107
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVC--DFGLSR 511
+ IVH DL + N++V K+ DFGL +
Sbjct: 108 -KAGIVHGDLTTSNIIVRDD---KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 32/154 (20%), Positives = 63/154 (40%), Gaps = 30/154 (19%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR------EVAIMK-----GLRHPN 419
+G+ +Y ++ +K I + + E +R E IM G+ P
Sbjct: 6 RGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVP- 64
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE--RLRLNMAYDVAKGMNYL 477
V + +P N IV EY+ L + +++ L ++ ++ + + L
Sbjct: 65 AVYFV----DPENFIIVMEYIEGEPL---------KDLINSNGMEELELSREIGRLVGKL 111
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511
H I+H DL + N+++ S + + DFGL+
Sbjct: 112 HSAG--IIHGDLTTSNMIL-SGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 9/86 (10%)
Query: 372 GSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 423
G+FG V A E VAVK+L + H D + + E+ I+ L +H NIV L
Sbjct: 49 GAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDEREALMSELKILSHLGQHKNIVNL 107
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL 449
+GA T + ++TEY G L L
Sbjct: 108 LGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 19/47 (40%), Positives = 29/47 (61%)
Query: 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 571
GTP+++APE+L P D ++ GV L+E +T P+ + TP QV
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQV 588
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 634 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.13 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.01 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.77 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.75 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.64 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.63 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.58 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.48 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.38 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.29 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 97.23 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.06 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.03 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.97 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.42 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 96.33 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.21 | |
| PLN02236 | 344 | choline kinase | 96.19 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.13 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 96.04 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.02 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.96 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.48 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.4 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.28 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.1 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.01 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.89 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.68 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-69 Score=523.42 Aligned_cols=200 Identities=52% Similarity=0.870 Sum_probs=189.1
Q ss_pred CchhhhhhhhhhcCccccCCCCCCceeeeeccCcccccccc-cc-ccCCCCCCcccccccCCCCCcceeEEEEecCCChh
Q 006703 59 DSAETVSHRFWVNGCLSYFDRILDGFYLIHGMDPYTWSIGT-NQ-RDAGLIPPYKSLKAVDPCNNLSIKVILIDKSSDPN 136 (634)
Q Consensus 59 ~~~~~~s~~~w~~~~l~~~~~i~dgfy~i~~~~~~~~~~~~-~~-~~~~~~p~~~~l~~~~~~~~~~~evilvd~~~D~~ 136 (634)
++||++|||||++|+|||+||||||||+|+||| |+ ++ .+.|||||+++|+++++ +++++|||||||++|++
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~------~~~~l~~~~~~~Psl~~L~~~~~-~~~~~EvIlVDr~~D~~ 73 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMD------CTNSLKEEFGRMPSLEDLQAVPP-DDSSREVILVDRRRDPS 73 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCC------CccccccccCCCCCHHHHhcCCC-CCCCeeEEEEccccCHH
Confidence 589999999999999999999999999999986 63 55 68999999999999994 68899999999999999
Q ss_pred HHHHHHHHHHHhhccC-CHHHHHHHHHHHHHhhcCCCCCCchhHhhhhHHHHHHHHHhhhCCeeeeeccccccccchhHH
Q 006703 137 LKELHNRVLSLLCDRI-TAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRAL 215 (634)
Q Consensus 137 L~~l~~~~~~~~~~~~-~~~~~~~~l~~~v~~~mg~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~g~~~~g~~rhra~ 215 (634)
|++|+|+|+++++++. ++++++++||++||++|||++.+++.. ..+|+.++++||. +++++|||+|++|+||||||
T Consensus 74 L~~L~~~a~~~~~~~~~~~~~~v~~LA~lVa~~MGG~~~~~~~~-~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRAL 150 (204)
T PF14381_consen 74 LKELEQRAHELSKGLSTNTKELVQKLAKLVADRMGGPVSDAEDM-LFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRAL 150 (204)
T ss_pred HHHHHHHHHHHHhccccCHHHHHHHHHHHHHHHhCCCCCcchhh-hHHHHHHHHHHHh--CCCeEEEeeecccchHHHHH
Confidence 9999999999999977 699999999999999999999987776 4589999998988 89999999999999999999
Q ss_pred HHHHHhhhcCCCceeeccccCCCC-CCCceEEEEecCCcceeeeccCCCCCcCC
Q 006703 216 LFKVLADLINLPCRIAKGCKYCRR-DDASSCLVQIGPDREYLVDLLEDPGVLSK 268 (634)
Q Consensus 216 lfk~lad~~~~~~~l~~g~~~~~~-~~~~~~~v~~~~~~~~~vd~~~~~g~l~~ 268 (634)
|||||||+||||||||||++|||+ +++++|+|++++++||+||||+.||+|++
T Consensus 151 LFKvLAD~iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 151 LFKVLADRIGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred HHHHHHHhcCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 999999999999999999999999 99999999999999999999999999974
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=402.21 Aligned_cols=261 Identities=48% Similarity=0.804 Sum_probs=238.2
Q ss_pred eeecceeeccCcEEEEEEEEcCCc-EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-cEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-NLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~~-vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~-~~~lV~E~~ 440 (634)
+...+.||+|+||+||+|.++++. ||+|++..........++|.+|+.+|.+++|||||+++|++.... .++|||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344456999999999999999999 999999888776666789999999999999999999999999988 799999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCccCCCCccc
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~~~~~~~~ 519 (634)
++|+|.++++.. .+..++...++.++.||++||.|||++++ ||||||||+|||++.++ ++||+|||+++........
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 999999999864 33469999999999999999999999986 99999999999999997 9999999999876654334
Q ss_pred CCCCCCCCcccCccccc--CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~--~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
.....||+.|||||++. ...++.|+||||||+++|||+||+.||....+.+....+.....++.+|..+++.+..++.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~ 280 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLME 280 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 45578999999999999 6699999999999999999999999999999988888888899999999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
+||..||.+||++.+|+..|+.+...-.
T Consensus 281 ~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 281 RCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 9999999999999999999999988644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=383.14 Aligned_cols=247 Identities=30% Similarity=0.507 Sum_probs=221.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc-EEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-LSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~-~~lV 436 (634)
...+...+.||+|..|+||+++++.++ +|+|++. -...+...+++.+|+++++.++||+||.+|++|..+.. .+|+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 356777889999999999999999665 9999984 34567777999999999999999999999999999985 9999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||++|+|.+++...+ .++|....+|+.+|++||.|||. ++ ||||||||+||||+.+|.+||||||.+....+
T Consensus 157 mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 99999999999987543 49999999999999999999996 78 99999999999999999999999999988766
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhhcCcccCCCCC-Cc
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS-----TPSQVISAVGFKGRRLEIPKN-VN 589 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~-~s 589 (634)
. ...+.+||..|||||.+.+..|+.++||||||++++||++|+.||... ...+...+|. ....+.+|.. ++
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEFS 308 (364)
T ss_pred h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccCC
Confidence 5 567889999999999999999999999999999999999999999775 4556666663 3456677776 99
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++++.|+..||.+||.+|||+.|+++
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=397.00 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=228.7
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|||++||.+++. +..||+|++.+... +....+.+.+|+++.++|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 67999999999999999999985 44599999987655 3445577889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|+|..++|..++++. ..++|..+..+++||+.||.|||+++ |+|||||..|+|++++.++||+|||+|.......
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999999744 35999999999999999999999999 9999999999999999999999999999887766
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
....+.+|||.|.|||++....++..+||||+||++|-|+.|++||...+..+....+ ......+|..++.+.++||.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I--k~~~Y~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI--KLNEYSMPSHLSAEAKDLIR 250 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH--HhcCcccccccCHHHHHHHH
Confidence 6778999999999999999999999999999999999999999999999999988888 44556678899999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~ 615 (634)
++|+.||.+|||+++|+.
T Consensus 251 ~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHhcCCcccCCCHHHHhc
Confidence 999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=371.22 Aligned_cols=259 Identities=26% Similarity=0.433 Sum_probs=227.4
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeec-eeecCCc-EEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG-AVTEPPN-LSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~-~~~~~~~-~~l 435 (634)
...|...++||.|+||+||+++...+ .+|.|.+.....+.........|+.+|++|+|||||++++ .|.++.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35688899999999999999987644 4999999887788888888999999999999999999999 4444444 899
Q ss_pred EEeecccCCHHHHhc-cCCCcccccHHHHHHHHHHHHHHHHHHHhCCC--CEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 436 VTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQRRP--PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 436 V~E~~~ggsL~~ll~-~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~--~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
|||+|.+|+|..+++ .++.+..+++..+|+++.|++.||.++|++-+ .|+||||||.||+++.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999995 33445569999999999999999999999433 499999999999999999999999999999
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC-CCCcHH
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPM 591 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~ 591 (634)
+.+......+.+|||.||+||.+.+.+|+.++||||+||++|||+..+.||.+.+-.+....|... .-+++| ..++..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHYSTD 256 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHhhhH
Confidence 887776778889999999999999999999999999999999999999999999988888888644 444566 778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
+..||..|+..||+.||+.-.++..++.
T Consensus 257 l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 9999999999999999997555555544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=373.26 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=220.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||+||.++.++++ +|+|++++...- ....+....|..+|.+++||.||+++..|++...+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3478899999999999999999888665 999999887653 3467888999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|+||+.||.|...|++.. .+++..+.-++.+|+.||.|||++| ||||||||+|||+|..|+++|+|||+++..-.
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999998654 3999999999999999999999999 99999999999999999999999999997555
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
....+.+.+||+.|||||++.+.+++..+|+||||+++|||++|.+||...+..++...+.. ...+..|..++++.+++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~-~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK-GKLPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-CcCCCCCccCCHHHHHH
Confidence 55567788999999999999999999999999999999999999999999999988888843 22355566699999999
Q ss_pred HHHhhhcCCCCCC
Q 006703 596 IETCWAEEPEIRP 608 (634)
Q Consensus 596 i~~cL~~dP~~RP 608 (634)
+.++|+.||++|.
T Consensus 257 l~~LL~rdp~~RL 269 (357)
T KOG0598|consen 257 LKKLLKRDPRQRL 269 (357)
T ss_pred HHHHhccCHHHhc
Confidence 9999999999995
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=377.36 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=218.2
Q ss_pred ccccCCCCCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHH-----HHHHHHHHHHHHHhCCCCCeeee
Q 006703 351 LQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHED-----RFKEFLREVAIMKGLRHPNIVLL 423 (634)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~-----~~~~~~~El~iL~~l~h~nIv~l 423 (634)
.....+...+..|+..+.||+|+||.|-+|..+. +.||||++.+...... ......+|+++|++++|||||++
T Consensus 162 ~~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~ 241 (475)
T KOG0615|consen 162 SSKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI 241 (475)
T ss_pred hccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence 3444555677899999999999999999997764 4599999987654321 12335799999999999999999
Q ss_pred eceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC---C
Q 006703 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---Y 500 (634)
Q Consensus 424 ~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~---~ 500 (634)
+++|..++..||||||++||.|.+.+-.+. .+.+..-..+++||+.|+.|||++| |+||||||+|||++.+ .
T Consensus 242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 242 KDFFEVPDSSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred eeeeecCCceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcce
Confidence 999999999999999999999999986544 4788888999999999999999999 9999999999999765 7
Q ss_pred cEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCC---CchHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHh
Q 006703 501 TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS---NEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVG 576 (634)
Q Consensus 501 ~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~---s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~-~~~~i~ 576 (634)
.+||+|||+|+...+. ...++.+|||.|.|||++.+... ..++|+|||||+||-+++|.+||....... ....+.
T Consensus 317 llKItDFGlAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~ 395 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL 395 (475)
T ss_pred EEEecccchhhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence 8999999999987643 35689999999999999987764 348899999999999999999998866554 555553
Q ss_pred hcC--cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 577 FKG--RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 577 ~~~--~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
... .-+.....++++..+||.+||..||++|||+.+.|.
T Consensus 396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222 223445689999999999999999999999999876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=370.51 Aligned_cols=251 Identities=27% Similarity=0.475 Sum_probs=223.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||.|+||+||+|+++.+ .||||.+.+........+.+..|+.+|+.++|||||.+++++..++.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 447788889999999999999998754 499999998877777778899999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC------CcEEEEecCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST------YTVKVCDFGLS 510 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~------~~ikL~DFGla 510 (634)
||||.||+|.+|+++.+ .+++..+..++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999998665 4999999999999999999999999 9999999999999754 46899999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-cCCCCCCc
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-LEIPKNVN 589 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s 589 (634)
+..... ....+.+|+|-|||||++..++|+.|+|+||+|++||+|++|+.||...++.+....+...... +.++..++
T Consensus 163 R~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 163 RFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred hhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 987644 3567889999999999999999999999999999999999999999999999988877554443 34455677
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+.+++...+..+|..|-++.+...
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhh
Confidence 77889999999999999988776543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.35 Aligned_cols=240 Identities=26% Similarity=0.435 Sum_probs=220.1
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
....+|...+.||.|+||+|.+++.+.++ +|+|++.+... .-.+.+...+|.++|+.+.||+++++++.+.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 34467888999999999999999988655 99999987765 3456677889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
|||||++||.|..++++.+ .+++..+..++.||+.||+|||+++ |++|||||+|||+|++|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999998655 3999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
. .+.+.+|||.|+|||+++.+++++++|+|||||++|||+.|.+||...++.++...| ......+|...+..+++
T Consensus 196 ~---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--~~~~v~fP~~fs~~~kd 270 (355)
T KOG0616|consen 196 G---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--LEGKVKFPSYFSSDAKD 270 (355)
T ss_pred C---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--HhCcccCCcccCHHHHH
Confidence 4 357889999999999999999999999999999999999999999999998888888 55667789999999999
Q ss_pred HHHHhhhcCCCCC
Q 006703 595 LIETCWAEEPEIR 607 (634)
Q Consensus 595 Li~~cL~~dP~~R 607 (634)
|+.++|..|-.+|
T Consensus 271 Ll~~LL~vD~t~R 283 (355)
T KOG0616|consen 271 LLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHhhhhHhh
Confidence 9999999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.75 Aligned_cols=259 Identities=37% Similarity=0.628 Sum_probs=232.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
...+...+.||+|-||.||.|.++++ +||+|.++...... ..|.+|+.+|++|+|+|||++++++..+..+|||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 35566678999999999999999987 79999998765544 467799999999999999999999999889999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|++.|+|.++|+..+ ...+...+.+.++.|||+|++||++++ +|||||-..||||+.+..+||+|||+|+...+..+
T Consensus 282 ~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999998633 345888999999999999999999999 99999999999999999999999999997655544
Q ss_pred c-CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 519 S-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 519 ~-~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
. .....-+..|+|||.+....++.+||||||||+||||+| |+.||.+....+++..+. .+.+++-|..+|+++.+++
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHHHHHHH
Confidence 3 334445679999999999999999999999999999999 899999999999998884 6778888999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
..||..+|++||||..+...|+.+.....
T Consensus 438 ~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 99999999999999999999999887544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=365.42 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=223.7
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCc
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~ 432 (634)
.....+|+.++.||+|+|++|++|+.+.++ ||||++.+..+ .+...+-+..|-.+|.+| .||.|++++..|+|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344578999999999999999999887554 99999876644 333445577899999999 89999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+|+|+||+++|+|.+++++.+ .+++.-+..++.+|+.||+|||++| ||||||||+|||+|+++++||+|||.|..
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999998765 4999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCccc-----------C--CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 006703 513 KPNTYIS-----------S--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 579 (634)
Q Consensus 513 ~~~~~~~-----------~--~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~ 579 (634)
+...... + ...+||..|.+||++.....++.+|+|+|||+||.|+.|++||.+.++.-+.+.| ..
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~ 301 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QA 301 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HH
Confidence 5432111 1 4578999999999999999999999999999999999999999999998888877 45
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+|+..++.+.+||+++|..||.+|+|..+|.+
T Consensus 302 l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 302 LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 667788999999999999999999999999988875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=367.23 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=223.4
Q ss_pred cccCCCCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceee
Q 006703 352 QMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428 (634)
Q Consensus 352 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~ 428 (634)
+.+........|..++.||+|+||.||+|+.++++ +|+|++++... ...+.+....|-.+|....+|+||+++..|+
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 33444556688999999999999999999988776 99999988765 5567788899999999999999999999999
Q ss_pred cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
+..++||||||++||++..+|.+.+ .+++..+..++.+++.|++.||+.| +|||||||+|+|||..|++||+|||
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeecccc
Confidence 9999999999999999999998665 4999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCC-----------------------Ccc-----c-------------------CCCCCCCCcccCcccccCCCCC
Q 006703 509 LSRSKPN-----------------------TYI-----S-------------------SKTAAGTPEWMAPEVLREDPSN 541 (634)
Q Consensus 509 la~~~~~-----------------------~~~-----~-------------------~~~~~gt~~y~APEvl~~~~~s 541 (634)
++..... ... . ....+|||.|+|||++.+.+|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 9852110 000 0 1234599999999999999999
Q ss_pred chHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 006703 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPS---FPSIM 614 (634)
Q Consensus 542 ~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Li~~cL~~dP~~RPs---~~~Il 614 (634)
..+|+||||||+||||.|.+||...++.++...+..+......| ..++++..+||.+||. ||++|.- +.||.
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999999999999999999999999999987776556555 4578999999999999 9999965 55543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.75 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=212.0
Q ss_pred ceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|....++|+|+||.||++++++++ ||||++....-++...+-.++|+++|++++|+|+|.++.+|.....+++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 5677889999999999999998776 99999988877677667789999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
|+..-|.++-+.++ .++...+.++++|+++|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....+...
T Consensus 83 ~dhTvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 83 CDHTVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred cchHHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 98866665544333 3889999999999999999999999 999999999999999999999999999987654444
Q ss_pred CCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-------------------C
Q 006703 520 SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------------G 579 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-------------------~ 579 (634)
-...+.|.+|+|||.+.| .+|++.+||||+||++.||++|++.|.+...-+....|... +
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 456678999999999988 78999999999999999999999999998876655444211 0
Q ss_pred cccCCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 RRLEIP----------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ~~~~~~----------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+-+ +.++..+.+|++.||..||++|++-++++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 245667999999999999999999999885
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=357.04 Aligned_cols=251 Identities=30% Similarity=0.513 Sum_probs=215.6
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC--cEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~--~~~lV 436 (634)
..+...+.||+|+||+||++.+.. ...|||......... .+.+.+|+++|.+++|||||++++...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 557778899999999999999885 559999987663222 577889999999999999999999854444 69999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCCCccCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGla~~~~~ 515 (634)
|||+++|+|.+++...+. .+++..+..+++||++||.|||++| |+|+||||+|||++. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999986654 4999999999999999999999999 999999999999999 79999999999886552
Q ss_pred ---CcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhhcCcccCCCCCCcH
Q 006703 516 ---TYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 516 ---~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.........||+.|||||++.+. ...+++|||||||++.||+||+.||.. ....+....+......|.+|..+++
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD 250 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence 22234567899999999999853 334599999999999999999999998 5666666666656666789999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
+.++|+.+|+..||++|||+.++|+..
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 999999999999999999999999843
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=362.82 Aligned_cols=257 Identities=31% Similarity=0.465 Sum_probs=224.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc---HHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCC
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH---EDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP 431 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~---~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~ 431 (634)
.....|...+.||+|+||+|++|.+. +..||+|++...... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999876 455999987665221 234456778999999998 999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC-CcEEEEecCCC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLS 510 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~-~~ikL~DFGla 510 (634)
.+|+||||+.||.|.+++... ..+.+..+..+++|++.|++|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999999863 34889999999999999999999999 9999999999999999 99999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCCC-C-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLREDP-S-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
...........+.+||+.|+|||++.+.. | ..++||||+||+||.|++|..||...+...+...+ ......+|..+
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~ 246 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYL 246 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCc
Confidence 97743344678899999999999999988 7 58899999999999999999999998888777775 56667788888
Q ss_pred -cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 589 -NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 589 -s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
+++++.|+.+||..||.+|+|+.+|+ .-.-+.+
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 99999999999999999999999999 4444444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=366.62 Aligned_cols=253 Identities=28% Similarity=0.516 Sum_probs=227.4
Q ss_pred CCCCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 355 NPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 355 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
....+...|....+||+|+.|.||.|+...++ ||||.+........ +-+.+|+.+|+..+|+|||.+++.|...+.
T Consensus 267 ~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 267 SQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred cCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence 34456678888999999999999999877554 99999877654433 457899999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+|+||||++||+|.+.+.... ++|.++..|++++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..
T Consensus 345 LWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred eEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeec
Confidence 999999999999999986443 899999999999999999999999 99999999999999999999999999988
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCCcHH
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPM 591 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~ 591 (634)
+........+.+|||.|||||+...+.|++++||||||++++||+-|++||...++....+.+...+. ....+..+++.
T Consensus 419 i~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~ 498 (550)
T KOG0578|consen 419 ISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPE 498 (550)
T ss_pred cccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHH
Confidence 77766677888999999999999999999999999999999999999999999999888888854433 34566789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++|+.+||..|+++|+++.+||+
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhc
Confidence 999999999999999999999997
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=366.91 Aligned_cols=264 Identities=36% Similarity=0.640 Sum_probs=230.9
Q ss_pred cCCCCCCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 354 QNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 354 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
.+...+...+...+.||+|+||+||+|+|-| .||||++.......+..+.|.+|+.+|++-+|.||+.++||+..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 4455556677788999999999999999876 48999999988888899999999999999999999999999998877
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
.||+-+|+|-+|+.+++.... .++..+.+.|++|+++|+.|||.++ |||||||..||++.++++|||+|||++...
T Consensus 463 AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999986654 4888999999999999999999999 999999999999999999999999999764
Q ss_pred CCC--cccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc---CCC
Q 006703 514 PNT--YISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---EIP 585 (634)
Q Consensus 514 ~~~--~~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~---~~~ 585 (634)
... ........|...|||||++. ..+|+..+||||||+++|||++|..||...+.++++..+......+ ...
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 322 22345667888999999985 4568999999999999999999999999888888887776543333 334
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 586 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 586 ~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
..++.++++|+..||+.++++||.|.+|+..|+.++++
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 56788999999999999999999999999999999984
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=363.30 Aligned_cols=247 Identities=30% Similarity=0.529 Sum_probs=226.3
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...+.||+|+||.||+|+.+.+. ||+|.+.+........+.+.+|+++++.++||||+.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 35777889999999999999888655 9999999888888888999999999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+.| +|..++...+ .++|..+..|+.+++.||.|||+++ |.|||+||.|||+++.+++|+||||+|+.+.....
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 9977 9999997554 4999999999999999999999999 99999999999999999999999999998766555
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......|||.|||||++.+.+|+..+|+|||||++|||++|++||......+.+..|. ......|...+..+.+|+..
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHH
Confidence 5667789999999999999999999999999999999999999999988888888773 44555667899999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
+|.+||.+|.|..+++.
T Consensus 234 LL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HhhcChhhcccHHHHhc
Confidence 99999999999999886
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.12 Aligned_cols=262 Identities=31% Similarity=0.568 Sum_probs=214.4
Q ss_pred CCcceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~ 430 (634)
+..+|...+.||+|+||.||+|.+. +..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3467888999999999999999752 2349999986542 334456789999999999 899999999988654
Q ss_pred -CcEEEEEeecccCCHHHHhccCCC-------------------------------------------------------
Q 006703 431 -PNLSIVTEYLSRGSLYKLLHIPDA------------------------------------------------------- 454 (634)
Q Consensus 431 -~~~~lV~E~~~ggsL~~ll~~~~~------------------------------------------------------- 454 (634)
..++++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 458999999999999999864221
Q ss_pred ----cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--cccCCCCCCCCc
Q 006703 455 ----RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPE 528 (634)
Q Consensus 455 ----~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~--~~~~~~~~gt~~ 528 (634)
+..+++..+..++.||++||.|||++| |+||||||+|||++.++.+||+|||+++..... ........+++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 124778888999999999999999999 999999999999999999999999999754322 112233456788
Q ss_pred ccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 006703 529 WMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607 (634)
Q Consensus 529 y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~R 607 (634)
|+|||++.+..++.++||||||+++|||++ |..||......+...........+..+..+++.+.+++.+||..||++|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999997 9999987654433333323344455677889999999999999999999
Q ss_pred CCHHHHHHHHHHHHHh
Q 006703 608 PSFPSIMETLQQFLMS 623 (634)
Q Consensus 608 Ps~~~Il~~L~~ll~~ 623 (634)
||+.+|++.|+++++.
T Consensus 322 Ps~~el~~~l~~~~~~ 337 (338)
T cd05102 322 PTFSALVEILGDLLQE 337 (338)
T ss_pred cCHHHHHHHHHHHHhc
Confidence 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.31 Aligned_cols=244 Identities=29% Similarity=0.456 Sum_probs=221.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~ 434 (634)
....|...+.||+|+||+|++++.+++. +|||++++..+ ..+..+..+.|.+++... +||.++.++.+|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467889999999999999999998766 99999988765 566778899999999988 5999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+.||++..+.+. ..+++..+..++..|+.||.|||++| ||+||||.+|||+|..|.+||+|||+++...
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999994433332 24999999999999999999999999 9999999999999999999999999999755
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
.....+.+.+|||.|+|||++.+..|+.++|+|||||++|||+.|+.||.+.+.+++...| ....+.+|..++.+..+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI--~~d~~~yP~~ls~ea~~ 597 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI--VNDEVRYPRFLSKEAIA 597 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--hcCCCCCCCcccHHHHH
Confidence 4455788999999999999999999999999999999999999999999999999999988 56677788999999999
Q ss_pred HHHHhhhcCCCCCCCH
Q 006703 595 LIETCWAEEPEIRPSF 610 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~ 610 (634)
++.++|++||++|.-.
T Consensus 598 il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHhccCcccccCC
Confidence 9999999999999654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=355.83 Aligned_cols=256 Identities=30% Similarity=0.516 Sum_probs=227.7
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.+..+. ||+|++..... .+..+++.+|+.+|.+++++||.++|+.|..+..++++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 356777789999999999999987554 99999976653 445578889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|||.||++.+++..... +++..+.-++++++.|+.|||.++ .+|||||+.|||+...|.+||+|||.+....+..
T Consensus 91 ey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999999975542 477888889999999999999999 9999999999999999999999999999888777
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
....+.+|||.|||||++.+..|+.++||||||++.+||++|.+||...+++.....|. +...|.+...+++.+++|+.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHH
Confidence 77789999999999999999999999999999999999999999999999976655552 44555666789999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.||++||+.||||.++++ .+||+..
T Consensus 245 ~CL~k~P~~RpsA~~LLK--h~FIk~a 269 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLK--HKFIKRA 269 (467)
T ss_pred HHhhcCcccCcCHHHHhh--hHHHHhc
Confidence 999999999999999998 6777763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.09 Aligned_cols=247 Identities=21% Similarity=0.377 Sum_probs=215.2
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeec----CCcEEEEEeecc
Q 006703 367 SNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLSIVTEYLS 441 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~----~~~~~lV~E~~~ 441 (634)
..||+|++|.||+|.+.+..||+|.+....... ...+.+.+|+.+|++++||||+++++++.+ ...++++|||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 578999999999999999999999987654332 335778899999999999999999999866 457899999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
+|+|.+++.... .+++...+.++.+++.||.|||+. + ++||||||+||+++.++.+||+|||++...... .
T Consensus 106 ~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~ 177 (283)
T PHA02988 106 RGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---P 177 (283)
T ss_pred CCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhccc---c
Confidence 999999997543 488889999999999999999985 7 889999999999999999999999998764332 2
Q ss_pred CCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 521 KTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+.....++.++..+++.+.+++.+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 34568899999999976 6789999999999999999999999999888777766655556667777899999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
||+.||++|||+.++++.|+.+.
T Consensus 258 cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 258 CTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HhcCCcccCcCHHHHHHHHHHHH
Confidence 99999999999999999998875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=348.83 Aligned_cols=242 Identities=27% Similarity=0.439 Sum_probs=210.0
Q ss_pred ceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 367 SNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
+.||+|+||.||+++++. ..+|+|++..... .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998764 4499999876533 3344567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCC
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 523 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~ 523 (634)
+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 9999886443 4889999999999999999999999 9999999999999999999999999987543333334456
Q ss_pred CCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 006703 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603 (634)
Q Consensus 524 ~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~d 603 (634)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....++..+++++.+++.+||..|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999998887776665553 3445677889999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 006703 604 PEIRP-----SFPSIME 615 (634)
Q Consensus 604 P~~RP-----s~~~Il~ 615 (634)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 234 PKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHcCCCCCCCHHHHHc
Confidence 99999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=352.29 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=211.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCC-cEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP-NLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~-~~~l 435 (634)
..+|...++||.|+||.||+|+.+.+. ||||.++.....-++ ..-.+|++.|++++ ||||+++.+.+.+.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 367888999999999999999877444 999998776544322 34468999999998 999999999998888 8999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|||||+ .+|++++..+ +..+++..+..|++||++||+|+|++| ++|||+||+|||+..+..+||+|||+|+...+
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 999995 4999999866 456999999999999999999999999 99999999999999999999999999997655
Q ss_pred CcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-------------
Q 006703 516 TYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------------- 581 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~------------- 581 (634)
.. .-...+.|..|+|||++.. ..|+.+.|||++||+++|+.+.++.|.+.+..+.+..+...-..
T Consensus 163 kp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 32 2345678999999999854 55799999999999999999999999999987776666432110
Q ss_pred -------c--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 582 -------L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 582 -------~--------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+ .+.+..+++..++|.+||..||++|||+.+.++.
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1 0113478899999999999999999999999873
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=348.60 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=215.3
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--Cc
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PN 432 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~ 432 (634)
......|...++||+|.||.||+|++..++ ||+|.++.....+.......+||.+|++++||||+++.+..... ..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 344577888999999999999999998766 99999988877666667788999999999999999999998776 68
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+|||+|||+. +|.-++....- .+++.++..+++||+.||+|+|++| |+|||||.+|||||.+|.+||+|||+|+.
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceee
Confidence 9999999976 88888876543 4999999999999999999999999 99999999999999999999999999996
Q ss_pred CCCCc-ccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-C-----c--cc
Q 006703 513 KPNTY-ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G-----R--RL 582 (634)
Q Consensus 513 ~~~~~-~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~-----~--~~ 582 (634)
+.... ......+-|..|+|||.+.|. .|+.++|+||.||||.||++|++.|.+.+..+....|... + . ..
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 54432 224566789999999999875 5799999999999999999999999999987765554211 0 0 00
Q ss_pred CCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 EIP-------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ~~~-------------------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+| ..+++...+|+..+|..||.+|.|+.+.|.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 246778899999999999999999999886
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.73 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=216.8
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
......|...+.||.|..++||+|+... ..||||++.......+ .+.+.+|+..++.++||||++++..|..+..+|
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 3445789999999999999999998874 4499999987766555 788999999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||+||.+||+.+++...-.. .++|..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999754333 3999999999999999999999999 9999999999999999999999999865443
Q ss_pred CCccc----CCCCCCCCcccCcccc--cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCC----
Q 006703 515 NTYIS----SKTAAGTPEWMAPEVL--REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI---- 584 (634)
Q Consensus 515 ~~~~~----~~~~~gt~~y~APEvl--~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~---- 584 (634)
..... ..+..||+.|||||++ +..+|+.|+||||||++..||.+|..||....++++.-..- +..++.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~~t~ 255 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTLLTS 255 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCcccc
Confidence 32222 2566899999999995 44678999999999999999999999999999998765442 222221
Q ss_pred ------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 585 ------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 585 ------~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+..++++|..||.+||.+|||+.++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1246778999999999999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=357.53 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=224.8
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeec-cccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQ-EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~-~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
+-|..++.||.|+.|.|-+|++.. +.+|||++.+. .........+.+|+-+|+.+.||||+++++.++...++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 567888999999999999998874 45999999776 455566677889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||++||.|++++-+++ .+++..+.++++||+.|+.|+|..+ |+||||||+|+|+|.++.|||+|||.|......
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999999997665 4999999999999999999999999 999999999999999999999999999865433
Q ss_pred ccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.-..+.||.|.|.|||++.|.+| +.++||||+||+||.|++|+.||++.+.......+ +.....+|.+++.+.++|+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLL 243 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHH
Confidence 24578899999999999999999 78999999999999999999999998888888777 5566778899999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~ 616 (634)
.+||..||.+|.|..+|++.
T Consensus 244 r~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHhccCccccccHHHHhhC
Confidence 99999999999999999883
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.56 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=213.0
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+|.++ +..+|+|++...... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 4677889999999999999987 455999998755432 2344668899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 82 YVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 999999999986443 4889999999999999999999999 999999999999999999999999998765332
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++..+++.+.++|.+
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHHH
Confidence 234579999999999999999999999999999999999999999988777666653 33456677889999999999
Q ss_pred hhhcCCCCCCC-----HHHHHHH
Q 006703 599 CWAEEPEIRPS-----FPSIMET 616 (634)
Q Consensus 599 cL~~dP~~RPs-----~~~Il~~ 616 (634)
||..||.+||+ +.++++.
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcC
Confidence 99999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=357.83 Aligned_cols=251 Identities=35% Similarity=0.632 Sum_probs=223.9
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
.+...+..++-||+|+.|.||+|+..+..||||+++... ..+|+-|++|+|+||+.+.++|.....++|||
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 444566677899999999999999999999999864321 16788999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|||..|.|...|+... .+.......+..+||.|+.|||.+. |||||||.-||||+.+..|||+|||.++...+.
T Consensus 192 EfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred eccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 9999999999997554 3778888899999999999999999 999999999999999999999999999875543
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
...-..+||..|||||++.+.+.++|+|||||||+||||+||..||.+.+...+++.+......++.|..+++.++-|++
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~K 345 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLK 345 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHH
Confidence 34457789999999999999999999999999999999999999999988888777776667778899999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.||+-.|..||+|.+|+..|.-+-..
T Consensus 346 qcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 346 QCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred HHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 99999999999999999988755443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.59 Aligned_cols=240 Identities=24% Similarity=0.387 Sum_probs=206.9
Q ss_pred eeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 369 FIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
||+|+||.||+|++..+ .+|+|++..... .......+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999999999998744 499999875432 334456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 525 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~g 525 (634)
.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..............|
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 99987543 4889999999999999999999999 999999999999999999999999998764333333445679
Q ss_pred CCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCC
Q 006703 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 605 (634)
Q Consensus 526 t~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~ 605 (634)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+ ......++..+++.+.+++.+||..||.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--HcCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999988877766555 3345567788999999999999999999
Q ss_pred CCCC---HHHHHH
Q 006703 606 IRPS---FPSIME 615 (634)
Q Consensus 606 ~RPs---~~~Il~ 615 (634)
+||+ +.+++.
T Consensus 234 ~R~~~~~~~e~l~ 246 (312)
T cd05585 234 RRLGYNGAQEIKN 246 (312)
T ss_pred HcCCCCCHHHHHc
Confidence 9975 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.34 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=214.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||.||+|+++. ..+|+|++..... .......+.+|+.++++++||||+++++++.+++..+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3678889999999999999999874 4499999876543 233456788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999987543 4788899999999999999999999 999999999999999999999999999865432
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.+....+. .....+|..++..+.+|+
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLV 246 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHH
Confidence 234579999999999999999999999999999999999999999888776666553 345567778999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 006703 597 ETCWAEEPEIRPS-----FPSIMET 616 (634)
Q Consensus 597 ~~cL~~dP~~RPs-----~~~Il~~ 616 (634)
.+||..||.+||+ +.+++..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999987 6887743
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.77 Aligned_cols=242 Identities=27% Similarity=0.445 Sum_probs=208.8
Q ss_pred ceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 367 SNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
+.||+|+||.||+++.+. ..||+|++..... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 468999999999998764 4599999876532 3344567789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCC
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 523 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~ 523 (634)
+|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 9998886443 4889999999999999999999999 9999999999999999999999999987533332233456
Q ss_pred CCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 006703 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603 (634)
Q Consensus 524 ~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~d 603 (634)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++.+.+++.+||..|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999998887776665553 3344567789999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 006703 604 PEIRP-----SFPSIME 615 (634)
Q Consensus 604 P~~RP-----s~~~Il~ 615 (634)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 234 PKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHhCCCCCCCHHHHHc
Confidence 99998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.17 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=216.0
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...++||+|.||.||+|++..+ .||||.++.............+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999998754 49999998887766666778899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|++- +|+..++... ..++..++..++.++++||+|||.+. |+||||||+|+|++.+|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9964 9999987444 46999999999999999999999999 99999999999999999999999999998877665
Q ss_pred cCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-Cc-----cc---------
Q 006703 519 SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR-----RL--------- 582 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~~-----~~--------- 582 (634)
.....+-|..|+|||.+.|. .|+..+||||.||++.||+-+.+-|.+.++-+....+-.. +. ++
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 55556889999999998775 5799999999999999999999988887765544433111 10 00
Q ss_pred -----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 583 -----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 583 -----------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.+....+....+|+.+||..||.+|+|+.|.++ ...+++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~ 286 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKS 286 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhc
Confidence 011235677899999999999999999999998 455553
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=342.92 Aligned_cols=243 Identities=27% Similarity=0.442 Sum_probs=209.8
Q ss_pred ceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 367 SNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
+.||+|+||.||+++++. ..+|+|++..... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999998864 4599999876532 3345567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCC
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 523 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~ 523 (634)
+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 9998886433 4889999999999999999999999 9999999999999999999999999987543322233456
Q ss_pred CCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 006703 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603 (634)
Q Consensus 524 ~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~d 603 (634)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+ ......+|..+++.+.+++.+||..|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEDIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh--ccCCccCCCCCCHHHHHHHHHHcCCC
Confidence 7999999999999999999999999999999999999999888777665555 23445677889999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 006703 604 PEIRP-----SFPSIMET 616 (634)
Q Consensus 604 P~~RP-----s~~~Il~~ 616 (634)
|++|| ++.++++.
T Consensus 234 P~~R~~~~~~~~~~il~h 251 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 99997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=349.84 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=230.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc-EEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-LSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~-~~lV~ 437 (634)
..|...+.+|+|+||.+++++++.. .+++|.+.............++|+.++++++|||||.+.+.|..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688899999999999999988744 49999998887766666678899999999999999999999988888 99999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
+||+||++.+.+.+.. ...+++..+..++.|++.|+.|||++. |.|||||+.|||+++++.|||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999997554 345999999999999999999999999 9999999999999999999999999999887766
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
....+..||+.|++||++.+.+|+.|+|||||||++|||++-+.+|...+....+..+.. ....++|..++.+++.+|+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~-~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR-GLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-ccCCCCCccccHHHHHHHH
Confidence 567788999999999999999999999999999999999999999999999998888853 3467788999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~ 616 (634)
.||..+|..||++.++|..
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.22 Aligned_cols=256 Identities=33% Similarity=0.499 Sum_probs=209.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcC----------------C--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCee
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN----------------S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 421 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~----------------~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv 421 (634)
...|...+.||+|+||.||+|.+.+ + .||+|++.... ......++.+|+.++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4678888999999999999997532 1 38999886543 344457789999999999999999
Q ss_pred eeeceeecCCcEEEEEeecccCCHHHHhccCC----------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 006703 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD----------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485 (634)
Q Consensus 422 ~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~----------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~Iv 485 (634)
++++++.+.+..+++|||+.+++|.+++.... ....+++..++.++.||+.||.|||+.| |+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--iv 160 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FV 160 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 99999999999999999999999999985321 1124677889999999999999999999 99
Q ss_pred eeccCCCcEEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh--CCC
Q 006703 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQK 561 (634)
Q Consensus 486 HrDIKP~NILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt--g~~ 561 (634)
||||||+|||++.++.+||+|||++....... .......++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999987543221 11233456789999999998889999999999999999986 577
Q ss_pred CCCCCChHHHHHHHhhc------CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 562 PWRNSTPSQVISAVGFK------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 562 Pf~~~~~~~~~~~i~~~------~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
||......+....+... ......+..++..+.+++.+||..+|++|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 88877766554433211 1112335568899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.37 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=209.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHH------------HHHHHHHHHHHHHhCCCCCeeeeec
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHED------------RFKEFLREVAIMKGLRHPNIVLLMG 425 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~------------~~~~~~~El~iL~~l~h~nIv~l~~ 425 (634)
..+|...+.||+|.||.|-+|++...+ ||||++.+...... ..++..+|+.+|+++.|+|||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 477889999999999999999887544 99999976543221 1357889999999999999999999
Q ss_pred eeecC--CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEE
Q 006703 426 AVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 503 (634)
Q Consensus 426 ~~~~~--~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ik 503 (634)
+..+. +.+|||+|||..|.+... ......+.+.++++++++++.||+|||.+| ||||||||+|+||+.+|++|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEE
Confidence 98765 469999999998877442 222233899999999999999999999999 99999999999999999999
Q ss_pred EEecCCCccCCCC-----cccCCCCCCCCcccCcccccCCC----CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 006703 504 VCDFGLSRSKPNT-----YISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 574 (634)
Q Consensus 504 L~DFGla~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~----~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~ 574 (634)
|+|||.+...+.. ........|||.|+|||...+.. .+.+.||||+||+||.|+.|+.||.+....+....
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998765222 11234578999999999987733 26788999999999999999999999999999888
Q ss_pred HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 575 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 575 i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
|.......+..+.+.+.+++||++||.+||++|.+..+|..
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 85444444444568999999999999999999999988865
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.52 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=215.1
Q ss_pred cceeecceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+.||+|+||.||+|.++ +..+|+|.+.... .......+.+|+..+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 56888899999999999999764 2348999886543 33444678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999987543 24889999999999999999999999 99999999999999999999999998765322
Q ss_pred Cc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
.. .......++..|+|||.+.+..++.++||||||+++||+++ |..||......+....+. ....++.+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLLH 238 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 21 11223345678999999999999999999999999999775 999999888777666653 3344556788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
+++.+||..+|.+|||+.+|++.|.++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=341.03 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=212.5
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+|++.. ..||+|++...... ......+.+|+.++..++||||+++++++...+..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 57788999999999999999874 45999998765432 2345678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999996443 4889999999999999999999999 99999999999999999999999999976433
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC------CCCcHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP------KNVNPMV 592 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------~~~s~~l 592 (634)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........+ ..+++++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence 3346679999999999999999999999999999999999999999988877666554322222112 2568999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.+++.+||..+|.+||++.++++.
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhC
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.23 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=207.5
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
|...+.||+|+||.||++.+. +..+|+|++....... .....+.+|+.++++++|+||+++++++.+++..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 567789999999999999876 4559999987654332 2334678999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|..++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-T 157 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-e
Confidence 999999888753322 24889999999999999999999999 9999999999999999999999999997643321 2
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--hcCcccCCCCCCcHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~s~~l~~Li~ 597 (634)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .......++..+++.+.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 245578999999999999999999999999999999999999998765432222111 123334566778999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHH
Q 006703 598 TCWAEEPEIRPS-----FPSIMET 616 (634)
Q Consensus 598 ~cL~~dP~~RPs-----~~~Il~~ 616 (634)
+||+.||.+||+ +.++++.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcC
Confidence 999999999997 7888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=338.95 Aligned_cols=242 Identities=26% Similarity=0.404 Sum_probs=207.9
Q ss_pred ceeeccCcEEEEEEEEc-----CCcEEEEEEeecccc--HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 367 SNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~--~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
+.||+|+||.||+++.. +..+|+|++...... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999763 345999998765332 23345678899999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence 99999999986543 4788889999999999999999999 999999999999999999999999998754333333
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+. .....++..+++.+.++|.+|
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 234 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKL 234 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 445679999999999999989999999999999999999999999888776665553 344567788999999999999
Q ss_pred hhcCCCCCC-----CHHHHHH
Q 006703 600 WAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 600 L~~dP~~RP-----s~~~Il~ 615 (634)
|..+|++|| ++.++++
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhc
Confidence 999999999 8888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=345.21 Aligned_cols=261 Identities=30% Similarity=0.500 Sum_probs=215.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE 429 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~ 429 (634)
.+...|...+.||+|+||.||+|.+.. ..||+|++.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 445678889999999999999997532 249999987553 233456788999999999 89999999999999
Q ss_pred CCcEEEEEeecccCCHHHHhccCC--------------------------------------------------------
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPD-------------------------------------------------------- 453 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~-------------------------------------------------------- 453 (634)
....+++|||+++|+|.++++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999985321
Q ss_pred -----------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc--cC
Q 006703 454 -----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--SS 520 (634)
Q Consensus 454 -----------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~--~~ 520 (634)
....+++..+++++.||++||.|||++| |+||||||+|||++.++.+||+|||++........ ..
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 0124778889999999999999999999 99999999999999999999999999875433211 11
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||..................+..+...++++.+++.+|
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 22335668999999998899999999999999999997 99999876655444343333344556667899999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHH
Q 006703 600 WAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~~L~~ll 621 (634)
|..||++|||+.+|++.|++++
T Consensus 352 l~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 352 WNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.17 Aligned_cols=243 Identities=27% Similarity=0.443 Sum_probs=208.4
Q ss_pred ceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 367 SNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
+.||+|+||.||++++.. ..+|+|++..... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999998764 4599999876543 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
+|..++.... .+++..+..++.||+.||.|||+ +| |+||||||+|||++.++.+||+|||++............
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 9998886443 48999999999999999999997 78 999999999999999999999999998753332223345
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..+++.+.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence 679999999999999999999999999999999999999998888776665552 344556778999999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 006703 603 EPEIRP-----SFPSIMET 616 (634)
Q Consensus 603 dP~~RP-----s~~~Il~~ 616 (634)
||++|+ ++.++++.
T Consensus 234 dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHhCCCCCCCHHHHhcC
Confidence 999996 89998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=344.56 Aligned_cols=261 Identities=36% Similarity=0.537 Sum_probs=209.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-cEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-NLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~-~~~lV~ 437 (634)
...|...+.||+|+||.||+|...+ +.||||.+....... ..+|.+|+.++.+++|||+|+++|||.+.+ ..++|+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 3566677899999999999999887 679999776554332 355999999999999999999999999988 599999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCC-CCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g-~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||+++|+|.+.++..... .++|.++++|+.++|+||+|||... |+|+||||||+|||+|.++.+||+|||+|+..+..
T Consensus 152 Eym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999865543 6899999999999999999999965 47999999999999999999999999999766541
Q ss_pred cccCCCC-CCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH--H-HHH----HHhhc----CcccCC
Q 006703 517 YISSKTA-AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--Q-VIS----AVGFK----GRRLEI 584 (634)
Q Consensus 517 ~~~~~~~-~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~--~-~~~----~i~~~----~~~~~~ 584 (634)
....... .||.+|+|||.+.....++++||||||++++||++|+.+.+...+. . ... .+... ...+.+
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 1111222 8999999999999999999999999999999999999887754311 1 111 11110 111222
Q ss_pred C-CCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 585 P-KNVN-----PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 585 ~-~~~s-----~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
. ...+ ..+..+..+|+..+|.+||++.++++.|+.+...
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 2 2223 2366778899999999999999999999766554
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.10 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=207.4
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHH---HhCCCCCeeeeeceeecCCcEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIM---KGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL---~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
|...+.||+|+||.||+|.+.. ..||+|++..... .....+.+.+|++++ +.++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 4567899999999999998874 4599999876532 233345666776665 456899999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|..+++.. .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999887642 3899999999999999999999999 999999999999999999999999998754333
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
........||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+. ......+..+++.+.++|
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li 232 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIM 232 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHH
Confidence 333445679999999999999999999999999999999999999999888777666553 334456778999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 006703 597 ETCWAEEPEIRP-----SFPSIMET 616 (634)
Q Consensus 597 ~~cL~~dP~~RP-----s~~~Il~~ 616 (634)
.+||..||.+|| ++.++++.
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 999999999999 57777663
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.18 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=214.1
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||+||+|++. +..||+|++....... .....+.+|+.++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5778899999999999999987 5569999987654322 445678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 82 YMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999999754 34899999999999999999999999 9999999999999999999999999987644332
Q ss_pred ----------------------------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH
Q 006703 518 ----------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 569 (634)
Q Consensus 518 ----------------------------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~ 569 (634)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 2234567999999999999999999999999999999999999999998877
Q ss_pred HHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 006703 570 QVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPS-FPSIMET 616 (634)
Q Consensus 570 ~~~~~i~~~~~~~~~~--~~~s~~l~~Li~~cL~~dP~~RPs-~~~Il~~ 616 (634)
+....+........+| ..+++.+.++|.+||. ||.+||+ +.++++.
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 7666664432333333 3469999999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.10 Aligned_cols=255 Identities=34% Similarity=0.547 Sum_probs=216.6
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..|...+.||+|+||.||+|...+. .+++|.+.... .......+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4677888999999999999987643 38899876443 334456789999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 500 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~ 500 (634)
+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCC
Confidence 999999999999999864321 135788899999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhh
Q 006703 501 TVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF 577 (634)
Q Consensus 501 ~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~ 577 (634)
.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR- 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 99999999987543221 12234456889999999998889999999999999999998 999999888877766654
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 578 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 578 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
....+..+..+++++.+|+.+||+.||++||++.+|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 334455677899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=361.77 Aligned_cols=263 Identities=33% Similarity=0.555 Sum_probs=229.7
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
.......+.||+|+||+||+|+..+ .-||||.++... ......+|.+|++++..++|||||+++|.+..++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3556677899999999999997653 229999987654 34466899999999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCC-----------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDA-----------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 501 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~-----------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ 501 (634)
++||+|||..|+|.+||..... +.+++..+.+.|+.|||.||+||-++. +|||||-..|+||.++..
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLV 641 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceE
Confidence 9999999999999999953221 334889999999999999999999999 999999999999999999
Q ss_pred EEEEecCCCccCCC-CcccCC-CCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 006703 502 VKVCDFGLSRSKPN-TYISSK-TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK 578 (634)
Q Consensus 502 ikL~DFGla~~~~~-~~~~~~-~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~ 578 (634)
|||+|||+++...+ .++... ...-..+|||||.+...++|++|||||+||+|||+++ |..||.+..+.+++..+...
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999986443 333333 3445779999999999999999999999999999998 89999999999999999654
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 579 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 579 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
.. .+.|..+|.++.+|+..||+.+|.+||+|++|-..|+..-+.+..
T Consensus 722 ~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 722 QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 44 889999999999999999999999999999999999998876543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=341.60 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=214.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC---cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS---DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~---~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
...|...+.||+|+||.||+|.+++. .+|+|++..... .......+.+|+.+++.++||||+++++++.++...++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 35688889999999999999987643 499999865533 23445678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999997543 4889999999999999999999999 99999999999999999999999999976543
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||...++......+. .....+|..+++.+.++
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 R---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNNCKHL 258 (340)
T ss_pred C---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHH
Confidence 2 245679999999999999989999999999999999999999999888776666553 33445677889999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHHH
Q 006703 596 IETCWAEEPEIRP-----SFPSIMET 616 (634)
Q Consensus 596 i~~cL~~dP~~RP-----s~~~Il~~ 616 (634)
+.+||..||++|+ +++++++.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999999995 89888764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.16 Aligned_cols=259 Identities=29% Similarity=0.493 Sum_probs=212.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~ 430 (634)
+...|...+.||+|+||.||+|.+. +..||+|++..... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3457888999999999999999742 22499999865432 23346788999999999 899999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCC--------------------------------------------------------
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDA-------------------------------------------------------- 454 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~-------------------------------------------------------- 454 (634)
...++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864221
Q ss_pred ----------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 455 ----------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 455 ----------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124778889999999999999999999 99999999999999999999999999876433211
Q ss_pred --cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 519 --SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 519 --~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
......++..|+|||++.+..++.++||||||+++|||++ |..||.................+...+...+.++.++
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 349 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI 349 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence 1122345668999999999999999999999999999998 8999987655443333333334445566778999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
+.+||..||++|||+.+|++.|++.
T Consensus 350 i~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 350 MKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHccCChhHCcCHHHHHHHHHhh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.52 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=204.4
Q ss_pred ceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||+++++.+ .+|+|++..........+.+.+|+.++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 577889999999999999998744 499999876654444456788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-c
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-I 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~-~ 518 (634)
++++++..+.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 82 VEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9988776654432 24889999999999999999999999 9999999999999999999999999998654322 1
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc------------------
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------------ 580 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~------------------ 580 (634)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 22345689999999999998899999999999999999999999987665443322211000
Q ss_pred -c-c----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -R-L----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -~-~----------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. + .....++..+.+|+.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0 011236788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.71 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=204.1
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||.|+||.||+|.... ..||+|++...... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 568889999999999999998874 44999998654322 223456789999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++ +|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9975 8988886433 23788899999999999999999999 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc----------------
Q 006703 519 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------------- 581 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~---------------- 581 (634)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3445678999999999865 56799999999999999999999999887766554433211000
Q ss_pred ------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
......+++++.+|+.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0011346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.24 Aligned_cols=237 Identities=25% Similarity=0.402 Sum_probs=204.3
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|+++.+ .||+|++..... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999998744 499999876532 233456677888888877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 99999886443 4889999999999999999999999 999999999999999999999999998754332233445
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. ......+..+++++.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccc
Confidence 679999999999999999999999999999999999999999988877766663 344556777999999999999999
Q ss_pred CCCCCCCH
Q 006703 603 EPEIRPSF 610 (634)
Q Consensus 603 dP~~RPs~ 610 (634)
||++||++
T Consensus 234 dP~~R~~~ 241 (320)
T cd05590 234 NPTMRLGS 241 (320)
T ss_pred CHHHCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=335.50 Aligned_cols=246 Identities=25% Similarity=0.398 Sum_probs=209.9
Q ss_pred eeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCC-CCeeeeeceeecCCcEEEEEe
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h-~nIv~l~~~~~~~~~~~lV~E 438 (634)
|...+.||+|+||.||+|++.++ .||+|++..... .......+..|.+++..++| ++|+++++++...+.+|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 67788999999999999988754 499999876533 23445678889999999976 568899999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 82 YVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999886433 3888999999999999999999999 99999999999999999999999999875332222
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++..+++.+.+++.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~ 234 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKG 234 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 3445679999999999999999999999999999999999999999888877776663 34556678899999999999
Q ss_pred hhhcCCCCCCCH-----HHHHH
Q 006703 599 CWAEEPEIRPSF-----PSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~-----~~Il~ 615 (634)
||..||.+|++. .++++
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhc
Confidence 999999999976 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.91 Aligned_cols=248 Identities=40% Similarity=0.690 Sum_probs=207.9
Q ss_pred ecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 365 DSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..+.||.|+||.||+|.+. +..|+||++... ......+.+.+|++.+++++||||+++++++......++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4578999999999999988 344899998543 344456889999999999999999999999998888999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC--C
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--T 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~--~ 516 (634)
|+++|+|.+++.... ...+++..++.|+.|+++||.|||+++ ++|++|+++||+++.++.+||+|||++..... .
T Consensus 82 ~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999998652 234899999999999999999999999 99999999999999999999999999876522 1
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
............|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+ ....++..+..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHH
Confidence 122344557789999999999889999999999999999999 78999998888877777 4556667788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L 617 (634)
+..||..+|++|||+.+|++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=339.46 Aligned_cols=239 Identities=26% Similarity=0.384 Sum_probs=206.9
Q ss_pred ceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 367 SNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
+.||+|+||.||+++.. +..+|+|++............+.+|+.++++++||||+++++++..+...|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998753 4559999997665444445667889999999999999999999999999999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCC
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 521 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~ 521 (634)
+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 999999986433 4899999999999999999999999 99999999999999999999999999876544333344
Q ss_pred CCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 006703 522 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601 (634)
Q Consensus 522 ~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~ 601 (634)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+. .....++..+++.+.+++.+||.
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~ 234 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFK 234 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhh
Confidence 5679999999999999889999999999999999999999999888777666553 33455677899999999999999
Q ss_pred cCCCCCCCHHH
Q 006703 602 EEPEIRPSFPS 612 (634)
Q Consensus 602 ~dP~~RPs~~~ 612 (634)
.||++||++.+
T Consensus 235 ~~P~~R~~a~~ 245 (318)
T cd05582 235 RNPANRLGAGP 245 (318)
T ss_pred cCHhHcCCCCC
Confidence 99999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.27 Aligned_cols=243 Identities=24% Similarity=0.391 Sum_probs=208.0
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|++.++ .+|+|++..... .......+..|.+++..+ +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999998754 599999876533 234446677899999876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++............
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 99998886443 3888999999999999999999999 999999999999999999999999998754333333445
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+. ......|..+++++.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhcc
Confidence 679999999999999999999999999999999999999999988877776663 333455677899999999999999
Q ss_pred CCCCCC-------CHHHHHHH
Q 006703 603 EPEIRP-------SFPSIMET 616 (634)
Q Consensus 603 dP~~RP-------s~~~Il~~ 616 (634)
||++|| ++.++++.
T Consensus 234 dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcC
Confidence 999999 77877753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.24 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=224.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|-||.||+|+.+.+. ||+|++.+..+.. ....++.+|+++-..|+||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3467888899999999999999988776 9999998776533 334678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
++||.++|++...|+.... ..+++...+.+++|++.|+.|+|..+ ++||||||+|+|++..+.+||+|||-+...+
T Consensus 100 ilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999973322 34899999999999999999999999 9999999999999999999999999998765
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||......+....+ ...+..+|..++...+++
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--RKVDLKFPSTISGGAADL 252 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--HHccccCCcccChhHHHH
Confidence 33567889999999999999999999999999999999999999999998877777777 455667789999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~ 616 (634)
|.+|+..+|.+|.+..++++.
T Consensus 253 I~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHhccCccccccHHHHhhh
Confidence 999999999999999998863
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.18 Aligned_cols=242 Identities=27% Similarity=0.455 Sum_probs=205.2
Q ss_pred ceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|++.+++ ||+|++..... .......+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987544 99999876532 223345566677777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++............
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 99999886433 4889999999999999999999999 999999999999999999999999999754333333455
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+ ....+.++..+++.+.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHccC
Confidence 67999999999999999999999999999999999999999998887776665 3345667788999999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 006703 603 EPEIRPSFP-SIME 615 (634)
Q Consensus 603 dP~~RPs~~-~Il~ 615 (634)
||.+||++. ++++
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05592 234 DPTKRLGVDGDIRQ 247 (316)
T ss_pred CHHHcCCChHHHHc
Confidence 999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.81 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=217.4
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC----
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP---- 431 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~---- 431 (634)
....+|...+.||+|+||+||+|++. +..||+|++............+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34478999999999999999999875 455999999877666666778889999999999999999988774332
Q ss_pred ----cEEEEEeecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEe
Q 006703 432 ----NLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 506 (634)
Q Consensus 432 ----~~~lV~E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~D 506 (634)
.+++||||+++|+|.+++... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999998632 22345899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCC
Q 006703 507 FGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 584 (634)
Q Consensus 507 FGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 584 (634)
||+++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+. ......+
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~-~~~~~~~ 265 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL-AGRYDPL 265 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCCC
Confidence 9998764332 112345679999999999999999999999999999999999999999888776655553 2334456
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+..+++++.+++.+||..||.+||++.++++.
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 78899999999999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.49 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=208.0
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||+||+|++.. ..+|+|++..... .......+.+|+.++.+++|+||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 46778899999999999998874 4599999876543 23344678889999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 82 FLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999997543 4899999999999999999999999 9999999999999999999999999987532110
Q ss_pred ----------------------------------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCC
Q 006703 518 ----------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 563 (634)
Q Consensus 518 ----------------------------------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf 563 (634)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCC---CCCCHHHHHHH
Q 006703 564 RNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPE---IRPSFPSIMET 616 (634)
Q Consensus 564 ~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~Li~~cL~~dP~---~RPs~~~Il~~ 616 (634)
...+..+....+........+|. .+++++.++|.+|+. +|. .||++.+|++.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 98888777766644333333443 478999999998765 444 46899999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.59 Aligned_cols=242 Identities=26% Similarity=0.445 Sum_probs=207.7
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||+||+|.+..+ .+|+|++..... .......+.+|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999988754 599999876532 233456677899999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++............
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 99998886443 4899999999999999999999999 999999999999999999999999998753322223345
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++..+++.+.++|.+||..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccC
Confidence 579999999999999999999999999999999999999999888777666553 344556778999999999999999
Q ss_pred CCCCCCCH-----HHHHH
Q 006703 603 EPEIRPSF-----PSIME 615 (634)
Q Consensus 603 dP~~RPs~-----~~Il~ 615 (634)
||.+|||+ .++++
T Consensus 234 dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHHHcCCCCCCCHHHHhc
Confidence 99999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.22 Aligned_cols=250 Identities=27% Similarity=0.353 Sum_probs=207.6
Q ss_pred ceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||+||+|++..+ .+|+|++..... .......+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477889999999999999988754 499999876543 34456778999999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999987543 4889999999999999999999999 9999999999999999999999999875321000
Q ss_pred ----------------------------------------------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHH
Q 006703 518 ----------------------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 551 (634)
Q Consensus 518 ----------------------------------------------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGv 551 (634)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhh--hcCCCCCCCHHHHHHH
Q 006703 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCW--AEEPEIRPSFPSIMET 616 (634)
Q Consensus 552 lL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Li~~cL--~~dP~~RPs~~~Il~~ 616 (634)
++|||++|..||...++.+....+........++ ..+++++.++|.+|+ ..++..||++.+++..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999998887766555553333333343 357999999999955 4566669999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.47 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=208.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||++++..++ +|+|++.... ......++.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 367888899999999999999987544 8888886542 3444567899999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||+++++|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999986433 388999999999999999999985 6 999999999999999999999999998765332
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc------------------
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------------ 578 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~------------------ 578 (634)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+...
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 234557999999999999999999999999999999999999999776654443222100
Q ss_pred ---------------------------CcccCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 579 ---------------------------GRRLEI-PKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 579 ---------------------------~~~~~~-~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
...+.. ...+++++.+|+.+||..||++|||+.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 001111 12467899999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.67 Aligned_cols=246 Identities=31% Similarity=0.528 Sum_probs=209.5
Q ss_pred eeeccCcEEEEEEEEc----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 368 NFIKGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
.||+|+||.||+|.++ +..+|+|++..........+.+.+|+.+++.+.|+||+++++++. .+..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 344999998766555556678999999999999999999999875 45678999999999
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc---C
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS---S 520 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~---~ 520 (634)
+|.+++.... .+++..+..++.|++.||.|||++| ++||||||.||+++.++.+||+|||++......... .
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999986433 4889999999999999999999999 999999999999999999999999998764432211 1
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
....++..|+|||.+.+..++.++|+||||+++|||++ |+.||......+....+. ....+..|..+++.+.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 22334578999999988889999999999999999998 999999888777666664 3445667788999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHH
Q 006703 600 WAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~~L~~l 620 (634)
|+.||++||++.+|.+.|+++
T Consensus 235 ~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 235 WTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred hccCchhCcCHHHHHHHHhcc
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.03 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=209.5
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+|++.. ..||+|++..... .......+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 57788999999999999999874 4599999976543 23445667899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 82 YLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999987543 4899999999999999999999999 99999999999999999999999999864321100
Q ss_pred --------------------------------------cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCC
Q 006703 519 --------------------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ 560 (634)
Q Consensus 519 --------------------------------------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~ 560 (634)
......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 011346999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 006703 561 KPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS---FPSIME 615 (634)
Q Consensus 561 ~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~Li~~cL~~dP~~RPs---~~~Il~ 615 (634)
.||...+..+....+........++. .+++.+.++|.+|+. +|.+|++ +.++++
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999888776665543333333333 578999999999997 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=333.45 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=209.5
Q ss_pred eeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEe
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
|...+.||+|+||.||+|++.++ .+|+|++..... .......+..|..++..+ .|++|+++++++...+.+++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 66788999999999999988754 499999876533 233345667788888877 58999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|..++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 82 YVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999886443 3889999999999999999999999 99999999999999999999999999875433333
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++++.+++.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 234 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKG 234 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHH
Confidence 3456679999999999999999999999999999999999999999988877776663 34455677899999999999
Q ss_pred hhhcCCCCCCCH-----HHHHH
Q 006703 599 CWAEEPEIRPSF-----PSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~-----~~Il~ 615 (634)
||..+|.+|++. .++++
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhc
Confidence 999999999984 55553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=341.31 Aligned_cols=262 Identities=31% Similarity=0.503 Sum_probs=216.9
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeec
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE 429 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~ 429 (634)
.+...|...+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 445788899999999999999998642 138999886543 3344467899999999995 9999999999999
Q ss_pred CCcEEEEEeecccCCHHHHhccCCC-------------------------------------------------------
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDA------------------------------------------------------- 454 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~------------------------------------------------------- 454 (634)
....++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998853210
Q ss_pred --------------------------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 455 --------------------------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 455 --------------------------------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
...+++..+..++.||++||.|||+++ |+|+||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill 270 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEE
Confidence 123677888999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 573 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~ 573 (634)
+.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 999999999999987543221 12234457788999999999999999999999999999997 899998765544433
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
.......++..+..++..+.+++.+||..+|++|||+.+|.+.|+++++
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 3333344556667889999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=319.12 Aligned_cols=258 Identities=24% Similarity=0.420 Sum_probs=214.2
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~-~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||.||+|+.. +..+|+|.+.... ........+.+|+.++++++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46778899999999999999875 4559999876533 23445567889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||+++++|.+++... .....+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999999988532 22235789999999999999999999999 999999999999999999999999998875543
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+......+..+...+..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3333455788999999999988899999999999999999999999965433 33333332222222233467889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
++.+||..+|++|||+.++++.|+++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=320.11 Aligned_cols=255 Identities=33% Similarity=0.566 Sum_probs=219.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
...|...+.||.|+||.||+|.+.+ ..+++|++..... .....+.+|+.+++.++|+||+++++++......+++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3567888999999999999998875 4489998765432 234568899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++..... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999975432 34789999999999999999999999 99999999999999999999999999976554433
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......++..|+|||.+.+..++.++||||||+++++|++ |+.||...+..+....+. ...+...+..+++.+.+++.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHH
Confidence 3334456778999999998899999999999999999998 899998887776666654 33455667789999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
+||..||.+|||+.+|++.|+++
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.16 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=204.1
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeecccc-HHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|+++.+ .||+|++...... ......+..|..++... +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999998754 4999998765321 23345567788888765 899999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||++............
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 99999886432 4888999999999999999999999 999999999999999999999999998753222223345
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. ...+.++..++..+.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFER 233 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999999999999999999999999999999999888777666553 344566778899999999999999
Q ss_pred CCCCCCCHH-HHH
Q 006703 603 EPEIRPSFP-SIM 614 (634)
Q Consensus 603 dP~~RPs~~-~Il 614 (634)
||++||++. +++
T Consensus 234 dP~~R~~~~~~~~ 246 (316)
T cd05620 234 DPTRRLGVVGNIR 246 (316)
T ss_pred CHHHcCCChHHHH
Confidence 999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.13 Aligned_cols=261 Identities=31% Similarity=0.555 Sum_probs=231.0
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-----c-EEEEEEeec-cccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-----D-VAVKILIEQ-EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-----~-vAvK~~~~~-~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
.+....++||+|+||.||+|+++.. . ||+|..+.. ........++++|.+++++++|||||+++|+..+...+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 3444558999999999999987632 2 799988763 35677889999999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++|||+|.||+|.++|+.... .++..+...++.+.+.||+|||+++ ++||||-.+|+|++.++.+||+|||+++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999986654 4888999999999999999999999 999999999999999999999999999865
Q ss_pred CCCcccCC-CCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 514 PNTYISSK-TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 514 ~~~~~~~~-~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.. ..... ...-...|+|||.+....++.++|||||||++||+++ |..||.+....++...+.....+...|...+++
T Consensus 313 ~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~ 391 (474)
T KOG0194|consen 313 SQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKE 391 (474)
T ss_pred cc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHH
Confidence 41 11112 2235679999999999999999999999999999999 788999999999999997788888889999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
+..++.+||..+|+.|||+.++.+.|+.+.+....
T Consensus 392 ~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 392 LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999999987553
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=355.60 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=214.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeec-eeec---C-
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMG-AVTE---P- 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~-~~~~---~- 430 (634)
...++++.+.|.+|||+.||+|+..+. .+|+|++... ++..+..+.+|+.+|++|+ |+|||.+++ .... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 346677889999999999999998754 5999998776 5677788999999999996 999999999 3321 1
Q ss_pred --CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 431 --PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 431 --~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
-.++|.||||.||.|-++++...... |++..+++|++++++|+.+||...|+|||||||-+||||+.++.+||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 23779999999999999998554444 999999999999999999999999999999999999999999999999999
Q ss_pred CCccCCCCcccC---------CCCCCCCcccCcccc---cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Q 006703 509 LSRSKPNTYISS---------KTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG 576 (634)
Q Consensus 509 la~~~~~~~~~~---------~~~~gt~~y~APEvl---~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~ 576 (634)
.++......... -...-|+.|+|||++ .+.+.++|+|||+|||+||-||....||....... |
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----I- 266 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----I- 266 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----E-
Confidence 987532211011 123479999999986 67888999999999999999999999998864332 2
Q ss_pred hcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 577 FKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 577 ~~~~~~~~~--~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
......+| +.++..+.+||..||..||++||++.|+++.+..+.....
T Consensus 267 -lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 267 -LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred -EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 23333344 5799999999999999999999999999999999887543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.21 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=215.4
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||+|++|.||++.+. +..+++|.+............+.+|++++++++||||+++++++..++..+++|||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 566788999999999999886 445999998766555566678999999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
++++|.+++.... ...+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++..........
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 82 ENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999987532 235889999999999999999999999 9999999999999999999999999988655443334
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhh
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL 600 (634)
....|++.|+|||++.+..++.++|+||||+++++|++|+.||...+..+....+. ....+.++..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHc
Confidence 45578899999999999999999999999999999999999998887666555543 33344556678999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 006703 601 AEEPEIRPSFPSIME 615 (634)
Q Consensus 601 ~~dP~~RPs~~~Il~ 615 (634)
+.+|++||++.++++
T Consensus 238 ~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 238 TKDYRQRPDTFQLLR 252 (256)
T ss_pred cCCcccCcCHHHHhh
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.42 Aligned_cols=254 Identities=32% Similarity=0.544 Sum_probs=214.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
...|...++||+|+||.||+|.+.+. .+++|.+..... ..+.+.+|+.++++++|+||+++++++......+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 46788899999999999999987644 489998754332 24678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999864322 34788889999999999999999999 99999999999999999999999999986544321
Q ss_pred c-CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 519 S-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 519 ~-~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.. ....+.+..++..+.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRMENCPDELYDIM 237 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Confidence 1 223345678999999998889999999999999999998 9999988877766666542 233444567899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
.+||..+|++|||++++++.|+++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=331.64 Aligned_cols=242 Identities=27% Similarity=0.419 Sum_probs=204.3
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|++.++ .||+|++..... .......+..|..++... +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998754 499999876532 123345566788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 99999986432 3788899999999999999999999 999999999999999999999999998753322223345
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. ..+.++..++..+.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhcc
Confidence 6799999999999999999999999999999999999999998887776666532 33456677899999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 006703 603 EPEIRPSFP-SIME 615 (634)
Q Consensus 603 dP~~RPs~~-~Il~ 615 (634)
||++||++. +++.
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05619 234 EPERRLGVKGDIRQ 247 (316)
T ss_pred CHhhcCCChHHHHc
Confidence 999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.29 Aligned_cols=254 Identities=37% Similarity=0.617 Sum_probs=214.8
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|.++ +..+++|++.... .....+.+|++++++++|+||+++++++..+..++++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 55778889999999999999876 4459999876432 234678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++..... ..+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999999864332 34888999999999999999999999 99999999999999999999999999876543321
Q ss_pred c-CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 519 S-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 519 ~-~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. ....+..+..++.++.+++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVYELM 238 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHH
Confidence 1 122234668999999999999999999999999999998 999998877766555543 3345566778999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
.+||..||++|||+.++++.|++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHccCCcccCCCHHHHHHHHHhhC
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.78 Aligned_cols=241 Identities=27% Similarity=0.414 Sum_probs=201.2
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeecccc-HHHHHHHHHHH-HHHHhCCCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREV-AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~-~~~~~~~~~El-~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|++..+ .+|+|++...... ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999998754 4999998765332 22223444444 456788999999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|.+++.... .+++..+..++.||++||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 99999986433 3778888999999999999999999 999999999999999999999999998754333333455
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++..+++.+.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHccc
Confidence 679999999999999999999999999999999999999999888777665553 233455677899999999999999
Q ss_pred CCCCCCCHHHHH
Q 006703 603 EPEIRPSFPSIM 614 (634)
Q Consensus 603 dP~~RPs~~~Il 614 (634)
||.+||++.+.+
T Consensus 234 ~p~~R~~~~~~~ 245 (325)
T cd05602 234 DRTKRLGAKDDF 245 (325)
T ss_pred CHHHCCCCCCCH
Confidence 999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=313.56 Aligned_cols=262 Identities=21% Similarity=0.356 Sum_probs=212.4
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc---
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--- 432 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~--- 432 (634)
..+.+|...+.||+|||+.||+++.-.+ .+|+|.+..+. .+..+..++|++..++++||||++++++...+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3457899999999999999999986543 49999998775 4455778899999999999999999999855443
Q ss_pred --EEEEEeecccCCHHHHhccCCCc-ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 433 --LSIVTEYLSRGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 433 --~~lV~E~~~ggsL~~ll~~~~~~-~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
.|++++|...|+|.+.++....+ ..+++.+++.|+.+|++||.+||+..|+++||||||.|||+...+.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 99999999999999999754433 369999999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCcccC---------CCCCCCCcccCcccccCC---CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 006703 510 SRSKPNTYISS---------KTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 577 (634)
Q Consensus 510 a~~~~~~~~~~---------~~~~gt~~y~APEvl~~~---~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~ 577 (634)
++..+-..... .....|..|+|||.+.-+ ..++++|||||||+||.|+.|..||........--+...
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 87543221111 122368899999998544 458999999999999999999999965332211111111
Q ss_pred cCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 578 KGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 578 ~~~~~~~~--~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
......+| ..+++.+.++|++||..||.+||++.+++..+.+++
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 22223333 458999999999999999999999999999998875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.84 Aligned_cols=255 Identities=34% Similarity=0.573 Sum_probs=216.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+.||+|+||.||+|.+... .+|+|++.... .......+.+|+.++++++|+||+++++++......++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4577889999999999999987532 48999876543 34445678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+|||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999875432 4889999999999999999999999 99999999999999999999999999987542
Q ss_pred --CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 516 --TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 516 --~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .....+.+..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 1112223345678999999999999999999999999999998 999998877766665553 233445567789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
.+++.+||..+|++||++.+|++.|++++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=333.95 Aligned_cols=238 Identities=28% Similarity=0.427 Sum_probs=201.0
Q ss_pred ceeeccCcEEEEEEEEcC--CcEEEEEEeecccc-HHHHHHHHHHHH-HHHhCCCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~-~~~~~~~~~El~-iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||+||+|.++. ..||+|++...... .....++.+|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999864 45999998765332 223344555554 56788999999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 99999886543 4889999999999999999999999 999999999999999999999999998754333333445
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++..+++.+.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence 679999999999999999999999999999999999999999888777666553 334456677899999999999999
Q ss_pred CCCCCCCHH
Q 006703 603 EPEIRPSFP 611 (634)
Q Consensus 603 dP~~RPs~~ 611 (634)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (323)
T cd05575 234 DRTKRLGAK 242 (323)
T ss_pred CHHhCCCCC
Confidence 999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.65 Aligned_cols=246 Identities=26% Similarity=0.442 Sum_probs=202.8
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|++. +..||+|++.... .......+.+|+.+++.++|+||+++++++...+.+++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 356777889999999999999886 4559999986543 3344567889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.+++|.... ..++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999999986532 2567788899999999999999999 9999999999999999999999999998654433
Q ss_pred ccCCCCCCCCcccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHhhcCcccCCCCCCc
Q 006703 518 ISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~-----~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~s 589 (634)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||......+. ...+ .....+..+..++
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 301 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPPEAPATAS 301 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCCCCCCccC
Confidence 33445679999999998743 2345689999999999999999999974332221 1122 1233455667889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.++.+||.+||..||++|||+.++++.
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999974
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=328.11 Aligned_cols=251 Identities=26% Similarity=0.430 Sum_probs=222.4
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
....+|...++||+|.||.|-+|... ++.||||.+++..+. +..+-.+.+|++||..++||||+.++..|...+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34577889999999999999999764 555999999888764 456678999999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
|||||..+|.|++|+...+ .+++..+..+++||+.|+.|+|+++ ++|||||.+|||+|.++++||+|||++..+.
T Consensus 130 ivMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999997654 4999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
... ..++.+|+|-|.+||++.|.+| ++.+|.||||++||-|+.|..||++.+...++.++.....+. +.-+....
T Consensus 205 ~~k-fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~ 280 (668)
T KOG0611|consen 205 DKK-FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDAS 280 (668)
T ss_pred ccc-HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHH
Confidence 432 4578899999999999999999 788999999999999999999999999988888886544332 33456778
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
-||.+||..||++|.|+.+|....
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhh
Confidence 899999999999999999987653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.21 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=199.0
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|+.+ +..+|+|++....... ....+.+|+.+++.++||||+++++++.++...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 467888999999999999999986 4459999986543222 2245678999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred ECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9996 57777775432 34788899999999999999999999 9999999999999999999999999987544333
Q ss_pred ccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhc-Cc--------------
Q 006703 518 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK-GR-------------- 580 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~-~~-------------- 580 (634)
.......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... +....+... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 333456789999999998654 5789999999999999999999999875432 221111100 00
Q ss_pred -cc-----CCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -RL-----EIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -~~-----~~~---------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+ ..+ ...++.+.+|+.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 000 123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.99 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=207.1
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||++.... ..||+|++..... .......+.+|++++++++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 46778999999999999998864 4499999876532 34455678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 82 FLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999986432 4889999999999999999999999 9999999999999999999999999986321100
Q ss_pred ------------c----------------------------------cCCCCCCCCcccCcccccCCCCCchHHHHHHHH
Q 006703 518 ------------I----------------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 551 (634)
Q Consensus 518 ------------~----------------------------------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGv 551 (634)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 006703 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIR---PSFPSIMET 616 (634)
Q Consensus 552 lL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~Li~~cL~~dP~~R---Ps~~~Il~~ 616 (634)
++|||++|..||......+....+........+|. .++.+++++|.+||. +|.+| +|+.+++..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999998887766655543333344443 578999999999997 77765 599988874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.13 Aligned_cols=249 Identities=35% Similarity=0.594 Sum_probs=211.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..|...+.||+|+||.||++.++.. .+|+|.+...... ..++.+|+.++++++||||+++++++......+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4567788999999999999988754 5899987644333 24678899999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI- 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~- 518 (634)
+++++|.++++.... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 81 MENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999999874332 4888999999999999999999999 99999999999999999999999999876433221
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.. ...+..+...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHH
Confidence 1223345668999999998889999999999999999999 8999988887776666643 3344456667899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L 617 (634)
+||..+|++|||+.++++.|
T Consensus 236 ~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHccCCcccCcCHHHHHHhh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=324.36 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=221.5
Q ss_pred CCCCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC
Q 006703 355 NPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431 (634)
Q Consensus 355 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~ 431 (634)
.......+|...+.||+|.-|+||+++.+++. +|+|++.+.... .....+...|-.||+.+.||.++.+|..|+.++
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 33444577888899999999999999998754 999999877653 566678889999999999999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..|++||||+||+|..+++++.. ..+++..+..++.+++-||+|||..| ||.|||||+||||.++|+|.|+||.++.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999999999876544 45999999999999999999999999 9999999999999999999999999874
Q ss_pred cCCC-----------------------------------C---------------------cccCCCCCCCCcccCcccc
Q 006703 512 SKPN-----------------------------------T---------------------YISSKTAAGTPEWMAPEVL 535 (634)
Q Consensus 512 ~~~~-----------------------------------~---------------------~~~~~~~~gt~~y~APEvl 535 (634)
.... . ...+...+||-.|.|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 2110 0 0112334699999999999
Q ss_pred cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCC----HH
Q 006703 536 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS----FP 611 (634)
Q Consensus 536 ~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs----~~ 611 (634)
.|...+.++|+|+||+++|||+.|..||.+.+..+....+..+....+-...++..+++||.++|.+||.+|.- +.
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 99999999999999999999999999999999999888885555444444578899999999999999999987 66
Q ss_pred HHHH
Q 006703 612 SIME 615 (634)
Q Consensus 612 ~Il~ 615 (634)
+|-+
T Consensus 388 eIK~ 391 (459)
T KOG0610|consen 388 EIKR 391 (459)
T ss_pred Hhhc
Confidence 6543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.62 Aligned_cols=254 Identities=33% Similarity=0.531 Sum_probs=214.7
Q ss_pred cceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..|...+.||+|+||.||+|...+ ..+|+|++..... .+....+.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457778899999999999997643 3499998865432 33457889999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCC-----------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcE
Q 006703 434 SIVTEYLSRGSLYKLLHIPD-----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 502 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~-----------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~i 502 (634)
+++|||+++++|.+++.... ....+++..+..++.|++.|+.|||++| ++|+||||+||+++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeE
Confidence 99999999999999996432 2245788999999999999999999999 9999999999999999999
Q ss_pred EEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 006703 503 KVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG 579 (634)
Q Consensus 503 kL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~ 579 (634)
||+|||++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+. ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cC
Confidence 999999987543221 11234446788999999999999999999999999999998 999998888777666654 33
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
.....+..++..+.+++.+||..||++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 334456678999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.03 Aligned_cols=254 Identities=30% Similarity=0.534 Sum_probs=210.0
Q ss_pred ecceeeccCcEEEEEEEEcCC----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------CcEE
Q 006703 365 DSSNFIKGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------PNLS 434 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------~~~~ 434 (634)
..+.||+|+||.||+|.+... .+|+|.+..........+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999988654 388888876555556667889999999999999999999976432 3478
Q ss_pred EEEeecccCCHHHHhccC---CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 435 IVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~---~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
++|||+.+++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCccc
Confidence 999999999999887421 22335889999999999999999999999 9999999999999999999999999988
Q ss_pred cCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 512 SKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 512 ~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
....... ......+++.|++||.+.+..++.++||||||+++|+|++ |+.||......+....+. .......+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 6543211 1223346778999999999999999999999999999999 899998877766555553 23344556778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
+..+.+++.+||..||++|||+.+|++.|++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.11 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=198.4
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-----CcEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNLS 434 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~-----~~~~ 434 (634)
+|...+.||+|+||.||+|.++. ..||+|++...........++.+|+.++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 46778999999999999998864 4599999875433344456788999999999999999999987543 2489
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+. ++|.+++.... .+++..+..++.||++||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 68888886433 3889999999999999999999999 9999999999999999999999999987543
Q ss_pred CCc---ccCCCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh------------
Q 006703 515 NTY---ISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------ 577 (634)
Q Consensus 515 ~~~---~~~~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~------------ 577 (634)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 11234579999999999876 6789999999999999999999999987654332211100
Q ss_pred -------------cC-cccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 578 -------------KG-RRLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 578 -------------~~-~~~~---~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.. .... ..+.+++.+.+++.+||..||++|||+.++++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0000 113467889999999999999999999999973
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=324.03 Aligned_cols=249 Identities=27% Similarity=0.350 Sum_probs=199.7
Q ss_pred ceeecceeeccCcEEEEEEEEc---CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC---CCCCeeeeeceee-----cC
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT-----EP 430 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l---~h~nIv~l~~~~~-----~~ 430 (634)
+|...+.||+|+||.||+|++. +..+|+|++............+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5777889999999999999874 23489998876544333334455677776665 6999999999874 34
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
..++++|||+. ++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999996 589888864332 24889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc---------
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------- 581 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--------- 581 (634)
...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+....+......
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 765433 2334567899999999999889999999999999999999999999987776555444211100
Q ss_pred ----------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ----------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ----------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+...+++.+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0112357788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=339.69 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=207.0
Q ss_pred ceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+|++..+ .+|+|++..... .......+.+|+.++++++|+||+++++.+.++..+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477889999999999999998644 499999876533 23445678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-- 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~-- 516 (634)
|+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999986543 4889999999999999999999999 999999999999999999999999997532100
Q ss_pred ---------------------------------------------cccCCCCCCCCcccCcccccCCCCCchHHHHHHHH
Q 006703 517 ---------------------------------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 551 (634)
Q Consensus 517 ---------------------------------------------~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGv 551 (634)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 006703 552 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPS---FPSIME 615 (634)
Q Consensus 552 lL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Li~~cL~~dP~~RPs---~~~Il~ 615 (634)
++|||++|+.||...++.+....+.........| ..+++++.++|.+|+ .+|.+|++ +.+++.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999888776665554333333333 467999999999986 59999987 887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=332.33 Aligned_cols=242 Identities=22% Similarity=0.402 Sum_probs=201.8
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeecccc-HHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||++++..+ .||+|++...... ......+.+|..+++++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999988744 4999999765432 33446688899999998 799999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++............
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 99998886432 4899999999999999999999999 999999999999999999999999998753322233445
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh--------HH-HHHHHhhcCcccCCCCCCcHHHH
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--------SQ-VISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~--------~~-~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
..||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... .+ ....+ ......+|..++..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~ 233 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAS 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHH
Confidence 6799999999999999999999999999999999999999963211 11 11222 3344567788999999
Q ss_pred HHHHHhhhcCCCCCCC------HHHHHH
Q 006703 594 ALIETCWAEEPEIRPS------FPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs------~~~Il~ 615 (634)
+++.+||+.||.+||+ +.++++
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 9999999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.80 Aligned_cols=255 Identities=30% Similarity=0.507 Sum_probs=213.7
Q ss_pred eecceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc------
Q 006703 364 IDSSNFIKGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN------ 432 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~------ 432 (634)
...+.||+|+||.||+|.... ..+|+|++............+.+|+..++.++|+||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456789999999999998753 349999987765556666789999999999999999999998865544
Q ss_pred EEEEEeecccCCHHHHhccC---CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 433 LSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~---~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
.+++|||+++++|..++... .....+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988432 12235899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCC
Q 006703 510 SRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK 586 (634)
Q Consensus 510 a~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 586 (634)
++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. .......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCc
Confidence 876433211 1222335678999999998889999999999999999999 899998887777665553 334555677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 587 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
.++..+.+++.+||..||++|||+.++++.|++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 89999999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=340.23 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=207.2
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+|++.. ..+|+|++..... .......+.+|+.++++++|+||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 57888999999999999998874 4499999865433 22344668899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-- 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~-- 516 (634)
|+++++|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999996543 4888999999999999999999999 999999999999999999999999997522100
Q ss_pred -----------------------------------------cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHH
Q 006703 517 -----------------------------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWE 555 (634)
Q Consensus 517 -----------------------------------------~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~e 555 (634)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 001123479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 006703 556 LITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRP---SFPSIMET 616 (634)
Q Consensus 556 Lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Li~~cL~~dP~~RP---s~~~Il~~ 616 (634)
|++|+.||....+.+....+.........+ ..+++.+.++|.+|+ .+|.+|+ |+.++++.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999888776655553333333333 468899999999977 5999999 88988864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.34 Aligned_cols=264 Identities=31% Similarity=0.558 Sum_probs=220.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE 429 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~ 429 (634)
...|...+.||+|+||.||++++.+ ..+|+|.+.... ......++.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3678999999999999999997642 248999887543 334456788999999999 79999999999999
Q ss_pred CCcEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
....+++|||+++++|.+++..... ...+++..++.++.|++.||.|||++| ++|+||||+||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 173 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV 173 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEE
Confidence 9999999999999999999964321 124788899999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCCccc--CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 573 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~~~~--~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~ 573 (634)
+.++.+||+|||++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 99999999999998765432111 122234568999999999889999999999999999998 889998877666555
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
.+. .......+..++.++.+++.+||..+|++|||+.++++.|+.++.....|
T Consensus 254 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~~ 306 (307)
T cd05098 254 LLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQ 306 (307)
T ss_pred HHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhcC
Confidence 543 33345667788999999999999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=313.14 Aligned_cols=248 Identities=37% Similarity=0.630 Sum_probs=215.2
Q ss_pred ceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 367 SNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
+.||+|+||.||+|.+. +..+++|++....... ....+.+|++.++.++|+||+++++++......+++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46899999999999887 4459999987654433 45788899999999999999999999999999999999999
Q ss_pred cCCHHHHhccCCC------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 442 RGSLYKLLHIPDA------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 442 ggsL~~ll~~~~~------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999975421 245899999999999999999999999 99999999999999999999999999987554
Q ss_pred Cc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 516 TY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 516 ~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
.. .......++..|+|||.+.+..++.++||||||+++++|++ |..||......+....+.. ......+..+++.+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 32 23445567889999999988889999999999999999999 6999999887777666643 44556777889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
.+++.+||..+|.+|||+.++++.|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=313.24 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=213.6
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc---HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~---~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
.|...+.||+|++|.||++... +..+++|.+...... ......+.+|+.++++++||||+++++++..+...+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 4777889999999999999875 456999998755332 22346788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
+||+++++|.+++.... .+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 83 MEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999886433 3788999999999999999999999 999999999999999999999999998754322
Q ss_pred cccC---CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 517 YISS---KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 517 ~~~~---~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
.... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...+................++..++..+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence 1111 3456788999999999999999999999999999999999999887776665555555556667888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+++.+||..+|++|||+.++++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.41 Aligned_cols=241 Identities=24% Similarity=0.408 Sum_probs=206.0
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEe
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E 438 (634)
|...+.||+|+||.||+|+++. ..||+|++..... .......+..|..+++.+. |++|+++++++...+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 5567899999999999998874 4499999876532 2334466788999998885 5788899999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 82 y~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999886443 3889999999999999999999999 99999999999999999999999999875433333
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .....+|..+++.+.+++.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKG 234 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHHH
Confidence 3455679999999999999999999999999999999999999999888777666663 33445677889999999999
Q ss_pred hhhcCCCCCCCH
Q 006703 599 CWAEEPEIRPSF 610 (634)
Q Consensus 599 cL~~dP~~RPs~ 610 (634)
||..+|.+|++.
T Consensus 235 ~l~~~p~~R~~~ 246 (323)
T cd05615 235 LMTKHPSKRLGC 246 (323)
T ss_pred HcccCHhhCCCC
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.47 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=202.8
Q ss_pred eeccCcEEEEEEEEcC--CcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 369 FIKGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
||+|+||+||++.+.. ..+|+|.+...... ......+..|+++++.++|+||+++.+++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6899999999998764 45999998765432 23345678899999999999999999999999999999999999999
Q ss_pred HHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCC
Q 006703 446 YKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 524 (634)
Q Consensus 446 ~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~ 524 (634)
..++.. ...+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 888743 223345899999999999999999999999 99999999999999999999999999876544333344567
Q ss_pred CCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV--GFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 525 gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+ ........++..+++.+.+++.+||+.
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence 999999999999999999999999999999999999999765432111111 112233455677899999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 006703 603 EPEIRP-----SFPSIMET 616 (634)
Q Consensus 603 dP~~RP-----s~~~Il~~ 616 (634)
||++|| +++++++.
T Consensus 239 ~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CHHHhcCCCCCCHHHHhcC
Confidence 999999 77888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=336.95 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=211.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||+++++.+ .+|+|++..... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346888999999999999999988744 499999875432 22334557789999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++|+|.+++... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998643 3788899999999999999999999 99999999999999999999999999876543
Q ss_pred Cc-ccCCCCCCCCcccCcccccCC----CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCC--CC
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLRED----PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NV 588 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~~~----~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~ 588 (634)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+........++. .+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 21 123456799999999998654 368899999999999999999999998887766666643333344443 57
Q ss_pred cHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEI--RPSFPSIMET 616 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~--RPs~~~Il~~ 616 (634)
+.++.++|.+||..+|++ |+|+.++++.
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 999999999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=331.20 Aligned_cols=238 Identities=29% Similarity=0.428 Sum_probs=200.4
Q ss_pred ceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHH-HHHhCCCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~-iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|++.. ..+|+|++..... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999864 4499999876543 2233344555554 67889999999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|...+.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++............
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 99988886432 4788899999999999999999999 999999999999999999999999998753333333445
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....++...+..+.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999999999999999999999999999999999888776665553 344566778899999999999999
Q ss_pred CCCCCCCHH
Q 006703 603 EPEIRPSFP 611 (634)
Q Consensus 603 dP~~RPs~~ 611 (634)
+|.+||++.
T Consensus 234 ~p~~R~~~~ 242 (321)
T cd05603 234 DQRRRLGAK 242 (321)
T ss_pred CHhhcCCCC
Confidence 999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.24 Aligned_cols=257 Identities=31% Similarity=0.580 Sum_probs=214.7
Q ss_pred eeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
|...+.||+|+||.||+|.... ..+++|.+.... ......++.+|+.+++.++||||+++++.+......++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5667899999999999998653 237777775443 23345678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCC---------------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcE
Q 006703 436 VTEYLSRGSLYKLLHIPD---------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 494 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~---------------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NI 494 (634)
+|||+.+++|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ni 158 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNV 158 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheE
Confidence 999999999999985321 1134788899999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 006703 495 LVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQV 571 (634)
Q Consensus 495 Lld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~ 571 (634)
+++.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++++|++ |..||.+..+.+.
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999987543221 12233345778999999988889999999999999999998 9999988887776
Q ss_pred HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 572 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 572 ~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
...+. .......+..++..+.+++.+||+.+|++||++.++++.|++++..
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 239 FNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 65553 2334455678899999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=312.26 Aligned_cols=246 Identities=34% Similarity=0.574 Sum_probs=205.7
Q ss_pred ceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCC
Q 006703 367 SNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGS 444 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggs 444 (634)
+.||+|+||.||+|.+. ++.+|+|.+... ...+....+.+|+.++++++|+||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46899999999999885 445999987543 344455678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC--CC
Q 006703 445 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KT 522 (634)
Q Consensus 445 L~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~--~~ 522 (634)
|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999986433 24789999999999999999999999 9999999999999999999999999987543221111 11
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~ 601 (634)
...+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .......+..++..+.+++.+||.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcC
Confidence 123457999999999889999999999999999997 899998777665544443 233445667789999999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 006703 602 EEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 602 ~dP~~RPs~~~Il~~L~ 618 (634)
.+|++|||+.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=319.81 Aligned_cols=252 Identities=25% Similarity=0.321 Sum_probs=209.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee--cCCcEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLS 434 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~--~~~~~~ 434 (634)
....|...+.|++|+||.||+|+++.+. ||+|.++...-.....-.-.+|+.+|.+++|||||.+-.... .-+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3466888899999999999999998665 999998766533333334569999999999999999988874 345699
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
||||||+. +|..++.... ..+....+..++.|+++|+.|||.++ |+||||||+|+|++.+|.+||+|||+|+.+.
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999976 8999997655 34888999999999999999999999 9999999999999999999999999999988
Q ss_pred CCcccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-Cc------------
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR------------ 580 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~~------------ 580 (634)
+........+-|..|+|||.+.+.+ |+++.|+||+||++.||+++++.|.+....+.+..|-.. +.
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 7766666778899999999998765 799999999999999999999999988776555444211 00
Q ss_pred ----------------ccCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 ----------------RLEIPK-NVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ----------------~~~~~~-~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+..++. .+++.-.+|+..+|..||.+|.|+.+-|+
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 001111 25688999999999999999999999886
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.47 Aligned_cols=262 Identities=30% Similarity=0.547 Sum_probs=213.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceee-c
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT-E 429 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~-~ 429 (634)
+..+|...+.||+|+||.||+|...+ ..||+|++.... .......+..|+.+++++ +|+||+++++++. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34578889999999999999997543 349999886543 334456788999999999 8999999999875 4
Q ss_pred CCcEEEEEeecccCCHHHHhccCCC-------------------------------------------------------
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDA------------------------------------------------------- 454 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~------------------------------------------------------- 454 (634)
+..++++|||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4678899999999999999853211
Q ss_pred ---cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcc
Q 006703 455 ---RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEW 529 (634)
Q Consensus 455 ---~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y 529 (634)
...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......++..|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125788999999999999999999999 9999999999999999999999999997643221 122334567789
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 006703 530 MAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608 (634)
Q Consensus 530 ~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RP 608 (634)
+|||++.+..++.++|||||||++|||++ |..||......+..............+...++++.+++.+||+.+|++||
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999998 99999876554433333223344455667889999999999999999999
Q ss_pred CHHHHHHHHHHHHHh
Q 006703 609 SFPSIMETLQQFLMS 623 (634)
Q Consensus 609 s~~~Il~~L~~ll~~ 623 (634)
++.+|++.|+.+++.
T Consensus 322 s~~ell~~l~~~~~~ 336 (337)
T cd05054 322 TFSELVEILGDLLQE 336 (337)
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999999873
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=318.08 Aligned_cols=255 Identities=31% Similarity=0.543 Sum_probs=212.0
Q ss_pred cceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..|...+.||+|+||.||+|.+. +..+++|.+.... .......+.+|+.++++++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 45677789999999999999852 2348888886543 3344567889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCC--------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC
Q 006703 435 IVTEYLSRGSLYKLLHIPD--------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 500 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~--------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~ 500 (634)
++|||+++++|.+++.... .+..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~~ 161 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCCC
Confidence 9999999999999985321 1234788899999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhh
Q 006703 501 TVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF 577 (634)
Q Consensus 501 ~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~ 577 (634)
.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR- 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 99999999987543221 11233445678999999988889999999999999999998 999998877666555553
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 578 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 578 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
....+..+..+++.+.+++.+||+.||++||++.+|++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 333455677889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.42 Aligned_cols=258 Identities=24% Similarity=0.420 Sum_probs=213.2
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||++... +..+++|.+..... ......++.+|+.+++.++|+||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4667789999999999999875 45599998765433 33445678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 439 YLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|+++++|.+++... .....+++..++.++.|+++||.|||++| ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 99999999988632 22345899999999999999999999999 9999999999999999999999999987654433
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--QVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... +....+......+..+...++.+.++
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence 3334557889999999999989999999999999999999999999765432 22222221112222234588999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
+.+||..||.+|||+.+|++.++++.
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.81 Aligned_cols=258 Identities=30% Similarity=0.506 Sum_probs=215.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--C----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--S----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...|...+.||+|+||.||+|.+.. . .||+|++.... ......++.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3568889999999999999998642 2 27888876432 334456788999999999999999999998764 57
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++++||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccc
Confidence 79999999999999987543 24788899999999999999999999 999999999999999999999999999865
Q ss_pred CCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 514 PNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 514 ~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+ ......+.+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 238 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCH
Confidence 43221 1222334678999999999999999999999999999998 99999887766654433 34445556677889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+.+++.+||..+|++|||+.+++..|..+.+..
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.53 Aligned_cols=238 Identities=23% Similarity=0.400 Sum_probs=198.1
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|++..+ .+|+|++..... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999988754 499999876543 233445677899988877 899999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++............
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 99988886433 4899999999999999999999999 999999999999999999999999998754333333445
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--------PSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ........ .......+|..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-ILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-HhcCCCCCCCCCCHHHHH
Confidence 679999999999999999999999999999999999999995311 11111111 133455678889999999
Q ss_pred HHHHhhhcCCCCCCCH
Q 006703 595 LIETCWAEEPEIRPSF 610 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~ 610 (634)
++.+||+.||++||++
T Consensus 235 ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 235 VLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHhcCCHHHcCCC
Confidence 9999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=312.89 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=215.1
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||.||+|... +..+++|.+..... .....+.+.+|++++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46788899999999999999886 55599998865433 3344577899999999999999999999999999999999
Q ss_pred eecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||+++++|..++... .....+++..++.++.+++.||.|||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999998532 22345889999999999999999999999 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhhcCcccCCCC-CCcHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKGRRLEIPK-NVNPMVA 593 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~-~~s~~l~ 593 (634)
........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+.. ...++.+. ..+..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHH
Confidence 3333455788999999999998899999999999999999999999965432 223333222 22233443 6888999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
++|.+||..+|.+|||+.+|++.|+++.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=311.91 Aligned_cols=250 Identities=37% Similarity=0.646 Sum_probs=216.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
...|...+.||.|+||.||+|...++.+++|.+..... ..+++.+|+.++++++|+||+++++++......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 35677788999999999999999998999999865532 457788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 82 MAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 999999999875432 24899999999999999999999999 9999999999999999999999999988653321
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
.....+..|+|||.+.+..++.++|+||||+++++|++ |..||......+....+. .......+...++.+.+++.+
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHHHH
Confidence 23345668999999988889999999999999999997 999998887766655553 233455667789999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~~L~~ 619 (634)
||..+|.+|||+.++++.|++
T Consensus 235 ~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 235 CWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HhccChhhCcCHHHHHHHHhc
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.06 Aligned_cols=250 Identities=34% Similarity=0.566 Sum_probs=211.2
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc-EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~-vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..|...+.||+|+||.||++.+.+.. +|+|.+...... ...+.+|+.++++++||||+++++++......+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45778889999999999999887654 999987654432 25688999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-c
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-I 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~-~ 518 (634)
+.+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 81 MSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999875432 4899999999999999999999999 9999999999999999999999999987543321 1
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+. ...+...+...++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHH
Confidence 1223345678999999998889999999999999999998 999998877766555553 33444456677899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~ 618 (634)
+||..+|.+|||+.+|++.|+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.94 Aligned_cols=261 Identities=32% Similarity=0.548 Sum_probs=215.6
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc----EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~----vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+.||+|+||.||+|..+..+ +++|.+... ......+.+.+|+.++.++ +||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 35777889999999999999876433 577776532 2334456788999999999 79999999999999999999
Q ss_pred EEeecccCCHHHHhccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcE
Q 006703 436 VTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 502 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~-------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~i 502 (634)
+|||+++++|.+++.... ....+++..++.++.|++.||+|||++| |+||||||+||+++.++.+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCeE
Confidence 999999999999986432 1124888999999999999999999999 9999999999999999999
Q ss_pred EEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcc
Q 006703 503 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRR 581 (634)
Q Consensus 503 kL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~ 581 (634)
||+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||......+....+. ....
T Consensus 159 kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~~ 236 (297)
T cd05089 159 KIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 236 (297)
T ss_pred EECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCC
Confidence 99999998643221 11112233557999999999889999999999999999997 999999888777665553 2334
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 582 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 582 ~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
...+..++..+.+|+.+||..+|.+|||+.++++.|++++.....
T Consensus 237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 456677899999999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=332.54 Aligned_cols=249 Identities=27% Similarity=0.360 Sum_probs=209.3
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+++++. ..+|+|++..... .......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 47778999999999999998864 4499999876543 23345668899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999997542 24899999999999999999999999 9999999999999999999999999997644321
Q ss_pred ccCCCCCCCCcccCccccc------CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCc
Q 006703 518 ISSKTAAGTPEWMAPEVLR------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVN 589 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~------~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s 589 (634)
.......||+.|+|||++. +..++.++|||||||++|+|++|+.||......+....+........++ ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 1233457999999999986 4567889999999999999999999998887766655553333223333 3578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+.+|+.+||. +|.+|||+.+++.
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 999999999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.11 Aligned_cols=255 Identities=32% Similarity=0.561 Sum_probs=211.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
..+|...+.||+|+||.||+|.+++ ..+|+|.+.... ......++.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568888999999999999998653 248999875432 22344678899999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCC-------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDA-------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~-------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
.+++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999864221 123577888999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCccc
Q 006703 506 DFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRL 582 (634)
Q Consensus 506 DFGla~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~ 582 (634)
|||++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+. .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcC
Confidence 9999875433211 1123345778999999999889999999999999999999 789998877766555443 33344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
..+..++..+.+++.+||..||++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 566778999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.09 Aligned_cols=254 Identities=34% Similarity=0.537 Sum_probs=213.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
...|...+.||+|++|.||+|.+.++ .+|+|.+...... .+++.+|+.++++++|+||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35678889999999999999987644 4899988654332 3567899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999986543 234789999999999999999999999 99999999999999999999999999876543211
Q ss_pred c-CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 519 S-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 519 ~-~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
. ......+..|+|||.+.+..++.++|+||||+++++|++ |+.||......+....+. .......+..+++.+.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHH
Confidence 1 112223457999999999999999999999999999999 999998887776665553 2334455677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
.+||+.+|++||++.+|++.|+++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHhhcCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=312.71 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=213.0
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||.|+||.||++.+.. ..+++|.+..... ....+.+.+|+.+++.++|+||+++++.+..++.++++|||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 6677899999999999998864 4499998865432 334567889999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
++++|.+++..... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 99999998864322 34789999999999999999999999 9999999999999999999999999987654433333
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhh
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL 600 (634)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+.+++.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHH
Confidence 45678999999999999889999999999999999999999999877766655553 33344566788999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 006703 601 AEEPEIRPSFPSIMET 616 (634)
Q Consensus 601 ~~dP~~RPs~~~Il~~ 616 (634)
..||++|||+.+|+..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=314.66 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=218.0
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|.|+.|+++.+. ++++|+|++....+.....+++.+|++|-+.++||||+++.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 356777789999999999999776 445999999877776667788999999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc---CCCcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld---~~~~ikL~DFGla~~~~ 514 (634)
|++.|+.|..-+-.. ...++..+-..++||++||.|+|.+| |||||+||+|+++- +...+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999986554322 45899999999999999999999999 99999999999995 34579999999998766
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCCCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l 592 (634)
.........|||.|||||++...+++..+|||+.||+||-|+.|.+||.+.+...+...+...... ++....++++.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 344556788999999999999999999999999999999999999999998888888777544333 33457899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++|+.+||+.||.+|.|+.+.|+
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhC
Confidence 99999999999999999998764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.27 Aligned_cols=248 Identities=34% Similarity=0.538 Sum_probs=208.4
Q ss_pred eeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||+|+||+||++.+.+.+ +|+|++..............+|+.++++++|+||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999998765 999999888766665556677999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
.+++|.+++.. ...+++..++.++.||++||.+||+++ |+|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccc---ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence 99999999972 234899999999999999999999999 9999999999999999999999999987543333345
Q ss_pred CCCCCCCcccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hhcCcccCC--CCCCcHHHHH
Q 006703 521 KTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV---GFKGRRLEI--PKNVNPMVAA 594 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~-~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i---~~~~~~~~~--~~~~s~~l~~ 594 (634)
....++..|+|||++. +...+.++|+||||+++++|++|..||...........+ ......... ....++.+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 6778899999999998 888899999999999999999999999987433322222 111111111 1223489999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+||..||++|||+.++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.34 Aligned_cols=259 Identities=33% Similarity=0.547 Sum_probs=217.3
Q ss_pred cceeecceeeccCcEEEEEEEEcC-----C--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-----S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-----~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..|...+.||+|+||.||++.... + .+|+|.+.... ......+.+|+.++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 567788899999999999997532 2 27888775432 34456788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCC----------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEE
Q 006703 434 SIVTEYLSRGSLYKLLHIPD----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 503 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~----------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ik 503 (634)
+++|||+++++|.+++.... ....+++..++.++.|++.||+|||++| ++||||||+||+++.++.+|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEE
Confidence 99999999999999986332 1234899999999999999999999999 99999999999999999999
Q ss_pred EEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCc
Q 006703 504 VCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 580 (634)
Q Consensus 504 L~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~ 580 (634)
|+|||++....... .......++..|+|||.+.+..++.++||||||+++++|++ |..||......+....+. ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence 99999987543221 11223445778999999999899999999999999999998 899998888777666653 233
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
....+...+.++.+++.+||..||.+|||+.++++.|+++.+..
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 34456678899999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=316.98 Aligned_cols=255 Identities=32% Similarity=0.542 Sum_probs=215.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
...|...+.||+|+||.||++..++ ..+++|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3567888999999999999998763 349999975443 23344678899999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCC-------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDA-------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~-------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
.+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999864321 224788899999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCccc
Q 006703 506 DFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRL 582 (634)
Q Consensus 506 DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~ 582 (634)
|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. ....+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCC
Confidence 999987543321 12234456789999999988889999999999999999998 999998888777766664 44456
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
..+..++..+.+++.+||..+|++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 677788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=331.50 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=200.8
Q ss_pred ceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHH-HHHhCCCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~-iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|++. +..+|+|++..... .......+..|.. +++.++||||+++++++..++..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999886 44599999875532 2233345556654 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 99998886433 4889999999999999999999999 999999999999999999999999998754333333445
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++...+..+.+++.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCCccCCCCCCHHHHHHHHHHhcc
Confidence 679999999999999999999999999999999999999999888777666553 233445567899999999999999
Q ss_pred CCCCCCCHHH
Q 006703 603 EPEIRPSFPS 612 (634)
Q Consensus 603 dP~~RPs~~~ 612 (634)
+|.+||++.+
T Consensus 234 ~p~~R~~~~~ 243 (325)
T cd05604 234 DRQRRLGAKE 243 (325)
T ss_pred CHHhcCCCCC
Confidence 9999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.25 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=203.2
Q ss_pred eeecceeeccCcEEEEEEEEc-----CCcEEEEEEeeccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~--~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~ 434 (634)
|...+.||+|+||.||+++.. +..+|+|++..... .....+.+.+|+.+++.+ +|+||+++++++..+..++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 667889999999999999763 34599999875432 223345678899999999 5999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 82 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999986433 3889999999999999999999999 9999999999999999999999999987543
Q ss_pred CC-cccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhcCcccCCCCCC
Q 006703 515 NT-YISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 515 ~~-~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 588 (634)
.. ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+ ....+.++..+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCC
Confidence 22 12233457999999999998754 78899999999999999999999964322 2222222 33455677789
Q ss_pred cHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RP-----s~~~Il~ 615 (634)
++.+.+++.+||..||++|| ++.++++
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 99999999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.57 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=211.3
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
.....|...+.||+|+||.||++++..+ .+|+|++..... .......+.+|+.+++.++||||+++++++.++..+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3447789999999999999999998754 499999865432 2333456789999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999998643 3788999999999999999999999 9999999999999999999999999998653
Q ss_pred CCc-ccCCCCCCCCcccCcccccCCC----CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCC--C
Q 006703 515 NTY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--N 587 (634)
Q Consensus 515 ~~~-~~~~~~~gt~~y~APEvl~~~~----~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~ 587 (634)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+........+|. .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 322 2234667999999999997643 68899999999999999999999998887776666644444444444 5
Q ss_pred CcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEI--RPSFPSIMET 616 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~--RPs~~~Il~~ 616 (634)
++..+++++.+||..++.+ |+|+.++++.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 6999999999999855543 8899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=311.33 Aligned_cols=246 Identities=33% Similarity=0.523 Sum_probs=207.7
Q ss_pred ceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 367 SNFIKGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
++||+|+||.||+|.+.. ..+|+|.+...... ...+++.+|+.+++++.|+||+++++++. ....+++|||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 479999999999997653 34899998766543 44567889999999999999999999876 456899999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc--
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-- 519 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~-- 519 (634)
+++|.+++.... .+++..++.++.|++.||.|||.++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999997543 4889999999999999999999999 999999999999999999999999998764332211
Q ss_pred -CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 520 -SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 520 -~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .......+..+++.+.+++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIML 232 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence 112223568999999999999999999999999999998 999998888776665553 33445667788999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
+||..+|++|||+.++++.|+++
T Consensus 233 ~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 233 SCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=311.81 Aligned_cols=249 Identities=35% Similarity=0.609 Sum_probs=210.4
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..|...+.||+|+||.||++.++++ .+|+|++....... ..+.+|+.++++++|+||+++++++......+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3467788999999999999988754 49999876543332 3577899999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++...+....
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999999875432 4889999999999999999999999 999999999999999999999999998764432211
Q ss_pred -CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 520 -SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 520 -~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+. ...+...+...++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence 122234568999999999999999999999999999999 899998877766665553 33445566778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L 617 (634)
+||..+|++|||+.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=311.79 Aligned_cols=246 Identities=30% Similarity=0.546 Sum_probs=205.8
Q ss_pred eeeccCcEEEEEEEEc--CC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 368 NFIKGSFGTVYHAEWR--NS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~--~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
.||+|+||.||+|.+. +. .+|+|++.... .....+.+.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999765 22 38899876543 3444567889999999999999999999875 45789999999999
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc---cC
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI---SS 520 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~---~~ 520 (634)
+|.+++.... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999986432 34899999999999999999999999 99999999999999999999999999875432211 11
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
....++..|+|||.+.+..++.++||||||+++|++++ |+.||......+....+. ...++..+...++++.+++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 12233578999999988889999999999999999996 999999887776655443 3445667788899999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHH
Q 006703 600 WAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~~L~~l 620 (634)
|..+|++||++.+|.+.|+++
T Consensus 235 ~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 235 WIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=317.18 Aligned_cols=258 Identities=33% Similarity=0.527 Sum_probs=216.3
Q ss_pred cceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..|...+.||+|+||.||+++..+ ..+++|.+.... ....+.+.+|+.++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 457778899999999999997542 127777765433 23335688999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 500 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~-------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~ 500 (634)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999996432 1234889999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhh
Q 006703 501 TVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF 577 (634)
Q Consensus 501 ~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~ 577 (634)
.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~- 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT- 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-
Confidence 99999999987543321 11234456788999999999999999999999999999998 999998888777665553
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 578 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 578 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
....+..+...+..+.+++.+||..+|++|||+.++++.|+++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 3334445567889999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=341.25 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=211.9
Q ss_pred cceeecceeeccCcEEEEEEEEcCC---cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~---~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||.||+|....+ .+++|.+... .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4588999999999999999987644 3788866433 2334456778999999999999999999999999999999
Q ss_pred eecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||+++++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999999988532 22345889999999999999999999999 999999999999999999999999999865432
Q ss_pred c--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 Y--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.. ....+.+..++..+.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCccCCHHHHH
Confidence 1 123455799999999999999999999999999999999999999998887776666543 2333456778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+|.+||..||++||++.+++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=325.45 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=208.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...++||+|+||.||++.+..+ .+|+|++.... .......+.+|++++++++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 36788889999999999999998744 48888876542 3444567889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999986433 488899999999999999999975 6 999999999999999999999999998754332
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--------------------
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-------------------- 576 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~-------------------- 576 (634)
......||..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 2234578999999999999889999999999999999999999997655433322110
Q ss_pred -----------------------hcCcccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 577 -----------------------FKGRRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 577 -----------------------~~~~~~~~~-~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.....+..+ ...+.++.+|+.+||..||++|||+.+++. ..+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHHhcC
Confidence 000111111 235788999999999999999999999986 4566544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=318.41 Aligned_cols=257 Identities=32% Similarity=0.589 Sum_probs=216.6
Q ss_pred cceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~ 432 (634)
..|...+.||+|+||.||++...+ ..+|+|.+.... ......++.+|+.+++++ +|+||+++++++..+..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 567888999999999999998753 238899876543 333446788999999999 89999999999999999
Q ss_pred EEEEEeecccCCHHHHhccC-------------CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC
Q 006703 433 LSIVTEYLSRGSLYKLLHIP-------------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~-------------~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~ 499 (634)
++++|||+++++|..+++.. .....+++..++.++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTED 168 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcCC
Confidence 99999999999999998632 12345889999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006703 500 YTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG 576 (634)
Q Consensus 500 ~~ikL~DFGla~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~ 576 (634)
+.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+....+.
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986543211 1222335678999999999899999999999999999997 999998887776665553
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 577 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 577 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
....+..+...+..+.+|+.+||..||++|||+.++++.|++++
T Consensus 249 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 249 -EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 33344566778999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.00 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=208.1
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
|...+.||+|+||.||++.+. +..||+|++....... .....+.+|+.+++.++|+||+++++++..++..+++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 667789999999999999876 4459999987654332 2235577899999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 82 MNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred cCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 999999988864322 34899999999999999999999999 9999999999999999999999999987653322 2
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--hcCcccCCCCCCcHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~s~~l~~Li~ 597 (634)
.....|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.........+. ........+..+++.+.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 234578999999999998889999999999999999999999998766543322221 123344556778999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHH
Q 006703 598 TCWAEEPEIRP-----SFPSIMET 616 (634)
Q Consensus 598 ~cL~~dP~~RP-----s~~~Il~~ 616 (634)
+||..||++|| ++.++++.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 88898763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.46 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=207.3
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+++.+. ..+|+|++..... .......+.+|+.++.+++|+||+++++.+.+++.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 46778899999999999998874 4499999875432 33445678889999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 82 FLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999986443 4899999999999999999999999 9999999999999999999999999986432110
Q ss_pred ----------------------------------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCC
Q 006703 518 ----------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 563 (634)
Q Consensus 518 ----------------------------------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf 563 (634)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 006703 564 RNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS---FPSIMET 616 (634)
Q Consensus 564 ~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~Li~~cL~~dP~~RPs---~~~Il~~ 616 (634)
...++.+....+........+|. .+++++.++|.+|+. ||.+|++ +.++++.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99888777666643333333443 478999999999875 9999985 5666553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=319.40 Aligned_cols=258 Identities=31% Similarity=0.515 Sum_probs=214.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~ 430 (634)
....|...+.||+|+||.||++.... ..+|+|.+.... .....+.+.+|+.+++++ +|+||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34678889999999999999997531 238888876543 234456788999999999 799999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
+..+++|||+.+++|.++++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999999974332 23899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCC
Q 006703 511 RSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 587 (634)
Q Consensus 511 ~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 587 (634)
........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..............+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 75433211 1223346778999999999999999999999999999998 99999877765544444333334445567
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
.++.+.+++.+||..+|++|||+.++++.|+++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=333.50 Aligned_cols=259 Identities=31% Similarity=0.521 Sum_probs=215.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~ 431 (634)
...|...+.||+|+||.||+|++.+ ..||+|++.... .......+.+|+++|.++. ||||+++++++....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3567778999999999999998653 249999997543 2333457889999999997 999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCCC---------------------------------------------------------
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDA--------------------------------------------------------- 454 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~--------------------------------------------------------- 454 (634)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999964321
Q ss_pred --------------------------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 455 --------------------------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 455 --------------------------------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
...+++..++.++.||+.||.|||+.+ ++||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence 123677788999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 573 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~ 573 (634)
+.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999987543211 12233457889999999999889999999999999999998 899998766555444
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
.......++..+..++.++.+++.+||..+|.+||++.+|++.|++++
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 433344456667788999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=312.15 Aligned_cols=254 Identities=33% Similarity=0.591 Sum_probs=213.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
....|...++||+|+||.||+|...+ ..+|+|.+....... .++.+|+.++++++|+||+++++++. ....+++|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH---HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 34678888999999999999998764 459999887554432 46789999999999999999999874 45789999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.+++|.+++..... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 80 EYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999864332 35888999999999999999999999 9999999999999999999999999987654221
Q ss_pred -ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 -~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......++..|+|||++.+..++.++||||||+++++|++ |+.||...+..+....+. .....+.+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHH
Confidence 12223446678999999998889999999999999999999 999998877766655553 233445667789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
+.+||+.+|++|||+++++..|+++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHccCChhhCCCHHHHHHHhhcC
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=312.18 Aligned_cols=254 Identities=33% Similarity=0.547 Sum_probs=212.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
...|...++||+|+||.||+|++.++ .+|+|++....... +++.+|+.++++++|+||+++++.+.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 46788999999999999999987654 48999886543322 467899999999999999999998754 56899999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++..... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999974322 34788999999999999999999999 99999999999999999999999999875443221
Q ss_pred -cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 519 -SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 519 -~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
......++..|+|||+..+..++.++|+||||+++|+|++ |..||......+....+. .......+..+++.+.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLM 236 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHHHHH
Confidence 1223446678999999998889999999999999999999 888998877766655543 2333445667899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
.+||..+|++|||+.++++.|+.++
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHccCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.26 Aligned_cols=251 Identities=26% Similarity=0.456 Sum_probs=217.5
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
+|...+.||.|+||.||.++... ..+++|.+...........++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999988764 4499999877666666677889999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999999997543 234889999999999999999999999 999999999999999999999999998765444333
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
.....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.. ......+..++..+.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHH
Confidence 4456789999999999988889999999999999999999999998887776666643 333344567899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 006703 600 WAEEPEIRPSFPSIMET 616 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~~ 616 (634)
|..+|.+||++.++++.
T Consensus 237 l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 237 LQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCcccCCCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.59 Aligned_cols=238 Identities=22% Similarity=0.386 Sum_probs=199.0
Q ss_pred ceeeccCcEEEEEEEEcCC--cEEEEEEeecccc-HHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|+...+ .+|+|++...... ......+.+|+.++.++ +|+||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999988754 4999998765432 34456688999999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 99998886433 4899999999999999999999999 999999999999999999999999998753332223445
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST------PSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
..||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+..... .......+|..++..+.+++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-HHhCCCCCCCCCCHHHHHHH
Confidence 679999999999999999999999999999999999999995322 11222222 13344557788999999999
Q ss_pred HHhhhcCCCCCCCH
Q 006703 597 ETCWAEEPEIRPSF 610 (634)
Q Consensus 597 ~~cL~~dP~~RPs~ 610 (634)
.+||..||.+|+++
T Consensus 235 ~~~L~~dP~~R~~~ 248 (327)
T cd05617 235 KGFLNKDPKERLGC 248 (327)
T ss_pred HHHhccCHHHcCCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.91 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=207.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-----CCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-----PPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-----~~~ 432 (634)
...|...+.||.|+||.|+.+.++.++ ||||.+...-.+....++..+|+++|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 355666789999999999999887554 9999987665566777889999999999999999999999865 345
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+|+|+|+| +.+|.+.++..+ .+++.++..+++|+++||.|+|+.+ ++||||||+|++++.+...||+|||+|+.
T Consensus 101 vYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceee
Confidence 99999999 669999987554 3999999999999999999999999 99999999999999999999999999998
Q ss_pred CCCC--cccCCCCCCCCcccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-------------
Q 006703 513 KPNT--YISSKTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG------------- 576 (634)
Q Consensus 513 ~~~~--~~~~~~~~gt~~y~APEvl~-~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~------------- 576 (634)
.... .......+.|..|+|||++. ...|+++.||||.||++.||++|++.|.+.+....+..+.
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 6532 12234567899999999974 5668999999999999999999999998877543322221
Q ss_pred -----------hcCcccCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 577 -----------FKGRRLEI-----PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 577 -----------~~~~~~~~-----~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+.. -+..++...+|+++||..||.+|+|+++.|.
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111211 2468899999999999999999999999987
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=320.58 Aligned_cols=261 Identities=33% Similarity=0.565 Sum_probs=214.0
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc----EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~----vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+.||+|+||.||+|.++.++ +++|.+... ........+.+|+.++.++ +|+||+++++++..+...++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 45777889999999999999876432 466655432 2334456788999999999 89999999999999999999
Q ss_pred EEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcE
Q 006703 436 VTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 502 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~i 502 (634)
+|||+++++|.+++..... ...+++..++.++.||+.||+|||++| ++||||||+|||++.++.+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCCcE
Confidence 9999999999999964321 234789999999999999999999999 9999999999999999999
Q ss_pred EEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcc
Q 006703 503 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRR 581 (634)
Q Consensus 503 kL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~ 581 (634)
||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ....
T Consensus 164 kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~ 241 (303)
T cd05088 164 KIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 241 (303)
T ss_pred EeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCc
Confidence 99999998643211 11222334668999999988889999999999999999998 999998877766555442 2223
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 582 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 582 ~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
...+...++.+.+++.+||..+|++||++.+++..|..++.....
T Consensus 242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 445566889999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.84 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=211.8
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-CCcEEEEEee
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIVTEY 439 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-~~~~~lV~E~ 439 (634)
|...+.||.|++|.||++.++. ..+++|.+..........+.+.+|+.++++++|+|++++++.+.. +..++++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 6778899999999999998764 449999987665555556778899999999999999999998764 4468999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++.... ...+++..++.++.+++.||.+||++| ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 82 CEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred cCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999986432 234899999999999999999999999 999999999999999999999999998765444333
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
.....+++.|+|||++.+..++.++|+||||+++++|++|+.||...+.......+. ....+..+...++.+.+++.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHH
Confidence 445678999999999999989999999999999999999999998877665544442 2333456677899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 006703 600 WAEEPEIRPSFPSIME 615 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~ 615 (634)
|+.||++|||+.++++
T Consensus 238 l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 238 LSKRPEKRPSVKSILR 253 (257)
T ss_pred hccCcccCCCHHHHhc
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.94 Aligned_cols=249 Identities=35% Similarity=0.623 Sum_probs=212.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeecee-ecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~-~~~~~~~lV~E~ 439 (634)
..|...+.||+|+||.||++...+..+++|.+.... ..+.+.+|+.++++++|+|++++++++ ..+...+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 467778899999999999999999999999875432 235688999999999999999999975 455679999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++..... ..+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 155 (256)
T cd05082 82 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 155 (256)
T ss_pred CCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecccc---
Confidence 999999999875432 24788999999999999999999999 999999999999999999999999998754332
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. ....+..+..+++.+.+++.+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 223345678999999999889999999999999999997 999998877776665553 233445667889999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~~L~~l 620 (634)
||..+|++|||+.++++.|+++
T Consensus 235 ~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 235 CWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.99 Aligned_cols=258 Identities=31% Similarity=0.513 Sum_probs=214.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...|...+.||+|+||+||+|++..+ .||+|++.... .......+.+|+.+++.++|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 36678889999999999999986533 27889876543 33344678899999999999999999998875 457
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 89999999999999987533 34889999999999999999999999 999999999999999999999999998765
Q ss_pred CCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 514 PNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 514 ~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+. .....+.+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCH
Confidence 43211 1222345678999999999999999999999999999998 899998877666555443 3344455677899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+.+++.+||..||++||++.++++.|+++.+..
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 9999999999999999999999999998886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=320.82 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=202.5
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|+++. ..+|+|.+...... .....+.+|+.++++++|+||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 568889999999999999998764 44999998654322 222456789999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++ +|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 9975 7877775433 24788899999999999999999999 99999999999999999999999999876443333
Q ss_pred cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-----------------
Q 006703 519 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------- 580 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~----------------- 580 (634)
......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 3345568999999999865 4578999999999999999999999988776544332211000
Q ss_pred c---c--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 R---L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ~---~--------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. + .....+++++.+++.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 0 011346889999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=332.13 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=209.8
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
.....|...+.||+|+||.||+++++.+ .+|+|++..... .......+.+|+.+++.++||||+++++++..+...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3447899999999999999999998754 499999865432 2334456788999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999999998643 3788899999999999999999999 9999999999999999999999999997654
Q ss_pred CCc-ccCCCCCCCCcccCcccccCCC----CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CC
Q 006703 515 NTY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KN 587 (634)
Q Consensus 515 ~~~-~~~~~~~gt~~y~APEvl~~~~----~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~ 587 (634)
... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+........++ ..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 321 1234567999999999997643 6889999999999999999999999888777666664433333333 46
Q ss_pred CcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEI--RPSFPSIMET 616 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~--RPs~~~Il~~ 616 (634)
+++.++++|.+||..++.+ |+++.++++.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 8999999999999844433 7889888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=316.41 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=213.2
Q ss_pred cceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..|...+.||+|+||.||+|.+.+ ..+|+|++.... .......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 346677899999999999998753 349999986543 333446788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 500 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~-------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~ 500 (634)
++++||+.+++|.+++.... .+..+++..++.++.|++.||.|||++| |+||||||+||+++.++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCC
Confidence 99999999999999984211 1234788889999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhh
Q 006703 501 TVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF 577 (634)
Q Consensus 501 ~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~ 577 (634)
.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR- 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 99999999987543221 11234456789999999988889999999999999999998 888998888777666653
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 578 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 578 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
.......+..++..+.+++.+||+.+|++||++.+|+..|++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 333445677899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=355.84 Aligned_cols=270 Identities=35% Similarity=0.561 Sum_probs=232.8
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEcCCc-------EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-------vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~ 428 (634)
+..+.......+.||+|.||.||.|...+.. ||+|.+.+. .+.....+|.+|..+|+.++|||||+++|.+.
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 3345567778889999999999999876322 788877554 35566789999999999999999999999999
Q ss_pred cCCcEEEEEeecccCCHHHHhccCC----CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEE
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 504 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~~----~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL 504 (634)
+....+|++|||.||+|..+|+... ....+.....+.++.|||+|+.||++++ +|||||...|+|++....+||
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEE
Confidence 9999999999999999999997541 1235888999999999999999999999 999999999999999999999
Q ss_pred EecCCCcc-CCCCcccCCCC-CCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcc
Q 006703 505 CDFGLSRS-KPNTYISSKTA-AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRR 581 (634)
Q Consensus 505 ~DFGla~~-~~~~~~~~~~~-~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~ 581 (634)
+|||+|+. ....++..... .-...|||||.+....++.|+|||||||++||+++ |..||...++.++...+...+ +
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R 922 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence 99999994 33333333333 45579999999999999999999999999999999 799999999988887664444 8
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 006703 582 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 629 (634)
Q Consensus 582 ~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~ 629 (634)
+..|..+++.+.+++..||+.+|++||+|..|++++.++++....++-
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 999999999999999999999999999999999999999987766554
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.71 Aligned_cols=262 Identities=31% Similarity=0.552 Sum_probs=219.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceee
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT 428 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~ 428 (634)
....|...+.||+|+||.||+|++.+ ..+|+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34678888999999999999997531 23888887643 2334457788999999999 8999999999999
Q ss_pred cCCcEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEE
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLL 495 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NIL 495 (634)
.....+++|||+.+++|.+++..... ...+++..+..++.||++||.|||++| ++||||||+||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 169 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence 99999999999999999999964321 134778889999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCCccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 006703 496 VDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVI 572 (634)
Q Consensus 496 ld~~~~ikL~DFGla~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~ 572 (634)
++.++.+||+|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999986543221 1223345678999999999889999999999999999998 78999888877776
Q ss_pred HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 573 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 573 ~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
..+. .......+..++..+.+++.+||..+|.+|||+.++++.|++++...
T Consensus 250 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 250 KLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 6653 23344556778999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=314.08 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=205.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||+|+||.||+|.+.. ..+|+|++..... .....+.+|+.++++++|+||+++++++..+...++|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 44678889999999999999998764 4489998865432 2335677899999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999999886433 4889999999999999999999999 999999999999999999999999998765433
Q ss_pred cccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc---CCCCCCcH
Q 006703 517 YISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---EIPKNVNP 590 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~s~ 590 (634)
........++..|+|||.+. ...++.++|+||||+++|||++|+.||....+.+....+......+ ..+..++.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 32334556889999999984 3446889999999999999999999997665544332221111111 12235789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
.+.+++.+||..+|++|||+.+|++.+
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.45 Aligned_cols=255 Identities=34% Similarity=0.565 Sum_probs=214.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
....|...+.||+|+||.||+|.+.+. .+++|.+...... .+++.+|+.++++++|+||+++++++......+++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 346788889999999999999987653 4899988754433 256889999999999999999999999989999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++..... ..+++..+..++.+++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999975432 24888999999999999999999999 9999999999999999999999999987654321
Q ss_pred -ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 -~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......++..|+|||.+.+..++.++|+||||+++++|++ |+.||...+.......+. .......+...+..+.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHH
Confidence 11223335678999999998889999999999999999998 999998877766665553 233445566779999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
+.+||..+|++||++.++++.|+++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHcccCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.34 Aligned_cols=247 Identities=36% Similarity=0.596 Sum_probs=211.0
Q ss_pred ceeeccCcEEEEEEEEcC---C--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 367 SNFIKGSFGTVYHAEWRN---S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~---~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
+.||+|++|.||+|.+.. + .+|+|.+...... ...+.+.+|+.++++++|+||+++++++.. ...+++|||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998753 2 3899988766544 556789999999999999999999999988 88999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc---c
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY---I 518 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~---~ 518 (634)
+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999999875432 35899999999999999999999999 9999999999999999999999999987654321 1
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.........+...+..+.+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 1223456788999999999899999999999999999998 999998888777666665444445556678899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~ 618 (634)
+||..+|++|||+.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.02 Aligned_cols=255 Identities=33% Similarity=0.517 Sum_probs=210.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-----C--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-----S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
...|...+.||+|+||.||+|.+.+ . .+++|.+.... .......+.+|+.++++++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567888999999999999998865 2 37777765432 23334568899999999999999999999999899
Q ss_pred EEEEEeecccCCHHHHhccCCC----cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC---cEEEE
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDA----RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVC 505 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~----~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~---~ikL~ 505 (634)
.+++|||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEec
Confidence 9999999999999999864321 124889999999999999999999999 99999999999998654 69999
Q ss_pred ecCCCccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCccc
Q 006703 506 DFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRL 582 (634)
Q Consensus 506 DFGla~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~ 582 (634)
|||++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||......+....+. ...+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcC
Confidence 9999876532211 1122334568999999999999999999999999999997 999998877766554442 34455
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
..+..++..+.+++.+||..+|++|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 667788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=316.51 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=196.2
Q ss_pred eeccCcEEEEEEEEc--CCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 369 FIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
||+|+||.||+++.+ +..+|+|.+....... .....+..|+.++++++||||+++++++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999876 4459999986543322 2234456799999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 525 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~g 525 (634)
.+++..... ..+++..++.++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAG 156 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCC
Confidence 988854332 34888999999999999999999999 9999999999999999999999999987654322 2234578
Q ss_pred CCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 006703 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS----QVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601 (634)
Q Consensus 526 t~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~ 601 (634)
+..|+|||++.+..++.++|||||||++|+|++|+.||...... +...... ..........+++++.+++.+||.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccccccccccCCHHHHHHHHHHhc
Confidence 99999999999988999999999999999999999999765432 2222111 111111224689999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 006703 602 EEPEIRPSFPSIME 615 (634)
Q Consensus 602 ~dP~~RPs~~~Il~ 615 (634)
.||++||++.++++
T Consensus 236 ~~P~~R~~~~~~~~ 249 (277)
T cd05607 236 KKPEDRLGSREKND 249 (277)
T ss_pred cCHhhCCCCccchh
Confidence 99999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.80 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=202.3
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||+|++|.||+|..+ +..+|+|++............+.+|+.++++++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 667789999999999999886 445999998665444444466789999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
. ++|.+++........+++..++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++..........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 7 588888865444446899999999999999999999999 9999999999999999999999999987544332223
Q ss_pred CCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC--------------------
Q 006703 521 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-------------------- 579 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-------------------- 579 (634)
....+++.|+|||++.+. .++.++||||||+++++|++|+.||...........+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 344678899999998654 46899999999999999999999998765433222110000
Q ss_pred -------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
........+++++.++|.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000112357889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.31 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=200.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------ 431 (634)
...|...+.||+|+||.||++.+.. ..+|+|++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4678899999999999999998764 45999998765444555677889999999999999999999986543
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..|++|||+.+ +|.+.+.. .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 47999999976 56665542 2788889999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--------------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-------------- 577 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~-------------- 577 (634)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 172 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 172 TACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 543321 23456789999999999999999999999999999999999999987664332211100
Q ss_pred ------cCcccC--------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 578 ------KGRRLE--------------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 578 ------~~~~~~--------------------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
....+. .....++.+.+|+.+||..||++|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 111246789999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.58 Aligned_cols=251 Identities=32% Similarity=0.552 Sum_probs=210.0
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..|...+.||+|++|.||++.+.++ .+++|.+...... .+.+.+|++++++++|+|++++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 5678888999999999999988754 5899987644322 256788999999999999999998875 4568899999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI- 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~- 518 (634)
+.+++|.++++.... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999975332 34788899999999999999999999 99999999999999999999999999976433221
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......++..|+|||...+...+.++|+||||+++|+|++ |+.||......+....+. ....+..+...+..+.+++.
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHH
Confidence 1223346678999999998889999999999999999999 899998877766655543 23344556778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
+||..||++||++.+|++.|++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 238 LCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.98 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=210.5
Q ss_pred cceeecceeeccCcEEEEEEEEcC--Cc----EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~----vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..|...+.||+|+||.||+|.+.. .. +++|.+... .......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 567778899999999999998853 32 666665432 223344677888999999999999999998754 5678
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+++||+++++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999997433 24889999999999999999999999 9999999999999999999999999997543
Q ss_pred CCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 515 NTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 515 ~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+ .....+..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCCHH
Confidence 221 12234456778999999998889999999999999999998 99999888776654444 234445556667889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+.+++.+||..||.+|||+.++++.|..+...
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.52 Aligned_cols=255 Identities=31% Similarity=0.542 Sum_probs=213.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+.||+|+||.||+|..+.. .||+|++... .......++..|+.++++++||||+++++++..+...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 4577888999999999999987633 3899987654 234456789999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999987543 24888999999999999999999999 99999999999999999999999999875433
Q ss_pred Cccc---CCCCC--CCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 516 TYIS---SKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 516 ~~~~---~~~~~--gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
.... ..... .+..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. .....+.+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 237 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCP 237 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCC
Confidence 2111 11111 2457999999999999999999999999999886 999998887776666553 233444556789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
..+.+++.+||..+|.+||++.+|+..|++++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 99999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.62 Aligned_cols=250 Identities=34% Similarity=0.599 Sum_probs=205.9
Q ss_pred ceeeccCcEEEEEEEEcCCc----EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeecc
Q 006703 367 SNFIKGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~~----vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
+.||+|+||.||+|.+.+++ +++|.+... ........+.+|+.+++++ +||||+++++++......+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999886543 577766532 2334446788999999999 79999999999999999999999999
Q ss_pred cCCHHHHhccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 442 RGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 442 ggsL~~ll~~~~-------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
+++|.+++.... ....+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCC
Confidence 999999986432 1124788999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCC
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 587 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 587 (634)
++...... ........+..|+|||++.+..++.++||||||++++||++ |..||...+..+....+. .......+..
T Consensus 158 l~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLN 235 (270)
T ss_pred Cccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCc
Confidence 98642211 11122234567999999988889999999999999999997 999998877666555553 2234445667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
++..+.+++.+||..||.+|||+.+++..|++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 8899999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.87 Aligned_cols=255 Identities=32% Similarity=0.535 Sum_probs=213.2
Q ss_pred cceeecceeeccCcEEEEEEEEcC--C---cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--S---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~---~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.+|...+.||+|+||.||+|.+.. . .+|+|.+.... .......+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 467788999999999999998742 1 38888876443 33445688999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999997543 24788999999999999999999999 99999999999999999999999999876543
Q ss_pred Cccc---CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 516 TYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 516 ~~~~---~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+.. ....+.+..+++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCCCCCCHH
Confidence 2111 112233568999999998889999999999999999886 9999988777665555532 2334455678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
+.+++.+||..+|.+||++.++++.|++++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.72 Aligned_cols=256 Identities=35% Similarity=0.512 Sum_probs=211.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC------------------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCee
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS------------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 421 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~------------------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv 421 (634)
..+|...+.||+|+||.||+|.+... .+|+|.+..... ....+.+.+|++++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence 35778889999999999999987542 278888765533 34557889999999999999999
Q ss_pred eeeceeecCCcEEEEEeecccCCHHHHhccCC--------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCc
Q 006703 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD--------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 493 (634)
Q Consensus 422 ~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~--------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~N 493 (634)
++++++..+...+++|||+.+++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhc
Confidence 99999999999999999999999999986433 1225899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh--CCCCCCCCChH
Q 006703 494 LLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPS 569 (634)
Q Consensus 494 ILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt--g~~Pf~~~~~~ 569 (634)
|+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999987543221 12234456789999999988889999999999999999998 78899877666
Q ss_pred HHHHHHhhc----C--cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 570 QVISAVGFK----G--RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 570 ~~~~~i~~~----~--~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
+........ . .....+...++++.+++.+||..||.+|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 655444322 1 112234567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.51 Aligned_cols=255 Identities=30% Similarity=0.484 Sum_probs=219.3
Q ss_pred eeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 368 NFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
.||+|.||+||-|++..+. .|||.+.... ....+-+++|+.+.++++|.|||+++|.+..+.++-|.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6999999999999998877 6777765433 33345688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEEecCCCccCCCCcccCCCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAA 524 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~DFGla~~~~~~~~~~~~~~ 524 (634)
.++++..-....-++..+-.+.+||++||.|||.+. |||||||-+||||+ -.|.+||+|||.++.......-+.+..
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 999986544333478889999999999999999999 99999999999997 689999999999987666555677889
Q ss_pred CCCcccCcccccCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 006703 525 GTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601 (634)
Q Consensus 525 gt~~y~APEvl~~~--~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~ 601 (634)
||..|||||++..+ +|++++|||||||++.||.||++||.... +......+.+-...|++|..++.+.+++|.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 99999999999665 47899999999999999999999997644 4555667777778899999999999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcCCCC
Q 006703 602 EEPEIRPSFPSIMETLQQFLMSSVCQP 628 (634)
Q Consensus 602 ~dP~~RPs~~~Il~~L~~ll~~~~~~~ 628 (634)
++|..||++.++|. ..|++...+-+
T Consensus 818 pd~~~R~sA~~LL~--DpFlq~~~kk~ 842 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQ--DPFLQHNNKKP 842 (1226)
T ss_pred CCcccCccHHHhcc--CcccccCCCCC
Confidence 99999999999997 56666543333
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.50 Aligned_cols=259 Identities=33% Similarity=0.554 Sum_probs=213.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
..+|...+.||+|+||.||+|..++ ..+|+|.+.... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3678888999999999999997542 248999875443 23334567899999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCC-------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDA-------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~-------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
.+++|||+++++|.+++..... ...++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999964221 233567788899999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCccc
Q 006703 506 DFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRL 582 (634)
Q Consensus 506 DFGla~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~ 582 (634)
|||+++....... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||......+....+. .....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 9999875433211 1122345678999999998889999999999999999998 788998877766555443 33344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
..+...++.+.+++.+||+.+|++|||+.++++.|++.+-
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 5566788999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.87 Aligned_cols=251 Identities=33% Similarity=0.553 Sum_probs=210.5
Q ss_pred cceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..|...+.||+|+||.||+|...+ ..+|+|.+....... ..+.+|+.++++++|+||+++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 567788899999999999998764 458999887654432 45889999999999999999999875 4568899999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI- 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~- 518 (634)
+++++|.+++..... ..+++..++.++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999864322 34789999999999999999999999 99999999999999999999999999876543221
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+. ....++.+...+..+.+++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHELML 237 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHH
Confidence 1122345668999999988889999999999999999999 899998877766665553 23345567788999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
+||..+|.+|||+.++.+.|++
T Consensus 238 ~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 238 QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.21 Aligned_cols=250 Identities=27% Similarity=0.478 Sum_probs=215.6
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
+|...+.||+|+||.||++... +..+++|.+...........++.+|+.++++++|+||+++++++......+++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 3677899999999999999876 44599999876555555567889999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999998864322 24788999999999999999999999 999999999999999999999999998765544333
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
.....|++.|+|||++.+...+.++|+||||+++++|++|+.||......+....+. ....+..+..++..+.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHH
Confidence 344568899999999999889999999999999999999999998877776665553 3344556778899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 006703 600 WAEEPEIRPSFPSIME 615 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~ 615 (634)
|..+|.+||++.++++
T Consensus 237 l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 237 FKRNPRDRPSVNSILE 252 (256)
T ss_pred hhCChhhCcCHHHHhh
Confidence 9999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.75 Aligned_cols=256 Identities=32% Similarity=0.550 Sum_probs=214.2
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.+|...+.||+|+||.||+|.+.+. .+++|...... .....+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4577788999999999999987543 38888875443 24455688999999999999999999998875 45789
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999975432 4889999999999999999999999 99999999999999999999999999876433
Q ss_pred Ccc-cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 516 TYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 516 ~~~-~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
... ......++..|+|||.+.+..++.++||||||++++||++ |..||......+....+. .......+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLY 238 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHH
Confidence 211 1223334568999999988889999999999999999986 999998887766655543 3344566778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+++.+||..+|.+|||+.++++.|+++...
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.61 Aligned_cols=261 Identities=30% Similarity=0.571 Sum_probs=217.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE 429 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~ 429 (634)
..+|...+.||+|+||.||+++..+ ..+|+|.+.... .......+.+|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3678888999999999999997531 238889876543 344456788999999999 69999999999999
Q ss_pred CCcEEEEEeecccCCHHHHhccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~-------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
....+++|||+++++|.+++.... ....+++..+..++.|++.||.|||++| ++|+||||+||++
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 167 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLV 167 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEE
Confidence 999999999999999999996432 1234888899999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCCccc--CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 573 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~~~~--~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~ 573 (634)
+.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999765432111 122234567999999998889999999999999999999 899998887776666
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+. .......+..++..+.+++.+||..+|++|||+.++++.|+++....
T Consensus 248 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 248 LLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 553 23344566788999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.37 Aligned_cols=262 Identities=30% Similarity=0.530 Sum_probs=212.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec-
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE- 429 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~- 429 (634)
+..+|...+.||+|+||.||+|.+. +..||||++.... .......+.+|+.++.++ +|+||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4467889999999999999999753 3459999986543 234456788999999999 68999999998754
Q ss_pred CCcEEEEEeecccCCHHHHhccCCC-------------------------------------------------------
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDA------------------------------------------------------- 454 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~------------------------------------------------------- 454 (634)
+...+++|||+++++|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4568999999999999999863210
Q ss_pred ---------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc--ccCCCC
Q 006703 455 ---------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTA 523 (634)
Q Consensus 455 ---------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~--~~~~~~ 523 (634)
...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++....... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 123677888999999999999999999 9999999999999999999999999987543221 112233
Q ss_pred CCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 524 ~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
.++..|+|||++.+..++.++||||||+++|+|++ |..||......+..............+...++.+.+++.+||..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 45678999999999899999999999999999997 89999776544333333233444555667889999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHh
Q 006703 603 EPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 603 dP~~RPs~~~Il~~L~~ll~~ 623 (634)
||++|||+.+|++.|+.+++.
T Consensus 322 ~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 322 EPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.77 Aligned_cols=250 Identities=28% Similarity=0.458 Sum_probs=210.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.... ..+++|++..... ...+.+.+|+.++++++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 4678888999999999999998764 4599999875532 24577889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999999987542 24889999999999999999999999 9999999999999999999999999987654433
Q ss_pred ccCCCCCCCCcccCcccccCC---CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc---CCCCCCcHH
Q 006703 518 ISSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---EIPKNVNPM 591 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~---~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~s~~ 591 (634)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...++.+....+......+ ..+...+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 233455788899999999777 78999999999999999999999998877666554443221121 223456788
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+++.+||..+|.+|||+.+|+.
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.36 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=216.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-CCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-~~~ 432 (634)
...|...+.||+|+||.||+|.+.. ..+++|.+... ........+.+|+.++++++|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678888999999999999998765 34888877533 345556778899999999999999999998755 567
Q ss_pred EEEEEeecccCCHHHHhccCCCc-----ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEec
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDAR-----VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 507 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~-----~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DF 507 (634)
.++++||+++++|.+++...... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECCC
Confidence 89999999999999998643221 35889999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCC
Q 006703 508 GLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI 584 (634)
Q Consensus 508 Gla~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 584 (634)
|+++....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...++.+....+.. ...+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCCCC
Confidence 99975432211 1123345678999999999889999999999999999999 9999988877766554432 333445
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+..+++.+.+++.+||..+|++|||+.++++.|+.+.+.
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 566789999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=311.94 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=207.9
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
|...+.||+|+||+||++.+.. ..+|+|++....... .....+.+|+.++++++|+||+.+++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5667889999999999998874 459999987654432 2335577899999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-S 157 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-c
Confidence 999999988864332 34899999999999999999999999 9999999999999999999999999986543221 2
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--cCcccCCCCCCcHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF--KGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~Li~ 597 (634)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+.. ......++..+++.+.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 2345789999999999998999999999999999999999999988766543333321 22233456678999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHH
Q 006703 598 TCWAEEPEIRPS-----FPSIMET 616 (634)
Q Consensus 598 ~cL~~dP~~RPs-----~~~Il~~ 616 (634)
+||..||++||+ +.+++..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcC
Confidence 999999999999 7788774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.66 Aligned_cols=250 Identities=33% Similarity=0.577 Sum_probs=202.9
Q ss_pred ceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee-cCCcEEEEEeec
Q 006703 367 SNFIKGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-EPPNLSIVTEYL 440 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~-~~~~~~lV~E~~ 440 (634)
+.||+|+||.||+|.+.. ..+|+|.+.... .......+.+|+.+++.++||||+++++++. .+...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998642 238888875322 3344577889999999999999999999764 556689999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc---
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--- 517 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~--- 517 (634)
.+++|.+++..... ..++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999975432 3567778889999999999999999 9999999999999999999999999987543211
Q ss_pred -ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 -~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......++..|+|||.+.+..++.++||||||+++|||++| .+||...+..+....+ .....+..+...++.+.++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCCcCCHHHHHH
Confidence 111233467789999999888899999999999999999995 6677766665554444 2334445566778999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
+.+||..+|++||++.+|++.|++++.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=307.61 Aligned_cols=255 Identities=33% Similarity=0.535 Sum_probs=212.9
Q ss_pred cceeecceeeccCcEEEEEEEEcC--C---cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--S---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~---~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+.||+|+||.||+|.... . .+++|.+.... .......+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456778899999999999998753 2 38888875442 33445678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999986433 34888999999999999999999999 99999999999999999999999999875433
Q ss_pred Cccc---CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 516 TYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 516 ~~~~---~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.... ......+..|+|||++.+..++.++||||||+++|||++ |+.||......+....+.. ....+.+..++..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHH
Confidence 2111 112223457999999998889999999999999999997 9999988777666666643 2344455678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
+.+++.+||..+|++||++.++++.|++++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.07 Aligned_cols=256 Identities=32% Similarity=0.483 Sum_probs=209.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC----------------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeee
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS----------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~----------------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l 423 (634)
..+|...+.||+|+||.||++.+.+. .+|+|.+... ........+.+|++++++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 46788889999999999999976432 2889987654 334455678999999999999999999
Q ss_pred eceeecCCcEEEEEeecccCCHHHHhccCCC---------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcE
Q 006703 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA---------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 494 (634)
Q Consensus 424 ~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~---------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NI 494 (634)
++++......+++|||+.+++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNC 160 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhE
Confidence 9999999999999999999999999854321 123678889999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh--CCCCCCCCChHH
Q 006703 495 LVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPSQ 570 (634)
Q Consensus 495 Lld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt--g~~Pf~~~~~~~ 570 (634)
+++.++.+||+|||++....... .......++..|+|||++.+..++.++||||||+++++|++ +..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999987543221 11223345678999999998889999999999999999998 678898877666
Q ss_pred HHHHHhh------cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 571 VISAVGF------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 571 ~~~~i~~------~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
....+.. .......+...++.+.+++.+||..||++|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 5543321 11122345567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=327.16 Aligned_cols=240 Identities=27% Similarity=0.417 Sum_probs=199.1
Q ss_pred eeccCcEEEEEEEEcC--CcEEEEEEeecccc-HHHHHHHHHHHHHHHhC---CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 369 FIKGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l---~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
||+|+||+||+|++.. ..+|+|++...... ......+..|..++... +||||+++++++......|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6899999999998874 45999998654332 23334556677777665 699999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|..++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 99998886433 4899999999999999999999999 999999999999999999999999998764333333456
Q ss_pred CCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC-CCCcHHHHHHHHHhh
Q 006703 523 AAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAALIETCW 600 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~l~~Li~~cL 600 (634)
..||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... ..++ ..+++.+.+++.+||
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~L 233 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--VRFPKNVLSDEGRQFVKGLL 233 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHc
Confidence 6799999999998765 47899999999999999999999999888877766664332 2333 357899999999999
Q ss_pred hcCCCCCC----CHHHHHH
Q 006703 601 AEEPEIRP----SFPSIME 615 (634)
Q Consensus 601 ~~dP~~RP----s~~~Il~ 615 (634)
..||++|| ++.++++
T Consensus 234 ~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCHHHCCCCCCCHHHHhc
Confidence 99999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.10 Aligned_cols=252 Identities=31% Similarity=0.490 Sum_probs=202.8
Q ss_pred eeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLS 434 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~~ 434 (634)
|...+.||+|+||+||++.+. +..+|+|++..... ......+.+|+.++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 377889999999999887543 33489999865432 23446788999999999999999999987553 4689
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+++++|.+++... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999998643 3899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH--HH------------HHHHhh
Q 006703 515 NTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--QV------------ISAVGF 577 (634)
Q Consensus 515 ~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~--~~------------~~~i~~ 577 (634)
.... ......++..|+|||.+.+..++.++||||||+++++|++|..||...... +. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 3221 112234566799999998888999999999999999999999998653321 00 001111
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 578 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 578 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
....++.+..++..+.+++.+||..+|.+|||+.++++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 12233446678899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.48 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=201.3
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-----cEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLSI 435 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~-----~~~l 435 (634)
|...+.||+|+||.||++.+. +..||+|++..........+++.+|+.+++.++|+||+++++++.... ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 556789999999999999875 455999998654434445567889999999999999999999998776 7899
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+. ++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 82 v~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred Eeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 999996 47777775332 4899999999999999999999999 99999999999999999999999999876432
Q ss_pred Cc-ccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc---------------
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--------------- 578 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~--------------- 578 (634)
.. .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...++.+....+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 21 122344678999999999775 4789999999999999999999999887765544333110
Q ss_pred --------Cccc-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 579 --------GRRL-------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 579 --------~~~~-------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
...+ .+....++++.+|+.+||..||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 1234568899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.71 Aligned_cols=249 Identities=26% Similarity=0.304 Sum_probs=196.4
Q ss_pred ceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhC---CCCCeeeeeceeec-----CC
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTE-----PP 431 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l---~h~nIv~l~~~~~~-----~~ 431 (634)
+|...+.||+|+||.||+|+++.+ .+|+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 367788999999999999988744 499998875433322223445666666655 79999999998754 34
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..+++|||+.+ +|.+++..... ..+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence 58999999975 88888864332 24899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc---------c-
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------R- 581 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~---------~- 581 (634)
...... ......+|..|+|||++.+..++.++|||||||++|+|++|.+||......+....+..... .
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 654322 23345689999999999999999999999999999999999999987766544333211000 0
Q ss_pred ---------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ---------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ---------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+.+++.+.+++.+||..||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112356788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.48 Aligned_cols=247 Identities=25% Similarity=0.328 Sum_probs=195.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------ 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------ 430 (634)
....|...+.||+|+||.||+|.+.. ..||+|++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 44679999999999999999998864 459999875432 1234799999999999999999876432
Q ss_pred --CcEEEEEeecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEe
Q 006703 431 --PNLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCD 506 (634)
Q Consensus 431 --~~~~lV~E~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~D 506 (634)
..+++||||+++ +|.+++.. ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence 247799999975 67666642 122345899999999999999999999999 99999999999998654 799999
Q ss_pred cCCCccCCCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------
Q 006703 507 FGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------ 579 (634)
Q Consensus 507 FGla~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------ 579 (634)
||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+....
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99998654322 23456789999999998764 68999999999999999999999998876654433321110
Q ss_pred ---------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 ---------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ---------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+|...++++.+||.+||..||.+|||+.+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 001134457889999999999999999999999984
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.11 Aligned_cols=256 Identities=34% Similarity=0.558 Sum_probs=212.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
...|...+.||+|+||.||+|...+ ..+|+|++.... ......++.+|+.++++++||||+++++++.++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567888899999999999998742 348999876543 33445678899999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCC-------------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPD-------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 493 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~-------------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~N 493 (634)
.+++|||+++++|.+++.... ....+++..++.++.|++.||.|||.++ ++||||||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~n 160 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRN 160 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhh
Confidence 999999999999999986321 1134788889999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 006703 494 LLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQ 570 (634)
Q Consensus 494 ILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~ 570 (634)
|+++.++.++|+|||++....... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987533221 11223345678999999998999999999999999999997 888998877777
Q ss_pred HHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 571 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 571 ~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
....+. .......+..++..+.+++.+||..+|.+|||+.++++.|++
T Consensus 241 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 666553 233344566789999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.46 Aligned_cols=246 Identities=34% Similarity=0.561 Sum_probs=207.9
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 367 SNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
++||+|+||.||++.+. +..+++|++...... .....+.+|+.++++++|+||+++++++......+++|||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46899999999999877 566999988765443 4456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc--CCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTA 523 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~--~~~~ 523 (634)
.+++..... .+++..+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++......... ....
T Consensus 80 ~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 999864332 4788899999999999999999999 999999999999999999999999998764422111 1222
Q ss_pred CCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 524 ~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.. ......+...+..+.+++.+||..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhcc
Confidence 34567999999998889999999999999999998 8999988877665555532 234445677899999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 006703 603 EPEIRPSFPSIMETLQ 618 (634)
Q Consensus 603 dP~~RPs~~~Il~~L~ 618 (634)
+|.+|||+.++++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.60 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=205.5
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+++... ..+|+|++..... .......+.+|+.+++.++|+||+++++++..+..+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 57788999999999999998874 4499999875432 33345668899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 82 YYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred cCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999996432 24889999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccCCCCCCCCcccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC---CCCc
Q 006703 518 ISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP---KNVN 589 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~-----~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s 589 (634)
.......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+....+........++ ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS 237 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence 12233569999999999863 456889999999999999999999999887766655554333323232 3579
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 006703 590 PMVAALIETCWAEEPEI--RPSFPSIMET 616 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~--RPs~~~Il~~ 616 (634)
+.+++++.+||..++++ |+++.++++.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999988654433 7899888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.04 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=205.4
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|.+.+ ..+|+|++.... ......+.+|+.+++.++||||+++++.+......+++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 567788999999999999998864 449999886543 2233567789999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++...+ .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 87 FCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999986443 4899999999999999999999999 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC-C--CCCCcHHH
Q 006703 519 SSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-I--PKNVNPMV 592 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~-~--~~~~s~~l 592 (634)
......|+..|+|||++. ...++.++|+|||||++|+|++|..||....+.............+. . ...++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 345567999999999974 45578899999999999999999999977665444333322221111 1 12577899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.++|.+||..+|++|||+.+|++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.92 Aligned_cols=247 Identities=31% Similarity=0.538 Sum_probs=208.2
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-------HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-------~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
|+....||+|++|.||+|.+. +..+++|.+...... ....+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999875 355999988654322 22346788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999996542 4788899999999999999999999 999999999999999999999999998765
Q ss_pred CCCcc------cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCC
Q 006703 514 PNTYI------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 587 (634)
Q Consensus 514 ~~~~~------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 587 (634)
..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+. ....+.++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSN 235 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcc
Confidence 42111 1123457889999999998889999999999999999999999998876655444432 2344566778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++..+.+++.+||..||.+||++.++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 8999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=313.67 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=210.3
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.+...|...+.||+|+||.||++.+. +..+++|.+....... ...+.+|+.+++.++|+||+++++.+......++
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 34468888999999999999999875 4459999887654332 3568899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++... .+++..+..++.|++.||.|||+.| |+|+||||+||+++.++.+||+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred eecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999999998632 3788899999999999999999999 99999999999999999999999999876443
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~ 594 (634)
.........+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+.... .....+..++..+.+
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence 3223344578999999999998888999999999999999999999998877654433332111 122345678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+||..+|++|||+.++++
T Consensus 249 li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhh
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.27 Aligned_cols=255 Identities=31% Similarity=0.537 Sum_probs=213.6
Q ss_pred cceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..|.....||.|+||.||+|+.+. ..+++|.+.... .......+.+|++++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 567788899999999999998652 238888875433 233456788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCc------ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEec
Q 006703 434 SIVTEYLSRGSLYKLLHIPDAR------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 507 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~------~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DF 507 (634)
+++|||+++++|.+++...... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999754422 15899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCC-cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCC
Q 006703 508 GLSRSKPNT-YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 585 (634)
Q Consensus 508 Gla~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 585 (634)
|++...... ........++..|+|||.+.+..++.++||||||+++++|++ |..||...........+.........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 998653322 122334456778999999988888999999999999999998 788998777766666654444444456
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 586 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 586 ~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
..+++.+.+++.+||..+|.+|||+.+++..|.
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=304.35 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=213.5
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCcEEEEEe
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIVTE 438 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~~~lV~E 438 (634)
|...+.||.|+||.||++.+.. ..+++|++..........+++.+|+.++++++|+||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 6677899999999999998764 448999987666666666788999999999999999999998753 456899999
Q ss_pred ecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHH-----hCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 439 YLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLH-----QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 439 ~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH-----~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
|+++++|.+++... .....+++..++.++.||+.||.||| +.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999998642 22345899999999999999999999 778 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
............+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+. ....+.++...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSEL 238 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHHH
Confidence 6554332445678999999999999889999999999999999999999999887665555543 333445677889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.+++.+||..+|++|||+.+|++.
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhC
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=309.80 Aligned_cols=248 Identities=27% Similarity=0.469 Sum_probs=206.5
Q ss_pred ceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||++.+..+. +++|.+... .......+.+|+.+++.++|+||+++++++..+...+++|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3566788999999999999987654 677776433 344557788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|..++.... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 99999988876432 24899999999999999999999999 999999999999999999999999998765443333
Q ss_pred CCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-CcccCCCCCCcHHHH
Q 006703 520 SKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVA 593 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~ 593 (634)
.....++..|+|||++. +..++.++|||||||++|+|++|+.||...+..+....+... ......+..++..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 44567899999999984 445678999999999999999999999887766554444222 122334567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++|.+||..||.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.85 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=205.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC-----
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP----- 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~----- 430 (634)
+...|...+.||+|+||.||+|...++ .+|+|++..... ....+.+|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346677788999999999999988644 489998865432 224677899999998 799999999998643
Q ss_pred -CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 431 -PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 431 -~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
...+++|||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCC
Confidence 458999999999999999875322 34889999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCcccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 584 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 584 (634)
+..............|+..|+|||++. +..++.++|||||||++|||++|+.||....+................
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 876543333345567899999999986 345788999999999999999999999877665554444332333334
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+..++..+.+++.+||..+|.+|||+.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 4567899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.89 Aligned_cols=258 Identities=33% Similarity=0.519 Sum_probs=208.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC------------------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCe
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN------------------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 420 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------------------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nI 420 (634)
+...|...+.||+|+||.||++++.+ ..+|+|++.... ......++.+|+.+++.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 34568889999999999999986432 137888876543 33445678899999999999999
Q ss_pred eeeeceeecCCcEEEEEeecccCCHHHHhccCCC--------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCC
Q 006703 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA--------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 492 (634)
Q Consensus 421 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~--------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~ 492 (634)
+++++++...+..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.| ++|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~ 159 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR 159 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence 9999999999999999999999999999864321 124777889999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh--CCCCCCCCCh
Q 006703 493 NLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTP 568 (634)
Q Consensus 493 NILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt--g~~Pf~~~~~ 568 (634)
||+++.++.++|+|||++....... .......++..|++||...+..++.++|+||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999987543221 11122344678999999888889999999999999999998 7889987766
Q ss_pred HHHHHHHhh------cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 569 SQVISAVGF------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 569 ~~~~~~i~~------~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
.+....... .....+.+..+++.+.+++.+||..||.+|||+.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 655433211 111223445688999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.93 Aligned_cols=251 Identities=29% Similarity=0.424 Sum_probs=221.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccH-HHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~ 434 (634)
....|...+.||.|.||.||+++.+.++ +|+|++.+..... .....+.+|+.+|+++. ||||+.+++.|.+...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4467888899999999999999887544 9999998776533 23467889999999998 999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC----CCcEEEEecCCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLS 510 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~----~~~ikL~DFGla 510 (634)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+.. ++.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999755 2999999999999999999999999 999999999999963 357999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc--ccCCCCCC
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--RLEIPKNV 588 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~ 588 (634)
..... .......+||+.|+|||++...+++..+||||+|+++|.|++|..||.+.+..+....+..... ..+....+
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 98766 4567889999999999999999999999999999999999999999999998877776644433 22334578
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+..++++|.+|+..||.+|+|+.++++.
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999999999999999999999983
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=301.29 Aligned_cols=246 Identities=33% Similarity=0.549 Sum_probs=206.6
Q ss_pred ceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 367 SNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
+.||+|+||.||+|...+ ..+|+|++.... .......+.+|+.++++++||||+++++++......+++|||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 368999999999998664 448999876543 333445688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc-CCCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAA 524 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~-~~~~~ 524 (634)
.+++..... .+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 80 ~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 80 LSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 999864432 3788999999999999999999999 999999999999999999999999998754332211 12234
Q ss_pred CCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 006703 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603 (634)
Q Consensus 525 gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~d 603 (634)
++..|+|||++.+..++.++||||||+++|++++ |..||...........+. ...+...+..++..+.+++.+||+.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 4667999999998889999999999999999998 999998877766655553 33344566778999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 006703 604 PEIRPSFPSIMETLQ 618 (634)
Q Consensus 604 P~~RPs~~~Il~~L~ 618 (634)
|++|||+.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=309.41 Aligned_cols=242 Identities=29% Similarity=0.416 Sum_probs=200.0
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||+|.+.. ..+|+|++.... .......+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35667899999999999998764 449999886542 334456788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~ 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--I 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--c
Confidence 9999997653 2778889999999999999999999 999999999999999999999999998765432 2
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcCcccCC-CCCCcHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-------QVISAVGFKGRRLEI-PKNVNPM 591 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~-~~~~s~~ 591 (634)
.....||..|+|||++.+..++.++|+||||+++|+|++|+.||...... +....+. ....+.. ....+++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 228 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEK 228 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHH
Confidence 34567899999999999999999999999999999999999999653321 1122221 1112222 2457889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+.+++.+||..+|++||++.++++.
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcC
Confidence 9999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=307.13 Aligned_cols=256 Identities=30% Similarity=0.532 Sum_probs=215.9
Q ss_pred cceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..|...+.||+|+||.||+|.++.+ .+|+|....... ......+.+|+.++++++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 5678889999999999999987532 378887765533 4445678899999999999999999999887 7899
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999999875432 3889999999999999999999999 9999999999999999999999999997654
Q ss_pred CCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 515 NTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 515 ~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.... ......++..|+|||.+....++.++|+||||++++|+++ |..||......+....+. .......+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHH
Confidence 3211 1112234568999999988889999999999999999998 999999888777666554 33445566678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+.+++.+||..+|.+|||+.++++.|.++.+.
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.14 Aligned_cols=251 Identities=27% Similarity=0.506 Sum_probs=219.5
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
+...|.....||.|+||.||+|..+.+. .|-|++... ..+.+++++-|+.||..+.||+||++++.|..++.++|+
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 4466677778999999999999988776 566776443 466778999999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
.|||.||-+..++-.-+ ..+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+.....+
T Consensus 108 iEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred EeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhH
Confidence 99999999988775333 24999999999999999999999999 999999999999999999999999998765555
Q ss_pred cccCCCCCCCCcccCcccc-----cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCCcH
Q 006703 517 YISSKTAAGTPEWMAPEVL-----REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNP 590 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl-----~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~ 590 (634)
........|||.|||||+. ...+|+.++||||||++|.||..+.+|....+++.++..+..... .+..|..++.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR 263 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence 5566788999999999985 567899999999999999999999999999999998887743222 2235678999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+|+.+||.+||..||++.+|++
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhh
Confidence 9999999999999999999999986
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.95 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=201.8
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------C
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------~ 431 (634)
..+|...+.||+|+||.||++.+. +..+|+|++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467889999999999999999876 44599999876554455557788999999999999999999987543 3
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 57999999965 67776642 2788889999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-----------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------- 580 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~----------- 580 (634)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 175 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 654322 23456789999999999999999999999999999999999999988776554333211000
Q ss_pred ---------cc--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 581 ---------RL--------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 581 ---------~~--------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
++ ......+..+++||.+||..||.+|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0011234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=304.31 Aligned_cols=248 Identities=30% Similarity=0.519 Sum_probs=210.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||++.... ..+++|.+..... ..++.+|++++++++|+||+++++++......++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 3568888999999999999999874 4589998754422 578889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999999986433 34899999999999999999999999 9999999999999999999999999988765443
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-CcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~Li 596 (634)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||....+.+....+... ......+..++..+.+++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 3344556889999999999999999999999999999999999999887665544333211 112223456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||..||++|||+.++++
T Consensus 234 ~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHhcChhhCcCHHHHhc
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=305.59 Aligned_cols=248 Identities=27% Similarity=0.449 Sum_probs=208.0
Q ss_pred eeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEF----HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~----~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
|...+.||+|+||.||+|... +..+|+|.+..... .......+.+|+.++++++|+||+++++++.+....+++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 567789999999999999874 44599998865432 1233466889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC-
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~- 516 (634)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 82 EFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999996543 3788999999999999999999999 999999999999999999999999988753211
Q ss_pred -----cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-CcccCCCCCCcH
Q 006703 517 -----YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNP 590 (634)
Q Consensus 517 -----~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~ 590 (634)
........++..|+|||++.+..++.++|+||||+++++|++|+.||...+.......+... ...+.++..+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11123456899999999999988999999999999999999999999876655443333222 334557778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.++|.+||..+|++||++.+++.
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.54 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=223.9
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
+-|...+.||+|.|+.|-+|++. +..||||++.+...+.-....+..|++.|+.++|||||++|........+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 56777789999999999999765 6669999999998888777889999999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE-cCCCcEEEEecCCCccCCCCc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-DSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl-d~~~~ikL~DFGla~~~~~~~ 517 (634)
.-++|+|++|+-+.+. .+.+..+.+++.||++|+.|+|+.. +|||||||+||.+ .+-|-+||.|||++..+. +.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCC-Cc
Confidence 9999999999965543 3999999999999999999999999 9999999999877 467899999999987643 23
Q ss_pred ccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
....+.+|...|-|||++.|..| .+++|||||||+||.|++|+.||...+..+....| ...+..+|..++.+.++||
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHH
Confidence 45678899999999999999998 57899999999999999999999999998888777 5667788999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||..||.+|.+.++|..
T Consensus 251 ~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHHhcCchhhccHHHHhc
Confidence 9999999999999999875
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=308.43 Aligned_cols=246 Identities=30% Similarity=0.472 Sum_probs=211.3
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
+|...+.||.|++|.||+|.+.. ..+++|++.... .......+.+|+.+++.++|+||+++++++.++...++++||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46667889999999999998864 449999886543 234446788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 9999999998754 4889999999999999999999999 999999999999999999999999999876544334
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCC-CcHHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN-VNPMVAALIET 598 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~s~~l~~Li~~ 598 (634)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...++.+....+.. ...+.++.. +++.+.+++.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHHHH
Confidence 4556788999999999998899999999999999999999999988776665544432 233344444 88999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
||..+|++|||+.++++
T Consensus 234 ~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 234 CLNKDPKERPSAKELLK 250 (274)
T ss_pred HhhCChhhCcCHHHHhh
Confidence 99999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=309.93 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=210.5
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...+...|...+.||.|+||.||+|+...+ .+++|++... .......+.+|+.+++.++|+||+++++++..+...
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 344567888999999999999999988754 4888887644 344557788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++||||+++++|..++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999988875433 24889999999999999999999999 999999999999999999999999998754
Q ss_pred CCCcccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCC
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKN 587 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~ 587 (634)
...........+++.|+|||.+. ...++.++|+||||+++|+|++|..||...+..+....+..... ....+..
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 43333344556889999999984 34568899999999999999999999987776554444321111 2234557
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++..+.+++.+||..+|++||++.++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 8899999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.49 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=201.2
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------C
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------~ 431 (634)
..+|...+.||+|+||.||++.+. +..+|+|++............+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 467888999999999999999876 44599999876554555567788999999999999999999988543 3
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..+++|||+++ +|.+.+.. .+++..+..++.|+++||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 47999999976 66666642 3788889999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------ 579 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------ 579 (634)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 168 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 168 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred cCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 654332 2345678999999999999999999999999999999999999998776544322111000
Q ss_pred --------cc--------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 580 --------RR--------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 580 --------~~--------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.. ...+...+..+.+||.+||..||++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 00112245678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.10 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=206.9
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC-eeeeeceeecCC------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPP------ 431 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n-Iv~l~~~~~~~~------ 431 (634)
..|...++||+|+||+||+|+.+.+ .||+|.++.....+.......+|+.+|+.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 5577788999999999999988744 4999999876443333355679999999999999 999999998777
Q ss_pred cEEEEEeecccCCHHHHhccCCCc-ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~-~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
.+++||||++. +|.+++...... ..++...++.+++||+.||+|||+++ |+||||||.||||+++|.+||+|||+|
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccchH
Confidence 79999999965 899998644321 34777899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc---------
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--------- 580 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~--------- 580 (634)
+...-+.......++|..|+|||++.+. .|+...||||+||+++||++++..|.+....+....+-..-.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 9755444445566789999999999887 679999999999999999999999999887655444421110
Q ss_pred -------ccCCC------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 581 -------RLEIP------------KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 581 -------~~~~~------------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
...++ +...+...+++.+||..+|.+|.|+...++.
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00111 1223578999999999999999999999885
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=302.37 Aligned_cols=247 Identities=30% Similarity=0.488 Sum_probs=212.2
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~---~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
|...+.||+|+||.||+|... +..+++|.+..... .....+.+.+|+.+++.++|+||+++++++..+..++++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999999999999886 45699999865432 2345577899999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999986442 3788999999999999999999999 9999999999999999999999999987654332
Q ss_pred ccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
......++..|++||.+.... ++.++|+||||+++|+|++|+.||......+....+......+.++..+++.+.+++
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence 234566889999999987776 899999999999999999999999887766655555443455667778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||..+|++||++.+++.
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhhcCcccCcCHHHHhc
Confidence 9999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=303.84 Aligned_cols=253 Identities=31% Similarity=0.551 Sum_probs=211.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
....|...+.||+|+||.||++.+.+ ..+++|.+.... .....+.+|+.++++++|+||+++++++.. ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 34678889999999999999998654 458888875432 234678899999999999999999999887 7889999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++..+.+||+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999975432 34788889999999999999999999 9999999999999999999999999987654321
Q ss_pred -ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 -~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......++..|+|||++....++.++|+||||++++++++ |+.||...+..+....+. .....+.+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNI 235 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHHHH
Confidence 11223345678999999998889999999999999999998 999998877766665553 233444556788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
+.+||..+|++||++.++++.|++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.52 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=206.0
Q ss_pred ceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+++++.+ .+|+|++..... .......+.+|+.++..++|+||+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 577889999999999999988754 499999875432 23344567889999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 y~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 82 YYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999997532 24889999999999999999999999 9999999999999999999999999987644322
Q ss_pred ccCCCCCCCCcccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC---CCCc
Q 006703 518 ISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP---KNVN 589 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~-----~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s 589 (634)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+.....+..++ ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence 12234579999999999876 457889999999999999999999999888777666654433333333 3468
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 006703 590 PMVAALIETCWAEEPEI--RPSFPSIMET 616 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~--RPs~~~Il~~ 616 (634)
+.+.+++.+||..++.+ |+++.++++.
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 99999999999865544 4678888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=316.06 Aligned_cols=261 Identities=31% Similarity=0.558 Sum_probs=217.4
Q ss_pred cceeecceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 430 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~ 430 (634)
.+|...+.||+|+||.||+|.+.+ ..+|+|.+... .......++.+|+.+++++ +|+||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 567888999999999999997532 13788977643 3344557889999999999 799999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 497 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~-------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld 497 (634)
...+++|||+++++|.+++.... ....++...+..++.|+++||.|||++| ++||||||+||+++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~ 168 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT 168 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc
Confidence 99999999999999999986432 1224778889999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCCccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006703 498 STYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISA 574 (634)
Q Consensus 498 ~~~~ikL~DFGla~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~ 574 (634)
.++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||...+..+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999876443211 1222334567999999999999999999999999999998 8999988877776665
Q ss_pred HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 575 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 575 i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
+. .......+...+..+.+++.+||..+|++|||+.++++.|++++....
T Consensus 249 ~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 249 LK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 53 233445667788999999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=305.88 Aligned_cols=247 Identities=28% Similarity=0.475 Sum_probs=196.4
Q ss_pred ceeeccCcEEEEEEEEcC----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|.... ..+++|.+.... .......+.+|+.+++.++|+||+++++.+......+++|||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 368999999999997542 237777665432 334446788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC--cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--cc
Q 006703 443 GSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YI 518 (634)
Q Consensus 443 gsL~~ll~~~~~--~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~--~~ 518 (634)
++|.+++..... ....++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999864332 223567788899999999999999999 999999999999999999999999998653221 11
Q ss_pred cCCCCCCCCcccCcccccC-------CCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCc----ccCCCC
Q 006703 519 SSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR----RLEIPK 586 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~-------~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~----~~~~~~ 586 (634)
......++..|+|||++.. ..++.++||||||+++|||++ |..||....+.+....+..... .+..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 2234456778999999743 356889999999999999999 7889988776655444322221 233445
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 587 NVNPMVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
.+++.+.+++..|| .||++|||+.+|++.|
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 78899999999998 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.63 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=206.8
Q ss_pred ceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+++++++. +|+|++.+... .......+.+|+.++..++|+||+++++++.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5777899999999999999987544 99999865432 23334557889999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC-c
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~-~ 517 (634)
|+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 82 y~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred ccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999997532 24889999999999999999999999 999999999999999999999999998754322 1
Q ss_pred ccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC---CCCc
Q 006703 518 ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP---KNVN 589 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s 589 (634)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..+| ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 2223457999999999986 3457889999999999999999999999888877776664433333333 4679
Q ss_pred HHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 006703 590 PMVAALIETCWAEEPEI--RPSFPSIMET 616 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~--RPs~~~Il~~ 616 (634)
+.+.+++.+||..++++ |+++.++++.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99999999999654444 6899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=308.67 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=211.9
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|.+.. ..+|+|++..... ......+.+|+.++++++|+||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 456677899999999999998764 4599998865432 3445778899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 83 YLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999988642 3788899999999999999999999 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......++..|+|||.+.+...+.++|+||||+++|+|++|+.||....+......+ .....+.++..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHHHH
Confidence 334456888999999999888999999999999999999999999887766555443 2233455566788999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~~ 616 (634)
||..+|++||++.+++..
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 236 CLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HcccCcccCcCHHHHHhC
Confidence 999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=305.96 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=197.3
Q ss_pred ceeeccCcEEEEEEEEcCC----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|...+. .+++|.+..... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 3689999999999986532 388888765543 23335788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC--CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc--c
Q 006703 443 GSLYKLLHIPD--ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--I 518 (634)
Q Consensus 443 gsL~~ll~~~~--~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~--~ 518 (634)
++|.+++.... .....++..+..++.|+++||.|||+++ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999986432 1234667788899999999999999999 9999999999999999999999999987543321 1
Q ss_pred cCCCCCCCCcccCcccccCC-------CCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcC----cccCCCC
Q 006703 519 SSKTAAGTPEWMAPEVLRED-------PSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG----RRLEIPK 586 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~-------~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~ 586 (634)
......++..|+|||++.+. .++.++|+||||+++|||++ |..||......+......... ..+.+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 22344578899999998643 35789999999999999996 999998877665443321111 1222334
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 587 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
..++.+.+++.+|| .+|++|||+.+|+..|+
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 57889999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=309.67 Aligned_cols=249 Identities=27% Similarity=0.479 Sum_probs=208.0
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||++.+. +..+|+|.+... ........+.+|+.++++++|+||+++++.+..+...+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4667789999999999999987 455999987654 2344457888999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
+++++|..++........+++..+..++.|++.||.|||+ .+ |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999998754333458999999999999999999997 47 999999999999999999999999998765332
Q ss_pred cCCCCCCCCcccCcccccCCC------CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--hcCcccCCCCCCcH
Q 006703 519 SSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNP 590 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~------~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~s~ 590 (634)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+. .....+.++..+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence 234556888999999986543 4789999999999999999999997765544333221 12334556777999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+++.+||..+|++||++.+++.
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhc
Confidence 9999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.90 Aligned_cols=252 Identities=28% Similarity=0.493 Sum_probs=211.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
+...|...+.||.|+||.||++.+. +..+|+|++... .....+.+.+|+.++++++|+||+++++++..+...++|
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 3456888899999999999999886 445999988644 344457788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 81 IEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred eeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999999986533 24899999999999999999999999 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCCcH
Q 006703 517 YISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNP 590 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~ 590 (634)
........+++.|+|||.+. ...++.++|+||||+++|+|++|+.||......+....+..... ....+..++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence 33344567899999999975 34567899999999999999999999988877665544422111 2233557889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.+.+++.+||..+|.+||++.++++.
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 99999999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=307.71 Aligned_cols=253 Identities=34% Similarity=0.545 Sum_probs=210.3
Q ss_pred cceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..+...++||+|+||.||+++.. +..+++|.+... .......+.+|+++++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45667889999999999999753 223778876543 234456789999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCC------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDA------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 501 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ 501 (634)
+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCCC
Confidence 999999999999999864321 124788999999999999999999999 999999999999999999
Q ss_pred EEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 006703 502 VKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK 578 (634)
Q Consensus 502 ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~ 578 (634)
+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+. .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-c
Confidence 9999999987543221 11223345788999999999999999999999999999998 899998877766655553 3
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 579 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 579 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
......+..+++.+.+++.+||..||.+||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 3344566788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=311.13 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=205.1
Q ss_pred eeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
|...+.||+|+||.||++.+..+ .+|+|.+....... .....+.+|+.++++++|++|+++++.+.+.+..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56678899999999999988744 59999886554332 2335577899999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 999999998854332 24889999999999999999999999 9999999999999999999999999987543322 2
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||...... +...... .......+..+++.+.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 23457899999999999999999999999999999999999999865432 1111111 1122345667899999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHH
Q 006703 597 ETCWAEEPEIRPS-----FPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs-----~~~Il~ 615 (634)
.+||+.||++||| +.++++
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHc
Confidence 9999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=304.24 Aligned_cols=247 Identities=35% Similarity=0.598 Sum_probs=209.9
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
..|...+.||+|+||.||++...+..+|+|...... ....+.+|+.++++++|+||+++++++..+ ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 567888999999999999999888889999985432 235678999999999999999999998654 479999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
.+++|.+++..... ..+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~ 154 (254)
T cd05083 81 SKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---V 154 (254)
T ss_pred CCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecccc---C
Confidence 99999999975432 34788999999999999999999999 999999999999999999999999998754322 1
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+. ....+..+..+++.+.+++.+|
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHH
Confidence 23344568999999998889999999999999999997 999998888776655553 2334445677899999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHH
Q 006703 600 WAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~~L~~ 619 (634)
|..+|++||++.+|++.|++
T Consensus 234 l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 234 WETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCChhhCcCHHHHHHHHcc
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.71 Aligned_cols=254 Identities=28% Similarity=0.484 Sum_probs=213.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||.|+||.||++.+. +..+++|.+...... ....+.+|+.+++.++|+||+++++++......+++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 3467899999999999999999865 455999988654332 235678999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
+||+++++|..++... .+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999999988633 3889999999999999999999999 999999999999999999999999998765433
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~L 595 (634)
........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...++.+....+.... .....+..+++.+.++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 323344578899999999998889999999999999999999999998887755544432211 2233456789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
|.+||..+|.+|||+.+|++ ..+++
T Consensus 249 i~~~l~~dp~~Rpt~~~il~--~~~~~ 273 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQ--HPFLK 273 (296)
T ss_pred HHHHhhcChhhCCCHHHHhh--ChHhh
Confidence 99999999999999999986 44444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.63 Aligned_cols=249 Identities=34% Similarity=0.604 Sum_probs=209.8
Q ss_pred cceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..|...+.||+|+||.||++.+. +..+++|++....... .++.+|++++++++||||+++++++......+++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 45777889999999999999876 5569999876554433 4577899999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI- 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~- 518 (634)
+.+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 81 MEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999999864432 3788899999999999999999999 99999999999999999999999999875433221
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+.. ......+...+..+.+++.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCCCCCHHHHHHHH
Confidence 1223345678999999998889999999999999999998 9999988777766665532 2333445667899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L 617 (634)
+||..+|++|||+.++++.|
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHcccChhhCCCHHHHHHhh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=307.53 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=203.5
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||+|.++ +..+|+|++..........+.+.+|+.++++++|+||+++++++......+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5777889999999999999887 44599998875543333335678999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|..++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 82 CDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred cCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 99988888765432 3899999999999999999999999 999999999999999999999999999865443323
Q ss_pred CCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-------------------
Q 006703 520 SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------- 579 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------------- 579 (634)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.+....+....+....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 334567889999999876 457899999999999999999999998777654433321100
Q ss_pred cccC----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 RRLE----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ~~~~----------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...+ ....++..+.+|+.+||..+|++|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 01246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.60 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=212.5
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||++... +..+++|.+............+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 3677889999999999999876 44499999877665556667899999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC-CcEEEEecCCCccCCCCcc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~-~~ikL~DFGla~~~~~~~~ 518 (634)
+++++|.+++..... ..+++..+..++.+++.||.|||+++ ++|+||||+||+++.+ +.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999975332 34789999999999999999999999 9999999999999854 468999999988654432
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......++..|+|||.+.+...+.++||||||+++|+|++|+.||...+.......+. ......++..+++.+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHH
Confidence 2234568899999999998888999999999999999999999998877665554443 233345667789999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
||..+|.+|||+.+++.
T Consensus 236 ~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 236 MLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HccCChhhCCCHHHHhh
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=309.54 Aligned_cols=247 Identities=29% Similarity=0.497 Sum_probs=209.9
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|.+.. ..+|+|.+..... ....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 456677889999999999998764 4489998764432 3345678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++... .+++..+..++.|+++|+.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999988632 3788999999999999999999999 99999999999999999999999999876544332
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......++..|+|||.+.+..++.++|+||||++++||++|+.||....+......+. ....+.++...+..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHH
Confidence 3334568889999999999889999999999999999999999998776655544432 233444556788999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
||..+|++|||+.+++.
T Consensus 236 ~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 236 CLNKDPRFRPTAKELLK 252 (277)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=325.86 Aligned_cols=242 Identities=24% Similarity=0.303 Sum_probs=193.7
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||++.+..+ .||+|.... ..+.+|+.++++++||||+++++++......+++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 35799999999999999999988744 489986421 34668999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC-
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~- 516 (634)
|++. ++|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 9995 68888875432 3788999999999999999999999 999999999999999999999999998753221
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhh------------
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-------SQVISAVGF------------ 577 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-------~~~~~~i~~------------ 577 (634)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1223356799999999999999999999999999999999999988754321 000000000
Q ss_pred --------------c-CcccC-CC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 578 --------------K-GRRLE-IP-----KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 578 --------------~-~~~~~-~~-----~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. ...+. .+ ..++.++.+||.+||+.||++|||+.++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000 00 134678999999999999999999999996
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=311.17 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=202.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||.|+||.||+|.++. ..||+|.+...... .....+.+|+.++++++|+||+++++++..+...+++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 3678899999999999999998864 45999988654322 22245678999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+. ++|.+++.... ..+++..+..++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 84 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 84 EYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred eccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 9997 48888886443 24788999999999999999999999 9999999999999999999999999987644333
Q ss_pred ccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-----------------
Q 006703 518 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------------- 579 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~----------------- 579 (634)
.......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 233445678999999998654 47889999999999999999999998877654433221100
Q ss_pred cc---c--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 RR---L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ~~---~--------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.. + .....+++.+++||.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0 011357889999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=319.73 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=199.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------Cc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------PN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------~~ 432 (634)
..|...+.||+|+||.||+|.+..+ .||+|++............+.+|+.++++++|+||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 5688889999999999999987644 499999876544444456678999999999999999999988543 34
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++++++ +++|.+++... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 95 ~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence 78999988 77998887532 3899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------ 579 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------ 579 (634)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 345578999999999877 567899999999999999999999998766544333221100
Q ss_pred ---------cccC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 580 ---------RRLE--------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 580 ---------~~~~--------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
..+. .....++.+.+|+.+||..||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 112356778999999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=318.63 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=219.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...++||+|+||.||+|.++.++ +|||.+.. +..++++..|+.+++++..++||++|+.|.....++|||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 356778899999999999999888666 78887643 345678899999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|||..|++.++++... ..+++..+..+++..++||+|||... -+|||||..|||++.+|..||+|||.|....++.
T Consensus 108 EYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 9999999999997544 35999999999999999999999988 8999999999999999999999999999887777
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~Li 596 (634)
....+..|||.|||||++..-.|+.++||||||++..||..|++||...+++..+..+..... ...-|..++.++.+++
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 777889999999999999999999999999999999999999999999999877666532111 1123456889999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~ 615 (634)
++||.++|++|.|+.++++
T Consensus 264 ~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHhcCCHHHHHHHHHHhh
Confidence 9999999999999999887
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=329.64 Aligned_cols=249 Identities=26% Similarity=0.302 Sum_probs=207.6
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCC-C-----CCeeeeeceee
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-H-----PNIVLLMGAVT 428 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h-----~nIv~l~~~~~ 428 (634)
.....+|...+.||+|+||.|-+|.+..++ ||||+++... ....+-..|+++|..++ | -|+|+++++|.
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 334458899999999999999999887654 9999997653 34456678999999996 4 48999999999
Q ss_pred cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC--CCcEEEEe
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCD 506 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~--~~~ikL~D 506 (634)
..+++|||+|.+ ..+|++++..++.++ ++...+..|+.||+.||.+||+.+ |||+||||+||||.. ...|||+|
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEe
Confidence 999999999999 559999998776654 899999999999999999999999 999999999999963 44899999
Q ss_pred cCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc------
Q 006703 507 FGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------ 580 (634)
Q Consensus 507 FGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~------ 580 (634)
||.|+......+ +.+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+.+..|.....
T Consensus 335 FGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 335 FGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999998665433 67788999999999999999999999999999999999999999887665544321100
Q ss_pred --------------------------------------------ccCCC-----------CCCcHHHHHHHHHhhhcCCC
Q 006703 581 --------------------------------------------RLEIP-----------KNVNPMVAALIETCWAEEPE 605 (634)
Q Consensus 581 --------------------------------------------~~~~~-----------~~~s~~l~~Li~~cL~~dP~ 605 (634)
....| ..-...+.+++++||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00011 01234689999999999999
Q ss_pred CCCCHHHHHH
Q 006703 606 IRPSFPSIME 615 (634)
Q Consensus 606 ~RPs~~~Il~ 615 (634)
+|+|+.+.++
T Consensus 492 ~R~tp~qal~ 501 (586)
T KOG0667|consen 492 ERITPAQALN 501 (586)
T ss_pred hcCCHHHHhc
Confidence 9999999887
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.06 Aligned_cols=244 Identities=27% Similarity=0.443 Sum_probs=211.3
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||++.+.. ..+|+|++..... .......+.+|++++++++||||+++++++.+....+++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 47778899999999999998864 5599999865543 23445678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... .+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999987543 4889999999999999999999999 999999999999999999999999998865443
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||......+....+. .....++..+++.+++++.+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHH
Confidence 345578999999999988888999999999999999999999998877655555442 44556778889999999999
Q ss_pred hhhcCCCCCC-----CHHHHHH
Q 006703 599 CWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RP-----s~~~Il~ 615 (634)
||..||.+|+ ++.++++
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HccCCHHHccCcccCCHHHHHc
Confidence 9999999998 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.33 Aligned_cols=248 Identities=27% Similarity=0.462 Sum_probs=206.4
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeecccc---HHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCcEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLS 434 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~---~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~~~ 434 (634)
.|...+.||+|+||.||+|.... ..+++|++...... ......+.+|+.++++++|+||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 46778899999999999998764 45999987654322 2344678899999999999999999998865 35688
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+++++|.+++.... .+++...+.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 83 l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999986433 3788899999999999999999999 9999999999999999999999999987543
Q ss_pred CCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 515 NTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 515 ~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+...........+.++..+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence 211 11233558889999999999889999999999999999999999998876666555554444456677778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+..++ +||..+|++||++.+|++
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhc
Confidence 99999 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=344.09 Aligned_cols=262 Identities=25% Similarity=0.332 Sum_probs=211.9
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
.+|...+.||+|+||.||+|.+.. ..||+|++...... ....+++.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 468888999999999999998864 45999998754332 334567899999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCC--------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 438 EYLSRGSLYKLLHIPD--------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~--------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
||++|++|.+++.... .....+...++.++.||++||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999985321 1123556778899999999999999999 99999999999999999999999999
Q ss_pred CccCCCC------------------cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 006703 510 SRSKPNT------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 571 (634)
Q Consensus 510 a~~~~~~------------------~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~ 571 (634)
+...... ........||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9754110 0011234699999999999999999999999999999999999999987655443
Q ss_pred HHHHhhcCcc-cCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHhc
Q 006703 572 ISAVGFKGRR-LEIPKNVNPMVAALIETCWAEEPEIR-PSFPSIMETLQQFLMSS 624 (634)
Q Consensus 572 ~~~i~~~~~~-~~~~~~~s~~l~~Li~~cL~~dP~~R-Ps~~~Il~~L~~ll~~~ 624 (634)
.......... ......+++.+.+++.+||..||++| ++++++++.|+++++..
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 3221111111 11124678999999999999999999 57888889999988753
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.28 Aligned_cols=248 Identities=29% Similarity=0.523 Sum_probs=208.1
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
+|...+.||+|+||.||++... +..+++|.+............+.+|+.++++++|+||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3677889999999999999875 44599999877665555678899999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++.... .+++..++.++.++++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999987542 3788899999999999999999999 999999999999999999999999998765433222
Q ss_pred C----CCCCCCCcccCcccccCCC---CCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcccCCCCC--Cc
Q 006703 520 S----KTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKN--VN 589 (634)
Q Consensus 520 ~----~~~~gt~~y~APEvl~~~~---~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~--~s 589 (634)
. ....++..|+|||.+.+.. .+.++||||||+++++|++|+.||..... ......+. ....+.+|.. ++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccC
Confidence 1 2356788999999998776 78999999999999999999999976543 33332332 2334445544 48
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+.+++.+||..+|.+|||+.+++.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=308.65 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=198.4
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
+|...+.||+|+||.||+|.+. +..+++|.+............+.+|+.++++++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3667789999999999999986 44599999876544433345677899999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+.+ +|.+++.... ..+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 975 7877775432 34899999999999999999999999 999999999999999999999999998765433333
Q ss_pred CCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhhc------------------C
Q 006703 520 SKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFK------------------G 579 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~-~~~~~~~~~i~~~------------------~ 579 (634)
.....++..|+|||++.+.. ++.++||||||+++|+|++|..|+.. .+..+....+... .
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 34456789999999987654 68999999999999999999888643 3332222111000 0
Q ss_pred cc---------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 RR---------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ~~---------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.. ......+++++.+++.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0112357889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.71 Aligned_cols=255 Identities=31% Similarity=0.510 Sum_probs=205.0
Q ss_pred cceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--Cc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~ 432 (634)
..|...+.||+|+||.||++++. +..+|+|.+.... .......+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45677889999999999999753 3349999976443 344456789999999999999999999998765 56
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999986443 24789999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHHH
Q 006703 513 KPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---------------PSQVISA 574 (634)
Q Consensus 513 ~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~---------------~~~~~~~ 574 (634)
...... ......++..|+|||++.+..++.++||||||+++|+|+++..|+.... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 543211 1223456778999999988889999999999999999999876542211 0111111
Q ss_pred HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 575 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 575 i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
+ ......+.+..++..+.+|+.+||+.||++|||+.++++.|+.++
T Consensus 239 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 239 L-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred H-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1 122334456678999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=311.28 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=210.2
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.....|...+.||+|+||.||++... +..+|+|.+...... ..+.+.+|+.+++.++|+||+++++++..+...++
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 34578888999999999999999875 455999998654433 23567899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 94 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred eecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999998643 3788899999999999999999999 99999999999999999999999999876543
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~ 594 (634)
.........+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.... .....+..++..+.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 3333345578899999999999889999999999999999999999998766544332222111 122345668899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+||..+|++||++.++++
T Consensus 248 li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=345.90 Aligned_cols=258 Identities=21% Similarity=0.361 Sum_probs=208.1
Q ss_pred CCCCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--C
Q 006703 355 NPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--P 430 (634)
Q Consensus 355 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~ 430 (634)
........|...+.||+|+||+||+|++.... +|+|++............+..|+.++++++||||++++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34445578999999999999999999987554 8999987766666667789999999999999999999998854 4
Q ss_pred CcEEEEEeecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCC-----CCEEeeccCCCcEEEcC------
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRR-----PPIVHRDLKSPNLLVDS------ 498 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g-----~~IvHrDIKP~NILld~------ 498 (634)
..+||||||+++++|.+++... .....+++..++.|+.||+.||.|||+.+ .+|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999998642 22235899999999999999999999843 23999999999999964
Q ss_pred -----------CCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCC
Q 006703 499 -----------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRN 565 (634)
Q Consensus 499 -----------~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~Pf~~ 565 (634)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||..
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3359999999997654322 2345579999999999854 4578999999999999999999999976
Q ss_pred CChHHHHHHHhhcCcccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 566 STPSQVISAVGFKGRRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 566 ~~~~~~~~~i~~~~~~~~~~-~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
............. .+.++ ...+..+.+||..||..+|.+||++.+++.
T Consensus 246 ~~~~~qli~~lk~--~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFSQLISELKR--GPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHHHHHHHHhc--CCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 6544333222111 12222 457899999999999999999999999985
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.01 Aligned_cols=249 Identities=39% Similarity=0.659 Sum_probs=210.1
Q ss_pred eecceeeccCcEEEEEEEEcC------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 364 IDSSNFIKGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...+.||.|+||.||++.+.. ..+|+|++..... ....+.+.+|+..++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 345789999999999998875 4599999865432 225578889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++...... .+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998743321 1899999999999999999999999 9999999999999999999999999987654331
Q ss_pred c-cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 I-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 ~-~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
. ......+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+.. ......+...+..+.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHH
Confidence 1 1112347789999999988889999999999999999998 7899988777766665543 33445566789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L 617 (634)
+.+||+.+|++|||+.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.44 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=204.0
Q ss_pred ceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||++.+..++ +++|.+... .......++.+|++++++++||||+++++++..++.++++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4778889999999999999887544 777776543 2344556788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999754 248899999999999999999997 57 999999999999999999999999998754332
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--------------------
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------------- 578 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-------------------- 578 (634)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 234557899999999998888999999999999999999999999765544433222111
Q ss_pred ---------------CcccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 579 ---------------GRRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 579 ---------------~~~~~~~-~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
...+..+ ..++.++++++.+||..+|++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111112 1367889999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.24 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=209.4
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||+|...+ ..+|+|.+....... .....+.+|+.+++.++|+||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 57788899999999999998865 559999987665442 355678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999987432 235899999999999999999999999 9999999999999999999999999876432110
Q ss_pred ----------------------------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH
Q 006703 518 ----------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 569 (634)
Q Consensus 518 ----------------------------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~ 569 (634)
.......||..|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112346888999999999998999999999999999999999999888776
Q ss_pred HHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 006703 570 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS----FPSIME 615 (634)
Q Consensus 570 ~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs----~~~Il~ 615 (634)
.....+............+++.+.+++.+||..||++||| +.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 6555443222222222337999999999999999999999 777777
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=305.42 Aligned_cols=249 Identities=35% Similarity=0.573 Sum_probs=206.4
Q ss_pred ceeeccCcEEEEEEEEcC--------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 367 SNFIKGSFGTVYHAEWRN--------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
+.||+|+||.||+|+..+ ..+++|.+.... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998763 348888875432 23345678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCC----CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-----cEEEEecCC
Q 006703 439 YLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-----TVKVCDFGL 509 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~----~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-----~ikL~DFGl 509 (634)
|+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999986321 2234788999999999999999999999 99999999999999877 899999999
Q ss_pred CccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCC
Q 006703 510 SRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK 586 (634)
Q Consensus 510 a~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 586 (634)
+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+. .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 236 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPE 236 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCcc
Confidence 87543221 11223356788999999999999999999999999999998 999998877766555443 233445667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 587 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
.+++.+.+++.+||..+|.+||++.+|++.|++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 789999999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.81 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=203.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec------
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE------ 429 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~------ 429 (634)
+...|...+.||+|+||.||+|.+.. ..+|+|++.... ....++..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34677888899999999999999864 448999875432 2335677899999998 79999999999853
Q ss_pred CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
....+++|||+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcc
Confidence 4578999999999999999864332 24788889999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCcccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 584 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 584 (634)
+..............|++.|+|||++. +..++.++|+||||+++|+|++|..||....+......+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 247 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence 876543332344567899999999986 345788999999999999999999999876665544433222222223
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...++..+.++|.+||..||.+|||+.+|++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 3468899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.21 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=206.2
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~---~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~ 433 (634)
..|...+.||+|+||.||++.+.. ..|++|.+..... .......+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 357778899999999999998764 4499998764321 233456788999999999999999999988663 468
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986432 3788889999999999999999999 999999999999999999999999998754
Q ss_pred CCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 514 PNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 514 ~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.... .......++..|+|||++.+..++.++|+||||+++|+|++|+.||..................+..|...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD 236 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence 3211 1223456889999999998888999999999999999999999999877665555544433444556777889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+++.+||. +|++||++.+|++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 99999999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.63 Aligned_cols=254 Identities=34% Similarity=0.533 Sum_probs=202.0
Q ss_pred cceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~ 432 (634)
.+|...+.||+|+||.||++... +..+++|.+.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 46777889999999999999753 3459999876442 3445678899999999999999999997643 456
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
++++|||+++++|.+++.... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 899999999999999986432 24889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHH---------------HHH
Q 006703 513 KPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---------------ISA 574 (634)
Q Consensus 513 ~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~---------------~~~ 574 (634)
...... ......++..|+|||.+.+..++.++||||||++++||++|..|+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 543211 11122344569999999988899999999999999999998776543221100 001
Q ss_pred HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 575 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 575 i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
..........+..++..+.+++.+||..+|++|||+.+|++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1112223345567889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.90 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=196.8
Q ss_pred cceeecc--CcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 366 SSNFIKG--SFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 366 ~~~LG~G--~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.+.||+| +|++||++..+.+ .||+|++............+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4678999 7899999988744 49999987665555556678889999999999999999999999999999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc---
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--- 518 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~--- 518 (634)
+++|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++++||+.+........
T Consensus 83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999864322 23889999999999999999999999 99999999999999999999999986543221110
Q ss_pred ----cCCCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-----------
Q 006703 519 ----SSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------- 581 (634)
Q Consensus 519 ----~~~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------- 581 (634)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+...........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1123356778999999976 45889999999999999999999999865544332221100000
Q ss_pred ---------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ---------------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ---------------------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+....+++.+.+|+.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0011235678999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.53 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=217.0
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
.+...|.+.+.||.|+||.||-|++..+. ||||.+..... ..+...++..|++.|++++|||++.+-++|..+...|
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 44567888999999999999999887443 99999876543 4566788999999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+|||||- |+-.+++.-.. .++.+..+..|..+.+.||+|||+.+ .||||||..|||++..|.+||+|||.|....
T Consensus 103 LVMEYCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 103 LVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 9999994 58889886332 35889999999999999999999999 9999999999999999999999999887543
Q ss_pred CCcccCCCCCCCCcccCcccc---cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl---~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
..++.+|||.|||||++ ..+.|+-++||||||++..||.-.++|+++.+.+.....|.....+.-....++..
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~ 253 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 253 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHH
Confidence 34688999999999997 45778999999999999999999999999999999988886433333334678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+|+..||.+-|.+|||..++++
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhh
Confidence 999999999999999999999886
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.32 Aligned_cols=249 Identities=29% Similarity=0.484 Sum_probs=210.8
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||+|+||.||++..+. ..+|+|.+..........+.+.+|+.++++++|+||+++++.+......++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 6678899999999999998874 44899998765444445567889999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCccCCCCccc
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~~~~~~~~ 519 (634)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 82 DGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999999864332 24789999999999999999999999 99999999999998875 5699999998765543333
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
.....|++.|+|||++.+..++.++|+||||+++++|++|+.||...+..+....+. .......+...+..+.+++.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 344568999999999988889999999999999999999999998877666554442 2333445567889999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 006703 600 WAEEPEIRPSFPSIME 615 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~ 615 (634)
|..+|++|||+.++++
T Consensus 238 l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 238 FKVSPRDRPSITSILK 253 (257)
T ss_pred hccChhhCcCHHHHhh
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.22 Aligned_cols=250 Identities=29% Similarity=0.422 Sum_probs=208.3
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||.|+||+||+|.... ..+++|++....... ....+.+|+.+++.++|+||+++++.+..+...+++||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47778899999999999998754 448999886554333 557889999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++........+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999975433345899999999999999999999999 999999999999999999999999998754432211
Q ss_pred ----CCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC-----CCCc
Q 006703 520 ----SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-----KNVN 589 (634)
Q Consensus 520 ----~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-----~~~s 589 (634)
.....|+..|+|||.+... .++.++|+||||+++++|++|+.||...+..+........ ..+.++ ..++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKYS 237 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCcccccccc
Confidence 2344688999999998777 7899999999999999999999999887766544443222 112222 2568
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+.+++.+||..||++|||+.+|++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 89999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.38 Aligned_cols=236 Identities=26% Similarity=0.446 Sum_probs=193.9
Q ss_pred ceeeccCcEEEEEEEEcCCc------------EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 367 SNFIKGSFGTVYHAEWRNSD------------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~~------------vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
+.||+|+||.||+|.+.++. +++|++...... ...+.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999887544 667765433211 4678899999999999999999999887 7789
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-------cEEEEec
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-------TVKVCDF 507 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-------~ikL~DF 507 (634)
++|||+++++|.+++..... .+++..+..++.||+.||.|||+++ |+|+||||+||+++.++ .+||+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999999975432 4888999999999999999999999 99999999999999877 7999999
Q ss_pred CCCccCCCCcccCCCCCCCCcccCcccccCC--CCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCC
Q 006703 508 GLSRSKPNTYISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI 584 (634)
Q Consensus 508 Gla~~~~~~~~~~~~~~gt~~y~APEvl~~~--~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 584 (634)
|++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||......+...... .....
T Consensus 153 g~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~ 225 (259)
T cd05037 153 GIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRL 225 (259)
T ss_pred Cccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCC
Confidence 99876433 2344567789999999877 78999999999999999999 588887765444333222 12222
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
+......+.+++.+||..+|.+|||+.++++.|
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 333348999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.03 Aligned_cols=258 Identities=33% Similarity=0.555 Sum_probs=211.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...|...+.||+|+||.||+|.+..+ .+|+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 35677888999999999999987532 26778775443 233345688999999999999999999988654 46
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++...
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence 79999999999999987543 24788899999999999999999999 999999999999999999999999999865
Q ss_pred CCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 514 PNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 514 ~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+....+. ....+..+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTI 238 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 43221 2233445778999999999999999999999999999997 899998876655544443 3444455667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+.+++.+||..+|++||++.++++.|+.+....
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 9999999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.44 Aligned_cols=238 Identities=23% Similarity=0.402 Sum_probs=192.7
Q ss_pred ceeeccCcEEEEEEEEcCC--------------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 367 SNFIKGSFGTVYHAEWRNS--------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~--------------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
+.||+|+||.||+|..... .+++|.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4689999999999975321 2777776443 23344678899999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc-------EEEE
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-------VKVC 505 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~-------ikL~ 505 (634)
.+++|||+++++|..++.... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++. ++++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999998886443 24889999999999999999999999 999999999999986654 8999
Q ss_pred ecCCCccCCCCcccCCCCCCCCcccCccccc-CCCCCchHHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHhhcCcccC
Q 006703 506 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQVISAVGFKGRRLE 583 (634)
Q Consensus 506 DFGla~~~~~~~~~~~~~~gt~~y~APEvl~-~~~~s~~sDVwSLGvlL~eLl-tg~~Pf~~~~~~~~~~~i~~~~~~~~ 583 (634)
|||++..... .....++..|+|||.+. +..++.++||||||+++|||+ +|..||......+..... .....
T Consensus 155 d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~ 227 (262)
T cd05077 155 DPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCM 227 (262)
T ss_pred CCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCcc
Confidence 9998865432 23456788999999986 466899999999999999997 588888776654433221 12222
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
.....++.+.+++.+||..||++||++.+|++.|
T Consensus 228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 3334568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.35 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=205.0
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceee----
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT---- 428 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~---- 428 (634)
......+|...+.||+|+||.||++.+.. ..+++|++..... ....+.+|+.+++++ +|+||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 33456788889999999999999998864 4599998754321 224577899999999 6999999999873
Q ss_pred -cCCcEEEEEeecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEe
Q 006703 429 -EPPNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 506 (634)
Q Consensus 429 -~~~~~~lV~E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~D 506 (634)
.+...+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEcc
Confidence 445799999999999999987522 22335888999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCcccCCCCCCCCcccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-c
Q 006703 507 FGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-R 580 (634)
Q Consensus 507 FGla~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~ 580 (634)
||++..............|++.|+|||++.. ..++.++|||||||++|+|++|+.||....+........... .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 9998765443333445678999999999853 446889999999999999999999998776644433321111 1
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
....+..++..+.+++.+||..||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 122345578899999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=300.05 Aligned_cols=246 Identities=28% Similarity=0.460 Sum_probs=201.0
Q ss_pred cceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 366 SSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
...||+|+||.||+|.+..+ .+++|.+.... ....+.+.+|+.++++++|+||+++++++..++..++++||++++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 35899999999999987654 38888775443 334467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCCCccCCCCcccCCC
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
+|.+++.........++..+..++.||+.||.|||+++ |+|+||||+||+++. .+.++|+|||++............
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence 99999875432222378888899999999999999999 999999999999976 679999999998765433223344
Q ss_pred CCCCCcccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 523 AAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~--~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
..+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... ............+.++..+++++.+++.+|
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC 248 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHH
Confidence 56899999999986644 788999999999999999999999765432 222222223344566778899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 006703 600 WAEEPEIRPSFPSIME 615 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~ 615 (634)
|..+|.+|||+.+++.
T Consensus 249 l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 249 FEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCCCchhCCCHHHHHh
Confidence 9999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.56 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=210.0
Q ss_pred eeecceeeccCcEEEEEEEEcC---CcEEEEEEeecc--------ccHHHHHHHHHHHHHHHh-CCCCCeeeeeceeecC
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN---SDVAVKILIEQE--------FHEDRFKEFLREVAIMKG-LRHPNIVLLMGAVTEP 430 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~---~~vAvK~~~~~~--------~~~~~~~~~~~El~iL~~-l~h~nIv~l~~~~~~~ 430 (634)
|...+.||+|+||.||++.+.. ..+|+|.+.... .......++.+|+.++.+ ++|+||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5667889999999999999875 448999875432 223445667889988875 6999999999999999
Q ss_pred CcEEEEEeecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
+..+++|||+++++|.+++.. ......+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999998843 1223358899999999999999999996 67 9999999999999999999999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......+.....+
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 160 LAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred ceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 987654432 3345668999999999998889999999999999999999999998877766555554333333333467
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
++.+.+++.+||..||++||++.++...+.
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=300.73 Aligned_cols=255 Identities=31% Similarity=0.537 Sum_probs=209.0
Q ss_pred eeecceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 431 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------ 431 (634)
|...+.||+|+||.||+|.++ +..+|+|++..........+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 345678999999999999864 244999998776656666778999999999999999999999885432
Q ss_pred cEEEEEeecccCCHHHHhccC---CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~---~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
..++++||+.+++|..++... .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 247889999999998887422 12234788899999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCC
Q 006703 509 LSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 585 (634)
Q Consensus 509 la~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 585 (634)
++....... .......+++.|++||.+.+..++.++||||||+++|+|++ |+.||......+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 988643221 11223345678999999998889999999999999999999 899998777666555443 23334455
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 586 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 586 ~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
...++.+.+++.+||..+|++|||+.+++..|+++
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.30 Aligned_cols=248 Identities=29% Similarity=0.477 Sum_probs=207.7
Q ss_pred cce-eecceeeccCcEEEEEEEEcCCc--EEEEEEeec--cccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc--E
Q 006703 361 THV-IDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQ--EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--L 433 (634)
Q Consensus 361 ~~~-~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~--~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~--~ 433 (634)
++| .....||+|+|-+||+|.+..++ ||--.++.. ...+...++|.+|+.+|+.|+|+||+++++++.+... +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 444 45678999999999999987666 443222222 2245566899999999999999999999999977665 7
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEEecCCCcc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRS 512 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~DFGla~~ 512 (634)
-+|+|.+..|+|..|+.+.. .++.+.+.+|++||++||.|||++.|||||||||-+||+|+ ..|.+||+|+|+|..
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 89999999999999997554 37888999999999999999999999999999999999998 468999999999998
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
..... ....+|||.|||||++. ..|++.+||||||++++||+|+..||.. .++.++..++.....+-.+..--.++
T Consensus 196 ~r~s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 196 LRKSH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred hhccc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 65543 34579999999999997 7799999999999999999999999976 66677766664433333344445789
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++||.+||.. ..+|||+.++|+
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhh
Confidence 99999999998 999999999987
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.97 Aligned_cols=255 Identities=32% Similarity=0.519 Sum_probs=207.5
Q ss_pred cceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~ 432 (634)
..|...+.||+|+||.||++.+. +..+|+|++...... .....+.+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45667789999999999999865 234999998755433 345778999999999999999999999877 667
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++|||+++++|.+++..... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||.+..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999975432 4889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHH
Q 006703 513 KPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--------------VISAV 575 (634)
Q Consensus 513 ~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~--------------~~~~i 575 (634)
...... ......++..|++||.+.+..++.++||||||++++||++|..|+....... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 542211 1122345667999999988889999999999999999999999986533221 01111
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 576 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 576 ~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
.........+..++.++.+++.+||..+|.+|||+.+|++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112233344566789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=299.74 Aligned_cols=241 Identities=28% Similarity=0.436 Sum_probs=207.3
Q ss_pred eeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 369 FIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
||.|++|.||++.+. +..+++|++...... ....+.+.+|+.+++.++|+||+++++.+.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999988 556999998765433 33456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 525 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~g 525 (634)
.+++.... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 154 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCG 154 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccC
Confidence 99997543 3888999999999999999999999 9999999999999999999999999988654432 2334568
Q ss_pred CCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 006703 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603 (634)
Q Consensus 526 t~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~d 603 (634)
++.|++||.+.+..++.++|+||||+++|+|++|..||.... +.+....+......+..|...++.+.+++.+||..+
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 899999999988889999999999999999999999998776 555555443334556677777999999999999999
Q ss_pred CCCCCC-----HHHHHH
Q 006703 604 PEIRPS-----FPSIME 615 (634)
Q Consensus 604 P~~RPs-----~~~Il~ 615 (634)
|++||+ +.++++
T Consensus 235 p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 235 PEERLGNLKGGIKDIKK 251 (262)
T ss_pred hhhCcCCcccCHHHHhc
Confidence 999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=301.72 Aligned_cols=248 Identities=29% Similarity=0.504 Sum_probs=211.5
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||.|+||.||+|.+.. ..+|+|++..... ......+.+|+.++++++|+||+++++++..+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 456677899999999999998753 4599998764432 3345678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++... .+++..+..++.|++.|+.+||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999998632 3789999999999999999999999 99999999999999999999999999876544332
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......++..|+|||.+.+...+.++|+||||+++|+|++|..||...........+. ....+.++..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHH
Confidence 3344568889999999988888999999999999999999999998877665555442 334455667789999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~~ 616 (634)
||..+|.+||++.+++..
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=304.13 Aligned_cols=238 Identities=24% Similarity=0.429 Sum_probs=195.8
Q ss_pred ceeeccCcEEEEEEEEcCC---------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 367 SNFIKGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~---------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
+.||.|+||.||+|..... .+++|.+.... ....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 4689999999999977532 27777764332 333467889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc--------EEEEecCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--------VKVCDFGL 509 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~--------ikL~DFGl 509 (634)
||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++. ++++|||+
T Consensus 79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999999975443 4788999999999999999999999 999999999999987654 69999998
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCcccCCCCC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 587 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 587 (634)
+..... .....++..|+|||++.+. .++.++||||||+++|+|++| ..||............ .....+|..
T Consensus 155 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~ 227 (258)
T cd05078 155 SITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLPAP 227 (258)
T ss_pred ccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCCCC
Confidence 865432 2345678899999999874 478999999999999999998 5666666554433222 234456667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
.+..+.+++.+||+.||++|||+.+|++.|
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.76 Aligned_cols=237 Identities=24% Similarity=0.404 Sum_probs=192.8
Q ss_pred eeeccCcEEEEEEEEcC--------------------------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCee
Q 006703 368 NFIKGSFGTVYHAEWRN--------------------------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 421 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~--------------------------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv 421 (634)
.||+|+||.||+|.... ..+++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 68999999999997421 127777765432 33346788899999999999999
Q ss_pred eeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-
Q 006703 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY- 500 (634)
Q Consensus 422 ~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~- 500 (634)
++++++......++||||+++++|..++.... ..+++..+..++.||++||.|||+++ |+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence 99999999999999999999999999986433 24788999999999999999999999 99999999999997543
Q ss_pred ------cEEEEecCCCccCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHH-hCCCCCCCCChHHHH
Q 006703 501 ------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQVI 572 (634)
Q Consensus 501 ------~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLl-tg~~Pf~~~~~~~~~ 572 (634)
.+|++|||++..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+.+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred ccCccceeeecCCcccccccc----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 489999998764322 123457888999998865 55799999999999999985 789999877665543
Q ss_pred HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 573 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 573 ~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
.... .....+...++.+.++|.+||..+|++|||+.+|++.|
T Consensus 232 ~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RFYE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHH---hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 3321 22334455678899999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=306.27 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=208.7
Q ss_pred ceeecceeeccCcEEEEEEEEcCC--cEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||++.+..+ .|++|.+...... ......+.+|+.+++.++||||+++++.+..++..+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 467788999999999999988754 4999988765432 3345678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-- 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~-- 516 (634)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999996443 4889999999999999999999999 999999999999999999999999988631110
Q ss_pred -------------cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-cc
Q 006703 517 -------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RL 582 (634)
Q Consensus 517 -------------~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~ 582 (634)
........++..|+|||.+.+..++.++|+||||+++|||++|..||.+..+.+....+..... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 0011234578899999999988899999999999999999999999998877766655533222 22
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
.....++..+.+++.+||..+|++||++.++.+.|+.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 2334678999999999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.02 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=202.7
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||+|.+++ ..+|+|++..........+.+.+|+++++.++||||+++++++..+...+++|||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 46778999999999999999864 4599998765544444456788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|..+..... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 82 VDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred CCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 99999988765432 3889999999999999999999999 999999999999999999999999998765443333
Q ss_pred CCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc------------------
Q 006703 520 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------------ 580 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~------------------ 580 (634)
.....++..|+|||++.+. .++.++||||||+++++|++|+.||......+....+.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 3345688899999998753 468899999999999999999999976654333222211000
Q ss_pred --cc---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 --RL---------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 --~~---------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+ .....++..+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 112356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=301.75 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=204.7
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
+|...+.||.|+||.||+|.+. ++.+++|++............+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3667789999999999999876 45599999877655455557788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-c
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-I 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~-~ 518 (634)
+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999986433 34899999999999999999999999 9999999999999999999999999988654332 1
Q ss_pred cCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc----------------
Q 006703 519 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------------- 581 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~---------------- 581 (634)
......++..|+|||.+.+.. ++.++||||||+++++|++|++||......+....+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 233456899999999986554 589999999999999999998888776654433222110000
Q ss_pred ------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.......+..+.+++.+||..+|++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0111346789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=296.68 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=217.3
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc------cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCC
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF------HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP 431 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~------~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~ 431 (634)
..|...+.||.|..+.|-++..+. ..+|+|++..... .....+.-.+|+.+|+++ .||+|+.+.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 456677899999999999987664 4489998854321 233445677899999999 6999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
.+++|+|.|+.|.|.+++...- .++++...+|++|+++|++|||.++ ||||||||+|||++++.++||+|||+|+
T Consensus 97 F~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceee
Confidence 9999999999999999997543 4999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCC------CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cC
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LE 583 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~------~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~ 583 (634)
..... ...+..+|||+|.|||.+... +|+..+|+|++||++|.|+.|-+||-.....-+...+...... .+
T Consensus 172 ~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 172 QLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 86543 356788999999999998543 4678899999999999999999999776666666666433322 33
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHhcCCC
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMSSVCQ 627 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~--~L~~ll~~~~~~ 627 (634)
-..+++...++||.+||..||.+|.|+++.|. .+.++.+...-+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~ 296 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQ 296 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccc
Confidence 34578999999999999999999999999986 466666654443
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.57 Aligned_cols=252 Identities=29% Similarity=0.435 Sum_probs=205.5
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCC----
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP---- 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~---- 431 (634)
+...|...+.||+|++|.||+|.++. ..+++|++..... ...++.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45788899999999999999999864 4489998765432 235688999999999 7999999999996544
Q ss_pred --cEEEEEeecccCCHHHHhccCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 432 --NLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 432 --~~~lV~E~~~ggsL~~ll~~~~-~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
.++++|||+++++|.+++.... .+..+++..++.++.|+++||.|||+++ ++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999986422 2345899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-cc
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RL 582 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~ 582 (634)
++..............++..|+|||++.. ..++.++||||||+++++|++|+.||...........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 98765544334455678999999999854 3457789999999999999999999987665554444422111 11
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+..++..+.+++.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 222347889999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=303.12 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=201.2
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||.|++|.||+|++. +..+++|.+............+.+|++++++++||||+++++++.++...+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 667789999999999999886 445999988655444444457889999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
. ++|..++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 82 ~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 82 H-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred c-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 6 588888864332 34889999999999999999999999 9999999999999999999999999987654332233
Q ss_pred CCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc------------------
Q 006703 521 KTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------------------ 581 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~------------------ 581 (634)
....++..|+|||.+.+.. ++.++||||||+++|+|+||+.||...........+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3445788999999987654 588999999999999999999999876654333222110000
Q ss_pred ---------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ---------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ---------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
......+++.+.++|.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0112346788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=293.85 Aligned_cols=248 Identities=32% Similarity=0.541 Sum_probs=214.6
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcEEEEEe
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVTE 438 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~~lV~E 438 (634)
|...+.||+|++|.||+|... +..+++|++..........+.+.+|+.++++++|+||+++++.+... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 566789999999999999987 55599999877765556678899999999999999999999999888 88999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 82 YVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999987543 5899999999999999999999999 99999999999999999999999999886554432
Q ss_pred --cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 519 --SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 519 --~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
......++..|+|||.+.+...+.++||||||+++++|++|..||.... .......+......+.++..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 1345678999999999988889999999999999999999999998766 3333334433345566777889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~ 615 (634)
|.+||..||++||++.+++.
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHhCcCChhhCCCHHHHhh
Confidence 99999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=303.23 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=204.9
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|+||.||+|.+.+ ..+++|++............+.+|++++++++|+||+++++++..++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 57788899999999999998874 4599998876554455557788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI- 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~- 518 (634)
++++.+..+.... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9987777665433 23889999999999999999999999 99999999999999999999999999886544322
Q ss_pred cCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------------------
Q 006703 519 SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------ 579 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------------ 579 (634)
......++..|+|||++.+. .++.++|+||||+++|+|++|+.||......+....+....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 23345678899999999888 78999999999999999999999998766544333221100
Q ss_pred --c----------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 --R----------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 --~----------~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. ....+..+++++.++|.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00123345889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=308.20 Aligned_cols=243 Identities=22% Similarity=0.375 Sum_probs=185.5
Q ss_pred cceeeccCcEEEEEEEEcC----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCcEEEEEee
Q 006703 366 SSNFIKGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIVTEY 439 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~~~lV~E~ 439 (634)
.++||+|+||.||+|+.+. ..+|+|.+...... ..+.+|+.++++++||||+++++++.. +...+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 4689999999999998653 34899988654332 345689999999999999999998854 4568999999
Q ss_pred cccCCHHHHhccCC------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE----cCCCcEEEEecCC
Q 006703 440 LSRGSLYKLLHIPD------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL 509 (634)
Q Consensus 440 ~~ggsL~~ll~~~~------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl----d~~~~ikL~DFGl 509 (634)
+.+ +|.+++.... ....+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 954 8888774221 1234889999999999999999999999 9999999999999 4567899999999
Q ss_pred CccCCCCc---ccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHH-
Q 006703 510 SRSKPNTY---ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS---------QVISAV- 575 (634)
Q Consensus 510 a~~~~~~~---~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~---------~~~~~i- 575 (634)
+....... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...... .....+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 97654322 123456789999999999774 5799999999999999999999999654321 000000
Q ss_pred hhcCcc-----------c------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 576 GFKGRR-----------L------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 576 ~~~~~~-----------~------------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...... + ......+..+.+||.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0 001123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=299.06 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=194.8
Q ss_pred eeeccCcEEEEEEEEcCC-c---EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 368 NFIKGSFGTVYHAEWRNS-D---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~~-~---vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
.||+|+||.||+++..+. . +++|.+.... .......+.+|+.+++.++||||+++++++......+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 689999999999975433 2 4455544332 2334578899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCC-cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--cccC
Q 006703 444 SLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISS 520 (634)
Q Consensus 444 sL~~ll~~~~~-~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~--~~~~ 520 (634)
+|.++++.... ....++..++.++.||++||.|||+.+ ++|+||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999975322 234677788899999999999999999 999999999999999999999999998642221 1122
Q ss_pred CCCCCCCcccCcccccC-------CCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcC----cccCCCCCC
Q 006703 521 KTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG----RRLEIPKNV 588 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~-------~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~ 588 (634)
....++..|+|||++.. ..++.++||||||+++|||++ +..||....+.+....+.... .++.++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34568889999999753 235788999999999999997 577887776655544432111 234445568
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
++.+.+++..|| .+|++||++.+|++.|.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 899999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=296.67 Aligned_cols=248 Identities=29% Similarity=0.463 Sum_probs=211.9
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||+|++|.||+|.+.. ..+++|++...... .....+.+|+..+.+++|+||+++++++......+++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46677899999999999998874 44999988765433 4557789999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
+++++|.+++... ..+++..++.++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999754 348999999999999999999999 99 99999999999999999999999999886554333
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhhcCcccCCCCC-CcHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAVGFKGRRLEIPKN-VNPMVAA 594 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~-~s~~l~~ 594 (634)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....+. ....+..+.. ++..+.+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHH
Confidence 3335568899999999999989999999999999999999999997764 344444443 3333445555 8999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+|.+||..+|++|||+.++++.
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.77 Aligned_cols=248 Identities=26% Similarity=0.434 Sum_probs=206.8
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|.....||+|+||.||++... +..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 44455678999999999999875 4459999875432 3344668899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 100 FLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999999988532 3788999999999999999999999 99999999999999999999999999876443333
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~Li~ 597 (634)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||......+....+.... .........+..+.+++.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 3345568999999999988889999999999999999999999998877765544442211 112223457889999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~ 616 (634)
+||..||.+|||+.++++.
T Consensus 254 ~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 254 LMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHccCChhHCcCHHHHhhC
Confidence 9999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.59 Aligned_cols=241 Identities=28% Similarity=0.437 Sum_probs=217.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|.||+|-+++.+.++ +|+|++++.-+ ..+....-..|-++|+..+||.+..+-..|+..+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56778899999999999999887554 99999987754 5666777889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||..||.|.-.+.+.. .+++.....+-..|+.||.|||+++ ||.||||.+|+|+|++|+|||+|||+++..-...
T Consensus 248 eyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhccccc
Confidence 9999999988776543 4899999999999999999999999 9999999999999999999999999998655555
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
....+.+|||.|.|||++....|+.++|+|.+||++|||++|+.||.+.+.......| ......+|..++++.+.|+.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI--l~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI--LMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH--HhhhccCCccCCHHHHHHHH
Confidence 5678999999999999999999999999999999999999999999998888777766 34566788999999999999
Q ss_pred HhhhcCCCCCC
Q 006703 598 TCWAEEPEIRP 608 (634)
Q Consensus 598 ~cL~~dP~~RP 608 (634)
.+|.+||.+|.
T Consensus 401 GLL~kdP~kRL 411 (516)
T KOG0690|consen 401 GLLKKDPKKRL 411 (516)
T ss_pred HHhhcChHhhc
Confidence 99999999994
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.29 Aligned_cols=246 Identities=32% Similarity=0.494 Sum_probs=205.8
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...+.||.|+||.||++.++ +..+++|.+..... .....++.+|+.++++++||||+++++.+......++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4566788999999999999987 44589998876543 34557788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 99999999997543 358899999999999999999999 88 9999999999999999999999999987543321
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhhcCcccCCCCC-CcHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-----PSQVISAVGFKGRRLEIPKN-VNPMV 592 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~-~s~~l 592 (634)
.....++..|+|||.+.+..++.++||||||+++++|++|..||.... ..+....+ .....+..+.. +++.+
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDF 233 (265)
T ss_pred -hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCHHH
Confidence 122678899999999999999999999999999999999999997642 22222222 12233444444 88999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.++|.+||..||++|||+.+++.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhh
Confidence 99999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=299.00 Aligned_cols=249 Identities=31% Similarity=0.508 Sum_probs=204.5
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc--------HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH--------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~--------~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~ 431 (634)
+|...+.||+|+||.||+|... +..+|+|.+...... ....+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999875 445999987543211 112356788999999999999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999987542 4888999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCc--ccCCCCCCCCcccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--
Q 006703 512 SKPNTY--ISSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-- 585 (634)
Q Consensus 512 ~~~~~~--~~~~~~~gt~~y~APEvl~~~~--~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 585 (634)
...... .......++..|+|||.+.... ++.++|+||||++++++++|..||......+....+........++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence 643321 1123446888999999987655 7889999999999999999999998766655444433233333333
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 586 --KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 586 --~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..++..+.+++.+||..+|++|||+.+++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 346899999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=303.58 Aligned_cols=255 Identities=24% Similarity=0.299 Sum_probs=206.5
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc---HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~---~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
|...+.||+|+||.||+|.+. +..+++|.+...... ......+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 566778999999999999876 456999998766544 333456778999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+ +++|.+++.... ..+++..++.++.||++||.|||++| ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 82 EFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred ccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 999 889999997543 24899999999999999999999999 9999999999999999999999999998655433
Q ss_pred ccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc----------------
Q 006703 518 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------------- 580 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~---------------- 580 (634)
.......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||......+....+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 33344567889999999855 4568999999999999999999888877665443322211000
Q ss_pred -----cc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 581 -----RL-----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 581 -----~~-----~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+ ......+..+.++|.+||..+|++|||+.++++ ..++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~ 288 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSND 288 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCC
Confidence 00 011345788999999999999999999999998 5555553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.68 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=197.8
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-----cE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~-----~~ 433 (634)
-.|...+.+|.|+||.||.|....+ .+|||..-...--. .+|+.+|+.+.|||||+++.+|.... +.
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 4577889999999999999988754 59999875443211 28999999999999999999884322 45
Q ss_pred EEEEeecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCCCc
Q 006703 434 SIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSR 511 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGla~ 511 (634)
.+||||++. +|.++++. ...+..++.-.+.-+++||++||.|||+.| |+||||||.|+|+|. .|.+||||||.|+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 689999976 88888863 112234777788889999999999999999 999999999999995 5999999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-C----------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G---------- 579 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~---------- 579 (634)
...... ...+...|..|+|||.+.|. .|+.+.||||.||++.||+.|++.|.+.+..+....+... +
T Consensus 175 ~L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 175 VLVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 765433 23566788999999998775 4799999999999999999999999987764443322110 0
Q ss_pred -cc------c---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 006703 580 -RR------L---------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLM 622 (634)
Q Consensus 580 -~~------~---------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~--~L~~ll~ 622 (634)
.. + .+....+++..+|+.++|..+|.+|.++.+++. .+..+..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 00 0 133467899999999999999999999999884 3444443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.94 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=209.2
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
|...+.||.|+||.||+|.+. +..+++|++...... ....+.+.+|+.++++++||||+++++.+..+...++++||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 677889999999999999987 455999998765432 24567889999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+.+++|.+++... ..+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 155 (258)
T cd05578 82 LLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-L 155 (258)
T ss_pred CCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-c
Confidence 9999999998754 34889999999999999999999999 9999999999999999999999999987654332 2
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... .......+..++..+.++|
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAI 233 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHH
Confidence 3456688899999999988899999999999999999999999987763 3333222 2255567778899999999
Q ss_pred HHhhhcCCCCCCCH--HHHH
Q 006703 597 ETCWAEEPEIRPSF--PSIM 614 (634)
Q Consensus 597 ~~cL~~dP~~RPs~--~~Il 614 (634)
.+||..||.+||++ .+++
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHccCChhHcCCccHHHHh
Confidence 99999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=294.11 Aligned_cols=251 Identities=31% Similarity=0.486 Sum_probs=217.6
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
+|...+.||.|+||.||++.+. +..+++|++............+.+|+++++.++|+|++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3667789999999999999987 55699999877665556667888999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 440 LSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~-~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
+++++|.+++.... ....+++..+..++.+++.||.|||++| ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 99999999986432 1245899999999999999999999999 99999999999999999999999999886554433
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
......|++.|+|||.+.+..++.++|+||+|+++++|++|..||......+...... ......++..++..+.+++.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3445678999999999998889999999999999999999999998887666655553 333455667889999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
||..+|++|||+.++++
T Consensus 238 ~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 238 LLQKDPEERPSIAQILQ 254 (258)
T ss_pred HcCCChhhCcCHHHHhc
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.86 Aligned_cols=247 Identities=28% Similarity=0.546 Sum_probs=214.5
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||+|++|.||++.+.. ..+++|.+............+.+|++++++++|+|++++++++......+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 5667899999999999998764 45999998877655566678999999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
++++|.+++... ..+++..++.++.|++.||.|||++| |+|+||||+||+++.++.++|+|||.+..........
T Consensus 82 ~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 82 ENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred CCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 999999998754 34899999999999999999999999 9999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhh
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL 600 (634)
....++..|+|||...+...+.++|+||+|+++++|++|..||............. ....+.++..+++.+.+++.+||
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 235 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCF 235 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHH
Confidence 45678999999999988888999999999999999999999998777655444443 23445567788999999999999
Q ss_pred hcCCCCCCCHHHHHH
Q 006703 601 AEEPEIRPSFPSIME 615 (634)
Q Consensus 601 ~~dP~~RPs~~~Il~ 615 (634)
..+|++|||+.+++.
T Consensus 236 ~~~p~~R~~~~~~l~ 250 (254)
T cd06627 236 QKDPNLRPTAKQLLK 250 (254)
T ss_pred hCChhhCcCHHHHhc
Confidence 999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.37 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=205.2
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||+||++.+. +..+|+|++.... .....+.+.+|+++++.++||||+++++++.....+++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 56778899999999999999887 4558999876543 33445778899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|+++++|.+++...+ .+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999886532 48899999999999999999997 57 999999999999999999999999998654322
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHhhcCcccCCCC
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-----------QVISAVGFKGRRLEIPK 586 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~ 586 (634)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... +....+. ....+.++.
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPS 235 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCc
Confidence 223557899999999998888999999999999999999999999865542 1112221 122233333
Q ss_pred -CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 587 -NVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 587 -~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.++..+.+|+.+||..||++|||+.++++.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 378899999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=298.39 Aligned_cols=248 Identities=28% Similarity=0.491 Sum_probs=205.3
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc----HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH----EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~----~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
|...+.||+|+||.||++... +..+|+|++...... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 566788999999999999875 445999998654321 22457789999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCccCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPN 515 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~~~~ 515 (634)
|||+.+++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||+++.++ .+||+|||.+.....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999986432 4889999999999999999999999 99999999999998765 699999999876543
Q ss_pred Ccc----cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhcCcccCCCCCC
Q 006703 516 TYI----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 516 ~~~----~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 588 (634)
... ......++..|+|||.+.+..++.++|+||||+++++|++|..||...... ............+..+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 211 122346788999999998888999999999999999999999999754432 2222222233445666778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+.+++.+||..+|.+|||+.++++
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=301.60 Aligned_cols=251 Identities=29% Similarity=0.498 Sum_probs=212.1
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.....|...+.||+|++|.||++.+. +..+++|++..... ....+.+|+.++++++|+||+++++++......++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34566888899999999999999987 55699999875543 44678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
++||+++++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999997543 24899999999999999999999999 99999999999999999999999998875443
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-cCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-LEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~ 594 (634)
.........++..|++||.+.+..++.++|+||||+++|+|++|+.||...++......+...... ...+..++..+.+
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 322334456888999999999888999999999999999999999999887776555444322221 1222347899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+|.+||+.+|.+|||+.++++
T Consensus 249 li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHhccChhhCcCHHHHhh
Confidence 999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=317.95 Aligned_cols=244 Identities=25% Similarity=0.299 Sum_probs=196.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcC----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..+|...+.||+|+||.||++...+ ..+++|.+... ....+|++++++++|+||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4679999999999999999997653 33788876543 224589999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+||++. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 164 v~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999995 5888887432 34899999999999999999999999 99999999999999999999999999875443
Q ss_pred Cc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhhc-----------
Q 006703 516 TY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS----QVISAVGFK----------- 578 (634)
Q Consensus 516 ~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~----~~~~~i~~~----------- 578 (634)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 1223457999999999999999999999999999999999999999765421 111100000
Q ss_pred -------------CcccC--CC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 579 -------------GRRLE--IP-----KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 579 -------------~~~~~--~~-----~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
..++. .+ ..++..+.++|.+||..||++|||+.+++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00110 11 2346788999999999999999999999874
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.98 Aligned_cols=254 Identities=27% Similarity=0.492 Sum_probs=209.3
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC---CCCeeeeeceeecCCcEEEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~---h~nIv~l~~~~~~~~~~~lV 436 (634)
.|...+.||+|+||.||+|.+. +..+++|.+.... ......++.+|+.++++++ |||++++++++..+...+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 3566788999999999999975 3449999876543 2334567889999999996 99999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.++++.. .+++..++.++.|++.||.|||+.| |+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999999998643 4889999999999999999999999 999999999999999999999999998865544
Q ss_pred cccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCC-CCcHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK-NVNPMVAA 594 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~s~~l~~ 594 (634)
........|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.. ...+.++. ..+.++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKLLRE 233 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHHHHH
Confidence 333445578999999999865 4468899999999999999999999988776554433321 22233333 37889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
++.+||..||++||++.++++ ..+++...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~--~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLK--SKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhh--ChHhhccc
Confidence 999999999999999999987 45555433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=300.10 Aligned_cols=248 Identities=25% Similarity=0.445 Sum_probs=197.4
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHH-HHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~i-L~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||++.+.. ..||+|++......... .++..|+.+ ++.++||||+++++++..+...+++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46778899999999999999874 45999998765433333 445556665 566789999999999999999999999
Q ss_pred ecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 439 YLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|++ ++|.+++.. ......+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 588887753 22334689999999999999999999997 8 999999999999999999999999998765432
Q ss_pred cccCCCCCCCCcccCcccccC----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcccCCC-CCCcH
Q 006703 517 YISSKTAAGTPEWMAPEVLRE----DPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIP-KNVNP 590 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~----~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~-~~~s~ 590 (634)
. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .+...... ....+.++ ..+++
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (283)
T cd06617 158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSP 235 (283)
T ss_pred c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccCH
Confidence 2 2233568899999999865 4468899999999999999999999975332 22222221 22233333 45789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.++|.+||..+|++||++.++++
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.70 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=208.0
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|.....||+|+||.||++.+. +..+++|.+..... ...+.+.+|+.+++.++||||+++++++..++..+++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 44555668999999999999875 55699999865432 223567899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|..++... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 99 FLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred cCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999999987532 3789999999999999999999999 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~Li~ 597 (634)
......++..|+|||++.+..++.++||||||++++||++|+.||....+.+....+.... .....+..+++.+.+++.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 3445678999999999998889999999999999999999999998877665554442211 112233467889999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~ 616 (634)
+||..+|++||++.++++.
T Consensus 253 ~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 253 RMLTREPQERATAQELLDH 271 (297)
T ss_pred HHhcCCcccCcCHHHHhhC
Confidence 9999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.53 Aligned_cols=253 Identities=30% Similarity=0.420 Sum_probs=204.8
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC----
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP---- 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~---- 430 (634)
.+...|...+.||+|+||.||++.... ..+|+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 446789999999999999999998864 4589998764322 234567899999998 899999999998643
Q ss_pred -CcEEEEEeecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 431 -PNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 431 -~~~~lV~E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
...++||||+++++|.++++.. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecc
Confidence 3589999999999999988632 12235889999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCC-----CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-ccc
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDP-----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRL 582 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~-----~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~ 582 (634)
++..............|+..|+|||.+.... ++.++|||||||++|+|++|+.||......+....+.... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 9876544333334567899999999986443 5889999999999999999999998877655544442211 112
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+...+..+.++|.+||..+|++||++.+++.
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 234567789999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=318.89 Aligned_cols=253 Identities=33% Similarity=0.567 Sum_probs=222.7
Q ss_pred eeecceeeccCcEEEEEEEEcCC----c--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNS----D--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~----~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
+...+.||.|-||.||+|.+.+- . ||||..+...... ..+.|+.|..++++++||||++++|.+.+ ...+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34457899999999999988643 2 8899887754433 36889999999999999999999999986 568999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||.++.|.|..|++.+.. .++......+++||+.||.|||+.. +|||||-..|||+....-+||+|||+++...+.
T Consensus 469 mEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 999999999999986553 4888899999999999999999999 999999999999999999999999999986553
Q ss_pred -cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 -YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 -~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
++......-...|||||-+.-..++.++|||.|||++||++. |..||.+..+.+++-.+ ..+.+++.|+.+|+.+..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPPNCPPALYS 623 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCCCCChHHHH
Confidence 444445556779999999999999999999999999999886 89999998887776655 367788999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
|+.+||+.+|.+||.+.+|...|..+++
T Consensus 624 lmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999988
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=324.94 Aligned_cols=245 Identities=19% Similarity=0.233 Sum_probs=190.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC------CCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR------HPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~------h~nIv~l~~~~~~~ 430 (634)
....|...+.||+|+||+||+|.+.. ..||||++.... .....+..|+.+++.++ |.+++++++++..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 35779999999999999999998764 449999986432 12233456777776664 45688999988654
Q ss_pred -CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCC--------
Q 006703 431 -PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTY-------- 500 (634)
Q Consensus 431 -~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~-------- 500 (634)
..+++|||++ +++|.+++.... .+++..+..|+.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 4688999988 678888876432 48899999999999999999998 48 99999999999998665
Q ss_pred --------cEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 006703 501 --------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI 572 (634)
Q Consensus 501 --------~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~ 572 (634)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred cccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998764322 234568999999999999999999999999999999999999999887765544
Q ss_pred HHHhhcCcc-------------------------cCC---------------CCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 006703 573 SAVGFKGRR-------------------------LEI---------------PKNVNPMVAALIETCWAEEPEIRPSFPS 612 (634)
Q Consensus 573 ~~i~~~~~~-------------------------~~~---------------~~~~s~~l~~Li~~cL~~dP~~RPs~~~ 612 (634)
..+...... +.. .....+.+.+||.+||..||++|||+.+
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 332111000 000 0012456789999999999999999999
Q ss_pred HHH
Q 006703 613 IME 615 (634)
Q Consensus 613 Il~ 615 (634)
+++
T Consensus 435 ~L~ 437 (467)
T PTZ00284 435 MTT 437 (467)
T ss_pred Hhc
Confidence 997
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=302.35 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=204.3
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~~lV 436 (634)
..|...+.||.|+||.||+|.+.. ..+++|.+............+.+|+.++++++||||+++++++... ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 457778899999999999999874 4499999876654444445677899999999999999999998777 889999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+.+ +|.+++..... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999975 89888865432 4899999999999999999999999 999999999999999999999999998865544
Q ss_pred cccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC----------------
Q 006703 517 YISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------------- 579 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~---------------- 579 (634)
........+++.|+|||.+.+.. ++.++|+||||+++++|++|..||......+....+....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 33334556788999999987654 5899999999999999999999998776654433221100
Q ss_pred -------------cccCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -------------RRLEIPKN-VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -------------~~~~~~~~-~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....++.. +++.+.++|.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00112222 5888999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.92 Aligned_cols=249 Identities=28% Similarity=0.461 Sum_probs=209.1
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeecc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQE---FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~---~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~ 433 (634)
..|...+.||+|+||.||++.+.. ..+++|.+.... ........+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 357788999999999999998764 459999875431 1234456788999999999999999999998664 458
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999986433 3788899999999999999999999 999999999999999999999999998754
Q ss_pred CCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 514 PNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 514 ~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.... .......++..|+|||.+.+..++.++|+||||+++++|++|+.||...........+......+.+|..+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence 3211 1123456889999999999988999999999999999999999999887766666655545556677889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+++.+||. +|..||++.+++.
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhc
Confidence 99999999999 6799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.93 Aligned_cols=248 Identities=29% Similarity=0.471 Sum_probs=213.4
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||.|+||.||++.... ..+++|.+............+.+|+.++++++|+||+++++++......+++|||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 6677899999999999998764 34999998766555555677889999999999999999999999999999999999
Q ss_pred ccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 441 SRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 441 ~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
++++|.+++... .....+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.+||+|||++...... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~ 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence 999999998642 22245889999999999999999999999 999999999999999999999999998875544 2
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
.....+++.|++||.+.+..++.++|+||||+++++|++|+.||...+..+....+. ....+..+...+.++.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHHH
Confidence 334568899999999999989999999999999999999999999888766655543 3334455667899999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 006703 600 WAEEPEIRPSFPSIME 615 (634)
Q Consensus 600 L~~dP~~RPs~~~Il~ 615 (634)
|..+|++|||+.+++.
T Consensus 237 l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 237 LQVKPKLRPNCDKILA 252 (256)
T ss_pred cCCCcccCCCHHHHhc
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.50 Aligned_cols=247 Identities=27% Similarity=0.453 Sum_probs=206.7
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|++|.||++.... ..+++|.+.... ....+.+.+|+.+++.++|+||+++++++...+..++++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 345556799999999999998754 459999875432 2334568899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++... .+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||.+........
T Consensus 97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 97 FLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999999998752 3788899999999999999999999 99999999999999999999999998875443332
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~Li~ 597 (634)
......|++.|+|||.+.+..++.++|+||||+++++|++|+.||...++.+....+..... ....+..++..+.+++.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence 33445689999999999988899999999999999999999999988777665554432211 11223347899999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~ 615 (634)
+||..+|++|||+.++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 251 RMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHcccChhhCcCHHHHcc
Confidence 999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=288.89 Aligned_cols=245 Identities=31% Similarity=0.525 Sum_probs=208.2
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||+|++|.||++.+. +..+++|++..... .....+.+|+.++++++|+||+++++++..+...++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 566789999999999999987 45599999866543 34577889999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
++++|.+++.... ..+++..+..++.|++.||.+||.++ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 80 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 80 SGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred CCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 9999999987543 34899999999999999999999999 99999999999999999999999999876544321 3
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCC--CCcHHHHHHHHH
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIET 598 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~Li~~ 598 (634)
....++..|+|||.+.+...+.++|+||||+++++|++|+.||...+.......... ...+..+. .++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHH
Confidence 456788999999999888889999999999999999999999988766555444432 22223333 348999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
||..||.+|||+.++++
T Consensus 234 ~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 234 CLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.90 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=206.9
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..+...|...+.||+|+||+||+|... +..|++|++..... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 344566888899999999999999875 45599998865432 334456788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++||||+. +++.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999997 47777765332 24889999999999999999999999 999999999999999999999999998754
Q ss_pred CCCcccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
... ....+++.|+|||++. ...++.++||||||+++|+|++|+.||...+.......+.........+..++.
T Consensus 166 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (307)
T cd06607 166 SPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD 241 (307)
T ss_pred CCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCH
Confidence 322 3456888999999874 455788999999999999999999999888776655554332222222345788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.+.+++.+||..+|++||++.+|+..
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.56 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=207.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||+|+||.||++... +..+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 3467888899999999999999865 44599998754432 2336688999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
+||+++++|.+++... .+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999999998643 3788899999999999999999999 999999999999999999999999988755443
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~L 595 (634)
........+++.|++||.+.+..++.++|+||||+++|++++|+.||...+..+....+.... .....+..++..+.++
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 333344568899999999988889999999999999999999999998776544333221111 1122334578899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~ 616 (634)
+.+||..+|++||++.+++..
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=327.77 Aligned_cols=259 Identities=32% Similarity=0.546 Sum_probs=229.2
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..+...+.||.|.||.|++|+.+-. .||||.++.. ..+.+..+|+.|..||.++.||||+++.+.........|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 4456668999999999999988732 2999998765 456667889999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|+|||++|+|..+|+.+.. .+..-++..+++.|+.|+.||-..+ +|||||-..|||++.+...|++|||+++.+.+
T Consensus 708 iTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999987664 3888888999999999999999999 99999999999999999999999999998755
Q ss_pred Cccc---CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 516 TYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 516 ~~~~---~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.... +..-.-..+|.|||.+...+++.++||||+|+++||.++ |..||=+..+.+++.++. .+.+++-|..+|..
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDCP~a 862 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDCPAA 862 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCCcHH
Confidence 4322 222223579999999999999999999999999999776 999999999999999984 56677778899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
|..|+..||.+|-.+||.|.||+..|.+++.+..
T Consensus 863 L~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 9999999999999999999999999999999843
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.36 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=201.1
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||.|++|.||+|.++ +..+++|++............+.+|+.+++.++|+||+++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456678999999999999875 455999998765444444456789999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
+ ++|.+++..... ..+++..++.++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 5 589998864332 34899999999999999999999999 9999999999999999999999999987644332222
Q ss_pred CCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC--------------------
Q 006703 521 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-------------------- 579 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-------------------- 579 (634)
....++..|+|||++.+. .++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 344568899999988664 46889999999999999999999998776543322211100
Q ss_pred -------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
........++..+.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 001123457789999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.48 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=201.8
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||.|++|.||+|++.. ..+|+|++...... .....+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 6778899999999999999864 44999998755322 22356778999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
++ +|.+++........+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 85 88888865443445899999999999999999999999 9999999999999999999999999987654333233
Q ss_pred CCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC----------------ccc-
Q 006703 521 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------------RRL- 582 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~----------------~~~- 582 (634)
....++..|++||++.+. .++.++|+||||+++|+|++|+.||...+..+....+.... ...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 445678899999998664 46889999999999999999999998776554433221100 000
Q ss_pred ----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 ----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ----------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+..+..+.+++.+||..||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011245788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.10 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=202.8
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~~l 435 (634)
...|...+.||+|+||.||+|.+. +..||+|.+............+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999886 44599999876543333334566899999999999999999998655 46899
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+.+ +|.+++.... ..+++..++.++.||++||.|||+.| ++|+||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999965 7888876432 34899999999999999999999999 99999999999999999999999999886544
Q ss_pred CcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc--------------
Q 006703 516 TYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-------------- 580 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-------------- 580 (634)
.........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 3222334456788999999865 4578999999999999999999999998887665544422110
Q ss_pred ---ccCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 ---RLEI-----------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ---~~~~-----------~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...+ ....++.+.++|.+||..||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0125788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.69 Aligned_cols=251 Identities=25% Similarity=0.269 Sum_probs=199.0
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCc-----E
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPN-----L 433 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~-----~ 433 (634)
.|...+.||+|+||.||+|.+.. ..||+|++............+.+|+.+++.++ |+||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 47778899999999999998864 45999987655433333456788999999995 6999999999877665 8
Q ss_pred EEEEeecccCCHHHHhccCCC--cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLS 510 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~--~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGla 510 (634)
|++|||+++ +|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||++
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccc
Confidence 999999986 78888753221 245899999999999999999999999 999999999999998 889999999998
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc---------
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--------- 580 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~--------- 580 (634)
..............+++.|+|||++.+ ..++.++|+||||+++|+|++|..||......+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 765433223334467889999998865 4568999999999999999999999987665544332211000
Q ss_pred -------------cc----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -------------RL----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -------------~~----~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+ ...+.+++.+.++|.+||..||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 011357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.87 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=223.1
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...++||+|.|+.|.++++. ++.||||++.+..........+.+|+++++.++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 466788899999999999999877 455999999998887777677999999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.+|.+++++...+. ..+..+..++.|+++|++|||+++ |+|||||.+|||++.+.++||+|||++..+.. .
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDY-G 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecc-c
Confidence 99999999999986553 666888999999999999999999 99999999999999999999999999998763 3
Q ss_pred ccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
....+.+|++.|.|||++.+..+ ++.+|+||+|++||-|+.|..||++.+..+..... ...+..+|..++.+..++|
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--l~gk~rIp~~ms~dce~lL 286 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--LRGKYRIPFYMSCDCEDLL 286 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--eeeeecccceeechhHHHH
Confidence 45689999999999999999988 78999999999999999999999998876665555 3345567778999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~ 616 (634)
+++|..+|.+|++.++|.+.
T Consensus 287 rk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 287 RKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred HHhhccCccccCCHHHhhhh
Confidence 99999999999999999763
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.14 Aligned_cols=243 Identities=22% Similarity=0.382 Sum_probs=185.0
Q ss_pred cceeeccCcEEEEEEEEcC----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee--cCCcEEEEEee
Q 006703 366 SSNFIKGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSIVTEY 439 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~--~~~~~~lV~E~ 439 (634)
..+||+|+||.||+|+.++ ..+|+|.+...... ..+.+|+.++++++||||+++++++. .+...+++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 4589999999999998753 34899987654322 34668999999999999999999884 45678999999
Q ss_pred cccCCHHHHhccC------CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE----cCCCcEEEEecCC
Q 006703 440 LSRGSLYKLLHIP------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL 509 (634)
Q Consensus 440 ~~ggsL~~ll~~~------~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl----d~~~~ikL~DFGl 509 (634)
+.+ +|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 965 777776421 12235889999999999999999999999 9999999999999 4667999999999
Q ss_pred CccCCCCcc---cCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHH----------HHHHH
Q 006703 510 SRSKPNTYI---SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----------VISAV 575 (634)
Q Consensus 510 a~~~~~~~~---~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~----------~~~~i 575 (634)
++....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 986543221 22345689999999999764 57999999999999999999999996543210 00000
Q ss_pred hhcC-----------------------cc------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 576 GFKG-----------------------RR------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 576 ~~~~-----------------------~~------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.... .. .......+..+.+|+.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00 0001123556889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.32 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=201.1
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|++|.||+|.++. ..+++|.+............+.+|+.++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 357788899999999999998764 459999886654444444678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCCCccCCCCc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGla~~~~~~~ 517 (634)
|+++ +|.+++..... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLDL-DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred cccc-cHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9964 77777754332 23678888999999999999999999 999999999999985 5679999999997654332
Q ss_pred ccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc---------------
Q 006703 518 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------------- 581 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--------------- 581 (634)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 233445678899999998664 5789999999999999999999999877665444332110000
Q ss_pred ----c--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ----L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ----~--------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+ .....+++.+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 012356888999999999999999999999987
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.26 Aligned_cols=243 Identities=30% Similarity=0.481 Sum_probs=204.3
Q ss_pred eeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 369 FIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
||.|+||.||++++. +..+++|++..... .......+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 688999999999987 45599999865543 234556788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc--------
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-------- 517 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~-------- 517 (634)
.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997543 4899999999999999999999999 9999999999999999999999999987543221
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCC--CcHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN--VNPMVAAL 595 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--~s~~l~~L 595 (634)
.......++..|++||.+.+...+.++|+||||+++++|++|..||......+....+.. .....+.. ++..+.++
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHH
Confidence 122345678899999999888889999999999999999999999998887776665533 22333444 48999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
+.+||..+|.+|||+..+.+.|+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhc
Confidence 99999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.44 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=197.2
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|++|.||+|..+ +..||+|.+...... .....+.+|+.++++++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 366888899999999999999876 455999998654322 12234668999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.+ +|.+++..... .+++..++.++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 83 e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 83 EYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 99975 89888864432 4889999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhh-cCc--------------
Q 006703 518 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGF-KGR-------------- 580 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-~~~~~~~i~~-~~~-------------- 580 (634)
.......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.... ..+....+.. ...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 22233457889999999875 457899999999999999999999997655 2221111100 000
Q ss_pred ----c------c---CCCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 ----R------L---EIPKNVN--PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ----~------~---~~~~~~s--~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. . .....++ ..+.+++.+||..+|++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0 0001233 78899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.11 Aligned_cols=243 Identities=28% Similarity=0.362 Sum_probs=199.7
Q ss_pred eeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 369 FIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
||+|+||+||++.+. +..+++|++...... ......+.+|++++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999876 445999998755432 22345567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 525 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~g 525 (634)
.+++..... ..+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.+||+|||.+...... .......+
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAG 156 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccC
Confidence 999865432 34899999999999999999999999 999999999999999999999999998764332 22334567
Q ss_pred CCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 006703 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV--GFKGRRLEIPKNVNPMVAALIETCWAEE 603 (634)
Q Consensus 526 t~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~s~~l~~Li~~cL~~d 603 (634)
+..|+|||.+.+..++.++|+||||+++++|++|+.||...........+ .........+...++.+.++|.+||..|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 88999999998888999999999999999999999999765441111111 1123344566778999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 006703 604 PEIRP-----SFPSIME 615 (634)
Q Consensus 604 P~~RP-----s~~~Il~ 615 (634)
|.+|| ++.+++.
T Consensus 237 p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 237 PEKRLGCRGGSADEVRE 253 (277)
T ss_pred hhHccCCCcccHHHHHh
Confidence 99999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.24 Aligned_cols=261 Identities=33% Similarity=0.511 Sum_probs=221.8
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
...+.......++||+|-||.|.+++..+ ..||+|+++....... ..+|..|+++|.+++||||+++++.|..++.++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~-r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA-RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH-HHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 34556778889999999999999999887 7799999987654443 478999999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+++||++.|+|.+++....... +......+|+.||+.||+||.+.+ +|||||.+.|+|+++++++||+|||.++...
T Consensus 612 mI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999998665433 455667789999999999999999 9999999999999999999999999998543
Q ss_pred CC-cccC-CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHhhc------CcccCC
Q 006703 515 NT-YISS-KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPSQVISAVGFK------GRRLEI 584 (634)
Q Consensus 515 ~~-~~~~-~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt--g~~Pf~~~~~~~~~~~i~~~------~~~~~~ 584 (634)
.. ++.. ...+-..+|||||.+...+++.++|+|+||+++||+++ .+.||...+.++++...... ..-+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 32 2222 23445789999999999999999999999999999876 58999998888776544221 123456
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
|..++..+.+++.+||+.+..+||||+++...|++.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 778999999999999999999999999999988865
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.97 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=189.9
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|++.++ .||+|+.... ....|+.++++++|+||+++++++......++|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4688899999999999999998755 4888874332 22468999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
++. ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... .
T Consensus 138 ~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P 211 (357)
T ss_pred ccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence 995 58888875433 34889999999999999999999999 999999999999999999999999998753322 1
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHhhcC-cccCCC-
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-----------QVISAVGFKG-RRLEIP- 585 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-----------~~~~~i~~~~-~~~~~~- 585 (634)
......||+.|+|||++.+..++.++|||||||++|||+++..|+....+. .....+.... ....++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 234567999999999999999999999999999999999865554332111 0011010000 000000
Q ss_pred -----------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 586 -----------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 586 -----------------------------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..++..+..||.+||+.||++|||+.++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 134667788999999999999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=349.72 Aligned_cols=250 Identities=29% Similarity=0.461 Sum_probs=216.7
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
-++....+||.|.||.||-|.+.+++ .|+|-+..+.........+.+|+.+|..++|||+|++++.-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 44566689999999999999887665 8999988777666666778899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
||.+|+|.++++... ..++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|.......
T Consensus 1315 yC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999997543 3777778888999999999999999 9999999999999999999999999998755442
Q ss_pred ---ccCCCCCCCCcccCcccccCC---CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 518 ---ISSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 518 ---~~~~~~~gt~~y~APEvl~~~---~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
...+...||+-|||||++.+. +...+.|||||||++.||+||+.||...+..=.+....-.+..|.+|..++.+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 223566899999999999654 45778999999999999999999998876654444444567889999999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
-++||.+||..||+.|-++.||++
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHH
Confidence 999999999999999988888776
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.60 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=199.9
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------C
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------~ 431 (634)
...|...+.||+|+||.||+|.+. +..+|+|++............+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 367888999999999999999876 44599999865544445556778999999999999999999988644 3
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..|+||||+.+ +|.+.+... +++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 57999999965 888777532 788899999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------ 579 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------ 579 (634)
...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+....
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 654432 2334568899999999999999999999999999999999999998766433222211000
Q ss_pred --------ccc---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 580 --------RRL---------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 580 --------~~~---------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.++ ..+...++.+.++|.+||..||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0011346678999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=296.13 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=196.5
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||+|+||.||+|... +..+++|++...... .....+.+|+.+++.++|+||+++++++..+...+++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3477899999999999999999876 455999998654322 2223567899999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred Eeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 99996 57766664322 23678888899999999999999999 999999999999999999999999998764433
Q ss_pred cccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhh-cC--------------
Q 006703 517 YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGF-KG-------------- 579 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~-~~-------------- 579 (634)
........+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... +....+.. ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 3333445678999999998764 4788999999999999999999999765532 11111100 00
Q ss_pred -c-----ccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -R-----RLEIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -~-----~~~~~---------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. ....+ ...+..+.+++.+|+..||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 00000 013578999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=299.54 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=207.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
+...|...+.||+|+||.||++++.. ..+|+|++..... .......+.+|+.++++++|+|++++++++..+...++
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 34557778899999999999998764 4599998865432 33445678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+|||+.+ +|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9999975 7777765332 34889999999999999999999999 99999999999999999999999998865432
Q ss_pred CcccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
.....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...........+............+++.+
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 253 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF 253 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHH
Confidence 23456889999999974 45678899999999999999999999988776665555543333333345678899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
++++.+||..+|.+||++.++++.+-
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChh
Confidence 99999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.80 Aligned_cols=242 Identities=29% Similarity=0.428 Sum_probs=197.7
Q ss_pred ceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHH-HhCCCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 367 SNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIM-KGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL-~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+.||+|+||.||+|.+. ++.+|+|++...... ......+..|..++ ...+|+||+++++++..++..+++|||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999885 456999998654332 22233444555444 445899999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~ 152 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKK 152 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----ccc
Confidence 99999997543 4889999999999999999999999 99999999999999999999999998875432 234
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc--ccCCCCCCcHHHHHHHHHhh
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--RLEIPKNVNPMVAALIETCW 600 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~Li~~cL 600 (634)
..++..|++||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .......+++.+.+++.+||
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 5688999999999888889999999999999999999999988887766555432221 22233468899999999999
Q ss_pred hcCCCCCCCHHHHHHHH
Q 006703 601 AEEPEIRPSFPSIMETL 617 (634)
Q Consensus 601 ~~dP~~RPs~~~Il~~L 617 (634)
+.+|++||++.++.+.|
T Consensus 233 ~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 233 CMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCHHHccCCCcHHHHH
Confidence 99999999776555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.78 Aligned_cols=243 Identities=21% Similarity=0.278 Sum_probs=192.8
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||++.+... .||+|.... ..+.+|+++|++++|+||+++++++..+...+++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4688889999999999999998754 488885321 235689999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
++. ++|..++.... ..+++..++.|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 241 ~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 995 58888775432 24899999999999999999999999 99999999999999999999999999976433211
Q ss_pred --cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhcCc--------
Q 006703 519 --SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--------PSQVISAVGFKGR-------- 580 (634)
Q Consensus 519 --~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~--------~~~~~~~i~~~~~-------- 580 (634)
......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ..++...+.....
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1234569999999999999999999999999999999999876553321 1222222211110
Q ss_pred -----------------ccCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 581 -----------------RLEIP-------KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 581 -----------------~~~~~-------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.+... ..++..+.+||.+||+.||.+|||+.++|+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 1345689999999999999999999999873
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=338.12 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=220.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||.|.+++++++. ||+|++.+-.. .......|..|-.+|.-.+.+.|+.++.+|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 367888999999999999999998666 99999876433 455667899999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC-C
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP-N 515 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~-~ 515 (634)
|||++||+|-.++.... .+++..+..++..|+.||..||+.| +|||||||+|||||..|++||+|||.+-.+. +
T Consensus 154 MdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999997554 4999999999999999999999999 9999999999999999999999999887655 4
Q ss_pred CcccCCCCCCCCcccCccccc----C-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCC
Q 006703 516 TYISSKTAAGTPEWMAPEVLR----E-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNV 588 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~----~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 588 (634)
....+...+|||.|.+||+++ + +.|++.+|+||+||++|||+.|..||......+....|........+| ..+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 455678889999999999984 3 568899999999999999999999999999988888886666666677 569
Q ss_pred cHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPS---FPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs---~~~Il~ 615 (634)
|++.++||.+.++ +|+.|.. +.+|..
T Consensus 309 SeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred CHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 9999999999887 8888988 666543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.54 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=210.1
Q ss_pred ceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~ 437 (634)
.|...+.||+|+||.||++... +..+++|++..... .......+.+|+.++++++ |+||+++++.+..++..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5777889999999999999886 45599999876433 3344467889999999998 999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.+++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 82 EYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999997543 4899999999999999999999999 9999999999999999999999999987644322
Q ss_pred --------------------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 006703 518 --------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 577 (634)
Q Consensus 518 --------------------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~ 577 (634)
.......++..|+|||++.+...+.++|+||||++++++++|+.||...........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~- 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL- 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-
Confidence 12233457889999999998889999999999999999999999998877655544442
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 006703 578 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF----PSIME 615 (634)
Q Consensus 578 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~----~~Il~ 615 (634)
.....++..+++.+.+++.+||+.+|.+|||+ .+++.
T Consensus 236 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 -KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 34455677889999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.80 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=197.1
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.|...+.||+|+||.||++.+.. ..+|+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45566789999999999998864 44999988755433 44567889999999996 9999999999999999999999
Q ss_pred ecccCCHHHHhcc--CCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 439 YLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 439 ~~~ggsL~~ll~~--~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|+.. ++.++... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 66554421 11123589999999999999999999985 8 99999999999999999999999999875433
Q ss_pred CcccCCCCCCCCcccCcccccCC---CCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcccCC----CCC
Q 006703 516 TYISSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEI----PKN 587 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~---~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~----~~~ 587 (634)
.. ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||..... .+....+. ....+.+ +..
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (288)
T cd06616 161 SI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEERE 238 (288)
T ss_pred CC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCCCc
Confidence 22 22344688999999999776 688999999999999999999999976542 12222221 1122222 234
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
++.++.+|+.+||..+|++|||+.+|++.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 78999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=293.89 Aligned_cols=248 Identities=30% Similarity=0.461 Sum_probs=200.8
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCcEEEEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIVT 437 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~~~lV~ 437 (634)
.|...+.||.|++|.||++.+.. ..+|+|.+..... .....++.+|++++++++|+||+++++++.. ...++++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778899999999999999864 4499998865433 2445778899999999999999999998854 34689999
Q ss_pred eecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999999887531 22334888999999999999999999999 999999999999999999999999998754332
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhhcCcccCCC------
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-----PSQVISAVGFKGRRLEIP------ 585 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~~------ 585 (634)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+.. ...+.++
T Consensus 159 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (287)
T cd06621 159 L--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNG 235 (287)
T ss_pred c--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCC
Confidence 1 224457889999999999999999999999999999999999997652 2233222221 1111111
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 586 KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 586 ~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...++.+.+++.+||..+|.+|||+.++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 235688999999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=294.04 Aligned_cols=241 Identities=25% Similarity=0.377 Sum_probs=192.5
Q ss_pred eeeccCcEEEEEEEEcC--CcEEEEEEeeccccHH-HHHHHHHHHHHH---HhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 368 NFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHED-RFKEFLREVAIM---KGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~-~~~~~~~El~iL---~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.||+|+||.||++.+.. ..+|+|.+........ ....+.+|..++ ...+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 47999999999998864 4599998876543221 122334444333 34479999999999999999999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCC
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 521 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~ 521 (634)
+++|.+++...+ .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++...... ...
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~ 153 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH 153 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--Ccc
Confidence 999999886433 4899999999999999999999999 999999999999999999999999998754332 223
Q ss_pred CCCCCCcccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 522 TAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--QVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 522 ~~~gt~~y~APEvl~-~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
...||..|+|||.+. +..++.++|+||+||++++|++|..||...... ...... .......++..+++.+.++|.+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHH
Confidence 457899999999986 456789999999999999999999999754321 111111 1223445677889999999999
Q ss_pred hhhcCCCCCC-----CHHHHHHH
Q 006703 599 CWAEEPEIRP-----SFPSIMET 616 (634)
Q Consensus 599 cL~~dP~~RP-----s~~~Il~~ 616 (634)
||..||.+|| |+.++++.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999 69998884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.46 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=203.5
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||+|++|.||++... +..+++|.+............+.+|+.++++++|+||+++++++..+...+++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345678999999999999876 444999988766555445577889999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
++ +|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 75 8888776533 34899999999999999999999999 9999999999999999999999999987655433223
Q ss_pred CCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc------------------
Q 006703 521 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------------------ 581 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~------------------ 581 (634)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 345688899999999877 7899999999999999999999999877765443332111000
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ----------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
......++..+.++|.+||..||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0112346789999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=291.75 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=193.9
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecC--CcEEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEP--PNLSIVT 437 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~--~~~~lV~ 437 (634)
|...+.||+|+||.||+|... +..+|+|++......... ....+|+.+++++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 456778999999999999876 445999988654322222 34457888898885 99999999999887 8899999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++.......
T Consensus 80 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 80 ELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred ecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99975 7777775332 34899999999999999999999999 999999999999999 999999999987654332
Q ss_pred ccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC----------------c
Q 006703 518 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------------R 580 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~----------------~ 580 (634)
......++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+....+.... .
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2234567899999997644 556889999999999999999999998877655433321100 0
Q ss_pred ccC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 RLE-----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ~~~-----------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
... ....++..+.++|.+||..+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 001 11356799999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=291.10 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=206.0
Q ss_pred ceeecceeeccCcEEEEEEEEcCC--cEEEEEEeecc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQE---FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~---~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
+|...+.||+|+||.||++.+... .+++|+++... .......++..|+.++++++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 367778999999999999987744 35666654322 2233334567899999999999999999999999999999
Q ss_pred EeecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 437 TEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|||+++++|.+++.. ......+++..++.++.|+++||.|||+.| ++|+||||+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998853 222345899999999999999999999999 999999999999975 5699999999876544
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.........+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+. ....+..+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 3333445668899999999988888999999999999999999999998776655544442 344455667789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~ 615 (634)
|.+||..+|++||++.++++
T Consensus 237 i~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHhcCChhhCcCHHHHhh
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.79 Aligned_cols=239 Identities=26% Similarity=0.381 Sum_probs=193.6
Q ss_pred eeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHH-HHHHHHH---HHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 368 NFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDR-FKEFLRE---VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~-~~~~~~E---l~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.||+|+||.||++.+.. ..||+|++......... ...+..| +..++...|++|+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 37999999999998764 45999998765433211 1223333 344455689999999999999999999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCC
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 521 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~ 521 (634)
|++|..++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... ...
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 153 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH 153 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCc
Confidence 99999988643 24899999999999999999999999 999999999999999999999999998754332 223
Q ss_pred CCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 522 TAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 522 ~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
...|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||..... ....... ....+.++..+++.+.+++.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLE 231 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHH
Confidence 45789999999999754 578999999999999999999999977632 2221111 23345667778999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHH
Q 006703 598 TCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RP-----s~~~Il~ 615 (634)
+||..+|.+|| ++.++++
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHh
Confidence 99999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.19 Aligned_cols=241 Identities=27% Similarity=0.444 Sum_probs=213.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
..|.....||+|+||.|.+|..+++. +|||++++.-+ ..+..+--+.|-++|... +-|.+++++.+|+..+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 45667789999999999999988776 99999987644 334445566788888776 678999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+.||+|.-.+++-+ .+.+..+..++.+|+-||-+||++| |+.||||.+|||++.+|++||+|||+++.---.
T Consensus 429 MEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999988776443 3888899999999999999999999 999999999999999999999999999864444
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
...+.+.+|||.|+|||++..++|+.++|+||+||+||||+.|++||.+.+..+..+.| ....-.+|..++.+..+++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--MEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHccCcCcccccHHHHHHH
Confidence 45678899999999999999999999999999999999999999999999999999988 4455667899999999999
Q ss_pred HHhhhcCCCCCC
Q 006703 597 ETCWAEEPEIRP 608 (634)
Q Consensus 597 ~~cL~~dP~~RP 608 (634)
+..|++.|.+|.
T Consensus 582 kg~ltK~P~kRL 593 (683)
T KOG0696|consen 582 KGLLTKHPGKRL 593 (683)
T ss_pred HHHhhcCCcccc
Confidence 999999999994
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=315.89 Aligned_cols=251 Identities=34% Similarity=0.593 Sum_probs=220.5
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc-----EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-----vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
+...+...++||+|+||.|++|.|+... ||||++....... ...+|.+|+.+|.+|+|+|++++|+.+.+ ...
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 3455666789999999999999998432 9999997765544 66899999999999999999999999988 778
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
.||||.++.|+|.+-|++ ..+..+.-.....++.||+.||.||.+++ +|||||-..|||+-....+||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceecc
Confidence 899999999999999987 44556888888999999999999999999 999999999999999899999999999876
Q ss_pred CCCc--cc-CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 514 PNTY--IS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 514 ~~~~--~~-~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
.... +. .....-...|+|||.+....++.++|||++||+||||++ |+.||.+....++...+. ...+++-|+.++
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~cs 341 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCS 341 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCCh
Confidence 5432 11 122234568999999999999999999999999999998 699999999999999997 778888899999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+.++++.||+.+|++||||..|.+
T Consensus 342 edIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHH
Confidence 99999999999999999999999974
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.82 Aligned_cols=237 Identities=29% Similarity=0.427 Sum_probs=205.4
Q ss_pred eeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 369 FIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
||+|+||.||++... +..+++|++...... ......+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999886 455999998766443 33556788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 525 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~g 525 (634)
.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..............+
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 99997543 3889999999999999999999999 999999999999999999999999998765443233456678
Q ss_pred CCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCC
Q 006703 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 605 (634)
Q Consensus 526 t~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~ 605 (634)
+..|++||.+.+...+.++|+||||+++|+|++|+.||......+....+. .....++...+..+.+++.+||..||+
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL--KDPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 899999999988888999999999999999999999998877655555553 255667788899999999999999999
Q ss_pred CCCCHHH
Q 006703 606 IRPSFPS 612 (634)
Q Consensus 606 ~RPs~~~ 612 (634)
+||++.+
T Consensus 234 ~R~~~~~ 240 (250)
T cd05123 234 KRLGSGG 240 (250)
T ss_pred hCCCccc
Confidence 9999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=302.45 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=206.6
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-----CcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~-----~~~ 433 (634)
..|...+.||+|+||+||++.+.. ..||+|.+............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 568889999999999999998764 4599999875433333446677899999999999999999988644 348
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++|||+. ++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 99999996 68888886432 4899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--------------
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------- 578 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-------------- 578 (634)
...........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 443223344567889999998865 45789999999999999999999999776543222111100
Q ss_pred ----------Cc--c---cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHHhcCCCCCCC
Q 006703 579 ----------GR--R---LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLMSSVCQPLSA 631 (634)
Q Consensus 579 ----------~~--~---~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~--L~~ll~~~~~~~~~~ 631 (634)
.. . ....+.+++.+.+++.+||+.+|++|||+.++++. |+.+... ...+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~-~~~~~~~ 307 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP-SDEPVCQ 307 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc-ccCccCC
Confidence 00 0 01224678899999999999999999999999987 6555333 3344433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=297.48 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=194.7
Q ss_pred eeecceeeccCcEEEEEEEEcC----CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN----SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSI 435 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~~l 435 (634)
|...+.||+|+||.||+|.... ..+|+|.+..... .......+.+|+.++++++||||+++++++.+. ..+++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 6677889999999999999854 5599999876431 122235567899999999999999999999888 78999
Q ss_pred EEeecccCCHHHHhccC--CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC----CCcEEEEecCC
Q 006703 436 VTEYLSRGSLYKLLHIP--DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGL 509 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~--~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~----~~~ikL~DFGl 509 (634)
||||+++ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 9999975 676666422 12235899999999999999999999999 999999999999998 99999999999
Q ss_pred CccCCCCcc---cCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHH-
Q 006703 510 SRSKPNTYI---SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---------VISAV- 575 (634)
Q Consensus 510 a~~~~~~~~---~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~---------~~~~i- 575 (634)
+........ ......+++.|+|||++.+. .++.++||||||+++++|++|+.||....... ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886443221 23345678999999988764 57899999999999999999999997654322 00000
Q ss_pred hh-----------------------cCcccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 576 GF-----------------------KGRRLEIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 576 ~~-----------------------~~~~~~~~-----------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.. .......+ ...+..+.+++.+||..||++|||+.++++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00001111 146678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.76 Aligned_cols=253 Identities=17% Similarity=0.204 Sum_probs=187.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccH--HH-------HHHHHHHHHHHHhCCCCCeeeee
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHE--DR-------FKEFLREVAIMKGLRHPNIVLLM 424 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~--~~-------~~~~~~El~iL~~l~h~nIv~l~ 424 (634)
....|...+.||+|+||+||+|.+.++ .+++|+........ +. ......++..+..+.|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346799999999999999999988765 35666543222110 00 01223444556677899999999
Q ss_pred ceeecCC----cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC
Q 006703 425 GAVTEPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 500 (634)
Q Consensus 425 ~~~~~~~----~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~ 500 (634)
++..... ..+++++++. .++.+++.... ..++..+..++.|+++||.|||+++ |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 8765443 3467888774 36666665322 2567888999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCccCCCCc-------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 006703 501 TVKVCDFGLSRSKPNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVI 572 (634)
Q Consensus 501 ~ikL~DFGla~~~~~~~-------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~ 572 (634)
.++|+|||+|+...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||..... ....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999987543211 112234699999999999999999999999999999999999999987632 2222
Q ss_pred HHHh----hc-CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 573 SAVG----FK-GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 573 ~~i~----~~-~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
.... .. ..........++++.+++..|+..+|++||++.+|++.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1110 00 111112345689999999999999999999999999876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.88 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=204.5
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|....+||+|+||.||++.... ..+|+|.+.... ......+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 34445689999999999998864 459999875332 23446788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++++|.+++... .+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 99 LEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccc
Confidence 9999999987532 3788899999999999999999999 999999999999999999999999988755433323
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~Li~~ 598 (634)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||......+....+.... ........+++.+.+++.+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence 344568899999999988888999999999999999999999998877665544442211 1122234678999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
||..+|.+||++.+++.
T Consensus 253 ~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 253 LLVRDPAQRATAAELLK 269 (292)
T ss_pred HHhCCcccCcCHHHHhc
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.34 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=196.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------ 431 (634)
...|...+.||+|+||.||+|.... ..+|+|.+............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 3578889999999999999998864 44999988655433333345668999999999999999999886543
Q ss_pred --cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 432 --NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 432 --~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
..+++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999965 7887775432 24899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCcc----cCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc---
Q 006703 510 SRSKPNTYI----SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--- 581 (634)
Q Consensus 510 a~~~~~~~~----~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--- 581 (634)
+........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 875433221 112345788999999886654 688999999999999999999999887765433222110000
Q ss_pred --------------cCCC-------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 --------------LEIP-------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 --------------~~~~-------------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...+ ...++.+.++|.+||..||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0001 113567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.93 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=203.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc-EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~-vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...++||+||.+.||++...+.. +|+|.+.....+.....-|.+|+..|.++ .|.+|+++++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 466788899999999999999877554 88888777777888888999999999999 5999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC--
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-- 515 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~-- 515 (634)
||- ..+|..+|+..... ++...+..+..||+.|+.++|..| |||.||||.|+|+ -+|.+||+|||+|.....
T Consensus 440 E~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 976 56999999865542 444478889999999999999999 9999999999999 567899999999986543
Q ss_pred CcccCCCCCCCCcccCcccccCCC-----------CCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcccC
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDP-----------SNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLE 583 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~-----------~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~ 583 (634)
+.......+||+.||+||.+.... .++++|||||||+||+|+.|+.||..-.. .....++.......+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 344456788999999999985432 35789999999999999999999976442 222333322222334
Q ss_pred CCCCC-cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 584 IPKNV-NPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 584 ~~~~~-s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+|..- +.++.++++.||..||++|||..++|.
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 44332 334999999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=297.51 Aligned_cols=247 Identities=22% Similarity=0.323 Sum_probs=196.1
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
.+.+|.|+++.|+++...+..+|+|++............+.+|+.++++++|+||+++++++......+++|||+++++|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 34455666666666666677799999987655556678899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-------
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI------- 518 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~------- 518 (634)
.+++..... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 999975422 24888999999999999999999999 99999999999999999999999998864332111
Q ss_pred cCCCCCCCCcccCcccccCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-----------------
Q 006703 519 SSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------------- 579 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~--~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~----------------- 579 (634)
......++..|+|||++... .++.++|+||||+++|||++|+.||................
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 12334577889999998763 57889999999999999999999998766543322111000
Q ss_pred ---------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 ---------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ---------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+..++..+.+++.+||..||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000111234567899999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=289.35 Aligned_cols=248 Identities=26% Similarity=0.357 Sum_probs=200.3
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcEEEEEe
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVTE 438 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~~lV~E 438 (634)
|...+.||.|+||.||+|...+ ..+++|++............+.+|+.+++.++|+|++++++++... ...+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4567889999999999998875 4599999987643344446788999999999999999999999888 88999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++ +|..++.... ..+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 8888886443 34899999999999999999999999 99999999999999999999999999876543321
Q ss_pred -cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc---------------
Q 006703 519 -SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------------- 581 (634)
Q Consensus 519 -~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--------------- 581 (634)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 1234457889999998765 45789999999999999999999999887765443333111000
Q ss_pred ------c--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ------L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ------~--------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. .+...+++.+.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 001113888999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=319.44 Aligned_cols=253 Identities=17% Similarity=0.233 Sum_probs=187.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc---EEEEEE---------------eeccccHHHHHHHHHHHHHHHhCCCCCee
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD---VAVKIL---------------IEQEFHEDRFKEFLREVAIMKGLRHPNIV 421 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~---vAvK~~---------------~~~~~~~~~~~~~~~El~iL~~l~h~nIv 421 (634)
...|...+.||+|+||+||++..+... .+.|.+ +...........+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 467899999999999999998765322 222211 01111222345678999999999999999
Q ss_pred eeeceeecCCcEEEEEeecccCCHHHHhccCCC--cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC
Q 006703 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499 (634)
Q Consensus 422 ~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~--~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~ 499 (634)
++++++...+..|++++++. ++|..++..... ........+..++.||+.||.|||++| |+||||||+|||++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 99999999999999999995 467776642211 122345677889999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCccCCCCc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC-CCCCC--hH-HHHHH
Q 006703 500 YTVKVCDFGLSRSKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP-WRNST--PS-QVISA 574 (634)
Q Consensus 500 ~~ikL~DFGla~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~P-f~~~~--~~-~~~~~ 574 (634)
+.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|||++|..+ |.... +. +....
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998654322 122346799999999999999999999999999999999998764 43222 11 11111
Q ss_pred HhhcC------------------------cccCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 575 VGFKG------------------------RRLEI-----PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 575 i~~~~------------------------~~~~~-----~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.... ....+ ...++..+.++|.+||..||++|||+.+++.
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11000 00000 0134567888899999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.09 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=198.8
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------- 431 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------- 431 (634)
..|...+.||+|+||.||+|..+. ..+++|++............+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 567788899999999999999864 45999998765433333356778999999999999999999987654
Q ss_pred ---cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 432 ---NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 432 ---~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
.+++++||+++ ++..++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999976 6767665432 24899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCcc-cCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc----
Q 006703 509 LSRSKPNTYI-SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---- 582 (634)
Q Consensus 509 la~~~~~~~~-~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~---- 582 (634)
++........ ......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+....+......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 9876543221 11223567889999988654 46889999999999999999999998766554433322110000
Q ss_pred ------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 ------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ------------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....++..+.+++.+||..+|.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 012246889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=293.33 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=203.2
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||+||+|.+. +..+++|++..... .......+.+|+.+++.++|+|++++++++.+....+++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34666778999999999999875 44599998865433 3344567889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.+ +|.+++.... ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++....
T Consensus 101 e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 101 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred ecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 99964 7777765332 24889999999999999999999999 9999999999999999999999999886432
Q ss_pred ccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
......|+..|+|||++. ...++.++||||||+++|+|++|..||...+.......+............++..+.+
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 223557889999999984 4567889999999999999999999998877666555543332222333457788999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
++.+||+.+|.+||++.+++..
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.69 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=194.3
Q ss_pred eeecc--CcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 368 NFIKG--SFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 368 ~LG~G--~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
.||.| +||+||++++. ++.||+|++..........+.+.+|+.+++.++||||+++++++..+...+++|||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 56666 99999999885 556999998766555556678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-----
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI----- 518 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~----- 518 (634)
+|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++++||+.+........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999875432 23889999999999999999999999 99999999999999999999999985432211100
Q ss_pred --cCCCCCCCCcccCcccccCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC---------------
Q 006703 519 --SSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------------- 579 (634)
Q Consensus 519 --~~~~~~gt~~y~APEvl~~~--~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~--------------- 579 (634)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||......+.........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 01122356679999999764 46899999999999999999999998765443322211000
Q ss_pred ------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 ------------------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ------------------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+..+++.+.+|+.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 001112345678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.29 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=203.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
+...|...+.||+|+||.||+|+... ..+++|.+..... ......++.+|+.+++.++|+|++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 33557777899999999999998864 4489998864322 33445678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+. ++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 999996 57777765332 24788999999999999999999999 99999999999999999999999999875432
Q ss_pred CcccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
.....+++.|+|||.+. ....+.++||||||+++|+|++|..||...+..+....+.........+..++..+
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06634 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243 (308)
T ss_pred ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHH
Confidence 23456888999999974 34578899999999999999999999987766555444432222222345688999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.++|.+||..+|++||++.++++.
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.58 Aligned_cols=244 Identities=24% Similarity=0.379 Sum_probs=223.7
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...+.....||-|+||.|-++..+++. +|+|++++..+ +-.+.+.+..|-++|..++.|.||++|..|.+..++||+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 355666778999999999999988776 89999876654 445567788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||-|-||.|...++..+ .+++..+..++..+++|++|||++| ||.|||||+|++++.+|-+||.|||+|+...+.
T Consensus 499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999998655 4999999999999999999999999 999999999999999999999999999987654
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
..+.+.+|||.|.|||++.++..+.++|.||||+++|||++|.+||.+.+++...+.+........+|..++....+||
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 3578899999999999999999999999999999999999999999999999999999877788899999999999999
Q ss_pred HHhhhcCCCCCCC
Q 006703 597 ETCWAEEPEIRPS 609 (634)
Q Consensus 597 ~~cL~~dP~~RPs 609 (634)
++++..+|.+|..
T Consensus 653 k~LCr~~P~ERLG 665 (732)
T KOG0614|consen 653 KKLCRDNPTERLG 665 (732)
T ss_pred HHHHhcCcHhhhc
Confidence 9999999999976
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.39 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=208.4
Q ss_pred ceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-----cEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLS 434 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~-----~~~ 434 (634)
+|...+.||.|++|.||+|++.. ..+++|.+..........+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 36778899999999999999864 55999988765433455577889999999999999999999997775 789
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+++ +|.+++.... .+++..++.++.||+.||.|||++| |+|+||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999974 8888886443 5899999999999999999999999 9999999999999999999999999988654
Q ss_pred CCc---ccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc---------
Q 006703 515 NTY---ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------- 581 (634)
Q Consensus 515 ~~~---~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--------- 581 (634)
... .......++..|+|||++.+. .++.++|+||||+++++|++|..||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 432 123345678899999999888 7899999999999999999999999887765544433221110
Q ss_pred --------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHH
Q 006703 582 --------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLM 622 (634)
Q Consensus 582 --------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~--L~~ll~ 622 (634)
......+++.+.+++.+||..+|.+|||+.+++.. |+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 01123468889999999999999999999999984 554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=284.64 Aligned_cols=248 Identities=25% Similarity=0.455 Sum_probs=204.2
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~ 437 (634)
........||.|+-|.|++++.+.++ .|||.+......+ ..+++...+.++.... +|+||+.++||..+..++|.|
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 34455678999999999999998755 8999998876544 4588888888887764 899999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|.| ...++.++.+... +++|..+-++...+++||.||..+. +|+|||+||+|||+|..|++||||||++....+..
T Consensus 171 elM-s~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 998 4477777765443 4999999999999999999998653 39999999999999999999999999997655432
Q ss_pred ccCCCCCCCCcccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhcCcccCCCC--CCcHH
Q 006703 518 ISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPK--NVNPM 591 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~---~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~--~~s~~ 591 (634)
......|.+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+.+ ++...+. ....+.++. ..++.
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~ePP~L~~~~gFSp~ 324 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NEEPPLLPGHMGFSPD 324 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hcCCCCCCcccCcCHH
Confidence 3346679999999999853 46788999999999999999999999885543 3333332 344454543 47999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+|+..||++|+.+||.+.++++
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHhc
Confidence 999999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.07 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=199.1
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee----cCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT----EPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~----~~~~~~ 434 (634)
..|...+.||.|+||.||+|... +..|++|++............+.+|+.++++++|+||+++++++. .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 56778889999999999999876 445999998755433344567788999999999999999999875 335689
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+. ++|.+++.... .+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 9999995 58988886443 3899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCccc----CCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-----------
Q 006703 515 NTYIS----SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK----------- 578 (634)
Q Consensus 515 ~~~~~----~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~----------- 578 (634)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 124468899999999865 45789999999999999999999999776543322211110
Q ss_pred -------------CcccC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 579 -------------GRRLE-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 579 -------------~~~~~-----~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..... +....++.+.++|.+||..+|++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111 12456889999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.25 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=201.4
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC--CcEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP--PNLS 434 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~--~~~~ 434 (634)
...|...+.||+|+||.||+|.+. +..+|+|.+............+.+|+.+++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 356788899999999999999876 44599998865433334445677899999999 999999999988643 4689
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+. ++|..++... .+++..++.++.||+.||.|||+.| |+|+||||+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 4898888643 4788899999999999999999999 9999999999999999999999999987543
Q ss_pred CCc-----ccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC---------
Q 006703 515 NTY-----ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------- 579 (634)
Q Consensus 515 ~~~-----~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~--------- 579 (634)
... .......||..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322 12233468899999998865 456889999999999999999999997765443322211100
Q ss_pred -----------------c---ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHH
Q 006703 580 -----------------R---RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLM 622 (634)
Q Consensus 580 -----------------~---~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~--L~~ll~ 622 (634)
. .......++.++.++|.+||..+|.+|||+.++++. ++++-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 0 011123478899999999999999999999999975 444433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=304.60 Aligned_cols=262 Identities=36% Similarity=0.595 Sum_probs=229.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....++-..+||-|-||.||.|.|+.-. ||||.++.... ..++|+.|..+|+.++|||+|++++.|..+..+|||
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3456677789999999999999998554 89998876543 347899999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
+|||..|+|.+||+..+.. .++....+.++.||..|++||..++ +|||||-..|+|+.++-.+|++|||+++.+...
T Consensus 342 TEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999999866543 4777788999999999999999999 999999999999999999999999999986554
Q ss_pred ccc-CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 YIS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~~-~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
.+. .....-...|.|||-+....++.++|||+|||+|||+.| |-.||.+.+..++...+ ..+.+..-|..+++.+.+
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-EkgyRM~~PeGCPpkVYe 497 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGYRMDGPEGCPPKVYE 497 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccccccCCCCCCHHHHH
Confidence 333 233335678999999999999999999999999999998 77899998887766555 467788889999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
|+..||+.+|.+||+|.+|-..|+.++.++...
T Consensus 498 LMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred HHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 999999999999999999999999999876543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=296.70 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=199.6
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-----Cc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~-----~~ 432 (634)
...|...+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 367888999999999999999876 4459999885422 223446678899999999999999999987544 35
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.++++||+.+ +|.+++... .+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceee
Confidence 8999999965 787777532 3889999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCcc---cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh-c---------
Q 006703 513 KPNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-K--------- 578 (634)
Q Consensus 513 ~~~~~~---~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~-~--------- 578 (634)
...... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 432211 1233568899999998754 5679999999999999999999999977654332211100 0
Q ss_pred --------------CcccC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHH
Q 006703 579 --------------GRRLE-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLM 622 (634)
Q Consensus 579 --------------~~~~~-----~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~--L~~ll~ 622 (634)
..... ..+..++.+.+++.+||..+|++|||+.++++. |+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000 113467889999999999999999999999986 665554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.38 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=212.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-----
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----- 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~----- 431 (634)
....+...+.||+|+||.||+++++.++ ||||.+...... ...+...+|+++|++++|+|||++++.-....
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~-r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL-RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhccc-chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3466777889999999999999987554 999998876532 33467889999999999999999999765433
Q ss_pred -cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc----CCCcEEEEe
Q 006703 432 -NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD----STYTVKVCD 506 (634)
Q Consensus 432 -~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld----~~~~ikL~D 506 (634)
...++||||.||+|...++.+++...+++...+.++.+++.||.|||.+| |+||||||.||++- ..-..||+|
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeec
Confidence 57899999999999999999988888999999999999999999999999 99999999999993 333689999
Q ss_pred cCCCccCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhhcC--
Q 006703 507 FGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPS----QVISAVGFKG-- 579 (634)
Q Consensus 507 FGla~~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~----~~~~~i~~~~-- 579 (634)
||.|+..++.. ...+.+||..|.+||.+.. +.++..+|.|||||++|+++||..||...... ++...+..+.
T Consensus 168 fG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 168 FGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 99999877654 6778899999999999984 77899999999999999999999999543222 2222221111
Q ss_pred -----------------cccCCCCCCcHH----HHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHhcC
Q 006703 580 -----------------RRLEIPKNVNPM----VAALIETCWAEEPEIRP--SFPSIMETLQQFLMSSV 625 (634)
Q Consensus 580 -----------------~~~~~~~~~s~~----l~~Li~~cL~~dP~~RP--s~~~Il~~L~~ll~~~~ 625 (634)
...+.|..++.. +...+..+|+.+|++|- .+.+....+..++....
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 112233344433 55566778899999998 88888888888887654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.17 Aligned_cols=255 Identities=33% Similarity=0.564 Sum_probs=210.9
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC--CCCCeeeeeceeecCC----cEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL--RHPNIVLLMGAVTEPP----NLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l--~h~nIv~l~~~~~~~~----~~~ 434 (634)
.++...+.||+|.||.||+|+|+|..||||++.... ...+.+|.+++++. +|+||+.+++.-..++ +++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 566778999999999999999999999999985432 24577888888876 9999999999864443 489
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC------CCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR------RPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~------g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
+|++|.+.|||+|||++.- ++....++++..++.||+|||.. +|.|.|||||+.||||.++++.-|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999998643 88899999999999999999943 3679999999999999999999999999
Q ss_pred CCccCCCC----cccCCCCCCCCcccCcccccCCCC------CchHHHHHHHHHHHHHHh-----C-----CCCCCCCC-
Q 006703 509 LSRSKPNT----YISSKTAAGTPEWMAPEVLREDPS------NEKSDVFSFGVILWELIT-----L-----QKPWRNST- 567 (634)
Q Consensus 509 la~~~~~~----~~~~~~~~gt~~y~APEvl~~~~~------s~~sDVwSLGvlL~eLlt-----g-----~~Pf~~~~- 567 (634)
+|....+. ....+..+||.+|||||++...-. -+.+||||||.++||++. | +.||.+..
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99764432 334577899999999999965432 346899999999999984 2 67886544
Q ss_pred ----hHHHHHHHhhcCcccCCCCCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 568 ----PSQVISAVGFKGRRLEIPKNVN-----PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 568 ----~~~~~~~i~~~~~~~~~~~~~s-----~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+++..-+..+..+|.+|..+. ..+..+++.||..||.-|.|+--|.+.|.++.++.
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 3556666666777887776543 35788899999999999999999999999998753
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=294.79 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=201.3
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------ 431 (634)
...|...+.||+|+||.||++... +..||+|++............+.+|+.++++++|+||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 467888999999999999999876 445999998654433444567889999999999999999999986554
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
.+++||||+ +++|.+++... .+++..++.++.|+++||.|||+.| |+||||||+||+++.++.++|+|||++.
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 358999999 77998887532 3889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc----------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------- 580 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~---------- 580 (634)
..... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+.....
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 167 QTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 64332 234567889999999876 4578999999999999999999999987665433222110000
Q ss_pred -------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 006703 581 -------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQF 620 (634)
Q Consensus 581 -------------------~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~--~L~~l 620 (634)
.......+++.+.++|.+||..||.+|||+.+++. .++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00122457888999999999999999999999994 44444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=285.66 Aligned_cols=231 Identities=22% Similarity=0.409 Sum_probs=187.7
Q ss_pred eeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeecccCCH
Q 006703 369 FIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 445 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL 445 (634)
||.|+||.||++..+. ..+|+|++........ |+.....+ +|+||+++++++...+..++||||+++++|
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 96 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL 96 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcH
Confidence 6999999999998764 3488888765432221 22222222 799999999999999999999999999999
Q ss_pred HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCccCCCCcccCCCCC
Q 006703 446 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYISSKTAA 524 (634)
Q Consensus 446 ~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~~~~~~~~~~~~~ 524 (634)
.+++.... .+++..++.++.|+++||.|||+.| ++||||||+||+++.++ .++|+|||++...... ....
T Consensus 97 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----~~~~ 167 (267)
T PHA03390 97 FDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYD 167 (267)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----ccCC
Confidence 99997543 5899999999999999999999999 99999999999999888 9999999998765432 2446
Q ss_pred CCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHH-hhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI-SAV-GFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 525 gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~-~~i-~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
++..|+|||++.+..++.++||||||+++++|++|+.||......... ... .........+...++.+.++|.+||+.
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 247 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKY 247 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhcc
Confidence 889999999999989999999999999999999999999755433221 111 112333445567899999999999999
Q ss_pred CCCCCCC-HHHHHH
Q 006703 603 EPEIRPS-FPSIME 615 (634)
Q Consensus 603 dP~~RPs-~~~Il~ 615 (634)
+|.+||+ ++++++
T Consensus 248 ~p~~R~~~~~~~l~ 261 (267)
T PHA03390 248 NINYRLTNYNEIIK 261 (267)
T ss_pred ChhhCCchHHHHhc
Confidence 9999996 688875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=286.24 Aligned_cols=248 Identities=27% Similarity=0.327 Sum_probs=197.6
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC---CCCCeeeeeceeecCCc-----
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPN----- 432 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l---~h~nIv~l~~~~~~~~~----- 432 (634)
|...+.||+|+||.||+|+++. ..+|+|++............+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567889999999999999874 5599999875543333334566777777666 69999999999987776
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999975 88888864332 24899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-----------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------- 581 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------- 581 (634)
..... ......++..|+|||++.+..++.++|+||||+++|+|++|..||......+....+......
T Consensus 157 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 54332 223445788999999999999999999999999999999999999887765544333211000
Q ss_pred --------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 --------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 --------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
......+++.+.+++.+||..||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0001234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=288.46 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=203.4
Q ss_pred eeecceeeccCcEEEEEEEEc-----CCcEEEEEEeecccc--HHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~--~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~ 434 (634)
|...+.||+|++|.||+++.. +..+|+|++...... ......+.+|+.+++++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 566789999999999999754 345999998754322 22345688999999999 5999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+.+++|.+++.... .+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999886432 4888899999999999999999999 9999999999999999999999999987643
Q ss_pred CCcc-cCCCCCCCCcccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhcCcccCCCCC
Q 006703 515 NTYI-SSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPKN 587 (634)
Q Consensus 515 ~~~~-~~~~~~gt~~y~APEvl~~~~--~s~~sDVwSLGvlL~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 587 (634)
.... ......|+..|+|||.+.+.. .+.++|+||||+++++|++|..||..... .+....+ .......+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKT 234 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCcc
Confidence 3221 122346889999999987765 68899999999999999999999964322 2222222 2334556677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
++..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 899999999999999999999988877766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=294.34 Aligned_cols=250 Identities=24% Similarity=0.278 Sum_probs=198.2
Q ss_pred Ccceee-cceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHH------------HHHHHHHHHHHHhCCCCCeeeee
Q 006703 360 STHVID-SSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDR------------FKEFLREVAIMKGLRHPNIVLLM 424 (634)
Q Consensus 360 ~~~~~~-~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~------------~~~~~~El~iL~~l~h~nIv~l~ 424 (634)
..+|.. .+.||.|+||.||+|.+. +..+|+|++......... ...+.+|+.++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345554 567999999999999876 445999998654332210 12467899999999999999999
Q ss_pred ceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEE
Q 006703 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 504 (634)
Q Consensus 425 ~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL 504 (634)
+++..+...+++|||+. ++|.+++... ..+++.....++.|++.||.|||+.| ++|+||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEE
Confidence 99999999999999997 5888888643 24889999999999999999999999 999999999999999999999
Q ss_pred EecCCCccCCCC--------------cccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChH
Q 006703 505 CDFGLSRSKPNT--------------YISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPS 569 (634)
Q Consensus 505 ~DFGla~~~~~~--------------~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~ 569 (634)
+|||++...... ........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998754411 11122335688899999987644 689999999999999999999999887765
Q ss_pred HHHHHHhhcCccc--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 570 QVISAVGFKGRRL--------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 570 ~~~~~i~~~~~~~--------------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+....+......+ ......+..+.+++.+||..+|++|||+.+++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 5443331110000 011345788999999999999999999999987
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=287.64 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=200.1
Q ss_pred eeecceeeccCcEEEEEEEEc-----CCcEEEEEEeeccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~--~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~ 434 (634)
|...+.||+|+||.||++... +..+|+|++..... .....+.+.+|+.+++++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 566789999999999999863 45599999865432 123345678899999999 5999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 82 LILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999986443 4788899999999999999999999 9999999999999999999999999987643
Q ss_pred CCc-ccCCCCCCCCcccCcccccCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhcCcccCCCCC
Q 006703 515 NTY-ISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPKN 587 (634)
Q Consensus 515 ~~~-~~~~~~~gt~~y~APEvl~~~--~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 587 (634)
... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... .+....+ ....++.+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCcc
Confidence 321 122345688999999998753 467899999999999999999999964332 2222221 2234456777
Q ss_pred CcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRP-----SFPSIMET 616 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RP-----s~~~Il~~ 616 (634)
+++.+.+++.+||..||++|| ++.++++.
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 899999999999999999997 77777663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=290.18 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=195.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------ 431 (634)
...|...+.||+|+||.||+|.++. ..+++|++............+.+|+.+++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4678899999999999999999864 45999998765443333345678999999999999999999875433
Q ss_pred --cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 432 --NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 432 --~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
.++++|||+.+ +|...+.... ..+++..+..++.|+++||.|||++| |+|+||||+||+++.++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999965 6766665432 34899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCccc-----------CCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 006703 510 SRSKPNTYIS-----------SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 577 (634)
Q Consensus 510 a~~~~~~~~~-----------~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~ 577 (634)
+......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8754332111 1223467889999987654 578999999999999999999999987776544333211
Q ss_pred cCcc---------------------cCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 578 KGRR---------------------LEIP-------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 578 ~~~~---------------------~~~~-------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.... ...+ ....+.+.+++.+||..||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1000 0000 234577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=286.84 Aligned_cols=248 Identities=26% Similarity=0.344 Sum_probs=201.9
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||+|++|.||+|+... ..+++|++............+..|+.++++++|+||+++++++......+++|||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 3456789999999999998874 55999998766433444466788999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
+ ++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 7 48999997543 24899999999999999999999999 9999999999999999999999999987654433233
Q ss_pred CCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-------------------c
Q 006703 521 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-------------------R 580 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-------------------~ 580 (634)
....++..|+|||.+.+. .++.++||||||++++||++|..||......+....+.... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 344567889999998776 78899999999999999999999998876554433221100 0
Q ss_pred cc--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 RL--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ~~--------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+ ...+..+..+.+++.+||..+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 011234788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=288.29 Aligned_cols=248 Identities=25% Similarity=0.452 Sum_probs=197.6
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||.||+|.+. +..+|+|.+....... ....+..|+.++.+. .|+||+++++++......+++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 56788899999999999999988 5569999987654332 345566777767666 5999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .+ |+||||+|+||+++.++.+||+|||++......
T Consensus 94 e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 47777765432 258899999999999999999997 57 999999999999999999999999998765433
Q ss_pred cccCCCCCCCCcccCcccccCCC----CCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhcCcccCCC--CCCc
Q 006703 517 YISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIP--KNVN 589 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~----~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~--~~~s 589 (634)
. ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... +....+. ....+..+ ..++
T Consensus 169 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 246 (296)
T cd06618 169 K-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-QEEPPSLPPNEGFS 246 (296)
T ss_pred C-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh-cCCCCCCCCCCCCC
Confidence 2 123345788999999987654 688999999999999999999999764332 2222221 12222222 3478
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+++.+++.+||..||++||++.+++..
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=295.98 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=201.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc-----
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----- 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~----- 432 (634)
...|...+.||+|++|.||+|++.. ..+|+|++............+.+|+.++++++|+||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 4678889999999999999999874 459999886554344445667889999999999999999998866554
Q ss_pred -EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 433 -LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 433 -~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
.++|+||+ +++|.+++... .+++..++.++.|+++||.|||+.| |+|+||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 66999988642 3899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc---------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------- 581 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--------- 581 (634)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+......
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 167 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 65332 344567889999999865 36789999999999999999999999877765543332111000
Q ss_pred --------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 --------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 --------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.......++.+.+++.+||..+|++|||+.+|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0111245889999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=295.53 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=200.6
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------c
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------N 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------~ 432 (634)
..|...+.||+|+||.||+|.+. +..+|+|++............+.+|+.+++.++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 56888899999999999999875 455999998654433334456789999999999999999999986543 4
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+++++||+.. +|..+.. ..+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 95 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 6899999964 7776653 13788999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------ 579 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------ 579 (634)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+....
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 167 ADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 432 2234567889999999876 457899999999999999999999998876544333221100
Q ss_pred ---------cccC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHHh
Q 006703 580 ---------RRLE--------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLMS 623 (634)
Q Consensus 580 ---------~~~~--------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~--L~~ll~~ 623 (634)
..+. ..+..++.+.++|.+||+.||++||++.+++.. ++.+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000 112467889999999999999999999999954 7776554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.26 Aligned_cols=247 Identities=28% Similarity=0.398 Sum_probs=196.6
Q ss_pred eeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEee
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
|...+.||+|++|.||+|...+ ..+++|.+....... ......+|+..+++++ |+||+++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 4567889999999999999864 449999876543322 2234557999999998 99999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+ +++|.+++.... ...+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 154 (283)
T cd07830 80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-P 154 (283)
T ss_pred C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-C
Confidence 9 779988886543 234899999999999999999999999 9999999999999999999999999987654322 2
Q ss_pred CCCCCCCCcccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-----------------
Q 006703 520 SKTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------------- 581 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~-~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------------- 581 (634)
.....++..|+|||++. +..++.++|+||||+++++|++|+.||......+....+......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23456888999999885 445789999999999999999999999876654433222110000
Q ss_pred -----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 -----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 -----------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.......+..+.+++.+||..+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0011223688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=296.46 Aligned_cols=248 Identities=27% Similarity=0.340 Sum_probs=210.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHH-HHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDR-FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~-~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|..-+.||+|+||.||-++.+.++ +|.|.+.+..++... .....+|-.+|++++.+.||.+-.+|...+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3466777889999999999999887666 899988766654322 2346789999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|+..|.||+|.-.|-..+. ..++++.+..++.+|+.||++||..+ ||.||+||+|||+|+.|+++|+|.|+|..++.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999877754443 45999999999999999999999999 99999999999999999999999999998766
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--cCcccCCCCCCcHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF--KGRRLEIPKNVNPMVA 593 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~ 593 (634)
.. .....+||.+|||||++.+..|+...|+|||||+||||+.|+.||...........+.. ......++...+++.+
T Consensus 340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAK 418 (591)
T ss_pred CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHH
Confidence 43 34455999999999999999999999999999999999999999976554333322221 3344567789999999
Q ss_pred HHHHHhhhcCCCCCCCH
Q 006703 594 ALIETCWAEEPEIRPSF 610 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~ 610 (634)
+|...+|++||.+|.-.
T Consensus 419 slc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHccCHHHhccC
Confidence 99999999999999654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=289.73 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=198.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-CCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-~~~~~l 435 (634)
....|...+.||.|+||.||++....+ .+|+|++..........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 346788899999999999999987744 49999886554334445677899999999999999999998865 567899
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+|||+ +++|..+++.. .+++..+..++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||.+.....
T Consensus 88 v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 88 VTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred Eeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 99999 56898887632 3778888899999999999999999 99999999999999999999999999875432
Q ss_pred CcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh-----------------
Q 006703 516 TYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF----------------- 577 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~----------------- 577 (634)
......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...........+..
T Consensus 161 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 161 ---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred ---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 2234567889999999766 5689999999999999999999999977664322111100
Q ss_pred -------cCcccC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 578 -------KGRRLE-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 578 -------~~~~~~-----~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
...... ....+++.+.++|.+||..+|++|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011 113567899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=321.47 Aligned_cols=246 Identities=26% Similarity=0.445 Sum_probs=193.5
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee---------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--------- 428 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~--------- 428 (634)
...|...+.||+||||.||+++++ +..||||++.... .......+.+|++.|.+++|||||+++..+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 356677899999999999999987 6669999998776 6666788999999999999999999988541
Q ss_pred ---------------------------------------------------------------------c----------
Q 006703 429 ---------------------------------------------------------------------E---------- 429 (634)
Q Consensus 429 ---------------------------------------------------------------------~---------- 429 (634)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred -----------------------C--------CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHH
Q 006703 430 -----------------------P--------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 478 (634)
Q Consensus 430 -----------------------~--------~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH 478 (634)
+ ..+||-||||+..+|.+++.++... -.....|+++++|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH
Confidence 0 2378999999998888888765432 146788999999999999999
Q ss_pred hCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC------------------CCcccCCCCCCCCcccCcccccCCC-
Q 006703 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP------------------NTYISSKTAAGTPEWMAPEVLREDP- 539 (634)
Q Consensus 479 ~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~------------------~~~~~~~~~~gt~~y~APEvl~~~~- 539 (634)
++| ||||||||.||+++..+.|||+|||+|+... .........+||.-|+|||++.+..
T Consensus 715 ~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 DQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred hCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999 9999999999999999999999999998511 0111234567999999999997765
Q ss_pred --CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh-cCcccCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 006703 540 --SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRRLEIP----KNVNPMVAALIETCWAEEPEIRPSFPS 612 (634)
Q Consensus 540 --~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~-~~~~~~~~----~~~s~~l~~Li~~cL~~dP~~RPs~~~ 612 (634)
|+.|+|+||||++|+||+. ||... ++....+.. +....+.+ ..--+.=+.+|.+|++.||.+|||+.+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 8999999999999999985 56442 333333321 11222222 122345678999999999999999999
Q ss_pred HHH
Q 006703 613 IME 615 (634)
Q Consensus 613 Il~ 615 (634)
+|+
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 885
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.57 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=196.5
Q ss_pred eeecceeeccCcEEEEEEEEcCC----cEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec----CCcE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE----PPNL 433 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~----~~~~ 433 (634)
|...+.||+|+||.||++.+.++ .+|+|++..........+.+.+|+.+++++ .|+||++++++... ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 56778999999999999998755 599998865433333456788999999999 59999999987532 2457
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++++||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 89999985 5888888533 24889999999999999999999999 999999999999999999999999999754
Q ss_pred CCCcc----cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc----------
Q 006703 514 PNTYI----SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK---------- 578 (634)
Q Consensus 514 ~~~~~----~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~---------- 578 (634)
..... ......||..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 32211 1233468999999998765 56799999999999999999999999876543322211100
Q ss_pred --------------Ccc-----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 579 --------------GRR-----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 579 --------------~~~-----~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
... .......+..+.+++.+||..||.+|||+.+++. ..++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~--~~~~~ 296 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE--HPYLA 296 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--Chhhh
Confidence 000 0112346789999999999999999999999976 34444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.79 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=197.7
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------Cc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------PN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------~~ 432 (634)
.+|...+.||+|+||.||++.+. +..||+|++..........+.+.+|+.++++++|+||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 67888899999999999999875 44599998876543344456788999999999999999999987543 34
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++++++ +++|.+++... .+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 78888887 77998887643 3888999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------ 579 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------ 579 (634)
... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+....
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 170 TDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 433 2334568899999999876 467889999999999999999999997766544332221100
Q ss_pred ------------ccc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 580 ------------RRL-----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 580 ------------~~~-----~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
..+ ......++.+.++|.+||..||.+||++.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 0112457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.12 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=195.7
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------- 430 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------- 430 (634)
..+|...+.||.|+||.||+|..+. ..|++|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4788999999999999999998874 4499998865543 3346678999999999999999999876543
Q ss_pred -------CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcE
Q 006703 431 -------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTV 502 (634)
Q Consensus 431 -------~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~i 502 (634)
...+++|||++ ++|.+++... .+++..++.++.||+.||.|||+.| |+||||||+||+++ .++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceE
Confidence 35789999997 4888887532 3889999999999999999999999 99999999999997 45678
Q ss_pred EEEecCCCccCCCCcc---cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 006703 503 KVCDFGLSRSKPNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 578 (634)
Q Consensus 503 kL~DFGla~~~~~~~~---~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~ 578 (634)
||+|||.+........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...++.+....+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999875432211 1123457889999998754 56788999999999999999999999877654443322110
Q ss_pred -----------------------Cccc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 579 -----------------------GRRL-----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 579 -----------------------~~~~-----~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.... .....++.++.+++.+||..||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 112357788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.62 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=207.5
Q ss_pred cCCCCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC
Q 006703 354 QNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430 (634)
Q Consensus 354 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~ 430 (634)
......+..|..++.||-|+||.|.++...++. +|+|.+.+... ...+......|-.||....++.||+++..|+++
T Consensus 622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 344455678899999999999999999877666 89999876653 455667788999999999999999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
+++|+||+|++||++..+|-+.+ .++|..+..++.++..|+++.|+.| +|||||||+|||||.+|+|||+|||++
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeecccc
Confidence 99999999999999999987665 4999999999999999999999999 999999999999999999999999998
Q ss_pred ccCC----CC--------------------------------------cccCCCCCCCCcccCcccccCCCCCchHHHHH
Q 006703 511 RSKP----NT--------------------------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548 (634)
Q Consensus 511 ~~~~----~~--------------------------------------~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwS 548 (634)
+-+. .. .+.....+||+.|+|||++....++..+|+||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 6210 00 00112346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC--CCCCCcHHHHHHHHHhhhcCCCCC
Q 006703 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMVAALIETCWAEEPEIR 607 (634)
Q Consensus 549 LGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~Li~~cL~~dP~~R 607 (634)
.||+||||+.|+.||-...+.+....+..+..-+. ...+++++..++|.+++. +++.|
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~R 916 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSR 916 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhh
Confidence 99999999999999998888776665544443333 346789999999987665 55555
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=279.09 Aligned_cols=241 Identities=25% Similarity=0.349 Sum_probs=198.4
Q ss_pred eecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceee----cCCcEEEE
Q 006703 364 IDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT----EPPNLSIV 436 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~----~~~~~~lV 436 (634)
+..+.||-|-.|.|..+..+. .++|+|++... ....+|+++.-.. .|+|||.+++.|. ....+.+|
T Consensus 65 is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 65 ISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred ehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 344789999999999997764 45999997543 2334788877666 6999999999884 34568899
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc---CCCcEEEEecCCCccC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSK 513 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld---~~~~ikL~DFGla~~~ 513 (634)
||+++||.|...++..+. ..++|..+..|+.||..|+.|||+.+ |.||||||+|+|.. .+..+||+|||+|+..
T Consensus 138 mE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999999875554 35999999999999999999999999 99999999999996 4558999999999865
Q ss_pred CCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhcCcccC--CCCC
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLE--IPKN 587 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~--~~~~ 587 (634)
.. .....+++-||.|.|||++...+|+..+|+||+||++|-|++|.+||...+- ..+...|.......+ -...
T Consensus 215 ~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 215 QE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred CC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 43 3456789999999999999999999999999999999999999999976653 233444432222222 2245
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++..+++|..+|..+|.+|.|+.++++
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 8999999999999999999999999886
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.26 Aligned_cols=243 Identities=30% Similarity=0.439 Sum_probs=207.0
Q ss_pred cceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccC
Q 006703 366 SSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
.+.||+|-||+||-|+++ ++.||||++.+-.+......++.+|+.||+++.||.||.+.-.|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999876 555999999999888777789999999999999999999999999999999999999887
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEEEEecCCCccCCCCcccC
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ikL~DFGla~~~~~~~~~~ 520 (634)
.|+-++.... +.+++.....++.||+.||.|||.++ |+|+||||+|||+.. -..+||||||+|+.++... ..
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FR 723 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FR 723 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-hh
Confidence 7877776443 34999999999999999999999999 999999999999964 3479999999999987764 34
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMVAALIETC 599 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~c 599 (634)
+..+|||.|.|||++.++.|+..-|+||.||++|--+.|..||..... .+.++...+. ..+.....++++..+||..+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-yPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-YPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-cCCCchhhcCHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999965432 2222222111 12223357899999999999
Q ss_pred hhcCCCCCCCHHHHH
Q 006703 600 WAEEPEIRPSFPSIM 614 (634)
Q Consensus 600 L~~dP~~RPs~~~Il 614 (634)
|...-.+|-|.+.-+
T Consensus 803 LqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHhcchHhhc
Confidence 999999998887654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=310.39 Aligned_cols=146 Identities=30% Similarity=0.497 Sum_probs=130.6
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...++||+|+||+||+|.+. +..||+|++..... .......+..|+.+++.++|+||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999988 55699999876543 3444567889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
||+.+++|.+++.... .+++..++.|+.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997543 3788899999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=279.47 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=203.3
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcE
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~ 433 (634)
............||.|+||+|++-.++.++ .|||.++.... +...+++..|.....+- +.||||+++|+...+...
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 344466777889999999999998887555 89999987765 44557888888776665 789999999999999999
Q ss_pred EEEEeecccCCHHHHhcc--CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 434 SIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~--~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
||.||.|. .||..+... .-.+..++|..+-.|....+.||.||-..- .||||||||+|||++..|.+||||||++.
T Consensus 139 WiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 139 WICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeecccchH
Confidence 99999995 477666531 112234899999999999999999998653 29999999999999999999999999987
Q ss_pred cCCCCcccCCCCCCCCcccCccccc--CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhcCcccC--CC-
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLE--IP- 585 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~--~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~--~~- 585 (634)
...+.. ......|...|||||.+. +..|+-++||||||++|+|+.||+.|+.+++.. +.+..+. .+..+. .+
T Consensus 217 qLv~Si-AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-~gdpp~l~~~~ 294 (361)
T KOG1006|consen 217 QLVDSI-AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-IGDPPILLFDK 294 (361)
T ss_pred hHHHHH-HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-cCCCCeecCcc
Confidence 654432 334567899999999984 345899999999999999999999999998762 2222332 222222 22
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 586 --KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 586 --~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
...+..+..+|..||.+|-..||.+.+++++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2478899999999999999999999998863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=307.81 Aligned_cols=255 Identities=34% Similarity=0.590 Sum_probs=217.7
Q ss_pred eecceeeccCcEEEEEEEEc---------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcE
Q 006703 364 IDSSNFIKGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~ 433 (634)
...+.||+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+ +|+||+.+++++.....+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 44459999999999999654 223899998777655 6678899999999999 699999999999999999
Q ss_pred EEEEeecccCCHHHHhccCC-----------Cc--ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPD-----------AR--VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 500 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~-----------~~--~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~ 500 (634)
++|+||+..|+|..+++... .. ..++....+.++.||+.|++||++.. ++||||-..|||+.++.
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecCCC
Confidence 99999999999999997544 01 13888999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCccCCC-CcccCCCCC--CCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHH
Q 006703 501 TVKVCDFGLSRSKPN-TYISSKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST-PSQVISAV 575 (634)
Q Consensus 501 ~ikL~DFGla~~~~~-~~~~~~~~~--gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~-~~~~~~~i 575 (634)
.+||+|||+|+.... ..+...... -...|||||.+....++.++||||+|++||||++ |..||.+.. ..+. ...
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHH
Confidence 999999999985333 223223333 3446999999999999999999999999999998 789999866 4444 334
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 576 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 576 ~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
...+.++..|..+++++.+++..||+.+|++||+|.++.+.|...++
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 45778889999999999999999999999999999999999999765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=256.71 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=205.9
Q ss_pred ceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.|...++||+|.||+||+|++.++. ||+|.++....++.......+|+.+|+.++|.|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999988766 99999987776666666788999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
|.. .|..+...-+ +.++...+..++.|+++||.++|+++ +.|||+||.|+||+.+|..||+|||+++.+.-+..-
T Consensus 83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 965 7888775333 45899999999999999999999999 999999999999999999999999999987665433
Q ss_pred CCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCc------c----------
Q 006703 520 SKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR------R---------- 581 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~------~---------- 581 (634)
....+-|..|++|.++.+.+ |++..|+||.||++.|+.. |.+.|.+.+..+....+-..-. .
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 44556799999999998866 6889999999999999987 6777888877665544422110 1
Q ss_pred --cCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 --LEIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 --~~~~---------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+| +.++..-++++.++|.-+|.+|.+++..++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111 234455789999999999999999998765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=284.50 Aligned_cols=257 Identities=31% Similarity=0.469 Sum_probs=210.4
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC--CCCCeeeeeceeecCC----cEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL--RHPNIVLLMGAVTEPP----NLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l--~h~nIv~l~~~~~~~~----~~~ 434 (634)
......+.||+|.||.||+|+..++.||||++. ....+.|.+|-+|++.. +|+||++++++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 344566789999999999999999999999964 44557788998888876 7999999999876555 799
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-------CCCEEeeccCCCcEEEcCCCcEEEEec
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-------RPPIVHRDLKSPNLLVDSTYTVKVCDF 507 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-------g~~IvHrDIKP~NILld~~~~ikL~DF 507 (634)
||++|.+.|+|.+||..+- +++....+|+..|++||+|||.. +|+|+|||||..||||.++++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999997543 89999999999999999999964 257999999999999999999999999
Q ss_pred CCCccCCC--CcccCCCCCCCCcccCcccccCCCC------CchHHHHHHHHHHHHHHhC------------CCCCC---
Q 006703 508 GLSRSKPN--TYISSKTAAGTPEWMAPEVLREDPS------NEKSDVFSFGVILWELITL------------QKPWR--- 564 (634)
Q Consensus 508 Gla~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~------s~~sDVwSLGvlL~eLltg------------~~Pf~--- 564 (634)
|+|..+.. ........+||.+|||||++.+.-. -.+.||||+|.+||||++. +.||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99986542 2223345689999999999866543 2467999999999999974 22343
Q ss_pred --CCChHHHHHHHhhcCcccCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 565 --NSTPSQVISAVGFKGRRLEIPKNV-----NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 565 --~~~~~~~~~~i~~~~~~~~~~~~~-----s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
....+++...+.....+|.+|..+ ...+.+.++.||.-|++.|.|+.=+.+.+.++......
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 122345556666677788877543 45689999999999999999999999999999887654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=302.44 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=217.6
Q ss_pred CCCCCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceee---
Q 006703 355 NPSGPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT--- 428 (634)
Q Consensus 355 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~--- 428 (634)
....+...++..+.||.|.+|.||+++.+ ++.+|+||+....... +++..|.++|+.. .|||++.++++|.
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34455678899999999999999999765 5669999986554333 4566889999988 6999999999984
Q ss_pred --cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEe
Q 006703 429 --EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 506 (634)
Q Consensus 429 --~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~D 506 (634)
.++.+|+|||||.|||..++++... ...+.|..+..|++.++.|+.+||.+. ++|||||-.|||++.++.+||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEee
Confidence 3567999999999999999997444 345999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCcccCCCCCCCCcccCcccccCCC-----CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc
Q 006703 507 FGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 581 (634)
Q Consensus 507 FGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~-----~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~ 581 (634)
||.+.....+.....+..|||.|||||++...+ |+..+|+||||++..||.-|.+|+...+++.....+. ...+
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-RNPP 245 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPP 245 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-CCCC
Confidence 999998888888888999999999999986543 5678999999999999999999999999988776663 2222
Q ss_pred cC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 LE--IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ~~--~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+. -|..++.++.++|..||.+|.++||+..++++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 22 34678999999999999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=275.86 Aligned_cols=241 Identities=26% Similarity=0.415 Sum_probs=197.4
Q ss_pred cceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEeeccc
Q 006703 366 SSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
.+.||+|+|+.|--+... +..+|||++.++..+ ...+..+|++++.++ .|+||++++++|+++..+|+|||.+.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH--sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH--SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCch--HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 368999999999888655 455999999887433 236788999999999 599999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC---CcEEEEecCCCccCCC----
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPN---- 515 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~---~~ikL~DFGla~~~~~---- 515 (634)
|+|...+++.. .+++..+..+.++|+.||.+||.+| |.|||+||+|||.... ..+||+||.+..-...
T Consensus 161 GplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 161 GPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred chHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99998887543 4999999999999999999999999 9999999999999643 4699999998753221
Q ss_pred ---CcccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-------H--------HHH
Q 006703 516 ---TYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTP-------S--------QVI 572 (634)
Q Consensus 516 ---~~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-------~--------~~~ 572 (634)
......+++|+..|||||+.. ...|++++|.|||||+||-|+.|++||.+.-. . ...
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 112235667888999999862 34579999999999999999999999965432 1 112
Q ss_pred HHHhhcCcccCCCC----CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 573 SAVGFKGRRLEIPK----NVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 573 ~~i~~~~~~~~~~~----~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..| +....++|. .++.+.+++|..+|..++.+|.++.+++.
T Consensus 316 esI--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESI--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHH--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 222 344555553 58999999999999999999999999887
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=271.73 Aligned_cols=218 Identities=22% Similarity=0.242 Sum_probs=180.5
Q ss_pred cCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCHHHHh
Q 006703 372 GSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL 449 (634)
Q Consensus 372 G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll 449 (634)
|.+|.||+++++.+ .+|+|.+.... .+.+|...+....||||+++++++......+++|||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999998644 49999986543 1224555556667999999999999999999999999999999998
Q ss_pred ccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCcc
Q 006703 450 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 529 (634)
Q Consensus 450 ~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y 529 (634)
.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+...... .....++..|
T Consensus 77 ~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y 148 (237)
T cd05576 77 SKFL---NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMY 148 (237)
T ss_pred HHhc---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccc
Confidence 6443 3889999999999999999999999 999999999999999999999999987654332 2334567789
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 006703 530 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 609 (634)
Q Consensus 530 ~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs 609 (634)
+|||.+.+..++.++|+||+|+++|+|++|..|+...... . .......+|..+++.+++++.+||+.||.+||+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 9999998888999999999999999999999887543211 0 112233466778999999999999999999999
Q ss_pred H
Q 006703 610 F 610 (634)
Q Consensus 610 ~ 610 (634)
+
T Consensus 223 ~ 223 (237)
T cd05576 223 A 223 (237)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=276.22 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=194.9
Q ss_pred cceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-CCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-~~~~ 433 (634)
..|...+.||+|.||.||+|..+++ .+|+|.++.+...........+|+.+++.++||||+.+...|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5677788999999999999954432 38999887663222222446699999999999999999999977 7889
Q ss_pred EEEEeecccCCHHHHhc--cCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC----CcEEEEec
Q 006703 434 SIVTEYLSRGSLYKLLH--IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST----YTVKVCDF 507 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~--~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~----~~ikL~DF 507 (634)
++++||.+. +|..+++ +......++...+.+|+.||+.|+.|||++. |+||||||.||||..+ |.+||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999976 7888874 2222346999999999999999999999999 9999999999999877 89999999
Q ss_pred CCCccCCCCc---ccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChH----------HHHH
Q 006703 508 GLSRSKPNTY---ISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPS----------QVIS 573 (634)
Q Consensus 508 Gla~~~~~~~---~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~----------~~~~ 573 (634)
|+++.+.+.. ......+-|..|+|||.+.|.. ||++.|||+.||++.||+|.++.|.+.... +...
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999866542 2345566799999999998765 699999999999999999998888543311 1100
Q ss_pred HHhhcCc-----cc---CCC--------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 574 AVGFKGR-----RL---EIP--------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 574 ~i~~~~~-----~~---~~~--------------------------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
-+...+. ++ .+| ..-++...+|+.+||+.||.+|.|+++.++.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 0000000 00 000 1123457889999999999999999998874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=285.17 Aligned_cols=263 Identities=26% Similarity=0.349 Sum_probs=211.5
Q ss_pred cccccCCCCCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-----HHHHHHHHHHHHHHHhCCCCCeee
Q 006703 350 DLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-----EDRFKEFLREVAIMKGLRHPNIVL 422 (634)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-----~~~~~~~~~El~iL~~l~h~nIv~ 422 (634)
..+.........+|..+..||+|+|+.||+|-+. .+-||+|+-...... ....+...+|.+|.+.|.||.||+
T Consensus 452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 3455566667788999999999999999999765 334899986544322 233466789999999999999999
Q ss_pred eeceee-cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc---C
Q 006703 423 LMGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---S 498 (634)
Q Consensus 423 l~~~~~-~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld---~ 498 (634)
+|++|. +.+.++-|+|||+|.+|.-||... ..++++.+..|+.||+.||.||....|+|||.||||.|||+- .
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence 999995 556799999999999999998744 359999999999999999999999999999999999999994 5
Q ss_pred CCcEEEEecCCCccCCCCccc-------CCCCCCCCcccCcccccCC----CCCchHHHHHHHHHHHHHHhCCCCCCCCC
Q 006703 499 TYTVKVCDFGLSRSKPNTYIS-------SKTAAGTPEWMAPEVLRED----PSNEKSDVFSFGVILWELITLQKPWRNST 567 (634)
Q Consensus 499 ~~~ikL~DFGla~~~~~~~~~-------~~~~~gt~~y~APEvl~~~----~~s~~sDVwSLGvlL~eLltg~~Pf~~~~ 567 (634)
.|.|||+|||+++.+....+. +....||.+|.+||.|.-. +.+.++||||.||++|.++.|+.||....
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 689999999999987654433 3456799999999998543 34889999999999999999999997755
Q ss_pred hHHHH-HH--Hh-hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 568 PSQVI-SA--VG-FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 568 ~~~~~-~~--i~-~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+.+ .. +. ......+..+-++.+.+.||.+||...-+.|.+..++..
T Consensus 689 sQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 689 SQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 43322 11 11 111122333568999999999999999999999888764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=293.54 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=197.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|.....+|.|+|+.|-.+.... ...++|++..... +-.+|+.++... +||||+++.+.+.++.+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 4566667779999999999998764 4489999876622 122677566555 799999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE-cCCCcEEEEecCCCccCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-DSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl-d~~~~ikL~DFGla~~~~~ 515 (634)
||.+.|+-+.+-+.... .....+..|+.+|+.|+.|||.+| +|||||||+|||+ +..++++|+|||.++....
T Consensus 395 ~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred ehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988777665332 222677789999999999999999 9999999999999 5899999999999986544
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
. ..+++-|..|.|||++....+++++|+||||++||+|++|+.||...... ++...+ ..+.+...++...++
T Consensus 469 ~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKd 541 (612)
T KOG0603|consen 469 S---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKD 541 (612)
T ss_pred h---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHH
Confidence 3 45678899999999999999999999999999999999999999876655 333333 344455889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
|+.+||..||++||++.++..
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHhccCChhhCcChhhhcc
Confidence 999999999999999999976
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=260.62 Aligned_cols=235 Identities=34% Similarity=0.542 Sum_probs=197.2
Q ss_pred CcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCHHHHhc
Q 006703 373 SFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 450 (634)
Q Consensus 373 ~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~ 450 (634)
+||.||+|...+ ..+++|++........ .+.+.+|++.+++++|+||+++++++......++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999875 5599999876543322 5788899999999999999999999999999999999999999999987
Q ss_pred cCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCccc
Q 006703 451 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 530 (634)
Q Consensus 451 ~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~ 530 (634)
.... +++..++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 80 ~~~~---~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 80 KRGR---LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred hccC---CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 5432 788999999999999999999999 9999999999999999999999999988654432 344567888999
Q ss_pred CcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhhcCcccCCCCC--CcHHHHHHHHHhhhcCCCCC
Q 006703 531 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKN--VNPMVAALIETCWAEEPEIR 607 (634)
Q Consensus 531 APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~--~s~~l~~Li~~cL~~dP~~R 607 (634)
+||.+.+...+.++|+||||+++++|++|..||.. ........... .......... ++..+.+++.+||..+|++|
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG-KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-ccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 99999988899999999999999999999999987 44444433332 2222221222 88999999999999999999
Q ss_pred CCHHHHHH
Q 006703 608 PSFPSIME 615 (634)
Q Consensus 608 Ps~~~Il~ 615 (634)
|++.++++
T Consensus 233 p~~~~~~~ 240 (244)
T smart00220 233 LTAEEALQ 240 (244)
T ss_pred cCHHHHhh
Confidence 99999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=296.56 Aligned_cols=256 Identities=33% Similarity=0.547 Sum_probs=221.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
......++||+|+||+||+|.+-.. +||+|++..... .....++.+|+-+|.+++|||++++++++.... +.
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 4556678999999999999987632 489998866543 334578999999999999999999999987655 88
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
||++|+++|+|.++++... ..+-.+..+.|.+||++||.|||.+. ++||||-..||||..-..+|+.|||+++...
T Consensus 774 lvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999999997543 34777889999999999999999999 9999999999999999999999999998765
Q ss_pred CCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 515 NTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 515 ~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
... +......-.+.|||-|.+....++.++|||||||++||++| |..|+.+....++...+. .+.++..|+.++-.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTID 928 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHH
Confidence 433 22333344678999999999999999999999999999998 899999998888776664 56678899999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+.-++.+||..|++.||+|+++...+..+.+.
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 99999999999999999999999999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=321.34 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=189.9
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
+...+.||+|+||.||+|+.. +..||+|.+...... ...|++.+++++||||+++++++.+++..++||||+
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 344568999999999999875 445999987543221 125688899999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
++++|.++++ .+++..+.+++.|+++||+|||.. .++|+||||||+||+++.++..++. ||.+.....
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999985 278889999999999999999943 1239999999999999998888775 665543211
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHh--hcC------cccCC-----
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--QVISAVG--FKG------RRLEI----- 584 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~--~~~~~i~--~~~------~~~~~----- 584 (634)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ... ..+.+
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 22346889999999999999999999999999999999999998543211 1111000 000 01111
Q ss_pred -CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 585 -PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 585 -~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+.....++.+++.+||..+|++|||+.++++.|+++.+..
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 1112335778999999999999999999999999998854
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=275.84 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=203.6
Q ss_pred ccccCCCCCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCC-C-C----Ceee
Q 006703 351 LQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-H-P----NIVL 422 (634)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h-~----nIv~ 422 (634)
+..+.......+|....++|+|.||.|-.+.+..++ ||+|+++.-. ...+..+-|+++|+++. + | -+++
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 334445556788999999999999999999887554 9999986543 22344567999999993 2 2 4788
Q ss_pred eeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-----
Q 006703 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD----- 497 (634)
Q Consensus 423 l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld----- 497 (634)
+.++|.-.++.+||+|.+ |.|+.+++..++. .+++..++..+++|+++++.+||+.+ ++|.||||+|||+.
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceE
Confidence 999999999999999998 7799999976554 35899999999999999999999999 99999999999992
Q ss_pred ---------------CCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC
Q 006703 498 ---------------STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP 562 (634)
Q Consensus 498 ---------------~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~P 562 (634)
++..|+|+|||.|+..... ..+.+.|..|+|||++.+-+|+.++||||+||+|+|+++|...
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 1346999999999875443 2577889999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhc-C------------------cccCCCC-------------------------CCcHHHHHHHHH
Q 006703 563 WRNSTPSQVISAVGFK-G------------------RRLEIPK-------------------------NVNPMVAALIET 598 (634)
Q Consensus 563 f~~~~~~~~~~~i~~~-~------------------~~~~~~~-------------------------~~s~~l~~Li~~ 598 (634)
|....+.+....+..- + .+...+. ..-..+.+|+.+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 9988866643222100 0 0111110 011358999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
||..||.+|+|+.+++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999886
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=262.73 Aligned_cols=242 Identities=21% Similarity=0.376 Sum_probs=204.3
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHH-HHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHED-RFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~-~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
..|.....||.|+|++|.+++.+.+. +|+|++++..+..+ ...=...|-.+..+. +||.+|.++.+|+.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 56788899999999999999887655 99999988766433 333345677777776 799999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
.||++||+|.-.+++. ..+++..+..+...|..||.|||++| |+.||||.+|||+|..|++||+|+|.++.--.+
T Consensus 330 ieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999986555433 34999999999999999999999999 999999999999999999999999999865555
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHhhcCcccCCCCCCc
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-------STPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
...+.+.+|||.|.|||++.+..|...+|+|+|||+++||+.|+.||+. .+..+....+ .......+|..++
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-ilekqiriprsls 483 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-ILEKQIRIPRSLS 483 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-Hhhhcccccceee
Confidence 5667899999999999999999999999999999999999999999952 1122222222 2445567788899
Q ss_pred HHHHHHHHHhhhcCCCCCC
Q 006703 590 PMVAALIETCWAEEPEIRP 608 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RP 608 (634)
-....+++.-|++||.+|.
T Consensus 484 vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhhHHHHHHhhcCCcHHhc
Confidence 8999999999999999994
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=264.76 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=197.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee--------c
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--------E 429 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~--------~ 429 (634)
...|....+||+|.||.||+|+.++++ ||+|++....-.........+|+++|+.++|+|++.++..+. +
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 366778889999999999999877544 787775443323323345679999999999999999999873 2
Q ss_pred CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
...+|+||.+|+. +|.-++.... ..++...+.+++.++..||.|+|... |+|||+||.|+||+++|.+||+|||+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccc
Confidence 3359999999965 8888886443 34888999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCccc----CCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc----
Q 006703 510 SRSKPNTYIS----SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---- 580 (634)
Q Consensus 510 a~~~~~~~~~----~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~---- 580 (634)
++.+...... -...+-|..|++||.+.|. .++++.|||..||++.||.++.+.+.+....+.+..+...-.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9764332111 1233458899999998765 579999999999999999999999999888776665532110
Q ss_pred --c--------------cCCCC-------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 581 --R--------------LEIPK-------------NVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 581 --~--------------~~~~~-------------~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+ ++++. .-.++..+|+..+|..||.+|+++++.+..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 11111 012467899999999999999999998863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=283.36 Aligned_cols=249 Identities=16% Similarity=0.173 Sum_probs=168.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeece------
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA------ 426 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~------ 426 (634)
....|...+.||+|+||.||+|.+..+ .+|+|.+...... +...++ .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 456789999999999999999988754 4999987543211 111111 1222222233322222
Q ss_pred eecCCcEEEEEeecccCCHHHHhccCCCc-----------------ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecc
Q 006703 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDAR-----------------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489 (634)
Q Consensus 427 ~~~~~~~~lV~E~~~ggsL~~ll~~~~~~-----------------~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDI 489 (634)
...+...++||||+.+++|.++++..... ....+..+..++.||+.||.|||+++ |+||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDL 281 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDV 281 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcC
Confidence 24556799999999999999998643211 01223456789999999999999999 999999
Q ss_pred CCCcEEEcC-CCcEEEEecCCCccCCCC-cccCCCCCCCCcccCcccccCCC----------------------CCchHH
Q 006703 490 KSPNLLVDS-TYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEVLREDP----------------------SNEKSD 545 (634)
Q Consensus 490 KP~NILld~-~~~ikL~DFGla~~~~~~-~~~~~~~~gt~~y~APEvl~~~~----------------------~s~~sD 545 (634)
||+|||++. ++.+||+|||+|...... ........+|+.|+|||.+.... ++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 679999999999754322 22334567899999999764322 234569
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc---------ccC----------CCCCCcHHHHHHHHHhhhcCCCC
Q 006703 546 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------RLE----------IPKNVNPMVAALIETCWAEEPEI 606 (634)
Q Consensus 546 VwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~---------~~~----------~~~~~s~~l~~Li~~cL~~dP~~ 606 (634)
||||||++|||+++..++.... ......+..... ... +.........+||.+||..||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999999777654321 111111110000 000 00112234568999999999999
Q ss_pred CCCHHHHHHH
Q 006703 607 RPSFPSIMET 616 (634)
Q Consensus 607 RPs~~~Il~~ 616 (634)
|||+.++++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999983
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=255.65 Aligned_cols=263 Identities=28% Similarity=0.461 Sum_probs=219.4
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcCCc-------EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeecee-e
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-T 428 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-------vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~-~ 428 (634)
....+++.....+-+|.||.||.|.+++.+ +.+|.++.+ .++-+...+..|-..+..+.|||+..+.+.. .
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 344466777778889999999999776433 555554433 3445567788999999999999999999987 5
Q ss_pred cCCcEEEEEeecccCCHHHHhc-----cCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEE
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 503 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~-----~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ik 503 (634)
+....++++.+..-|+|..++. .......++..+...++.|++.|++|||+++ +||.||-..|.+|++...+|
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEE
Confidence 5667899999999999999997 3333344677788889999999999999999 99999999999999999999
Q ss_pred EEecCCCccCCCCcccC--CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCc
Q 006703 504 VCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 580 (634)
Q Consensus 504 L~DFGla~~~~~~~~~~--~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~ 580 (634)
|+|=.+++......+.. ..-..+..||+||.+.+..++.++|+|||||++|||+| |+.|+...+|.++...++ .+.
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-dGy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-DGY 515 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-ccc
Confidence 99999998543222221 12234568999999999999999999999999999998 899999999999888774 677
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+...|.++|+++..++.-||...|++||++.|+...|.+|...
T Consensus 516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 8888999999999999999999999999999999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.19 Aligned_cols=130 Identities=25% Similarity=0.352 Sum_probs=111.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCC-----C---CCeeeeeceee--
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-----H---PNIVLLMGAVT-- 428 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-----h---~nIv~l~~~~~-- 428 (634)
.+|...++||.|-|++||++.+.... ||+|+.+... -..+..+.||++|++++ | .+||+++++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 89999999999999999999988544 9999986543 22345678999999983 2 48999999995
Q ss_pred --cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 429 --EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 429 --~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
.+.+++||+|++ |.+|..++.....++ ++...+..|++||+.||.|||... +|||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 456899999999 779999998776655 899999999999999999999874 49999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=279.35 Aligned_cols=251 Identities=28% Similarity=0.455 Sum_probs=219.3
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.+..+|.....+|+|+||.||+++++.+ ..|+|+++... .+..+-+..|+-+++..+|+||+.+++.+...+.++|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 4557888889999999999999998754 48999987653 2334556689999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
+||||.||+|.+.-+-. +++++.++....++.++|+.|||+.| -+|||||-.||+++..|.+||.|||.+-.+..
T Consensus 90 cMEycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhh
Confidence 99999999999987644 45999999999999999999999999 89999999999999999999999999987777
Q ss_pred CcccCCCCCCCCcccCcccc---cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc---CCCCCCc
Q 006703 516 TYISSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---EIPKNVN 589 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl---~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~s 589 (634)
.........||+.|||||+- ....|...+|||++|++..|+--.+.|....++++...........+ +-+...+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 77777889999999999986 56678999999999999999999999999999998877664433332 3345789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+.+|++.+|.++|++|||++.++.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhee
Confidence 99999999999999999999998775
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=282.78 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=191.8
Q ss_pred cceeecceeeccCcEE-EEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGT-VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~-Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.-|...+.+|.|+.|+ ||+|.+.++.||||.+.... .....+|+..|+.- .|||||++++.-.+.+..||..|
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3455567899999986 79999999999999875433 33455999999998 69999999999999999999999
Q ss_pred ecccCCHHHHhccCCCccc-ccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-----CCcEEEEecCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVV-VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSRS 512 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~-l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-----~~~ikL~DFGla~~ 512 (634)
.|. .+|.+++........ ...-..+.++.|+++||++||+.+ ||||||||.||||+. ...++|+|||+++.
T Consensus 584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 995 599999976311111 111345778999999999999999 999999999999975 24799999999987
Q ss_pred CCCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 513 KPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 513 ~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
..... .......||-+|+|||++.....+.++|||||||++|+.++| ..||...-..+........ ....+....
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~-~L~~L~~~~ 739 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY-TLVHLEPLP 739 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc-ceeeeccCc
Confidence 55432 224566799999999999999999999999999999999986 8999876554432221110 011111111
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+..+||.+|++++|..||++.+|+.
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 128999999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=268.88 Aligned_cols=255 Identities=19% Similarity=0.156 Sum_probs=181.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEc------------------CCcEEEEEEeeccccH--H----------HHHHHHHH
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR------------------NSDVAVKILIEQEFHE--D----------RFKEFLRE 408 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~------------------~~~vAvK~~~~~~~~~--~----------~~~~~~~E 408 (634)
....|...++||+|+||.||+|... +..||||.+....... + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4578999999999999999999641 2349999986432110 0 01223457
Q ss_pred HHHHHhCCCCCe-----eeeeceeec--------CCcEEEEEeecccCCHHHHhccCCC---------------------
Q 006703 409 VAIMKGLRHPNI-----VLLMGAVTE--------PPNLSIVTEYLSRGSLYKLLHIPDA--------------------- 454 (634)
Q Consensus 409 l~iL~~l~h~nI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~ll~~~~~--------------------- 454 (634)
+.++.+++|.++ +++++++.. ....++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 677777643 3568999999999999999863211
Q ss_pred cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-ccCCCCCCCCcccCcc
Q 006703 455 RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-ISSKTAAGTPEWMAPE 533 (634)
Q Consensus 455 ~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~-~~~~~~~gt~~y~APE 533 (634)
...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++....... .......+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 112456788899999999999999999 9999999999999999999999999986543221 1122334588999999
Q ss_pred cccCCCC----------------------CchHHHHHHHHHHHHHHhCCC-CCCCCChHH-----------HHHHHhhcC
Q 006703 534 VLREDPS----------------------NEKSDVFSFGVILWELITLQK-PWRNSTPSQ-----------VISAVGFKG 579 (634)
Q Consensus 534 vl~~~~~----------------------s~~sDVwSLGvlL~eLltg~~-Pf~~~~~~~-----------~~~~i~~~~ 579 (634)
++..... ..+.||||+||++++|+++.. ||....... .........
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9854321 124699999999999999875 665322110 001111111
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEP---EIRPSFPSIME 615 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP---~~RPs~~~Il~ 615 (634)
.........++...+|+.+||..+| .+|+|+.++++
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1222335678999999999999766 68999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=232.68 Aligned_cols=210 Identities=42% Similarity=0.649 Sum_probs=184.1
Q ss_pred eeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCHH
Q 006703 369 FIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~ 446 (634)
||+|++|.||++... +..+++|++....... ....+.+|+..++.++|++|+++++++......+++||++.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999988 6669999987654332 3467889999999999999999999999999999999999999999
Q ss_pred HHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCCCccCCCCcccCCCCCC
Q 006703 447 KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAG 525 (634)
Q Consensus 447 ~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGla~~~~~~~~~~~~~~g 525 (634)
+++.... ..+++..++.++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+..............+
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 9987542 24888999999999999999999999 999999999999998 899999999998765443222345668
Q ss_pred CCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCC
Q 006703 526 TPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604 (634)
Q Consensus 526 t~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP 604 (634)
...|++||.+... ..+.+.|+|++|+++++| +.+.+++.+|+..+|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p 202 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDP 202 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCc
Confidence 8899999999877 778999999999999998 789999999999999
Q ss_pred CCCCCHHHHHHH
Q 006703 605 EIRPSFPSIMET 616 (634)
Q Consensus 605 ~~RPs~~~Il~~ 616 (634)
.+||++.++++.
T Consensus 203 ~~R~~~~~l~~~ 214 (215)
T cd00180 203 EKRPSAKEILEH 214 (215)
T ss_pred ccCcCHHHHhhC
Confidence 999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=267.25 Aligned_cols=257 Identities=22% Similarity=0.263 Sum_probs=209.6
Q ss_pred ccccCCCCCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC------CCCeee
Q 006703 351 LQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR------HPNIVL 422 (634)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~------h~nIv~ 422 (634)
+.+..+......|.+....|+|-||+|.+|.+. +..|||||+..... ..+.=..|+.+|++|+ --|+++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 345556667789999999999999999999876 45599999987643 3344558999999995 248999
Q ss_pred eeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCc
Q 006703 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYT 501 (634)
Q Consensus 423 l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ 501 (634)
++.+|...+++|||||.+ ..+|.++|.+-+.+..+....+..++.|++-||..|-..| |+|.||||+|||+++ +..
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcce
Confidence 999999999999999998 5699999988777777999999999999999999999999 999999999999984 568
Q ss_pred EEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc
Q 006703 502 VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 581 (634)
Q Consensus 502 ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~ 581 (634)
+||||||.|....... ..+..-+..|+|||++.|.+|+...|+||.||+||||.||+..|.+.++.++...+.....+
T Consensus 576 LKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 9999999987654432 22334456899999999999999999999999999999999999998887776543211100
Q ss_pred -------------------------------------------c------------CCCC---CCcHHHHHHHHHhhhcC
Q 006703 582 -------------------------------------------L------------EIPK---NVNPMVAALIETCWAEE 603 (634)
Q Consensus 582 -------------------------------------------~------------~~~~---~~s~~l~~Li~~cL~~d 603 (634)
| .+|. ..-..+.+|+.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 0 0000 01135899999999999
Q ss_pred CCCCCCHHHHHH
Q 006703 604 PEIRPSFPSIME 615 (634)
Q Consensus 604 P~~RPs~~~Il~ 615 (634)
|++|.|..|.|.
T Consensus 734 P~KRit~nqAL~ 745 (752)
T KOG0670|consen 734 PEKRITVNQALK 745 (752)
T ss_pred hhhcCCHHHHhc
Confidence 999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=235.26 Aligned_cols=214 Identities=26% Similarity=0.406 Sum_probs=171.6
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~ 434 (634)
...+.......||.|++|.|-+-++..++ .|+|.+...-. ....++..+|+.+..+. .+|.+|.+++.+.+....+
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 34455666788999999998777766444 89999876644 44557888999887766 7999999999999999999
Q ss_pred EEEeecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 435 IVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
|.||.+. .||..+-.. -.....++|..+-+|+..+++||.|||++- .++|||+||+||||+..|.+|+||||++-..
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999994 588877641 112234899999999999999999999874 3999999999999999999999999999876
Q ss_pred CCCcccCCCCCCCCcccCccccc----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLR----EDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAV 575 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i 575 (634)
.+.. ...-..|...|||||.+. ...|+-++||||||+++.||.+++.||..+.. -+...++
T Consensus 200 ~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 200 VDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 5542 222356888999999874 34688999999999999999999999987653 3333333
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=266.15 Aligned_cols=201 Identities=25% Similarity=0.412 Sum_probs=173.6
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHH------HHHHHHHHHHHHhCC---CCCeeeeece
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDR------FKEFLREVAIMKGLR---HPNIVLLMGA 426 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~------~~~~~~El~iL~~l~---h~nIv~l~~~ 426 (634)
.....|...+.+|.|+||.|++|.++... |+||.+.+.+.-.+. +-.+-.|+.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34456888899999999999999988554 889988777543322 223667999999996 9999999999
Q ss_pred eecCCcEEEEEeec-ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 427 VTEPPNLSIVTEYL-SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 427 ~~~~~~~~lV~E~~-~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
|++++++||+||-. +|.+|.+++..+. .++|..+..|++|++-|+++||++| |||||||-+||+++.+|-+||+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEe
Confidence 99999999999965 4668999997543 4999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCcccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCC
Q 006703 506 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRN 565 (634)
Q Consensus 506 DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~ 565 (634)
|||.|....+. ......||..|.|||++.|.+| ++.-|||+||++||.++....||.+
T Consensus 713 dfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998765443 3467789999999999999988 7788999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=247.90 Aligned_cols=245 Identities=26% Similarity=0.333 Sum_probs=197.4
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------c
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------N 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------~ 432 (634)
.+|...+.+|.|.. .|.-+-+. +++||+|....+.......++..+|+.++..++|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57788888999998 66666443 777999998766444455577889999999999999999999996543 4
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.|+|||++.. +|...+. ..++-..+.+|++|++.|+.|||+.| |+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcc
Confidence 8999999955 8888876 23777889999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-C------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G------------ 579 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~------------ 579 (634)
.... ......+.|..|+|||++.+.++.+.+||||+||++.||++|...|.+.+.-+....+... +
T Consensus 168 e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 5544 3456778899999999999999999999999999999999999999876643322222110 0
Q ss_pred -------ccc---------CCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -------RRL---------EIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -------~~~---------~~~-----------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.++ .+| +.-....++++.+||..||++|.+++++|.
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 011 112345899999999999999999999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=229.79 Aligned_cols=244 Identities=22% Similarity=0.355 Sum_probs=191.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCC--c
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP--N 432 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~--~ 432 (634)
+....|...+++|+|-|+.||.|... +.+++||+++.. ..+.+.+|+++|+.++ ||||+++++...+.. .
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 35578889999999999999999854 566999997543 3467889999999996 999999999997654 5
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEEecCCCc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSR 511 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~DFGla~ 511 (634)
..+++||+.+.+...+.. .++...+..++.++++||.|+|+.| |+|||+||.|++|| ..-..+|+|+|+|.
T Consensus 110 paLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred chhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHh
Confidence 789999999887776653 2777788899999999999999999 99999999999998 45689999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCC-CCh-HHHHHHHhhcC---------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRN-STP-SQVISAVGFKG--------- 579 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~-~~~-~~~~~~i~~~~--------- 579 (634)
..... ..-.-.+.+..|..||.+.. ..++.+-|+|||||+|..|+..+.||.. .++ ++...-....+
T Consensus 182 FYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 182 FYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 75332 23345567788999999854 5579999999999999999999999854 332 33221111000
Q ss_pred -----ccc--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -----RRL--------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -----~~~--------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+ ....-.+++..+|+.++|..|-.+|+|+.+.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000 001124689999999999999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-28 Score=241.00 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=193.4
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC----
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP---- 431 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~---- 431 (634)
.....+...+.||-|+||.||.+.+. +..+++|.+..-...-..-+++.+|+++|.-++|.|++..++..+...
T Consensus 50 qqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 50 QQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred cccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 33445566778999999999999876 444899887554333344578899999999999999999998876544
Q ss_pred -cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 432 -NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 432 -~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
.+|+++|.+. .+|..++-..+ .++...++-+++||++||.|||+.+ |.||||||.|+|++.+...||||||++
T Consensus 130 qEiYV~TELmQ-SDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 130 QELYVLTELMQ-SDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHHHH-hhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccc
Confidence 3678889885 47887776554 3888899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCc-ccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC---------
Q 006703 511 RSKPNTY-ISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------- 579 (634)
Q Consensus 511 ~~~~~~~-~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~--------- 579 (634)
+...... ......+-|-.|+|||++.|.. |+.+.||||.||++.||+..+..|...++-+....+...-
T Consensus 204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 9754321 1122234577899999997754 7999999999999999999999998888765544332110
Q ss_pred ---------------cccCCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 ---------------RRLEIP--------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ---------------~~~~~~--------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+.++ ..-..+...+...++..+|++|.+..+.+.
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 011111 123356777888899999999988776654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=224.02 Aligned_cols=207 Identities=36% Similarity=0.536 Sum_probs=173.8
Q ss_pred eecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 364 IDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
...+.||+|++|.||++...+ ..+++|.+...... ...+.+.+|+..+++++|+|++++++++......++++|+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456789999999999998875 56999998765433 245678899999999999999999999999999999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-ccC
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-ISS 520 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~-~~~ 520 (634)
+++|.+++...... +++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999998754321 788899999999999999999999 9999999999999999999999999987654331 122
Q ss_pred CCCCCCCcccCcccc-cCCCCCchHHHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHH
Q 006703 521 KTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELITLQKPWRN-STPS-QVISAV 575 (634)
Q Consensus 521 ~~~~gt~~y~APEvl-~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~-~~~~-~~~~~i 575 (634)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++. ++...+
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 345678899999999 667778899999999999999999999977 3443 444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=222.52 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=189.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeec-eeecCCcEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG-AVTEPPNLS 434 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~-~~~~~~~~~ 434 (634)
....|...+.||+|.||.+-+++++++. +++|.+..+. ...++|.+|..---.| .|.||+.-|+ .|+..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3467888899999999999999999765 8888876543 3346788886554444 5899997766 467778899
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc--CCCcEEEEecCCCcc
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRS 512 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld--~~~~ikL~DFGla~~ 512 (634)
+++||++.|+|..-+...+ +-|.-...++.|++.||.|+|+++ +||||||.+||||- +...+||||||+.+.
T Consensus 99 F~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccc
Confidence 9999999999998776433 777888899999999999999999 99999999999994 334899999999886
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCC-----CCchHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhhcCcccCC
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDP-----SNEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEI 584 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~-----~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~---~~~~i~~~~~~~~~ 584 (634)
.+.+. .....+-.|.+||+..... ..+.+|+|.||++++.++||.+||.....++ ...........+..
T Consensus 173 ~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 173 VGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred cCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 54432 3344567899999875433 2678899999999999999999997533222 11122222333344
Q ss_pred C---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 585 P---KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 585 ~---~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
| ...++.+..++++-|+.++++|--..+..+.-..
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 4 4578889999999999999999666666555433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=235.93 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=192.3
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE 429 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~ 429 (634)
.......|...++||+|+|++||++.+.. ..||+|.+...... .++.+|+++|..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 34555778889999999999999997654 34999998765432 4577999999999 58999999999999
Q ss_pred CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEEecC
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFG 508 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~DFG 508 (634)
++...+|+||++.....++.. .++...+..+++.++.||.++|++| ||||||||+|+|.+ ..+.-.|+|||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEech
Confidence 999999999999999888875 2667888999999999999999999 99999999999998 56788999999
Q ss_pred CCccCC-----------------C------------------Cc---------ccCCCCCCCCcccCcccccCCCC-Cch
Q 006703 509 LSRSKP-----------------N------------------TY---------ISSKTAAGTPEWMAPEVLREDPS-NEK 543 (634)
Q Consensus 509 la~~~~-----------------~------------------~~---------~~~~~~~gt~~y~APEvl~~~~~-s~~ 543 (634)
+|.... . .. .......||++|+|||++...+. +++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 996100 0 00 00112359999999999977665 889
Q ss_pred HHHHHHHHHHHHHHhCCCCCCCCChH-----HHH---------HHHhhcCc--------c------------c-------
Q 006703 544 SDVFSFGVILWELITLQKPWRNSTPS-----QVI---------SAVGFKGR--------R------------L------- 582 (634)
Q Consensus 544 sDVwSLGvlL~eLltg~~Pf~~~~~~-----~~~---------~~i~~~~~--------~------------~------- 582 (634)
+||||.||+++.++++..||.....+ ++. ......+. . .
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 99999999999999999998654321 111 00000000 0 0
Q ss_pred --------C-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 --------E-IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 --------~-~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. .....+..+.+|+.+||..||.+|.|+++.|+
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 00123457899999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-24 Score=224.97 Aligned_cols=257 Identities=21% Similarity=0.220 Sum_probs=204.6
Q ss_pred ceeecceeeccCcEEEEEEEEcCCc---EEEEEEeeccccHHHHHHHHHHHHHHHhCC----CCCeeeeecee-ecCCcE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLR----HPNIVLLMGAV-TEPPNL 433 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~---vAvK~~~~~~~~~~~~~~~~~El~iL~~l~----h~nIv~l~~~~-~~~~~~ 433 (634)
.|...++||+|+||.||++.+.... +|+|+......... ..+..|..++..+. ..++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7999999999999999999987653 88888765432211 14567888888885 36999999999 588889
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC-----CcEEEEecC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-----YTVKVCDFG 508 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~-----~~ikL~DFG 508 (634)
||||+.+ |.+|.++..... ...++...+..|+.|++.+|.+||+.| ++||||||+|+++... ..++|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999988 889999886444 445999999999999999999999999 9999999999999754 469999999
Q ss_pred CCc--cCCCCc----cc----CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 006703 509 LSR--SKPNTY----IS----SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 578 (634)
Q Consensus 509 la~--~~~~~~----~~----~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~ 578 (634)
+++ ...... .. .....||.+|+++.+..+...+++.|+||++.++.+++.|..||...........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 321111 01 12344999999999999999999999999999999999999999776643333332221
Q ss_pred CcccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 579 GRRLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 579 ~~~~~---~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
..... .....+.++..+...+-..+..++|.+..+...|+......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111 33456788888888888899999999999999999988875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-25 Score=209.62 Aligned_cols=165 Identities=19% Similarity=0.296 Sum_probs=130.6
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
|+|.+++...+ ..+++..++.++.|+++||.|||+++ ||+||+++.++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~ 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----Q 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----c
Confidence 68899987433 34999999999999999999999987 999999999999999 9998765432 2
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhhcCccc-----CCCCCCcH--HHHH
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRL-----EIPKNVNP--MVAA 594 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~-----~~~~~~s~--~l~~ 594 (634)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....... ..+..+++ .+.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD 143 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence 368999999999999999999999999999999999999997654322 121211110100 11222333 6999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
++.+||..+|++|||+.++++.+..+..+.
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 999999999999999999999998876653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=261.74 Aligned_cols=193 Identities=23% Similarity=0.260 Sum_probs=140.7
Q ss_pred CCC-CCeeeeecee-------ecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 006703 415 LRH-PNIVLLMGAV-------TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486 (634)
Q Consensus 415 l~h-~nIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvH 486 (634)
++| .||+++++++ .....++.+||++ +++|.+++.... ..+++..++.++.||++||.|||++| |+|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 345 5777788877 3345678889988 569999997433 34899999999999999999999999 999
Q ss_pred eccCCCcEEEcCCC-------------------cEEEEecCCCccCCCCc----------------ccCCCCCCCCcccC
Q 006703 487 RDLKSPNLLVDSTY-------------------TVKVCDFGLSRSKPNTY----------------ISSKTAAGTPEWMA 531 (634)
Q Consensus 487 rDIKP~NILld~~~-------------------~ikL~DFGla~~~~~~~----------------~~~~~~~gt~~y~A 531 (634)
|||||+||||+..+ .+|++|||+++...... .......||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 45566666654321100 00112357889999
Q ss_pred cccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 006703 532 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 611 (634)
Q Consensus 532 PEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~ 611 (634)
||++.+..++.++|||||||+||||++|..|+..... ....+......+.. ....+....++.+||.++|.+||++.
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChH
Confidence 9999999999999999999999999999888754221 11122111111111 11245567889999999999999999
Q ss_pred HHHH
Q 006703 612 SIME 615 (634)
Q Consensus 612 ~Il~ 615 (634)
++++
T Consensus 261 eil~ 264 (793)
T PLN00181 261 ELLQ 264 (793)
T ss_pred HHhh
Confidence 9986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=217.45 Aligned_cols=251 Identities=30% Similarity=0.596 Sum_probs=215.7
Q ss_pred ecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCC
Q 006703 365 DSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGS 444 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggs 444 (634)
..-+|.+...|..|+|++.+..++.|++...........+|.+|.-.|+-+.||||+.+++.+....++.++..|++.|+
T Consensus 194 l~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34567788899999999999999999987766655555778899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCC
Q 006703 445 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 524 (634)
Q Consensus 445 L~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~ 524 (634)
|+.+++... ....+..++.+++.++++|++|||+..|-|----|....++||++.+.+|.--. +++ ........
T Consensus 274 lynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad-~kf----sfqe~gr~ 347 (448)
T KOG0195|consen 274 LYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMAD-TKF----SFQEVGRA 347 (448)
T ss_pred HHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccc-cee----eeeccccc
Confidence 999998543 345788899999999999999999998655566789999999999887764211 111 01223455
Q ss_pred CCCcccCcccccCCCC---CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 006703 525 GTPEWMAPEVLREDPS---NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601 (634)
Q Consensus 525 gt~~y~APEvl~~~~~---s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~ 601 (634)
..|.|++||.++.++. -+++|+|||++++|||.|...||....+++.-..+...+.+..+|+.++..+..|+.-|++
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmn 427 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMN 427 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhc
Confidence 6789999999988775 3578999999999999999999999999998888888999999999999999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHH
Q 006703 602 EEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 602 ~dP~~RPs~~~Il~~L~~ll 621 (634)
.||.+||.|+.|+-.|++++
T Consensus 428 edpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 428 EDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCcCCCcceehhhHHHhc
Confidence 99999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-22 Score=203.00 Aligned_cols=251 Identities=32% Similarity=0.467 Sum_probs=203.2
Q ss_pred eeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHH-HHHHHHHHHHHHHhCCCC-CeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHED-RFKEFLREVAIMKGLRHP-NIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~-~~~~~~~El~iL~~l~h~-nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
|...+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566778999999999999888 6689999877655443 567899999999999988 7999999997777789999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCccCCCCcc-
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYI- 518 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~~~~~~~- 518 (634)
.++++.+++........++......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999977754331124888999999999999999999999 99999999999999888 799999999875443321
Q ss_pred -----cCCCCCCCCcccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhcCcc-c--C
Q 006703 519 -----SSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRR-L--E 583 (634)
Q Consensus 519 -----~~~~~~gt~~y~APEvl~~---~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~----~~~~~~i~~~~~~-~--~ 583 (634)
......||..|++||.+.+ ...+...|+|++|++++++++|..||..... .+....+...... . .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2467789999999999988 5778999999999999999999999877663 3444333322222 1 1
Q ss_pred CCCCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 584 IPKNV----NPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 584 ~~~~~----s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
..... ...+.+++.+++..+|..|.+.......
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11222 2689999999999999999998887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=201.13 Aligned_cols=260 Identities=20% Similarity=0.261 Sum_probs=211.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~l 435 (634)
....|...++||+|+||.+|.|.... ..||||+-....-+ .++..|.++.+.++ ...|..+..+..+..+-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 34788999999999999999998764 45999987554332 34568889999986 4788889999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc---CCCcEEEEecCCCcc
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRS 512 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld---~~~~ikL~DFGla~~ 512 (634)
||+.+ |.+|+++++....+ ++.++++-++-|++.-++|+|.++ ++||||||+|+|.. -...+.|+|||+|+.
T Consensus 89 VMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhh
Confidence 99998 88999999755443 888899999999999999999999 99999999999995 345799999999985
Q ss_pred CCC-------CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhhc---C
Q 006703 513 KPN-------TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS---AVGFK---G 579 (634)
Q Consensus 513 ~~~-------~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~---~i~~~---~ 579 (634)
.-+ ++.......||.+|.+=....+...+.+.|+-|+|.+|..+..|..||.+..+....+ .+... .
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 432 2333456679999999888888888999999999999999999999999877643322 22211 1
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
....+....|.++...+.-|-..--++-|+...+-+.++-++.+..-+
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~ 291 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQ 291 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcccc
Confidence 122345778999999999999999999999999999999888765443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-23 Score=207.32 Aligned_cols=257 Identities=18% Similarity=0.257 Sum_probs=212.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
...+|.+.++||+|+||..+.|.+. +..||||.-.... ..-++..|.+.++.| ..++|...+.+..++.+..|
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 3467999999999999999999754 7779999864432 224567888899888 57999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-----CCcEEEEecCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLS 510 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-----~~~ikL~DFGla 510 (634)
|+|.+ |.||+++..-.+.+ ++.+.+..++.||+.-++|+|++. +|.|||||+|+||.. ...|.++|||+|
T Consensus 102 VidLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 99999 88999998755543 889999999999999999999999 999999999999963 336999999999
Q ss_pred ccCCC-------CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhcCc
Q 006703 511 RSKPN-------TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGR 580 (634)
Q Consensus 511 ~~~~~-------~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~---~~~~~i~~~~~ 580 (634)
+...+ ++.......||.+||+=....|..-+.+.|+-|||-++++++.|..||.+.... +....|.....
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 85432 233456677999999999999999999999999999999999999999886643 33444433322
Q ss_pred cc---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 581 RL---EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 581 ~~---~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.. .+...+|.++..-+.-.-+.+-.+-|+++.+...|..++...
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 22 244678999999999999999999999999999999988653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=206.24 Aligned_cols=165 Identities=19% Similarity=0.192 Sum_probs=126.5
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC---CcEEEEEEeeccc---cHHHHHHHHHHHHHHHhCCCCCeee-eeceeecCC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN---SDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVL-LMGAVTEPP 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---~~vAvK~~~~~~~---~~~~~~~~~~El~iL~~l~h~nIv~-l~~~~~~~~ 431 (634)
....|...+.||+|+||+||+|.++. ..+|||++..... .......+.+|+++|++++|+||+. ++++ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 34678899999999999999998753 3379998653311 2334466899999999999999985 4432 4
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecc-CCCcEEEcCCCcEEEEecCCC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL-KSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDI-KP~NILld~~~~ikL~DFGla 510 (634)
..|+||||++|++|... . . .. ...++.++++||.|||++| |+|||| ||+|||++.++.+||+|||+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~-~-----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R-P-----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-C-c-----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 57999999999999632 1 1 11 1467889999999999999 999999 999999999999999999999
Q ss_pred ccCCCCcc--------cCCCCCCCCcccCcccccCCC
Q 006703 511 RSKPNTYI--------SSKTAAGTPEWMAPEVLREDP 539 (634)
Q Consensus 511 ~~~~~~~~--------~~~~~~gt~~y~APEvl~~~~ 539 (634)
+....... ......+++.|+|||.+....
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 86433211 113456888999999985443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=226.86 Aligned_cols=246 Identities=23% Similarity=0.292 Sum_probs=189.5
Q ss_pred eecceeeccCcEEEEEEEEc--CCcEEEEEEe----eccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 364 IDSSNFIKGSFGTVYHAEWR--NSDVAVKILI----EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~----~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
.....+|.|++|.|+.+... ...++.|... ...........+..|+.+-.+++|+|++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988777544 2224444332 22222233334778888889999999998888887777666669
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|||++ +|..++... ..+....+-.++.|++.|+.|||..| |.|||+||+|++++.+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999988754 23777788899999999999999999 9999999999999999999999999987643322
Q ss_pred ----ccCCCCCCCCcccCcccccCCCCCc-hHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhh------cCcccCCC
Q 006703 518 ----ISSKTAAGTPEWMAPEVLREDPSNE-KSDVFSFGVILWELITLQKPWRNSTPSQVI-SAVGF------KGRRLEIP 585 (634)
Q Consensus 518 ----~~~~~~~gt~~y~APEvl~~~~~s~-~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~-~~i~~------~~~~~~~~ 585 (634)
......+|+..|.|||++.+..|.+ ..||||.|+++..|.+|+.||......+.. ..... ......+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 3356778999999999999999965 579999999999999999999765543322 11110 11112233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 586 KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 586 ~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..++...+.+|.+||..+|.+|.|+.+|++
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 467889999999999999999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-22 Score=216.54 Aligned_cols=225 Identities=26% Similarity=0.360 Sum_probs=186.6
Q ss_pred eeccCcEEEEEEEEc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEeeccc
Q 006703 369 FIKGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
+|+|+||.|++++.- +..+|+|+.++.............|..++..++ ||.++++..+++.+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 689999999987432 444888888766543332235557888888886 99999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
+.|...+.... .+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-... .
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----~ 152 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----I 152 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhh----h
Confidence 98877665333 2677777788889999999999999 9999999999999999999999999998644332 2
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
.+||..|||||++. ....++|.||+|++.+||++|..||.. ++...| ....+..|..++...++++..++..
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhh
Confidence 29999999999998 667889999999999999999999988 333333 4456778899999999999999999
Q ss_pred CCCCCCCH
Q 006703 603 EPEIRPSF 610 (634)
Q Consensus 603 dP~~RPs~ 610 (634)
+|..|.-.
T Consensus 225 ~p~nrLg~ 232 (612)
T KOG0603|consen 225 NPENRLGA 232 (612)
T ss_pred CHHHHhcc
Confidence 99999655
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.5e-20 Score=184.14 Aligned_cols=172 Identities=14% Similarity=0.151 Sum_probs=134.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHH-HHHH------HHHHHHHHHhCCCCCeeeeeceeecC--
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHED-RFKE------FLREVAIMKGLRHPNIVLLMGAVTEP-- 430 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~-~~~~------~~~El~iL~~l~h~nIv~l~~~~~~~-- 430 (634)
..+|...+.||.|+||.||++...+..+|+|++........ .... +.+|++.+.++.|++|..+.+++.+.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 47899999999999999999887777899999876543322 2233 57899999999999999999886543
Q ss_pred ------CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEE
Q 006703 431 ------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 504 (634)
Q Consensus 431 ------~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL 504 (634)
...+++|||++|.+|.++.. +++ ....+++.+|..||..| ++|||+||+||+++.++ ++|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEE
Confidence 35889999999999988742 333 24569999999999999 99999999999999888 999
Q ss_pred EecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHH
Q 006703 505 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 557 (634)
Q Consensus 505 ~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLl 557 (634)
+|||.......... ....+....+..++|+|+||+++.-+.
T Consensus 176 iDfg~~~~~~e~~a------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKA------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhh------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99998765422110 011334445667899999999998765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-20 Score=212.95 Aligned_cols=245 Identities=21% Similarity=0.245 Sum_probs=184.4
Q ss_pred ceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEF--HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~--~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.+...+.||++.|=+|.+|++.+..|+||++.++.. +-....+-..|++ ...+++||++++.-....+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 567788999999999999999888899999977652 3333445555666 5666999999999988888889999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc--CCCCc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTY 517 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~--~~~~~ 517 (634)
+.. +|+|.+. .+..+.....+.|+.|++.||..+|..| |+|||||.+||||+..+.+.|+||..-+. .+...
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 955 8988875 3456888888899999999999999999 99999999999999999999999986543 22111
Q ss_pred c-c----CCCCCCCCcccCcccccCC----------C-CCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCc
Q 006703 518 I-S----SKTAAGTPEWMAPEVLRED----------P-SNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 580 (634)
Q Consensus 518 ~-~----~~~~~gt~~y~APEvl~~~----------~-~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~ 580 (634)
. . ..+......|.|||.|... + .+++-||||+||+++||++ |++||.-...-. .-.....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a---Yr~~~~~ 253 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA---YRSGNAD 253 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh---HhccCcc
Confidence 0 1 1122234479999988542 2 4678899999999999998 577775332111 1100000
Q ss_pred c--cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 581 R--LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 581 ~--~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
. .-+...-++.+++||..|+..||.+|.++++.|+.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 01112235589999999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=185.89 Aligned_cols=236 Identities=18% Similarity=0.252 Sum_probs=154.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCC----------CCeeeeece
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRH----------PNIVLLMGA 426 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h----------~nIv~l~~~ 426 (634)
...++..+.||.|+++.||.+++.. +.+|+|++..... .....+++.+|.-....+.+ -.++..++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 3567788999999999999999987 4599999865542 23355677777655554322 223333332
Q ss_pred ee---------cC---C-----cEEEEEeecccCCHHHHhcc----CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 006703 427 VT---------EP---P-----NLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485 (634)
Q Consensus 427 ~~---------~~---~-----~~~lV~E~~~ggsL~~ll~~----~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~Iv 485 (634)
.. .. . +.+++|+-+ .++|.+++.. ......+....+..+..|+++.+++||++| ++
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lV 167 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LV 167 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eE
Confidence 21 11 1 246788877 4588888641 222223444455677799999999999999 99
Q ss_pred eeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccC--------CCCCchHHHHHHHHHHHHHH
Q 006703 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--------DPSNEKSDVFSFGVILWELI 557 (634)
Q Consensus 486 HrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~--------~~~s~~sDVwSLGvlL~eLl 557 (634)
|+||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999877654432211 344578999997643 24688999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 006703 558 TLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607 (634)
Q Consensus 558 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~R 607 (634)
++..||....+..... ........+|+.++.||..+|..||++|
T Consensus 245 C~~lPf~~~~~~~~~~------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999998765432111 0222233789999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=177.85 Aligned_cols=140 Identities=20% Similarity=0.156 Sum_probs=105.9
Q ss_pred cceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHH------------------------HHHHHHHHHHHHhCCCCCe
Q 006703 366 SSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDR------------------------FKEFLREVAIMKGLRHPNI 420 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~------------------------~~~~~~El~iL~~l~h~nI 420 (634)
.+.||+|+||.||+|... +..||+|+++........ ......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999875 566999999765321111 1123459999999987776
Q ss_pred eeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHH-HhCCCCEEeeccCCCcEEEcCC
Q 006703 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL-HQRRPPIVHRDLKSPNLLVDST 499 (634)
Q Consensus 421 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yL-H~~g~~IvHrDIKP~NILld~~ 499 (634)
.....+.. ...+|||||++|+++....... ..+++..+..++.|++.+|.+| |+.| |+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence 44332222 2238999999987775543212 2488899999999999999999 6889 99999999999998 4
Q ss_pred CcEEEEecCCCccC
Q 006703 500 YTVKVCDFGLSRSK 513 (634)
Q Consensus 500 ~~ikL~DFGla~~~ 513 (634)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=170.90 Aligned_cols=185 Identities=17% Similarity=0.149 Sum_probs=139.1
Q ss_pred ecceeeccCcEEEEEEEEcCCcEEEEEEeeccccH--HHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEeecc
Q 006703 365 DSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHE--DRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~--~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
....|++|+||+||.+...+.+++.+.+.....-. -....+.+|+++|+++. |++|++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 34679999999999988777777777665544311 11235789999999995 5889999886 45799999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecc-CCCcEEEcCCCcEEEEecCCCccCCCCccc-
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL-KSPNLLVDSTYTVKVCDFGLSRSKPNTYIS- 519 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDI-KP~NILld~~~~ikL~DFGla~~~~~~~~~- 519 (634)
|.+|...+.. ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9998654321 11357789999999999999 999999 799999999999999999999854432210
Q ss_pred ------------CCCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCC
Q 006703 520 ------------SKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRN 565 (634)
Q Consensus 520 ------------~~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~Pf~~ 565 (634)
......++.|+.|+...- .+.-...+.++.|..+|.++|+..|+-.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 011226778888876432 2223567999999999999999988644
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=170.89 Aligned_cols=141 Identities=21% Similarity=0.180 Sum_probs=108.8
Q ss_pred cceeeccCcEEEEEEEEc-CCcEEEEEEeeccccH------------------------HHHHHHHHHHHHHHhCCCCCe
Q 006703 366 SSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHE------------------------DRFKEFLREVAIMKGLRHPNI 420 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~------------------------~~~~~~~~El~iL~~l~h~nI 420 (634)
.+.||+|++|.||+|.+. ++.||||++....... .....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357999999999999876 6679999987652110 001234578999999999887
Q ss_pred eeeeceeecCCcEEEEEeecccCCHHHH-hccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcC
Q 006703 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKL-LHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDS 498 (634)
Q Consensus 421 v~l~~~~~~~~~~~lV~E~~~ggsL~~l-l~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~ 498 (634)
.....+... ..++||||++|+++... +.. ..++...+..++.|++.++.+||+ .| |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-
Confidence 544443333 24899999998755333 321 237788889999999999999999 99 99999999999998
Q ss_pred CCcEEEEecCCCccCCC
Q 006703 499 TYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 499 ~~~ikL~DFGla~~~~~ 515 (634)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=179.74 Aligned_cols=197 Identities=24% Similarity=0.361 Sum_probs=152.3
Q ss_pred CCCCeeeeeceeec---------------------------CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHH
Q 006703 416 RHPNIVLLMGAVTE---------------------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 468 (634)
Q Consensus 416 ~h~nIv~l~~~~~~---------------------------~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~ 468 (634)
+|||||++..+|.+ +..+|+||..++. +|..++-... .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 69999999998732 3458999998865 9999986443 55567778899
Q ss_pred HHHHHHHHHHhCCCCEEeeccCCCcEEEc--C--CCcEEEEecCCCccCCCCcc------cCCCCCCCCcccCcccccCC
Q 006703 469 DVAKGMNYLHQRRPPIVHRDLKSPNLLVD--S--TYTVKVCDFGLSRSKPNTYI------SSKTAAGTPEWMAPEVLRED 538 (634)
Q Consensus 469 qIa~aL~yLH~~g~~IvHrDIKP~NILld--~--~~~ikL~DFGla~~~~~~~~------~~~~~~gt~~y~APEvl~~~ 538 (634)
|+++|+.|||++| |.|||+|.+|||+. . -....|+|||.+-...+... .....-|...-||||+....
T Consensus 349 QlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999999 99999999999994 3 33688999997653322111 11233477889999998654
Q ss_pred C------CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 006703 539 P------SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPS 612 (634)
Q Consensus 539 ~------~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~ 612 (634)
+ .-.++|.|+.|.+.||+++...||.+...+-.-..-......+.+|..+++.++.++...|+.||.+|++.+-
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 3 1458999999999999999999998855443322223355677889999999999999999999999999876
Q ss_pred HHHHHHH
Q 006703 613 IMETLQQ 619 (634)
Q Consensus 613 Il~~L~~ 619 (634)
....|+-
T Consensus 507 AANvl~L 513 (598)
T KOG4158|consen 507 AANVLNL 513 (598)
T ss_pred HHhHHHH
Confidence 6655543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.3e-19 Score=200.79 Aligned_cols=205 Identities=29% Similarity=0.418 Sum_probs=154.4
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|..++.|-.|+||.||.++++ .+.+|+|+-+...+-. + ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilR-------n---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILR-------N---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccchhhh-------c---cccccCCccee----------------
Confidence 366777889999999999999887 5568885522221110 1 22223344333
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC---
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--- 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~--- 514 (634)
|+=..++...+ .++. +++.+++|||+.| |+|||+||+|++|+.-|++|++|||+++..-
T Consensus 136 -----gDc~tllk~~g---~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -----chhhhhcccCC---CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 33334443222 1332 3388999999999 9999999999999999999999999986311
Q ss_pred ------------CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh-cCcc
Q 006703 515 ------------NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRR 581 (634)
Q Consensus 515 ------------~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~-~~~~ 581 (634)
.........+||+.|+|||++..+.|++.+|+|++|+++||++.|..||++.++++....+.. ....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 011224566899999999999999999999999999999999999999999999998766532 3344
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 006703 582 LEIPKNVNPMVAALIETCWAEEPEIRP 608 (634)
Q Consensus 582 ~~~~~~~s~~l~~Li~~cL~~dP~~RP 608 (634)
++-...++++.+++|.++|..+|..|.
T Consensus 278 pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 278 PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 455667899999999999999999993
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=197.39 Aligned_cols=244 Identities=21% Similarity=0.247 Sum_probs=183.6
Q ss_pred cceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC---CCCeeeeeceeecCCcEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~---h~nIv~l~~~~~~~~~~~lV 436 (634)
..|.+.+.||+|+||+||+|...+ ..||+|+-+....-+-.+ -.+++.+|+ -+.|..+..++.-.+.-++|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 456677899999999999997665 449999987665433221 122333333 35677777777778888999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-------CCCcEEEEecCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-------STYTVKVCDFGL 509 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-------~~~~ikL~DFGl 509 (634)
+||.+.|+|.++++ ....+++..+..++.||+.-+++||..+ |||+||||+|+||. ...-++|+|||.
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 99999999999998 3345999999999999999999999999 99999999999994 234699999998
Q ss_pred Ccc---CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCC
Q 006703 510 SRS---KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 586 (634)
Q Consensus 510 a~~---~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 586 (634)
+.- +++. .......+|-.|-++|+..|++|++..|.|.|+.+++-|+.|+.--. .+ -..+.....++.
T Consensus 848 siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-~~-------g~~~~~~~~~~R 918 (974)
T KOG1166|consen 848 SIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-KN-------GSSWMVKTNFPR 918 (974)
T ss_pred ceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-cC-------Ccceeccccchh
Confidence 863 2222 24567788999999999999999999999999999999999875210 00 000111111222
Q ss_pred CC-cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 587 NV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 587 ~~-s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.. .+...+++..+|+.|-..=|...+|...|+..+..
T Consensus 919 y~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 919 YWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred hhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 22 24567788899996666669999999988887764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.2e-17 Score=160.97 Aligned_cols=136 Identities=22% Similarity=0.372 Sum_probs=114.8
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccHH------HHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 367 SNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHED------RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~------~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
+.||+|++|.||+|.+.+..+++|+......... ...++.+|+.++..+.|++|+....++.+....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5789999999999999888899998764432211 2245788999999999999887777777778899999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+|++|.+++.... . .+..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999886321 1 77889999999999999999 99999999999999 78999999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=163.37 Aligned_cols=135 Identities=21% Similarity=0.249 Sum_probs=103.8
Q ss_pred eecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeceeecCC---cEE
Q 006703 364 IDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-----RHPNIVLLMGAVTEPP---NLS 434 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-----~h~nIv~l~~~~~~~~---~~~ 434 (634)
...+.||+|+||.||. +. ....+||++..... ...+.+.+|+++++.+ .||||+++++++..+. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999996 33 22257888765432 2336788999999999 5799999999998764 333
Q ss_pred -EEEee--cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHH-HHHHhCCCCEEeeccCCCcEEEcC----CCcEEEEe
Q 006703 435 -IVTEY--LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM-NYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCD 506 (634)
Q Consensus 435 -lV~E~--~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL-~yLH~~g~~IvHrDIKP~NILld~----~~~ikL~D 506 (634)
+|+|| +.+++|.+++.... +++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 55799999996432 5555 35678888887 9999999 999999999999974 34799999
Q ss_pred cCCC
Q 006703 507 FGLS 510 (634)
Q Consensus 507 FGla 510 (634)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-17 Score=181.13 Aligned_cols=210 Identities=33% Similarity=0.562 Sum_probs=166.1
Q ss_pred HHhCCCCCeeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCC
Q 006703 412 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491 (634)
Q Consensus 412 L~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP 491 (634)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.... ..+++.....+++++++||.|||..- ...|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecc
Confidence 356789999999999999999999999999999999997533 34888899999999999999999876 139999999
Q ss_pred CcEEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCC-------CCchHHHHHHHHHHHHHHhCCCC
Q 006703 492 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDP-------SNEKSDVFSFGVILWELITLQKP 562 (634)
Q Consensus 492 ~NILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~-------~s~~sDVwSLGvlL~eLltg~~P 562 (634)
.|.+++....+||+|||+........ .......-..-|.|||.+.+.. .+++.|+||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987654210 0111111234689999987642 36678999999999999999999
Q ss_pred CCCCC----hHHHHHHHhhcCc---ccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 563 WRNST----PSQVISAVGFKGR---RLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 563 f~~~~----~~~~~~~i~~~~~---~~~~~--~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
|.... +.+++..+..... +|.+. ...++++..++..||..+|.+||++.++-..++.+.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 96632 3355555433122 22222 145668999999999999999999999999999988754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.3e-17 Score=158.97 Aligned_cols=132 Identities=20% Similarity=0.338 Sum_probs=108.6
Q ss_pred eeeccCcEEEEEEEEcCCcEEEEEEeeccccH------HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 368 NFIKGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~------~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.||+|+||.||++.+.+.++++|......... ....++.+|+++++.+.|+++.....++......+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999999999888889999965433211 123567889999999988876655555566677899999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
|++|.+++.... . .++.+++.+|.+||+.| ++|+|++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998875321 1 77999999999999999 99999999999999 88999999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=177.97 Aligned_cols=138 Identities=22% Similarity=0.302 Sum_probs=115.2
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccH------HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~------~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..|...+.||+|+||+||++.+.+..+++|+........ ....++.+|+++++.++|++|+....+..+....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 444667899999999999999888877777654332211 12356889999999999999998887777777889
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+||||++|++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999998874 34678999999999999999 9999999999999 677999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=177.68 Aligned_cols=178 Identities=25% Similarity=0.379 Sum_probs=133.9
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
.++||.|++|...+|.+++.++......+....+.++.|++.|++| ++ .+|+|+||.||++..+..+||+|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 3588999999999999999876666668888999999999999999 78 999999999999999999999999998
Q ss_pred ccCCCCc------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccC
Q 006703 511 RSKPNTY------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLE 583 (634)
Q Consensus 511 ~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 583 (634)
....... .......||..||+||.+.+..|+.++||||||++|+|++. -..++..... ...+.....++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhcCCCChH
Confidence 7644332 12345579999999999999999999999999999999997 2222211111 111111111111
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
+.... ++=..|+.+++.+.|.+|| ..+...+..
T Consensus 481 ~~~d~-p~e~~ll~~lls~~p~~RP--~~~~~~~~~ 513 (516)
T KOG1033|consen 481 FLQDY-PEEYTLLQQLLSPSPEERP--SAIEVALHE 513 (516)
T ss_pred HhhcC-cHHHHHHHHhcCCCcccCc--hHHHHhhhh
Confidence 22233 3446799999999999999 444444443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=155.45 Aligned_cols=143 Identities=20% Similarity=0.144 Sum_probs=108.3
Q ss_pred ceeecceeeccCcEEEEEEE-E--cCCcEEEEEEeeccccH----------------------HHHHHHHHHHHHHHhCC
Q 006703 362 HVIDSSNFIKGSFGTVYHAE-W--RNSDVAVKILIEQEFHE----------------------DRFKEFLREVAIMKGLR 416 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~-~--~~~~vAvK~~~~~~~~~----------------------~~~~~~~~El~iL~~l~ 416 (634)
.|...+.||+|+||.||+|. + .+..||+|++....... .....+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45667899999999999998 3 36679999987543210 01123568999999996
Q ss_pred CC--CeeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcE
Q 006703 417 HP--NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 494 (634)
Q Consensus 417 h~--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NI 494 (634)
+. .+++++++ ...++||||++|.+|..+.... ..+....+..++.|++.++.+||..| .++|+||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhE
Confidence 53 34455543 2358999999998887654221 23556667889999999999999986 499999999999
Q ss_pred EEcCCCcEEEEecCCCccC
Q 006703 495 LVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 495 Lld~~~~ikL~DFGla~~~ 513 (634)
+++ ++.++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999988754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=149.49 Aligned_cols=138 Identities=19% Similarity=0.124 Sum_probs=106.1
Q ss_pred ceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccH--------------------HHHHHHHHHHHHHHhCCCC--
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHE--------------------DRFKEFLREVAIMKGLRHP-- 418 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~--------------------~~~~~~~~El~iL~~l~h~-- 418 (634)
.|...+.||+|+||.||++... ++.+|||++....... ........|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3566788999999999999875 5679999876543110 0112356788899988776
Q ss_pred CeeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC
Q 006703 419 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS 498 (634)
Q Consensus 419 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~ 498 (634)
.++..++ ....+++|||++|++|..+... .....++.+++.++.++|+.| ++|+||||+||+++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC
Confidence 3444443 2456899999999998775431 234578899999999999999 999999999999999
Q ss_pred CCcEEEEecCCCccCC
Q 006703 499 TYTVKVCDFGLSRSKP 514 (634)
Q Consensus 499 ~~~ikL~DFGla~~~~ 514 (634)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.8e-17 Score=184.86 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=196.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc---EEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~---vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~l 435 (634)
...|...+.||+|+|+.|-.....+.. +|+|.+...........+...|..+-+.+. |.|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 456667777999999999988764333 666666554433444456667888888886 9999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHH-hCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCccC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSK 513 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH-~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~~ 513 (634)
.++|..|+++...+..... ...+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..++.|||+|...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999999888832221 12555667788999999999999 888 99999999999999999 9999999999865
Q ss_pred CC---CcccCCCCCC-CCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-c--ccCCC
Q 006703 514 PN---TYISSKTAAG-TPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-R--RLEIP 585 (634)
Q Consensus 514 ~~---~~~~~~~~~g-t~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~--~~~~~ 585 (634)
.. ........+| ++.|.|||...+.. ..+..|+||+|+++.-+++|..||...........-.... . .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 44 2333456678 99999999998854 4778899999999999999999997655443221111111 1 13344
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 586 KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 586 ~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..++.....++.+++..+|..|.+.+++..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccc
Confidence 678889999999999999999999888754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=141.42 Aligned_cols=136 Identities=21% Similarity=0.134 Sum_probs=96.5
Q ss_pred cceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHH----------------------HHHHHHHHHhCCCCC--e
Q 006703 366 SSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKE----------------------FLREVAIMKGLRHPN--I 420 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~----------------------~~~El~iL~~l~h~n--I 420 (634)
.+.||+|+||+||+|... ++.||+|++............ ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999887 666999998754322211111 135666666664432 4
Q ss_pred eeeeceeecCCcEEEEEeecccCCHHH-HhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcC
Q 006703 421 VLLMGAVTEPPNLSIVTEYLSRGSLYK-LLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDS 498 (634)
Q Consensus 421 v~l~~~~~~~~~~~lV~E~~~ggsL~~-ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~ 498 (634)
.+++++ ...+++|||++++.+.. .+.... .. ..+..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence 444443 23589999999854321 111100 11 4567889999999999999 88 99999999999999
Q ss_pred CCcEEEEecCCCccC
Q 006703 499 TYTVKVCDFGLSRSK 513 (634)
Q Consensus 499 ~~~ikL~DFGla~~~ 513 (634)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=132.59 Aligned_cols=133 Identities=22% Similarity=0.225 Sum_probs=111.3
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC--CCeeeeeceeecCCcEEEEEeecccC
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPPNLSIVTEYLSRG 443 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h--~nIv~l~~~~~~~~~~~lV~E~~~gg 443 (634)
.+.||.|.++.||++...+..+++|....... ...+.+|+.+++.+++ .++++++.+....+..+++|||+.+.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46799999999999998888899998765432 3567789999999976 58999999888888899999999987
Q ss_pred CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCC-CCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 444 sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g-~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+..+ +......++.++++++.+||... .+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77553 44556678899999999999852 1299999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.9e-14 Score=145.03 Aligned_cols=137 Identities=15% Similarity=0.144 Sum_probs=106.7
Q ss_pred cceee-ccCcEEEEEEEEcCCcEEEEEEeeccc-----------cHHHHHHHHHHHHHHHhCCCCCe--eeeeceeecCC
Q 006703 366 SSNFI-KGSFGTVYHAEWRNSDVAVKILIEQEF-----------HEDRFKEFLREVAIMKGLRHPNI--VLLMGAVTEPP 431 (634)
Q Consensus 366 ~~~LG-~G~fG~Vy~a~~~~~~vAvK~~~~~~~-----------~~~~~~~~~~El~iL~~l~h~nI--v~l~~~~~~~~ 431 (634)
...|| .|+.|+||.+...+..+++|.+..... ......++.+|+.++.++.|++| +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34677 899999999998888899998854321 11233567889999999988775 67776643322
Q ss_pred c----EEEEEeeccc-CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEe
Q 006703 432 N----LSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 506 (634)
Q Consensus 432 ~----~~lV~E~~~g-gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~D 506 (634)
. .++|||+++| .+|.+++... .+++. .+.+++.+|.+||.+| |+|+||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEE
Confidence 2 3599999997 6898887532 24443 3568999999999999 99999999999999888999999
Q ss_pred cCCCcc
Q 006703 507 FGLSRS 512 (634)
Q Consensus 507 FGla~~ 512 (634)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.2e-13 Score=145.85 Aligned_cols=246 Identities=26% Similarity=0.216 Sum_probs=182.5
Q ss_pred eeecceeec--cCcEEEEEEEE--c--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 363 VIDSSNFIK--GSFGTVYHAEW--R--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 363 ~~~~~~LG~--G~fG~Vy~a~~--~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
+.....+|. |.+|.||.+.. . ...+|+|.-+.....+....+-.+|......+ .|+|.++.+..+...+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 345577888 99999999987 3 33488887443332222223334666666666 59999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHH----HHHHHHhCCCCEEeeccCCCcEEEcCC-CcEEEEecCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----GMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLS 510 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~----aL~yLH~~g~~IvHrDIKP~NILld~~-~~ikL~DFGla 510 (634)
-+|++. .+|..+.+... ..+++..++..+.+... ||.++|+.+ ++|.|+||.||+...+ ...+++|||+.
T Consensus 196 qtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCccee
Confidence 999994 68888887443 34888899999999999 999999999 9999999999999988 89999999998
Q ss_pred ccCCCCcccC-----CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC
Q 006703 511 RSKPNTYISS-----KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 585 (634)
Q Consensus 511 ~~~~~~~~~~-----~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 585 (634)
..+....... ....|...|++||...+. ++...|+|++|.++.+..++..++....... ...+.......++.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGYIPLEFC 348 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCC-ccccccccCchhhh
Confidence 7655443222 233788899999988544 6788999999999999998866553321110 00011111223344
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 586 KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 586 ~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...+.++...+..|+..+|..|+++..+..
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 556777888999999999999999887764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.8e-12 Score=137.20 Aligned_cols=144 Identities=21% Similarity=0.250 Sum_probs=98.7
Q ss_pred eecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccH---H-------------------------HH----------HH
Q 006703 364 IDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHE---D-------------------------RF----------KE 404 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~---~-------------------------~~----------~~ 404 (634)
...+.||+|++|.||+|+.+ ++.||||+.+...... + .. -+
T Consensus 120 fd~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 120 FEEKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred CCCcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 34567999999999999885 6679999985431100 0 00 12
Q ss_pred HHHHHHHHHhCC-----CCCeeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHH-HHHHHH
Q 006703 405 FLREVAIMKGLR-----HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK-GMNYLH 478 (634)
Q Consensus 405 ~~~El~iL~~l~-----h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~-aL~yLH 478 (634)
+.+|.+.+.+++ +++|.-..-+.......+++|||++|.+|.++....... .+ ...++..++. .+..+|
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHH
Confidence 555666666652 343332222222234578999999999998876432111 21 2345666666 478899
Q ss_pred hCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 479 ~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
..| ++|+|+||.||+++.++.++|+|||++....
T Consensus 275 ~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.5e-11 Score=117.12 Aligned_cols=130 Identities=20% Similarity=0.113 Sum_probs=95.4
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCe-eeeeceeecCCcEEEEEeecccCC
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYLSRGS 444 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~ggs 444 (634)
.+.|+.|.++.||+++..+..+++|+...... ....+..|+.+++.+.+.++ ++++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 35678899999999998888899998654321 11235688888888865444 4455443 234589999999987
Q ss_pred HHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCC---CEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 445 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP---PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 445 L~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~---~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+.... . ....++.+++++|..||..+. .++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 75430 1 112456799999999999871 249999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.3e-11 Score=113.37 Aligned_cols=132 Identities=23% Similarity=0.333 Sum_probs=108.2
Q ss_pred eeeccCcEEEEEEEEcCCcEEEEEEeeccccHHH------HHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 368 NFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDR------FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~------~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.+++|+-+.+|.+.+.+.++++|.-......... ..+..+|.+++.+++--.|.-.+=+..+.....|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 5678999999999888888888876555443322 2456789999999987777766667788888999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
|..|.+++... ...++..+-.-+.-||..| |+|+||.++||++.... +.++|||++..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888643 2456788888899999999 99999999999997765 99999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3e-10 Score=126.13 Aligned_cols=163 Identities=19% Similarity=0.235 Sum_probs=120.9
Q ss_pred CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHH
Q 006703 384 NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 463 (634)
Q Consensus 384 ~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~ 463 (634)
+.++.|...+...- .......+-++.|+.++||||+++++.+..+..+|+|+|.+. .|..++.. +.....
T Consensus 37 ~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred CCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 34466665544432 334556688899999999999999999999999999999885 56666653 234556
Q ss_pred HHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCch
Q 006703 464 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543 (634)
Q Consensus 464 ~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~ 543 (634)
...+.||+.||.|||..+ .++|++|.-+.|+|+..|.+||++|.++...............--.|..|+.+.... -.
T Consensus 107 ~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 667899999999998654 399999999999999999999999998764332221112222233466777654333 35
Q ss_pred HHHHHHHHHHHHHHhC
Q 006703 544 SDVFSFGVILWELITL 559 (634)
Q Consensus 544 sDVwSLGvlL~eLltg 559 (634)
.|.|.||++++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-11 Score=126.36 Aligned_cols=201 Identities=22% Similarity=0.338 Sum_probs=142.2
Q ss_pred HHHHhCCCCCeeeeeceeecCC-----cEEEEEeecccCCHHHHhccCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 006703 410 AIMKGLRHPNIVLLMGAVTEPP-----NLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483 (634)
Q Consensus 410 ~iL~~l~h~nIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~ll~~~~-~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~ 483 (634)
..|-++-|.|||+++.|+.+.+ ...+++||+.-|++..+|++.. ....+....-.+|+.||+.||.|||+..|+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3445567999999999986544 4789999999999999997433 234577777889999999999999999999
Q ss_pred EEeeccCCCcEEEcCCCcEEEEecCCCccCCC--C--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC
Q 006703 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--T--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 559 (634)
Q Consensus 484 IvHrDIKP~NILld~~~~ikL~DFGla~~~~~--~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg 559 (634)
|+|+++..+.|++..+|-||++--.-....+. . ........+-++|.+||.=.....+-++|||+||+...||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888854322211110 0 0112233467789999977666677889999999999999987
Q ss_pred CCCCCCCC-hHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 560 QKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 560 ~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..--.+.. ..+....+.. . +-.--+..-+.++.+|+...|..||+++.++-
T Consensus 279 Eiq~tnseS~~~~ee~ia~--~---i~~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN--V---IIGLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceeehhhhhhh--h---eeeccCccccCcCcccccCCCCCCcchhhhhc
Confidence 65322211 1111111100 0 00111233456888999999999999998764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.8e-11 Score=134.56 Aligned_cols=139 Identities=19% Similarity=0.185 Sum_probs=89.2
Q ss_pred ceeeccCcEEEEEEEEc--CCcEEEEEEeecccc----------------------------H----HHHH------HHH
Q 006703 367 SNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH----------------------------E----DRFK------EFL 406 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~----------------------------~----~~~~------~~~ 406 (634)
+.||+|++|+||+|+.+ ++.||||+.+..... . +..+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 68999999999999986 466999998754210 0 1111 134
Q ss_pred HHHHHHHhCC----CCCeeeeeceee-cCCcEEEEEeecccCCHHHHhc--cCC-CcccccHHHHHHHHHHHHHHHHHHH
Q 006703 407 REVAIMKGLR----HPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLH--IPD-ARVVVDERLRLNMAYDVAKGMNYLH 478 (634)
Q Consensus 407 ~El~iL~~l~----h~nIv~l~~~~~-~~~~~~lV~E~~~ggsL~~ll~--~~~-~~~~l~e~~~~~i~~qIa~aL~yLH 478 (634)
+|+..+.+++ +.+.+.+-..+. -....++||||+.|+.+.++.. ..+ ....+.+..+..++.|++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4554444442 332232222221 1345679999999999987532 211 111233444444445544
Q ss_pred hCCCCEEeeccCCCcEEEcCCC----cEEEEecCCCccCC
Q 006703 479 QRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLSRSKP 514 (634)
Q Consensus 479 ~~g~~IvHrDIKP~NILld~~~----~ikL~DFGla~~~~ 514 (634)
..| ++|+|+||.||+++.++ .++++|||+....+
T Consensus 278 ~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 578 99999999999999887 99999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.8e-12 Score=142.83 Aligned_cols=246 Identities=22% Similarity=0.259 Sum_probs=180.6
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeecc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~-~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
+.+...+-+-+|+++.++.+.-.+++ .+.|+..... +.....+....+-.++-..++|.++.....+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 33444556778999999988655443 3444332211 11111222223333333345677776666677788899999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC---
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--- 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~--- 514 (634)
+|+.+++|...++... ..+...+...+..+..++++||... +.|+|++|.|+++...+..++.|||+.....
T Consensus 884 ~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred HHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999987554 2555556677788999999999998 9999999999999999999999998432100
Q ss_pred ----C------------------------CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Q 006703 515 ----N------------------------TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS 566 (634)
Q Consensus 515 ----~------------------------~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~ 566 (634)
. .........+|+.|.+||...+......+|+|+.|++++|.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 001123345899999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhc-CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 006703 567 TPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 611 (634)
Q Consensus 567 ~~~~~~~~i~~~-~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~ 611 (634)
.+.++...+... ...+..+...+.+.++++.+.+..+|.+|..+.
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 998887666332 233445567899999999999999999997665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.6e-10 Score=111.09 Aligned_cols=137 Identities=18% Similarity=0.164 Sum_probs=98.3
Q ss_pred ceeeccCcEEEEEEEEcC--------CcEEEEEEeeccc--c------------------HHHHHHHH----HHHHHHHh
Q 006703 367 SNFIKGSFGTVYHAEWRN--------SDVAVKILIEQEF--H------------------EDRFKEFL----REVAIMKG 414 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--------~~vAvK~~~~~~~--~------------------~~~~~~~~----~El~iL~~ 414 (634)
..||.|--+.||.|...+ ..+|+|+.+.... . ....+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468899999999997553 5699999753311 0 01112233 79999999
Q ss_pred CCC--CCeeeeeceeecCCcEEEEEeecccCCHHH-HhccCCCcccccHHHHHHHHHHHHHHHHHH-HhCCCCEEeeccC
Q 006703 415 LRH--PNIVLLMGAVTEPPNLSIVTEYLSRGSLYK-LLHIPDARVVVDERLRLNMAYDVAKGMNYL-HQRRPPIVHRDLK 490 (634)
Q Consensus 415 l~h--~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~-ll~~~~~~~~l~e~~~~~i~~qIa~aL~yL-H~~g~~IvHrDIK 490 (634)
+.. -+++.++++ ...++||||+.+..+.. .+.. ..+++.....+..+++.+|..| |..| ++|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence 943 466677764 45689999997653321 1211 1245556677889999999999 8899 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCCccCC
Q 006703 491 SPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 491 P~NILld~~~~ikL~DFGla~~~~ 514 (634)
+.||+++ ++.++|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4679999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-09 Score=113.54 Aligned_cols=255 Identities=18% Similarity=0.201 Sum_probs=169.6
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeece----e--ec-CCcEEEEE
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA----V--TE-PPNLSIVT 437 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~----~--~~-~~~~~lV~ 437 (634)
...||+|+-+.+|-.-.-...|| |+......... .+ .+..|... .||-+-.=+.+ . -+ ....-++|
T Consensus 16 gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~--aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQ--AQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchhhchhh-eeecCCCchHH--HH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 46799999999998654444455 77766543222 21 22223333 45533221111 1 11 22266788
Q ss_pred eecccCC-HHHHh---ccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 438 EYLSRGS-LYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 438 E~~~ggs-L~~ll---~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+.++|.. +..+. .+.+.-....+....+.++.++.+.+.||..| .+-+|++++|+|++.++.+.|+|-..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceeec
Confidence 8887652 33333 23333345788999999999999999999999 999999999999999999999986543322
Q ss_pred CCCcccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhC-CCCCCCCC-------hHHHHHHH-hh--
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITL-QKPWRNST-------PSQVISAV-GF-- 577 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~-------~~~~~~~i-~~-- 577 (634)
. ........+|...|.+||... +...+...|-|.||+++++++.| +.||.+.. +.+...+. .+
T Consensus 168 ~-ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 168 A-NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred c-CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 2 223346778999999999864 34457788999999999999887 89996543 23321111 00
Q ss_pred --cCccc------CCC-CCCcHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 006703 578 --KGRRL------EIP-KNVNPMVAALIETCWAE--EPEIRPSFPSIMETLQQFLMSSVCQPL 629 (634)
Q Consensus 578 --~~~~~------~~~-~~~s~~l~~Li~~cL~~--dP~~RPs~~~Il~~L~~ll~~~~~~~~ 629 (634)
...+. .+| ..+++.+..|+.+|++. ++.-|||++.++..|-.+-++...=.+
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v 309 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV 309 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence 11111 122 35789999999999974 467999999999988887776544333
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.4e-10 Score=106.58 Aligned_cols=145 Identities=17% Similarity=0.201 Sum_probs=111.7
Q ss_pred ecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHH------HHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 365 DSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDR------FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~------~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
....+-+|+-+.|+++.+.++...||.-......... ..+..+|.++|.++.--.|.-..=++.+.....|.||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4567889999999999999999888876555443332 2457789999999976666655556777778899999
Q ss_pred eccc-CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC---cEEEEecCCCcc
Q 006703 439 YLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS 512 (634)
Q Consensus 439 ~~~g-gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~---~ikL~DFGla~~ 512 (634)
|++| .++.+++...-... ........++..|-+.+.-||.++ |+|+||..+||++..++ .+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 47788875433222 233334688999999999999999 99999999999997544 458999999865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.3e-11 Score=132.34 Aligned_cols=247 Identities=21% Similarity=0.175 Sum_probs=178.5
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc---CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~ 433 (634)
....+|-....||.|.|+.|+....+ +..+++|...+..........-..|+.+...+ .|.+++.+...+...++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34466777889999999999998754 22377777665544333222234566666666 589999988888888888
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC-CcEEEEecCCCcc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRS 512 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~-~~ikL~DFGla~~ 512 (634)
|+--|||.++++...+.... .+++..++.+..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||....
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccc
Confidence 89999999998877663222 3778888999999999999999999 9999999999999875 7889999998864
Q ss_pred CCCCcccCCCCCCCCccc--CcccccCCCCCchHHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 513 KPNTYISSKTAAGTPEWM--APEVLREDPSNEKSDVFSFGVILWELITLQKP-WRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~--APEvl~~~~~s~~sDVwSLGvlL~eLltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
..- ......++.++. +++......+..+.|++|||..+.+.+++... +....-.. ......+......
T Consensus 417 ~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~------i~~~~~p~~~~~~ 487 (524)
T KOG0601|consen 417 LAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT------IRSGDTPNLPGLK 487 (524)
T ss_pred cce---ecccccccccccccchhhccccccccccccccccccccccccCcccCccccccee------eecccccCCCchH
Confidence 221 112222333444 55555666778999999999999999998653 32222111 1223233334444
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMETLQ 618 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~L~ 618 (634)
..+..+.+.+...++..||.+.++....+
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 88899999999999999999988766544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.3e-09 Score=106.28 Aligned_cols=141 Identities=18% Similarity=0.209 Sum_probs=105.6
Q ss_pred ceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC--CCeeeeeceeecC---CcEEEEEeec
Q 006703 367 SNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEP---PNLSIVTEYL 440 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h--~nIv~l~~~~~~~---~~~~lV~E~~ 440 (634)
+.|+.|.++.||++...+ ..+++|+....... ....++..|..+++.+.+ .++.+++.+.... ...+++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568899999999998876 67999987544321 123467789999999965 3456777766553 2678999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR---------------------------------------- 480 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~---------------------------------------- 480 (634)
+|.++...+.. ..+++.....++.+++++|..||+.
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888775431 1366667777888888888888842
Q ss_pred --------------CCCEEeeccCCCcEEEcC--CCcEEEEecCCCcc
Q 006703 481 --------------RPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS 512 (634)
Q Consensus 481 --------------g~~IvHrDIKP~NILld~--~~~ikL~DFGla~~ 512 (634)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 124799999999999998 66789999997764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.3e-08 Score=101.35 Aligned_cols=134 Identities=20% Similarity=0.116 Sum_probs=96.3
Q ss_pred EEEEEEEEcCCcEEEEEEeeccccHHHHH----------HHHHHHHHHHhCCCCCe--eeeeceeec-----CCcEEEEE
Q 006703 375 GTVYHAEWRNSDVAVKILIEQEFHEDRFK----------EFLREVAIMKGLRHPNI--VLLMGAVTE-----PPNLSIVT 437 (634)
Q Consensus 375 G~Vy~a~~~~~~vAvK~~~~~~~~~~~~~----------~~~~El~iL~~l~h~nI--v~l~~~~~~-----~~~~~lV~ 437 (634)
..|.+....+..+.||......... ..+ .+.+|.+.+.++...+| +.++++... ....++||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3466777777788999764433111 111 36788888888843333 344555532 23478999
Q ss_pred eecccC-CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-------CCcEEEEecCC
Q 006703 438 EYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-------TYTVKVCDFGL 509 (634)
Q Consensus 438 E~~~gg-sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-------~~~ikL~DFGl 509 (634)
|++++. +|.+++..... ...+......++.+++..+.-||..| |+|+|+++.|||++. +..+.|+||+.
T Consensus 115 e~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999886 89998853211 23556677889999999999999999 999999999999975 46899999997
Q ss_pred Ccc
Q 006703 510 SRS 512 (634)
Q Consensus 510 a~~ 512 (634)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-07 Score=92.82 Aligned_cols=126 Identities=26% Similarity=0.254 Sum_probs=81.3
Q ss_pred EEEEEEEc-CCcEEEEEEeeccc--c----------------------HHHHHHHHHHHHHHHhCCCC--Ceeeeeceee
Q 006703 376 TVYHAEWR-NSDVAVKILIEQEF--H----------------------EDRFKEFLREVAIMKGLRHP--NIVLLMGAVT 428 (634)
Q Consensus 376 ~Vy~a~~~-~~~vAvK~~~~~~~--~----------------------~~~~~~~~~El~iL~~l~h~--nIv~l~~~~~ 428 (634)
.||.|... +..+|+|+.+.... . .-......+|.++|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38888875 55699999753311 0 01123467899999999765 566776543
Q ss_pred cCCcEEEEEeecc--cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHH-HHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 429 EPPNLSIVTEYLS--RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY-LHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 429 ~~~~~~lV~E~~~--ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~y-LH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.||+++.+ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEE
Confidence 3479999998 66665554322 1123445677788886665 57888 9999999999999887 89999
Q ss_pred ecCCCccC
Q 006703 506 DFGLSRSK 513 (634)
Q Consensus 506 DFGla~~~ 513 (634)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.4e-07 Score=96.41 Aligned_cols=214 Identities=17% Similarity=0.210 Sum_probs=149.9
Q ss_pred cEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee----cCCcEEEEEeeccc-CCHH
Q 006703 374 FGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT----EPPNLSIVTEYLSR-GSLY 446 (634)
Q Consensus 374 fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~----~~~~~~lV~E~~~g-gsL~ 446 (634)
..+.|++... +..|++|++........ .....-+++++++.|.|||++.+.|. .+..+++|++|+++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3578888765 44488888733221111 11224467899999999999999886 34568999999985 4676
Q ss_pred HHhcc------------CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 447 KLLHI------------PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 447 ~ll~~------------~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++... ...+...++..+|.++.|+..||.++|+.| +..+-|.|.+|+++++..++|+-.|......
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 66521 122345888999999999999999999999 9999999999999999888888777655432
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~-Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
... . |.+. --++-|.=.||.+++.|.||.. -+......+.. ...+...++.+++
T Consensus 445 ~d~------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------~~~I~~~yS~D~r 499 (655)
T KOG3741|consen 445 EDP------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------LTRITTTYSTDLR 499 (655)
T ss_pred CCC------------C--cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHH--------HHHhhhhhhHHHH
Confidence 221 0 1111 1246789999999999999843 33333333221 1123456788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
+++.-..+.++++ -++.+++..+
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHHH
Confidence 9999999999987 5777776554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.6e-07 Score=91.85 Aligned_cols=105 Identities=24% Similarity=0.225 Sum_probs=81.6
Q ss_pred HHHHHHHHHHHhCCC--CCeeeeeceeecCC----cEEEEEeecccC-CHHHHhccCCCcccccHHHHHHHHHHHHHHHH
Q 006703 403 KEFLREVAIMKGLRH--PNIVLLMGAVTEPP----NLSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475 (634)
Q Consensus 403 ~~~~~El~iL~~l~h--~nIv~l~~~~~~~~----~~~lV~E~~~gg-sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~ 475 (634)
.+..+|...+..+.. =.+++.+++..... ..++|+|++++. +|.+++..... .+......++.++++.+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 456788888877743 33445666554422 358999999884 79998874322 556677889999999999
Q ss_pred HHHhCCCCEEeeccCCCcEEEcCCC---cEEEEecCCCcc
Q 006703 476 YLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS 512 (634)
Q Consensus 476 yLH~~g~~IvHrDIKP~NILld~~~---~ikL~DFGla~~ 512 (634)
-||.+| |+|+|+++.|||++.++ .+.|+||+-+..
T Consensus 133 ~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 99999999999998776 899999997664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.5e-08 Score=108.80 Aligned_cols=147 Identities=17% Similarity=0.292 Sum_probs=106.2
Q ss_pred HHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-c--------CCCCCCCCcccCcccccCC
Q 006703 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-S--------SKTAAGTPEWMAPEVLRED 538 (634)
Q Consensus 468 ~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~-~--------~~~~~gt~~y~APEvl~~~ 538 (634)
.+++.|+.|+|..- .+||+.|.|++|.++.++.+||+-|+.+........ . .....-...|.|||++.+.
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 35669999999863 399999999999999999999999998764332110 0 1111245689999999998
Q ss_pred CCCchHHHHHHHHHHHHHH-hCCCCCCCCChHHH--HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 539 PSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQV--ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 539 ~~s~~sDVwSLGvlL~eLl-tg~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+.++|+||+|+++|-+. +|+..+........ ...-............++.++++-+.+++..++.-||++..+..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 8899999999999999999 45554443322111 11111112223345789999999999999999999997776653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=88.96 Aligned_cols=135 Identities=22% Similarity=0.181 Sum_probs=98.2
Q ss_pred eecceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-------HHH-------------HHHHHHHHHHHHhCCCC--Ce
Q 006703 364 IDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFH-------EDR-------------FKEFLREVAIMKGLRHP--NI 420 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~-------~~~-------------~~~~~~El~iL~~l~h~--nI 420 (634)
....+||-|--|.||.|... +.++++|.-+....+ .+. .....+|.++|+.+... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999886 777999975322111 011 12356899999999654 77
Q ss_pred eeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC
Q 006703 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 500 (634)
Q Consensus 421 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~ 500 (634)
++.+++ +...+||||++|..|...- ++....-.++..|++-+.-+-..| |||+|+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCC
Confidence 777764 6678999999997776542 122233345556666666666778 99999999999999999
Q ss_pred cEEEEecCCCcc
Q 006703 501 TVKVCDFGLSRS 512 (634)
Q Consensus 501 ~ikL~DFGla~~ 512 (634)
.++++||-.+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.3e-06 Score=83.62 Aligned_cols=139 Identities=19% Similarity=0.135 Sum_probs=101.8
Q ss_pred eccCcEEEEEEEEcCCcEEEEEEeecccc----HHHHHHHHHHHHHHHhCCC--CCeeeeeceeec----CCcEEEEEee
Q 006703 370 IKGSFGTVYHAEWRNSDVAVKILIEQEFH----EDRFKEFLREVAIMKGLRH--PNIVLLMGAVTE----PPNLSIVTEY 439 (634)
Q Consensus 370 G~G~fG~Vy~a~~~~~~vAvK~~~~~~~~----~~~~~~~~~El~iL~~l~h--~nIv~l~~~~~~----~~~~~lV~E~ 439 (634)
|.||-+.|++....+..+-+|........ +.....|.+|+..++++.. -.++++..+... .-..+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 56899999999888888888876422110 2234678899999999843 235555522211 1236799997
Q ss_pred ccc-CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc--EEEEecCCCc
Q 006703 440 LSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSR 511 (634)
Q Consensus 440 ~~g-gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~--ikL~DFGla~ 511 (634)
+.+ .+|.+++..... ...+......++.++++.+.-||..| +.|+|+.+.||+++..+. ++++||.-++
T Consensus 107 L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 107 MAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 753 488888754322 23677778899999999999999999 999999999999986666 9999997554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.9e-06 Score=84.03 Aligned_cols=137 Identities=12% Similarity=0.154 Sum_probs=83.9
Q ss_pred ceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC--eeeeeceeecCCcEEEEEeecccCC
Q 006703 367 SNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAVTEPPNLSIVTEYLSRGS 444 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~ggs 444 (634)
..||+|..+.||+. .+..+++|...... . .....+|.++++.+..-+ +.+.+++..+.+...++||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 35567888865432 1 134568999998885433 4677877777778889999999863
Q ss_pred -HHHHh---------------------ccCCC-cccccHHHHHHHHH----------HHHHH-HHHHH--hCCCCEEeec
Q 006703 445 -LYKLL---------------------HIPDA-RVVVDERLRLNMAY----------DVAKG-MNYLH--QRRPPIVHRD 488 (634)
Q Consensus 445 -L~~ll---------------------~~~~~-~~~l~e~~~~~i~~----------qIa~a-L~yLH--~~g~~IvHrD 488 (634)
+...+ +.-.. ...++.. ...+.. .+.+. ..+|. ...+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 22111 11000 0001100 000100 01111 12222 2233589999
Q ss_pred cCCCcEEEcCCCcEEEEecCCCc
Q 006703 489 LKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 489 IKP~NILld~~~~ikL~DFGla~ 511 (634)
+.|.||++++++ +.++||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.5e-06 Score=81.97 Aligned_cols=137 Identities=19% Similarity=0.216 Sum_probs=89.3
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHH-HHH------HHHHHHHHHhCCC---CCeeeeecee---
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDR-FKE------FLREVAIMKGLRH---PNIVLLMGAV--- 427 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~-~~~------~~~El~iL~~l~h---~nIv~l~~~~--- 427 (634)
..|...+.+-......|.+....+..+.+|..+........ ... ..+.+..+.+++. .....++.+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 44555566666677788888888888999987654322111 111 2234444444432 2222322222
Q ss_pred --ecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 428 --TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 428 --~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
.-....+++|||++|..|.++.. +++ .+...+.+++.-||+.| +.|+|.+|.|+++++++ ++++
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEEE
Confidence 22234668999999988877543 333 24456778899999999 99999999999998654 9999
Q ss_pred ecCCCc
Q 006703 506 DFGLSR 511 (634)
Q Consensus 506 DFGla~ 511 (634)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.7e-06 Score=92.68 Aligned_cols=141 Identities=18% Similarity=0.244 Sum_probs=91.7
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeeccccH----------------------------HHH----------HHHHH
Q 006703 367 SNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHE----------------------------DRF----------KEFLR 407 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~----------------------------~~~----------~~~~~ 407 (634)
+.|+.++-|.||+|+.+ ++.||||+.+..-... ... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57889999999999998 6789999975431110 000 11445
Q ss_pred HHHHHHhCC-----CCCeeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHH-HHHHHhCC
Q 006703 408 EVAIMKGLR-----HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG-MNYLHQRR 481 (634)
Q Consensus 408 El~iL~~l~-----h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~a-L~yLH~~g 481 (634)
|...+.+++ .++|.-..=|..-...-.++|||++|..+.+........ ++.+ .++..++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHH---HHHHHHHHHHHHHHHhcC
Confidence 555555552 344333332333345568999999999998885322211 3322 233333333 23333467
Q ss_pred CCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 482 ~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|.|.+|.||+++.+|.+.+.|||+....+
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999886543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.8e-05 Score=78.54 Aligned_cols=142 Identities=18% Similarity=0.192 Sum_probs=81.7
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCC--Ceeeeecee---ecCCcEEEEEeec
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGAV---TEPPNLSIVTEYL 440 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~--nIv~l~~~~---~~~~~~~lV~E~~ 440 (634)
.+.|+.|..+.||++...+..+++|+.... .....+.+|..+++.+... .+.+++.+. ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 357889999999999998878999986443 2335566888888877422 355666543 2233478999999
Q ss_pred ccCCHHH----------------Hh---ccC-CCcccccHHH---------HHHH------------HHHHHH-HHHHHH
Q 006703 441 SRGSLYK----------------LL---HIP-DARVVVDERL---------RLNM------------AYDVAK-GMNYLH 478 (634)
Q Consensus 441 ~ggsL~~----------------ll---~~~-~~~~~l~e~~---------~~~i------------~~qIa~-aL~yLH 478 (634)
+|..+.. .+ +.. .......... .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111 0000000000 0000 111222 233333
Q ss_pred h-----CCCCEEeeccCCCcEEEc-CCCcEEEEecCCCc
Q 006703 479 Q-----RRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSR 511 (634)
Q Consensus 479 ~-----~g~~IvHrDIKP~NILld-~~~~ikL~DFGla~ 511 (634)
. ....++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 222499999999999999 66667899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.2e-05 Score=79.80 Aligned_cols=138 Identities=20% Similarity=0.179 Sum_probs=83.9
Q ss_pred eeccCc-EEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEeecccCCHH
Q 006703 369 FIKGSF-GTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 446 (634)
Q Consensus 369 LG~G~f-G~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~ 446 (634)
|-.|.+ ..||+....+.++.+|+..... ..++.+|+++++.+. +--+++++.+...++..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 334555 7899998766678888864432 234557888888773 445667888777767789999999998876
Q ss_pred HHh-------------------ccCCC-cccccHH--HHHHHHH--------------------HHHHHHHHHHh-----
Q 006703 447 KLL-------------------HIPDA-RVVVDER--LRLNMAY--------------------DVAKGMNYLHQ----- 479 (634)
Q Consensus 447 ~ll-------------------~~~~~-~~~l~e~--~~~~i~~--------------------qIa~aL~yLH~----- 479 (634)
... +.... ...+... ....... .+...+..|-.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 442 11000 0011100 0000000 01111222211
Q ss_pred CCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 480 ~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12358999999999999998778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=7.5e-05 Score=75.36 Aligned_cols=137 Identities=23% Similarity=0.166 Sum_probs=93.9
Q ss_pred eeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHH----------------------HHHHHHHHHHHhCC--CCCeee
Q 006703 368 NFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRF----------------------KEFLREVAIMKGLR--HPNIVL 422 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~----------------------~~~~~El~iL~~l~--h~nIv~ 422 (634)
.|.+|--+.||+|... +..+|+|+.+......... .=...|.+.|+++. +=.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 6677888899999764 5669999986553221110 01345888888874 344555
Q ss_pred eeceeecCCcEEEEEeecccCCH-HHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCC
Q 006703 423 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTY 500 (634)
Q Consensus 423 l~~~~~~~~~~~lV~E~~~ggsL-~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~ 500 (634)
.+.+.. ..++|||+....+ .-.|. . ..+....+..+..++++.+.-|-. .+ +||+||..-|||+. ++
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~Lk--D--v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLK--D--VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCcc--c--CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CC
Confidence 565433 4799999965311 11111 1 113333677788899999998877 77 99999999999999 88
Q ss_pred cEEEEecCCCccCCC
Q 006703 501 TVKVCDFGLSRSKPN 515 (634)
Q Consensus 501 ~ikL~DFGla~~~~~ 515 (634)
.+.++|||.|....+
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999998876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.4e-06 Score=96.65 Aligned_cols=185 Identities=22% Similarity=0.231 Sum_probs=136.5
Q ss_pred eecceeeccCcEEEEEEEEcCCc-EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC-eeeeeceeecCCcEEEEEeecc
Q 006703 364 IDSSNFIKGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~~~-vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n-Iv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.....+++|+++++++.+...+. ...+.+..+ ....-++++|.+++||| .+..++-++.++..++.++++.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 33456889999999998765444 223333222 23346888999999999 7778888888889999999998
Q ss_pred cC-CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccC
Q 006703 442 RG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 520 (634)
Q Consensus 442 gg-sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~ 520 (634)
++ +-..... .....+.+.+...+.+.-++++++||+.. =+|+| ||+..+ +..++.||+......... ..
T Consensus 318 ~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 318 TGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred CCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 77 3322221 11122444555667777888999999875 58888 777755 689999999887665543 45
Q ss_pred CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Q 006703 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 565 (634)
Q Consensus 521 ~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~ 565 (634)
+...+|+.++|||+.....+..+.|.|++|+-..++.-|.+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 778899999999999999999999999999887777777666543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00019 Score=68.95 Aligned_cols=138 Identities=21% Similarity=0.216 Sum_probs=97.0
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCee-eeeceeecCCcEE
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV-LLMGAVTEPPNLS 434 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv-~l~~~~~~~~~~~ 434 (634)
...........+.|++|.+|.||++.+.+..+|+|+-+..... ..+..|.++|..+...++. +++.|-.+ +
T Consensus 17 ~~~~~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r----~~l~kEakiLeil~g~~~~p~vy~yg~~----~ 88 (201)
T COG2112 17 VEEGKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPR----RNLEKEAKILEILAGEGVTPEVYFYGED----F 88 (201)
T ss_pred eeccchhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcch----hhHHHHHHHHHHhhhcCCCceEEEechh----h
Confidence 3344445566688999999999999999999999997655432 4566899999998776665 44443332 4
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccC-CCcEEEcCCCcEEEEecCCCccC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK-SPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIK-P~NILld~~~~ikL~DFGla~~~ 513 (634)
+.|||+.|..|.++-... +.++ +..+++.-.-|...| |-|+.|. |...+|-+++.+.|+||..|+..
T Consensus 89 i~me~i~G~~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG------DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcCcchhhhhhcc------cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 559999998887765321 2222 345666666677778 9898885 44455545558999999988743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00019 Score=72.61 Aligned_cols=73 Identities=12% Similarity=0.090 Sum_probs=45.1
Q ss_pred ceeeccCcE-EEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCC---CeeeeeceeecC---CcEEEEEee
Q 006703 367 SNFIKGSFG-TVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP---NIVLLMGAVTEP---PNLSIVTEY 439 (634)
Q Consensus 367 ~~LG~G~fG-~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~---nIv~l~~~~~~~---~~~~lV~E~ 439 (634)
+.|+.|+.. .||+. +..+++|+..... ....+.+|.++++.+... .+.++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 356666665 59986 3457777644321 224677899999887532 344555443332 235889999
Q ss_pred cccCCHH
Q 006703 440 LSRGSLY 446 (634)
Q Consensus 440 ~~ggsL~ 446 (634)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00026 Score=84.72 Aligned_cols=80 Identities=16% Similarity=0.212 Sum_probs=55.7
Q ss_pred ecceeeccCcEEEEEEEEcCC----cEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCe--eeeeceeecC---CcEE
Q 006703 365 DSSNFIKGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNI--VLLMGAVTEP---PNLS 434 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nI--v~l~~~~~~~---~~~~ 434 (634)
..+.|+.|.+..+|+....+. .+++|+........ ....+.+|.++++.+. |.+| ++++.++.+. ...|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 456788999999999877652 46777653322111 1235779999999985 6655 6777777654 4678
Q ss_pred EEEeecccCCH
Q 006703 435 IVTEYLSRGSL 445 (634)
Q Consensus 435 lV~E~~~ggsL 445 (634)
+||||++|..+
T Consensus 121 lVME~v~G~~~ 131 (822)
T PLN02876 121 YIMEYLEGRIF 131 (822)
T ss_pred EEEEecCCccc
Confidence 99999998653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00051 Score=67.91 Aligned_cols=130 Identities=22% Similarity=0.294 Sum_probs=91.6
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeecc--------------ccHHHHHHHHHHHHHHHhCC------CCCeeeeec
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQE--------------FHEDRFKEFLREVAIMKGLR------HPNIVLLMG 425 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~--------------~~~~~~~~~~~El~iL~~l~------h~nIv~l~~ 425 (634)
...||+|+.-.||..-. +....||+..... .......+..+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 45789999999998532 2336888887665 11122456667777766665 789999999
Q ss_pred eeecCCcEEEEEeecc------cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC
Q 006703 426 AVTEPPNLSIVTEYLS------RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499 (634)
Q Consensus 426 ~~~~~~~~~lV~E~~~------ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~ 499 (634)
+.+.+...-+|+|.+. ..+|.+++.... +++ . +...+-+-..||-.++ |+.+|++|.||++...
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQALDEFKRYLLDHH--IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHHHHHHHHHHHcC--CeecCCCcccEEEEec
Confidence 9999999999999775 346788875332 444 2 2334444556777888 9999999999999532
Q ss_pred --C--cEEEEe
Q 006703 500 --Y--TVKVCD 506 (634)
Q Consensus 500 --~--~ikL~D 506 (634)
+ .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 577787
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00092 Score=70.37 Aligned_cols=80 Identities=10% Similarity=0.022 Sum_probs=57.6
Q ss_pred ceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC---CCeeeeeceeec---CCcEEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVLLMGAVTE---PPNLSI 435 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h---~nIv~l~~~~~~---~~~~~l 435 (634)
.....+.||.|..+.||+....+..+.+|..+.. ... ..+..|...|+.+.. -.|+++++++.+ .+..++
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~-~~~---~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSF-STP---GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEeccc-ccc---hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3445568999999999999876667777874331 111 356789888888842 367788877654 356899
Q ss_pred EEeecccCCH
Q 006703 436 VTEYLSRGSL 445 (634)
Q Consensus 436 V~E~~~ggsL 445 (634)
|||+++|.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00026 Score=79.36 Aligned_cols=142 Identities=18% Similarity=0.218 Sum_probs=90.3
Q ss_pred eecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccH---H--------------------------HHH------HHHH
Q 006703 364 IDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHE---D--------------------------RFK------EFLR 407 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~---~--------------------------~~~------~~~~ 407 (634)
...+.||.-+.|.||+|+.++. .||||+-+..--+. + ..+ +|.+
T Consensus 164 f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 164 FDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred cCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 4456899999999999998854 49999975442111 0 001 2445
Q ss_pred HHHHHHhC----CCCC------eeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHH-HH
Q 006703 408 EVAIMKGL----RHPN------IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM-NY 476 (634)
Q Consensus 408 El~iL~~l----~h~n------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL-~y 476 (634)
|.+...++ .|-+ |++++-. ....-.++|||++|..+.++-...... ++.. .++..+.++. +-
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~---~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG--ISPH---DILNKLVEAYLEQ 316 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC--CCHH---HHHHHHHHHHHHH
Confidence 55544444 3444 4444432 223568999999999887775322221 4433 3444444442 23
Q ss_pred HHhCCCCEEeeccCCCcEEEcC----CCcEEEEecCCCccCC
Q 006703 477 LHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSRSKP 514 (634)
Q Consensus 477 LH~~g~~IvHrDIKP~NILld~----~~~ikL~DFGla~~~~ 514 (634)
|=..| ++|+|-+|.||++++ ++.+.+.|||+.....
T Consensus 317 If~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHhcC--CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 33556 999999999999983 6789999999987543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00027 Score=69.27 Aligned_cols=103 Identities=18% Similarity=0.166 Sum_probs=79.1
Q ss_pred HHHHHHHHhCCC-CCeeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCC-CC
Q 006703 406 LREVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PP 483 (634)
Q Consensus 406 ~~El~iL~~l~h-~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g-~~ 483 (634)
.+|.-+++.+.+ +++++++|++-. ++++||...+++......-..-...++..+.+|+.++++.+.+|+..- ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 368888888865 699999999844 679999987655421100001123789999999999999999998742 13
Q ss_pred EEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 484 IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+.-.|++|+|+-++.++.+|++|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00092 Score=65.97 Aligned_cols=127 Identities=23% Similarity=0.264 Sum_probs=92.0
Q ss_pred cceeecceeeccCc-EEEEEEEEcCCcEEEEEEeec---c-------ccH---------HHHHHHHHHHHHHHhCC---C
Q 006703 361 THVIDSSNFIKGSF-GTVYHAEWRNSDVAVKILIEQ---E-------FHE---------DRFKEFLREVAIMKGLR---H 417 (634)
Q Consensus 361 ~~~~~~~~LG~G~f-G~Vy~a~~~~~~vAvK~~~~~---~-------~~~---------~~~~~~~~El~iL~~l~---h 417 (634)
..+...+.||.|.- |.||+++..+..+|+|++..- . ... ....-|..|.+...+++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888999999999 999999999999999993221 0 110 12235788988888884 4
Q ss_pred CCe--eeeeceeecC------------------CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHH
Q 006703 418 PNI--VLLMGAVTEP------------------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 477 (634)
Q Consensus 418 ~nI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yL 477 (634)
.+. +++++|..-. ....||.||++... .+. .+-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence 455 8999987221 12457788776532 122 23356788889999
Q ss_pred HhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 478 H~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
|..| |+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC--eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999987 2479999865
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0011 Score=66.78 Aligned_cols=73 Identities=16% Similarity=0.195 Sum_probs=45.7
Q ss_pred cceeeccCcEEEEEEEEc---CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC-eeeeeceeecCCcEEEEEeecc
Q 006703 366 SSNFIKGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n-Iv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.+.|..|-...+|++... +..+++|+....... .....+|+.+++.+...+ .++++..... .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence 356777888899999766 356888875432111 112236888888884333 3455443321 47999999
Q ss_pred cCCH
Q 006703 442 RGSL 445 (634)
Q Consensus 442 ggsL 445 (634)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00088 Score=79.63 Aligned_cols=232 Identities=18% Similarity=0.192 Sum_probs=152.5
Q ss_pred eeccCcEEEEEEEEcCCc------EEEEEEeecc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc----EEEEE
Q 006703 369 FIKGSFGTVYHAEWRNSD------VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----LSIVT 437 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~~~~------vAvK~~~~~~-~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~----~~lV~ 437 (634)
+-.-.+|+++..++.... +-++.-.... ...........|+..+..+.|+|++.++.|...... ..+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 344566778877665221 2221111111 112233444567788888899999999988755443 23456
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCC---cEEEcCCCcEEEE--ecCCCcc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP---NLLVDSTYTVKVC--DFGLSRS 512 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~---NILld~~~~ikL~--DFGla~~ 512 (634)
+++...++...+...+ ..+......+..++.+|+.|+|+.. ..|.-+..+ +--.+..+.+..+ ||+.+..
T Consensus 266 ~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~ 340 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKP 340 (1351)
T ss_pred hhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhccccc
Confidence 7888888888776443 3777888889999999999999986 556555444 4444566666666 8988776
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCc--hHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNE--KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~--~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.++.. .......+..+.++|......+.. ..|+|++|..+..+..|..+-..... ....++.....
T Consensus 341 l~d~~-~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-----------~~~~l~~~~~~ 408 (1351)
T KOG1035|consen 341 LPDNE-KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-----------PVSLLDVLSTS 408 (1351)
T ss_pred CCCcc-cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-----------hhhhhccccch
Confidence 65543 223444566788888887766644 47999999999999887654322110 01111222223
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
++..+..+|+..++++|+++.++++..
T Consensus 409 ~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 409 ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhhhhhcchhhhhccchhhhhhch
Confidence 788889999999999999999998853
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0012 Score=67.63 Aligned_cols=137 Identities=12% Similarity=0.051 Sum_probs=76.4
Q ss_pred eeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCe-eeeeceeecCCcEEEEEeecccCCHHH
Q 006703 369 FIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYLSRGSLYK 447 (634)
Q Consensus 369 LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~ggsL~~ 447 (634)
+..|-...+|+....+..+++|+........ .-...+|..+++.+...++ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4457788999998777778888743321110 0123578888888854333 34444322 368999999876542
Q ss_pred H--------------h---ccCCC-cccccHH-HHHHHHHHH---------HHHHHHHHhC------CCCEEeeccCCCc
Q 006703 448 L--------------L---HIPDA-RVVVDER-LRLNMAYDV---------AKGMNYLHQR------RPPIVHRDLKSPN 493 (634)
Q Consensus 448 l--------------l---~~~~~-~~~l~e~-~~~~i~~qI---------a~aL~yLH~~------g~~IvHrDIKP~N 493 (634)
. + |.... ...++.. .+..+..++ ...+..+-.. .+.++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1 11110 1111111 111111111 1112222111 1248999999999
Q ss_pred EEEcCCCcEEEEecCCCcc
Q 006703 494 LLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 494 ILld~~~~ikL~DFGla~~ 512 (634)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999987764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00049 Score=55.27 Aligned_cols=53 Identities=23% Similarity=0.248 Sum_probs=43.5
Q ss_pred cccccchhHHHHHHHhhhcCCCceeeccccCC---------CCCCCceEEEEecCCcceeeec
Q 006703 206 SVGLCVHRALLFKVLADLINLPCRIAKGCKYC---------RRDDASSCLVQIGPDREYLVDL 259 (634)
Q Consensus 206 ~~g~~rhra~lfk~lad~~~~~~~l~~g~~~~---------~~~~~~~~~v~~~~~~~~~vd~ 259 (634)
+.|.|.+.|.||+.|+..+|||||+|.|..-. ....|+++.|..+ ++=+.+|.
T Consensus 5 ~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~-~~W~~~D~ 66 (68)
T smart00460 5 KYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE-GGWVPVDP 66 (68)
T ss_pred cceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC-CCeEEEeC
Confidence 57999999999999999999999999995443 3678889999986 44455664
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0063 Score=63.52 Aligned_cols=143 Identities=15% Similarity=0.113 Sum_probs=83.8
Q ss_pred ecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCC--Ceeeeece------eecCCcEEEE
Q 006703 365 DSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGA------VTEPPNLSIV 436 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~--nIv~l~~~------~~~~~~~~lV 436 (634)
..+.|..|....+|+....+..+++|+... ... ..+..|+.+++.+.+. .+++++.. ...++..+++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDSGRYVLTLFEK--VSA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred heecccCccccceEEEEeCCCcEEEEEcCC--CCh---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 345677788889999987777899998654 111 3455677777777432 24454442 1334567899
Q ss_pred EeecccCCHHH----H-------h---ccC--CCc------ccccHHHH----------HHHHHHHHHHHHHHHhC----
Q 006703 437 TEYLSRGSLYK----L-------L---HIP--DAR------VVVDERLR----------LNMAYDVAKGMNYLHQR---- 480 (634)
Q Consensus 437 ~E~~~ggsL~~----l-------l---~~~--~~~------~~l~e~~~----------~~i~~qIa~aL~yLH~~---- 480 (634)
++|++|..+.. . + +.. ... ....+... ......+..++.++...
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99999876532 0 0 100 000 00010000 00111233344454431
Q ss_pred -CCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 481 -RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 481 -g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
...++|+|+.|.||++++++.+.|+||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 12499999999999999887788999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0094 Score=63.02 Aligned_cols=143 Identities=11% Similarity=0.124 Sum_probs=76.4
Q ss_pred ecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC--CCCeeeeece------eecCCcEEEE
Q 006703 365 DSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGA------VTEPPNLSIV 436 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~--h~nIv~l~~~------~~~~~~~~lV 436 (634)
..+.|+.|....+|+....+..+++|+.. ...... +..|+.+++.+. .-.+.+++.. ....+..+++
T Consensus 26 ~~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~~~---l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTAED---LPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred ccchhccccccceEEEEeCCCcEEEEEec--cCChHH---hHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 34556778888999998777779999865 222222 223444444442 1123333321 1234567899
Q ss_pred EeecccCCHH-----------HHh---ccCCCc--------ccccH-HHHH------------HHHHH-HHHHHHHHHh-
Q 006703 437 TEYLSRGSLY-----------KLL---HIPDAR--------VVVDE-RLRL------------NMAYD-VAKGMNYLHQ- 479 (634)
Q Consensus 437 ~E~~~ggsL~-----------~ll---~~~~~~--------~~l~e-~~~~------------~i~~q-Ia~aL~yLH~- 479 (634)
++|++|..+. ..+ +..... ..+.+ .... ..+.+ +...+..+..
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 9999987532 111 110000 00101 0000 01111 1112233321
Q ss_pred ----CCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 480 ----RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 480 ----~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
...+++|+|++|.||+++.+...-|+||+.+..
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 112499999999999999766668999998763
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.00015 Score=87.57 Aligned_cols=237 Identities=14% Similarity=0.029 Sum_probs=146.8
Q ss_pred EEEEEEEEcCC---cEEEEEEeeccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCcEEEEEeecccCCHH
Q 006703 375 GTVYHAEWRNS---DVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIVTEYLSRGSLY 446 (634)
Q Consensus 375 G~Vy~a~~~~~---~vAvK~~~~~~~---~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~ggsL~ 446 (634)
+.-+++.+-.+ .+.+|+.+.-.+ .+...+-...|..-++...|+++.....-... ....+..++|+.+|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 33444444333 256666543322 23333444556666666789888776654432 33478899999999999
Q ss_pred HHhccCCC-cccccHHHHHHHHHHHHHHHHHHHhC---CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCC
Q 006703 447 KLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQR---RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 522 (634)
Q Consensus 447 ~ll~~~~~-~~~l~e~~~~~i~~qIa~aL~yLH~~---g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~ 522 (634)
..+-+.-. ...++...+.....+.+.+..-+|+. |..-+|+++|+-|.+|..+..+|++++|+.+...........
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl 1399 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGL 1399 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhh
Confidence 98853322 22344444444444446665555543 335799999999999999999999999999954444334556
Q ss_pred CCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 523 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 523 ~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
..+++.|+.|++...-.++.++|+|..|+.+|....|..+|...........+ ....-..++...|.+.......+|..
T Consensus 1400 ~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgii-dn~tf~sIe~l~pgdaNve~~~~Ll~ 1478 (2724)
T KOG1826|consen 1400 ELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGII-DNHTFFSIEKLKPGDANVEALHRLLW 1478 (2724)
T ss_pred hhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcc-cccccccccccCCCcccHHHHHHHHH
Confidence 67888999999998888899999999999999999888776432111111111 01111223333344444455555555
Q ss_pred CCCCCCCHHH
Q 006703 603 EPEIRPSFPS 612 (634)
Q Consensus 603 dP~~RPs~~~ 612 (634)
.-..||.-..
T Consensus 1479 K~~~rp~q~i 1488 (2724)
T KOG1826|consen 1479 KYMERPGQYI 1488 (2724)
T ss_pred Hhhhcchhhh
Confidence 5556655433
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0083 Score=63.22 Aligned_cols=145 Identities=17% Similarity=0.205 Sum_probs=81.7
Q ss_pred eecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCC--Ceeeeecee------ecCCcEEE
Q 006703 364 IDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGAV------TEPPNLSI 435 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~--nIv~l~~~~------~~~~~~~l 435 (634)
...+.++.|....+|+....+..+++|+..... .. ..+..|+.++..+... .+++++... ...+..++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred eeccccCCccccceEEEEeCCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 335566777778999988766678888764421 12 2334566666666321 244444421 23456789
Q ss_pred EEeecccCCHHH-----------Hh---ccCCCc------c--ccc-HHHH--H----------HHHHHHHHHHHHHHhC
Q 006703 436 VTEYLSRGSLYK-----------LL---HIPDAR------V--VVD-ERLR--L----------NMAYDVAKGMNYLHQR 480 (634)
Q Consensus 436 V~E~~~ggsL~~-----------ll---~~~~~~------~--~l~-e~~~--~----------~i~~qIa~aL~yLH~~ 480 (634)
+++|++|..+.. .+ +..... . ..+ +... . .....+...++++...
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 999998855321 11 110000 0 000 0000 0 0112233445555431
Q ss_pred -----CCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 481 -----RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 481 -----g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
..+++|+|+++.||++++++...|+||+.+..
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 12499999999999999887778999997753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.011 Score=64.50 Aligned_cols=77 Identities=14% Similarity=0.025 Sum_probs=53.0
Q ss_pred cceeeccCcEEEEEEEEcCC--cEEEEEEeeccc---c--HHHHHHHHHHHHHHHhCC---CCCeeeeeceeecCCcEEE
Q 006703 366 SSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF---H--EDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~---~--~~~~~~~~~El~iL~~l~---h~nIv~l~~~~~~~~~~~l 435 (634)
.+.||.|.+..||++...+. .++||.-..... . +-...+...|.+.|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 45789999999999998765 689998532110 0 112356667888887762 3467777766 4466789
Q ss_pred EEeecccCC
Q 006703 436 VTEYLSRGS 444 (634)
Q Consensus 436 V~E~~~ggs 444 (634)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0072 Score=63.36 Aligned_cols=74 Identities=18% Similarity=0.234 Sum_probs=45.5
Q ss_pred ceeeccCcEEEEEEEEcC--------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC-eeeeeceeecCCcEEEEE
Q 006703 367 SNFIKGSFGTVYHAEWRN--------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~~--------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n-Iv~l~~~~~~~~~~~lV~ 437 (634)
+.|..|-...||+....+ ..+++|+...... ...+..+|.++++.+...+ ..++++++.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 345567777899987654 4588888544321 1123457888888874333 3455555432 3589
Q ss_pred eecccCCHHH
Q 006703 438 EYLSRGSLYK 447 (634)
Q Consensus 438 E~~~ggsL~~ 447 (634)
||++|..+..
T Consensus 77 e~i~G~~l~~ 86 (302)
T cd05156 77 EFIPSRTLTT 86 (302)
T ss_pred heeCCCcCCH
Confidence 9998877643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0032 Score=65.89 Aligned_cols=133 Identities=17% Similarity=0.169 Sum_probs=90.6
Q ss_pred eeecceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-------HHH-----------H--HHHHHHHHHHHhCC-C-CC
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFH-------EDR-----------F--KEFLREVAIMKGLR-H-PN 419 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~-------~~~-----------~--~~~~~El~iL~~l~-h-~n 419 (634)
+-.+++||-|--+.||.+.+. +++.++|+-+....+ .+. + -...+|...|+.+. | =-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 445678999999999999887 677887764322111 000 0 12345777777773 2 23
Q ss_pred eeeeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC
Q 006703 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499 (634)
Q Consensus 420 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~ 499 (634)
|++.++ .+..++|||++.|..|.+.-+... . -.+...+..-+.-|-.+| +||+|..-=||+++.+
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d------~---~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRHVED------P---PTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeeecCC------h---HHHHHHHHHHHHHHHHcC--ceecccchheeEEecC
Confidence 445554 356789999999988876544222 1 233445555566777888 9999999999999999
Q ss_pred CcEEEEecCCC
Q 006703 500 YTVKVCDFGLS 510 (634)
Q Consensus 500 ~~ikL~DFGla 510 (634)
+.++++||--.
T Consensus 239 ~~i~vIDFPQm 249 (465)
T KOG2268|consen 239 DKIVVIDFPQM 249 (465)
T ss_pred CCEEEeechHh
Confidence 99999999744
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.027 Score=59.66 Aligned_cols=132 Identities=17% Similarity=0.206 Sum_probs=78.6
Q ss_pred cCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC--CCeeeeeceeecCC--cEEEEEeecccCCHHH
Q 006703 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPP--NLSIVTEYLSRGSLYK 447 (634)
Q Consensus 372 G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h--~nIv~l~~~~~~~~--~~~lV~E~~~ggsL~~ 447 (634)
|-.-.+|.....++.+++. ...............+|+.+++.+.- --+...++.+.++. ..|.||+|+.|..+.+
T Consensus 36 G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 4334456655556667776 32212233344556688888888843 33445555565555 6799999998843332
Q ss_pred HhccCCCcccccHHHHHHHH-HHHHHH--------------------------------------------------HHH
Q 006703 448 LLHIPDARVVVDERLRLNMA-YDVAKG--------------------------------------------------MNY 476 (634)
Q Consensus 448 ll~~~~~~~~l~e~~~~~i~-~qIa~a--------------------------------------------------L~y 476 (634)
-+.... .. ..++ ..+++. ..+
T Consensus 115 ~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 115 ALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred cCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 221100 00 0111 133333 334
Q ss_pred HHhCCC------CEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 477 LHQRRP------PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 477 LH~~g~------~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
|+.+-+ .++|+|+++.||+++.++.+=+.||+++..
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 443322 599999999999999888899999998875
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.0023 Score=56.58 Aligned_cols=53 Identities=23% Similarity=0.270 Sum_probs=40.7
Q ss_pred cccccchhHHHHHHHhhhcCCCceeeccccCC----------CCCCCceEEEEecCCcceeee
Q 006703 206 SVGLCVHRALLFKVLADLINLPCRIAKGCKYC----------RRDDASSCLVQIGPDREYLVD 258 (634)
Q Consensus 206 ~~g~~rhra~lfk~lad~~~~~~~l~~g~~~~----------~~~~~~~~~v~~~~~~~~~vd 258 (634)
..|.|..-|.||..|+..+|||||+|.|.... +.+.|++|.|.+++..=+.+|
T Consensus 50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 35999999999999999999999999996652 355689999999555534444
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.054 Score=56.77 Aligned_cols=28 Identities=29% Similarity=0.423 Sum_probs=24.6
Q ss_pred CEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 483 ~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4999999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.047 Score=58.71 Aligned_cols=143 Identities=18% Similarity=0.232 Sum_probs=78.4
Q ss_pred eeecceeeccCcEEEEEEEEcC------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCe-eeeeceeecCCcEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSI 435 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nI-v~l~~~~~~~~~~~l 435 (634)
......|-.|-.-.+|++...+ ..+++|+..... ... -.-.+|..+++.+...++ .++++.+..+ .
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-echHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 3444556567888899987532 357788764331 111 112478888888854333 3555555432 5
Q ss_pred EEeecccCCHHHH-----------------hccCC---CcccccHHHHHHHHHH-----------------HHHHHHHHH
Q 006703 436 VTEYLSRGSLYKL-----------------LHIPD---ARVVVDERLRLNMAYD-----------------VAKGMNYLH 478 (634)
Q Consensus 436 V~E~~~ggsL~~l-----------------l~~~~---~~~~l~e~~~~~i~~q-----------------Ia~aL~yLH 478 (634)
|++|+++.+|..- +|... .........+.+++.+ +...+..|.
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 8999987776421 11111 0101112222222211 111122221
Q ss_pred ----hCC--CCEEeeccCCCcEEEcC-CCcEEEEecCCCcc
Q 006703 479 ----QRR--PPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS 512 (634)
Q Consensus 479 ----~~g--~~IvHrDIKP~NILld~-~~~ikL~DFGla~~ 512 (634)
... ..++|+|+++.|||+++ ++.++|+||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111 24899999999999986 46899999987753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.042 Score=57.21 Aligned_cols=30 Identities=23% Similarity=0.422 Sum_probs=25.2
Q ss_pred CEEeeccCCCcEEEcCCCc-EEEEecCCCcc
Q 006703 483 PIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS 512 (634)
Q Consensus 483 ~IvHrDIKP~NILld~~~~-ikL~DFGla~~ 512 (634)
.++|+|++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997554 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.0073 Score=66.00 Aligned_cols=55 Identities=29% Similarity=0.457 Sum_probs=46.5
Q ss_pred cccccchhHHHHHHHhhhcCCCceeeccccCCC-------CCCCceEEEEecCCcceeeeccC
Q 006703 206 SVGLCVHRALLFKVLADLINLPCRIAKGCKYCR-------RDDASSCLVQIGPDREYLVDLLE 261 (634)
Q Consensus 206 ~~g~~rhra~lfk~lad~~~~~~~l~~g~~~~~-------~~~~~~~~v~~~~~~~~~vd~~~ 261 (634)
--++|--=|.|||.||-.+||||.+|+|+--.+ .-.|+|++|++.+.- |+||.--
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~~y-y~VDtTw 269 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDNEY-YLVDTTW 269 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECCeE-EEEeeec
Confidence 347888999999999999999999999984444 778999999997744 8899843
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.036 Score=58.07 Aligned_cols=77 Identities=16% Similarity=0.158 Sum_probs=47.2
Q ss_pred ceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC---CCCCeeeeeceeecCCcEEEEEe
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l---~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.....+.++.|....+|+....+..+.+|+-.... ...|..|..-|+.| ..-.+++++++....+..+++||
T Consensus 18 ~i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 18 KITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp ---EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred ceeeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 34556778889999999998667779999865222 13455777777776 34568889998877777899999
Q ss_pred ecccC
Q 006703 439 YLSRG 443 (634)
Q Consensus 439 ~~~gg 443 (634)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.065 Score=56.55 Aligned_cols=30 Identities=23% Similarity=0.234 Sum_probs=27.1
Q ss_pred CEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 483 ~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+++|+|+.+.||++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999998999999987763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.16 Score=55.71 Aligned_cols=83 Identities=14% Similarity=0.010 Sum_probs=53.9
Q ss_pred ecceeeccCcEEEEEEEEcCCcEEEEEEeeccc--cH---HHHHHHHHHHHHHHhCC---CCCeeeeeceeecCCcEEEE
Q 006703 365 DSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEF--HE---DRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~--~~---~~~~~~~~El~iL~~l~---h~nIv~l~~~~~~~~~~~lV 436 (634)
..+.||.|....||+....+..++||.-..... .. -...+-..|...|+.+. ..++++++.+.. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 456789999999999988766788988642111 00 01233445666776653 357888887766 446788
Q ss_pred Eeeccc--CCHHHHh
Q 006703 437 TEYLSR--GSLYKLL 449 (634)
Q Consensus 437 ~E~~~g--gsL~~ll 449 (634)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.043 Score=54.81 Aligned_cols=117 Identities=12% Similarity=0.077 Sum_probs=74.9
Q ss_pred cCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecccCCHHHHhcc
Q 006703 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 451 (634)
Q Consensus 372 G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~ 451 (634)
|+-++.-.++.+-.+..+|+++.....- ...-|.++.+++.++. .|+++..- ..-.+-++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 4555555554444456666665443321 1134568888888763 56777632 33346689999853211
Q ss_pred CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 452 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 452 ~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
.. ..++.-=+++|.-.|+..+..+|+|-.|+||+-|+.|.+||.|-+.
T Consensus 142 ------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11 1122222567888896655699999999999999999999999874
|
The function of this family is unknown. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.095 Score=56.08 Aligned_cols=140 Identities=22% Similarity=0.217 Sum_probs=92.1
Q ss_pred ceeeccCcEEEEEEEEc-CCcEEEEEEeecccc-----------------------HHHHHH-HHHHHHHHHhCCCCCee
Q 006703 367 SNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFH-----------------------EDRFKE-FLREVAIMKGLRHPNIV 421 (634)
Q Consensus 367 ~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~-----------------------~~~~~~-~~~El~iL~~l~h~nIv 421 (634)
..|..|--+.||.|... +..+|||+.+..... ....+. ...|++.|++++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 46777888999999766 445999998544211 111111 23588888888655543
Q ss_pred eeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc
Q 006703 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 501 (634)
Q Consensus 422 ~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ 501 (634)
-.--... ....|||+|+.+.... .-... ...++...+..+-.+++.-+.-|.+.. .+||.||.--|+|+ .+|.
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~-aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c-~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWA-APKLK--DASLSTSKARELYQQCVRIMRRLYQKC-RLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCc-Ccccc--cccCChHHHHHHHHHHHHHHHHHHHHh-ceeccchhhhhheE-ECCE
Confidence 2221111 2357999999643221 11111 123667778888889999999886653 39999999999999 5568
Q ss_pred EEEEecCCCccC
Q 006703 502 VKVCDFGLSRSK 513 (634)
Q Consensus 502 ikL~DFGla~~~ 513 (634)
++++|.+-+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999999877643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.14 Score=54.68 Aligned_cols=141 Identities=14% Similarity=0.153 Sum_probs=76.0
Q ss_pred ecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCe-eeeeceeecCCcEEEEEe
Q 006703 365 DSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nI-v~l~~~~~~~~~~~lV~E 438 (634)
..+.|..|-.-.+|+....+. .+++|+.-.... ..-.-.+|..+++.+..-++ +++++++..+ ++.+
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQS 90 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeeh
Confidence 344555577788998875532 577887643211 11112378888888854444 3555555321 5889
Q ss_pred ecccCCHHHH-------h----------ccCC---CcccccHHHHHHHHHH----------------------HHHHHHH
Q 006703 439 YLSRGSLYKL-------L----------HIPD---ARVVVDERLRLNMAYD----------------------VAKGMNY 476 (634)
Q Consensus 439 ~~~ggsL~~l-------l----------~~~~---~~~~l~e~~~~~i~~q----------------------Ia~aL~y 476 (634)
|+++..|..- + |... .+.......+.++..+ +..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 9887765220 1 1111 0101111222222211 1111222
Q ss_pred HH----hCC--CCEEeeccCCCcEEEcC-CCcEEEEecCCCcc
Q 006703 477 LH----QRR--PPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS 512 (634)
Q Consensus 477 LH----~~g--~~IvHrDIKP~NILld~-~~~ikL~DFGla~~ 512 (634)
+. ..+ ...+|+|+.+.|||+++ ++.++++||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 21 111 14799999999999974 57899999998753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.052 Score=60.21 Aligned_cols=155 Identities=20% Similarity=0.183 Sum_probs=92.5
Q ss_pred HHHHHHHHHHHhCCCCCeeeeeceeec-CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCC
Q 006703 403 KEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481 (634)
Q Consensus 403 ~~~~~El~iL~~l~h~nIv~l~~~~~~-~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g 481 (634)
.++.-....++.+.|+|...++++-.. .....+|||++ +.||++++.... .... ++. .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~----------s~~-------~~~ 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDE----------SLL-------AHG 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchh----------hhc-------ccc
Confidence 345567788999999999999987643 33478899999 669999886443 1111 000 122
Q ss_pred CCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCC
Q 006703 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK 561 (634)
Q Consensus 482 ~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~ 561 (634)
+.|-. .++.+| -+.... .... .+|+|||++|.++.++.-|..
T Consensus 88 --~~~~~------------~~~~td-~~~t~~-------~~~~----------------~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 88 --VLHLN------------IIYITD-HFLTKY-------PSPI----------------GPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred --cceeh------------hhhccc-cccccC-------CCCC----------------CcchhhhhHHHHHHHHHHhhH
Confidence 33322 122333 111100 1111 149999999999999999988
Q ss_pred CCCCCChHHHHHHHhhcCccc----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 006703 562 PWRNSTPSQVISAVGFKGRRL----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 614 (634)
Q Consensus 562 Pf~~~~~~~~~~~i~~~~~~~----------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il 614 (634)
.|......+....+....... .+-..+++.+..+.++|+...|..||.+.++.
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 776655544333221111110 01123556677888889998888888665543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.23 Score=50.05 Aligned_cols=77 Identities=16% Similarity=0.196 Sum_probs=55.9
Q ss_pred ecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC---CCCCeeeeeceeecCCcEEEEEeecc
Q 006703 365 DSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l---~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
..+.+--|.--..|...+...++.+|+- .......|..|+.-|+.+ +.-.|.+++.+.....+.|+||||++
T Consensus 20 er~~v~gG~inea~~v~dg~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 20 EREEVSGGDINEAWRLRDGTDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred cccccCCccccceeEeecCCcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 3344445666667888777778999873 334445677787777766 34568899999999999999999998
Q ss_pred cCCHH
Q 006703 442 RGSLY 446 (634)
Q Consensus 442 ggsL~ 446 (634)
-+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 75554
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.51 Score=50.95 Aligned_cols=73 Identities=15% Similarity=0.067 Sum_probs=45.1
Q ss_pred eeeccCcEEEEEEEEcCC--cEEEEEEeecc-----ccHHHHHHHHHHHHHHHhCC--CC-CeeeeeceeecCCcEEEEE
Q 006703 368 NFIKGSFGTVYHAEWRNS--DVAVKILIEQE-----FHEDRFKEFLREVAIMKGLR--HP-NIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~-----~~~~~~~~~~~El~iL~~l~--h~-nIv~l~~~~~~~~~~~lV~ 437 (634)
.||.|....||++...+. .++||.-..-. .-+-...+..-|...|+... .| .+++++. .++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478899999999987653 58888743111 00111234456777776652 24 4555553 4556667999
Q ss_pred eeccc
Q 006703 438 EYLSR 442 (634)
Q Consensus 438 E~~~g 442 (634)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.87 Score=48.70 Aligned_cols=136 Identities=21% Similarity=0.275 Sum_probs=80.7
Q ss_pred CcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC---CCCeee---e----eceeecCCcEEEEEeeccc
Q 006703 373 SFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVL---L----MGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 373 ~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~---h~nIv~---l----~~~~~~~~~~~lV~E~~~g 442 (634)
.-..||+....+..+++|+.... ... .++..|+..++.+. .+-.++ . +..+..+...+.+++|++|
T Consensus 37 ~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G 112 (331)
T COG2334 37 EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG 112 (331)
T ss_pred ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence 44679999988888988887665 333 34556777777762 111112 1 1112222478889999999
Q ss_pred CCHHH-Hh--------------c---------cCCCcccccHHH-------------HHHHHHHHHHHHHHHHhCCC---
Q 006703 443 GSLYK-LL--------------H---------IPDARVVVDERL-------------RLNMAYDVAKGMNYLHQRRP--- 482 (634)
Q Consensus 443 gsL~~-ll--------------~---------~~~~~~~l~e~~-------------~~~i~~qIa~aL~yLH~~g~--- 482 (634)
..+.. .. + ++.......+.. -.....++...+..+...-+
T Consensus 113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l 192 (331)
T COG2334 113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL 192 (331)
T ss_pred cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence 88873 11 1 001111111210 01123344455555554321
Q ss_pred ---C--EEeeccCCCcEEEcCCCc-EEEEecCCCcc
Q 006703 483 ---P--IVHRDLKSPNLLVDSTYT-VKVCDFGLSRS 512 (634)
Q Consensus 483 ---~--IvHrDIKP~NILld~~~~-ikL~DFGla~~ 512 (634)
+ +||+|+.|.||+++.+.. +-++|||-+..
T Consensus 193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred CcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 2 899999999999998874 88999997763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.16 Score=54.35 Aligned_cols=106 Identities=17% Similarity=0.218 Sum_probs=71.6
Q ss_pred cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
...+.|++|++. |++|...- .-...++..|+.+.+.-++-+..+- +.-|||+.-.||||+ +|.|.|+||-
T Consensus 297 e~~y~yl~~kdh-gt~is~ik-------~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISIIK-------ADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecC-Cceeeeee-------cccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee-cCceEEEEee
Confidence 344577888877 55664321 2456778889999888888887765 489999999999999 9999999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHH
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLG 550 (634)
+++..... ..+...++--|-.|.|.. +..-+||-+-
T Consensus 367 lsRl~~~q-----~~isy~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 367 LSRLSYSQ-----GIISYNRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred eeecccCC-----ceeeccccCchhhhcCcc-ceeeeHHHHH
Confidence 99843221 112222333444454333 5666777653
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.25 Score=53.89 Aligned_cols=75 Identities=16% Similarity=0.054 Sum_probs=47.8
Q ss_pred cceeeccCcEEEEEEEEc--CCcEEEEEEeecc-cc---HHHHHHHHHHHHHHHhCC--CC-CeeeeeceeecCCcEEEE
Q 006703 366 SSNFIKGSFGTVYHAEWR--NSDVAVKILIEQE-FH---EDRFKEFLREVAIMKGLR--HP-NIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~-~~---~~~~~~~~~El~iL~~l~--h~-nIv~l~~~~~~~~~~~lV 436 (634)
.+.||.|.-..||++.+. +..++||.-..-- .. +-...+..-|...|+... .| ++++++. .++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 567899999999999975 4458888743111 10 112345556777777662 33 5566663 455667788
Q ss_pred Eeeccc
Q 006703 437 TEYLSR 442 (634)
Q Consensus 437 ~E~~~g 442 (634)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.68 E-value=1.3 Score=48.41 Aligned_cols=79 Identities=15% Similarity=0.143 Sum_probs=44.9
Q ss_pred eecceeeccCcEEEEEEEEcCC---cEEEEE-Eeec-cccHHHHHHHHHHHHHHHhCCCC-CeeeeeceeecCCcEEEEE
Q 006703 364 IDSSNFIKGSFGTVYHAEWRNS---DVAVKI-LIEQ-EFHEDRFKEFLREVAIMKGLRHP-NIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~~---~vAvK~-~~~~-~~~~~~~~~~~~El~iL~~l~h~-nIv~l~~~~~~~~~~~lV~ 437 (634)
...+.|..|-...+|++...+. .+.+|. +... .......-.-.+|+++++.+... .-.++++.+.. +++.
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ 128 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ 128 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence 4445666688899999975432 222221 1111 01111111123788899988544 44466666543 6999
Q ss_pred eecccCCHH
Q 006703 438 EYLSRGSLY 446 (634)
Q Consensus 438 E~~~ggsL~ 446 (634)
||++|.+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 634 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-111 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-110 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-38 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-37 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-37 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-37 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-37 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-36 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-36 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-36 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-36 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-36 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-36 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-36 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-36 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-36 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-36 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-36 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-36 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-36 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-36 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-35 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-35 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-35 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-35 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-35 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-35 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-35 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-35 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-35 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-35 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-35 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-35 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-35 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-35 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-35 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-35 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-35 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-35 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-34 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-34 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-34 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-34 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-34 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-34 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-34 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-34 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-34 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-33 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-33 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-33 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-33 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-33 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-33 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-33 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-33 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-33 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-33 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-33 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-33 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-33 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-33 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-33 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-33 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-33 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-33 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-33 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-33 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-33 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-33 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-32 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-32 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-32 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-32 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-32 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-32 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-32 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-32 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-32 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-32 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-32 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-32 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-32 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-32 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-32 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-31 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-31 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-31 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-31 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-31 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-31 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-31 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-31 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-31 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-31 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-31 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-31 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-31 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-31 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-31 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-31 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-30 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-30 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-30 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-30 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-30 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-30 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-30 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-30 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-30 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-30 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-30 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-30 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-30 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-30 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-30 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-30 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-30 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-30 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-30 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-30 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-30 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-30 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-30 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-30 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-30 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-30 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-30 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-30 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-30 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-30 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-30 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-30 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-30 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-30 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-30 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-30 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-30 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-30 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-30 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-30 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-30 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-30 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-30 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-30 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-30 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-30 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-29 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-29 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-29 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-29 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-29 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-29 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-29 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-29 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-29 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-29 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-29 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-29 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-29 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-29 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-29 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-29 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-29 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-29 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-29 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-29 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-29 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-29 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-29 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-29 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-29 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-29 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-29 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-29 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-29 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-29 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-29 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-29 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-29 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-29 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-29 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-29 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-29 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-29 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-29 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-29 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-29 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-29 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-29 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-29 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-29 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-29 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-29 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-29 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-29 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-29 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-28 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-28 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-28 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-28 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-28 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-28 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-28 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-28 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-28 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-28 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-28 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-28 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-28 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-28 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-28 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-28 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-28 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-28 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-28 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-28 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-27 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-27 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-27 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-27 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-27 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-27 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-27 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-27 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-27 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-26 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-26 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-26 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-26 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-26 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-26 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-26 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-26 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-26 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-25 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-25 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-25 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-25 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-25 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-25 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-25 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-25 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-25 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-24 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-24 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-24 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-24 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-24 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-24 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-24 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-24 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-24 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-24 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-24 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-24 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-24 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-24 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-24 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-24 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-24 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-24 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-24 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-24 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-24 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-24 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-24 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-24 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-24 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-24 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-24 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-24 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-24 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-24 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-24 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-24 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-24 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-24 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-23 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-23 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-23 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-23 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-23 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-23 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-23 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-23 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-23 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-23 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-23 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-23 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-22 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-22 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-22 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-22 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-22 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-22 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-22 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-21 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-21 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-21 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-21 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-21 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-21 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-20 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-20 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-20 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-20 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-20 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-20 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-20 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-20 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-20 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-20 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-19 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-19 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 634 | |||
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-150 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-133 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-132 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-128 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-125 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-125 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-125 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-125 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-123 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-107 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-106 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-105 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-101 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-100 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 8e-92 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-76 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-74 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-73 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-73 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-72 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-71 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-71 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-71 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-71 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 8e-71 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 9e-71 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-70 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-70 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-70 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-70 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-70 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-70 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-70 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-70 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-69 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-69 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-69 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-69 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-69 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-69 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 8e-69 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-69 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-68 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-68 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-68 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-68 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-68 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-67 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-67 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-67 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-66 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-66 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-66 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-66 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-65 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-65 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-65 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-64 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-64 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-64 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-64 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-64 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-64 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-64 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 6e-64 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-63 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-62 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-62 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-56 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-56 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-55 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-52 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-52 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-50 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-50 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-50 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 7e-50 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-50 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-49 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-49 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-49 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-48 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 9e-48 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-47 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-47 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-46 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-46 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-46 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-44 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-44 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-44 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-43 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-43 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-43 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-43 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-43 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-42 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-42 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-42 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-42 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 8e-42 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-41 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-41 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-40 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-14 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-40 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-40 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-39 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 7e-39 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 7e-39 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-38 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-38 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-37 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-37 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-37 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-37 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-37 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-37 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-37 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 7e-37 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-37 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-36 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-36 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-36 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-36 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-36 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-36 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-36 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-36 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-36 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-35 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-35 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-35 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-35 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-35 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-35 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-35 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-35 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-35 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-35 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-35 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-35 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-34 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-34 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-34 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-05 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-34 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-34 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-34 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-34 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-34 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-34 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-34 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-33 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-33 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-33 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-33 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-33 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 9e-33 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-32 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-32 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-32 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-31 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-31 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-30 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-30 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-30 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-29 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-29 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-29 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-29 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-29 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-28 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-28 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-28 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-27 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-27 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-27 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-27 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-27 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-27 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-27 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 8e-27 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 8e-27 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-26 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-26 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-26 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-26 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-26 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-26 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-26 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-26 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 9e-26 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-25 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-25 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-25 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-25 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-25 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-25 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 9e-25 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-24 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-24 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-24 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-23 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-23 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-23 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-22 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-22 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-22 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-22 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 7e-22 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-21 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-21 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-21 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 7e-21 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-21 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-20 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-20 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-20 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-19 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-18 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-18 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-17 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-16 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-16 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-13 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-13 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-11 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 5e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 4e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 8e-06 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-04 |
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 434 bits (1118), Expect = e-150
Identities = 190/258 (73%), Positives = 219/258 (84%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
GSFGTV+ AEW SDVAVKIL+EQ+FH +R EFLREVAIMK LRHPNIVL MGAVT+P
Sbjct: 47 AGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
PNLSIVTEYLSRGSLY+LLH AR +DER RL+MAYDVAKGMNYLH R PPIVHR+LK
Sbjct: 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK 166
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 550
SPNLLVD YTVKVCDFGLSR K +T++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFG
Sbjct: 167 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 551 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 610
VILWEL TLQ+PW N P+QV++AVGFK +RLEIP+N+NP VAA+IE CW EP RPSF
Sbjct: 227 VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 286
Query: 611 PSIMETLQQFLMSSVCQP 628
+IM+ L+ + S+V P
Sbjct: 287 ATIMDLLRPLIKSAVPPP 304
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-133
Identities = 73/255 (28%), Positives = 136/255 (53%), Gaps = 11/255 (4%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
+ G ++ W+ +D+ VK+L +++ + ++F E ++ HPN++ ++GA P
Sbjct: 20 ENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79
Query: 431 P--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
P + +++T ++ GSLY +LH VVD+ + A D+A+GM +LH P I
Sbjct: 80 PAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA 138
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN---EKSD 545
L S ++++D T ++ + S S P W+APE L++ P + +D
Sbjct: 139 LNSRSVMIDEDMTARISMADVKFSF-----QSPGRMYAPAWVAPEALQKKPEDTNRRSAD 193
Query: 546 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 605
++SF V+LWEL+T + P+ + + ++ V +G R IP ++P V+ L++ C E+P
Sbjct: 194 MWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPA 253
Query: 606 IRPSFPSIMETLQQF 620
RP F I+ L++
Sbjct: 254 KRPKFDMIVPILEKM 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 387 bits (995), Expect = e-132
Identities = 93/260 (35%), Positives = 132/260 (50%), Gaps = 17/260 (6%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHE--DRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G FG VY A W +VAVK + + +E + L+HPNI+ L G
Sbjct: 17 IGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP-PIVHR 487
+ PNL +V E+ G L ++L + + +N A +A+GMNYLH PI+HR
Sbjct: 77 KEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 488 DLKSPNLLVDSTY--------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 539
DLKS N+L+ +K+ DFGL+R T + +AAG WMAPEV+R
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASM 190
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
++ SDV+S+GV+LWEL+T + P+R V V L IP A L+E C
Sbjct: 191 FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDC 250
Query: 600 WAEEPEIRPSFPSIMETLQQ 619
W +P RPSF +I++ L
Sbjct: 251 WNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 377 bits (969), Expect = e-128
Identities = 92/266 (34%), Positives = 143/266 (53%), Gaps = 23/266 (8%)
Query: 371 KGSFGTVYHAEW--RNSDVAVKILIEQEFHED-----RFKEFLREVAIMKGLRHPNIVLL 423
KG FG V+ S VA+K LI + + +F+EF REV IM L HPNIV L
Sbjct: 29 KGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
G + PP +V E++ G LY L D + ++L + D+A G+ Y+ + PP
Sbjct: 89 YGLMHNPPR--MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 484 IVHRDLKSPNLLVDS-----TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL--R 536
IVHRDL+SPN+ + S KV DFGLS+ ++ G +WMAPE +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGNFQWMAPETIGAE 201
Query: 537 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGRRLEIPKNVNPMVAA 594
E+ EK+D +SF +IL+ ++T + P+ + ++ I+ + +G R IP++ P +
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN 261
Query: 595 LIETCWAEEPEIRPSFPSIMETLQQF 620
+IE CW+ +P+ RP F I++ L +
Sbjct: 262 VIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-125
Identities = 94/260 (36%), Positives = 144/260 (55%), Gaps = 15/260 (5%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
GSFGTVY +W DVAVK+L + + F EV +++ RH NI+L MG T P
Sbjct: 34 SGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP 92
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
L+IVT++ SLY LH + + + + +++A A+GM+YLH + I+HRDLK
Sbjct: 93 Q-LAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAK--SIIHRDLK 147
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPEVLREDPSN---EKSD 545
S N+ + TVK+ DFGL+ K S + +G+ WMAPEV+R SN +SD
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 546 VFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRR---LEIPKNVNPMVAALIETCWA 601
V++FG++L+EL+T Q P+ N Q+I VG ++ N + L+ C
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 267
Query: 602 EEPEIRPSFPSIMETLQQFL 621
++ + RPSFP I+ +++
Sbjct: 268 KKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-125
Identities = 81/265 (30%), Positives = 134/265 (50%), Gaps = 20/265 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
KG FG VYH W +VA++++ + +ED+ K F REV + RH N+VL MGA P
Sbjct: 43 KGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
P+L+I+T +LY ++ ++V+D +A ++ KGM YLH + I+H+DLK
Sbjct: 102 PHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLK 157
Query: 491 SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT-----AAGTPEWMAPEVLR--------- 536
S N+ D+ V + DFGL + G +APE++R
Sbjct: 158 SKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEED 216
Query: 537 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596
+ P ++ SDVF+ G I +EL + P++ +I +G + + ++ ++
Sbjct: 217 KLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276
Query: 597 ETCWAEEPEIRPSFPSIMETLQQFL 621
CWA E E RP+F +M+ L++
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-125
Identities = 95/273 (34%), Positives = 143/273 (52%), Gaps = 18/273 (6%)
Query: 360 STHVIDSSNFI------KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMK 413
S H+ID +G+FG V A+WR DVA+K + E K F+ E+ +
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI----ESESERKAFIVELRQLS 56
Query: 414 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 473
+ HPNIV L GA P + +V EY GSLY +LH + ++ ++G
Sbjct: 57 RVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 474 MNYLHQRRP-PIVHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMA 531
+ YLH +P ++HRDLK PNLL+ + TV K+CDFG + ++K G+ WMA
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMA 171
Query: 532 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNP 590
PEV +EK DVFS+G+ILWE+IT +KP+ P+ I G R + KN+
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231
Query: 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
+ +L+ CW+++P RPS I++ + +
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 367 bits (943), Expect = e-123
Identities = 82/268 (30%), Positives = 122/268 (45%), Gaps = 19/268 (7%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
KG FG R + + + F E+ + FL+EV +M+ L HPN++ +G + +
Sbjct: 20 KGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79
Query: 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490
L+ +TEY+ G+L ++ D++ R++ A D+A GM YLH I+HRDL
Sbjct: 80 KRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMN--IIHRDLN 135
Query: 491 SPNLLVDSTYTVKVCDFGLSR--------------SKPNTYISSKTAAGTPEWMAPEVLR 536
S N LV V V DFGL+R K T G P WMAPE++
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 537 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAAL 595
+EK DVFSFG++L E+I + P + + + P N P +
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPI 255
Query: 596 IETCWAEEPEIRPSFPSIMETLQQFLMS 623
C +PE RPSF + L+ M
Sbjct: 256 TVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-107
Identities = 82/316 (25%), Positives = 131/316 (41%), Gaps = 63/316 (19%)
Query: 346 TADRDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF 405
T RD+ + G KG +G V+ W+ +VAVKI ++ K +
Sbjct: 5 TVARDITLLECVG------------KGRYGEVWRGSWQGENVAVKIFSSRDE-----KSW 47
Query: 406 LREVAI--MKGLRHPNIVLLMGAVT----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 459
RE + LRH NI+ + + L ++T Y GSLY L +D
Sbjct: 48 FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLD 103
Query: 460 ERLRLNMAYDVAKGMNYLH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513
L + +A G+ +LH Q +P I HRDLKS N+LV + D GL+
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 514 PNTY----ISSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELIT----- 558
+ + + GT +MAPEVL E S ++ D+++FG++LWE+
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 559 -----LQKPWRNSTPSQ-----VISAVGFKGRRLEIPKNVN-----PMVAALIETCWAEE 603
+ P+ + P+ + V +R IP +A L++ CW +
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 604 PEIRPSFPSIMETLQQ 619
P R + I +TL +
Sbjct: 284 PSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = e-106
Identities = 84/293 (28%), Positives = 121/293 (41%), Gaps = 47/293 (16%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
KG +G V+ +WR VAVK+ E + E+ +RH NI+ + A +
Sbjct: 47 KGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVLMRHENILGFIAADIKG 103
Query: 431 ----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH------QR 480
L ++T+Y GSLY L +D + L +AY G+ +LH Q
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGTPEWMAPEVLR 536
+P I HRDLKS N+LV T + D GL+ I T GT +M PEVL
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 537 ED------PSNEKSDVFSFGVILWELIT----------LQKPWRNSTPSQ-----VISAV 575
E S +D++SFG+ILWE+ Q P+ + PS + V
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
Query: 576 GFKGRRLEIPKN-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
K R P + L+ CWA P R + + +TL + S
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-101
Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 47/293 (16%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-- 428
KG FG V+ +WR +VAVKI +E + E+ LRH NI+ + A
Sbjct: 52 KGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKD 108
Query: 429 --EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH------QR 480
L +V++Y GSL+ L+ R V + +A A G+ +LH Q
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY----ISSKTAAGTPEWMAPEVLR 536
+P I HRDLKS N+LV T + D GL+ + I+ GT +MAPEVL
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 537 ED------PSNEKSDVFSFGVILWELITL----------QKPWRNSTPS-----QVISAV 575
+ S +++D+++ G++ WE+ Q P+ + PS ++ V
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 284
Query: 576 GFKGRRLEIPKN-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
+ R IP ++A ++ CW R + I +TL Q
Sbjct: 285 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = e-100
Identities = 77/310 (24%), Positives = 128/310 (41%), Gaps = 53/310 (17%)
Query: 356 PSGPSTHVIDSSNFI------KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREV 409
G S +G FG V+ A+ N VAVKI Q+ + + EV
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNE---YEV 69
Query: 410 AIMKGLRHPNIVLLMGAVTEPPN----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 465
+ G++H NI+ +GA + L ++T + +GSL L VV +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCH 125
Query: 466 MAYDVAKGMNYLHQ--------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--N 515
+A +A+G+ YLH+ +P I HRD+KS N+L+ + T + DFGL+
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 516 TYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKP-------- 562
+ + GT +MAPEVL + + + D+++ G++LWEL +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 563 --------WRNSTPSQVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAEEPEIRPS 609
++ + + V K +R + M+ IE CW + E R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 610 FPSIMETLQQ 619
+ E + Q
Sbjct: 306 AGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 8e-92
Identities = 77/329 (23%), Positives = 121/329 (36%), Gaps = 69/329 (20%)
Query: 364 IDSSNFI------KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMK--GL 415
+D N +G +G VY VAVK+ + F+ E I + +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLM 64
Query: 416 RHPNIVLLMGAVTEPP-----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 470
H NI + +V EY GSL K L D +A+ V
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSV 120
Query: 471 AKGMNYLH-------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY------ 517
+G+ YLH +P I HRDL S N+LV + T + DFGLS
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 518 --ISSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELI---TLQKPWRN 565
++ + GT +MAPEVL + + ++ D+++ G+I WE+ T P +
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 566 STPSQV---------------ISAVGFKGRRLEIPKNVNP------MVAALIETCWAEEP 604
Q+ V + +R + P+ + IE CW ++
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 605 EIRPSFPSIMETLQQFLMSSVCQPLSAQP 633
E R + E + + LM + S P
Sbjct: 301 EARLTAQXAEERMAE-LMMIWERNKSVSP 328
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 5e-76
Identities = 115/394 (29%), Positives = 169/394 (42%), Gaps = 53/394 (13%)
Query: 239 RDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVEN 298
R + + LV G ++LV + SV H
Sbjct: 22 RAEVAELLVHSG---DFLVRESQGKQ---------EYVLSVLWDGLPRHFI--------- 60
Query: 299 IRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSG 358
I+SL LY ++ F PS + Q L +++ + +
Sbjct: 61 IQSLDNLYRLEGEG--F-----PSIPLLIDHLLSTQQPLTKKSG--------VVLHRAVP 105
Query: 359 PSTHVIDSSNFI------KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVA 410
V++ + + +G+FG V+ R N+ VAVK E + + +FL+E
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEAR 164
Query: 411 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 470
I+K HPNIV L+G T+ + IV E + G L AR+ V L+ M D
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ--MVGDA 222
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP-NTYISSKTAAGTP-E 528
A GM YL + +HRDL + N LV +K+ DFG+SR + Y +S P +
Sbjct: 223 AAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 529 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 587
W APE L + +SDV+SFG++LWE +L P+ N + Q V KG RL P+
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPEL 339
Query: 588 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
V L+E CWA EP RPSF +I + LQ
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 5e-74
Identities = 94/292 (32%), Positives = 141/292 (48%), Gaps = 26/292 (8%)
Query: 334 PQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILI 393
Q F R+ W + +L++ G KG FG V ++R + VAVK +
Sbjct: 7 AQDEFYRSGWALNMK-ELKLLQTIG------------KGEFGDVMLGDYRGNKVAVKCIK 53
Query: 394 EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLHIP 452
+ FL E ++M LRH N+V L+G + E L IVTEY+++GSL L
Sbjct: 54 NDATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 109
Query: 453 DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512
V+ + L L + DV + M YL VHRDL + N+LV KV DFGL++
Sbjct: 110 GRSVLGGDCL-LKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK- 165
Query: 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQV 571
+ T +W APE LRE + KSDV+SFG++LWE+ + + P+ V
Sbjct: 166 --EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223
Query: 572 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
+ V KG +++ P P V +++ CW + +RPSF + E L+
Sbjct: 224 VPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-73
Identities = 91/289 (31%), Positives = 134/289 (46%), Gaps = 23/289 (7%)
Query: 354 QNPSGPSTHVIDSSNFI------KGSFGTVYHAEWRNSD-----VAVKILIEQEF-HEDR 401
+ P T +I + GSFG V EW VAVK L +
Sbjct: 5 EGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 402 FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDER 461
+F+REV M L H N++ L G V PP + +VTE GSL L ++
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 462 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYI 518
A VA+GM YL +R +HRDL + NLL+ + VK+ DFGL R + Y+
Sbjct: 124 S--RYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 519 SSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 576
P W APE L+ + SD + FGV LWE+ T Q+PW SQ++ +
Sbjct: 180 MQ-EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
Query: 577 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625
+G RL P++ + ++ CWA +PE RP+F ++ + L + + +
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 6e-73
Identities = 79/262 (30%), Positives = 121/262 (46%), Gaps = 16/262 (6%)
Query: 372 GSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G+FGTVY W VA+K L E KE L E +M + +P++ L+G
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLG 84
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ ++T+ + G L + + + L LN +AKGMNYL RR +V
Sbjct: 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-QYL-LNWCVQIAKGMNYLEDRR--LV 139
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEK 543
HRDL + N+LV + VK+ DFGL++ P +WMA E + +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+GV +WEL+T KP+ S++ S + KG RL P V ++ CW
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMRKCWMI 258
Query: 603 EPEIRPSFPSIMETLQQFLMSS 624
+ + RP F ++ +
Sbjct: 259 DADSRPKFRELIIEFSKMARDP 280
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 5e-72
Identities = 89/260 (34%), Positives = 137/260 (52%), Gaps = 11/260 (4%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V+ + VAVK L + D FL E +MK L+H +V L VT+
Sbjct: 23 AGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P I+TEY+ GSL L P + +L L+MA +A+GM ++ +R +HRDL
Sbjct: 80 EPIY-IITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFIEERN--YIHRDL 135
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFS 548
++ N+LV T + K+ DFGL+R + +++ A P +W APE + KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 549 FGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG++L E++T + P+ T +VI + +G R+ P N + L+ CW E PE R
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
Query: 608 PSFPSIMETLQQFLMSSVCQ 627
P+F + L+ F ++ Q
Sbjct: 255 PTFDYLRSVLEDFFTATEGQ 274
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-71
Identities = 93/300 (31%), Positives = 140/300 (46%), Gaps = 19/300 (6%)
Query: 330 YKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFI------KGSFGTVYHAEWR 383
Y D L R + + Q+ S ++ KG FG V ++R
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR 215
Query: 384 NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSR 442
+ VAVK + + FL E ++M LRH N+V L+G + E L IVTEY+++
Sbjct: 216 GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 502
GSL L V+ + L L + DV + M YL VHRDL + N+LV
Sbjct: 272 GSLVDYLRSRGRSVLGGDCL-LKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVA 328
Query: 503 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QK 561
KV DFGL++ + T +W APE LRE + KSDV+SFG++LWE+ + +
Sbjct: 329 KVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385
Query: 562 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
P+ V+ V KG +++ P P V +++ CW + RP+F + E L+
Sbjct: 386 PYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-71
Identities = 86/281 (30%), Positives = 131/281 (46%), Gaps = 20/281 (7%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
KG FG+V A+ + D VAVK+L +EFLRE A MK HP++ L+G
Sbjct: 33 KGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG 92
Query: 426 AVTE------PPNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNY 476
P ++ ++ G L+ L I + + + + D+A GM Y
Sbjct: 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEV 534
L R +HRDL + N ++ TV V DFGLSR Y A+ P +W+A E
Sbjct: 153 LSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALES 210
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
L ++ SDV++FGV +WE++T Q P+ +++ + + G RL+ P V
Sbjct: 211 LADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GGNRLKQPPECMEEVY 269
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 634
L+ CW+ +P+ RPSF + L+ L S PL
Sbjct: 270 DLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-71
Identities = 97/303 (32%), Positives = 143/303 (47%), Gaps = 24/303 (7%)
Query: 326 IDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNS 385
++ W + D+ M++ G G +G VY W+
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERT-DITMKHKLG------------GGQYGEVYEGVWKKY 244
Query: 386 --DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443
VAVK L E + EFL+E A+MK ++HPN+V L+G T P I+TE+++ G
Sbjct: 245 SLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301
Query: 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 503
+L L + + V L L MA ++ M YL ++ +HR+L + N LV + VK
Sbjct: 302 NLLDYLRECNRQEVSAVVL-LYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVK 358
Query: 504 VCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QK 561
V DFGLSR +TY + A +W APE L + + KSDV++FGV+LWE+ T
Sbjct: 359 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418
Query: 562 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
P+ SQV + K R+E P+ V L+ CW P RPSF I + +
Sbjct: 419 PYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477
Query: 622 MSS 624
S
Sbjct: 478 QES 480
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 7e-71
Identities = 89/257 (34%), Positives = 133/257 (51%), Gaps = 11/257 (4%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
+G FG V+ W + VA+K L + FL+E +MK LRH +V L V+E
Sbjct: 194 QGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P IVTEY+S+GSL L + + +L ++MA +A GM Y+ + VHRDL
Sbjct: 251 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVERMN--YVHRDL 306
Query: 490 KSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
++ N+LV KV DFGL+R + N Y + + A +W APE KSDV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 549 FGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG++L EL T + P+ +V+ V +G R+ P + L+ CW +EPE R
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEER 425
Query: 608 PSFPSIMETLQQFLMSS 624
P+F + L+ + S+
Sbjct: 426 PTFEYLQAFLEDYFTST 442
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 8e-71
Identities = 87/254 (34%), Positives = 132/254 (51%), Gaps = 11/254 (4%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V +W+ DVAVK++ E ED EF +E M L HP +V G ++
Sbjct: 18 SGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+ IVTEY+S G L L + + L M YDV +GM +L + +HRDL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ--LLEMCYDVCEGMAFLESHQ--FIHRDL 130
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFS 548
+ N LVD VKV DFG++R + S P +W APEV + KSDV++
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 549 FGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG+++WE+ +L + P+ T S+V+ V +G RL P + + ++ +CW E PE R
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQIMYSCWHELPEKR 249
Query: 608 PSFPSIMETLQQFL 621
P+F ++ +++
Sbjct: 250 PTFQQLLSSIEPLR 263
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 9e-71
Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 11/254 (4%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V+ W N VA+K + E E+ +F+ E +M L HP +V L G E
Sbjct: 18 SGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+ +VTE++ G L L + L M DV +GM YL + ++HRDL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAET--LLGMCLDVCEGMAYLEEAC--VIHRDL 130
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFS 548
+ N LV +KV DFG++R + +S T P +W +PEV + KSDV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 549 FGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FGV++WE+ + + P+ N + S+V+ + G RL P+ + V ++ CW E PE R
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDR 249
Query: 608 PSFPSIMETLQQFL 621
P+F ++ L +
Sbjct: 250 PAFSRLLRQLAEIA 263
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 1e-70
Identities = 88/300 (29%), Positives = 151/300 (50%), Gaps = 24/300 (8%)
Query: 331 KPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNS-DVAV 389
PQ +++ +W + + L+++ G G FG V+ A + VAV
Sbjct: 171 SSKPQKPWEKDAWEIPRE-SLKLEKKLG------------AGQFGEVWMATYNKHTKVAV 217
Query: 390 KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL 449
K + + FL E +MK L+H +V L VT+ P I+TE++++GSL L
Sbjct: 218 KTMKPGSMSVE---AFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFL 273
Query: 450 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509
+ +L ++ + +A+GM ++ QR +HRDL++ N+LV ++ K+ DFGL
Sbjct: 274 KSDEGSKQPLPKL-IDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGL 330
Query: 510 SRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNST 567
+R + N Y + + A +W APE + KSDV+SFG++L E++T + P+ +
Sbjct: 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390
Query: 568 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627
+VI A+ +G R+ P+N + ++ CW PE RP+F I L F ++ Q
Sbjct: 391 NPEVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-70
Identities = 93/258 (36%), Positives = 132/258 (51%), Gaps = 11/258 (4%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G +G VY W+ VAVK L E + EFL+E A+MK ++HPN+V L+G T
Sbjct: 23 GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
P I+TE+++ G+L L + + V L L MA ++ M YL ++ +HRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAMEYLEKKN--FIHRD 136
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVF 547
L + N LV + VKV DFGLSR ++ A P +W APE L + + KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 548 SFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
+FGV+LWE+ T P+ SQV + K R+E P+ V L+ CW P
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 607 RPSFPSIMETLQQFLMSS 624
RPSF I + + S
Sbjct: 256 RPSFAEIHQAFETMFQES 273
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-70
Identities = 79/257 (30%), Positives = 119/257 (46%), Gaps = 14/257 (5%)
Query: 372 GSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG VY + N VAVK + +++ ++F+ E IMK L HP+IV L+G
Sbjct: 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIVKLIGI 81
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+ E P I+ E G L L + V + + + K M YL VH
Sbjct: 82 IEEEPTW-IIMELYPYGELGHYLERNKNSLKVLT--LVLYSLQICKAMAYLESIN--CVH 136
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSD 545
RD+ N+LV S VK+ DFGLSR + + P +WM+PE + SD
Sbjct: 137 RDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASD 196
Query: 546 VFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
V+ F V +WE+++ ++P+ VI + KG RL P P++ L+ CW +P
Sbjct: 197 VWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDP 255
Query: 605 EIRPSFPSIMETLQQFL 621
RP F ++ +L
Sbjct: 256 SDRPRFTELVCSLSDVY 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-70
Identities = 84/254 (33%), Positives = 131/254 (51%), Gaps = 11/254 (4%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V + +WR DVA+K++ E ED EF+ E +M L H +V L G T+
Sbjct: 34 TGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
+ I+TEY++ G L L R + L M DV + M YL ++ +HRDL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQ--LLEMCKDVCEAMEYLESKQ--FLHRDL 146
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFS 548
+ N LV+ VKV DFGLSR + +S + P W PEVL + KSD+++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 549 FGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FGV++WE+ +L + P+ T S+ + +G RL P + V ++ +CW E+ + R
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADER 265
Query: 608 PSFPSIMETLQQFL 621
P+F ++ + +
Sbjct: 266 PTFKILLSNILDVM 279
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-70
Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 19/266 (7%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
KG FG VYH E+ + A+K L + + FLRE +M+GL HPN++ L+G
Sbjct: 31 KGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV-EAFLREGLLMRGLNHPNVLALIG 89
Query: 426 AVT--EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+ E ++ Y+ G L + + P V + + + VA+GM YL +++
Sbjct: 90 IMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLI--SFGLQVARGMEYLAEQK-- 144
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGT--P-EWMAPEVLREDP 539
VHRDL + N ++D ++TVKV DFGL+R Y S + P +W A E L+
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 540 SNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598
KSDV+SFGV+LWEL+T P+R+ P + + +GRRL P+ + +++
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSLYQVMQQ 263
Query: 599 CWAEEPEIRPSFPSIMETLQQFLMSS 624
CW +P +RP+F ++ ++Q + +
Sbjct: 264 CWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-70
Identities = 79/270 (29%), Positives = 125/270 (46%), Gaps = 21/270 (7%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
+G FG+V + D VAVK + + +EFL E A MK HPN++ L+G
Sbjct: 44 EGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103
Query: 426 AVTE-----PPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNY 476
E P ++ ++ G L+ L + + + L L D+A GM Y
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL-LKFMVDIALGMEY 162
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEV 534
L R +HRDL + N ++ TV V DFGLS+ Y A P +W+A E
Sbjct: 163 LSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 220
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
L + KSDV++FGV +WE+ T P+ ++ + G RL+ P++ +
Sbjct: 221 LADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELY 279
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
++ +CW +P RP+F + L++ L S
Sbjct: 280 EIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 5e-70
Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 17/265 (6%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
+G FG VYH ++D AVK L + +FL E IMK HPN++ L+G
Sbjct: 35 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNVLSLLG 93
Query: 426 AVTEP-PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ +V Y+ G L + V + + VAKGM YL ++
Sbjct: 94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG--FGLQVAKGMKYLASKK--F 149
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGT-P-EWMAPEVLREDPS 540
VHRDL + N ++D +TVKV DFGL+R Y P +WMA E L+
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 541 NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
KSDV+SFGV+LWEL+T P+ + + + +GRRL P+ + ++ C
Sbjct: 210 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKC 268
Query: 600 WAEEPEIRPSFPSIMETLQQFLMSS 624
W + E+RPSF ++ + +
Sbjct: 269 WHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 9e-70
Identities = 75/262 (28%), Positives = 123/262 (46%), Gaps = 16/262 (6%)
Query: 372 GSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G FGTV+ W V +K++ ++ + + + + L H +IV L+G
Sbjct: 24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHMLAIGSLDHAHIVRLLG 82
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
L +VT+YL GSL + + + L LN +AKGM YL + +V
Sbjct: 83 LCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGP-QLL-LNWGVQIAKGMYYLEEHG--MV 137
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEK 543
HR+L + N+L+ S V+V DFG++ P+ + A TP +WMA E + +
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ 197
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+GV +WEL+T +P+ ++V + KG RL P+ V ++ CW
Sbjct: 198 SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTIDVYMVMVKCWMI 256
Query: 603 EPEIRPSFPSIMETLQQFLMSS 624
+ IRP+F + +
Sbjct: 257 DENIRPTFKELANEFTRMARDP 278
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-69
Identities = 94/277 (33%), Positives = 138/277 (49%), Gaps = 28/277 (10%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+FG V+ AE N VAVK L ++ K+F RE ++ L+H +IV
Sbjct: 25 EGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMAYDV 470
G + L +V EY+ G L K L H PDA ++VD + R L++A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-E 528
A GM YL + VHRDL + N LV + VK+ DFG+SR +T Y P
Sbjct: 143 ASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 529 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 587
WM PE + +SDV+SFGVILWE+ T ++PW + ++VI + +GR LE P+
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-QGRVLERPRV 259
Query: 588 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
V ++ CW EP+ R + I + L ++
Sbjct: 260 CPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-69
Identities = 100/335 (29%), Positives = 148/335 (44%), Gaps = 41/335 (12%)
Query: 320 DPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGSFGTVYH 379
+ G+ + +PQ ++ + ++ G +G+FG V+
Sbjct: 13 EGKGSGLQGHIIENPQYFSDACVHHIKRRD-IVLKWELG------------EGAFGKVFL 59
Query: 380 AEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432
AE N VAVK L +E E ++F RE ++ L+H +IV G TE
Sbjct: 60 AECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117
Query: 433 LSIVTEYLSRGSLYKLL--HIPDARVVVDERLR----------LNMAYDVAKGMNYLHQR 480
L +V EY+ G L + L H PDA+++ L +A VA GM YL
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLRED 538
VHRDL + N LV VK+ DFG+SR +T Y P WM PE +
Sbjct: 178 H--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR 235
Query: 539 PSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
+SDV+SFGV+LWE+ T ++PW + ++ I + +GR LE P+ P V A++
Sbjct: 236 KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMR 294
Query: 598 TCWAEEPEIRPSFPSIMETLQQFL-MSSVCQPLSA 631
CW EP+ R S + LQ V +
Sbjct: 295 GCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 329
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-69
Identities = 89/257 (34%), Positives = 133/257 (51%), Gaps = 11/257 (4%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
+G FG V+ W + VA+K L + FL+E +MK LRH +V L V+E
Sbjct: 277 QGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P IVTEY+S+GSL L + + +L ++MA +A GM Y+ + VHRDL
Sbjct: 334 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVERMN--YVHRDL 389
Query: 490 KSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
++ N+LV KV DFGL+R + N Y + + A +W APE KSDV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 549 FGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG++L EL T + P+ +V+ V +G R+ P + L+ CW +EPE R
Sbjct: 450 FGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEER 508
Query: 608 PSFPSIMETLQQFLMSS 624
P+F + L+ + S+
Sbjct: 509 PTFEYLQAFLEDYFTST 525
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-69
Identities = 83/278 (29%), Positives = 120/278 (43%), Gaps = 34/278 (12%)
Query: 371 KGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
KG+FG+V + VAVK L Q E+ ++F RE+ I+K L+H NIV
Sbjct: 20 KGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 425 GAVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
G + ++ EYL GSL L R+ +L L + KGM YL +R
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-IKL-LQYTSQICKGMEYLGTKR- 134
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTP-EWMAPEVLREDP 539
+HRDL + N+LV++ VK+ DFGL++ P + K +P W APE L E
Sbjct: 135 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 540 SNEKSDVFSFGVILWELITL----------------QKPWRNSTPSQVISAVGFKGRRLE 583
+ SDV+SFGV+L+EL T +I + RL
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLP 252
Query: 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
P + ++ CW RPSF + + Q
Sbjct: 253 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 8e-69
Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 16/262 (6%)
Query: 372 GSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G+FGTVY W VA+K L E + KE L E +M + +P++ L+G
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLG 84
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ ++T+ + G L + + + L LN +AKGMNYL RR +V
Sbjct: 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-QYL-LNWCVQIAKGMNYLEDRR--LV 139
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEK 543
HRDL + N+LV + VK+ DFGL++ P +WMA E + +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+GV +WEL+T KP+ S++ S + KG RL P V ++ CW
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMVKCWMI 258
Query: 603 EPEIRPSFPSIMETLQQFLMSS 624
+ + RP F ++ +
Sbjct: 259 DADSRPKFRELIIEFSKMARDP 280
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 8e-69
Identities = 96/289 (33%), Positives = 136/289 (47%), Gaps = 33/289 (11%)
Query: 371 KGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
KG+FG+V + + VAVK L Q D+ ++F RE+ I+K L IV
Sbjct: 33 KGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 425 GAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
G P +L +V EYL G L L AR+ RL L + + KGM YL RR
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA-SRL-LLYSSQICKGMEYLGSRR- 147
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTP-EWMAPEVLREDP 539
VHRDL + N+LV+S VK+ DFGL++ P Y + +P W APE L ++
Sbjct: 148 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 540 SNEKSDVFSFGVILWELITL-QKPWRNSTP--------------SQVISAVGFKGRRLEI 584
+ +SDV+SFGV+L+EL T K S S+++ + +G+RL
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE-EGQRLPA 265
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 633
P V L++ CWA P+ RPSF ++ L S A
Sbjct: 266 PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 8e-69
Identities = 83/265 (31%), Positives = 126/265 (47%), Gaps = 17/265 (6%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
+G FG VYH ++D AVK L + +FL E IMK HPN++ L+G
Sbjct: 99 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNVLSLLG 157
Query: 426 AVTEP-PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ +V Y+ G L + V + + VAKGM +L ++
Sbjct: 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG--FGLQVAKGMKFLASKK--F 213
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGT--P-EWMAPEVLREDPS 540
VHRDL + N ++D +TVKV DFGL+R + S G P +WMA E L+
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 541 NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
KSDV+SFGV+LWEL+T P+ + + + +GRRL P+ + ++ C
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKC 332
Query: 600 WAEEPEIRPSFPSIMETLQQFLMSS 624
W + E+RPSF ++ + +
Sbjct: 333 WHPKAEMRPSFSELVSRISAIFSTF 357
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 9e-69
Identities = 80/260 (30%), Positives = 138/260 (53%), Gaps = 15/260 (5%)
Query: 372 GSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
G+FG+V +R DVA+K+L + D +E +RE IM L +P IV L+G
Sbjct: 21 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLIGVC 79
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ +V E G L+K L + V + + V+ GM YL ++ VHR
Sbjct: 80 QAEALM-LVMEMAGGGPLHKFLVGKREEIPVSN--VAELLHQVSMGMKYLEEKN--FVHR 134
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKS 544
DL + N+L+ + + K+ DFGLS+ ++Y ++++A P +W APE + + +S
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194
Query: 545 DVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
DV+S+GV +WE ++ QKP++ +V++ + +G+R+E P P + AL+ CW +
Sbjct: 195 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYK 253
Query: 604 PEIRPSFPSIMETLQQFLMS 623
E RP F ++ + ++ S
Sbjct: 254 WEDRPDFLTVEQRMRACYYS 273
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-68
Identities = 86/274 (31%), Positives = 138/274 (50%), Gaps = 21/274 (7%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+GSFG VY + VA+K + E +R EFL E ++MK ++V L
Sbjct: 35 QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKEFNCHHVVRL 93
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----LNMAYDVAKGMNY 476
+G V++ ++ E ++RG L L P + MA ++A GM Y
Sbjct: 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEV 534
L+ + VHRDL + N +V +TVK+ DFG++R T Y P WM+PE
Sbjct: 154 LNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 211
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
L++ SDV+SFGV+LWE+ TL ++P++ + QV+ V +G L+ P N M+
Sbjct: 212 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGGLLDKPDNCPDMLF 270
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627
L+ CW P++RPSF I+ ++++ + +
Sbjct: 271 ELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-68
Identities = 83/265 (31%), Positives = 130/265 (49%), Gaps = 15/265 (5%)
Query: 372 GSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
G+FGTV ++ VAVKIL + E L E +M+ L +P IV ++G
Sbjct: 28 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ +V E G L K L R V D+ + + + + V+ GM YL + VHR
Sbjct: 88 EAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNI-IELVHQVSMGMKYLEESN--FVHR 141
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKS 544
DL + N+L+ + + K+ DFGLS+ Y ++T P +W APE + + KS
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 201
Query: 545 DVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
DV+SFGV++WE + QKP+R S+V + + KG R+ P + L+ CW +
Sbjct: 202 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYD 260
Query: 604 PEIRPSFPSIMETLQQFLMSSVCQP 628
E RP F ++ L+ + V +
Sbjct: 261 VENRPGFAAVELRLRNYYYDVVNEG 285
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 3e-68
Identities = 85/278 (30%), Positives = 120/278 (43%), Gaps = 34/278 (12%)
Query: 371 KGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
KG+FG+V + VAVK L Q E+ ++F RE+ I+K L+H NIV
Sbjct: 51 KGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 425 GAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
G L ++ EYL GSL L R+ +L L + KGM YL +R
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-IKL-LQYTSQICKGMEYLGTKR- 165
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTP-EWMAPEVLREDP 539
+HRDL + N+LV++ VK+ DFGL++ P Y K +P W APE L E
Sbjct: 166 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 540 SNEKSDVFSFGVILWELITL----------------QKPWRNSTPSQVISAVGFKGRRLE 583
+ SDV+SFGV+L+EL T +I + RL
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLP 283
Query: 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
P + ++ CW RPSF + + Q
Sbjct: 284 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-68
Identities = 82/257 (31%), Positives = 127/257 (49%), Gaps = 14/257 (5%)
Query: 372 GSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG V+ + + + VA+K R ++FL+E M+ HP+IV L+G
Sbjct: 26 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLIGV 84
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+TE P I+ E + G L L + + + + AY ++ + YL +R VH
Sbjct: 85 ITENPVW-IIMELCTLGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKR--FVH 139
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
RD+ + N+LV S VK+ DFGLSR + +TY + +WMAPE + SD
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD 199
Query: 546 VFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
V+ FGV +WE++ KP++ + VI + G RL +P N P + +L+ CWA +P
Sbjct: 200 VWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDP 258
Query: 605 EIRPSFPSIMETLQQFL 621
RP F + L L
Sbjct: 259 SRRPRFTELKAQLSTIL 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 7e-68
Identities = 86/260 (33%), Positives = 129/260 (49%), Gaps = 16/260 (6%)
Query: 372 GSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G FG VY + S VA+K L + R +FL E IM H NI+ L G
Sbjct: 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNIIRLEG 113
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+++ + I+TEY+ G+L K L D V + + M +A GM YL V
Sbjct: 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ--LVGMLRGIAAGMKYLANMN--YV 169
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT--P-EWMAPEVLREDPSNE 542
HRDL + N+LV+S KV DFGLSR + ++ T +G P W APE +
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 543 KSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
SDV+SFG+++WE++T ++P+ + +V+ A+ G RL P + + L+ CW
Sbjct: 230 ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQ 288
Query: 602 EEPEIRPSFPSIMETLQQFL 621
+E RP F I+ L + +
Sbjct: 289 QERARRPKFADIVSILDKLI 308
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-67
Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 25/285 (8%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
G+FG VY + VAVK L E +D +FL E I+ H NIV
Sbjct: 40 HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIISKFNHQNIVRC 98
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LNMAYDVAKGMNYLHQ 479
+G + I+ E ++ G L L R L L++A D+A G YL +
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158
Query: 480 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEV 534
+HRD+ + N L+ K+ DFG++R Y A P +WM PE
Sbjct: 159 NH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 535 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
E K+D +SFGV+LWE+ +L P+ + + +V+ V G R++ PKN V
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKNCPGPVY 275
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMSS----VCQPLSAQPL 634
++ CW +PE RP+F I+E ++ P+ PL
Sbjct: 276 RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPL 320
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 3e-67
Identities = 90/263 (34%), Positives = 125/263 (47%), Gaps = 15/263 (5%)
Query: 371 KGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G G V + R + VA+K L R ++FL E +IM HPNI+ L G
Sbjct: 59 SGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASIMGQFDHPNIIRLEG 117
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
VT IVTEY+ GSL L D + + + + M V GM YL V
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLG--YV 173
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
HRDL + N+LVDS KV DFGLSR P+ ++ W APE + +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 543 KSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
SDV+SFGV++WE++ ++P+ N T VIS+V +G RL P + L+ CW
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCPHALHQLMLDCWH 292
Query: 602 EEPEIRPSFPSIMETLQQFLMSS 624
++ RP F I+ L + S
Sbjct: 293 KDRAQRPRFSQIVSVLDALIRSP 315
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 7e-67
Identities = 95/372 (25%), Positives = 149/372 (40%), Gaps = 42/372 (11%)
Query: 287 HPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSG---TAIDQDYKPDPQALFQRASW 343
H + T EN+ + + SP++ L + T + +Y +
Sbjct: 8 HHHDYDIPTTENLYFQGAMGS-ELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66
Query: 344 NVTADRDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD-------VAVKILIEQE 396
V + + G G+FG VY + VAVK L E
Sbjct: 67 EVPRKN-ITLIRGLG------------HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 113
Query: 397 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV 456
+D +FL E I+ H NIV +G + I+ E ++ G L L R
Sbjct: 114 SEQDE-LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 457 VVDERLR----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGL 509
L L++A D+A G YL + +HRD+ + N L+ K+ DFG+
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
Query: 510 SRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNS 566
+R Y A P +WM PE E K+D +SFGV+LWE+ +L P+ +
Sbjct: 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
Query: 567 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS-- 624
+ +V+ V G R++ PKN V ++ CW +PE RP+F I+E ++
Sbjct: 291 SNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
Query: 625 --VCQPLSAQPL 634
P+ PL
Sbjct: 350 INTALPIEYGPL 361
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-66
Identities = 80/272 (29%), Positives = 123/272 (45%), Gaps = 27/272 (9%)
Query: 372 GSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
FG VY VA+K L ++ R +EF E + L+HPN+V L+
Sbjct: 20 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQHPNVVCLL 78
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMAYDVA 471
G VT+ LS++ Y S G L++ L P + V + R +++ +A
Sbjct: 79 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIA 138
Query: 472 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EW 529
GM YL +VH+DL + N+LV VK+ D GL R Y + P W
Sbjct: 139 AGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRW 196
Query: 530 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 588
MAPE + + SD++S+GV+LWE+ + +P+ + V+ + + L P +
Sbjct: 197 MAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQVLPCPDDC 255
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620
V AL+ CW E P RP F I L+ +
Sbjct: 256 PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-66
Identities = 83/277 (29%), Positives = 131/277 (47%), Gaps = 32/277 (11%)
Query: 371 KGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G FG V + VAVK L + + +E+ I++ L H NIV
Sbjct: 31 EGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIVKYK 89
Query: 425 GAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
G TE + ++ E+L GSL + L ++ + ++ L A + KGM+YL R+
Sbjct: 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL-KQQ-LKYAVQICKGMDYLGSRQ- 146
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTP-EWMAPEVLREDP 539
VHRDL + N+LV+S + VK+ DFGL+++ Y + K +P W APE L +
Sbjct: 147 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 540 SNEKSDVFSFGVILWELITL---------------QKPWRNSTPSQVISAVGFKGRRLEI 584
SDV+SFGV L EL+T T +++++ + +G+RL
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK-EGKRLPC 264
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
P N V L+ CW +P R SF +++E + L
Sbjct: 265 PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-66
Identities = 87/282 (30%), Positives = 131/282 (46%), Gaps = 35/282 (12%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+FG V+ A VAVK+L E+ + + +F RE A+M +PNIV L
Sbjct: 57 EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNIVKL 115
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR------------------ 463
+G + ++ EY++ G L + L P +
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 464 -LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSK 521
L +A VA GM YL +R+ VHRDL + N LV VK+ DFGLSR+ + Y +
Sbjct: 176 QLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 233
Query: 522 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 579
P WM PE + + +SDV+++GV+LWE+ + +P+ +VI V G
Sbjct: 234 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DG 292
Query: 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
L P+N + L+ CW++ P RPSF SI LQ+
Sbjct: 293 NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 9e-66
Identities = 84/259 (32%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 372 GSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG V + VA+K L + R ++FL E +IM HPNI+ L G
Sbjct: 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGV 114
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
VT+ + IVTEY+ GSL L DA+ V + + M +A GM YL VH
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG--YVH 170
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
RDL + N+L++S KV DFGL R P +++ W +PE +
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA 230
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+G++LWE+++ ++P+ + VI AV +G RL P + + L+ CW +
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQK 289
Query: 603 EPEIRPSFPSIMETLQQFL 621
+ RP F I+ L + +
Sbjct: 290 DRNNRPKFEQIVSILDKLI 308
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-65
Identities = 83/263 (31%), Positives = 128/263 (48%), Gaps = 14/263 (5%)
Query: 372 GSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G FG V+ + + + VA+K R ++FL+E M+ HP+IV L+G
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLIGV 459
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+TE P I+ E + G L L + + + L + AY ++ + YL +R VH
Sbjct: 460 ITENPVW-IIMELCTLGELRSFLQVRKFSLDL-ASL-ILYAYQLSTALAYLESKR--FVH 514
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSD 545
RD+ + N+LV S VK+ DFGLSR ++ + P +WMAPE + SD
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574
Query: 546 VFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
V+ FGV +WE++ KP++ + VI + G RL +P N P + +L+ CWA +P
Sbjct: 575 VWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDP 633
Query: 605 EIRPSFPSIMETLQQFLMSSVCQ 627
RP F + L L Q
Sbjct: 634 SRRPRFTELKAQLSTILEEEKLQ 656
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 4e-65
Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 42/287 (14%)
Query: 371 KGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G FG V + ++ VAVK L + R + +E+ I++ L H +I+
Sbjct: 41 EGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEIDILRTLYHEHIIKYK 99
Query: 425 GAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LNMAYDVAKGMNYLH 478
G + +L +V EY+ GSL L + L A + +GM YLH
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLP--------RHSIGLAQLLLFAQQICEGMAYLH 151
Query: 479 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTP-EWMAPEVL 535
+ +HRDL + N+L+D+ VK+ DFGL+++ P Y + +P W APE L
Sbjct: 152 AQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 536 REDPSNEKSDVFSFGVILWELITL---------------QKPWRNSTPSQVISAVGFKGR 580
+E SDV+SFGV L+EL+T T ++ + +G
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-RGE 268
Query: 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627
RL P V L++ CW E RP+F +++ L+ Q
Sbjct: 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 5e-65
Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 35/285 (12%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G FG V A + VAVK+L E ++ L E ++K + HP+++ L
Sbjct: 33 EGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR------------------ 463
GA ++ L ++ EY GSL L +
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 464 -LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSK 521
++ A+ +++GM YL + + +VHRDL + N+LV +K+ DFGLSR +
Sbjct: 152 LISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209
Query: 522 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 579
+ P +WMA E L + +SDV+SFGV+LWE++TL P+ P ++ + + G
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK-TG 268
Query: 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
R+E P N + + L+ CW +EP+ RP F I + L++ ++
Sbjct: 269 HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-64
Identities = 87/281 (30%), Positives = 141/281 (50%), Gaps = 30/281 (10%)
Query: 371 KGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 420
+G+FG V AE D VAVK+L + + E + + E+ +MK + +H NI
Sbjct: 45 EGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMA 467
+ L+GA T+ L ++ EY S+G+L + L P + R ++
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT- 526
Y +A+GM YL ++ +HRDL + N+LV +K+ DFGL+R N KT G
Sbjct: 164 YQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 527 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEI 584
P +WMAPE L + +SDV+SFGV++WE+ TL P+ ++ + +G R++
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDK 280
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625
P N + ++ CW P RP+F ++E L + L +
Sbjct: 281 PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-64
Identities = 74/247 (29%), Positives = 123/247 (49%), Gaps = 14/247 (5%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA-- 426
+GSF TVY + +VA L +++ + + F E ++KGL+HPNIV +
Sbjct: 36 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95
Query: 427 --VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
V + +VTE ++ G+L L + ++ + + KG+ +LH R PPI
Sbjct: 96 STVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 485 VHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
+HRDLK N+ + +VK+ D GL+ K ++ +K GTPE+MAPE+ E +E
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEK-YDES 209
Query: 544 SDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
DV++FG+ + E+ T + P+ +Q+ V + K P V +IE C +
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269
Query: 603 EPEIRPS 609
+ R S
Sbjct: 270 NKDERYS 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-64
Identities = 87/283 (30%), Positives = 141/283 (49%), Gaps = 30/283 (10%)
Query: 371 KGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 420
+G FG V AE D VAVK+L + + E + + E+ +MK + +H NI
Sbjct: 91 EGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMA 467
+ L+GA T+ L ++ EY S+G+L + L P + R ++
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT- 526
Y +A+GM YL ++ +HRDL + N+LV +K+ DFGL+R N KT G
Sbjct: 210 YQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 527 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEI 584
P +WMAPE L + +SDV+SFGV++WE+ TL P+ ++ + +G R++
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDK 326
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627
P N + ++ CW P RP+F ++E L + L + +
Sbjct: 327 PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-64
Identities = 87/286 (30%), Positives = 141/286 (49%), Gaps = 30/286 (10%)
Query: 371 KGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 420
+G+FG V AE + VAVK+L +D + + E+ +MK + +H NI
Sbjct: 79 EGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNI 137
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMA 467
+ L+GA T+ L ++ EY S+G+L + L P ++ A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT- 526
Y VA+GM YL ++ +HRDL + N+LV +K+ DFGL+R + KT G
Sbjct: 198 YQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255
Query: 527 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEI 584
P +WMAPE L + +SDV+SFGV+LWE+ TL P+ ++ + +G R++
Sbjct: 256 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EGHRMDK 314
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 630
P N + ++ CW P RP+F ++E L + + + Q +
Sbjct: 315 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-64
Identities = 61/274 (22%), Positives = 110/274 (40%), Gaps = 34/274 (12%)
Query: 372 GSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 422
G+F ++ R V +K+L + H + + F ++M L H ++VL
Sbjct: 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
G +V E++ GSL L + + +L +A +A M++L +
Sbjct: 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT- 133
Query: 483 PIVHRDLKSPNLLVDSTYT--------VKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPE 533
++H ++ + N+L+ +K+ D G+S + K W+ PE
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----TVLPKDILQERIPWVPPE 187
Query: 534 VLREDPS-NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591
+ + N +D +SFG LWE+ + KP + + +L PK
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DRHQLPAPK--AAE 244
Query: 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625
+A LI C EP+ RPSF +I+ L +
Sbjct: 245 LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 5e-64
Identities = 81/284 (28%), Positives = 128/284 (45%), Gaps = 31/284 (10%)
Query: 371 KGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 422
G+FG V A VAVK+L +R + + E+ ++ L H NIV
Sbjct: 33 AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVN 91
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-------------LNMA 467
L+GA T ++TEY G L L L+ +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGT 526
Y VAKGM +L + +HRDL + N+L+ K+CDFGL+R N K A
Sbjct: 152 YQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 527 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN-STPSQVISAVGFKGRRLE 583
P +WMAPE + +SDV+S+G+ LWEL +L P+ S+ + +G R+
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-EGFRML 268
Query: 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627
P++ + +++TCW +P RP+F I++ +++ + S
Sbjct: 269 SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNH 312
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-64
Identities = 89/274 (32%), Positives = 131/274 (47%), Gaps = 26/274 (9%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 425
+G+FG V A + A+K + E +D ++F E+ ++ L HPNI+ L+G
Sbjct: 35 EGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLG 93
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMAYDVAK 472
A L + EY G+L L L+ A DVA+
Sbjct: 94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMA 531
GM+YL Q++ +HRDL + N+LV Y K+ DFGLSR KT P WMA
Sbjct: 154 GMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPVRWMA 209
Query: 532 PEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590
E L SDV+S+GV+LWE+++L P+ T +++ + +G RLE P N +
Sbjct: 210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDD 268
Query: 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
V L+ CW E+P RPSF I+ +L + L
Sbjct: 269 EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 6e-64
Identities = 77/261 (29%), Positives = 133/261 (50%), Gaps = 15/261 (5%)
Query: 371 KGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G+FG+V +R DVA+K+L + D +E +RE IM L +P IV L+G
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLIGV 404
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+ +V E G L+K L + V + + V+ GM YL ++ VH
Sbjct: 405 CQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSN--VAELLHQVSMGMKYLEEKN--FVH 459
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
R+L + N+L+ + + K+ DFGLS+ + + Y + +W APE + + +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+GV +WE ++ QKP++ +V++ + +G+R+E P P + AL+ CW
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIY 578
Query: 603 EPEIRPSFPSIMETLQQFLMS 623
+ E RP F ++ + ++ S
Sbjct: 579 KWEDRPDFLTVEQRMRACYYS 599
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 3e-63
Identities = 83/284 (29%), Positives = 130/284 (45%), Gaps = 32/284 (11%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 422
+G+FG V A+ D VAVK+L E + + E+ I+ + H N+V
Sbjct: 37 RGAFGQVIEADAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 423 LMGAVT--EPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR-----------LNMA 467
L+GA T P L ++ E+ G+L L + + +
Sbjct: 96 LLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGT 526
+ VAKGM +L R+ +HRDL + N+L+ VK+CDFGL+R K A
Sbjct: 155 FQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 527 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN-STPSQVISAVGFKGRRLE 583
P +WMAPE + + +SDV+SFGV+LWE+ +L P+ + + +G R+
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-EGTRMR 271
Query: 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627
P P + + CW EP RP+F ++E L L ++ Q
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-62
Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 372 GSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 423
G+FG V A VAVK+L H D + + E+ IM L +H NIV L
Sbjct: 57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKS-TAHADEKEALMSELKIMSHLGQHENIVNL 115
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLL-------HIPDARVVVDERLR----LNMAYDVAK 472
+GA T + ++TEY G L L A + + L+ + VA+
Sbjct: 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWM 530
GM +L + +HRD+ + N+L+ + + K+ DFGL+R + YI A +WM
Sbjct: 176 GMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM 233
Query: 531 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNS-TPSQVISAVGFKGRRLEIPKNV 588
APE + + +SDV+S+G++LWE+ +L P+ S+ V G ++ P
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK-DGYQMAQPAFA 292
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 628
+ ++++ CWA EP RP+F I LQ+ +
Sbjct: 293 PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 6e-62
Identities = 86/286 (30%), Positives = 130/286 (45%), Gaps = 36/286 (12%)
Query: 371 KGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 422
G+FG V +A VAVK+L E + + + E+ +M L H NIV
Sbjct: 55 SGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMTQLGSHENIVN 113
Query: 423 LMGAVTEPPNLSIVTEYLSRGSL--------------------YKLLHIPDARVVVDERL 462
L+GA T + ++ EY G L K L + V+
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 463 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSK 521
L AY VAKGM +L + VHRDL + N+LV VK+CDFGL+R + +
Sbjct: 174 LLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 231
Query: 522 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN-STPSQVISAVGFK 578
A P +WMAPE L E KSDV+S+G++LWE+ +L P+ + +
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-N 290
Query: 579 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
G +++ P + ++++CWA + RPSFP++ L L +
Sbjct: 291 GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-56
Identities = 67/263 (25%), Positives = 127/263 (48%), Gaps = 12/263 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+GSFG + +K + +E REVA++ ++HPNIV +
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
E +L IV +Y G L+K ++ V+ E L+ + + ++H R+ I+HRD
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRD 150
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+KS N+ + TV++ DFG++R +T ++ GTP +++PE+ P N KSD+++
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G +L+EL TL+ + + ++ + G + + + + +L+ + P RP
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 609 S------FPSIMETLQQFLMSSV 625
S I + +++FL +
Sbjct: 270 SVNSILEKGFIAKRIEKFLSPQL 292
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-56
Identities = 72/255 (28%), Positives = 119/255 (46%), Gaps = 13/255 (5%)
Query: 371 KGSFGTVYHAEWRNSD---VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
GS+G R SD + K + ++ + + EV +++ L+HPNIV
Sbjct: 16 TGSYGRCQKIR-RKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDR 73
Query: 427 VTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+ + N L IV EY G L ++ R +DE L + + + H+R
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 484 ---IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
++HRDLK N+ +D VK+ DFGL+R + +KT GTP +M+PE +
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
NEKSD++S G +L+EL L P+ + ++ + +G+ IP + + +I
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEIITRML 252
Query: 601 AEEPEIRPSFPSIME 615
+ RPS I+E
Sbjct: 253 NLKDYHRPSVEEILE 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-55
Identities = 67/254 (26%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 371 KGSFGTVYHAEWRNSD---VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
+G F VY A D VA+K + I + ++E+ ++K L HPN++ +
Sbjct: 42 RGQFSEVYRAA-CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 100
Query: 427 VTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
E L+IV E G L +++ H + ++ ER + + ++H RR ++
Sbjct: 101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VM 158
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
HRD+K N+ + +T VK+ D GL R + ++ + GTP +M+PE + E+ N KSD
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 218
Query: 546 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK----NVNPMVAALIETCWA 601
++S G +L+E+ LQ P+ + + ++ K + + P + + + L+ C
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 276
Query: 602 EEPEIRPSFPSIME 615
+PE RP + +
Sbjct: 277 PDPEKRPDVTYVYD 290
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 63/265 (23%), Positives = 117/265 (44%), Gaps = 34/265 (12%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV------- 421
G FG V+ A+ R +K ++ ++ REV + L H NIV
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKR-VKYNN-----EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 422 ---------LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 472
+ ++ L I E+ +G+L + + +D+ L L + + K
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQITK 133
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 532
G++Y+H ++ +++RDLK N+ + T VK+ DFGL S N + GT +M+P
Sbjct: 134 GVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSP 190
Query: 533 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592
E + ++ D+++ G+IL EL+ + + S+ + R I +
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT----DLRDGIISDIFDKKE 244
Query: 593 AALIETCWAEEPEIRPSFPSIMETL 617
L++ +++PE RP+ I+ TL
Sbjct: 245 KTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 8e-52
Identities = 65/319 (20%), Positives = 120/319 (37%), Gaps = 23/319 (7%)
Query: 305 LYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVI 364
++ +HS DL + ++ P+ + R + +PS P +
Sbjct: 1 MHHHHHHSSGVDLGTE--NLYFQSMHQLQPRRVSFRGE--ASETLQSPGYDPSRPESFFQ 56
Query: 365 DSSNFI----KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RH 417
S + GS+G V+ + AVK + L EV + + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 418 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 477
P V L A E L + TE SL + H + E D + +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQ--HCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 537
H + +VH D+K N+ + K+ DFGL T + + G P +MAPE+L+
Sbjct: 174 HSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQEGDPRYMAPELLQG 230
Query: 538 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 596
+DVFS G+ + E+ + Q + +G E ++ + +++
Sbjct: 231 SY-GTAADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLSSELRSVL 285
Query: 597 ETCWAEEPEIRPSFPSIME 615
+P++R + +++
Sbjct: 286 VMMLEPDPKLRATAEALLA 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 27/285 (9%)
Query: 360 STHVIDSSNFI-KGSFGTVYHAEWRNSDVAVKILIEQEFHEDR--FKEFLREVAIMKGLR 416
+ N + +G FG VY N+ VAVK L ++F +E+ +M +
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 417 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 476
H N+V L+G ++ +L +V Y+ GSL L D + +R +A A G+N+
Sbjct: 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPE 533
LH+ +HRD+KS N+L+D +T K+ DFGL+R+ T ++S+ GT +MAPE
Sbjct: 149 LHE--NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-IVGTTAYMAPE 205
Query: 534 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV- 592
LR + KSD++SFGV+L E+IT Q++ + K + K + +
Sbjct: 206 ALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYID 262
Query: 593 --------------AALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
++ C E+ RP + + LQ+ S
Sbjct: 263 KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-50
Identities = 70/248 (28%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
KG++G VY R+ +A+K I + + E+A+ K L+H NIV +G+
Sbjct: 32 KGTYGIVYAG--RDLSNQVRIAIKE-IPERDSRY-SQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+E + I E + GSL LL + +E+ + +G+ YLH + IVH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVH 145
Query: 487 RDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS--NEK 543
RD+K N+L+++ +K+ DFG S+ ++T GT ++MAPE++ + P +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 544 SDVFSFG-VILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
+D++S G I+ E+ T + P+ P + VG EIP++++ A I C+
Sbjct: 206 ADIWSLGCTII-EMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264
Query: 602 EEPEIRPS 609
+P+ R
Sbjct: 265 PDPDKRAC 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-50
Identities = 70/250 (28%), Positives = 110/250 (44%), Gaps = 25/250 (10%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
+GSFG V+ ++ AVK + + F + E+ GL P IV L GA
Sbjct: 68 RGSFGEVHRM--KDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
V E P ++I E L GSL +L+ + E L +G+ YLH RR I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILH 173
Query: 487 RDLKSPNLLVDST-YTVKVCDFGLSR-----SKPNTYISSKTAAGTPEWMAPEVLREDPS 540
D+K+ N+L+ S +CDFG + + ++ GT MAPEV+ P
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETC 599
+ K D++S ++ ++ PW + + + EIP + P+ A I+
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293
Query: 600 WAEEPEIRPS 609
+EP R S
Sbjct: 294 LRKEPVHRAS 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-50
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 26/278 (9%)
Query: 365 DSSNFI-KGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 422
D I G FG VY R+ + VA+K + EF E+ + RHP++V
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE--EFETEIETLSFCRHPHLVS 99
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMNYLHQRR 481
L+G E + ++ +Y+ G+L + L+ D + RL + A+G++YLH
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-- 157
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLRED 538
I+HRD+KS N+L+D + K+ DFG+S+ T++S+ GT ++ PE +
Sbjct: 158 RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGTLGYIDPEYFIKG 216
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-----FKGRRLE------IPKN 587
EKSDV+SFGV+L+E++ + S P ++++ +LE +
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276
Query: 588 VNP----MVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ P C A E RPS ++ L+ L
Sbjct: 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-50
Identities = 54/262 (20%), Positives = 104/262 (39%), Gaps = 24/262 (9%)
Query: 371 KGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAV 427
G V+ A+K + +E + E+A + L+ + I+ L
Sbjct: 38 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ +V E L L + +D R + ++ + ++ +HQ IVH
Sbjct: 98 ITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHS 151
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDPS----- 540
DLK N L+ +K+ DFG++ T + + GT +M PE +++ S
Sbjct: 152 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 541 ------NEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVA 593
+ KSDV+S G IL+ + + P++ + A+ +E P +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 270
Query: 594 ALIETCWAEEPEIRPSFPSIME 615
+++ C +P+ R S P ++
Sbjct: 271 DVLKCCLKRDPKQRISIPELLA 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 59/318 (18%), Positives = 117/318 (36%), Gaps = 32/318 (10%)
Query: 321 PSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFI------KGSF 374
P G+ + + + + T D D + S + + G
Sbjct: 12 PRGSGMKETAAAKFERQHMDSPDLGTDDDD--KASSSANECISVKGRIYSILKQIGSGGS 69
Query: 375 GTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAVTEPP 431
V+ A+K + +E + E+A + L+ + I+ L
Sbjct: 70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129
Query: 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491
+ +V E L L + +D R + ++ + ++ +HQ IVH DLK
Sbjct: 130 YIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP 183
Query: 492 PNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDPSN-------- 541
N L+ +K+ DFG++ T + + G +M PE +++ S+
Sbjct: 184 ANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 542 ---EKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
KSDV+S G IL+ + + P++ + A+ +E P + +++
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 302
Query: 598 TCWAEEPEIRPSFPSIME 615
C +P+ R S P ++
Sbjct: 303 CCLKRDPKQRISIPELLA 320
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 54/262 (20%), Positives = 104/262 (39%), Gaps = 24/262 (9%)
Query: 371 KGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAV 427
G V+ A+K + +E + E+A + L+ + I+ L
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ +V E L L + +D R + ++ + ++ +HQ IVH
Sbjct: 79 ITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHS 132
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDPS----- 540
DLK N L+ +K+ DFG++ T + + GT +M PE +++ S
Sbjct: 133 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191
Query: 541 ------NEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVA 593
+ KSDV+S G IL+ + + P++ + A+ +E P +
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 251
Query: 594 ALIETCWAEEPEIRPSFPSIME 615
+++ C +P+ R S P ++
Sbjct: 252 DVLKCCLKRDPKQRISIPELLA 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-49
Identities = 62/271 (22%), Positives = 108/271 (39%), Gaps = 32/271 (11%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G FG V+ A+ + D A+K I E ++ +REV + L HP IV A
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 429 EPPN------------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 476
E L I + + +L ++ + + L++ +A+ + +
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA------------ 524
LH + ++HRDLK N+ VKV DFGL +
Sbjct: 134 LHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191
Query: 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 584
GT +M+PE + + + K D+FS G+IL+EL L + ++ V + +
Sbjct: 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTLTDVR-NLKFPPL 248
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
P +++ + P RP +I+E
Sbjct: 249 FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-48
Identities = 56/265 (21%), Positives = 98/265 (36%), Gaps = 38/265 (14%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 425
G FG+V+ A+K + + LREV L +H ++V
Sbjct: 21 SGEFGSVFKC--VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
A E ++ I EY + GSL + E ++ V +G+ Y+H +
Sbjct: 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--L 136
Query: 485 VHRDLKSPNLLVD-------------------STYTVKVCDFGLSRSKPNTYISSKTAAG 525
VH D+K N+ + + K+ D G + + G
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEG 192
Query: 526 TPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 584
++A EVL+E+ K+D+F+ + + + RN I +GR I
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI----RQGRLPRI 248
Query: 585 PKNVNPMVAALIETCWAEEPEIRPS 609
P+ ++ L++ +PE RPS
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPS 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 9e-48
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 45/279 (16%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+FG V A A+K + E++ L EV ++ L H +V A
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 429 EPPNLS-------------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475
E N I EY G+LY L I + + + + ++
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL--IHSENLNQQRDEYWRLFRQILEALS 130
Query: 476 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--------------K 521
Y+H + I+HRDLK N+ +D + VK+ DFGL+++ +
Sbjct: 131 YIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 522 TAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR 580
+A GT ++A EVL NEK D++S G+I +E+ + ++ + +
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNILKKL--RSV 244
Query: 581 RLEIP----KNVNPMVAALIETCWAEEPEIRPSFPSIME 615
+E P N + +I +P RP +++
Sbjct: 245 SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 51/270 (18%), Positives = 102/270 (37%), Gaps = 24/270 (8%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G F V E + A+K ++ E + +E RE + + HPNI+ L+
Sbjct: 39 EGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 429 EPPN----LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
++ + RG+L+ + + D + E L + + +G+ +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KG 154
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA---------GTPEWMAPEV 534
HRDLK N+L+ + D G S+ A T + APE+
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 535 LRE---DPSNEKSDVFSFGVILWELITLQKPWR-NSTPSQVISAVGFKGRRLEIPKNVNP 590
+E++DV+S G +L+ ++ + P+ ++ + +
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSS 274
Query: 591 MVAALIETCWAEEPEIRPSFPSIMETLQQF 620
+ L+ + +P RP P ++ L+
Sbjct: 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 74/285 (25%), Positives = 130/285 (45%), Gaps = 35/285 (12%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAV 427
+G F VY A+ + A+K L+ E E++ + ++EV MK L HPNIV A
Sbjct: 38 EGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 428 TEPPNLS-------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
+ S ++ L +G L + L ++R + L + Y + + ++H++
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA------------GTPE 528
+PPI+HRDLK NLL+ + T+K+CDFG + + + S +A TP
Sbjct: 156 KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM 215
Query: 529 WMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 585
+ PE++ P EK D+++ G IL+ L Q P+ + ++++ + IP
Sbjct: 216 YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG------KYSIP 269
Query: 586 KNVN--PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 628
+ + +LI PE R S ++ LQ+ + P
Sbjct: 270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 72/212 (33%), Positives = 115/212 (54%), Gaps = 10/212 (4%)
Query: 365 DSSNFI-KGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 422
+ N + +G FG VY + + VAVK L E E + +F EV ++ H N++
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQR- 480
L G P +V Y++ GS+ L P+++ +D R +A A+G+ YLH
Sbjct: 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTA-AGTPEWMAPEVLRE 537
P I+HRD+K+ N+L+D + V DFGL++ +T+++ TA GT +APE L
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLST 209
Query: 538 DPSNEKSDVFSFGVILWELITLQKPWRNSTPS 569
S+EK+DVF +GV+L ELIT Q+ + + +
Sbjct: 210 GKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-46
Identities = 76/249 (30%), Positives = 121/249 (48%), Gaps = 26/249 (10%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KGSFG V+ + VA+KI I+ E ED ++ +E+ ++ P + G+
Sbjct: 32 KGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ L I+ EYL GS LL +DE + ++ KG++YLH + +HRD
Sbjct: 91 KDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK--KIHRD 144
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+K+ N+L+ VK+ DFG++ +T I T GTP WMAPEV+++ + K+D++S
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 204
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--------LIETCW 600
G+ EL + P P +V+ IPKN P + +E C
Sbjct: 205 LGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKPLKEFVEACL 255
Query: 601 AEEPEIRPS 609
+EP RP+
Sbjct: 256 NKEPSFRPT 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-46
Identities = 63/281 (22%), Positives = 106/281 (37%), Gaps = 26/281 (9%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+ V+ + + A+K+ +RE ++K L H NIV L A+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-AIE 76
Query: 429 EPP---NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
E + ++ E+ GSLY +L P + E L + DV GMN+L + IV
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IV 134
Query: 486 HRDLKSPNLLV----DSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPS 540
HR++K N++ D K+ DFG +R + + + GT E++ P++
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMYERAVL 192
Query: 541 --------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592
D++S GV + T P+R + V +K +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG--AISG 250
Query: 593 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 633
E + P S+ LQ L + L A
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 18/251 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAV 427
KG FG VY A + S +A+K+L + + + + REV I LRHPNI+ L G
Sbjct: 19 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ + ++ EY G++Y+ L DE+ ++A ++Y H +R ++HR
Sbjct: 79 HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKR--VIHR 133
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+K NLL+ S +K+ DFG S P++ GT +++ PE++ +EK D++
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLW 191
Query: 548 SFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
S GV+ +E + + P+ +T + IS V F P V LI P
Sbjct: 192 SLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISRLLKHNP 246
Query: 605 EIRPSFPSIME 615
RP ++E
Sbjct: 247 SQRPMLREVLE 257
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 61/307 (19%), Positives = 109/307 (35%), Gaps = 51/307 (16%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+ V+ + + A+K+ +RE ++K L H NIV L A+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-AIE 76
Query: 429 EPP---NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
E + ++ E+ GSLY +L P + E L + DV GMN+L + IV
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IV 134
Query: 486 HRDLKSPNLLV----DSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPS 540
HR++K N++ D K+ DFG +R + + + GT E++ P++
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMYERAVL 192
Query: 541 --------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--------- 583
D++S GV + T P+R + V +K +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 584 ------------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625
+ + + ++ ++ + E F L V
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV 312
Query: 626 CQPLSAQ 632
S Q
Sbjct: 313 IHVFSLQ 319
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-44
Identities = 69/251 (27%), Positives = 122/251 (48%), Gaps = 18/251 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMGAV 427
KG FG VY A + + +A+K+L + + ++ + L RE+ I LRHPNI+ +
Sbjct: 24 KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ + ++ E+ RG LYK L R DE+ ++A ++Y H+R+ ++HR
Sbjct: 84 HDRKRIYLMLEFAPRGELYKEL-QKHGR--FDEQRSATFMEELADALHYCHERK--VIHR 138
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+K NLL+ +K+ DFG S P+ + +T GT +++ PE++ +EK D++
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGKTHDEKVDLW 196
Query: 548 SFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
GV+ +E + P+ + + ++ I V K P ++ LI P
Sbjct: 197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-----FPPFLSDGSKDLISKLLRYHP 251
Query: 605 EIRPSFPSIME 615
R +ME
Sbjct: 252 PQRLPLKGVME 262
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 64/242 (26%), Positives = 118/242 (48%), Gaps = 11/242 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+ GTVY A + VA++ + + + + + + E+ +M+ ++PNIV + +
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQ-MNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L +V EYL+ GSL ++ +DE + + + + +LH + ++HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRD 141
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+KS N+L+ +VK+ DFG T GTP WMAPEV+ K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPEIR 607
G++ E+I + P+ N P + + + G L+ P+ ++ + + C + E R
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261
Query: 608 PS 609
S
Sbjct: 262 GS 263
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 64/255 (25%), Positives = 112/255 (43%), Gaps = 20/255 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+ G V+ + S +A K+ I E + +RE+ ++ P IV GA
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+SI E++ GSL ++L + E++ ++ V KG+ YL ++ I+HRD
Sbjct: 102 SDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK-IMHRD 157
Query: 489 LKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
+K N+LV+S +K+CDFG L S N+++ GT +M+PE L+ + +S
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQS 211
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
D++S G+ L E+ + P ++ G ++E P +
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMF---GCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 605 EIRPSFPSIMETLQQ 619
+I E L
Sbjct: 269 MDSRPPMAIFELLDY 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 63/242 (26%), Positives = 121/242 (50%), Gaps = 11/242 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+GS G V A ++S VAVK+ ++ + R + EV IM+ +H N+V + +
Sbjct: 55 EGSTGIVCLAREKHSGRQVAVKM-MDLR-KQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L ++ E+L G+L ++ +V ++E + V + + YLH + ++HRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG--VIHRD 166
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+KS ++L+ VK+ DFG K+ GTP WMAPEV+ + D++S
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPEIR 607
G+++ E++ + P+ + +P Q + + +L+ V+P++ +E +P+ R
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286
Query: 608 PS 609
+
Sbjct: 287 AT 288
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 46/210 (21%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 371 KGSFGTVYHAEWRNSDVAVKIL---------------IEQEFHEDRFKEFLREVAIMKGL 415
+G F + E N A+K ++ + ++ +F E+ I+ +
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 416 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDV 470
++ + G +T + I+ EY+ S+ K + + ++ + V
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 530
+Y+H + I HRD+K N+L+D VK+ DFG S + I K + GT E+M
Sbjct: 161 LNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSRGTYEFM 217
Query: 531 APEVL--REDPSNEKSDVFSFGVILWELIT 558
PE + K D++S G+ L+ +
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-43
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 17/227 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G FG V +++ VA+K QE + + E+ IMK L HPN+V
Sbjct: 24 TGGFGYVLRWIHQDTGEQVAIKQ-CRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 429 EPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
L+ + EY G L K L+ + + E + D++ + YLH+ R
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR- 141
Query: 483 PIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 538
I+HRDLK N+++ K+ D G ++ GT +++APE+L +
Sbjct: 142 -IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAPELLEQK 198
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 585
D +SFG + +E IT +P+ + + I
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 42/269 (15%)
Query: 371 KGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+ V A + VA+K I E + E L+E+ M HPNIV +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARV-----VVDERLRLNMAYDVAKGMNYLHQRRPP 483
L +V + LS GS+ ++ A+ V+DE + +V +G+ YLH+
Sbjct: 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-- 141
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISS-KTAAGTPEWMAPEVLRED 538
+HRD+K+ N+L+ +V++ DFG L+ T KT GTP WMAPEV+ +
Sbjct: 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV 201
Query: 539 PS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--- 594
+ K+D++SFG+ EL T P+ P +V+ + +N P +
Sbjct: 202 RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---------MLTLQNDPPSLETGVQ 252
Query: 595 --------------LIETCWAEEPEIRPS 609
+I C ++PE RP+
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 63/251 (25%), Positives = 111/251 (44%), Gaps = 15/251 (5%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAV 427
KGSF VY AE ++ +VA+K++ ++ ++ + EV I L+HP+I+ L
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ + +V E G + + L E + + + GM YLH I+HR
Sbjct: 81 EDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLHSHG--ILHR 136
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DL NLL+ +K+ DFGL+ + T GTP +++PE+ +SDV+
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVW 196
Query: 548 SFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
S G + + L+ + P+ T + ++ +P ++ LI P
Sbjct: 197 SLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-----MPSFLSIEAKDLIHQLLRRNP 251
Query: 605 EIRPSFPSIME 615
R S S+++
Sbjct: 252 ADRLSLSSVLD 262
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 22/254 (8%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
KG F + ++ A KI+ + + ++ E++I + L H ++V
Sbjct: 25 KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVVGFH 81
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
G + + +V E R SL +L R + E + G YLH+ R +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR--V 136
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
+HRDLK NL ++ VK+ DFGL+ K GTP ++APEVL + + +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
DV+S G I++ L+ + P+ S + I + IPK++NP+ A+LI+
Sbjct: 197 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQKMLQ 251
Query: 602 EEPEIRPSFPSIME 615
+P RP+ ++
Sbjct: 252 TDPTARPTINELLN 265
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-42
Identities = 66/242 (27%), Positives = 121/242 (50%), Gaps = 11/242 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+GS+G+VY A + + VA+K + E +E ++E++IM+ P++V G+
Sbjct: 39 EGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ +L IV EY GS+ ++ + + + E + KG+ YLH R +HRD
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTL--TEDEIATILQSTLKGLEYLHFMR--KIHRD 150
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+K+ N+L+++ K+ DFG++ +T T GTP WMAPEV++E N +D++S
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 210
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPEIR 607
G+ E+ + P+ + P + I + P+ + ++ C + PE R
Sbjct: 211 LGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270
Query: 608 PS 609
+
Sbjct: 271 AT 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 8e-42
Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 25/260 (9%)
Query: 371 KGSFGTVYHAE-WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT 428
G+ GT+ + + N DVAVK + + F REV +++ HPN++
Sbjct: 34 HGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ I E + +L + + D + + G+ +LH IVHRD
Sbjct: 89 DRQFQYIAIELCA-ATLQEYVEQKDFAH--LGLEPITLLQQTTSGLAHLHSLN--IVHRD 143
Query: 489 LKSPNLLV-----DSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPS 540
LK N+L+ + DFGL + +++ GT W+APE+L ED
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 541 ---NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG-FKGRRLEIPKNVNPMVAAL 595
D+FS G + + +I+ P+ S Q +G L K+ + + L
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIAREL 263
Query: 596 IETCWAEEPEIRPSFPSIME 615
IE A +P+ RPS +++
Sbjct: 264 IEKMIAMDPQKRPSAKHVLK 283
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 68/259 (26%), Positives = 117/259 (45%), Gaps = 32/259 (12%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
KG F + ++ A KI+ + + ++ E++I + L H ++V
Sbjct: 51 KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVVGFH 107
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
G + + +V E R SL +L R + E + G YLH+ R +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR--V 162
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS-----KTAAGTPEWMAPEVLREDP 539
+HRDLK NL ++ VK+ DFGL+ T + K GTP ++APEVL +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALI 596
+ + DV+S G I++ L+ + P+ S + I + IPK++NP+ A+LI
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLI 272
Query: 597 ETCWAEEPEIRPSFPSIME 615
+ +P RP+ ++
Sbjct: 273 QKMLQTDPTARPTINELLN 291
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 70/253 (27%), Positives = 126/253 (49%), Gaps = 26/253 (10%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+FG VY A+ + + A K+ IE + E+ ++++ E+ I+ HP IV L+GA
Sbjct: 29 DGAFGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L I+ E+ G++ ++ D + E + + + +N+LH +R I+HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGL--TEPQIQVVCRQMLEALNFLHSKR--IIHRD 142
Query: 489 LKSPNLLVDSTYTVKVCDFGLS------RSKPNTYISSKTAAGTPEWMAPEV-----LRE 537
LK+ N+L+ +++ DFG+S K +++I GTP WMAPEV +++
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCETMKD 196
Query: 538 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 596
P + K+D++S G+ L E+ ++ P P +V+ + L P + +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 597 ETCWAEEPEIRPS 609
+ + PE RPS
Sbjct: 257 KIALDKNPETRPS 269
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 8/238 (3%)
Query: 392 LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 451
+ + RF++ V + + + + + + + + LS +
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184
Query: 452 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511
+ E L + ++ VAKGM +L R+ +HRDL + N+L+ VK+CDFGL+R
Sbjct: 185 LYKDFLTLEHL-ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 241
Query: 512 S--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN-ST 567
K Y+ A +WMAPE + + +SDV+SFGV+LWE+ +L P+
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301
Query: 568 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625
+ + +G R+ P P + + CW EP RP+F ++E L L ++
Sbjct: 302 DEEFCRRL-KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 39/174 (22%), Positives = 68/174 (39%), Gaps = 19/174 (10%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 422
+G+FG V A+ D VAVK+L E H + + + E+ I+ + H N+V
Sbjct: 32 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVN 90
Query: 423 LMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
L+GA T+P L ++ E+ G+L L V +G +Y+
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV----PYKTKGARFRQGKDYVG--- 143
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 535
+ DLK + S+ + F +S + +++ E L
Sbjct: 144 --AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-40
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 37/256 (14%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
GSFG VY A + VA+K + + +++++ ++EV ++ LRHPN + G
Sbjct: 64 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 123
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+V EY GS LL + + E + + +G+ YLH ++HR
Sbjct: 124 LREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN--MIHR 178
Query: 488 DLKSPNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEV---LREDPSNE 542
D+K+ N+L+ VK+ DFG + + N+++ GTP WMAPEV + E +
Sbjct: 179 DVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDEGQYDG 232
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA-------- 594
K DV+S G+ EL + P N + I +N +P + +
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHIAQNESPALQSGHWSEYFR 283
Query: 595 -LIETCWAEEPEIRPS 609
+++C + P+ RP+
Sbjct: 284 NFVDSCLQKIPQDRPT 299
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 49/232 (21%), Positives = 91/232 (39%), Gaps = 27/232 (11%)
Query: 372 GSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
TV A V V+ + + + E+ + K HPNIV
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97
Query: 430 PPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L +VT +++ GS L+ H D ++E + V K ++Y+H VHR
Sbjct: 98 DNELWVVTSFMAYGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIHHMG--YVHR 152
Query: 488 DLKSPNLLVDSTYTVKVCDFGLS------RSKPNT-YISSKTAAGTPEWMAPEVLREDPS 540
+K+ ++L+ V + + + + K + W++PEVL+++
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 541 --NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590
+ KSD++S G+ EL P+++ +Q++ LE P
Sbjct: 213 GYDAKSDIYSVGITACELANGHVPFKDMPATQML---------LEKLNGTVP 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 21/253 (8%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KG+F V A +VA+KI+ + + + ++ REV IMK L HPNIV L +
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLHQRRPPI 484
L ++ EY S G ++ L V R++ A + + Y HQ+R I
Sbjct: 85 TEKTLYLIMEYASGGEVFDYL-------VAHGRMKEKEARSKFRQIVSAVQYCHQKR--I 135
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN-E 542
VHRDLK+ NLL+D+ +K+ DFG S + G P + APE+ + +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYDGP 193
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
+ DV+S GVIL+ L++ P+ ++ V + IP ++ L++
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 603 EPEIRPSFPSIME 615
P R + IM+
Sbjct: 252 NPIKRGTLEQIMK 264
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 68/262 (25%), Positives = 116/262 (44%), Gaps = 38/262 (14%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA- 426
G++G VY + A+K++ + D +E +E+ ++K H NI GA
Sbjct: 34 NGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 427 -----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
L +V E+ GS+ L+ + E + ++ +G+++LHQ +
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL-KEEWIAYICREILRGLSHLHQHK 149
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS- 540
++HRD+K N+L+ VK+ DFG+S T T GTP WMAPEV+ D +
Sbjct: 150 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 207
Query: 541 ----NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL- 595
+ KSD++S G+ E+ P + P + + F IP+N P + +
Sbjct: 208 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FL-----IPRNPAPRLKSKK 258
Query: 596 --------IETCWAEEPEIRPS 609
IE+C + RP+
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPA 280
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 19/192 (9%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KG+F V + + + A KI+ ++ F++ RE I + L+HPNIV L ++
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
E +V + ++ G L+ + AR E + + + + Y H IV
Sbjct: 76 EESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESIAYCHSNG--IV 127
Query: 486 HRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSN 541
HR+LK NLL+ S VK+ DFGL+ + AGTP +++PEVL++DP +
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYS 185
Query: 542 EKSDVFSFGVIL 553
+ D+++ GVIL
Sbjct: 186 KPVDIWACGVIL 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 65/263 (24%), Positives = 121/263 (46%), Gaps = 31/263 (11%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMGAV 427
+G++G V S +AVK I + K L ++ I M+ + P V GA+
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 75
Query: 428 TEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
++ I E + SL K + D + E + +A + K + +LH + ++H
Sbjct: 76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIH 133
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS----NE 542
RD+K N+L+++ VK+CDFG+S + ++ AG +MAPE + + + +
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSV 192
Query: 543 KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAA------- 594
KSD++S G+ + EL L+ P+ + TP Q + + + +P + A
Sbjct: 193 KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ---------VVEEPSPQLPADKFSAEF 243
Query: 595 --LIETCWAEEPEIRPSFPSIME 615
C + + RP++P +M+
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQ 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 59/188 (31%), Positives = 97/188 (51%), Gaps = 13/188 (6%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G FG V+ E + +A KI I+ +D+ +E E+++M L H N++ L A
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKI-IKTRGMKDK-EEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
++ +V EY+ G L+ I D + E + + +G+ ++HQ I+H D
Sbjct: 157 SKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLD 212
Query: 489 LKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
LK N+L + +K+ DFGL+R KP + K GTPE++APEV+ D + +D
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVNYDFVSFPTD 270
Query: 546 VFSFGVIL 553
++S GVI
Sbjct: 271 MWSVGVIA 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 19/192 (9%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KG+F V + + + A KI+ ++ F++ RE I + L+HPNIV L ++
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
E +V + ++ G L+ + AR E + + + + Y H IV
Sbjct: 99 EESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESIAYCHSNG--IV 150
Query: 486 HRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSN 541
HR+LK NLL+ S VK+ DFGL+ + AGTP +++PEVL++DP +
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYS 208
Query: 542 EKSDVFSFGVIL 553
+ D+++ GVIL
Sbjct: 209 KPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 16/191 (8%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KG+F V + + A I+ ++ ++ RE I + L+HPNIV L +++
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
E + ++ + ++ G L+ + AR E + + + + + HQ +V
Sbjct: 81 EEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAVLHCHQMG--VV 132
Query: 486 HRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
HR+LK NLL+ S VK+ DFGL+ + AGTP +++PEVLR+DP +
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192
Query: 543 KSDVFSFGVIL 553
D+++ GVIL
Sbjct: 193 PVDLWACGVIL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 55/249 (22%), Positives = 107/249 (42%), Gaps = 16/249 (6%)
Query: 371 KGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMGAV 427
G+ G V+ +AVK + + +++ K L ++ + +K P IV G
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQ-MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF 93
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
++ I E + + + + ER+ M + K + YL ++ ++HR
Sbjct: 94 ITNTDVFIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLKEKHG-VIHR 149
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE----- 542
D+K N+L+D +K+CDFG+S + + +AG +MAPE + +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208
Query: 543 KSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
++DV+S G+ L EL T Q P++N + + + L + + ++ C
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCL 268
Query: 601 AEEPEIRPS 609
++ RP
Sbjct: 269 TKDHRKRPK 277
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 20/195 (10%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
G F V +++ + A K R +E REV+I++ + H N++ L
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR-EEIEREVSILRQVLHHNVITL 80
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
++ ++ E +S G L+ L + + E + + G+NYLH ++
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 484 IVHRDLKSPNLLVDS----TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 538
I H DLK N+++ +K+ DFGL+ + K GTPE++APE++ +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYE 193
Query: 539 PSNEKSDVFSFGVIL 553
P ++D++S GVI
Sbjct: 194 PLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 20/195 (10%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
G F V +++ A K R ++ REV+I+K ++HPN++ L
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR-EDIEREVSILKEIQHPNVITL 79
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
++ ++ E ++ G L+ L + + E + G+ YLH +
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 484 IVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 538
I H DLK N+++ +K+ DFGL+ K GTPE++APE++ +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYE 192
Query: 539 PSNEKSDVFSFGVIL 553
P ++D++S GVI
Sbjct: 193 PLGLEADMWSIGVIT 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 20/195 (10%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
G F V + + + A K L R +E REV I++ +RHPNI+ L
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-EEIEREVNILREIRHPNIITL 73
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
++ ++ E +S G L+ L + + E + G++YLH +R
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHSKR-- 128
Query: 484 IVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 538
I H DLK N+++ +K+ DFG++ + K GTPE++APE++ +
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYE 186
Query: 539 PSNEKSDVFSFGVIL 553
P ++D++S GVI
Sbjct: 187 PLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 28/199 (14%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
G F V +++ + A K R +E REV+I++ + HPNI+ L
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-EEIEREVSILRQVLHPNIITL 80
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----GMNYLHQ 479
++ ++ E +S G L+ + E L A K G+NYLH
Sbjct: 81 HDVYENRTDVVLILELVSGGELFD-------FLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 480 RRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 534
++ I H DLK N+++ +K+ DFGL+ + K GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 535 LREDPSNEKSDVFSFGVIL 553
+ +P ++D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 35/261 (13%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMGAV 427
+G++G+V + S +AVK I E K+ L ++ + M+ P IV GA+
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90
Query: 428 TEPPNLSIVTEYLSRGSLYKLLH--IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ I E +S S K V+ E + + K +N+L + I+
Sbjct: 91 FREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-II 148
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE--- 542
HRD+K N+L+D + +K+CDFG+S ++ I+ AG +MAPE + S +
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 543 -KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAA------ 594
+SDV+S G+ L+EL T + P+ ++ ++ + K P ++
Sbjct: 208 VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ---------VVKGDPPQLSNSEEREF 258
Query: 595 ------LIETCWAEEPEIRPS 609
+ C ++ RP
Sbjct: 259 SPSFINFVNLCLTKDESKRPK 279
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 13/188 (6%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+FG V+ + + K I + D+ E++IM L HP ++ L A
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKF-INTPYPLDK-YTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ + ++ E+LS G L+ I + E +N +G+ ++H+ IVH D
Sbjct: 119 DKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLD 174
Query: 489 LKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
+K N++ ++ +VK+ DFGL+ P+ + K T E+ APE++ +P +D
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTD 232
Query: 546 VFSFGVIL 553
+++ GV+
Sbjct: 233 MWAIGVLG 240
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 60/192 (31%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 371 KGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
G+F V+ + R + A+K I F + + E+A++K ++H NIV L
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLEDIY 75
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ +V + +S G L+ D R V E+ + V + YLH+ I
Sbjct: 76 ESTTHYYLVMQLVSGGELF------DRILERGVYTEKDASLVIQQVLSAVKYLHENG--I 127
Query: 485 VHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 541
VHRDLK NLL + + + DFGLS+ + N + TA GTP ++APEVL + P +
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVLAQKPYS 185
Query: 542 EKSDVFSFGVIL 553
+ D +S GVI
Sbjct: 186 KAVDCWSIGVIT 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 69/192 (35%), Positives = 98/192 (51%), Gaps = 20/192 (10%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KGSFG V + R + + AVK++ + LREV ++K L HPNI+ L +
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ + IV E + G L+ D R E + V G+ Y+H+ IV
Sbjct: 92 DSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IV 143
Query: 486 HRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSN 541
HRDLK N+L++S +K+ DFGLS + NT + K GT ++APEVLR +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVLRG-TYD 200
Query: 542 EKSDVFSFGVIL 553
EK DV+S GVIL
Sbjct: 201 EKCDVWSAGVIL 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 58/279 (20%), Positives = 106/279 (37%), Gaps = 42/279 (15%)
Query: 371 KGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT 428
GS GTV ++ VAVK + D L E+ ++ HPN++ + T
Sbjct: 25 YGSSGTVVFQGSFQGRPVAVKRM-----LIDFCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 429 EPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
L I E + +L L+ + + E +++ +A G+ +LH + I
Sbjct: 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--I 136
Query: 485 VHRDLKSPNLLVDST-------------YTVKVCDFGLSR----SKPNTYISSKTAAGTP 527
+HRDLK N+LV ++ + + DFGL + + + + +GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 528 EWMAPEVLRED-------PSNEKSDVFSFGVILWELITLQKP--WRNSTPSQVI--SAVG 576
W APE+L E D+FS G + + +++ K + I
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFS 256
Query: 577 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
+ +++ LI +P RP+ ++
Sbjct: 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 13/190 (6%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+FG V+ E R+S + +K I ++ + ++ E+ ++K L HPNI+ +
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90
Query: 429 EPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ N+ IV E G L +++ + E + + + Y H + +VH+
Sbjct: 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHK 148
Query: 488 DLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
DLK N+L T +K+ DFGL+ K + + AAGT +MAPEV + D K
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFKRD-VTFK 205
Query: 544 SDVFSFGVIL 553
D++S GV++
Sbjct: 206 CDIWSAGVVM 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 80/289 (27%), Positives = 125/289 (43%), Gaps = 63/289 (21%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKIL------------------------IEQEFHEDRF 402
KGS+G V A N + A+K+L
Sbjct: 23 KGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 403 KEFLREVAIMKGLRHPNIVLLMGAVTEPPN---LSIVTEYLSRGSLYKLLHIPDARVVVD 459
++ +E+AI+K L HPN+V L+ V + PN L +V E +++G + + V
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVME--------VPTL 131
Query: 460 ERLRLNMA----YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515
+ L + A D+ KG+ YLH ++ I+HRD+K NLLV +K+ DFG+S N
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVS----N 185
Query: 516 TYISS----KTAAGTPEWMAPEVLREDPSN---EKSDVFSFGVILWELITLQKPWRNSTP 568
+ S GTP +MAPE L E + DV++ GV L+ + Q P+ +
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 569 SQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPSFPSIME 615
+ S + K + LE P ++ + LI + PE R P I
Sbjct: 246 MCLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 70/255 (27%), Positives = 112/255 (43%), Gaps = 20/255 (7%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++G V A R + VAVKI ++ + D + +E+ I K L H N+V G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLHQRRPPI 484
E + EY S G L+ R+ D + A + + G+ YLH I
Sbjct: 76 EGNIQYLFLEYCSGGELF-------DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--I 126
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLREDP-SN 541
HRD+K NLL+D +K+ DFGL+ GT ++APE+L+
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAALIETCW 600
E DV+S G++L ++ + PW + S + + + P K ++ AL+
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 601 AEEPEIRPSFPSIME 615
E P R + P I +
Sbjct: 247 VENPSARITIPDIKK 261
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKI-------LIEQEFHEDRFKEFLREVAIMKGL-RHPNI 420
+G V + + + AVKI E ++ + L+EV I++ + HPNI
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYL 477
+ L +V + + +G L+ D +V + E+ + + + + L
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELF------DYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLR 536
H+ IVHRDLK N+L+D +K+ DFG S P + + GTP ++APE++
Sbjct: 141 HKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIE 196
Query: 537 EDPS------NEKSDVFSFGVIL 553
+ ++ D++S GVI+
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-36
Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G V + + A+KI+ + + L EVA++K L HPNI+ L
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ N +V E G L+ + R+ +E + V G+ YLH+ IVHRD
Sbjct: 107 DKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRD 161
Query: 489 LKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
LK NLL++S +K+ DFGLS + + K GT ++APEVLR+ +EK
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRK-KYDEKC 218
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAV 575
DV+S GVIL+ L+ P+ T +++ V
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQEILRKV 249
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 13/193 (6%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
KG F V R + AVKI+ ++ RE +I L+HP+IV L+
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHPHIVELL 92
Query: 425 GAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+ L +V E++ L +++ DA V E + + + + + Y H
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-- 150
Query: 484 IVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
I+HRD+K +L+ S VK+ FG++ + + + GTP +MAPEV++ +P
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY 210
Query: 541 NEKSDVFSFGVIL 553
+ DV+ GVIL
Sbjct: 211 GKPVDVWGCGVIL 223
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 54/190 (28%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAV 427
+G F V +++ + A K L ++ +D E L E+A+++ + P ++ L
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ ++ EY + G ++ L +P+ +V E + + + +G+ YLHQ IVH
Sbjct: 99 ENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHL 155
Query: 488 DLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
DLK N+L+ S Y +K+ DFG+SR + + GTPE++APE+L DP
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYDPITTA 213
Query: 544 SDVFSFGVIL 553
+D+++ G+I
Sbjct: 214 TDMWNIGIIA 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 13/188 (6%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+FG V+ R + + A K + D+ + +E+ M LRHP +V L A
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKF-VMTPHESDK-ETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ + ++ E++S G L++ + D + E + V KG+ ++H+ VH D
Sbjct: 225 DDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLD 280
Query: 489 LKSPNLLVDST--YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
LK N++ + +K+ DFGL+ P + K GT E+ APEV P +D
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 546 VFSFGVIL 553
++S GV+
Sbjct: 339 MWSVGVLS 346
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 25/200 (12%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKIL------IEQEFHEDRFKEFLREVAIMKGLR-HPNIV 421
+G V R + + AVKI+ + E E+ + RE I++ + HP+I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
L+ + + +V + + +G L+ L +V + E+ ++ + + +++LH
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDP 539
IVHRDLK N+L+D +++ DFG S +P + + GTP ++APE+L+
Sbjct: 220 N--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSM 275
Query: 540 S------NEKSDVFSFGVIL 553
++ D+++ GVIL
Sbjct: 276 DETHPGYGKEVDLWACGVIL 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 29/201 (14%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKIL------IEQEFHEDRFKEFLREVAIMKGLRHPNIVL 422
G+ G V A R + VA++I+ I D E+ I+K L HP I+
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 479
+ + + IV E + G L+ D + E Y + + YLH+
Sbjct: 205 IKNFF-DAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 480 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 535
I+HRDLK N+L+ S +K+ DFG S+ + + +T GTP ++APEVL
Sbjct: 258 NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPEVL 313
Query: 536 REDPS---NEKSDVFSFGVIL 553
+ N D +S GVIL
Sbjct: 314 VSVGTAGYNRAVDCWSLGVIL 334
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 73/256 (28%), Positives = 119/256 (46%), Gaps = 26/256 (10%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMGAV 427
G+FG V E + VAVKIL Q+ + RE+ +K RHP+I+ L +
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLHQRRPP 483
+ P + +V EY+S G L+ + R+ A + ++Y H+
Sbjct: 81 STPTDFFMVMEYVSGGELF-------DYICKHGRVEEMEARRLFQQILSAVDYCHRHM-- 131
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEVLREDP- 539
+VHRDLK N+L+D+ K+ DFGLS N +T+ G+P + APEV+
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
+ + D++S GVIL+ L+ P+ + + + +G IP+ +N VA L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVATLLMHM 245
Query: 600 WAEEPEIRPSFPSIME 615
+P R + I E
Sbjct: 246 LQVDPLKRATIKDIRE 261
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 22/192 (11%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+GS+G V A + + A K I + F ED F +E+ IMK L HPNI+ L
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKK-IPKYFVEDV-DRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+ ++ +V E + G L+ + + V E + DV + Y H+ +
Sbjct: 77 DNTDIYLVMELCTGGELF------ERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VA 128
Query: 486 HRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSN 541
HRDLK N L + +K+ DFGL+ KP + +T GTP +++P+VL
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEG-LYG 185
Query: 542 EKSDVFSFGVIL 553
+ D +S GV++
Sbjct: 186 PECDEWSAGVMM 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 70/255 (27%), Positives = 110/255 (43%), Gaps = 20/255 (7%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++G V A R + VAVKI ++ + D + +E+ I K L H N+V G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----GMNYLHQRRPPI 484
E + EY S G L+ R+ D + A G+ YLH I
Sbjct: 76 EGNIQYLFLEYCSGGELF-------DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--I 126
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLREDP-SN 541
HRD+K NLL+D +K+ DFGL+ GT ++APE+L+
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAALIETCW 600
E DV+S G++L ++ + PW + S + + + P K ++ AL+
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 601 AEEPEIRPSFPSIME 615
E P R + P I +
Sbjct: 247 VENPSARITIPDIKK 261
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 44/188 (23%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G FG V+ +S K ++ + D+ +E++I+ RH NI+ L +
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKF-VKVK-GTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L ++ E++S +++ I + ++ER ++ + V + + +LH I H D
Sbjct: 72 SMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFD 127
Query: 489 LKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
++ N++ + + T+K+ +FG +R KP + PE+ APEV + D + +D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 546 VFSFGVIL 553
++S G ++
Sbjct: 186 MWSLGTLV 193
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-35
Identities = 71/211 (33%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
KGSFG V + R + + AVK++ + LREV ++K L HPNI+ L +
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ + IV E + G L+ + R E + V G+ Y+H+ IVHRD
Sbjct: 92 DSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRD 146
Query: 489 LKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
LK N+L++S +K+ DFGLS + NT + K GT ++APEVLR +EK
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVLRG-TYDEKC 203
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAV 575
DV+S GVIL+ L++ P+ ++ V
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 62/256 (24%), Positives = 115/256 (44%), Gaps = 26/256 (10%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL------REVAIMKGLRHPNIVL 422
G+FG V+ A + N +V VK + +++ ED + E E+AI+ + H NI+
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 423 LMGAVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
++ +V E G L+ + D +DE L + + + YL +
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDP- 539
I+HRD+K N+++ +T+K+ DFG + + T GT E+ APEVL +P
Sbjct: 151 --IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPEVLMGNPY 206
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
+ +++S GV L+ L+ + P+ + + A + P V+ + +L+
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENPFCE--LEETVEA------AIHPPYLVSKELMSLVSGL 258
Query: 600 WAEEPEIRPSFPSIME 615
PE R + ++
Sbjct: 259 LQPVPERRTTLEKLVT 274
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+ VY + + + A+K+L + + E+ ++ L HPNI+ L
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
P +S+V E ++ G L+ D + ER + + + + YLH+ IV
Sbjct: 119 TPTEISLVLELVTGGELF------DRIVEKGYYSERDAADAVKQILEAVAYLHENG--IV 170
Query: 486 HRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSN 541
HRDLK NLL + +K+ DFGLS+ + + KT GTP + APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYG 228
Query: 542 EKSDVFSFGVIL 553
+ D++S G+I
Sbjct: 229 PEVDMWSVGIIT 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 59/201 (29%), Positives = 88/201 (43%), Gaps = 29/201 (14%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKIL------IEQEFHEDRFKEFLREVAIMKGLRHPNIVL 422
G+ G V A R + VA+KI+ I D E+ I+K L HP I+
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 479
+ + + IV E + G L+ D + E Y + + YLH+
Sbjct: 80 IKNFF-DAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 480 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 535
I+HRDLK N+L+ S +K+ DFG S+ + + +T GTP ++APEVL
Sbjct: 133 NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPEVL 188
Query: 536 REDPS---NEKSDVFSFGVIL 553
+ N D +S GVIL
Sbjct: 189 VSVGTAGYNRAVDCWSLGVIL 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 16/189 (8%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAV 427
+GSF + S AVKI I + + +E+ +K HPNIV L
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKI-ISKRMEANTQ----KEITALKLCEGHPNIVKLHEVF 75
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ + +V E L+ G L++ I + E + + ++++H +VHR
Sbjct: 76 HDQLHTFLVMELLNGGELFE--RI-KKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHR 130
Query: 488 DLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
DLK NLL + +K+ DFG +R KP KT T + APE+L ++ +E
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190
Query: 545 DVFSFGVIL 553
D++S GVIL
Sbjct: 191 DLWSLGVIL 199
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 50/269 (18%), Positives = 97/269 (36%), Gaps = 23/269 (8%)
Query: 362 HVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 421
++ N + + E + + ++ M N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
+ + L I + + +L ++ + + + L++ +A+ + +LH +
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA------------GTPEW 529
++HRDLK N+ VKV DFGL + GT +
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 530 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--- 586
M+PE + + + K D+FS G+IL+EL+ ++I+ V R L+ P
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QMERVRIITDV----RNLKFPLLFT 296
Query: 587 NVNPMVAALIETCWAEEPEIRPSFPSIME 615
P +++ + P RP I+E
Sbjct: 297 QKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 17/53 (32%), Positives = 28/53 (52%), Gaps = 3/53 (5%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 421
+G FG V+ A+ + + + A+K I E ++ +REV + L HP IV
Sbjct: 16 RGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIV 67
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 40/285 (14%), Positives = 87/285 (30%), Gaps = 47/285 (16%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLR----------- 416
+ A + + V + + + K+ EV ++ LR
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 417 -----------HPNIVLLMGAVTEPPNLSIVTEYL----SRGSLYKLLHIPDARVVVDER 461
P ++ + ++ +++ + + +L + + +
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 462 L----RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517
L RL + V + + LH +VH L+ ++++D V + F +
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 518 ISSKTAA-GTPEWMAPEVLREDPSNEK-----SDVFSFGVILWELITLQKPWRNSTPSQV 571
+S PE A +L + D ++ G+ ++ + P +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 572 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616
+ KN+ V AL+E E R MET
Sbjct: 326 SEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 25/201 (12%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAV 427
+G+ V + + AVKI IE++ R REV ++ + H N++ L+
Sbjct: 23 EGAHARVQTCINLITSQEYAVKI-IEKQPGHIR-SRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
E +V E + GS+ L HI R +E + DVA +++LH + I HR
Sbjct: 81 EEEDRFYLVFEKMRGGSI--LSHI-HKRRHFNELEASVVVQDVASALDFLHNKG--IAHR 135
Query: 488 DLKSPNLLV---DSTYTVKVCDFGLSRS-KPNTYISS------KTAAGTPEWMAPEVLRE 537
DLK N+L + VK+CDF L K N S T G+ E+MAPEV+
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 538 DPSNEKS-----DVFSFGVIL 553
D++S GVIL
Sbjct: 196 FSEEASIYDKRCDLWSLGVIL 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 28/277 (10%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRH--PNIVL 422
G FG+VY N VA+K + I EV ++K + ++
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 423 LMGAVTEPPNLSIVTEYLS-RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
L+ P + ++ E L+ + R + E L + + V + + + H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHNCG 169
Query: 482 PPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP- 539
++HRD+K N+L+D +K+ DFG +T GT + PE +R
Sbjct: 170 --VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 225
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
+ V+S G++L++++ P+ + ++I ++ + V+ LI C
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHD--EEIIRG------QVFFRQRVSSECQHLIRWC 277
Query: 600 WAEEPEIRPSFPSIMET--LQQFLMSSVCQPLSAQPL 634
A P RP+F I +Q L+ + L
Sbjct: 278 LALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 314
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KGSFG V + + + AVK++ +++ + + LREV ++K L HPNI+ L
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ +V E + G L+ + +R E + V G+ Y+H+ + IVHR
Sbjct: 96 EDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHR 150
Query: 488 DLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
DLK NLL++S +++ DFGLS + + + K GT ++APEVL +EK
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPEVLHG-TYDEK 207
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAV 575
DV+S GVIL+ L++ P+ + ++ V
Sbjct: 208 CDVWSTGVILYILLSGCPPFNGANEYDILKKV 239
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 36/233 (15%), Positives = 76/233 (32%), Gaps = 30/233 (12%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+F VY A + + +K+ E F + + +K +
Sbjct: 75 EGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERLKPSMQHMFMKF 132
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
A +V E S G+L +++ V+ + L ++ A + + +H
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192
Query: 482 PPIVHRDLKSPNLLVDSTYT-----------VKVCDFGLSRSK----PNTYISSKTAAGT 526
I+H D+K N ++ + + + + D G S T T
Sbjct: 193 --IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF--TAKCET 248
Query: 527 PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 579
+ E+L P N + D F ++ ++ + + F+
Sbjct: 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 61/262 (23%), Positives = 117/262 (44%), Gaps = 30/262 (11%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEF--HEDRFKEFLREVAIMKGLRHPNIVLL- 423
+GS+G V +S+ AVKIL +++ + +E+ +++ LRH N++ L
Sbjct: 15 EGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 424 --MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD----VAKGMNYL 477
+ + +V EY + ++L V ++R + A+ + G+ YL
Sbjct: 73 DVLYNEE-KQKMYMVMEYCV-CGMQEMLDS-----VPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVL 535
H + IVH+D+K NLL+ + T+K+ G++ + +T+ G+P + PE+
Sbjct: 126 HSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 536 REDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
S K D++S GV L+ + T P+ ++ + IP + P ++
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKGSYAIPGDCGPPLS 241
Query: 594 ALIETCWAEEPEIRPSFPSIME 615
L++ EP R S I +
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQ 263
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIM-KGLRHPNIVLLMGAV 427
GS+ + + + AVKI+ + ++ E+ I+ + +HPNI+ L
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ + +VTE + G L + + ER + + + K + YLH + +VHR
Sbjct: 86 DDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG--VVHR 140
Query: 488 DLKSPNLLV----DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
DLK N+L + ++++CDFG ++ T T ++APEVL +
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAA 200
Query: 544 SDVFSFGVIL 553
D++S GV+L
Sbjct: 201 CDIWSLGVLL 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 58/258 (22%), Positives = 100/258 (38%), Gaps = 28/258 (10%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGLR----HPNI 420
KG FGTV+ VA+K++ + EVA++ + HP +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
+ L+ +V E L+ + + + E V + + H
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 480 RRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 538
R +VHRD+K N+L+D K+ DFG + GT + PE +
Sbjct: 158 RG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSPPEWISRH 213
Query: 539 P-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
+ V+S G++L++++ P+ +++ A L P +V+P ALI
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERD--QEILEA------ELHFPAHVSPDCCALIR 265
Query: 598 TCWAEEPEIRPSFPSIME 615
C A +P RPS I+
Sbjct: 266 RCLAPKPSSRPSLEEILL 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 25/222 (11%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-----------IEQEFHEDRFKEFLREVAIMKGLRH 417
G++G V + +N A+K++ + + E +E E++++K L H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 418 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 477
PNI+ L + +VTE+ G L++ + R DE N+ + G+ YL
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGICYL 162
Query: 478 HQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPE 533
H+ IVHRD+K N+L+++ +K+ DFGLS + + + GT ++APE
Sbjct: 163 HKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE 218
Query: 534 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 575
VL++ NEK DV+S GVI++ L+ P+ +I V
Sbjct: 219 VLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 41/290 (14%), Positives = 83/290 (28%), Gaps = 56/290 (19%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLR----------- 416
+ A + + V + E + ++ EV ++ LR
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 417 --------------HPNIVLLMGAVTEPPNLSIVTEY-LSRGSLYK----LLHIPDARVV 457
++ + + LS Y + +L LL
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 458 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517
+ RL + V + + LH +VH L+ ++++D V + F +
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV-RDGAR 259
Query: 518 ISSKTAAGTPEWMAPEVL-----------REDPSNEKSDVFSFGVILWELITLQKPWRNS 566
++ + + PE+ R D ++ G++++ + P
Sbjct: 260 ---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316
Query: 567 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616
+ KN+ V AL+E E R MET
Sbjct: 317 AALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 24/198 (12%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+FG + VAVK + ++ + RE+ + LRHPNIV +
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEVIL 86
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD----VAKGMNYLHQRRPPI 484
P +L+I+ EY S G LY R+ R + A + G++Y H + I
Sbjct: 87 TPTHLAIIMEYASGGELY-------ERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--I 137
Query: 485 VHRDLKSPNLLVDSTYT--VKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPSN 541
HRDLK N L+D + +K+CDFG S+ S ++ K+ GTP ++APEVL +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLRQEYD 195
Query: 542 -EKSDVFSFGVILWELIT 558
+ +DV+S GV L+ ++
Sbjct: 196 GKIADVWSCGVTLYVMLV 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 70/254 (27%), Positives = 119/254 (46%), Gaps = 23/254 (9%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMGAV 427
+GSFG V A VA+K + Q + + RE++ +K LRHP+I+ L +
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLHQRRPP 483
T P ++ +V EY G L+ + V +R+ + + + Y H+ +
Sbjct: 79 TTPTDIVMVIEYAG-GELFDYI-------VEKKRMTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDP-SN 541
IVHRDLK NLL+D VK+ DFGLS ++ KT+ G+P + APEV+ +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEVINGKLYAG 186
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
+ DV+S G++L+ ++ + P+ + + V +P ++P +LI
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIV 244
Query: 602 EEPEIRPSFPSIME 615
+P R + I
Sbjct: 245 ADPMQRITIQEIRR 258
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 35/289 (12%), Positives = 63/289 (21%), Gaps = 50/289 (17%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA- 426
G V+ A+K+ + E + L +
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 427 -------------------------VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDER 461
N ++ S L L D V
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGD 190
Query: 462 L----RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517
+ + + L + +VH NL + + + D
Sbjct: 191 EGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG--- 245
Query: 518 ISSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---- 570
+ A+ P AP + + G+ ++ + L P+ TP
Sbjct: 246 -TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 571 ---VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616
+ G + V LI + R MET
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 67/256 (26%), Positives = 99/256 (38%), Gaps = 54/256 (21%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+GS+G V A + A+KI+ I Q +D + EV +MK L HPNI L
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV-ERIKTEVRLMKKLHHPNIARLY 94
Query: 425 GAVTEPPNLSIVTEYLSRGSLY-------------------------------------K 447
+ + +V E G L
Sbjct: 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 448 LLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVC 505
V E+L N+ + ++YLH + I HRD+K N L + ++ +K+
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLV 212
Query: 506 DFGLSR----SKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITL 559
DFGLS+ Y T AGTP ++APEVL + K D +S GV+L L+
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
Query: 560 QKPWRNSTPSQVISAV 575
P+ + IS V
Sbjct: 273 AVPFPGVNDADTISQV 288
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 60/248 (24%), Positives = 117/248 (47%), Gaps = 20/248 (8%)
Query: 372 GSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAVT 428
G TVY AE N VA+K + ++ + F REV L H NIV ++
Sbjct: 22 GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
E +V EY+ +L + + + + +N + G+ + H R IVHRD
Sbjct: 82 EDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRD 136
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
+K N+L+DS T+K+ DFG++++ T + + GT ++ +PE + + ++E +D++
Sbjct: 137 IKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIY 196
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK-------NVNPMVAALIETCW 600
S G++L+E++ + P+ T ++ K + +P ++ ++ +I
Sbjct: 197 SIGIVLYEMLVGEPPFNGETA----VSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRAT 252
Query: 601 AEEPEIRP 608
++ R
Sbjct: 253 EKDKANRY 260
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-32
Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 26/256 (10%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMGAV 427
G+FG V + VAVKIL Q+ + RE+ +K RHP+I+ L +
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLHQRRPP 483
+ P ++ +V EY+S G L+ + + RL + + G++Y H+
Sbjct: 86 STPSDIFMVMEYVSGGELF-------DYICKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEVLREDP- 539
+VHRDLK N+L+D+ K+ DFGLS N +T+ G+P + APEV+
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
+ + D++S GVIL+ L+ P+ + + + P+ +NP V +L++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVISLLKHM 250
Query: 600 WAEEPEIRPSFPSIME 615
+P R + I E
Sbjct: 251 LQVDPMKRATIKDIRE 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 54/255 (21%), Positives = 100/255 (39%), Gaps = 36/255 (14%)
Query: 372 GSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAV- 427
G G VY AE R VA+K++ E + F+ RE L+ P++V +
Sbjct: 45 GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV----PIH 100
Query: 428 ---TEPPNLSIVTEYLSRGSLYKLLH----IPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
L + ++ L +L + R V + + ++ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAV-------AIVRQIGSALDAAHAA 153
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAPEVLREDP 539
HRD+K N+LV + + DFG++ + + + GT +MAPE E
Sbjct: 154 G--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK------NVNPMVA 593
+ ++D+++ +L+E +T P++ S + + + IP+ +
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-----NQAIPRPSTVRPGIPVAFD 266
Query: 594 ALIETCWAEEPEIRP 608
A+I A+ PE R
Sbjct: 267 AVIARGMAKNPEDRY 281
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 49/194 (25%), Positives = 80/194 (41%), Gaps = 24/194 (12%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA- 426
G G V R + A+K+L + +EV P+IV ++
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 427 ---VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMNYLHQRRP 482
L I+ E + G L+ I + ER + D+ + +LH
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN- 148
Query: 483 PIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 539
I HRD+K NLL S +K+ DFG ++ + +T TP ++APEVL +
Sbjct: 149 -IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAPEVLGPEK 205
Query: 540 SNEKSDVFSFGVIL 553
++ D++S GVI+
Sbjct: 206 YDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 25/195 (12%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA- 426
G G V + + A+K+L + REV + + P+IV ++
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 427 ---VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMNYLHQRRP 482
L IV E L G L+ I D ER + + + + YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 181
Query: 483 PIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 538
I HRD+K NLL S +K+ DFG ++ + + T TP ++APEVL +
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPEVLGPE 238
Query: 539 PSNEKSDVFSFGVIL 553
++ D++S GVI+
Sbjct: 239 KYDKSCDMWSLGVIM 253
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 16/253 (6%)
Query: 354 QNPSGPSTHVIDSSNFIK----GSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFL 406
Q P P + F K GSF TV A + A+KIL ++ E++
Sbjct: 19 QPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 78
Query: 407 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 466
RE +M L HP V L + L Y G L L +I + R
Sbjct: 79 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYT 136
Query: 467 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-- 524
A ++ + YLH + I+HRDLK N+L++ +++ DFG ++ ++ +
Sbjct: 137 A-EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 584
GT ++++PE+L E + + SD+++ G I+++L+ P+R + + +
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDF 251
Query: 585 PKNVNPMVAALIE 597
P+ P L+E
Sbjct: 252 PEKFFPKARDLVE 264
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 69/254 (27%), Positives = 120/254 (47%), Gaps = 27/254 (10%)
Query: 372 GSFGTVYHAEWR--NSDVAVKILIEQEFHEDR-FKE-FLREVAIMKGLRHPNIVLL--MG 425
G V+ A + DVAVK+L + D F F RE L HP IV + G
Sbjct: 23 GGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81
Query: 426 AVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
P IV EY+ +L ++H + + + + D + +N+ HQ
Sbjct: 82 EAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG-- 136
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPS 540
I+HRD+K N+++ +T VKV DFG++R N+ + GT ++++PE R D
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP------KNVNPMVAA 594
+ +SDV+S G +L+E++T + P+ +P +V ++ R + + ++ + A
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPIPPSARHEGLSADLDA 252
Query: 595 LIETCWAEEPEIRP 608
++ A+ PE R
Sbjct: 253 VVLKALAKNPENRY 266
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 53/259 (20%), Positives = 93/259 (35%), Gaps = 38/259 (14%)
Query: 372 GSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAV 427
G G +Y A RN + V +K L+ + + + E + + HP+IV + V
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFV 148
Query: 428 TEPPNLS-----IVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
IV EY+ SL + +P A + ++ ++YLH
Sbjct: 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA-------IAYLLEILPALSYLHSI 201
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
+V+ DLK N+++ +K+ D G + GTP + APE++R P+
Sbjct: 202 G--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTGPT 254
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
+D+++ G L L + L+ L+
Sbjct: 255 -VATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTY----DSYGRLLRRAI 305
Query: 601 AEEPEIRPSFPSIMETLQQ 619
+P R F + E Q
Sbjct: 306 DPDPRQR--FTTAEEMSAQ 322
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEF-----LREVAIMKGLRHPNIVLLM 424
GS+G V+ R++ VA+K +F E LRE+ ++K L+HPN+V L+
Sbjct: 14 GSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
L +V EY ++ L + V E L ++ + + +N+ H+
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELD--RYQRGVPEHLVKSITWQTLQAVNFCHKHN--C 123
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLREDP 539
+HRD+K N+L+ +K+CDFG +R ++ + E W +PE+L D
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 540 SNEKS-DVFSFGVILWELITLQ 560
DV++ G + EL++
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 36/208 (17%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLL 423
G++GTV+ A+ R + VA+K + ++ + E LRE+ ++K L+H NIV L
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRL 66
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+ L++V E+ + L K +D + + + + KG+ + H R
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-APEVL 535
++HRDLK NLL++ +K+ +FGL+R+ Y + E W P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--------SAEVVTLWYRPPDVL 173
Query: 536 REDPS-NEKSDVFSFGVILWELITLQKP 562
+ D++S G I EL +P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 76/359 (21%), Positives = 156/359 (43%), Gaps = 20/359 (5%)
Query: 260 LEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDD 319
+D P ++ + + + P + ++ + + + ++ +P+ + ++
Sbjct: 42 PQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVE--TPE-EREE 98
Query: 320 DPSGTAIDQDYKPDPQALFQRASWNVTADRD--LQMQNPSGPSTHVIDSSNFI------K 371
+ D A +D +M+ H + + F K
Sbjct: 99 WTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGK 158
Query: 372 GSFGTVYHAEWRNSDV--AVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+FG V + + + A+KIL ++ +D L E +++ RHP + L +
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L V EY + G L+ H+ RV ++R R A ++ ++YLH + +V+RD
Sbjct: 219 THDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN-VVYRD 274
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
LK NL++D +K+ DFGL + + KT GTPE++APEVL ++ D +
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 334
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
GV+++E++ + P+ N ++ + + + P+ + P +L+ ++P+ R
Sbjct: 335 LGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 372 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEF-----LREVAIMKGLRHPNIVLLM 424
GS+G V +++ VA+K +F E + +RE+ ++K LRH N+V L+
Sbjct: 36 GSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ +V E++ ++ L +D ++ + + G+ + H I
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLE--LFPNGLDYQVVQKYLFQIINGIGFCHSHN--I 145
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE----WM-APEVLR 536
+HRD+K N+LV + VK+CDFG +R + Y E W APE+L
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--------DDEVATRWYRAPELLV 197
Query: 537 EDPSNEKS-DVFSFGVILWELITLQ 560
D K+ DV++ G ++ E+ +
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 34/207 (16%)
Query: 371 KGSFGTVYHAEWRNSD-VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GSFG V+ A+ SD VA+K +L ++ F RE+ IM+ ++HPN+V L
Sbjct: 50 NGSFGVVFQAKLVESDEVAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLKAFFY 102
Query: 429 EPPN------LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
+ L++V EY+ ++Y+ H + + L Y + + + Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 482 PPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM-APEV 534
I HRD+K NLL+D + +K+ DFG ++ +PN YI S+ + APE+
Sbjct: 162 --ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-------YYRAPEL 212
Query: 535 -LREDPSNEKSDVFSFGVILWELITLQ 560
D++S G ++ EL+ Q
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 66/242 (27%), Positives = 117/242 (48%), Gaps = 14/242 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG+FG V + + A+KIL ++ D + E +++ RHP + L A
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L V EY + G L+ H+ RV +ER R A ++ + YLH R +V+R
Sbjct: 75 QTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSRD--VVYR 129
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPSNEKSD 545
D+K NL++D +K+ DFGL K + GTPE++APEVL ++ D
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 187
Query: 546 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 605
+ GV+++E++ + P+ N ++ + + + P+ ++P +L+ ++P+
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPK 245
Query: 606 IR 607
R
Sbjct: 246 QR 247
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-28
Identities = 58/233 (24%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G+FG V + +N+D A+KIL + + F+E E ++ I L
Sbjct: 84 RGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDSKWITTLH 140
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
A + NL +V +Y G L LL + R+ +E R +A ++ ++ +HQ
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLA-EMVIAIDSVHQLH--Y 196
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
VHRD+K N+L+D +++ DFG + + + S A GTP++++PE+L+ +
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 544 S-----DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591
D +S GV ++E++ + P+ + + + R + P V +
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 67/246 (27%), Positives = 121/246 (49%), Gaps = 17/246 (6%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KGSFG V + ++ A+K + +Q+ E + + +E+ IM+GL HP +V L +
Sbjct: 25 KGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ ++ +V + L G L H+ +E ++L + ++ ++YL +R I+HR
Sbjct: 85 QDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR--IIHR 139
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKS-- 544
D+K N+L+D V + DF ++ T T AGT +MAPE+ S
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 545 -DVFSFGVILWELITLQKPW--RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
D +S GV +EL+ ++P+ R+ST S+ I F+ + P + + +L++
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-FETTVVTYPSAWSQEMVSLLKKLLE 256
Query: 602 EEPEIR 607
P+ R
Sbjct: 257 PNPDQR 262
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 35/203 (17%)
Query: 372 GSFGTVYHAEWRNSD-VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLLM 424
G++G VY A+ VA+K I ++ E E +RE++++K L HPNIV L+
Sbjct: 32 GTYGVVYKAKDSQGRIVALKRIRLDAE------DEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ L++V E++ + L K+L + + + + Y + +G+ + HQ R I
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQHR--I 140
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-APEVLR 536
+HRDLK NLL++S +K+ DFGL+R+ +Y T E W AP+VL
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEVVTLWYRAPDVLM 192
Query: 537 EDPS-NEKSDVFSFGVILWELIT 558
+ D++S G I E+IT
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMIT 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 73/326 (22%), Positives = 139/326 (42%), Gaps = 15/326 (4%)
Query: 280 FVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQ 339
F+ S + V+ L + + + + Q ++
Sbjct: 256 FMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGT 315
Query: 340 RASWNVTADRDLQMQNPSGPSTHVIDSSNFI----KGSFGTVYHAEWRNSD--VAVKILI 393
+A TA+ + N + NF+ KGSFG V +E + +D AVKIL
Sbjct: 316 KAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 394 EQEFHEDRFKEFLR-EVAIM-KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 451
+ +D E E ++ + P + L L V EY++ G L HI
Sbjct: 376 KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM--YHI 433
Query: 452 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511
+ A ++A G+ +L + I++RDLK N+++DS +K+ DFG+ +
Sbjct: 434 QQVGRFKEPHAVFYAA-EIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK 490
Query: 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 571
+++KT GTP+++APE++ P + D ++FGV+L+E++ Q P+ ++
Sbjct: 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550
Query: 572 ISAVGFKGRRLEIPKNVNPMVAALIE 597
++ + PK+++ A+ +
Sbjct: 551 FQSIMEH--NVAYPKSMSKEAVAICK 574
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 39/207 (18%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLL 423
G F TVY A +N++ VA+K I + H K+ LRE+ +++ L HPNI+ L
Sbjct: 21 GQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+ A N+S+V +++ L ++ D +V+ +G+ YLHQ
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-APEVL 535
I+HRDLK NLL+D +K+ DFGL++S Y T + W APE+L
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------THQVVTRWYRAPELL 184
Query: 536 ---RE-DPSNEKSDVFSFGVILWELIT 558
R D+++ G IL EL+
Sbjct: 185 FGARMYGVG---VDMWAVGCILAELLL 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 35/203 (17%)
Query: 372 GSFGTVYHAEWR-NSDVAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLLM 424
G++G VY A+ A+K I +E+E E +RE++I+K L+H NIV L
Sbjct: 13 GTYGVVYKAQNNYGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNIVKLY 66
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
+ L +V E+L + L KLL ++ + + G+ Y H RR +
Sbjct: 67 DVIHTKKRLVLVFEHLDQ-DLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRR--V 121
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-APEVLR 536
+HRDLK NLL++ +K+ DFGL+R+ Y T E W AP+VL
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--------THEIVTLWYRAPDVLM 173
Query: 537 EDPS-NEKSDVFSFGVILWELIT 558
+ D++S G I E++
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVN 196
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 35/208 (16%)
Query: 371 KGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
GSFG VY A+ +S VA+K +L ++ RFK RE+ IM+ L H NIV L
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFK--NRELQIMRKLDHCNIVRLRYFF 116
Query: 428 TEPPN------LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
L++V +Y+ ++Y++ H A+ + Y + + + Y+H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 481 RPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM-APE 533
I HRD+K NLL+D T +K+CDFG ++ +PN YI S+ + APE
Sbjct: 176 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-------YYRAPE 226
Query: 534 V-LREDPSNEKSDVFSFGVILWELITLQ 560
+ DV+S G +L EL+ Q
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 50/232 (21%), Positives = 100/232 (43%), Gaps = 15/232 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G+F V + + + A+KI+ + + F E ++ I L A
Sbjct: 71 RGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ L +V EY G L LL R+ + R +A ++ ++ +H+ VHR
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MARFYLA-EIVMAIDSVHRLG--YVHR 186
Query: 488 DLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS-- 544
D+K N+L+D +++ DFG + + + + S A GTP++++PE+L+ +
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 545 -----DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591
D ++ GV +E+ Q P+ + ++ + L +P +
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 50/235 (21%)
Query: 352 QMQNPSGPSTHVIDSSNFIK------GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRF 402
M + PS ID + + G++G VY A ++ VA+K I +E E
Sbjct: 21 SMSVSAAPSATSID--RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE------ 72
Query: 403 KE-----FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 457
+E +REV+++K L+H NI+ L + L ++ EY L K + D
Sbjct: 73 EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPD 128
Query: 458 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLSRS 512
V R+ + Y + G+N+ H RR +HRDLK NLL+ + +K+ DFGL+R+
Sbjct: 129 VSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
Query: 513 K---PNTYISSKTAAGTPE----WM-APEVLREDPS-NEKSDVFSFGVILWELIT 558
+ T E W PE+L + D++S I E++
Sbjct: 187 FGIPIRQF--------THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 70/246 (28%), Positives = 115/246 (46%), Gaps = 21/246 (8%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIM-KGLRHPNIVLL 423
KGSFG V+ AE++ ++ A+K L + + D + + E ++ HP + +
Sbjct: 27 KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
NL V EYL+ G L HI R A ++ G+ +LH +
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLM--YHIQSCHKFDLSRATFYAA-EIILGLQFLHSKG-- 138
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPSN 541
IV+RDLK N+L+D +K+ DFG+ K N +KT GTP+++APE+L N
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQKYN 196
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601
D +SFGV+L+E++ Q P+ ++ ++ P+ + L+ +
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFV 254
Query: 602 EEPEIR 607
EPE R
Sbjct: 255 REPEKR 260
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 18/274 (6%)
Query: 331 KPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIK----GSFGTVYHAEWRNSD 386
K Q + D + + PS + +D + IK GSFG V + + S
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 387 --VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 443
A+KIL +Q+ + + E L E I++ + P +V L + + NL +V EY++ G
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 444 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 503
++ H+ + R A + YLH +++RDLK NLL+D ++
Sbjct: 127 EMF--SHLRRIGRFSEPHARFYAA-QIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 504 VCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 563
V DFG ++ + T GTPE +APE++ N+ D ++ GV+++E+ P+
Sbjct: 182 VTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 564 RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
P Q+ + ++ P + + + L+
Sbjct: 239 FADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLR 270
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 64/262 (24%), Positives = 125/262 (47%), Gaps = 22/262 (8%)
Query: 349 RDLQMQNPSGPSTHVIDSSNFI------KGSFGTVYHAEWRNSDV-----AVKILIEQEF 397
+++ + + D S F +GSFG V+ + + A+K+L +
Sbjct: 6 KEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL 65
Query: 398 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 457
E I+ + HP IV L A L ++ ++L G L+ + +
Sbjct: 66 KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF--TRLSKEVMF 123
Query: 458 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517
+E ++ +A ++A +++LH I++RDLK N+L+D +K+ DFGLS K +
Sbjct: 124 TEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLS--KESID 178
Query: 518 ISSKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 575
K + GT E+MAPEV+ + +D +SFGV+++E++T P++ + ++ +
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238
Query: 576 GFKGRRLEIPKNVNPMVAALIE 597
+L +P+ ++P +L+
Sbjct: 239 LKA--KLGMPQFLSPEAQSLLR 258
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G FG V+ + + + A K L +++ ++ + E I+ + IV L
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLNKKRLKKR---KGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 425 GAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQRRP 482
A +L +V ++ G + Y + ++ + E R A + G+ +LHQR
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLHQRN- 309
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
I++RDLK N+L+D V++ D GL+ +K AGTP +MAPE+L + +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 543 KSDVFSFGVILWELITLQKPWRN 565
D F+ GV L+E+I + P+R
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRA 391
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 29/200 (14%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
G++ TVY + + +D VA+K I +E HE+ +REV+++K L+H NIV L +
Sbjct: 13 GTYATVYKGKSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+L++V EYL + L + L D +++ + + +G+ Y H+++ ++HR
Sbjct: 70 HTEKSLTLVFEYLDK-DLKQYLD--DCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHR 124
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-APEVLREDP 539
DLK NLL++ +K+ DFGL+R+K TY E W P++L
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTY--------DNEVVTLWYRPPDILLGST 176
Query: 540 S-NEKSDVFSFGVILWELIT 558
+ + D++ G I +E+ T
Sbjct: 177 DYSTQIDMWGVGCIFYEMAT 196
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKEF----LREVAIMKGLR---HPNIV 421
G++GTVY A +S VA+K + + +REVA+++ L HPN+V
Sbjct: 20 GAYGTVYKARDPHSGHFVALKSVRVPNG--GGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 422 LLMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 476
LM +++V E++ + L L + E ++ M +G+++
Sbjct: 78 RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM-RQFLRGLDF 135
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPE----WM 530
LH IVHRDLK N+LV S TVK+ DFGL+R S TP W
Sbjct: 136 LHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVVVTLWY 185
Query: 531 -APEVLREDPSNEKSDVFSFGVILWELIT 558
APEVL + D++S G I E+
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 22/231 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+G+FG V +++ A+K+L + E F E IM P +V L A
Sbjct: 79 RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 138
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA--Y--DVAKGMNYLHQRRPP 483
+ L +V EY+ G L L+ + + A Y +V ++ +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMS--------NYDVPEKWARFYTAEVVLALDAIHSMG-- 188
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
+HRD+K N+L+D + +K+ DFG + + TA GTP++++PEVL+ +
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 543 K----SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589
D +S GV L+E++ P+ + S + L P + +
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 44/210 (20%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLL 423
G++ TVY + + VA+K + ++ E E +RE+++MK L+H NIV L
Sbjct: 16 GTYATVYKGLNKTTGVYVALKEVKLDSE-------EGTPSTAIREISLMKELKHENIVRL 68
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA------YDVAKGMNYL 477
+ L++V E++ L K + D+R V + L + + + +G+ +
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM 530
H+ + I+HRDLK NLL++ +K+ DFGL+R+ NT+ + E W
Sbjct: 125 HENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--------SSEVVTLWY 174
Query: 531 -APEVLREDPS-NEKSDVFSFGVILWELIT 558
AP+VL + + D++S G IL E+IT
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 68/272 (25%), Positives = 124/272 (45%), Gaps = 19/272 (6%)
Query: 346 TADRDLQMQNPSGPSTHVIDSSNFI----KGSFGTVYHAEWRNSD--VAVKILIEQEFHE 399
T + + N + NF+ KGSFG V +E + +D AVKIL + +
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 400 -DRFKEFLREVAIM-KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 457
D + + E ++ + P + L L V EY++ G L HI
Sbjct: 61 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRF 118
Query: 458 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517
+ A ++A G+ +L + I++RDLK N+++DS +K+ DFG+ K N +
Sbjct: 119 KEPHAVFYAA-EIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC--KENIW 173
Query: 518 ISSKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 575
T GTP+++APE++ P + D ++FGV+L+E++ Q P+ ++ ++
Sbjct: 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233
Query: 576 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
+ PK+++ A+ + + P R
Sbjct: 234 MEH--NVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 15/243 (6%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLR-EVAIM-KGLRHPNIVLLMGA 426
KGSFG V A + +V AVK+L ++ + + ++ + E ++ K ++HP +V L +
Sbjct: 48 KGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L V +Y++ G L+ H+ R ++ R R A ++A + YLH IV+
Sbjct: 108 FQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLHSLN--IVY 162
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPSNEKS 544
RDLK N+L+DS + + DFGL K N +S T+ GTPE++APEVL + P +
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTV 220
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
D + G +L+E++ P+ + +++ + K L++ N+ L+E ++
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDR 278
Query: 605 EIR 607
R
Sbjct: 279 TKR 281
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
KG FG V + R + A K L I++ L E I++ + +V L
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKQILEKVNSRFVVSLA 250
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
A L +V ++ G L ++ + R A ++ G+ LH+ R I
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRER--I 307
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
V+RDLK N+L+D +++ D GL+ P + K GT +MAPEV++ +
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 545 DVFSFGVILWELITLQKPWRN 565
D ++ G +L+E+I Q P++
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQ 387
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 64/266 (24%), Positives = 117/266 (43%), Gaps = 18/266 (6%)
Query: 310 NHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNF 369
H K + D I++ + +FQ+ + R Q +N ++ +
Sbjct: 134 GHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSV 193
Query: 370 I----KGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPN 419
+G FG VY ++ A+K L I+ + E ++++ P
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 420 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
IV + A P LS + + ++ G L+ H+ V + +R A ++ G+ ++H
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEADMRFYAA-EIILGLEHMHN 310
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 539
R +V+RDLK N+L+D V++ D GL+ + GT +MAPEVL++
Sbjct: 311 RF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGV 366
Query: 540 SNEKS-DVFSFGVILWELITLQKPWR 564
+ + S D FS G +L++L+ P+R
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFR 392
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 15/243 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIM-KGLRHPNIVLLMGA 426
KGSFG V A + + AVK+L + +D E E I+ HP + L
Sbjct: 33 KGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
P L V E+++ G L HI +R + R R A ++ + +LH + I++
Sbjct: 93 FQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALMFLHDKG--IIY 147
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPSNEKS 544
RDLK N+L+D K+ DFG+ K TA GTP+++APE+L+E
Sbjct: 148 RDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYGPAV 205
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
D ++ GV+L+E++ P+ + A+ + P ++ ++++ + P
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDATGILKSFMTKNP 263
Query: 605 EIR 607
+R
Sbjct: 264 TMR 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIM-KGLRHPNIVLLMGA 426
+GS+ V + +D A+K++ ++ ++ + E + + HP +V L
Sbjct: 19 RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L V EY++ G L + H+ R + +E R A +++ +NYLH+R I++
Sbjct: 79 FQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--IIY 133
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPSNEKS 544
RDLK N+L+DS +K+ D+G+ K T+ GTP ++APE+LR +
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 191
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQ 570
D ++ GV+++E++ + P+ S
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 371 KGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIM-KGLRHPNIVLLMGA 426
+GS+ V + +D A++++ ++ ++ + E + + HP +V L
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
L V EY++ G L + H+ R + +E R A +++ +NYLH+R I++
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--IIY 176
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPSNEKS 544
RDLK N+L+DS +K+ D+G+ K T+ GTP ++APE+LR +
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 234
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQ 570
D ++ GV+++E++ + P+ S
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 44/212 (20%)
Query: 372 GSFGTVYHA-EWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLR---HPN 419
G++G V+ A + +N VA+K + ++ +E +REVA+++ L HPN
Sbjct: 22 GAYGKVFKARDLKNGGRFVALKRVRVQTG------EEGMPLSTIREVAVLRHLETFEHPN 75
Query: 420 IVLLMGAVT-----EPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKG 473
+V L T L++V E++ + L L +P V +M + + +G
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP--EPGVPTETIKDMMFQLLRG 132
Query: 474 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPE--- 528
+++LH R +VHRDLK N+LV S+ +K+ DFGL+R S T
Sbjct: 133 LDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TSVVVT 182
Query: 529 -WM-APEVLREDPSNEKSDVFSFGVILWELIT 558
W APEVL + D++S G I E+
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 58/230 (25%), Positives = 113/230 (49%), Gaps = 13/230 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGAV 427
GSFG V+ R++ A+K+L ++ + E E ++ + HP I+ + G
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ + ++ +Y+ G L+ + ++ + + A +V + YLH + I++R
Sbjct: 76 QDAQQIFMIMDYIEGGELF--SLLRKSQRFPNPVAKFYAA-EVCLALEYLHSKD--IIYR 130
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DLK N+L+D +K+ DFG ++ P+ + T GTP+++APEV+ P N+ D +
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWW 187
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
SFG++++E++ P+ +S + + L P N V L+
Sbjct: 188 SFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLS 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/238 (25%), Positives = 115/238 (48%), Gaps = 22/238 (9%)
Query: 371 KGSFGTVY---HAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIV 421
KG +G V+ N+ A+K+L I + + E I++ ++HP IV
Sbjct: 27 KGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKAERNILEEVKHPFIV 84
Query: 422 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
L+ A L ++ EYLS G L+ + + + +++ +A +++ + +LHQ+
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELF--MQLEREGIFMEDTACFYLA-EISMALGHLHQKG 141
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDP 539
I++RDLK N++++ VK+ DFGL K + + + T GT E+MAPE+L
Sbjct: 142 --IIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597
N D +S G ++++++T P+ + I + +L +P + L++
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQEARDLLK 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 45/234 (19%)
Query: 355 NPSGPSTHVIDSSNFIK----GSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLR 407
S +D + G+FGTV + + VA+K + + RF+ R
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFR--NR 65
Query: 408 EVAIMKGLR---HPNIVLLMGAVTEPPN--------LSIVTEYLSRGSLYKLL-HIPDAR 455
E+ IM+ L HPNIV L + L++V EY+ +L++ + +
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ 123
Query: 456 VVVDERL-RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRS- 512
V L ++ + + + + + LH + HRD+K N+LV+ + T+K+CDFG ++
Sbjct: 124 VAPPPILIKVFL-FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 513 ---KPNT-YISSKTAAGTPEWM-APEVLREDPSNEKS-DVFSFGVILWELITLQ 560
+PN YI S+ + APE++ + + D++S G I E++ +
Sbjct: 183 SPSEPNVAYICSR-------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 372 GSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPNIVLL 423
G+FG V+ A R + VA+K +L+E E KE F LRE+ I++ L+H N+V L
Sbjct: 28 GTFGEVFKARHRKTGQKVALKKVLMENE------KEGFPITALREIKILQLLKHENVVNL 81
Query: 424 MGAVTEP--------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475
+ ++ +V ++ L LL V + + G+
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLY 138
Query: 476 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM- 530
Y+H+ + I+HRD+K+ N+L+ +K+ DFGL+R+ + +S+ T W
Sbjct: 139 YIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPNRYTNRVVTLWYR 195
Query: 531 APEVLREDPS-NEKSDVFSFGVILWELITLQKP 562
PE+L + D++ G I+ E+ T + P
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 44/201 (21%), Positives = 69/201 (34%), Gaps = 58/201 (28%)
Query: 371 KGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA- 426
G G V + + A+K+L + REV + + P+IV ++
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 427 ---VTEPPNLSIVTEYLSRGSLY----KLLHIP----DARVVVDERLRLNMAYDVAKGMN 475
L IV E L G L+ +A ++ + + +
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------KSIGEAIQ 131
Query: 476 YLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 532
YLH I HRD+K NLL S +K+ DFG A
Sbjct: 132 YLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AK 168
Query: 533 EVLREDPSNEKSDVFSFGVIL 553
E E ++ D++S GVI+
Sbjct: 169 ETTGE-KYDKSCDMWSLGVIM 188
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 29/246 (11%), Positives = 69/246 (28%), Gaps = 42/246 (17%)
Query: 372 GSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAVT 428
+ A + VA+ + Q D + L + + P + ++ V
Sbjct: 42 VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+V E++ GSL ++ D +R +A + H+ +
Sbjct: 102 TRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIR--AMQSLAAAADAAHRA--GVALSI 154
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+ V V + +N + D+
Sbjct: 155 DHPSRVRVSIDGDVVLAYPATMP---------------------------DANPQDDIRG 187
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGF-KGRRLEIPKNVNPMV----AALIETCWAEE 603
G L+ L+ + P + ++ + P +++ + +A+ +
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247
Query: 604 PEIRPS 609
IR +
Sbjct: 248 GGIRSA 253
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431
G++G VY A+ ++ ++Q RE+A+++ L+HPN++ L
Sbjct: 32 GTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA 91
Query: 432 NLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMA------YDVAKGMNYLHQRRPP 483
+ + + +Y L+ ++ A + ++L Y + G++YLH
Sbjct: 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148
Query: 484 IVHRDLKSPNLLVDSTY----TVKVCDFGLSR--SKP-NTYISSKTAAGTPE----WM-A 531
++HRDLK N+LV VK+ D G +R + P A P W A
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-----ADLDPVVVTFWYRA 203
Query: 532 PEVLREDPSNEKS-DVFSFGVILWELITLQ 560
PE+L K+ D+++ G I EL+T +
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 24/205 (11%)
Query: 371 KGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEF---------LREVAIMKGLRHPNI 420
GS+G V + VA+K + LRE+ ++ HPNI
Sbjct: 32 SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 421 VLLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 474
+ L +VTE + L +++H V+ + ++ M Y + G+
Sbjct: 92 LGLRDIFV-HFEEPAMHKLYLVTELMRT-DLAQVIHDQRI-VISPQHIQYFM-YHILLGL 147
Query: 475 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 534
+ LH+ +VHRDL N+L+ + +CDF L+R + + APE+
Sbjct: 148 HVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRWYRAPEL 204
Query: 535 LREDPSNEKS-DVFSFGVILWELIT 558
+ + K D++S G ++ E+
Sbjct: 205 VMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 65/320 (20%), Positives = 134/320 (41%), Gaps = 52/320 (16%)
Query: 308 IDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHV-IDS 366
+ +H + + SG A +T +L+ N +G + V I++
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQL-----LTVKHELRTANLTGHAEKVGIEN 55
Query: 367 SNFI----KGSFGTVYHAEWRNSDV-----AVKIL-----------IEQEFHEDRFKEFL 406
+ G++G V+ + A+K+L E E ++ L
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE---RQVL 112
Query: 407 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 466
+ + P +V L A L ++ +Y++ G L+ H+ + +++ +
Sbjct: 113 EHIR-----QSPFLVTLHYAFQTETKLHLILDYINGGELF--THLSQRERFTEHEVQIYV 165
Query: 467 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-- 524
++ + +LH+ I++RD+K N+L+DS V + DFGL SK ++ A
Sbjct: 166 G-EIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL--SKEFVADETERAYDF 220
Query: 525 -GTPEWMAPEVLREDPSNEKSDV--FSFGVILWELITLQKPW----RNSTPSQVISAVGF 577
GT E+MAP+++R S V +S GV+++EL+T P+ ++ +++ +
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
Query: 578 KGRRLEIPKNVNPMVAALIE 597
P+ ++ + LI+
Sbjct: 281 S--EPPYPQEMSALAKDLIQ 298
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
G+ G V A +VA+K + + F K RE+ +MK + H NI+ L+
Sbjct: 35 SGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 93
Query: 428 TEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
T +L IV E + +L +++ + + ER+ + Y + G+ +LH
Sbjct: 94 TPQKSLEEFQDVYIVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCGIKHLHSAG 147
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 541
I+HRDLK N++V S T+K+ DFGL+R+ +++ + T + APEV+
Sbjct: 148 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYK 204
Query: 542 EKSDVFSFGVILWELIT 558
E D++S G I+ E+I
Sbjct: 205 ENVDIWSVGCIMGEMIK 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 33/205 (16%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAV 427
+G + V+ A ++ V VKIL + K+ RE+ I++ LR PNI+ L V
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 428 TEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+P ++V E+++ +L + D +R M Y++ K ++Y H I+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYM-YEILKALDYCHSMG--IM 152
Query: 486 HRDLKSPNLLVDSTY-TVKVCDFGLSRSKP-----NTYISSKTAAGTPEWM-APEVLRED 538
HRD+K N+++D + +++ D+GL+ N ++S+ + PE+L +
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR-------YFKGPELLVDY 205
Query: 539 PSNEKS-DVFSFGVILWELITLQKP 562
+ S D++S G +L +I ++P
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 371 KGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
+G++G V A + VA+K + + F + F LRE+ I+K +H NI+ +
Sbjct: 21 EGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 428 TEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
P + I+ E + L++++ +++ D+ ++ + Y + + LH
Sbjct: 79 R-PDSFENFNEVYIIQELMQT-DLHRVIS---TQMLSDDHIQYFI-YQTLRAVKVLHGSN 132
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----------A 531
++HRDLK NLL++S +KVCDFGL+R + + G M A
Sbjct: 133 --VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 532 PEVLREDPS-NEKSDVFSFGVILWELIT 558
PEV+ + DV+S G IL EL
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 29/202 (14%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
G+ G V A D VA+K + + F K RE+ +MK + H NI+ L+
Sbjct: 72 SGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 130
Query: 428 TEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
T L +V E + +L +++ + + ER+ + Y + G+ +LH
Sbjct: 131 TPQKTLEEFQDVYLVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCGIKHLHSAG 184
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM-----APEVLR 536
I+HRDLK N++V S T+K+ DFGL+R+ +++ TP + APEV+
Sbjct: 185 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRYYRAPEVIL 236
Query: 537 EDPSNEKSDVFSFGVILWELIT 558
E D++S G I+ E++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVR 258
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 28/201 (13%)
Query: 371 KGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G+V A + VA+K L E K RE+ ++K ++H N++ L+ T
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93
Query: 429 EPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
+L +V ++ L K++ + +E+++ + Y + KG+ Y+H
Sbjct: 94 PASSLRNFYDFYLVMPFMQT-DLQKIMGLK----FSEEKIQYLV-YQMLKGLKYIHSAG- 146
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEW-MAPEVLRED 538
+VHRDLK NL V+ +K+ DFGL+R Y+ ++ W APEV+
Sbjct: 147 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-------WYRAPEVILSW 198
Query: 539 PSNEKS-DVFSFGVILWELIT 558
++ D++S G I+ E++T
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLT 219
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 27/201 (13%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
G++G+V A VAVK + + F K RE+ ++K ++H N++ L+
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKK-LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 97
Query: 428 TEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
T +L +VT + L ++ + + D+ ++ + Y + +G+ Y+H
Sbjct: 98 TPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLI-YQILRGLKYIHSAD 152
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAPEVLRED 538
I+HRDLK NL V+ +K+ DFGL+R + Y++ T + APE++
Sbjct: 153 --IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA------TRWYRAPEIMLNW 204
Query: 539 PS-NEKSDVFSFGVILWELIT 558
N+ D++S G I+ EL+T
Sbjct: 205 MHYNQTVDIWSVGCIMAELLT 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 40/232 (17%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
+GS+G VY A +N++ VA+K + + F + K LRE+ I+ L+ I+ L +
Sbjct: 36 RGSYGYVYLAYDKNTEKNVAIK-KVNRMFEDLIDCKRILREITILNRLKSDYIIRLY-DL 93
Query: 428 TEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
P +L IV E L KL P + +E ++ + Y++ G N++H+
Sbjct: 94 IIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF--LTEEHIKTIL-YNLLLGENFIHESG 149
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----------- 530
I+HRDLK N L++ +VKVCDFGL+R+ + ++
Sbjct: 150 --IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 531 -----------APEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ 570
APE++ + + D++S G I EL+ + + N ++
Sbjct: 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 29/202 (14%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
G++G V A + VA+K + + F + F K RE+ ++K +RH N++ L+
Sbjct: 35 SGAYGAVCSAVDGRTGAKVAIK-KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF 93
Query: 428 TEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
T L +V ++ L KL+ + ++R++ + Y + KG+ Y+H
Sbjct: 94 TPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLV-YQMLKGLRYIHAAG 148
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWM-APEVLRE 537
I+HRDLK NL V+ +K+ DFGL+R + Y+ ++ W APEV+
Sbjct: 149 --IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-------WYRAPEVILN 199
Query: 538 DPSNEKS-DVFSFGVILWELIT 558
++ D++S G I+ E+IT
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMIT 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 69/241 (28%)
Query: 371 KGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL---- 423
GSFG V A+K +L + R+K RE+ IMK L H NI+ L
Sbjct: 17 TGSFGIVCEVFDIESGKRFALKKVLQDP-----RYK--NRELDIMKVLDHVNIIKLVDYF 69
Query: 424 ----------------------------MGAVTEPPN------LSIVTEYLSRGSLYKLL 449
+ N L+++ EY+ +L+K+L
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVL 128
Query: 450 -HIPDARVVV-DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCD 506
+ + + + + Y + + + ++H I HRD+K NLLV+S T+K+CD
Sbjct: 129 KSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 507 FGLSRS----KPNT-YISSKTAAGTPEWM-APEVLREDPS-NEKSDVFSFGVILWELITL 559
FG ++ +P+ YI S+ + APE++ D++S G + ELI
Sbjct: 186 FGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 560 Q 560
+
Sbjct: 239 K 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 45/236 (19%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
GS+G V A + VA+K I + F + K LRE+AI+ L H ++V ++ +
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIK-KILRVFEDLIDCKRILREIAILNRLNHDHVVKVL-DI 120
Query: 428 TEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 481
P ++ +V E KL P + + ++ + Y++ G+ Y+H
Sbjct: 121 VIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY--LTELHIKTLL-YNLLVGVKYVHSAG 176
Query: 482 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----------- 530
I+HRDLK N LV+ +VKVCDFGL+R+ + +P
Sbjct: 177 --ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 531 ----------------APEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPS 569
APE++ + ++ DV+S G I EL+ + K
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 56/243 (23%), Positives = 104/243 (42%), Gaps = 50/243 (20%)
Query: 352 QMQNPSGPSTHVIDSSNFI------------KGSFGTVYHA--EWRNSDVAVKILIEQEF 397
M + ++ F +G++G V A VA+K + F
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF 63
Query: 398 HEDRF-KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLH 450
+ + LRE+ I+ RH NI+ + + P + IV + + LYKLL
Sbjct: 64 EHQTYCQRTLREIKILLRFRHENIIGINDIIR-APTIEQMKDVYIVQDLME-TDLYKLLK 121
Query: 451 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510
+ + ++ + + Y + +G+ Y+H ++HRDLK NLL+++T +K+CDFGL+
Sbjct: 122 ---TQHLSNDHICYFL-YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 511 RSKPNTYISSKTAAGTPEWM----------APEVLREDPS-NEKSDVFSFGVILWELITL 559
R + ++ APE++ + D++S G IL E+++
Sbjct: 176 R-------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS- 227
Query: 560 QKP 562
+P
Sbjct: 228 NRP 230
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 371 KGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLR-HPNIVLLMGA 426
KG++G V+ + R VAVK I F + RE+ I+ L H NIV L+
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV 77
Query: 427 VTEPPNLS---IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+ N +V +Y+ L+ ++ A ++ + + Y + K + YLH
Sbjct: 78 LR-ADNDRDVYLVFDYME-TDLHAVIR---ANILEPVHKQYVV-YQLIKVIKYLHSGG-- 129
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM------------- 530
++HRD+K N+L+++ VKV DFGLSRS N + +
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 531 --------APEVLREDPS-NEKSDVFSFGVILWELIT 558
APE+L + D++S G IL E++
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
G G V+ A + D VA+K ++ + + K LRE+ I++ L H NIV + +
Sbjct: 21 CGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 428 TEPPNLS--------------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 473
+ IV EY+ L +L +++E RL M Y + +G
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFM-YQLLRG 132
Query: 474 MNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYISSKTAAG---TPEW 529
+ Y+H ++HRDLK NL +++ +K+ DFGL+R Y + T +
Sbjct: 133 LKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 530 MAPEVLREDPS-NEKSDVFSFGVILWELIT 558
+P +L + + D+++ G I E++T
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 371 KGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH------PNIVL 422
KGSFG V A + VA+K++ + ++ E+ I++ LR N++
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
++ T ++ + E LS +LY+L+ + +R A+ + + ++ LH+ R
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALHKNR- 220
Query: 483 PIVHRDLKSPN-LLVDSTYT-VKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVLRE 537
I+H DLK N LL + +KV DFG S + TYI S+ + APEV+
Sbjct: 221 -IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------YRAPEVILG 273
Query: 538 DPSNEKSDVFSFGVILWELIT 558
D++S G IL EL+T
Sbjct: 274 ARYGMPIDMWSLGCILAELLT 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 24/201 (11%)
Query: 371 KGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP------NIVL 422
KGSFG V A VA+KI+ + + EV +++ + IV
Sbjct: 64 KGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
L +L +V E LS +LY LL + R V R A + + +L
Sbjct: 121 LKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLATPEL 178
Query: 483 PIVHRDLKSPN-LLVDSTYT-VKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVLRE 537
I+H DLK N LL + + +K+ DFG S + YI S+ + +PEVL
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRSPEVLLG 232
Query: 538 DPSNEKSDVFSFGVILWELIT 558
P + D++S G IL E+ T
Sbjct: 233 MPYDLAIDMWSLGCILVEMHT 253
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 47/215 (21%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 371 KGSFGTVYHAE--WRNSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLR----------- 416
G F TV+ A+ N+ VA+KI+ + + E E+ +++ +
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLLQRVNDADNTKEDSMG 84
Query: 417 HPNIVLLMGAVT----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 472
+I+ L+ ++ +V E L +L L+ + R + ++ ++ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVK-QISKQLLL 142
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVD------STYTVKVCDFGLSRSKPN---TYISSKTA 523
G++Y+H RR I+H D+K N+L++ + +K+ D G + I ++
Sbjct: 143 GLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR-- 199
Query: 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 558
E+ +PEVL P +D++S +++ELIT
Sbjct: 200 ----EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 66/232 (28%)
Query: 371 KGSFGTVYHA--EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRH-----PNIVL 422
G+FG V AVK++ +++ E I+K +++ NIV
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNNIVK 100
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAYDVAKGM 474
G ++ ++ E L SLY+++ HI D + ++ K +
Sbjct: 101 YHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIK---------LYCIEILKAL 150
Query: 475 NYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------------VKVCDFG- 508
NYL + + H DLK N LL D + +K+ DFG
Sbjct: 151 NYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 509 --LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 558
+ I+++ + APEV+ + SD++SFG +L EL T
Sbjct: 209 ATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 49/228 (21%), Positives = 88/228 (38%), Gaps = 62/228 (27%)
Query: 371 KGSFGTVYHA---EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRHP------NI 420
+G+FG V S VA+KI+ ++ E E+ ++K ++
Sbjct: 29 EGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENKFLC 84
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAYDVAK 472
VL+ ++ I E L + + ++ L +P R +MAY +
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVR---------HMAYQLCH 134
Query: 473 GMNYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------VKVCDFG---LS 510
+ +LH+ + + H DLK N L V+S + ++V DFG
Sbjct: 135 ALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 558
T ++++ + PEV+ E + DV+S G IL+E
Sbjct: 193 HEHHTTIVATRH------YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 55/228 (24%), Positives = 85/228 (37%), Gaps = 62/228 (27%)
Query: 371 KGSFGTVYHA---EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRHP------NI 420
+G+FG V + VAVKI+ + E E+ +++ L
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNSTFRC 79
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAYDVAK 472
V ++ ++ IV E L S Y + + R MAY + K
Sbjct: 80 VQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIR---------KMAYQICK 129
Query: 473 GMNYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------VKVCDFG---LS 510
+N+LH + + H DLK N L V S YT +KV DFG
Sbjct: 130 SVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 558
+T +S++ + APEV+ ++ DV+S G IL E
Sbjct: 188 DEHHSTLVSTRH------YRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 1e-11
Identities = 32/183 (17%), Positives = 60/183 (32%), Gaps = 42/183 (22%)
Query: 371 KGSFGTVYHAEWRNSDVAVKIL------IEQEFHEDRFKEFLREVAIMKGL--------- 415
+G FG V+ ++ VA+KI+ + H+ F+E L E+ I K L
Sbjct: 30 EGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89
Query: 416 RHPNIVLLMGAV----TEPPNLSIVTEY--------------LSRGSLYKLLHIPDA--- 454
R + L + PP L ++ L+ +L
Sbjct: 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID 149
Query: 455 -----RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509
+ ++ + + + + + HRDL N+L+ T K+
Sbjct: 150 LEQMRTKLSSLATAKSILHQLTASL-AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLN 208
Query: 510 SRS 512
+S
Sbjct: 209 GKS 211
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 48/252 (19%), Positives = 88/252 (34%), Gaps = 76/252 (30%)
Query: 372 GSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----HPN---IV 421
G F TV+ + VA+K++ E + + E+ ++K +R PN +V
Sbjct: 48 GHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNREMVV 104
Query: 422 LLMGAVTEP-PN---LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 477
L+ N + +V E L L K + + + + ++ + V +G++YL
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDYL 162
Query: 478 HQRRPPIVHRDLKSPNLLV----------------------------------------- 496
H + I+H D+K N+L+
Sbjct: 163 H-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 497 --------DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
VK+ D G + K T T ++ + EVL N +D+
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGYNTPADI 276
Query: 547 FSFGVILWELIT 558
+S + +EL T
Sbjct: 277 WSTACMAFELAT 288
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 36/221 (16%), Positives = 74/221 (33%), Gaps = 28/221 (12%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
+G FG +Y A+ +S V + E+ + P + +
Sbjct: 45 QGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104
Query: 430 PPNLSIVTEYLS-----RGSLYKLLHIP-------DARVVVDERLRLNMAYDVAKGM--- 474
L + + S G Y+ + + +R ++ +
Sbjct: 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDI 164
Query: 475 -NYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNTYISSKTAA 524
Y+H+ VH D+K+ NLL++ +V D+GL+ K +
Sbjct: 165 LEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD 222
Query: 525 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 565
GT E+ + + + + D+ G + + +T PW +
Sbjct: 223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 46/220 (20%), Positives = 80/220 (36%), Gaps = 44/220 (20%)
Query: 371 KGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAV 427
G+FG + + + N VA+K+ E + R + E K L I +
Sbjct: 19 CGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYLHQRRPP 483
++V E L SL L + D L +A + Y+H +
Sbjct: 75 PCGKYNAMVLELLGP-SLEDLFDL------CDRTFSLKTVLMIAIQLISRMEYVHSKN-- 125
Query: 484 IVHRDLKSPNLLV-----DSTYTVKVCDFGLSRS--KPNT-----YISSKTAAGTPEWMA 531
+++RD+K N L+ + + + DF L++ P T Y K+ GT +M+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 532 P------EVLREDPSNEKSDVFSFGVILWELITLQKPWRN 565
E R D D+ + G + + PW+
Sbjct: 186 INTHLGKEQSRRD------DLEALGHMFMYFLRGSLPWQG 219
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 46/212 (21%), Positives = 78/212 (36%), Gaps = 30/212 (14%)
Query: 371 KGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAV 427
GSFG +Y +VA+K E + + + E I K ++ I +
Sbjct: 19 SGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
E +V E L SL L + + + L L A + + Y+H + +HR
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLL--ADQMISRIEYIHSKN--FIHR 129
Query: 488 DLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTA-----------AGTPEWMAPE 533
D+K N L+ V + DFGL++ Y ++T GT + +
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKK----YRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 534 VLREDPSNEKSDVFSFGVILWELITLQKPWRN 565
+ + D+ S G +L PW+
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 47/316 (14%), Positives = 92/316 (29%), Gaps = 70/316 (22%)
Query: 22 TEESYQLQLAMALRLSSQA--ASADDPHFLALSSCDRHTDSAETVSHR-----FWVNGCL 74
+E L L L Q + LS AE++ W +
Sbjct: 300 PDEVKSL-LLKYLDCRPQDLPREVLTTNPRRLSII------AESIRDGLATWDNWKHVNC 352
Query: 75 SYFDRILDGFYLIHGMDPYT-----WSIGTNQRDAGLIPP------------YKSLKAVD 117
I++ ++ ++P + A IP + V+
Sbjct: 353 DKLTTIIESS--LNVLEPAEYRKMFDRLSVFPPSA-HIPTILLSLIWFDVIKSDVMVVVN 409
Query: 118 PCNNLSIKVILIDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLA----NLVCNHMGGTT 173
+ S L++K + + + L L ++ E A+H+ N+
Sbjct: 410 KLHKYS----LVEKQPKESTISIPSIYLELKV-KLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 174 STEEEEFDKQW-SECAEHLKDC--------LNSVVLPIGSLSVGLCVHRALLFKVLADLI 224
D+ + S HLK+ V L L + H + + ++
Sbjct: 465 IPPYL--DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR-HDSTAWNASGSIL 521
Query: 225 NLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLED------PGVLSKPDSSLNRTAS 278
N ++ Y +D P E LV+ + D ++ + L R A
Sbjct: 522 NTLQQLKFYKPYICDND---------PKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
Query: 279 VFVSSPLYHPRFKAVE 294
+ ++ K V+
Sbjct: 573 MAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 42/412 (10%), Positives = 107/412 (25%), Gaps = 143/412 (34%)
Query: 235 KYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVE 294
+Y +D ++ + + +++ D S+ E
Sbjct: 15 QYQYKD-----ILSV-----FEDAFVDNFDCKDVQDM----PKSILSK-----------E 49
Query: 295 TVENI----RSLAKLYFIDNHSPKFD-LDDDPS-------GTAIDQDYKPDPQALFQRAS 342
+++I +++ + F L + +YK
Sbjct: 50 EIDHIIMSKDAVSGTLRL------FWTLLSKQEEMVQKFVEEVLRINYK----------- 92
Query: 343 WNVTADRDLQMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF 402
+ ++ + + + PS + I+ + + + ++ V K + + +
Sbjct: 93 FLMSPIKT-EQRQPSMMTRMYIEQRDRL-----------YNDNQVFAKYNVSRLQPYLKL 140
Query: 403 KEFLRE------VAI--MKG-----------------LRHPNIV--LLMGAVTEPPNLSI 435
++ L E V I + G + + L + P +
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP---IVHRDLKSP 492
+ + L D + +LR++ + L + +V ++++
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSS--NIKLRIHSIQAELR--RLLKSKPYENCLLVLLNVQNA 256
Query: 493 NLLVDSTYTVKVCDFG-----LSRSKPNT-YISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
+ +R K T ++S+ T L D E +
Sbjct: 257 K-------AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD---EVKSL 306
Query: 547 FS--FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596
+L P +V NP ++I
Sbjct: 307 LLKYLDCRPQDL-----------PREV--------------LTTNPRRLSII 333
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 48/212 (22%), Positives = 81/212 (38%), Gaps = 30/212 (14%)
Query: 371 KGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAV 427
GSFG +Y N +VA+K E + + + L E I + L+ I +
Sbjct: 17 SGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYLHQRRPP 483
E +V + L SL L + +L L +A M ++H +
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNF------CSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 484 IVHRDLKSPNLLV---DSTYTVKVCDFGLSRS--KPNT-----YISSKTAAGTPEWMAPE 533
+HRD+K N L+ V + DFGL++ +T Y +K GT + +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 534 VLREDPSNEKSDVFSFGVILWELITLQKPWRN 565
+ + D+ S G +L + PW+
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 43/218 (19%), Positives = 75/218 (34%), Gaps = 40/218 (18%)
Query: 371 KGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAV 427
+GSFG ++ N VA+K E + E K L I +
Sbjct: 20 EGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYLHQRRPP 483
E + +V + L SL LL + + + AK M +H++
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDL------CGRKFSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 484 IVHRDLKSPNLLVDSTYT-----VKVCDFGLSRSKPNTYISSKTAA-----------GTP 527
+V+RD+K N L+ + + V DFG+ + Y T GT
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF----YRDPVTKQHIPYREKKNLSGTA 182
Query: 528 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 565
+M+ + + D+ + G + + PW+
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 40/187 (21%), Positives = 67/187 (35%), Gaps = 33/187 (17%)
Query: 371 KGSFGTVYHAE--WRNSDVAVKIL-IE-----QEFHEDRFKEFLREVAIMKGLRHPNIVL 422
G FG +Y A + A ++ +E F E +F + + + +K +
Sbjct: 47 SGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD 106
Query: 423 LMG-------AVTEPPNLS---IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 472
+G +TE S +V E L L K+ + L + +
Sbjct: 107 YLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS---GQNGTFKKSTVLQLGIRMLD 162
Query: 473 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNTYISSKTA 523
+ Y+H+ VH D+K+ NLL+ +V D+GLS K K
Sbjct: 163 VLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 524 AGTPEWM 530
GT E+
Sbjct: 221 NGTIEFT 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 35/188 (18%), Positives = 65/188 (34%), Gaps = 32/188 (17%)
Query: 371 KGSFGTVYHAE----------WRNSDVAVKI-------LIEQEFHEDRFKEF-LREVAIM 412
+ + G +Y A + ++K+ EQ F + K + + +
Sbjct: 52 RDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKL 111
Query: 413 KGLRHPNIVLLMG-AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 471
I MG V + +V L R SL L + + V+ ER L +A +
Sbjct: 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSP-KHVLSERSVLQVACRLL 169
Query: 472 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNTYISSKT 522
+ +LH+ VH ++ + N+ VD +V +G + S
Sbjct: 170 DALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227
Query: 523 AAGTPEWM 530
G E++
Sbjct: 228 HEGDLEFI 235
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 634 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.88 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 96.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.4 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.2 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.16 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.92 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 95.27 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.09 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 94.52 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.92 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 90.89 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.26 | |
| 2q3z_A | 687 | Transglutaminase 2; transglutaminase 2, tissue tra | 88.85 | |
| 1g0d_A | 695 | Protein-glutamine gamma-glutamyltransferase; tissu | 86.38 | |
| 1ex0_A | 731 | Coagulation factor XIII A chain; transglutaminase, | 82.46 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=447.60 Aligned_cols=251 Identities=27% Similarity=0.455 Sum_probs=219.9
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...+.||+|+||+||+|+++ +..||||++..........+++.+|+++|++++|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999987 4459999998887777777889999999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
||+||+|.+++..... ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+|+.......
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999964432 34789999999999999999999999 99999999999999999999999999987654332
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ...++++..+++++.+||.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHH
Confidence 33456799999999999999999999999999999999999999999998888777753 33456778899999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006703 599 CWAEEPEIRPSFPSIME 615 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~ 615 (634)
||..||++|||+.++++
T Consensus 260 ~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HTCSSGGGSCCHHHHHT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=434.72 Aligned_cols=258 Identities=35% Similarity=0.554 Sum_probs=221.7
Q ss_pred cceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
..+...++||+|+||+||+|++++ ..||||++... .....++|.+|+++|++++|||||++++++.+.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 567888999999999999998753 34999998654 345567899999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCC------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDA------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 501 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ 501 (634)
+||||||++|+|.++++.... ...+++..++.|+.||++||.|||+++ |+||||||+||||+.++.
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCc
Confidence 999999999999999965421 245899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 006703 502 VKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK 578 (634)
Q Consensus 502 ikL~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~ 578 (634)
+||+|||+|+..... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+....+. .
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-Q 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH-H
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c
Confidence 999999999865332 122345679999999999999999999999999999999999 899999999888877764 4
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 579 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 579 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
..+++.|..+++++.+|+.+||..||++|||+.+|++.|+.+.+.
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 556778899999999999999999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=434.44 Aligned_cols=260 Identities=33% Similarity=0.546 Sum_probs=226.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
...|+..++||+|+||+||+|++.+ ..||||++... .....++|.+|+++|++++|||||++++++.+++.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 3678889999999999999998752 34999998654 34456789999999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCC----------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcE
Q 006703 433 LSIVTEYLSRGSLYKLLHIPD----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 502 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~----------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~i 502 (634)
++||||||++|+|.++++... ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcE
Confidence 999999999999999996532 2345999999999999999999999999 9999999999999999999
Q ss_pred EEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 006703 503 KVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG 579 (634)
Q Consensus 503 kL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~ 579 (634)
||+|||+|+...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+. ..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-HT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 999999997543322 12334568999999999999999999999999999999998 899999999988887774 45
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+++.|..+++++.+|+.+||..||++|||+.+|++.|+++.+.+
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 567788899999999999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=430.05 Aligned_cols=257 Identities=37% Similarity=0.618 Sum_probs=215.4
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
...+...++||+|+||+||+|++++ .||||+++.........+.|.+|+.++++++|||||++++++.+ +.++|||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 3567778899999999999998764 59999998766667777899999999999999999999998865 568999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--c
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--Y 517 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~--~ 517 (634)
|++|+|.++++... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+..... .
T Consensus 113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999997543 34899999999999999999999999 999999999999999999999999999865432 2
Q ss_pred ccCCCCCCCCcccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cc---cCCCCCCcH
Q 006703 518 ISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RR---LEIPKNVNP 590 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~---~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~---~~~~~~~s~ 590 (634)
......+||+.|||||++.+ .+++.++|||||||++|||+||+.||.+.+.......+.... .. +..+..+++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 23456789999999999964 458999999999999999999999998877655444333222 22 235578999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
.+.+|+.+||..||++|||+.+|++.|+.+..
T Consensus 269 ~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 99999999999999999999999999987644
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=437.53 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=220.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
+...|...++||+|+||+||+|+++.+ .||||++...... ..+.+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456799999999999999999999744 4999999755432 235678999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||||+||+|.+++... .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+|+.....
T Consensus 150 mEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp ECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999999999743 3899999999999999999999999 999999999999999999999999999876655
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~L 595 (634)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... .....+..+++++++|
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 445667899999999999999999999999999999999999999999999888777764322 1233445789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~ 615 (634)
|.+||..||++|||+.++++
T Consensus 304 i~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=425.62 Aligned_cols=247 Identities=30% Similarity=0.490 Sum_probs=212.4
Q ss_pred eeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec----CCcEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLSIV 436 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~----~~~~~lV 436 (634)
|...++||+|+||+||+|.++.++ ||+|++..........++|.+|+++|++++|||||++++++.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356678999999999999988554 9999998777777777889999999999999999999999864 3568999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCCCccCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGla~~~~~ 515 (634)
||||+||+|.+++.+.. .+++..+..++.||+.||.|||+++++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999997543 489999999999999999999999877999999999999984 78999999999986544
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
. ...+.+||+.|||||++.+ +++.++|||||||++|||+||+.||.+... ..+...+......+.++...++++.+
T Consensus 185 ~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 185 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 3 3456789999999999875 599999999999999999999999977554 44444454333444566778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
||.+||..||++|||+.++++
T Consensus 262 li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=433.28 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=220.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||+||+|+++.+ .||+|++.+... .....+.+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999998744 499999976543 2334567899999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC-
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~- 516 (634)
|||+||+|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997543 4999999999999999999999999 999999999999999999999999999875432
Q ss_pred -cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 517 -YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 -~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.....+.+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ..+.+|..+++++++|
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dl 264 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDL 264 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTCCHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCcccCHHHHHH
Confidence 2234577899999999999999999999999999999999999999999998888877743 4456788999999999
Q ss_pred HHHhhhcCCCCCCCHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIM 614 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il 614 (634)
|.+||.+||++|||+.|++
T Consensus 265 i~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGT
T ss_pred HHHHccCCHhHCcChHHHc
Confidence 9999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=430.15 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=223.6
Q ss_pred CcceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
...+...++||+|+||+||+|++. +..||||++.... .....++|.+|+.++++++|||||++++++.+++.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 356777889999999999999874 2459999986543 33345789999999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC
Q 006703 433 LSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~-------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~ 499 (634)
++||||||++|+|.++|.... .+..+++..+..|+.||+.||.|||+++ ||||||||+||||+.+
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK 181 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCC
Confidence 999999999999999996432 1245899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006703 500 YTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG 576 (634)
Q Consensus 500 ~~ikL~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~ 576 (634)
+.+||+|||+|+..... ........||+.|||||++.+..++.++|||||||++|||+| |..||.+.+..++...+.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999999864322 223445689999999999999999999999999999999998 899999999988887774
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 577 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 577 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
...+++.|..+++.+.+|+.+||..||++|||+.+|++.|+.+
T Consensus 262 -~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 -NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 4456678889999999999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=431.56 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=219.4
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...++||+|+||.||+|+++. ..||||++...... .+|+.++++++|||||++++++.+++.+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 568888999999999999999884 45999999765432 379999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCccCCCCc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~~~~~~ 517 (634)
||+||+|.++++..+ .+++..+..++.||+.||.|||++| |+||||||+||||+.+| .+||+|||+|+......
T Consensus 131 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999997543 4999999999999999999999999 99999999999999887 69999999998654321
Q ss_pred -----ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-cCCCCCCcHH
Q 006703 518 -----ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-LEIPKNVNPM 591 (634)
Q Consensus 518 -----~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~ 591 (634)
......+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+...... ..++..+++.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 1234467999999999999999999999999999999999999999887776666666443332 3577889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
+.+||.+||.+||++|||+.||++.|...++...
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999988643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=438.87 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=221.8
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.+...|...++||+|+||.||+|+++. ..||||++....... .+.+.+|+.+|++++|||||+++++|.+++.+||
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 345779999999999999999999984 449999997654322 3567899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|||||+||+|.+++... .+++..+..++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+....
T Consensus 226 VmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999999999999643 3899999999999999999999999 99999999999999999999999999987655
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~ 594 (634)
........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... .....+..+++++++
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 5445567889999999999999999999999999999999999999999999888877764332 233445679999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
||.+||..||++|||+.++++
T Consensus 380 li~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=417.56 Aligned_cols=246 Identities=29% Similarity=0.457 Sum_probs=203.2
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
++|...+.||+|+||+||+|+++ ++.||+|++.+.... .....++.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999987 445999999766543 333567899999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+ +|+|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 679999887543 4999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+. ...+.+|..+++++++||
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 243 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLI 243 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHH
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHH
Confidence 3456789999999999998886 689999999999999999999999988888777664 344567888999999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||..||++|||+.++++
T Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHHc
Confidence 9999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=433.73 Aligned_cols=266 Identities=30% Similarity=0.531 Sum_probs=228.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC-------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCC-CCeeeeeceeec-
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTE- 429 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~-------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h-~nIv~l~~~~~~- 429 (634)
+..+|...+.||+|+||+||+|.+.+. .||||++.... .....+.|.+|+++|.+++| ||||++++++..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 347899999999999999999998753 38999986554 34455789999999999965 899999999865
Q ss_pred CCcEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
+..++||||||++|+|.++|+.... +..+++..+..++.||++||.|||+++ ||||||||+|||+
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl 218 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL 218 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceee
Confidence 4568999999999999999964321 345899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 573 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~ 573 (634)
+.++.+||+|||+|+..... ........||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+...
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865432 223345678999999999999999999999999999999998 899999877655554
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
.......++..|..+++++.+++.+||..||++|||+.+|++.|+++++++..|
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~q 352 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 352 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC--
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhCC
Confidence 444566778888999999999999999999999999999999999999987765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=430.53 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=212.3
Q ss_pred cceeecceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.+|...+.||+|+||+||+|++. +..||+|++...........++.+|+.+|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 2349999997665433333467799999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|||||+||+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997543 4999999999999999999999999 99999999999999999999999999986554
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
......+.+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ..+.+|..+++++.+|
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQFLSPEAQSL 256 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCcCCHHHHHH
Confidence 44445677899999999999999999999999999999999999999999999888877743 4456788899999999
Q ss_pred HHHhhhcCCCCCCCH-----HHHHH
Q 006703 596 IETCWAEEPEIRPSF-----PSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~-----~~Il~ 615 (634)
|.+||..||++|||+ +++++
T Consensus 257 i~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 257 LRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHcccCHHHCCCCCcCCHHHHHc
Confidence 999999999999984 67664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=407.05 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=194.3
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------- 431 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------- 431 (634)
..|...+.||+|+||+||+|+++ +..||||++.... .....+++.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35788899999999999999987 4459999987654 3444577899999999999999999999986544
Q ss_pred -----cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEe
Q 006703 432 -----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 506 (634)
Q Consensus 432 -----~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~D 506 (634)
.+|+|||||++|+|.+++.........++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999986655445677788999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCcc------------cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHH
Q 006703 507 FGLSRSKPNTYI------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVIS 573 (634)
Q Consensus 507 FGla~~~~~~~~------------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~ 573 (634)
||+|+....... .....+||+.|||||++.+..++.++|||||||++|||++ ||...... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999986543211 1234579999999999999999999999999999999996 77653221 1222
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+. ....++.+...++.+.+||.+||..||++|||+.++++
T Consensus 239 ~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 239 DVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221 11222222345677889999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=407.41 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=203.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC----cEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~----~~~lV 436 (634)
.+|+..++||+|+||+||+|+++++.||||++..... ....+..|+..+.+++|||||++++++.+++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4577889999999999999999999999999865432 1122345677777889999999999997654 58999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC------CCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR------RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~------g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
||||++|+|.++++.. .+++..+.+++.|++.||.|||++ .++|+||||||+||||+.++.+||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999754 388999999999999999999987 123999999999999999999999999999
Q ss_pred ccCCCCc----ccCCCCCCCCcccCcccccCC------CCCchHHHHHHHHHHHHHHhCCCCCC----------CC----
Q 006703 511 RSKPNTY----ISSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVILWELITLQKPWR----------NS---- 566 (634)
Q Consensus 511 ~~~~~~~----~~~~~~~gt~~y~APEvl~~~------~~s~~sDVwSLGvlL~eLltg~~Pf~----------~~---- 566 (634)
+...... ......+||+.|||||++.+. .++.++|||||||++|||+||..||. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 7643321 122345799999999999765 35779999999999999999976553 21
Q ss_pred -ChHHHHHHHhhcCcccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 567 -TPSQVISAVGFKGRRLEIPKN-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 567 -~~~~~~~~i~~~~~~~~~~~~-----~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
...+....+.....++.+|.. .++.+.+|+.+||..||++|||+.+|++.|+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 123344444444455555543 345789999999999999999999999999998875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=392.93 Aligned_cols=272 Identities=70% Similarity=1.122 Sum_probs=232.6
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
.....|...+.||+|+||+||+|++.++.||+|++...........++.+|+.++++++||||+++++++......++||
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 44578999999999999999999999989999999887777777788999999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++........+++..++.++.||+.||.|||++|++|+||||||+||+++.++.+||+|||++.......
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999999999986655455999999999999999999999998779999999999999999999999999998655544
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+........++..+++.+.++|.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 44566789999999999999999999999999999999999999999999988888877777778888999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 629 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~ 629 (634)
+||..||.+|||+.++++.|+.++++...+|.
T Consensus 274 ~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987655543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=405.08 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=210.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee------cCC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT------EPP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~------~~~ 431 (634)
..+|...+.||+|+||+||+|+++. ..||||++..........+++.+|+++|++++|||||++++++. +.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3679999999999999999999874 45999999776666666678999999999999999999999875 346
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
.+|||||||+ |+|.+++...+ .+++..+..+++||+.||.|||++| |+||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceee
Confidence 7999999996 57999887543 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCC----cccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc----
Q 006703 512 SKPNT----YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---- 582 (634)
Q Consensus 512 ~~~~~----~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~---- 582 (634)
..... .....+.+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....+......+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 65332 2234567899999999998876 46999999999999999999999999988877666553211110
Q ss_pred -------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 -------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 -------------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+.+++++.+||.+||..||++|||+.++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 011357899999999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=387.42 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=197.6
Q ss_pred CcceeecceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~ 433 (634)
...|...++||+|+||+||+|+++ +..||+|++..... ..++.+|+++|+.+ +||||++++++|.+.+++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 467999999999999999999875 23499998865432 24577999999998 699999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC-CcEEEEecCCCcc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRS 512 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~-~~ikL~DFGla~~ 512 (634)
|+||||+++++|.++++ .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999984 2889999999999999999999999 9999999999999876 7999999999975
Q ss_pred CCCCc----------------------------ccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCC
Q 006703 513 KPNTY----------------------------ISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPW 563 (634)
Q Consensus 513 ~~~~~----------------------------~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf 563 (634)
..... ......+||+.|+|||++.+.+ ++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43211 1123457999999999998764 899999999999999999999999
Q ss_pred CCCC-hHHHHHHHhhc----------------------------------------------------CcccCCCCCCcH
Q 006703 564 RNST-PSQVISAVGFK----------------------------------------------------GRRLEIPKNVNP 590 (634)
Q Consensus 564 ~~~~-~~~~~~~i~~~----------------------------------------------------~~~~~~~~~~s~ 590 (634)
...+ ..+....+... .........+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 6543 33222221100 000112245789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+||.+||..||++|||+.|+++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 9999999999999999999999885
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=408.31 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=217.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...+.||+|+||.||+|+++.+ .||+|++.... ....+.+.+|+.+|+.++|||||+++++|.++..+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5799999999999999999998754 49999987653 3334678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC--CCcEEEEecCCCccCCCC
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~--~~~ikL~DFGla~~~~~~ 516 (634)
||+||+|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+|||++. .+.+||+|||+|+.....
T Consensus 235 ~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 235 FMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred ecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999986433 34999999999999999999999999 999999999999985 489999999999876443
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCCCCcHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l~~ 594 (634)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...... ...+..+++++.+
T Consensus 311 ~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp S-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred C-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 334568999999999999999999999999999999999999999999998888777543332 2334678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
||.+||..||.+|||+.++++
T Consensus 390 li~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=409.76 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=210.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeecccc----HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFH----EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~----~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
....|...+.||+|+||.||+|+++.++ ||+|++.+.... .........++.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3477999999999999999999998554 999999765432 1222333445677788899999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+|||||||+||+|.+++...+ .+++..+..++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.
T Consensus 267 lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999997543 4999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCcccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhhcCcccCCCCCC
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~-~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 588 (634)
.... ...+.+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.+ ..++...+ ....+.+|..+
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~~ 417 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSF 417 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTTS
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCccC
Confidence 5443 345679999999999996 4679999999999999999999999997643 23333333 33456678889
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPS-----FPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs-----~~~Il~ 615 (634)
++++++||.+||..||.+|++ +.+|++
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 999999999999999999998 677765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=371.11 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=221.6
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.+. +..||+|++..........+++.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 367999999999999999999985 455999999887777777788999999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999986443 3899999999999999999999999 9999999999999999999999999997654332
Q ss_pred ccCCCCCCCCcccCcccccCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s-~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+.. ....+|..+++.+.+|+
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFYMSTDCENLL 245 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHH
Confidence 34567899999999999988874 899999999999999999999999998887776643 34556778999999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||..||.+|||+.++++
T Consensus 246 ~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTT
T ss_pred HHHCCCChhHCcCHHHHhc
Confidence 9999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=355.18 Aligned_cols=258 Identities=28% Similarity=0.573 Sum_probs=230.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC--CcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~--~~~~lV 436 (634)
....|...+.||+|+||.||+|+++++.+|+|++..........+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 447889999999999999999999988999999988776677778899999999999999999999999877 789999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++..... ..+++..++.++.||+.||.|||+++++|+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 999999999999975432 34899999999999999999999988789999999999999999999999999876432
Q ss_pred cccCCCCCCCCcccCcccccCCCCCc---hHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNE---KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~---~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
.....||+.|+|||++.+..++. ++||||||+++|+|++|+.||......+....+......+..+..+++.+.
T Consensus 165 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3kmu_A 165 ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241 (271)
T ss_dssp ---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHH
T ss_pred ---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 23557899999999998765544 899999999999999999999999888877777667777888899999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
+++.+||..||++|||+.++++.|+++..
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 242 KLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=362.19 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=218.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.....|...+.||+|+||+||+|.+. +..||+|++....... .+.+.+|+.++++++||||+++++++...+..++
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 34578999999999999999999876 4459999987654333 3567899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999999999754 3889999999999999999999999 99999999999999999999999999987655
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~ 594 (634)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.... .....+..+++.+.+
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence 4444566789999999999999999999999999999999999999999888776655553322 234456778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+||..||++|||+.++++
T Consensus 249 li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhh
Confidence 999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=367.01 Aligned_cols=278 Identities=29% Similarity=0.474 Sum_probs=213.1
Q ss_pred cCCCCCCcceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee
Q 006703 354 QNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428 (634)
Q Consensus 354 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~ 428 (634)
........+|...+.||+|+||.||+|++..+ .||+|++..........+++.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 34445567899999999999999999987643 5899998776555666788999999999999999999999998
Q ss_pred cCCcE------EEEEeecccCCHHHHhccCC---CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC
Q 006703 429 EPPNL------SIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499 (634)
Q Consensus 429 ~~~~~------~lV~E~~~ggsL~~ll~~~~---~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~ 499 (634)
..... +++|||+.+++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+||+++.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence 77655 99999999999999985322 2225899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006703 500 YTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG 576 (634)
Q Consensus 500 ~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~ 576 (634)
+.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999999997643322 12234456889999999999999999999999999999999 999999888877666553
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCC
Q 006703 577 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 634 (634)
Q Consensus 577 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~~~p~ 634 (634)
.......+..+++.+.+++.+||..||++|||+.++++.|++++...-..+.+..||
T Consensus 254 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 254 -GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred -cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 344566678899999999999999999999999999999999999877777766664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=370.52 Aligned_cols=264 Identities=30% Similarity=0.553 Sum_probs=227.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceee
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT 428 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~ 428 (634)
....|...+.||+|+||.||+|++.+ ..||+|++... ......+.+.+|+.+++++ +||||+++++++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 44789999999999999999998742 13999998655 3445567899999999999 8999999999999
Q ss_pred cCCcEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEE
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLL 495 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NIL 495 (634)
+.+.+|+||||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEE
Confidence 99999999999999999999975431 234789999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 006703 496 VDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVI 572 (634)
Q Consensus 496 ld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~ 572 (634)
++.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999998654322 12334557889999999999999999999999999999999 99999988877766
Q ss_pred HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 573 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 573 ~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
..+. ....+..+..+++.+.+++.+||..||++|||+.++++.|++++.....
T Consensus 316 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 316 KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 6553 3445667788999999999999999999999999999999999976543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=364.28 Aligned_cols=264 Identities=34% Similarity=0.496 Sum_probs=226.2
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
.....|...+.||+|+||.||+|.+.. ..||||++.... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 345789999999999999999999862 239999986543 44455789999999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred cEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999996443 24899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 513 KPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 513 ~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 279 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGC 279 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCc
Confidence 54321 12334456788999999999999999999999999999999 999999988888777664 34456677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
++.+.+++.+||..||++|||+.+|++.|+.++++....
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 999999999999999999999999999999999875544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.33 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=219.7
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||+||+|+++. ..||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3678999999999999999999874 4599999976532 223346788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||++|++|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999987433 4899999999999999999999999 999999999999999999999999999864444
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+.. ....+|..+++++.++|
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 236 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 3445677899999999999999999999999999999999999999999888777766643 34557788999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 006703 597 ETCWAEEPEIRP-----SFPSIMET 616 (634)
Q Consensus 597 ~~cL~~dP~~RP-----s~~~Il~~ 616 (634)
.+||..||++|| ++.+|++.
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999 89999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=350.50 Aligned_cols=257 Identities=32% Similarity=0.573 Sum_probs=224.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
...|...+.||+|+||.||+|.+.+ ..||+|++....... +++.+|+.++++++||||+++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 4678999999999999999999864 459999987655443 457899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred eCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999996543 34899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......+...++.+.+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 240 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 240 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHHHHHH
Confidence 22345567889999999999999999999999999999999 999999988887777664 3345566778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+||..||++|||+.++++.|+++.++.
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 9999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=367.20 Aligned_cols=269 Identities=30% Similarity=0.560 Sum_probs=232.3
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeecee
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 427 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~ 427 (634)
....+|...+.||+|+||.||+|++.+ ..||+|++.... ......++.+|+++++++ +||||+++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 445789999999999999999998753 249999987653 445567899999999999 999999999999
Q ss_pred ecCCcEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcE
Q 006703 428 TEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 494 (634)
Q Consensus 428 ~~~~~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NI 494 (634)
..++..++||||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 222 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 222 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceE
Confidence 999999999999999999999964431 235899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 006703 495 LVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQV 571 (634)
Q Consensus 495 Lld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~ 571 (634)
|++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998654322 22344567889999999999999999999999999999999 9999999888877
Q ss_pred HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 006703 572 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 630 (634)
Q Consensus 572 ~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~ 630 (634)
...+. .......+..+++++.+|+.+||..||++|||+.+|++.|++++.....+..+
T Consensus 303 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 303 FKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp HHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred HHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 66663 44456677889999999999999999999999999999999999887766654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.79 Aligned_cols=265 Identities=30% Similarity=0.543 Sum_probs=225.1
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE 429 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~ 429 (634)
.....|...+.||+|+||.||+|++.+ ..||||++.... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 345789999999999999999998643 349999987543 344457899999999999 78999999999877
Q ss_pred CCc-EEEEEeecccCCHHHHhccCCC------------------------------------------------------
Q 006703 430 PPN-LSIVTEYLSRGSLYKLLHIPDA------------------------------------------------------ 454 (634)
Q Consensus 430 ~~~-~~lV~E~~~ggsL~~ll~~~~~------------------------------------------------------ 454 (634)
.+. .++||||+++++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 554 9999999999999999975432
Q ss_pred ---------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--cccCCCC
Q 006703 455 ---------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTA 523 (634)
Q Consensus 455 ---------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~--~~~~~~~ 523 (634)
+..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... .......
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 122889999999999999999999999 999999999999999999999999999864332 2233455
Q ss_pred CCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 006703 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602 (634)
Q Consensus 524 ~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~ 602 (634)
.||+.|+|||++.+..++.++||||||+++|+|++ |..||......+..............+..+++.+.+++.+||..
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 68889999999999999999999999999999998 99999887765555555455566777888999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcC
Q 006703 603 EPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 603 dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
||.+|||+.++++.|++++++..
T Consensus 336 dP~~Rps~~ell~~L~~~~~~~~ 358 (359)
T 3vhe_A 336 EPSQRPTFSELVEHLGNLLQANA 358 (359)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHHT
T ss_pred ChhhCCCHHHHHHHHHHHHHHhc
Confidence 99999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=351.52 Aligned_cols=255 Identities=36% Similarity=0.617 Sum_probs=212.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCcEEEEEEeecccc--HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~--~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.+.++.+|+|++...... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 467899999999999999999999888999998655332 223467889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCC-CEEeeccCCCcEEEcC--------CCcEEEEecC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP-PIVHRDLKSPNLLVDS--------TYTVKVCDFG 508 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~-~IvHrDIKP~NILld~--------~~~ikL~DFG 508 (634)
||+++++|.+++... .+++..++.++.|++.||.|||++|. +|+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999998633 48999999999999999999999873 3789999999999985 6789999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.........+..+
T Consensus 162 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 162 LAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp C---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred cccccccc--cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 99865433 2235679999999999999999999999999999999999999999988888777776666667788899
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
++.+.+++.+||..||.+|||+.++++.|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=355.03 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=208.6
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccH------------------------HHHHHHHHHHHHHHh
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHE------------------------DRFKEFLREVAIMKG 414 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~------------------------~~~~~~~~El~iL~~ 414 (634)
..|...+.||+|+||.||+|.+..+ .||+|++....... ...+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6789999999999999999988744 49999987654211 123568899999999
Q ss_pred CCCCCeeeeeceeec--CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCC
Q 006703 415 LRHPNIVLLMGAVTE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 492 (634)
Q Consensus 415 l~h~nIv~l~~~~~~--~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~ 492 (634)
++||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 999999999999976 5679999999999999886543 24899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCC---CCchHHHHHHHHHHHHHHhCCCCCCCCChH
Q 006703 493 NLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTPS 569 (634)
Q Consensus 493 NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~ 569 (634)
|||++.++.+||+|||++..............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999987554433345668999999999998765 378999999999999999999999988877
Q ss_pred HHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 570 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 570 ~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+.......+....+++.+.++|.+||..||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 7766665444444444678999999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=374.46 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=220.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.+..+ .+|+|++............+.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 36788999999999999999988744 4999999887766666778999999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc---CCCcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld---~~~~ikL~DFGla~~~~ 514 (634)
||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 90 E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999987543 4899999999999999999999999 99999999999998 46789999999998766
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCC--CCCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l 592 (634)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+. ...+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 5544455678999999999999999999999999999999999999999999888887777544333322 24789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||.+||..||.+|||+.++++
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=370.01 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=213.5
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
..|...+.||+|+||+||+|+++. ..||+|++..... .......+.+|..+++.+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 678999999999999999999874 4499999976533 233446678999999988 799999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||++|++|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 103 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999997543 4899999999999999999999999 999999999999999999999999999865444
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++.+.++|
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLHEDATGIL 255 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 4455677899999999999999999999999999999999999999999998888777743 44566788999999999
Q ss_pred HHhhhcCCCCCCCH------HHHHH
Q 006703 597 ETCWAEEPEIRPSF------PSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~------~~Il~ 615 (634)
.+||..||.+||++ .++++
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhh
Confidence 99999999999998 66665
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=358.88 Aligned_cols=259 Identities=32% Similarity=0.501 Sum_probs=215.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||+||+|.+.. ..+|+|++... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4688999999999999999999874 44999987543 4556678999999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp ECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999997543 24899999999999999999999999 9999999999999999999999999997643322
Q ss_pred cc--------------CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hhcCccc
Q 006703 518 IS--------------SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GFKGRRL 582 (634)
Q Consensus 518 ~~--------------~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i-~~~~~~~ 582 (634)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||............ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 12567999999999999999999999999999999999999998654332110000 0001122
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
..+..+++.+.+++.+||..||++|||+.++++.|+++....
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 346778899999999999999999999999999999988754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=354.58 Aligned_cols=262 Identities=31% Similarity=0.567 Sum_probs=226.2
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~ 430 (634)
.....|...+.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 345789999999999999999998742 349999986543 455567899999999999999999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCC---------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecc
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDA---------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~---------------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDI 489 (634)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~di 176 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDL 176 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cccccc
Confidence 999999999999999999975432 234889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCC
Q 006703 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNS 566 (634)
Q Consensus 490 KP~NILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~ 566 (634)
||+||+++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997653321 22345567889999999999989999999999999999999 99999988
Q ss_pred ChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 567 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 567 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
...+....+. .......+..+++.+.+++.+||..||++|||+.++++.|++++..
T Consensus 257 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 8777665553 3345567788999999999999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.87 Aligned_cols=259 Identities=31% Similarity=0.534 Sum_probs=223.3
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....+|...+.||+|+||.||++.+.+. .||+|++....... +++.+|++++++++||||+++++++.+.+..++|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 3457899999999999999999998865 49999987665443 4578999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp ECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999997532 34899999999999999999999999 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 Y-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......+...++.+.+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYT 252 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHHHHH
Confidence 2 22344557889999999999999999999999999999998 999999988877776664 33455567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
++.+||..||.+|||+.++++.|++++...
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 999999999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=354.63 Aligned_cols=265 Identities=30% Similarity=0.483 Sum_probs=226.0
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE 429 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~ 429 (634)
.....|...+.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34478999999999999999999863 2349999987553 334457889999999999 99999999999999
Q ss_pred CCcEEEEEeecccCCHHHHhccCCC---------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcE
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDA---------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 494 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~---------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NI 494 (634)
++..++||||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni 176 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceE
Confidence 9999999999999999999975432 124899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCCccCCCCcc--cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 006703 495 LVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQV 571 (634)
Q Consensus 495 Lld~~~~ikL~DFGla~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~ 571 (634)
+++.++.+||+|||++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999986543321 2334457889999999999999999999999999999998 9999988776555
Q ss_pred HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 572 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 572 ~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
.............+..+++.+.+++.+||..||.+|||+.++++.|++++.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 544444455556677899999999999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.07 Aligned_cols=251 Identities=26% Similarity=0.432 Sum_probs=218.6
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.++ +..||+|++............+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 367899999999999999999987 445999999877666667788999999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC---CcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~---~~ikL~DFGla~~~~ 514 (634)
||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999886443 4899999999999999999999999 9999999999999854 469999999998655
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l 592 (634)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.+ ..+++++
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 183 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred CCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 332 3345689999999999999999999999999999999999999999988877776664433322222 4679999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.+||.+||..||++|||+.++++.
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999998863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=368.70 Aligned_cols=260 Identities=34% Similarity=0.541 Sum_probs=224.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.....|...+.||+|+||.||+|.++ +..||+|++... .......++.+|++++++++||||+++++++......++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 34478899999999999999999997 455999998654 344455678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 190 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999997433 24889999999999999999999999 99999999999999999999999999986443
Q ss_pred CcccC--CCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 516 TYISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 516 ~~~~~--~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
..... ....+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+++.|..+++.+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 344 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAV 344 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 32221 12235678999999998889999999999999999998 999999988877665553 445667788899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 593 AALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.+++.+||..||++|||+.+|++.|+++.+.
T Consensus 345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=361.94 Aligned_cols=263 Identities=33% Similarity=0.526 Sum_probs=225.0
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~ 430 (634)
.....|...+.||+|+||.||+|++.+ ..||+|++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345788999999999999999999875 459999987543 345567899999999999999999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCC---------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecc
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDA---------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~---------------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDI 489 (634)
+..++||||+++++|.+++..... ...+++..++.++.||++||.|||++| |+||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dl 200 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDL 200 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence 999999999999999999965321 145899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCC
Q 006703 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNS 566 (634)
Q Consensus 490 KP~NILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~ 566 (634)
||+||+++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999999999987543221 12345568899999999999999999999999999999999 99999998
Q ss_pred ChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 567 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 567 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
...+....+. ....+..+..+++.+.+++.+||..||.+|||+.++++.|+++....
T Consensus 281 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 281 AHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 8877776663 34445677889999999999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.60 Aligned_cols=261 Identities=24% Similarity=0.388 Sum_probs=218.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
...+|...+.||+|+||.||+|++. +..||+|++..... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3478999999999999999999987 44599999865543 44556789999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++.... .+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999997443 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc---cCCCCCCcHH
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---LEIPKNVNPM 591 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~s~~ 591 (634)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................. ...+..+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 32 2234557999999999999999999999999999999999999999998876655444222211 2345778999
Q ss_pred HHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHhc
Q 006703 592 VAALIETCWAEEPEIRP-SFPSIMETLQQFLMSS 624 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RP-s~~~Il~~L~~ll~~~ 624 (634)
+.++|.+||..||.+|| ++.++.+.|+.++...
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 99999999999999998 9999999999887653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=351.21 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=212.6
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
.....|...+.||+|+||.||+|.+..+ .+|+|++.... .....+.+.+|+.++++++||||+++++++. ++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3457899999999999999999988642 28888875432 3445578899999999999999999999985 467
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC------
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccc
Confidence 899999999999999997543 24899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 513 KPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 513 ~~~~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 244 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54322 12334457789999999999999999999999999999996 999999888777666653 3345567788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+.+++.+||..||++|||+.++++.|+++++..
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.14 Aligned_cols=256 Identities=33% Similarity=0.590 Sum_probs=223.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...+|...+.||+|+||.||+|.++++ .||+|++....... .++.+|+.++++++||||+++++++.+....++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 457899999999999999999998866 49999987665443 45789999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999997532 24899999999999999999999999 9999999999999999999999999997654332
Q ss_pred -ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 -~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+...++.+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHHH
Confidence 22344557788999999999889999999999999999999 999999888877766653 344455667789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
+.+||..||.+|||+.++++.|+.+..
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 999999999999999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.01 Aligned_cols=251 Identities=23% Similarity=0.398 Sum_probs=216.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHH----HHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHED----RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~----~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
....|...+.||+|+||.||+|.++. ..||+|++........ ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34679999999999999999999874 4599999976643221 23568899999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC----cEEEEecC
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFG 508 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~----~ikL~DFG 508 (634)
+++||||++|++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999996543 4899999999999999999999999 99999999999998776 79999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCC
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPK 586 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~ 586 (634)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+...... ...+.
T Consensus 165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 99865443 2345667999999999999999999999999999999999999999998888877766433221 12335
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 587 NVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+++.+.+||.+||..||.+|||+.++++
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 78999999999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.87 Aligned_cols=253 Identities=26% Similarity=0.327 Sum_probs=207.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
+...+|...+.||+|+||+||+|++. +..||+|++............+.+|+.++++++||||+++++++.++...++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 45588999999999999999999985 44599999876654444557788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++ +|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 999986 7877776433 34899999999999999999999999 999999999999999999999999999876544
Q ss_pred cccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--------------
Q 006703 517 YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-------------- 581 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~-------------- 581 (634)
........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+......
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 444556688999999999976 55799999999999999999999999887765544443211000
Q ss_pred --------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 --------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 --------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
......+++++.+||.+||..||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0112356789999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.01 Aligned_cols=265 Identities=30% Similarity=0.477 Sum_probs=222.0
Q ss_pred CCcceeecc-eeeccCcEEEEEEEEc----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 359 PSTHVIDSS-NFIKGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 359 ~~~~~~~~~-~LG~G~fG~Vy~a~~~----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
....|...+ .||+|+||.||+|.+. +..||+|++..........+++.+|+.++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346777777 9999999999999664 23499999877655555567899999999999999999999999 56778
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999997543 4899999999999999999999999 999999999999999999999999999765
Q ss_pred CCCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 514 PNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 514 ~~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. ....+..+..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 246 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCP 246 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 43221 1223456789999999998889999999999999999999 999999988877666653 344566778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 630 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~ 630 (634)
+.+.+++.+||+.||++|||+.++++.|++++.+......+
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 287 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 287 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcccc
Confidence 99999999999999999999999999999999876544433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=349.21 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=208.0
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...+.||+|+||+||+|++.. ..||+|++............+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 468899999999999999999874 449999998776666666788899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++ ++.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9987 5555554322 34899999999999999999999999 99999999999999999999999999987655444
Q ss_pred cCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHhhcCc----------------
Q 006703 519 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGR---------------- 580 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf-~~~~~~~~~~~i~~~~~---------------- 580 (634)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..|| ...+..+....+.....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 455678899999999998766 799999999999999999887774 55555544444321100
Q ss_pred -----------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -----------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -----------~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.......+++.+.+|+.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 01122357899999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.80 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=218.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
...|...+.||+|+||.||+|+++.++ ||+|++..... .......+..|..++..+ +||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 367999999999999999999998644 99999876532 223346678999999988 89999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999997433 3899999999999999999999999 99999999999999999999999999986444
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++.+|
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAI 251 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHH
Confidence 33445677899999999999999999999999999999999999999999888887777643 3456778899999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHH
Q 006703 596 IETCWAEEPEIRPS-----FPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs-----~~~Il~ 615 (634)
|.+||..||.+||+ +.+|++
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999999995 577765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.79 Aligned_cols=246 Identities=24% Similarity=0.412 Sum_probs=217.0
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||.||+|+.+ +..||+|++...... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467899999999999999999987 445999998765322 22345678999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999997543 4899999999999999999999999 999999999999999999999999999865432
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+.. ....+|..+++++.++|
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLL 234 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHH
Confidence 3466899999999999999999999999999999999999999999888777766643 34566788999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHH
Q 006703 597 ETCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RP-----s~~~Il~ 615 (634)
.+||..||.+|| ++.++++
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhccCHHHcCCCcCCCHHHHhc
Confidence 999999999999 8888885
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.33 Aligned_cols=244 Identities=22% Similarity=0.380 Sum_probs=210.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
...|...+.||+|+||.||+|+++.+ .||+|++..... .......+.+|..+++++ +||||+++++++.+...+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 36789999999999999999998754 499999987654 344567788999999988 89999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999987433 4899999999999999999999999 99999999999999999999999999986444
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHhhcCcccCCCC
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS---------TPSQVISAVGFKGRRLEIPK 586 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~ 586 (634)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+ ......+|.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 240 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 240 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCCT
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCCC
Confidence 334456778999999999999999999999999999999999999999652 222233333 234456778
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCH
Q 006703 587 NVNPMVAALIETCWAEEPEIRPSF 610 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RPs~ 610 (634)
.+++.+.++|.+||..||.+||++
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 899999999999999999999995
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=346.28 Aligned_cols=265 Identities=32% Similarity=0.601 Sum_probs=222.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE-E
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL-S 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~-~ 434 (634)
..|...+.||+|+||+||+|.+..+ .+|+|++... ......+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4566678999999999999987533 3888887643 3345567889999999999999999999999776665 9
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+.+++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999997533 34889999999999999999999999 9999999999999999999999999997644
Q ss_pred CC----cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 515 NT----YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 515 ~~----~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
.. ........+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+. .......+..++
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 254 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCP 254 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccch
Confidence 32 1223455688999999999999999999999999999999995 55566666665555443 444556678899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 631 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~~ 631 (634)
+.+.+++.+||..||.+|||+.++++.|++++..........
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~~~ 296 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQ 296 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCBCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccchhh
Confidence 999999999999999999999999999999999876665443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=372.75 Aligned_cols=255 Identities=34% Similarity=0.599 Sum_probs=222.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-cEEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-NLSIVT 437 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~-~~~lV~ 437 (634)
....|...+.||+|+||.||+|.++++.||||++.... ..+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44788999999999999999999999899999987543 2356889999999999999999999986655 799999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999975432 23789999999999999999999999 999999999999999999999999999854332
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. ...++..|..+++.+.++|
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHH
Confidence 233467889999999999999999999999999999998 999999888777666653 4456677889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+||..||++|||+.+|++.|+++....
T Consensus 420 ~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 420 KNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=356.91 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=206.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEc-----CCcEEEEEEeecccc--HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~--~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~ 431 (634)
....|...+.||+|+||.||+++.. +..+|+|++...... ......+.+|+.++++++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 3478999999999999999999873 445999998765432 233456789999999999999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999997433 4889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.. ....++..+++.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~ 247 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPYLTQE 247 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCTTSCHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHH
Confidence 644333334566899999999999999999999999999999999999999999888777666632 345667889999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHH
Q 006703 592 VAALIETCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RP-----s~~~Il~ 615 (634)
+.++|.+||..||.+|| ++.++++
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 99999999999999999 7778876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.21 Aligned_cols=259 Identities=34% Similarity=0.602 Sum_probs=208.8
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
....+|...+.||+|+||.||+|++.+ .+|+|++..........+.+.+|+.++++++|+||++++++. .....++||
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 445789999999999999999998655 599999987766677778899999999999999999999965 556789999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC-
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~- 516 (634)
||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999996443 34899999999999999999999999 999999999999999999999999998754321
Q ss_pred -cccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-Ccc---cCCCCCC
Q 006703 517 -YISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR---LEIPKNV 588 (634)
Q Consensus 517 -~~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~~~---~~~~~~~ 588 (634)
........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+........ ... ......+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 12234557999999999986 667889999999999999999999999886655443333222 222 2234578
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
++.+.+++.+||..||++|||+.++++.|+++.+
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 9999999999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=365.62 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=216.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
...|...+.||+|+||.||+|+++.+ .||+|++..... .......+..|..+++.+ +||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 46799999999999999999998754 499999876532 122345677899999877 99999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 96 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999997533 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ..+.+|..+++.+.++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDL 248 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHHHH
Confidence 33345677899999999999999999999999999999999999999999888887777643 3456678899999999
Q ss_pred HHHhhhcCCCCCCCHH-HHH
Q 006703 596 IETCWAEEPEIRPSFP-SIM 614 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~-~Il 614 (634)
|.+||..||.+||++. +|+
T Consensus 249 i~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHhcCCHhHcCCChHHHH
Confidence 9999999999999997 654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=344.17 Aligned_cols=266 Identities=32% Similarity=0.544 Sum_probs=224.0
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
......|...+.||+|+||.||+|.+.+. .||+|++...... .+.+.+|+.++++++||||+++++++.. +..++
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 34557899999999999999999998765 5999998765433 2568899999999999999999998864 56899
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++..... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999999964321 24899999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......+..+++.+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELY 240 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHHHH
Confidence 32 22344567889999999998889999999999999999999 999999988877766653 3344556778999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 630 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~ 630 (634)
+++.+||..||++|||+.++++.|++++.....+..+
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 277 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC------
T ss_pred HHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCCC
Confidence 9999999999999999999999999999887665543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=360.12 Aligned_cols=264 Identities=32% Similarity=0.499 Sum_probs=220.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~ 430 (634)
....|...+.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 4578999999999999999999973 2249999987543 333446788999999999 899999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCCc--------------------ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDAR--------------------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~--------------------~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIK 490 (634)
+..++||||+++++|.+++...... ..+++..++.++.||+.||.|||++| |+|||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dik 199 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLA 199 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCS
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence 9999999999999999999754321 23789999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCC
Q 006703 491 SPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST 567 (634)
Q Consensus 491 P~NILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~ 567 (634)
|+||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999997543221 12234457889999999999999999999999999999998 999998877
Q ss_pred hHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 568 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 568 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
..............+..+..+++.+.+++.+||..||.+|||+.++++.|+.++....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 6555555544555666778899999999999999999999999999999999887643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=342.50 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=220.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||+|+||.||+|.+.. ..||+|++............+.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 45789999999999999999999874 4599999988777777778899999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc---EEEEecCCCccC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLSRSK 513 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~---ikL~DFGla~~~ 513 (634)
|||+++++|.+++.... .+++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+|||++...
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999988886443 4899999999999999999999999 999999999999986554 999999999765
Q ss_pred CCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC--CCCCCcHH
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPM 591 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~ 591 (634)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+........ ....+++.
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 159 NDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp CSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred ccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 4432 33456799999999999999999999999999999999999999999888877776654433332 23578999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+++.+||..||++|||+.++++
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHcccChhhCCCHHHHhc
Confidence 999999999999999999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.48 Aligned_cols=259 Identities=32% Similarity=0.539 Sum_probs=213.2
Q ss_pred CcceeecceeeccCcEEEEEEEEc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
...|...+.||+|+||.||+|+++ +..||+|++.... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 367888999999999999999875 3349999986543 4455678999999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+++++|.++++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999997543 34899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 515 NTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 515 ~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .....+.+..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccccH
Confidence 3221 1223345778999999999999999999999999999998 999999988877776664 3344556678999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+.+++.+||..||++|||+.+|++.|++++++.
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 9999999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=350.05 Aligned_cols=261 Identities=31% Similarity=0.484 Sum_probs=213.3
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-- 429 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-- 429 (634)
....+|...+.||+|+||+||+|++. +..||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34578999999999999999999852 345999998654 34555788999999999999999999998854
Q ss_pred CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
...+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 456899999999999999997543 24899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH---------------H
Q 006703 510 SRSKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---------------V 571 (634)
Q Consensus 510 a~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~---------------~ 571 (634)
+....... .......+|..|+|||++.+..++.++||||||+++|+|++|..||....... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 98654321 12234457778999999999999999999999999999999999986532211 1
Q ss_pred HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 572 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 572 ~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.........+.+.+..+++++.+++.+||..||++|||+.++++.|+++.++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111234455677889999999999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=344.31 Aligned_cols=264 Identities=29% Similarity=0.494 Sum_probs=224.4
Q ss_pred cceeecc-eeeccCcEEEEEEEEc----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSS-NFIKGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~-~LG~G~fG~Vy~a~~~----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+ .||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4555554 9999999999999864 3349999987653 345567899999999999999999999999 4567999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999996433 34899999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 516 TY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 516 ~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. ....+..+..+++.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPE 241 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCcCHH
Confidence 21 11234457889999999998889999999999999999998 999999888777666553 34456678899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 631 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~~ 631 (634)
+.++|.+||..||.+|||+.++++.|++++.+.......+
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 9999999999999999999999999999999876655543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.33 Aligned_cols=257 Identities=36% Similarity=0.641 Sum_probs=215.9
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHH-----HHHHHHHHHHHHhCCCCCeeeeeceeec
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDR-----FKEFLREVAIMKGLRHPNIVLLMGAVTE 429 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~-----~~~~~~El~iL~~l~h~nIv~l~~~~~~ 429 (634)
......|...+.||+|+||+||+|++. +..||+|++......... .+.+.+|+.++++++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 344578999999999999999999986 445999998655432211 1678899999999999999999999876
Q ss_pred CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc-----EEE
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKV 504 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~-----ikL 504 (634)
.. ++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||||+||+++.++. +||
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred CC--eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 65 69999999999998886443 3489999999999999999999999877999999999999987776 999
Q ss_pred EecCCCccCCCCcccCCCCCCCCcccCccccc--CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhcCc
Q 006703 505 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGR 580 (634)
Q Consensus 505 ~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~--~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~--~~~i~~~~~ 580 (634)
+|||++..... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99999985433 234567999999999984 45568999999999999999999999987654433 444444556
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
.+.++..+++.+.+++.+||..||++|||+.++++.|+++
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 6778889999999999999999999999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=365.88 Aligned_cols=244 Identities=22% Similarity=0.387 Sum_probs=209.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeecccc-HHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~-~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
...|...+.||+|+||+||+|+++.++ ||+|++.+.... ......+.+|..+++++ +||||+++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999988554 999999876543 33345677899999887 89999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++|+|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999987543 4899999999999999999999999 99999999999999999999999999986444
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHhhcCcccCCCC
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---------PSQVISAVGFKGRRLEIPK 586 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~ 586 (634)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ......+|.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 283 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 283 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCCT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCCC
Confidence 4445667889999999999999999999999999999999999999996432 12222233 334566788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCH
Q 006703 587 NVNPMVAALIETCWAEEPEIRPSF 610 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RPs~ 610 (634)
.+++.+.+||.+||..||.+||++
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 899999999999999999999995
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.29 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=205.4
Q ss_pred cceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.+|...+.||+|+||+||+|++. +..+|+|++............+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999986 45599999876654443446678999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++ +|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 976 8988887543 34889999999999999999999999 999999999999999999999999998765443333
Q ss_pred CCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-----------------
Q 006703 520 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------------- 581 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------------- 581 (634)
.....||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 4456789999999999764 5799999999999999999999999988776655443211000
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ----------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
......+++.+.+||.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0122457899999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=348.52 Aligned_cols=272 Identities=23% Similarity=0.390 Sum_probs=211.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~-~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||+|.+. +..||+|++.... ........+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999976 4559999987543 344556788999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 436 VTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
||||+++++|.+++... .....+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999998631 12235899999999999999999999999 9999999999999999999999999988655
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--PSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
..........||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+.........+..+++.+
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 44333455679999999999999999999999999999999999999997643 3334444433233333346789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006703 593 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 632 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~~~ 632 (634)
.+++.+||..||++|||+.++++.|+++.......+.++-
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~~~ 307 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-------
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhhhc
Confidence 9999999999999999999999999999999888777653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=353.41 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=212.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC---------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~---------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~ 429 (634)
...+|...+.||+|+||+||+|.+..+ .||+|++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 347899999999999999999987642 49999986543 2334678899999999999999999999999
Q ss_pred CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc--------
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-------- 501 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~-------- 501 (634)
++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999997543 23889999999999999999999999 999999999999998876
Q ss_pred EEEEecCCCccCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcC
Q 006703 502 VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 579 (634)
Q Consensus 502 ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~ 579 (634)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++| ..||............ .
T Consensus 160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---E 232 (289)
T ss_dssp EEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H
T ss_pred eeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---h
Confidence 999999998754332 23457889999999987 6789999999999999999995 5556555554443333 2
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 633 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~~~p 633 (634)
.....+...++.+.+++.+||..||++|||+.++++.|++++.+....+.++.|
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~~~~ 286 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHH 286 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------------
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCcccc
Confidence 344566677889999999999999999999999999999999988877776655
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=352.61 Aligned_cols=266 Identities=30% Similarity=0.533 Sum_probs=223.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~ 430 (634)
....|...+.||+|+||.||+|.+.+ ..||+|++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 45789999999999999999998642 349999987553 344557789999999999 799999999998765
Q ss_pred C-cEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 431 P-NLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 431 ~-~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
+ .++++|||+++++|.+++..... +..+++..++.++.||+.||.|||++| |+||||||+||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~ 181 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL 181 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEE
Confidence 4 59999999999999999975432 223889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 573 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~ 573 (634)
+.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999997643321 12334567889999999999999999999999999999998 999998876554444
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
...........+..+++.+.+++.+||..||.+|||+.++++.|+++++....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 315 (316)
T 2xir_A 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315 (316)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhccC
Confidence 333345556677889999999999999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=353.22 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=215.1
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH----HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~----~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...|...+.||+|+||.||+|.+. +..||+|++....... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 367889999999999999999987 4459999987654321 1246788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC----cEEEEecCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL 509 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~----~ikL~DFGl 509 (634)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999643 34899999999999999999999999 99999999999998877 899999999
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc--CCCCC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKN 587 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~ 587 (634)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... ..+..
T Consensus 165 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 165 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp CEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 98654322 3345679999999999999999999999999999999999999999888877766654322221 22357
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++.+.+||.+||..||++|||+.++++
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 8999999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=358.26 Aligned_cols=256 Identities=29% Similarity=0.419 Sum_probs=209.4
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC----cEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLS 434 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~----~~~ 434 (634)
....|...+.||+|+||+||+|++.+..||+|++.... .......+|+.++++++||||+++++++.... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 44789999999999999999999998889999986543 23345567999999999999999999997754 379
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC----------CCCEEeeccCCCcEEEcCCCcEEE
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR----------RPPIVHRDLKSPNLLVDSTYTVKV 504 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~----------g~~IvHrDIKP~NILld~~~~ikL 504 (634)
+||||+++++|.+++... .+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 99 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCEEE
T ss_pred EEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeEEE
Confidence 999999999999999753 389999999999999999999999 8 999999999999999999999
Q ss_pred EecCCCccCCCCc--ccCCCCCCCCcccCcccccCC-----CCCchHHHHHHHHHHHHHHhCCCCCCCCC----------
Q 006703 505 CDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLRED-----PSNEKSDVFSFGVILWELITLQKPWRNST---------- 567 (634)
Q Consensus 505 ~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~-----~~s~~sDVwSLGvlL~eLltg~~Pf~~~~---------- 567 (634)
+|||++....... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.+..
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 9999997644322 123446799999999999874 44668899999999999999999996542
Q ss_pred ------hHHHHHHHhhcCcccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 568 ------PSQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 568 ------~~~~~~~i~~~~~~~~~~~-----~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.......+......+.++. ..++++.+||.+||..||++|||+.++++.|+++.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1222222322233333332 2345699999999999999999999999999998775
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=341.10 Aligned_cols=256 Identities=32% Similarity=0.577 Sum_probs=223.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
...|...+.||+|+||.||++.+.+. .||+|++....... +.+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 46789999999999999999998644 59999987655433 467899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++.... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999997543 34889999999999999999999999 9999999999999999999999999988654321
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.. ......+...++.+.+++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li 238 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIM 238 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHH
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCCccCcHHHHHHH
Confidence 22345567889999999999999999999999999999999 8999999888777766643 334556677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.+||..||++|||+.++++.|+++.++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=348.35 Aligned_cols=260 Identities=30% Similarity=0.475 Sum_probs=213.9
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP- 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~- 430 (634)
.....|...+.||+|+||.||+|++. +..||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 33467899999999999999999852 4459999987553 223346788999999999999999999999876
Q ss_pred -CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 431 -PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 431 -~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
...++||||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccc
Confidence 67899999999999999995433 24899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCC--------------ChHHHH
Q 006703 510 SRSKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS--------------TPSQVI 572 (634)
Q Consensus 510 a~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~--------------~~~~~~ 572 (634)
+....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+... ......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 98654332 2244567888999999999999999999999999999999998876322 111222
Q ss_pred HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 573 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 573 ~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
............+..+++.+.+++.+||..||.+|||+.++++.|+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 22223445566778899999999999999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=360.40 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=217.8
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||.||+|+++ +..||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 478999999999999999999987 44599999876543 223346788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999997543 3899999999999999999999999 999999999999999999999999999865432
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ....+|..+++.+.++|
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 3456799999999999999999999999999999999999999999888887777643 34567788999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHH
Q 006703 597 ETCWAEEPEIRPS-----FPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs-----~~~Il~ 615 (634)
.+||..||.+||+ +.+|++
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhhcCHHhccCCccCCHHHHHh
Confidence 9999999999998 888875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=354.48 Aligned_cols=248 Identities=19% Similarity=0.323 Sum_probs=214.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.+..+ .+|+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 46899999999999999999998754 49999886442 33456889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC--CCcEEEEecCCCccCCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~--~~~ikL~DFGla~~~~~ 515 (634)
||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999997543 34899999999999999999999999 999999999999986 78999999999986543
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC--CCCCCcHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMVA 593 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~ 593 (634)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+........ ....+++++.
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 22 23445789999999999998899999999999999999999999999888877766643332221 2257899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++.+||..||.+|||+.++++
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999999999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=349.56 Aligned_cols=256 Identities=33% Similarity=0.602 Sum_probs=212.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
...|...+.||+|+||.||++++.+..||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 467889999999999999999999888999998543 234678899999999999999999998874 47999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh---CCCCEEeeccCCCcEEEcCCCc-EEEEecCCCccCCC
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ---RRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRSKPN 515 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~---~g~~IvHrDIKP~NILld~~~~-ikL~DFGla~~~~~ 515 (634)
+++++|.+++........+++..++.++.|+++||.|||+ +| |+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999999866554558899999999999999999999 77 999999999999998876 79999999975433
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhhcCcccCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ..........+..+..+++.+.+
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence 2 2345699999999999999999999999999999999999999986543221 11222244556667889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
++.+||..||++|||+.++++.|+++.+....
T Consensus 236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999876443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=349.54 Aligned_cols=270 Identities=28% Similarity=0.468 Sum_probs=219.7
Q ss_pred cccCCCCCCcceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeece
Q 006703 352 QMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426 (634)
Q Consensus 352 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~ 426 (634)
...........|...+.||+|+||.||+|.+... .||+|++..........+.+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 3444445568899999999999999999987642 49999988776666667889999999999999999999999
Q ss_pred eecCC-----cEEEEEeecccCCHHHHhccC---CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC
Q 006703 427 VTEPP-----NLSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS 498 (634)
Q Consensus 427 ~~~~~-----~~~lV~E~~~ggsL~~ll~~~---~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~ 498 (634)
+.... ..+++|||+++++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+||+++.
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~ 182 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRD 182 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECT
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcC
Confidence 97655 359999999999999998422 23345899999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 006703 499 TYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAV 575 (634)
Q Consensus 499 ~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i 575 (634)
++.+||+|||++....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 9999999999997653321 12334567889999999999999999999999999999999 89999988877666555
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 576 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 576 ~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
. ....+..+..+++.+.+++.+||..||.+|||+.++++.|++++++.
T Consensus 263 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 L-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp H-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred H-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3 34456677889999999999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=350.78 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=213.5
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|++. +..||||++...... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 34667789999999999999986 555999998755432 23568899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++... .+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 123 ~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 123 FLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp CCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred cCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 99999999998643 3899999999999999999999999 99999999999999999999999999987654443
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~Li~ 597 (634)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..... ....+..+++.+.+++.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence 44567899999999999999999999999999999999999999998888776665533221 12233467899999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~ 615 (634)
+||..||++|||+.++++
T Consensus 277 ~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 277 RMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHSCSSTTTSCCHHHHHT
T ss_pred HHccCChhhCcCHHHHhc
Confidence 999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=352.21 Aligned_cols=266 Identities=30% Similarity=0.548 Sum_probs=226.9
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc---------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeecee
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 427 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~ 427 (634)
.....|...+.||+|+||.||+|++. +..||+|++.... .......+.+|+.+++++ +||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34578999999999999999999875 2349999986543 445567889999999999 899999999999
Q ss_pred ecCCcEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcE
Q 006703 428 TEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 494 (634)
Q Consensus 428 ~~~~~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NI 494 (634)
...+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 188 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV 188 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceE
Confidence 999999999999999999999975432 124889999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 006703 495 LVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQV 571 (634)
Q Consensus 495 Lld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~ 571 (634)
+++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 99999999999999998654322 12344567889999999998889999999999999999999 9999999888776
Q ss_pred HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 572 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 572 ~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
...+. .......+..+++.+.+++.+||..||.+|||+.++++.|++++......
T Consensus 269 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 269 FKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp HHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 66553 33455677889999999999999999999999999999999999865443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=359.38 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=210.2
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH---HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE---DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~---~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
...|...+.||+|+||.||+|.++ +..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 367899999999999999999987 4459999986543211 12467889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc---EEEEecCCC
Q 006703 435 IVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLS 510 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~---ikL~DFGla 510 (634)
+||||+++++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||++
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998887532 22234899999999999999999999999 999999999999986554 999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCCCC
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNV 588 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~ 588 (634)
..............||+.|+|||++.+..++.++|||||||++|+|++|..||.... .+....+...... +.....+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence 876554444556789999999999999999999999999999999999999998754 3333333222111 1122568
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+.+||.+||..||++|||+.++++
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.81 Aligned_cols=260 Identities=32% Similarity=0.537 Sum_probs=218.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
....|...+.||+|+||.||+|.+..+ .||+|++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 346788899999999999999987643 29999987543 34455678999999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999997543 34899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 513 KPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 513 ~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...++..+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 275 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 275 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCcccC
Confidence 54321 11223446789999999999999999999999999999999 999999888877776664 33455567789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
++.+.+++.+||..||++||++.++++.|++++...
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999998763
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=364.38 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=208.0
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeecccc-HHHHHHHHHHHHH-HHhCCCCCeeeeeceeecCCcE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~-~~~~~~~~~El~i-L~~l~h~nIv~l~~~~~~~~~~ 433 (634)
.....|...+.||+|+||.||+|+++.++ ||+|++.+.... ......+.+|..+ ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34478999999999999999999987544 899999876543 3344566777776 4678999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
|+||||++|++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999987533 4889999999999999999999999 999999999999999999999999999864
Q ss_pred CCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
..........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.. ....++..+++.+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~ 267 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSAR 267 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHH
Confidence 3333345677899999999999999999999999999999999999999999888887776643 34556788999999
Q ss_pred HHHHHhhhcCCCCCCCHHH
Q 006703 594 ALIETCWAEEPEIRPSFPS 612 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~ 612 (634)
+||.+||..||.+||++.+
T Consensus 268 ~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHcccCHHhCCCCCC
Confidence 9999999999999999853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.89 Aligned_cols=261 Identities=32% Similarity=0.520 Sum_probs=216.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc-----EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeecee-ecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~-----vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~-~~~~~~ 433 (634)
...|...+.||+|+||+||+|.+.... +|+|.+.... .....+.+.+|+.++++++||||+++++++ ..+...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 467888999999999999999875332 7888876432 345567899999999999999999999985 556688
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999997533 34789999999999999999999999 999999999999999999999999999865
Q ss_pred CCCc----ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 514 PNTY----ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 514 ~~~~----~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ +.+||...+..+....+. .......+..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 257 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYC 257 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccC
Confidence 4322 12334557889999999999999999999999999999999 677777766655554442 34455567788
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
++.+.+++.+||..||++|||+.++++.|++++.....
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999999986544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=346.11 Aligned_cols=260 Identities=35% Similarity=0.583 Sum_probs=225.8
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.....|...+.||+|+||.||+|.+.. ..+|+|++..... ..+.+.+|+.++++++||||+++++++.++...++
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 455789999999999999999999984 4499999865432 34678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++..... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999975432 34899999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+. .......+..+++.+.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 242 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVY 242 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCHHHH
Confidence 32 22334456889999999999999999999999999999999 999999888777665553 3445567788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+++.+||..||.+|||+.++++.|++++...
T Consensus 243 ~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 243 ELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.37 Aligned_cols=259 Identities=18% Similarity=0.211 Sum_probs=216.5
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
..+|...+.||+|+||.||+|.+. +..||+|++...... ..+.+|+.+++.+ +|+||+++++++......++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 467999999999999999999975 445999998654322 3467899999999 799999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc-----EEEEecCCCc
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLSR 511 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~-----ikL~DFGla~ 511 (634)
|||+ +++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+||+++.++. +||+|||++.
T Consensus 85 ~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999 9999999975432 4899999999999999999999999 999999999999987765 9999999998
Q ss_pred cCCCCcc-------cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhhc---
Q 006703 512 SKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAVGFK--- 578 (634)
Q Consensus 512 ~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~---~~~~~~~i~~~--- 578 (634)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 6543221 2345679999999999999999999999999999999999999998743 33333332211
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 579 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 579 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
.........+++.+.+++.+||..||++|||+.+|++.|+++++.....
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 2222344578999999999999999999999999999999999875543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=372.02 Aligned_cols=262 Identities=31% Similarity=0.543 Sum_probs=225.5
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
.....|...+.||+|+||.||+|.+++ ..||||++...... .+.+.+|+.++++++||||+++++++. ....++|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 345788999999999999999999874 45999998765432 367889999999999999999999986 5678999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+.+|+|.++++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999974321 24788899999999999999999999 999999999999999999999999999875432
Q ss_pred cc-cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 YI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~-~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+....+....+. ...+.+.+..+++.+.+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYN 416 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 21 2234456789999999999999999999999999999999 999999988888777664 34556667889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
++.+||..||++|||+.+|++.|+++......|
T Consensus 417 li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred HHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 999999999999999999999999988765444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.66 Aligned_cols=260 Identities=27% Similarity=0.491 Sum_probs=220.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||+|.+..++ +|+|++....... .....+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4477999999999999999999988654 9999986654322 224568899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999986432 3899999999999999999999999 99999999999999999999999999865443
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. ......+..+++.+.+|
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHH
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHH
Confidence 3 2345679999999999999999999999999999999999999999988877766663 33445677899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 629 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~ 629 (634)
|.+||..||++|||+.++++ ..++++....+.
T Consensus 238 i~~~l~~~p~~Rps~~e~l~--h~~~~~~~~~~~ 269 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLE--HPWITANSSKPS 269 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHH--CHHHHHHCSSCC
T ss_pred HHHHhccChhhCCCHHHHhh--CccccCCccCcc
Confidence 99999999999999999998 466666555443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=353.33 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=213.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc------EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~------vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...|...+.||+|+||+||+|++..++ ||+|.+.... .....+++.+|+.++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 477899999999999999999986432 4666654332 2334467889999999999999999999998754 7
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++++||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 89999999999999997543 34899999999999999999999999 999999999999999999999999998764
Q ss_pred CCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 514 PNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 514 ~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 3321 22334456889999999999999999999999999999999 999999888776655553 3445567788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.+.+++.+||..||++|||+.++++.|+.+...
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=371.68 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=209.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||+|++..+ .||+|++..... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999998744 599999876532 33445677899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
||||+++++|.+++.... .+++..+..++.||+.||.|||+ +| |+||||||+|||++.++.+||+|||++....
T Consensus 226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999986443 48999999999999999999998 89 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++.+.+
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKS 378 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHH
Confidence 444445677899999999999999999999999999999999999999999888877766643 345567889999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHH
Q 006703 595 LIETCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RP-----s~~~Il~ 615 (634)
||.+||..||.+|| |+.++++
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 99999999999999 9999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=345.06 Aligned_cols=256 Identities=35% Similarity=0.602 Sum_probs=215.1
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-CcEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-PNLSIV 436 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~-~~~~lV 436 (634)
.....|...+.||+|+||+||++++++..||+|++.... ..+.+.+|+.++++++||||+++++++... ...++|
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 345789999999999999999999998889999986543 345788999999999999999999987544 579999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... ...+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999996432 123788999999999999999999999 999999999999999999999999998764432
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ....+..+..+++.+.++
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 246 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEV 246 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHHH
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHHHH
Confidence 234467889999999999999999999999999999998 999999887776665553 334566778899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+.+||..||.+|||+.++++.|+++....
T Consensus 247 i~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 247 MKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 99999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.02 Aligned_cols=263 Identities=30% Similarity=0.478 Sum_probs=223.6
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~ 430 (634)
.....|...+.||+|+||.||+|++.+ ..||||++.... ......++.+|+.++++++||||+++++++.+.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345788999999999999999998643 249999986443 344456788999999999999999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCC----CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC---cEE
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVK 503 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~----~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~---~ik 503 (634)
...++||||+++++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+|
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999996432 2235889999999999999999999999 99999999999998554 599
Q ss_pred EEecCCCccCCC--CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCc
Q 006703 504 VCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 580 (634)
Q Consensus 504 L~DFGla~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~ 580 (634)
|+|||+++.... .........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. ...
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999874321 1112334567899999999999999999999999999999998 999999988887776664 344
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
....+..+++.+.+|+.+||..||++|||+.+|++.|+.+.+..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 55667889999999999999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.19 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=206.5
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...+.||+|+||+||+|.+. +..||+|++..........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56889999999999999999987 4459999987776666666788899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999999886443 3899999999999999999999999 99999999999999999999999999987654443
Q ss_pred cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------------------
Q 006703 519 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------ 579 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------------ 579 (634)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 4456689999999999976 567999999999999999999999999888766554332110
Q ss_pred -cccCC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -RRLEI----------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -~~~~~----------~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...+. ...+++.+.+|+.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 1357889999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=354.00 Aligned_cols=262 Identities=31% Similarity=0.502 Sum_probs=223.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC-------cEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~-------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~ 430 (634)
....|...+.||+|+||.||+|.+.+. .||+|++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 347889999999999999999998642 48999986553 344557789999999999 899999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCC-----------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPD-----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 499 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~-----------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~ 499 (634)
+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+||+++.+
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCC
Confidence 99999999999999999986432 1234789999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006703 500 YTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG 576 (634)
Q Consensus 500 ~~ikL~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~ 576 (634)
+.+||+|||++...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 99999999999754322 112334557889999999999999999999999999999998 999998877655555554
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 577 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 577 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
........+...++.+.+++.+||..||.+|||+.+|++.|+++.+.
T Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 45555666778899999999999999999999999999999998875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.72 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=223.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
....+|...+.||+|+||.||++.+..+ .+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 3457899999999999999999998744 499999876543 3455677889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999999886432 4899999999999999999999999 9999999999999999999999999998755
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
..........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....++..+++.+.+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 244 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAAS 244 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHH
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHH
Confidence 44334456779999999999999999999999999999999999999999888777665553 3445667889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
++.+||..||++|||+.++++ ..++.+
T Consensus 245 li~~~l~~~p~~Rps~~~ll~--~~~~~~ 271 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLN--DEFFTS 271 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred HHHHHcccChhhCcCHHHHhh--Chheec
Confidence 999999999999999999998 345554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.91 Aligned_cols=260 Identities=30% Similarity=0.467 Sum_probs=218.9
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCc-----EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-----vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
.....|...+.||+|+||.||+|.+.+.. ||+|++.... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 34578999999999999999999876432 8999886553 34455789999999999999999999999875 45
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 689999999999999997433 24889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 513 KPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 513 ~~~~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCH
Confidence 54322 12344567889999999999999999999999999999998 999998877766655553 3344556778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+.+++.+||..||++|||+.++++.|+++++..
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=346.59 Aligned_cols=251 Identities=30% Similarity=0.547 Sum_probs=203.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHh--CCCCCeeeeeceeec----CCc
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLLMGAVTE----PPN 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~--l~h~nIv~l~~~~~~----~~~ 432 (634)
....|...+.||+|+||+||+|++.+..||+|++.... ...+..|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 45789999999999999999999988889999986432 2344566666666 799999999998643 355
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHH--------hCCCCEEeeccCCCcEEEcCCCcEEE
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--------QRRPPIVHRDLKSPNLLVDSTYTVKV 504 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH--------~~g~~IvHrDIKP~NILld~~~~ikL 504 (634)
.++||||+++++|.++++.. .+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEE
T ss_pred eEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999999643 3899999999999999999999 888 999999999999999999999
Q ss_pred EecCCCccCCCCcc----cCCCCCCCCcccCcccccCC------CCCchHHHHHHHHHHHHHHhC----------CCCCC
Q 006703 505 CDFGLSRSKPNTYI----SSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVILWELITL----------QKPWR 564 (634)
Q Consensus 505 ~DFGla~~~~~~~~----~~~~~~gt~~y~APEvl~~~------~~s~~sDVwSLGvlL~eLltg----------~~Pf~ 564 (634)
+|||++........ ......||+.|+|||++.+. .+++++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999875332211 13345799999999999877 445799999999999999999 88886
Q ss_pred CCCh-----HHHHHHHhhcCcccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 565 NSTP-----SQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 565 ~~~~-----~~~~~~i~~~~~~~~~~~-----~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
.... .............+.++. ..++.+.+++.+||..||++|||+.++++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 5322 223333333333444432 3567899999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=352.21 Aligned_cols=250 Identities=28% Similarity=0.342 Sum_probs=207.1
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.+. +..||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 468999999999999999999987 445999998655332 23356889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC--
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-- 515 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~-- 515 (634)
||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999987443 4899999999999999999999999 99999999999999999999999999975432
Q ss_pred CcccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhhcCcccCCCCCCcHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .................+++.+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 1222346689999999999988776 789999999999999999999998765532 22222222222233356899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+|+.+||..||.+|||+.++++
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCChhhCcCHHHHhh
Confidence 9999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=353.66 Aligned_cols=265 Identities=28% Similarity=0.426 Sum_probs=216.5
Q ss_pred CCCCCCcceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 355 NPSGPSTHVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 355 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
........|...+.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34455678999999999999999999976 45699998765432 3346788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 434 SIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~-~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999986443 2235899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHhhcC----
Q 006703 513 KPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS-------AVGFKG---- 579 (634)
Q Consensus 513 ~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~-------~i~~~~---- 579 (634)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+... ......
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 43221 12234458999999999999999999999999999999999999997654422110 000000
Q ss_pred ccc----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 580 RRL----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 580 ~~~----~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
..+ .++...+..+.+++.+||..||++|||+.++++.|+.+++.
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 011 12234567899999999999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.67 Aligned_cols=251 Identities=30% Similarity=0.481 Sum_probs=212.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec----CCc
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPN 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~----~~~ 432 (634)
....|...+.||+|+||.||+|.+..+. ||+|++..........+.+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3466888889999999999999987554 8999988777677777889999999999999999999998854 456
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEEecCCCc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSR 511 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~DFGla~ 511 (634)
+++||||+++++|.+++.... .+++..++.++.||+.||.|||+++++|+|+||||+||+++ .++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 899999999999999997432 48899999999999999999999876799999999999998 78899999999997
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhcCcccCCCCCCcH
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~ 590 (634)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .....+.........+...++
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 64433 2345679999999998874 5899999999999999999999999885544 444444333334455667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.++|.+||..||.+|||+.++++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCCCHHHHhh
Confidence 9999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.52 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=212.5
Q ss_pred CCCCcceeecceeecc--CcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 357 SGPSTHVIDSSNFIKG--SFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G--~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
......|...+.||+| +||+||+|+++ +..||+|++............+.+|+.++++++||||+++++++.+++.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3455889999999999 99999999997 4459999998877667777889999999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999999975422 24899999999999999999999999 99999999999999999999999998754
Q ss_pred CCC-------CcccCCCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC----
Q 006703 513 KPN-------TYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---- 579 (634)
Q Consensus 513 ~~~-------~~~~~~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~---- 579 (634)
... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 221 1112334578999999999987 578999999999999999999999998766544433221100
Q ss_pred ----------------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 580 ----------------------------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 580 ----------------------------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.....+..+++.+.+||.+||..||.+|||+.++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0112345678999999999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=367.65 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=215.4
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||+||+|+++.+ .||+|++.+.... ......+.+|+.+++.++||||+++++++.++..+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 447899999999999999999999754 4999998653321 1122347799999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||++||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 147 V~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999998643 3899999999999999999999999 99999999999999999999999999976543
Q ss_pred Cc-ccCCCCCCCCcccCcccccCCC----CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCC
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNV 588 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~~~~----~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 588 (634)
.. ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+........+| ..+
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccc
Confidence 32 2345778999999999998766 7899999999999999999999999999888777775433333333 478
Q ss_pred cHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEI--RPSFPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~--RPs~~~Il~ 615 (634)
++++++||.+||..+|.+ ||++.+|++
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 999999999999999988 999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.91 Aligned_cols=247 Identities=29% Similarity=0.458 Sum_probs=210.2
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 467999999999999999999985 4459999987553322 2235688999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 678888886432 4899999999999999999999999 999999999999999999999999999865443
Q ss_pred cccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
. .....+||+.|+|||++.+..+ ++++||||||+++|+|++|+.||......+....+ .......|..+++.+.+|
T Consensus 162 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 162 N-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSL 238 (336)
T ss_dssp B-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHH
T ss_pred c-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHH
Confidence 2 3456789999999999988876 78999999999999999999999876544332222 223445677899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~ 615 (634)
|.+||..||.+|||+.++++
T Consensus 239 i~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHHh
Confidence 99999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.47 Aligned_cols=261 Identities=29% Similarity=0.454 Sum_probs=216.7
Q ss_pred cceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~ 432 (634)
..|...+.||+|+||+||++.+. +..||+|++.... .......+.+|+.++++++||||+++++++.+ ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 33488999999999999998763 3449999987653 34556788999999999999999999999977 467
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+++||||+++++|.+++.... +++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 899999999999999997543 889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHH
Q 006703 513 KPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--------------VISAV 575 (634)
Q Consensus 513 ~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~--------------~~~~i 575 (634)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||....... .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 54432 12345568889999999999999999999999999999999999997543211 11112
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCC
Q 006703 576 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 628 (634)
Q Consensus 576 ~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~ 628 (634)
.........+..+++.+.+||.+||..||++|||+.++++.|+.+......++
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 22344566778899999999999999999999999999999999988765543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=368.59 Aligned_cols=265 Identities=33% Similarity=0.521 Sum_probs=222.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
.....|...+.||+|+||.||+|.+.++ .||||++...... .+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 3457789999999999999999999865 4999998765433 2568899999999999999999999876 678999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 257 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999996432 124889999999999999999999999 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 Y-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
. .......+|..|+|||++.+..++.++||||||+++|||++ |+.||.+....+....+. ...+++.+..+++.+.+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 2 12234457889999999999999999999999999999999 999999988888776664 44556677889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 630 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~ 630 (634)
++.+||..||++|||+.+|++.|++++.+...+..+
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 999999999999999999999999998876555443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.15 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=212.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||+|++..++ ||+|++..... .......+.+|+.+++.++||||+++++++.+....|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3478999999999999999999988554 99999876542 22334678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+.|++|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 93 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999997543 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCcccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhhcCcccCCCCCCc
Q 006703 516 TYISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~---~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~s 589 (634)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....+ ......+|..++
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWS 244 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTSC
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcCC
Confidence 3 23456789999999999964 458999999999999999999999997543 23333333 334556778899
Q ss_pred HHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPS-FPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs-~~~Il~ 615 (634)
+.+.+||.+||..||.+||+ +.+|++
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 99999999999999999998 666654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.31 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=211.6
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC--cE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NL 433 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~--~~ 433 (634)
.....|...+.||+|+||+||+|.+. +..||+|++....... ..+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34578999999999999999999998 4559999987554322 2456789999999999999999999987655 78
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE----cCCCcEEEEecCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL 509 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl----d~~~~ikL~DFGl 509 (634)
++||||+++++|.+++........+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999999986555455999999999999999999999999 9999999999999 7888899999999
Q ss_pred CccCCCCcccCCCCCCCCcccCccccc--------CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhh
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLR--------EDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGF 577 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~--------~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~----~~~~~~i~~ 577 (634)
+....... ......||+.|+|||++. +..++.++||||||+++|||++|+.||..... .+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98754432 334567999999999986 57789999999999999999999999964332 233333221
Q ss_pred cCc-------------------c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 578 KGR-------------------R----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 578 ~~~-------------------~----~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
... . ..++..+++.+.+++.+||..||++|||+.++++...+-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 110 0 012234567899999999999999999999999987754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=353.38 Aligned_cols=258 Identities=29% Similarity=0.499 Sum_probs=215.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc------EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~------vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
....|...+.||+|+||+||+|.+..++ +++|.+.... .......+.+|+.++++++||||+++++++. +..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 4578999999999999999999986443 6666664332 1222245678999999999999999999886 467
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred cEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccc
Confidence 899999999999999997542 35888999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 513 KPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 513 ~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 243 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICT 243 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCc
Confidence 54322 12344567889999999999999999999999999999999 999999888777665553 344566677889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+.+.+++.+||..||.+|||+.++++.|+.+.+.
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.89 Aligned_cols=266 Identities=32% Similarity=0.555 Sum_probs=222.7
Q ss_pred CCCCCCcceeecceeeccCcEEEEEEEEcCCc----EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 006703 355 NPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE 429 (634)
Q Consensus 355 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~----vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~ 429 (634)
.+......|...+.||+|+||.||+|++..++ +++|.+.... .......+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred cccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 34444578899999999999999999887543 4888876432 334456788999999999 89999999999999
Q ss_pred CCcEEEEEeecccCCHHHHhccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~-------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV 175 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEE
Confidence 999999999999999999997543 2235899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAV 575 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i 575 (634)
+.++.+||+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp CGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred cCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 99999999999998753321 22334567889999999998889999999999999999998 99999998887776666
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 576 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 576 ~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
. .......+..+++.+.++|.+||..||.+|||+.++++.|++++....
T Consensus 255 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 255 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp G-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred h-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 4 334556677899999999999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.38 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=196.7
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.++ +..||+|++..... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 367888999999999999999887 44599999875532 222356779999999999999999999999999999999
Q ss_pred eecccCCHHHHhccC---CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~---~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
||++ ++|.+++... .....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9998 5999888532 22234899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-------------
Q 006703 515 NTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------- 580 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~------------- 580 (634)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 443344566899999999999764 579999999999999999999999998887766554421100
Q ss_pred -------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -------------------~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+..+..+++.+.+||.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 01122357889999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=349.62 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=201.8
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------- 431 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------- 431 (634)
..|...+.||+|+||.||+|+++ +..||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 56888999999999999999987 4459999997654 3334577899999999999999999999885543
Q ss_pred --------------------------------------------------cEEEEEeecccCCHHHHhccCCCcccccHH
Q 006703 432 --------------------------------------------------NLSIVTEYLSRGSLYKLLHIPDARVVVDER 461 (634)
Q Consensus 432 --------------------------------------------------~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~ 461 (634)
..+++|||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 389999999999999999876666667788
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc------------ccCCCCCCCCcc
Q 006703 462 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY------------ISSKTAAGTPEW 529 (634)
Q Consensus 462 ~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~------------~~~~~~~gt~~y 529 (634)
.++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++....... .......||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999999999 9999999999999999999999999998654431 123445799999
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 006703 530 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 609 (634)
Q Consensus 530 ~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs 609 (634)
+|||++.+..++.++||||||+++|+|++|..|+... ........ ....+......++.+.++|.+||..||++|||
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 9999999999999999999999999999987764221 11111111 11222222445778899999999999999999
Q ss_pred HHHHHH
Q 006703 610 FPSIME 615 (634)
Q Consensus 610 ~~~Il~ 615 (634)
+.++++
T Consensus 320 ~~~~l~ 325 (332)
T 3qd2_B 320 ATDIIE 325 (332)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.80 Aligned_cols=257 Identities=30% Similarity=0.515 Sum_probs=212.4
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--E----EEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--V----AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--v----AvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...|...+.||+|+||.||+|.+..++ + ++|.+.... .......+.+|+.++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 477999999999999999999986443 4 666554332 2233467889999999999999999999998754 8
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++++|+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred eEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 89999999999999997543 24899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 514 PNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 514 ~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 3321 22334456889999999999999999999999999999999 999999888777665553 4445667788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.+.+++.+||..||.+|||+.++++.|+++...
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=342.83 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=190.4
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||.||+|++. +..||+|++....... .....+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 67899999999999999999985 4559999986543221 22467889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+|+||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999997543 34899999999999999999999999 9999999999999999999999999998755433
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+ .......+..++.++.++|.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~ 244 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIH 244 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CSSCCCCCTTSCHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hhcccCCccccCHHHHHHHH
Confidence 3344567999999999999988999999999999999999999999877655544433 22334567788999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~ 615 (634)
+||..||++|||+.++++
T Consensus 245 ~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 245 QLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHSCSSGGGSCCHHHHTT
T ss_pred HHcccCHhhCCCHHHHhc
Confidence 999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.15 Aligned_cols=254 Identities=28% Similarity=0.397 Sum_probs=209.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~---~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..+|...+.||+|+||.||+|.+..+ .+|+|++..... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 37789999999999999999998754 499999876532 2344578899999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccC-------------------------------------CCcccccHHHHHHHHHHHHHHHHHH
Q 006703 435 IVTEYLSRGSLYKLLHIP-------------------------------------DARVVVDERLRLNMAYDVAKGMNYL 477 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~-------------------------------------~~~~~l~e~~~~~i~~qIa~aL~yL 477 (634)
+||||+++++|.+++... .....+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 0122357788999999999999999
Q ss_pred HhCCCCEEeeccCCCcEEEcCCC--cEEEEecCCCccCCC----CcccCCCCCCCCcccCcccccC--CCCCchHHHHHH
Q 006703 478 HQRRPPIVHRDLKSPNLLVDSTY--TVKVCDFGLSRSKPN----TYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSF 549 (634)
Q Consensus 478 H~~g~~IvHrDIKP~NILld~~~--~ikL~DFGla~~~~~----~~~~~~~~~gt~~y~APEvl~~--~~~s~~sDVwSL 549 (634)
|+++ |+||||||+||+++.++ .+||+|||++..... .........||+.|+|||++.+ ..++.++|||||
T Consensus 185 H~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9999 99999999999998666 899999999975322 1112346679999999999975 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 550 GVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 550 GvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
|+++|+|++|+.||......+....+.........+ ..+++.+.+||.+||..||.+|||+.++++
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999988887776664443333222 347899999999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=349.83 Aligned_cols=261 Identities=31% Similarity=0.533 Sum_probs=222.3
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~ 430 (634)
....+|...+.||+|+||.||+|.+. +..||+|++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 44578999999999999999999876 3459999986543 334456789999999999999999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCC-------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEE
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPD-------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 503 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~-------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ik 503 (634)
+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+||+++.++.+|
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCCeEE
Confidence 99999999999999999986422 1134688999999999999999999999 99999999999999999999
Q ss_pred EEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCc
Q 006703 504 VCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 580 (634)
Q Consensus 504 L~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~ 580 (634)
|+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-EGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-TTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH-cCC
Confidence 99999997543221 12234457889999999999999999999999999999999 899999988877766653 334
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
....+..+++.+.+++.+||..||.+|||+.++++.|++++.
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 455677899999999999999999999999999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.44 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=223.3
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
....+|...+.||+|+||.||++.+..+ .+|+|++..... .....+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3457899999999999999999998754 499999876543 3455677889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 118 lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999999986432 4899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
..........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.. ....++..+++.+.+
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 270 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIPKHINPVAAS 270 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHH
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc--CCCCCCccCCHHHHH
Confidence 443344567799999999999999999999999999999999999999998887766655532 344567789999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+|.+||..||++|||+.++++ ..++.+
T Consensus 271 li~~~l~~dp~~Rps~~ell~--~~~~~~ 297 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLN--DEFFTS 297 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc--CccccC
Confidence 999999999999999999998 344544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=346.96 Aligned_cols=259 Identities=29% Similarity=0.474 Sum_probs=213.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeecc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQE--FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~--~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|.+.+..+|+|++.... ......+.+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 445566899999999999999988889999986543 223445778899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++++|.+++........+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 9999999999975544456899999999999999999999999 9999999999999999999999999987644321
Q ss_pred -ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHhhc---------CcccC
Q 006703 518 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----VISAVGFK---------GRRLE 583 (634)
Q Consensus 518 -~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~----~~~~i~~~---------~~~~~ 583 (634)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+ ....+... .....
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 12345679999999999875 47899999999999999999999997654322 11111110 11112
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
.+...++.+.+++.+||..||.+|||+.++++.|+++..
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 233456789999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=356.84 Aligned_cols=264 Identities=16% Similarity=0.200 Sum_probs=209.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHH---------HHHHHHHHHHHHhCCCCCeee
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDR---------FKEFLREVAIMKGLRHPNIVL 422 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~---------~~~~~~El~iL~~l~h~nIv~ 422 (634)
....|...+.||+|+||.||+|.+.. ..||+|++......... ...+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998864 35999998755321110 123455667778889999999
Q ss_pred eeceeecC----CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-
Q 006703 423 LMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD- 497 (634)
Q Consensus 423 l~~~~~~~----~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld- 497 (634)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 99998664 4589999999 999999997543 34899999999999999999999999 99999999999999
Q ss_pred -CCCcEEEEecCCCccCCCCcc-------cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH
Q 006703 498 -STYTVKVCDFGLSRSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 569 (634)
Q Consensus 498 -~~~~ikL~DFGla~~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~ 569 (634)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999975432211 123445999999999999999999999999999999999999999864322
Q ss_pred HHHH-HHhh--cCcc------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 570 QVIS-AVGF--KGRR------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 570 ~~~~-~i~~--~~~~------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
.... .... .... ...+..+++++.+++..||..||++||++.+|++.|+++++.....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 2211 1110 0000 0112578999999999999999999999999999999999875443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=343.22 Aligned_cols=262 Identities=33% Similarity=0.544 Sum_probs=213.4
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC---C--cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN---S--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---~--~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
....|...+.||+|+||+||+|++.. . .||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 34789999999999999999998642 2 389998876543 2345678999999999999999999999998765
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++|||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++..
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 889999999999999997432 34889999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 513 KPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 513 ~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
...... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.........+..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 543221 2234567889999999998889999999999999999999 999999999888887776666666677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
++.+.+++.+||..||++|||+.++++.|+++.+...
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 9999999999999999999999999999998876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=372.95 Aligned_cols=259 Identities=35% Similarity=0.580 Sum_probs=224.8
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.....|...+.||+|+||.||+|.++. ..||||++...... .+.+.+|+.++++++||||+++++++.....+++
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 345778999999999999999999984 45999998755433 3678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999975332 34889999999999999999999999 99999999999999999999999999987543
Q ss_pred Cc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..+....+. ...+...+..+++.+.
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVY 449 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 22 22334456789999999999999999999999999999999 999999888777665553 3455667788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+||.+||..||++|||+.+|++.|+.+++.
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.59 Aligned_cols=255 Identities=17% Similarity=0.222 Sum_probs=211.5
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||+||+|++. +..||+|++...... ..+.+|+.+++++ +||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 367899999999999999999976 445999998654322 3577999999999 999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc-----EEEEecCCCc
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLSR 511 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~-----ikL~DFGla~ 511 (634)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 9999 899999997542 34899999999999999999999999 999999999999998877 9999999998
Q ss_pred cCCCCcc-------cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhcCc-
Q 006703 512 SKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGR- 580 (634)
Q Consensus 512 ~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~---~~~~~i~~~~~- 580 (634)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 6433211 134668999999999999999999999999999999999999999875432 33333311111
Q ss_pred --ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 581 --RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 581 --~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.......++ ++.+++.+||..||.+||++.+|++.|+++.+..
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 111223455 9999999999999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=338.21 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=221.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
.....|...+.||+|+||.||+|++..++ ||+|++....... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 34478999999999999999999987544 9999986543322 22356889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+++++|.+++.... .+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++....
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999987543 3899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....++..+++.+.+
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKD 241 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHH
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHH
Confidence 32 2345679999999999999999999999999999999999999999888777665553 3445677889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
+|.+||..||.+|||+.++++. .+++.....
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h--~~~~~~~~~ 272 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEH--PWVKANSRR 272 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTC--HHHHHHCCC
T ss_pred HHHHHhhcCHhhCCCHHHHhhC--HHHHhhccc
Confidence 9999999999999999999973 455544433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=341.58 Aligned_cols=250 Identities=29% Similarity=0.506 Sum_probs=219.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
+...|...+.||+|+||.||+|.+. +..||+|++...... ...+.+.+|+.++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3466899999999999999999886 445999998765432 3346788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++... .+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++......
T Consensus 99 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999998642 4899999999999999999999999 999999999999999999999999999876554
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. ....+.++..+++.+.+++
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 251 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFV 251 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHH
Confidence 444556789999999999999999999999999999999999999999888877665553 3445566778999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~ 616 (634)
.+||..||.+|||+.++++.
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTC
T ss_pred HHHcCCChhhCcCHHHHhhC
Confidence 99999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.82 Aligned_cols=264 Identities=25% Similarity=0.368 Sum_probs=211.2
Q ss_pred cCCCCCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC
Q 006703 354 QNPSGPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430 (634)
Q Consensus 354 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~ 430 (634)
..+.....+|...+.||+|+||.||+|++.. ..||+|++..... .......+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 3444556889999999999999999999864 4499999976543 345567789999999999999999999998765
Q ss_pred Cc----EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEe
Q 006703 431 PN----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 506 (634)
Q Consensus 431 ~~----~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~D 506 (634)
.. .++||||+++++|.++++... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~D 159 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD 159 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEee
Confidence 44 499999999999999997443 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc-
Q 006703 507 FGLSRSKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL- 582 (634)
Q Consensus 507 FGla~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~- 582 (634)
||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+...........+
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence 99997644321 12334568999999999999999999999999999999999999999988877665553332222
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHH-HHHHHHHHHH
Q 006703 583 -EIPKNVNPMVAALIETCWAEEPEIRPSFPS-IMETLQQFLM 622 (634)
Q Consensus 583 -~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~-Il~~L~~ll~ 622 (634)
.....+++.+.++|.+||..||++||++.+ +...|.+...
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 233568999999999999999999986555 4455555544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=350.56 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=213.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
+...|...+.||+|+||+||+|++. +..||+|++..... .......+.+|+.++++++||||+++++++..++..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 3466889999999999999999976 44499999876543 34455788999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+. |+|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 132 v~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 999997 57877775322 34899999999999999999999999 99999999999999999999999999976543
Q ss_pred CcccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
.....||+.|+|||++. +..++.++||||||+++|||++|+.||...+.......+.........+..+++.+
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 24567999999999984 56789999999999999999999999998887776666644444444556789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.++|.+||..||++|||+.++++
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcccChhhCcCHHHHhh
Confidence 99999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.84 Aligned_cols=262 Identities=33% Similarity=0.498 Sum_probs=215.2
Q ss_pred CcceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee--cCC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~--~~~ 431 (634)
...|...+.||+|+||.||+|++. +..||+|++... .....+.+.+|+.++++++|+||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 478999999999999999999852 334999998654 3444567899999999999999999999886 556
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence 6999999999999999997432 24899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHH
Q 006703 512 SKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--------------QVISA 574 (634)
Q Consensus 512 ~~~~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~--------------~~~~~ 574 (634)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 654322 1234556888999999999998999999999999999999999998654332 11122
Q ss_pred HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 575 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 575 i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
..........+..+++.+.+++.+||..||++|||+.++++.|+.+.......
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 22334456677889999999999999999999999999999999998765443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.39 Aligned_cols=263 Identities=31% Similarity=0.504 Sum_probs=211.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee-cCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-EPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~-~~~~~ 433 (634)
...|...+.||+|+||.||+|.+... .+|+|.+... ......+++.+|+.++++++||||+++++++. .++..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35677889999999999999987532 2788887643 23455678999999999999999999999864 45678
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999999997543 24788999999999999999999999 999999999999999999999999999754
Q ss_pred CCCc----ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 514 PNTY----ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 514 ~~~~----~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |.+||...+..+....+. .......+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~ 321 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYC 321 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 3321 11234457889999999999999999999999999999999 688888776655554443 34455667789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCC
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 628 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~ 628 (634)
++.+.+++.+||..||++|||+.++++.|++++.......
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 9999999999999999999999999999999998765443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=342.78 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=216.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee--cCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~--~~~~~~l 435 (634)
...|...+.||+|+||.||++.+.. ..+|+|++..........+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4688999999999999999999874 44999999877666667788999999999999999999999874 4678999
Q ss_pred EEeecccCCHHHHhccCC-CcccccHHHHHHHHHHHHHHHHHHHhCC---CCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 436 VTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRR---PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~-~~~~l~e~~~~~i~~qIa~aL~yLH~~g---~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ .+|+|+||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996422 2234899999999999999999999976 249999999999999999999999999987
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.............||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.. .....++..+++.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcccCHH
Confidence 654332222344689999999999999999999999999999999999999999887776665543 3344677789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETL 617 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L 617 (634)
+.++|.+||..||++|||+.+|++.+
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 99999999999999999999998743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=366.50 Aligned_cols=250 Identities=29% Similarity=0.486 Sum_probs=218.6
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
.....|...+.||+|+||.||+|++. +..||+|++....... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34478999999999999999999987 5559999987654322 23467889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 93 lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999997543 4899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCcccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 593 (634)
... .....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+. ......|..+++.+.
T Consensus 168 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 244 (476)
T 2y94_A 168 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPSVI 244 (476)
T ss_dssp TTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHHHH
T ss_pred ccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHHHH
Confidence 432 3456789999999999988876 789999999999999999999999888777766663 334556778999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+||.+||..||.+|||+.++++
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCchhCcCHHHHHh
Confidence 9999999999999999999997
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=366.45 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=215.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||+||+|+++.++ ||+|++.+.... ......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 4478999999999999999999998644 999998754321 1122347899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 152 V~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999999997532 34899999999999999999999999 99999999999999999999999999976443
Q ss_pred C-cccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC---C
Q 006703 516 T-YISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP---K 586 (634)
Q Consensus 516 ~-~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~---~ 586 (634)
. .......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+........+| .
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 2 22334568999999999997 5568999999999999999999999999999888777764433333333 4
Q ss_pred CCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 006703 587 NVNPMVAALIETCWAEEPEI--RPSFPSIME 615 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~--RPs~~~Il~ 615 (634)
.+++.+.+||.+||..+|++ ||++.++++
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 58999999999999888888 999999886
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=374.88 Aligned_cols=260 Identities=29% Similarity=0.486 Sum_probs=218.9
Q ss_pred cceeeccCcEEEEEEEEcC----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 366 SSNFIKGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
...||+|+||.||+|.++. ..||||++.... .....+++.+|+++|++++||||+++++++.. +..++||||+.
T Consensus 341 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~ 418 (613)
T 2ozo_A 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 418 (613)
T ss_dssp EEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCC
Confidence 3489999999999998752 239999987653 23345778999999999999999999999976 56999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc---
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--- 518 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~--- 518 (634)
+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 419 ~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 419 GGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp TCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred CCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999999996443 34899999999999999999999999 99999999999999999999999999986543211
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+. ...++..+..+++.+.+||.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 573 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMS 573 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHH
Confidence 1223345689999999999999999999999999999998 999999988888776664 44566778889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 632 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~~~ 632 (634)
+||..||++|||+.+|++.|+.+..+.........
T Consensus 574 ~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s 608 (613)
T 2ozo_A 574 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608 (613)
T ss_dssp HTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSS
T ss_pred HHcCCChhHCcCHHHHHHHHHHHHHHhccccCCcc
Confidence 99999999999999999999999988766555443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=343.82 Aligned_cols=250 Identities=22% Similarity=0.386 Sum_probs=215.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHH----HHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHED----RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~----~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...|...+.||+|+||.||+|.+.. ..+|+|++........ ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3678999999999999999999874 4599999876543221 246788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC----cEEEEecCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL 509 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~----~ikL~DFGl 509 (634)
++||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999997543 4899999999999999999999999 99999999999999887 799999999
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCCC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKN 587 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~ 587 (634)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 98654432 334567999999999999999999999999999999999999999998887776665432221 122357
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++.+.++|.+||..||++|||+.++++
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 8999999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=335.41 Aligned_cols=247 Identities=26% Similarity=0.364 Sum_probs=212.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.+.++. +|+|++....... .+.+.+|+.++++++||||+++++++.+....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 367889999999999999999988654 8999987654332 357889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE---cCCCcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl---d~~~~ikL~DFGla~~~~ 514 (634)
||+++++|.+++.... .+++..++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999886433 3899999999999999999999999 9999999999999 788999999999997654
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCC--CCCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l 592 (634)
... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+.......+. ...+++.+
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 161 PGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp TTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred Ccc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 332 34566799999999998765 899999999999999999999999998887777666433222211 13689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+++.+||..||++|||+.++++
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.83 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=208.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC--CCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h--~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||++.+.. ..||+|++..........+.+.+|+.++++++| +||+++++++..+...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35779999999999999999998764 349999998777677777889999999999976 999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|||+ .+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||++.....
T Consensus 87 v~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9995 5779999997543 4889999999999999999999999 99999999999997 67899999999986543
Q ss_pred Ccc--cCCCCCCCCcccCcccccC-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcc
Q 006703 516 TYI--SSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRR 581 (634)
Q Consensus 516 ~~~--~~~~~~gt~~y~APEvl~~-----------~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~ 581 (634)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ......+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 221 2345679999999999865 6789999999999999999999999987543 2333334334455
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 582 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 582 ~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
..++...++.+.+|+.+||..||.+|||+.++++.
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 56777889999999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=354.58 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=214.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||+|.++.+ .+|+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 36799999999999999999998744 49999986543 223457889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC--CCcEEEEecCCCccCCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~--~~~ikL~DFGla~~~~~ 515 (634)
||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. .+.+||+|||++.....
T Consensus 128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999987543 24899999999999999999999999 999999999999974 57899999999986543
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc--ccCCCCCCcHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--RLEIPKNVNPMVA 593 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~ 593 (634)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... .......+++++.
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred Cc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 32 22345799999999999999999999999999999999999999999888777666643322 2234457899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+||.+||..||++|||+.++++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHhh
Confidence 9999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.93 Aligned_cols=252 Identities=20% Similarity=0.280 Sum_probs=211.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||+||+|+++ +..||+|++.+... .......+.+|..++..++||||+++++++.+.+.+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4478999999999999999999987 44599999875432 22223457899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||++||+|.+++...+ ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 139 VmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999997533 24899999999999999999999999 99999999999999999999999999976543
Q ss_pred Cc-ccCCCCCCCCcccCccccc-------CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc---cCC
Q 006703 516 TY-ISSKTAAGTPEWMAPEVLR-------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---LEI 584 (634)
Q Consensus 516 ~~-~~~~~~~gt~~y~APEvl~-------~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~---~~~ 584 (634)
.. ......+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+...... +..
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 22 2234568999999999997 356899999999999999999999999998888777666433222 223
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIR---PSFPSIME 615 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~R---Ps~~~Il~ 615 (634)
+..+++++++||.+||. +|.+| |++.+|++
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 46799999999999999 99998 58988875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.61 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=199.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...+|...+.||+|+||+||+|.+..+ .||+|++............+.+|+.++++++||||+++++++.++...++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 347899999999999999999988744 499999976655555566788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-----CCCcEEEEecCCCc
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-----STYTVKVCDFGLSR 511 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-----~~~~ikL~DFGla~ 511 (634)
|||+++ +|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.
T Consensus 112 ~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999975 9999987543 3899999999999999999999999 99999999999994 45569999999997
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC-------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE------- 583 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~------- 583 (634)
.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+......+.
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 6544433445667899999999998754 79999999999999999999999998887766555432111000
Q ss_pred ---------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 584 ---------------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 584 ---------------------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++..+++++.+||.+||..||++|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 01126789999999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=353.14 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=206.0
Q ss_pred eeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
+...+.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 444678999999999999986 44599999876542 34467889999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE--cCCCcEEEEecCCCccCCCCcc
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV--DSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl--d~~~~ikL~DFGla~~~~~~~~ 518 (634)
++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 169 ~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 169 DGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999886433 34899999999999999999999999 9999999999999 567899999999998654332
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc--CCCCCCcHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALI 596 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l~~Li 596 (634)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....... .....+++++.+||
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 3345679999999999999999999999999999999999999999988877766664332222 22356899999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||..||.+|||+.++++
T Consensus 324 ~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhhCCCHHHHhc
Confidence 9999999999999999997
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=350.87 Aligned_cols=250 Identities=29% Similarity=0.424 Sum_probs=198.5
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....+|...+.||+|+||+||++++.. ..||+|++....... +.+.+|+.+++.++||||+++++++......++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 345789999999999999999999874 449999987654332 456799999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc--EEEEecCCCccC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRSK 513 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~--ikL~DFGla~~~ 513 (634)
||||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||+++..
T Consensus 94 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999999986433 3899999999999999999999999 999999999999987665 999999998753
Q ss_pred CCCcccCCCCCCCCcccCcccccCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhcCcccCCCCCC
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLREDPSNEK-SDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~~-sDVwSLGvlL~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 588 (634)
... .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||..... ......+.......+....+
T Consensus 169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 322 23345679999999999988887655 8999999999999999999987543 23333332222233333468
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
++.+.+||.+||..||++|||+.++++.
T Consensus 248 s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 248 SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 9999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.81 Aligned_cols=245 Identities=21% Similarity=0.238 Sum_probs=201.8
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...++||+|+||+||+|++. +..||||++...........++..|+..+.++ +|+||+++++++.+....++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57889999999999999999987 44599999876655555555666677666655 8999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 668988886443 34899999999999999999999999 9999999999999999999999999987654432
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ...+......+.++..+++.+.+++.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHH
Confidence 3345679999999999876 689999999999999999999777655332 22232223334455678999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~ 615 (634)
+||..||++|||+.++++
T Consensus 287 ~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHSCSSTTTSCCHHHHHT
T ss_pred HHcCCChhhCcCHHHHHh
Confidence 999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=344.84 Aligned_cols=261 Identities=19% Similarity=0.224 Sum_probs=210.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||.||+|.+.. ..||+|++..... .....+.+.+|+.++++++||||+++++++..++..+++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 3679999999999999999999874 4499999876543 334457789999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... .+++..++.++.|++.||.|||++| |+|+||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997432 4899999999999999999999999 999999999999999999999999998765432
Q ss_pred c-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCCcHHHHH
Q 006703 517 Y-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~ 594 (634)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..... ....+..+++.+.+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 2 223455799999999999999999999999999999999999999988776654444432222 22456788999999
Q ss_pred HHHHhhhcCCCCCC-CHHHHHHHHHHHHHhcC
Q 006703 595 LIETCWAEEPEIRP-SFPSIMETLQQFLMSSV 625 (634)
Q Consensus 595 Li~~cL~~dP~~RP-s~~~Il~~L~~ll~~~~ 625 (634)
+|.+||..||++|| |+.++++.|++++....
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 99999999999999 99999999999877654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.65 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=202.4
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHH--HHHHHHHhCCCCCeeeeecee-----ecC
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFL--REVAIMKGLRHPNIVLLMGAV-----TEP 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~--~El~iL~~l~h~nIv~l~~~~-----~~~ 430 (634)
.....|...+.||+|+||.||+|++.+..||+|++..... ..+. .|+..+..++|+||+++++.+ ...
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred cChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 3457899999999999999999999888899999865432 2233 344445568999999999754 233
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC---------CCCEEeeccCCCcEEEcCCCc
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR---------RPPIVHRDLKSPNLLVDSTYT 501 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~---------g~~IvHrDIKP~NILld~~~~ 501 (634)
..+++||||+++++|.+++.... .++..++.++.||+.||.|||++ + |+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 46789999999999999996443 58888999999999999999999 8 999999999999999999
Q ss_pred EEEEecCCCccCCCC--------cccCCCCCCCCcccCcccccC-------CCCCchHHHHHHHHHHHHHHhCCCCCCCC
Q 006703 502 VKVCDFGLSRSKPNT--------YISSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELITLQKPWRNS 566 (634)
Q Consensus 502 ikL~DFGla~~~~~~--------~~~~~~~~gt~~y~APEvl~~-------~~~s~~sDVwSLGvlL~eLltg~~Pf~~~ 566 (634)
+||+|||++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999764322 112235579999999999987 34567899999999999999997776332
Q ss_pred Ch------------------HHHHHHHhhcCcccCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 567 TP------------------SQVISAVGFKGRRLEIPKN------VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 567 ~~------------------~~~~~~i~~~~~~~~~~~~------~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
.. ......+.....++.++.. +++.+.+||.+||..||++|||+.++++.|++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11 1222222223344444443 44589999999999999999999999999999998
Q ss_pred hcCCCC
Q 006703 623 SSVCQP 628 (634)
Q Consensus 623 ~~~~~~ 628 (634)
......
T Consensus 319 ~~~~~~ 324 (336)
T 3g2f_A 319 IWERNK 324 (336)
T ss_dssp CCCC--
T ss_pred HHHhcc
Confidence 765543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=354.32 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=198.1
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCC--cEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP--NLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~--~~~l 435 (634)
.+|...+.||+|+||.||+|.+.. ..||+|++...........++.+|+.+++.+. ||||+++++++...+ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 578899999999999999998874 45999998766555666778889999999997 999999999997544 6899
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||++ ++|..++... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 999997 4898888643 3889999999999999999999999 99999999999999999999999999975432
Q ss_pred C---------------------cccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 006703 516 T---------------------YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS 573 (634)
Q Consensus 516 ~---------------------~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~ 573 (634)
. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 111234579999999999987 678999999999999999999999999888766554
Q ss_pred HHhhcCccc---------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCC
Q 006703 574 AVGFKGRRL---------------------------------------------EIPKNVNPMVAALIETCWAEEPEIRP 608 (634)
Q Consensus 574 ~i~~~~~~~---------------------------------------------~~~~~~s~~l~~Li~~cL~~dP~~RP 608 (634)
.+......+ ..+..+++.+.+|+.+||..||++||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 442110000 11236789999999999999999999
Q ss_pred CHHHHHHH
Q 006703 609 SFPSIMET 616 (634)
Q Consensus 609 s~~~Il~~ 616 (634)
|+.++++.
T Consensus 322 t~~e~l~H 329 (388)
T 3oz6_A 322 SANDALKH 329 (388)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhCC
Confidence 99999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=344.33 Aligned_cols=254 Identities=32% Similarity=0.547 Sum_probs=206.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC--CCCCeeeeeceeecC----CcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL--RHPNIVLLMGAVTEP----PNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l--~h~nIv~l~~~~~~~----~~~ 433 (634)
..+|...+.||+|+||.||+|++++..||+|++..... ..+..|..++... +||||+++++++... ...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 36889999999999999999999988899999864421 2334555555554 899999999999877 689
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC--------CCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR--------RPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~--------g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
++||||+++++|.+++... .+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEEE
Confidence 9999999999999999643 389999999999999999999998 8 9999999999999999999999
Q ss_pred ecCCCccCCCCccc----CCCCCCCCcccCcccccCCCCCch------HHHHHHHHHHHHHHhC----------CCCCCC
Q 006703 506 DFGLSRSKPNTYIS----SKTAAGTPEWMAPEVLREDPSNEK------SDVFSFGVILWELITL----------QKPWRN 565 (634)
Q Consensus 506 DFGla~~~~~~~~~----~~~~~gt~~y~APEvl~~~~~s~~------sDVwSLGvlL~eLltg----------~~Pf~~ 565 (634)
|||++......... .....||+.|+|||++.+...+.. +||||||+++|||++| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999754432211 235679999999999988776554 9999999999999999 777755
Q ss_pred CCh-----HHHHHHHhhcCcccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 566 STP-----SQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 566 ~~~-----~~~~~~i~~~~~~~~~~~-----~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
... ......+......+..+. .+++.+.+++.+||..||.+|||+.++++.|+++.++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 322 223333333333444443 46678999999999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=337.50 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=207.2
Q ss_pred eeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeec
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 440 (634)
+.....||+|+||.||+|.+..+ .||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34455899999999999998644 49999987653 233467889999999999999999999999999999999999
Q ss_pred ccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCCCccCCCCccc
Q 006703 441 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 441 ~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGla~~~~~~~~~ 519 (634)
++++|.+++........+++..++.++.||+.||.|||++| |+|+||||+||+++. ++.+||+|||++.........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 99999999976544445788999999999999999999999 999999999999987 899999999999865543333
Q ss_pred CCCCCCCCcccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~--~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ............+.++..+++.+.+++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 45667999999999997654 789999999999999999999999764432 222233333455677888999999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006703 597 ETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||..||++|||+.++++
T Consensus 260 ~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHT
T ss_pred HHHccCChhhCCCHHHHhc
Confidence 9999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=350.11 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=207.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||.||+|.++.+ .||+|++...... ..+|+.++.++ +||||+++++++.++...|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 46788999999999999999998744 4999998765432 23688888887 799999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC----CcEEEEecCCCcc
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS 512 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~----~~ikL~DFGla~~ 512 (634)
|||+.+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||+... +.+||+|||++..
T Consensus 95 ~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999987543 4899999999999999999999999 9999999999998532 3599999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHhhcCccc--CCCCC
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN---STPSQVISAVGFKGRRL--EIPKN 587 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~---~~~~~~~~~i~~~~~~~--~~~~~ 587 (634)
............||+.|+|||++.+..++.++|||||||++|+|++|..||.. ....+....+....... ..+..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 55443445567899999999999888889999999999999999999999976 34455555554332222 23467
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++++.+||.+||..||++|||+.++++
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=348.60 Aligned_cols=247 Identities=26% Similarity=0.364 Sum_probs=195.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||+|+||.||+|++.++ .||+|++.... ..+.+.+|+.++++++||||+++++++......++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 346789999999999999999999754 49999987543 235677899999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEEEEecCCCccC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSK 513 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ikL~DFGla~~~ 513 (634)
|||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++...
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999987543 4899999999999999999999999 999999999999975 889999999999865
Q ss_pred CCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhhcCcc--cCCCCCCcH
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRR--LEIPKNVNP 590 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~-~~~~i~~~~~~--~~~~~~~s~ 590 (634)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ....+...... .+....++.
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 4322 2345679999999999999999999999999999999999999998766554 33333222211 223357899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+||.+||..||++|||+.++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.73 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=209.4
Q ss_pred ccCCCCCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec
Q 006703 353 MQNPSGPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE 429 (634)
Q Consensus 353 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~ 429 (634)
..........|...+.||+|+||.||+|++. +..||+|++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3444556788999999999999999999985 555999998755332 25677999999999 79999999999976
Q ss_pred ------CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEE
Q 006703 430 ------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 503 (634)
Q Consensus 430 ------~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ik 503 (634)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEE
Confidence 467999999999999999997542 235889999999999999999999999 99999999999999999999
Q ss_pred EEecCCCccCCCCcccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 006703 504 VCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 578 (634)
Q Consensus 504 L~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~ 578 (634)
|+|||++..............||+.|+|||++. +..++.++||||||+++|+|++|..||...........+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 999999987554433345667999999999997 566889999999999999999999999988877766655443
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 579 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 579 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
......+..+++.+.++|.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 3333445678999999999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=343.66 Aligned_cols=263 Identities=27% Similarity=0.454 Sum_probs=198.2
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceee--------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVT-------- 428 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~-------- 428 (634)
..+|...+.||+|+||.||+|++. +..||+|++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 367899999999999999999985 4559999986543 444567889999999995 999999999983
Q ss_pred cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
....++++|||+. |+|.+++........+++..++.++.||+.||.|||++|++|+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 3445899999996 689888865333345999999999999999999999987779999999999999999999999999
Q ss_pred CCccCCCCcc------------cCCCCCCCCcccCcccc---cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 006703 509 LSRSKPNTYI------------SSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS 573 (634)
Q Consensus 509 la~~~~~~~~------------~~~~~~gt~~y~APEvl---~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~ 573 (634)
++........ ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 9986543211 11245689999999998 56678999999999999999999999997755443322
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 629 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~ 629 (634)
.......+...++.+.+|+.+||..||++|||+.++++.|+.+.......+.
T Consensus 264 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~ 315 (337)
T 3ll6_A 264 ----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred ----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence 1223334566788899999999999999999999999999999987655444
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=337.03 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=206.5
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||++.+.. ..+|+|++...... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 678999999999999999999874 45999998765432 224678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE---cCCCcEEEEecCCCccCC
Q 006703 439 YLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 439 ~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl---d~~~~ikL~DFGla~~~~ 514 (634)
|+++++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+||++ +.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999988532 12235899999999999999999999999 9999999999999 456789999999997654
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC-CCCCCcHHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-IPKNVNPMVA 593 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~l~ 593 (634)
... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+............. ....+++.+.
T Consensus 179 ~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Ccc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 332 345667999999999986 4688999999999999999999999999888777666544333322 2245789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++.+||..||++|||+.++++
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.52 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=208.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
...+|...+.||+|+||.||+|++.. ..||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 34789999999999999999999884 4599999987766666667788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999988876443 3899999999999999999999999 999999999999999999999999999865544
Q ss_pred cccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc---------------
Q 006703 517 YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--------------- 580 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~--------------- 580 (634)
........||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 4444566799999999999876 679999999999999999999999998877655443321100
Q ss_pred -----cc---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -----RL---------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -----~~---------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+ .....+++.+.+|+.+||..||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 011357899999999999999999999999886
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=335.20 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=209.0
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||+||+|.+. +..||+|++...........++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 367889999999999999999987 55599999987655555667888999999999 999999999999999999999
Q ss_pred EeecccCCHHHHhccCCC-cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-----------------
Q 006703 437 TEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----------------- 498 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~-~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~----------------- 498 (634)
|||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999964321 134899999999999999999999999 999999999999984
Q ss_pred --CCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 006703 499 --TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 575 (634)
Q Consensus 499 --~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i 575 (634)
...+||+|||.+...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+....... .+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HH
Confidence 447999999999865443 345699999999999876 55789999999999999999988775543322 22
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 576 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 576 ~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+.++..+++.+.+++.+||..||++|||+.++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 241 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 234455677889999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=349.94 Aligned_cols=267 Identities=31% Similarity=0.513 Sum_probs=217.2
Q ss_pred cCCCCCCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 354 QNPSGPSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 354 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
.........|...+.||+|+||.||+|.+.+ .+|+|++..........+.+.+|+.++++++|+||+++++++......
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3344456789999999999999999998875 599999876544443445677899999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++|||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++ ++.+||+|||++...
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999997543 34888999999999999999999999 99999999999998 679999999998753
Q ss_pred CC-----CcccCCCCCCCCcccCcccccC---------CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 006703 514 PN-----TYISSKTAAGTPEWMAPEVLRE---------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 579 (634)
Q Consensus 514 ~~-----~~~~~~~~~gt~~y~APEvl~~---------~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~ 579 (634)
.. .........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 21 1122334568999999999874 457899999999999999999999999988887776665443
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
.....+..+++.+.+++.+||..||++|||+.++++.|+++.+....
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 33334456889999999999999999999999999999998876443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=345.34 Aligned_cols=263 Identities=30% Similarity=0.483 Sum_probs=219.8
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~ 430 (634)
.....|...+.||+|+||.||+|++. +..||+|++.... ......++.+|+.++++++||||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 45588999999999999999999843 3349999986443 344556788999999999999999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCC----cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEE
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDA----RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVK 503 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~----~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ik 503 (634)
...++||||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+||+++. +..+|
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999974432 234889999999999999999999999 999999999999984 45699
Q ss_pred EEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCc
Q 006703 504 VCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 580 (634)
Q Consensus 504 L~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~ 580 (634)
|+|||++...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cCC
Confidence 9999998643221 112234567899999999999999999999999999999998 999999888777666553 344
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+..+..+++.+.++|.+||..||.+|||+.++++.|+.+.+..
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 55667789999999999999999999999999999999988754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=363.81 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=213.7
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||+||+|.+. +..||+|++............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 67889999999999999999987 4459999987654433345678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc---CCCcEEEEecCCCccCCC
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld---~~~~ikL~DFGla~~~~~ 515 (634)
|+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 102 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999886432 4899999999999999999999999 99999999999995 456799999999986543
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCC--CCCCcHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMVA 593 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~ 593 (634)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......... ...+++.+.
T Consensus 177 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 177 NT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp C-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 32 3456679999999999976 4899999999999999999999999999988887777544433332 246899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+||.+||..||.+|||+.++++.
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999973
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=367.67 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=215.5
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH-HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~-~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||+|+++ +..||+|++....... .....+.+|+.++++++||||+++++++.+...+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 4478999999999999999999987 4459999987654322 234678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCC-CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 436 VTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~-~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
||||++|++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999986432 2345999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhhcCcccCCCCCCcH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+. .....+|..+++
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKFSP 418 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTSCH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCcccCH
Confidence 44333455689999999999999999999999999999999999999997753 344444442 334566788999
Q ss_pred HHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSF-----PSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~-----~~Il~ 615 (634)
.+.+||.+||..||.+||++ .+|++
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 99999999999999999975 66664
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=363.61 Aligned_cols=254 Identities=30% Similarity=0.413 Sum_probs=211.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||+||+|+++.+ .+|+|++............+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999998744 4999999876544444567889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ikL~DFGla~~~~ 514 (634)
||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++....
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999998886432 4899999999999999999999999 999999999999975 4569999999998654
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC--CCCCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l 592 (634)
... ......||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+........ ....+++.+
T Consensus 191 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 191 NQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp TTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred CCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 432 345667999999999986 4689999999999999999999999999998888777754433322 225789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIMET--LQQF 620 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~~--L~~l 620 (634)
.+||.+||..||.+|||+.++++. |++.
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999999863 4444
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=346.41 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=212.5
Q ss_pred CCcceeec-ceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEE
Q 006703 359 PSTHVIDS-SNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 359 ~~~~~~~~-~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~ 434 (634)
....|... +.||+|+||.||+|.+. +..||+|++............+.+|+.+++.+ .||||+++++++.+....+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 34666666 88999999999999987 45599999887655444456788999999999 5699999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEEEEecCCCc
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSR 511 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ikL~DFGla~ 511 (634)
+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+||+++. ++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred EEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 9999999999999986432 235899999999999999999999999 999999999999987 7899999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc--ccCCCCCCc
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--RLEIPKNVN 589 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s 589 (634)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..... .......++
T Consensus 183 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 183 KIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp EC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred ccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence 654332 23456799999999999999999999999999999999999999999888777665543332 233446789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+.++|.+||..||++|||+.++++
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 99999999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.26 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=208.2
Q ss_pred cceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC--CCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~--h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||.||++.+.. ..||||++............+.+|+.++++++ |+||+++++++..++.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 569999999999999999998764 44999999877666677788999999999996 599999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
| +.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56789999997543 4888899999999999999999999 99999999999995 5799999999998654321
Q ss_pred --ccCCCCCCCCcccCcccccC-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcccC
Q 006703 518 --ISSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLE 583 (634)
Q Consensus 518 --~~~~~~~gt~~y~APEvl~~-----------~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~ 583 (634)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 12345679999999999865 3688999999999999999999999987543 334444433344556
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
++...++.+.+||.+||..||++|||+.++++.
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 677788999999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=378.74 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=219.8
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
...|...+.||+|+||.||+|+++.++ ||||++..... .......+..|..++..+ +|++|+++++++.+.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467899999999999999999988654 99999876532 223346678899999988 79999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|..++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999997543 4899999999999999999999999 99999999999999999999999999986444
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.........||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+..+....+. .....+|..+++++.+|
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 572 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAI 572 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHH
Confidence 4445567889999999999999999999999999999999999999999999888887774 45566788999999999
Q ss_pred HHHhhhcCCCCCCCH-----HHHHH
Q 006703 596 IETCWAEEPEIRPSF-----PSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~-----~~Il~ 615 (634)
|.+||..||++||++ .+|++
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhc
Confidence 999999999999997 66664
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.91 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=214.7
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHH----HHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHED----RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~----~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..|...+.||+|+||.||+|++. +..+|+|++........ ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999987 45599999876543221 2467889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC----cEEEEecCCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLS 510 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~----~ikL~DFGla 510 (634)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999643 24899999999999999999999999 99999999999998776 8999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCCCC
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNV 588 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~ 588 (634)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..+
T Consensus 160 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 160 HKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp EECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred eeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 8654322 234567999999999999999999999999999999999999999998887766655332221 1223578
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHh
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMS 623 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~--~L~~ll~~ 623 (634)
++.+.+++.+||..||++|||+.++++ .++.+...
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 899999999999999999999999998 45555443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=375.00 Aligned_cols=252 Identities=31% Similarity=0.505 Sum_probs=215.7
Q ss_pred cceeeccCcEEEEEEEEcC----CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 366 SSNFIKGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~----~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.+.||+|+||.||+|.+.. ..||||++..........+++.+|+.++++++||||+++++++.. +..++||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4589999999999997642 349999998765555556789999999999999999999999865 56889999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc---c
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY---I 518 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~---~ 518 (634)
+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...... .
T Consensus 453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999996433 4899999999999999999999999 9999999999999999999999999997653321 1
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+....+....+. ...++..+..+++++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHH
Confidence 2233456789999999999999999999999999999998 999999998888776664 44566778899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+||..||++|||+.+|++.|+++..+.
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=370.49 Aligned_cols=264 Identities=33% Similarity=0.525 Sum_probs=227.0
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
.....|...+.||+|+||.||+|.+.++ .||||++...... .+.|.+|+.+|++++|+||+++++++.+ ...++|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 3457788999999999999999999864 4999998765433 2568899999999999999999999876 678999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+.+++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999964321 24889999999999999999999999 999999999999999999999999999865432
Q ss_pred cc-cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 YI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~-~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+....+. ...+...+..+++.+.+
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 495 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 21 2234457889999999999999999999999999999999 999999988888776664 44456677889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 629 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~ 629 (634)
||.+||..||++|||+.+|++.|+.++.+...+..
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~ 530 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSC
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccC
Confidence 99999999999999999999999999876655543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.82 Aligned_cols=255 Identities=20% Similarity=0.238 Sum_probs=201.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-----CcEEEEEEeeccccHH---------HHHHHHHHHHHHHhCCCCCeeeeec
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-----SDVAVKILIEQEFHED---------RFKEFLREVAIMKGLRHPNIVLLMG 425 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----~~vAvK~~~~~~~~~~---------~~~~~~~El~iL~~l~h~nIv~l~~ 425 (634)
...|...+.||+|+||.||+|.+.. ..+|+|++........ ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4789999999999999999999864 4499999876532111 1134678899999999999999999
Q ss_pred eeec----CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-
Q 006703 426 AVTE----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY- 500 (634)
Q Consensus 426 ~~~~----~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~- 500 (634)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCC
Confidence 9877 77899999999 999999997543 5899999999999999999999999 99999999999998777
Q ss_pred -cEEEEecCCCccCCCCc-------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCC--ChHH
Q 006703 501 -TVKVCDFGLSRSKPNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS--TPSQ 570 (634)
Q Consensus 501 -~ikL~DFGla~~~~~~~-------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~--~~~~ 570 (634)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999999997543211 1124557999999999999999999999999999999999999999652 2222
Q ss_pred HHHHHhhcCcccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 571 VISAVGFKGRRLEIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 571 ~~~~i~~~~~~~~~~---------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
..... ......++ ..+++.+.+++.+||..||++|||+.+|++.|+++..
T Consensus 270 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 21111 11111111 2789999999999999999999999999999987543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=333.82 Aligned_cols=248 Identities=30% Similarity=0.483 Sum_probs=207.1
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
..+|...+.||+|+||.||+|.+. +..||+|++...... ......+.+|+.+++.++||||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367899999999999999999987 556999998754322 22345788999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.... .+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999996443 3889999999999999999999999 999999999999999999999999999865443
Q ss_pred cccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
. ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......+....+. ......+..+++.+.++
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 165 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVATL 241 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred c-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHHHH
Confidence 2 2345678999999999988776 689999999999999999999999888777666553 23445677889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+||..||++|||+.++++
T Consensus 242 i~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHh
Confidence 99999999999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.43 Aligned_cols=259 Identities=19% Similarity=0.244 Sum_probs=211.4
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeecee-ecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~-~~~~~~~lV 436 (634)
...|...+.||+|+||.||+|++. +..||+|++...... .++.+|+.+++.++|++++..+.++ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 468999999999999999999975 445999998665432 3477999999999887766555544 667788999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE---cCCCcEEEEecCCCccC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl---d~~~~ikL~DFGla~~~ 513 (634)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||++ +.++.+||+|||++...
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999 889999997433 24899999999999999999999999 9999999999999 48889999999999864
Q ss_pred CCCcc-------cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHH---hhcCc
Q 006703 514 PNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAV---GFKGR 580 (634)
Q Consensus 514 ~~~~~-------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~---~~~~~~i---~~~~~ 580 (634)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+....+ .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 43221 23456799999999999999999999999999999999999999976432 1122222 11122
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
...++..+++.+.+++.+||+.||++|||+.+|++.|++++.....+
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 22344678999999999999999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=345.98 Aligned_cols=238 Identities=26% Similarity=0.394 Sum_probs=181.7
Q ss_pred cceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEeeccc
Q 006703 366 SSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSR 442 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~g 442 (634)
.+.||+|+||.||+|.++. ..||+|++.... ...+.+|+.+++.+. ||||+++++++.+....++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 3689999999999999874 459999986432 245678999999996 99999999999999999999999999
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC---cEEEEecCCCccCCCCccc
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~---~ikL~DFGla~~~~~~~~~ 519 (634)
++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++.........
T Consensus 91 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 91 GELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 99999997543 4899999999999999999999999 99999999999997665 8999999999876554444
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhhcCcccCCC----CCC
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-------SQVISAVGFKGRRLEIP----KNV 588 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~----~~~ 588 (634)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+....+.. .....+ ..+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSFEGEAWKNV 243 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCCCSHHHHTS
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCCCcccccCC
Confidence 5667889999999999999999999999999999999999999976443 333444422 222222 358
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++++.+||.+||..||.+|||+.++++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=351.86 Aligned_cols=259 Identities=28% Similarity=0.397 Sum_probs=207.5
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
.....|...+.||+|+||.||+|.+. ++.||+|++....... ....+.+|+.+++.++||||+++++++......++|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred HHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 44578889999999999999999865 5559999986543221 123578999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCC-CcccccHHHHHHHHHHHHHHHHHHHhC---CCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 437 TEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQR---RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~-~~~~l~e~~~~~i~~qIa~aL~yLH~~---g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
|||+.+++|.+++.... ....+++..++.++.|++.||.|||++ | |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCccccc
Confidence 99999999999997543 334589999999999999999999999 8 99999999999999999999999999986
Q ss_pred CCCCc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhhc--C-----
Q 006703 513 KPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-----PSQVISAVGFK--G----- 579 (634)
Q Consensus 513 ~~~~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-----~~~~~~~i~~~--~----- 579 (634)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+... .
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 54322 22344569999999999998889999999999999999999999995211 00011111000 0
Q ss_pred -----cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 580 -----RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 580 -----~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
.....+...++.+.+++.+||..||.+|||+.+|++.|+.
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0111222345789999999999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=341.40 Aligned_cols=252 Identities=25% Similarity=0.284 Sum_probs=203.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH---HHHHHHHHHHHHHHhC---CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE---DRFKEFLREVAIMKGL---RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~---~~~~~~~~El~iL~~l---~h~nIv~l~~~~~~~ 430 (634)
...+|...+.||+|+||+||+|++. +..||+|++....... .....+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3478999999999999999999975 4459999987543211 1112344666666655 599999999999765
Q ss_pred C-----cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 431 P-----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 431 ~-----~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
. ..+++|||+. ++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 5 4899999997 599999875443 23899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc---
Q 006703 506 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--- 582 (634)
Q Consensus 506 DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--- 582 (634)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+......+
T Consensus 163 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999998654322 3345678999999999999999999999999999999999999999988877665543211100
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 ----------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ----------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+++.+.+||.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 012357899999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.21 Aligned_cols=259 Identities=19% Similarity=0.242 Sum_probs=207.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeecee-ecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~-~~~~~~~l 435 (634)
....|...+.||+|+||.||+|++.. ..||+|++...... .++.+|+.+++.++|++++..+..+ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 34779999999999999999999764 44999986554322 3467899999999887766655554 77778999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE---cCCCcEEEEecCCCcc
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRS 512 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl---d~~~~ikL~DFGla~~ 512 (634)
+|||+ +++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 99999 8999999974332 3899999999999999999999999 9999999999999 7889999999999986
Q ss_pred CCCCc-------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHH---hhcC
Q 006703 513 KPNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAV---GFKG 579 (634)
Q Consensus 513 ~~~~~-------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~---~~~~~i---~~~~ 579 (634)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... +....+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 44321 1234567999999999999999999999999999999999999999764432 111111 1111
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
........+++.+.+++.+||..||++|||+.++++.|++++.....
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 22223367899999999999999999999999999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.43 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=203.8
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------ 431 (634)
...|...+.||+|+||.||+|.+. +..||+|++..........+++.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999986 445999998766555666678999999999999999999999997653
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 78999998753 3899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-----------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------- 579 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~----------- 579 (634)
..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.+.+..+....+....
T Consensus 177 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 177 QADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp ECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 75432 345678999999999987 678999999999999999999999999887765544332110
Q ss_pred ------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 ------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+....++.+.+|+.+||..||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 011233567899999999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.69 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=210.2
Q ss_pred cccCCCCCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-----CCCeeeee
Q 006703 352 QMQNPSGPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----HPNIVLLM 424 (634)
Q Consensus 352 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-----h~nIv~l~ 424 (634)
...........|...+.||+|+||+||+|++. +..||+|++... ......+..|+.+++.+. ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 44445555688999999999999999999986 445999998643 233456678999999996 99999999
Q ss_pred ceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC------
Q 006703 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS------ 498 (634)
Q Consensus 425 ~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~------ 498 (634)
+++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcccccccc
Confidence 9999999999999999 8899999975443 24889999999999999999999999 999999999999975
Q ss_pred -------------------CCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC
Q 006703 499 -------------------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 559 (634)
Q Consensus 499 -------------------~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg 559 (634)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999864432 3456799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCccc------------------------CCC--------------------CCCcHHHHHH
Q 006703 560 QKPWRNSTPSQVISAVGFKGRRL------------------------EIP--------------------KNVNPMVAAL 595 (634)
Q Consensus 560 ~~Pf~~~~~~~~~~~i~~~~~~~------------------------~~~--------------------~~~s~~l~~L 595 (634)
+.||...+..+....+....... ..+ ...++.+.+|
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 99999888766554442211100 011 1123778899
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+||..||++|||+.++++
T Consensus 336 i~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCChhhCCCHHHHhc
Confidence 99999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.86 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=199.6
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...+.||+|+||+||+|.+. +..||+|++..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46889999999999999999987 44499999865432 1122245579999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+++ +|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 81 YLDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9975 8888886543 24889999999999999999999999 99999999999999999999999999986554444
Q ss_pred cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc---------------
Q 006703 519 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--------------- 582 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--------------- 582 (634)
......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 4456678999999999876 567999999999999999999999999988776655442211100
Q ss_pred -------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 -------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 -------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 112357889999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.75 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=196.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||+|+||+||+|++. +..||+|++............+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3478999999999999999999985 44599999977655455545556666678888999999999999999999999
Q ss_pred EeecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 437 TEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
|||+++ +|.+++.. ......+++..++.++.||+.||.|||++ | |+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999975 88777743 11223589999999999999999999998 9 9999999999999999999999999997654
Q ss_pred CCcccCCCCCCCCcccCcccc----cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhhcCcccCCCCCCc
Q 006703 515 NTYISSKTAAGTPEWMAPEVL----REDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl----~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s 589 (634)
... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||.... .................+..++
T Consensus 162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 432 23445799999999996 56678999999999999999999999998643 3333333333333333345789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 99999999999999999999999988
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=330.05 Aligned_cols=249 Identities=28% Similarity=0.355 Sum_probs=208.3
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|.+. +..||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 56888999999999999999987 455999998755432 334678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-- 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~-- 516 (634)
|+++++|.+++... ..+++..++.++.|++.||.|||++| |+|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998643 24899999999999999999999999 999999999999999999999999998754321
Q ss_pred cccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... ....+............+++.+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence 122345679999999999988775 789999999999999999999998765432 222222222222233568999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+||..||.+|||+.++++
T Consensus 241 li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHCCCCchhCCCHHHHhc
Confidence 999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.96 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=211.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeecccc--HHHHHHHHHHHHHHHhCCCCCeeeeecee--ecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAV--TEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~--~~~~~~~~~El~iL~~l~h~nIv~l~~~~--~~~~~~ 433 (634)
..+|...+.||+|+||.||++.+..+ .+|+|++...... ......+.+|+.++++++||||+++++++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36788999999999999999998644 5999998765432 23456789999999999999999999998 445689
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++||||+.++ |.+++.... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 767665432 234899999999999999999999999 999999999999999999999999999764
Q ss_pred CCC--cccCCCCCCCCcccCcccccCCCC--CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 514 PNT--YISSKTAAGTPEWMAPEVLREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 514 ~~~--~~~~~~~~gt~~y~APEvl~~~~~--s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
... ........||+.|+|||++.+... +.++||||||+++|+|++|+.||...+..+....+.. ....++..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~ 237 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSYAIPGDCG 237 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCCCCSSSC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCCCCCCccC
Confidence 321 222345679999999999987544 7899999999999999999999999888777666633 3445677899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+.+.++|.+||..||.+|||+.++++. .+++.
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~--~~~~~ 269 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQH--SWFRK 269 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHS--HHHHS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC--ccccc
Confidence 999999999999999999999999973 44544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=361.46 Aligned_cols=250 Identities=27% Similarity=0.452 Sum_probs=211.5
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccH-----------HHHHHHHHHHHHHHhCCCCCeeeeec
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHE-----------DRFKEFLREVAIMKGLRHPNIVLLMG 425 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~-----------~~~~~~~~El~iL~~l~h~nIv~l~~ 425 (634)
....|...+.||+|+||+||+|.++.+ .+|+|++....... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999998754 49999987654332 22467889999999999999999999
Q ss_pred eeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC---cE
Q 006703 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TV 502 (634)
Q Consensus 426 ~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~---~i 502 (634)
++.+....++||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999886432 4899999999999999999999999 99999999999998765 69
Q ss_pred EEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc
Q 006703 503 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 582 (634)
Q Consensus 503 kL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~ 582 (634)
||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 189 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp EECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999999998654432 3456789999999999874 58999999999999999999999999999888877775433322
Q ss_pred C--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 E--IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ~--~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. ....+++.+.+||.+||..||.+|||+.++++
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2 22578999999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.43 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=211.4
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||.||++++. +..||+|++..... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 467899999999999999999987 45599999875432 22356789999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE---cCCCcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl---d~~~~ikL~DFGla~~~~ 514 (634)
||+++++|.+++.... .+++..++.++.|++.||.|||++| |+|+||||+||++ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 86 QLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999986432 4899999999999999999999999 9999999999999 788899999999987643
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCCCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l 592 (634)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..+++.+
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 161 NG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp CB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred CC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 32 223346899999999999999999999999999999999999999998887776666443322 23446789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.++|.+||..||++|||+.++++
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.88 Aligned_cols=252 Identities=25% Similarity=0.297 Sum_probs=203.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH---HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE---DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~---~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
....|...+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3477899999999999999999987 4459999986543222 1224678999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++||||+++ +|..++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999986 8888886443 34788899999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc----------
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---------- 582 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~---------- 582 (634)
...........||+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+......+
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 5544445567899999999999764 47999999999999999999999999888776655442211100
Q ss_pred -----------C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 -----------E-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 -----------~-----~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. +...+++.+.+||.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 11456789999999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.82 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=200.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------C
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------~ 431 (634)
..+|...+.||+|+||+||+|.+..+ .||||++..........+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 36789999999999999999988744 499999987765666678899999999999999999999999655 3
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..|+||||++++ |.+.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 579999999764 6666542 2889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-----------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------- 580 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~----------- 580 (634)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 213 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 65433 234567899999999999999999999999999999999999999999887665544421100
Q ss_pred ---------ccC---------CCCC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 ---------RLE---------IPKN-----------VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ---------~~~---------~~~~-----------~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+. ++.. .++.+.+||.+||..||++|||+.++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000 1567999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.18 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=211.1
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
.......|...+.||+|+||.||+|.+. +..||+|++.... .......+.+|+.++++++||||+++++++..++..
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3445688999999999999999999998 4459999987653 445567889999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++ | |+||||||+||+++.++.+||+|||++..
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999997543 488999999999999999999996 8 99999999999999999999999999865
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG---------------- 576 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~---------------- 576 (634)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 182 LIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred cccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 3221 2345679999999999999999999999999999999999999998877655432221
Q ss_pred -------------------------hcCcccCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 577 -------------------------FKGRRLEI-PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 577 -------------------------~~~~~~~~-~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+.. +..+++++.+||.+||..||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01111222 2357899999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=353.86 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=214.8
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC--cE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NL 433 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~--~~ 433 (634)
.....|...+.||+|+||+||+|++. +..||+|++....... ....+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34578999999999999999999998 4459999987554322 2356789999999999999999999987655 78
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE----cCCCcEEEEecCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL 509 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl----d~~~~ikL~DFGl 509 (634)
++||||+++++|.+++........+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999999986555455999999999999999999999999 9999999999999 7788899999999
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccC--------CCCCchHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhh
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLRE--------DPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGF 577 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~--------~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~----~~~~~~~i~~ 577 (634)
+....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ..+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 98754432 3446679999999999865 456789999999999999999999996422 2333333321
Q ss_pred cCcc-----------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 578 KGRR-----------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 578 ~~~~-----------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.... ..++..+++.+.+++.+||..||++|||+.++++.+++++...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1100 0112335678999999999999999999999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.29 Aligned_cols=250 Identities=26% Similarity=0.316 Sum_probs=190.4
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-----CCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-----PPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-----~~~ 432 (634)
...|...+.||+|+||+||+|.++. ..||||++..........+++.+|+.+|++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999998874 459999997765566667889999999999999999999999843 356
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999998 468999887543 4899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCc---------------------------ccCCCCCCCCcccCcccc-cCCCCCchHHHHHHHHHHHHHHh------
Q 006703 513 KPNTY---------------------------ISSKTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELIT------ 558 (634)
Q Consensus 513 ~~~~~---------------------------~~~~~~~gt~~y~APEvl-~~~~~s~~sDVwSLGvlL~eLlt------ 558 (634)
..... ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 53221 112345789999999986 56678999999999999999998
Q ss_pred -----CCCCCCCCCh--------------------HHHHHHHhh-cC----------------------------cccCC
Q 006703 559 -----LQKPWRNSTP--------------------SQVISAVGF-KG----------------------------RRLEI 584 (634)
Q Consensus 559 -----g~~Pf~~~~~--------------------~~~~~~i~~-~~----------------------------~~~~~ 584 (634)
|+++|.+... ......+.. .+ .....
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 6667755431 011110000 00 00112
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+..++.+.+||.+||..||++|||+.++++
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2456899999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.80 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=209.0
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.....|...+.||+|+||.||+|.+. +..||+|++..... ...+.+|+.++++++||||+++++++......++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34577999999999999999999987 45599999875432 2467899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++.....
T Consensus 102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999986322 34899999999999999999999999 99999999999999999999999999976554
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cccCCCCCCcHHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA 594 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~ 594 (634)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.... .....+..+++.+.+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 4444456689999999999999999999999999999999999999999887766554443221 122334567899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++.+||..||.+|||+.++++
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHccCChhhCcCHHHHHh
Confidence 999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.49 Aligned_cols=243 Identities=24% Similarity=0.393 Sum_probs=207.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccH------HHHHHHHHHHHHHHhCCCCCeeeeeceeecCC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~------~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~ 431 (634)
...|...+.||+|+||.||+|.+..+ .||+|++....... .....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 36789999999999999999988644 49999987664321 12345678999999999999999999999999
Q ss_pred cEEEEEeecccC-CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 432 NLSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 432 ~~~lV~E~~~gg-sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
..++||||+.++ +|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999766 9999987543 4899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ........+..++
T Consensus 178 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~ 248 (335)
T 3dls_A 178 AYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVS 248 (335)
T ss_dssp EECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCC
T ss_pred eECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccC
Confidence 8654432 2345679999999999988887 8899999999999999999999976322 1223344566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
+.+.+||.+||..||++|||+.++++.
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.78 Aligned_cols=254 Identities=30% Similarity=0.504 Sum_probs=210.6
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHh--CCCCCeeeeeceeecCC----cEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLLMGAVTEPP----NLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~--l~h~nIv~l~~~~~~~~----~~~ 434 (634)
..|...+.||+|+||.||+|++.+..||+|++.... ...+.+|.++++. ++||||+++++++.... ..+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 578889999999999999999988889999985432 2456788888887 68999999999998776 799
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHH--------hCCCCEEeeccCCCcEEEcCCCcEEEEe
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--------QRRPPIVHRDLKSPNLLVDSTYTVKVCD 506 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH--------~~g~~IvHrDIKP~NILld~~~~ikL~D 506 (634)
+||||+++++|.+++... .+++..++.++.|++.||.||| +++ |+||||||+||+++.++.+||+|
T Consensus 117 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECC
T ss_pred EEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEE
Confidence 999999999999999743 3899999999999999999999 888 99999999999999999999999
Q ss_pred cCCCccCCCCcc----cCCCCCCCCcccCcccccCCC------CCchHHHHHHHHHHHHHHhC----------CCCCCCC
Q 006703 507 FGLSRSKPNTYI----SSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITL----------QKPWRNS 566 (634)
Q Consensus 507 FGla~~~~~~~~----~~~~~~gt~~y~APEvl~~~~------~s~~sDVwSLGvlL~eLltg----------~~Pf~~~ 566 (634)
||++........ ......||+.|+|||++.+.. ++.++||||||+++|||++| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 999975433221 234567999999999997763 23689999999999999999 7898764
Q ss_pred C-----hHHHHHHHhhcCcccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 567 T-----PSQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 567 ~-----~~~~~~~i~~~~~~~~~~~-----~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
. .......+.....++.++. ..++.+.+|+.+||..||++|||+.+|++.|+++.++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 3 2333333433334444443 345689999999999999999999999999999988643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=366.48 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=215.1
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
.....|...+.||+|+||.||+|+++ +..||+|++...... ......+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 44578999999999999999999987 445999998765432 223456789999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||++||+|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999875432 34899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhhcCcccCCCCCCcH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..++...+ ......++..+++
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s~ 414 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFSP 414 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSCH
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCCH
Confidence 332 2345689999999999999999999999999999999999999998754 23333333 2334556788999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RP-----s~~~Il~ 615 (634)
.+.+||.+||..||.+|| ++.++++
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 999999999999999999 7888875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=349.58 Aligned_cols=245 Identities=25% Similarity=0.342 Sum_probs=193.1
Q ss_pred cceeec-ceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHH-hCCCCCeeeeeceeec----CCc
Q 006703 361 THVIDS-SNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMK-GLRHPNIVLLMGAVTE----PPN 432 (634)
Q Consensus 361 ~~~~~~-~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~-~l~h~nIv~l~~~~~~----~~~ 432 (634)
..|... +.||+|+||+||++.++.+ .||||++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 345444 7899999999999998744 4999998642 24557888874 4589999999998865 567
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEEEEecCC
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL 509 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ikL~DFGl 509 (634)
+|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999999975432 34899999999999999999999999 999999999999987 78999999999
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHhhcCccc--C
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----VISAVGFKGRRL--E 583 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~----~~~~i~~~~~~~--~ 583 (634)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ....+....... .
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 211 AKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp CEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred ccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 9865432 23356789999999999999999999999999999999999999997655322 222232222222 2
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
....+++++.+||.+||..||++|||+.++++.
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 225689999999999999999999999999973
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.12 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=208.9
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec---------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--------- 429 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--------- 429 (634)
..|...+.||+|+||.||+|.+. +..||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 67889999999999999999987 5569999987553 245689999999999999999998854
Q ss_pred -------CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcE
Q 006703 430 -------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 502 (634)
Q Consensus 430 -------~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~i 502 (634)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCE
Confidence 445899999999999999996432 234899999999999999999999999 9999999999999999999
Q ss_pred EEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc
Q 006703 503 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 582 (634)
Q Consensus 503 kL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~ 582 (634)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+... ......+ ...
T Consensus 162 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~----~~~ 234 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL----RDG 234 (284)
T ss_dssp EECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH----HTT
T ss_pred EECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh----hcc
Confidence 999999988654432 234567999999999999999999999999999999999999887532 1112222 123
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
.++..+++.+.+++.+||..||.+|||+.++++.|..+.++...
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 35567899999999999999999999999999999998776443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.03 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=199.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-----C
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----P 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~-----~ 431 (634)
....|...+.||+|+||.||+|.+..++ ||||++..........+++.+|+++|++++|+||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3478999999999999999999987554 99999976655566678899999999999999999999999766 5
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 7999999996 59999987543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcc----------------------cCCCCCCCCcccCcccc-cCCCCCchHHHHHHHHHHHHHHhC---------
Q 006703 512 SKPNTYI----------------------SSKTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELITL--------- 559 (634)
Q Consensus 512 ~~~~~~~----------------------~~~~~~gt~~y~APEvl-~~~~~s~~sDVwSLGvlL~eLltg--------- 559 (634)
....... ......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 6543211 13566899999999986 566689999999999999999984
Q ss_pred --CCCCCCCCh-----------------HHHH------------------------HHHhhcCcccC-----CCCCCcHH
Q 006703 560 --QKPWRNSTP-----------------SQVI------------------------SAVGFKGRRLE-----IPKNVNPM 591 (634)
Q Consensus 560 --~~Pf~~~~~-----------------~~~~------------------------~~i~~~~~~~~-----~~~~~s~~ 591 (634)
.++|.+... .... ..+........ ..+.+++.
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 334433320 0000 01100001111 11458999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+||.+||..||++|||+.++++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=362.62 Aligned_cols=250 Identities=30% Similarity=0.445 Sum_probs=215.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||+|++. +..||+|++...... ......+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999987 445999998765432 2334678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE---cCCCcEEEEecCCCcc
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRS 512 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl---d~~~~ikL~DFGla~~ 512 (634)
||||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999886443 4899999999999999999999999 9999999999999 4678999999999876
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCcH
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNP 590 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~ 590 (634)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.........+ ..+++
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 179 FEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp BCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred ccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 54322 2234579999999999976 68999999999999999999999999999888887775544333333 46899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhh
Confidence 9999999999999999999999997
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.31 Aligned_cols=259 Identities=31% Similarity=0.495 Sum_probs=214.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEc------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC-
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP- 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~- 431 (634)
....|...+.||+|+||.||++++. +..||+|++... .....+.+.+|+.++++++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 4577899999999999999999852 445999998654 3445577899999999999999999999886644
Q ss_pred -cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 432 -NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 432 -~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcch
Confidence 7899999999999999997543 24889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH---------------HH
Q 006703 511 RSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---------------VI 572 (634)
Q Consensus 511 ~~~~~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~---------------~~ 572 (634)
........ ......++..|+|||++.+..++.++||||||+++|+|++|..||......- ..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 86543321 1234567888999999998889999999999999999999999886431110 01
Q ss_pred HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 573 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 573 ~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
.........++.+..+++.+.++|.+||..||++|||+.+|++.|+++...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111122344566788999999999999999999999999999999999865
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.73 Aligned_cols=257 Identities=17% Similarity=0.230 Sum_probs=210.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcC----------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeee-------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN----------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL------- 422 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~----------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~------- 422 (634)
...|...+.||+|+||.||+|++.. ..||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4789999999999999999999864 45999998654 35679999999999999987
Q ss_pred --------eeceeec-CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCc
Q 006703 423 --------LMGAVTE-PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 493 (634)
Q Consensus 423 --------l~~~~~~-~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~N 493 (634)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 4555554 67899999999 999999997542 235999999999999999999999999 9999999999
Q ss_pred EEEcCCC--cEEEEecCCCccCCCCcc-------cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCC
Q 006703 494 LLVDSTY--TVKVCDFGLSRSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 564 (634)
Q Consensus 494 ILld~~~--~ikL~DFGla~~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~ 564 (634)
||++.++ .+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 999999999976443211 1234579999999999999999999999999999999999999998
Q ss_pred CCC--hHHHHHHHhh-cCcccCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 565 NST--PSQVISAVGF-KGRRLEIP------KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 565 ~~~--~~~~~~~i~~-~~~~~~~~------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
... .......... ......+. ..+++.+.+++.+||..||++|||+.+|++.|+++++.....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 764 2222222211 11111111 256899999999999999999999999999999999876543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.54 Aligned_cols=253 Identities=27% Similarity=0.485 Sum_probs=208.1
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
......|...+.||+|+||.||+|.+.. ..+|+|++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3456889999999999999999999974 459999886543 223467889999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++....
T Consensus 93 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999999886432 23899999999999999999999999 9999999999999999999999999875422
Q ss_pred CCcccCCCCCCCCcccCcccc-----cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCC
Q 006703 515 NTYISSKTAAGTPEWMAPEVL-----REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNV 588 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl-----~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~ 588 (634)
..........||+.|+|||++ .+..++.++||||||+++|+|++|..||...+.......+..... ....+..+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcccc
Confidence 222223456799999999998 467789999999999999999999999999887766655533222 22345678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+..+.+++.+||..||++|||+.++++
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 999999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=329.80 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=213.5
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-------cHHHHHHHHHHHHHHHhCC-CCCeeeeecee
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-------HEDRFKEFLREVAIMKGLR-HPNIVLLMGAV 427 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-------~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~ 427 (634)
.....|...+.||+|+||.||+|.++. ..||+|++..... .....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 445789999999999999999999875 4499999875531 1233466889999999995 99999999999
Q ss_pred ecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEec
Q 006703 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 507 (634)
Q Consensus 428 ~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DF 507 (634)
......++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999999743 24899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCcccCCCCCCCCcccCccccc------CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc
Q 006703 508 GLSRSKPNTYISSKTAAGTPEWMAPEVLR------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 581 (634)
Q Consensus 508 Gla~~~~~~~~~~~~~~gt~~y~APEvl~------~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~ 581 (634)
|++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||...+..+....+......
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 9997654322 345567999999999985 456789999999999999999999999988877766665443333
Q ss_pred cCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 LEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ~~~~--~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...+ ..+++.+.+++.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 2222 468899999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.40 Aligned_cols=263 Identities=20% Similarity=0.289 Sum_probs=209.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee----cCCc
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT----EPPN 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~----~~~~ 432 (634)
...+|...+.||+|+||.||++++. +..||+|++... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3478999999999999999999975 455999998654 3445577889999999999999999999986 3457
Q ss_pred EEEEEeecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 433 LSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
.++||||+.+++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 89999999999999998642 12345899999999999999999999999 9999999999999999999999999887
Q ss_pred cCCCCccc---------CCCCCCCCcccCcccccCCC---CCchHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhh
Q 006703 512 SKPNTYIS---------SKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGF 577 (634)
Q Consensus 512 ~~~~~~~~---------~~~~~gt~~y~APEvl~~~~---~s~~sDVwSLGvlL~eLltg~~Pf~~~~~--~~~~~~i~~ 577 (634)
........ .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ......+ .
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~ 261 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-Q 261 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-H
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-h
Confidence 54321100 11234799999999997654 58899999999999999999999953111 1111112 1
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 578 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 578 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
.....+.+..+++.+.++|.+||..||.+|||+.++++.|+++......
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 2233444567899999999999999999999999999999987654433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.42 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=211.4
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc--c----HHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCC
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF--H----EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP 431 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~--~----~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~ 431 (634)
..|...+.||+|+||.||+|.+. +..||||++..... . ....+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 56888899999999999999986 55699999875431 1 22345688999999999 7999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.| |+|+||||+||+++.++.+||+|||++.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCccc
Confidence 999999999999999998743 24899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCcccCCCCCCCCcccCcccccC------CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC--
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRE------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-- 583 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~------~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~-- 583 (634)
...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+........
T Consensus 249 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 249 HLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred ccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 654332 3456789999999999863 3578899999999999999999999998887776666543332222
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+++.+.++|.+||..||++|||+.++++
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12467899999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=342.37 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=205.1
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-------- 429 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-------- 429 (634)
..+|...+.||+|+||.||+|++. +..||+|++............+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999986 4459999987665444444567899999999999999999999876
Q ss_pred CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
.+..++||||+++ +|.+.+.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4468999999976 6766665433 23899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCC----CcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--c
Q 006703 510 SRSKPN----TYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--L 582 (634)
Q Consensus 510 a~~~~~----~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~ 582 (634)
+..... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+...... +
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 976432 1222345678999999999976 45799999999999999999999999998877666555321111 1
Q ss_pred CCCCC----------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 EIPKN----------------------------VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ~~~~~----------------------------~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..... .++.+.+||.+||..||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111 2678999999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.44 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=212.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHH---------------HHHHHHHHHHHHHhCCCCCeeee
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHED---------------RFKEFLREVAIMKGLRHPNIVLL 423 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~---------------~~~~~~~El~iL~~l~h~nIv~l 423 (634)
....|...+.||+|+||.||+|.+.+..||+|++........ ....+.+|+.++++++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 347899999999999999999999777799999875532211 12678899999999999999999
Q ss_pred eceeecCCcEEEEEeecccCCHHHH------hccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEE
Q 006703 424 MGAVTEPPNLSIVTEYLSRGSLYKL------LHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 424 ~~~~~~~~~~~lV~E~~~ggsL~~l------l~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILl 496 (634)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||.|||+ +| |+|+||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEE
Confidence 9999999999999999999999998 5432 13459999999999999999999999 99 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCC-CCCc-hHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNE-KSDVFSFGVILWELITLQKPWRNSTP-SQVIS 573 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~-~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~ 573 (634)
+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||..... .+...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred cCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 99999999999999865433 34566799999999999887 5665 99999999999999999999988776 55555
Q ss_pred HHhhcCcccCCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 574 AVGFKGRRLEIP-------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 574 ~i~~~~~~~~~~-------------------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+.. ....++ ..+++.+.+|+.+||..||.+|||+.++++
T Consensus 264 ~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 NIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 5532 222333 568999999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.04 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=197.9
Q ss_pred Ccceeec-ceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 360 STHVIDS-SNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 360 ~~~~~~~-~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
...|... +.||+|+||+||+|.+. +..||+|++...... ....+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3556664 78999999999999876 455999998765322 235688999999985 79999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc---EEEEecCCCcc
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLSRS 512 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~---ikL~DFGla~~ 512 (634)
||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++. +||+|||++..
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999997542 4899999999999999999999999 999999999999987765 99999999875
Q ss_pred CCCCc-------ccCCCCCCCCcccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCh------------
Q 006703 513 KPNTY-------ISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTP------------ 568 (634)
Q Consensus 513 ~~~~~-------~~~~~~~gt~~y~APEvl~~-----~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~------------ 568 (634)
..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 43211 11234569999999999975 4578899999999999999999999977542
Q ss_pred ---HHHHHHHhhcCcccCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 569 ---SQVISAVGFKGRRLEIP----KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 569 ---~~~~~~i~~~~~~~~~~----~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
......+.. ....++ ..+++.+.+||.+||..||++|||+.++++
T Consensus 244 ~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 222223321 222223 468899999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.64 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=197.9
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------c
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------N 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------~ 432 (634)
..|...+.||+|+||.||+|.+.. ..||+|++............+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 678999999999999999998874 44999999876555666678899999999999999999999997665 6
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.++||||+.+ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 105 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 8999999975 78787752 3889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-----------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------- 581 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------- 581 (634)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 177 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 54322 234567999999999999999999999999999999999999999988876655544221110
Q ss_pred ---------cC--------------CCC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ---------LE--------------IPK------NVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ---------~~--------------~~~------~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+. .+. ..++.+.+||.+||..||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 000 12568999999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=330.58 Aligned_cols=248 Identities=30% Similarity=0.465 Sum_probs=212.3
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...+.||+|+||.||+|++. +..||+|++............+.+|+.++++++||||+++++++.+....+++||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 67889999999999999999986 4559999997665544445778899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC---CcEEEEecCCCccCCC
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPN 515 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~---~~ikL~DFGla~~~~~ 515 (634)
|+++++|.+++.... .+++..++.++.||+.||.|||++| |+|+||||+||+++.+ +.+||+|||++.....
T Consensus 102 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999998886432 4899999999999999999999999 9999999999999754 4799999999876543
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC--CCCcHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVA 593 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~ 593 (634)
.. ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+.........+ ..+++.+.
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 177 NT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp CS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 22 22344588999999998764 8899999999999999999999999988877766664433332222 57899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++.+||..||++|||+.++++
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcccChhhCcCHHHHhc
Confidence 9999999999999999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.62 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=206.1
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-----C
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----P 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~-----~ 431 (634)
...+|...+.||+|+||.||+|.+..+ .||+|++.... .......+.+|++++++++||||+++++++... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 347899999999999999999998744 49999987543 344557789999999999999999999998654 4
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..++||||+.+ +|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 68999999975 899988643 3899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcc---cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-------
Q 006703 512 SKPNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------- 580 (634)
Q Consensus 512 ~~~~~~~---~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~------- 580 (634)
....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 6543221 1245589999999998754 4589999999999999999999999988876655444321100
Q ss_pred -----------------c-----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -----------------R-----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -----------------~-----~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 1122467899999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=349.97 Aligned_cols=249 Identities=27% Similarity=0.367 Sum_probs=195.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeecccc------HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~------~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~ 431 (634)
...|...+.||+|+||+||+|.+..+ .||+|++...... ......+.+|+.+|++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36789999999999999999998754 5999998765432 1222357899999999999999999999865 4
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC---cEEEEecC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFG 508 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~---~ikL~DFG 508 (634)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 5899999999999999886443 4899999999999999999999999 99999999999997544 59999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhhcC--ccc
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKG--RRL 582 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~---~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~-~~~~i~~~~--~~~ 582 (634)
++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ....+.... ..+
T Consensus 288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 998755432 3346679999999999854 567889999999999999999999997654322 222221111 112
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+++.+.+||.+||..||++|||+.++++
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 223568999999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.67 Aligned_cols=244 Identities=24% Similarity=0.351 Sum_probs=204.7
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE-----
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL----- 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~----- 433 (634)
..|...+.||+|+||.||+|.+.. ..||+|++..........+++.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 678899999999999999999874 4599999987666666678899999999999999999999999877665
Q ss_pred -EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 434 -SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 434 -~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
++||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 122 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 588887742 2899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc----------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------- 581 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~---------- 581 (634)
.... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 194 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 5432 345678999999999987 67899999999999999999999999988876655444211000
Q ss_pred -------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 -------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 -------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...+..+++.+.+||.+||..||++|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1123467899999999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=345.04 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=189.8
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC------Cc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------PN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~------~~ 432 (634)
.+|...+.||+|+||.||+|.+..+ .||+|++..........+++.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 6789999999999999999988744 499999876655556667889999999999999999999998654 56
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++||++ +++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 89999999 67999888642 3899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc----------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------- 581 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~---------- 581 (634)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 182 TADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 5432 345679999999999987 67899999999999999999999999988876554433211000
Q ss_pred -----------c--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 -----------L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 -----------~--------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+ ......++.+.+||.+||..||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 011356889999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.40 Aligned_cols=248 Identities=27% Similarity=0.369 Sum_probs=198.4
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeecccc------HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~------~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
..|...+.||+|+||.||+|.+..+ .||+|++...... ......+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 6788999999999999999998754 4999998654321 122345789999999999999999999987655
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc---EEEEecCC
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGL 509 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~---ikL~DFGl 509 (634)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++. +||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 899999999999999886433 4899999999999999999999999 999999999999986654 99999999
Q ss_pred CccCCCCcccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhcC--cccC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKG--RRLE 583 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~-~~~~~i~~~~--~~~~ 583 (634)
+....... ......||+.|+|||++. +..++.++||||||+++|+|++|..||...... .....+.... ..+.
T Consensus 164 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 164 SKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 98654321 122346899999999974 566899999999999999999999999765432 2222221111 1122
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+..+++.+.++|.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 33568999999999999999999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=352.76 Aligned_cols=245 Identities=15% Similarity=0.155 Sum_probs=195.0
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHH---HHHHhCCCCCeeeee-------
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREV---AIMKGLRHPNIVLLM------- 424 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El---~iL~~l~h~nIv~l~------- 424 (634)
.....|...+.||+|+||+||+|++. +..||||++..... .....+.+.+|+ +++++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 45678999999999999999999865 55699999976532 334557788999 455555899999998
Q ss_pred ceeecCC-----------------cEEEEEeecccCCHHHHhccCC----CcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 006703 425 GAVTEPP-----------------NLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483 (634)
Q Consensus 425 ~~~~~~~-----------------~~~lV~E~~~ggsL~~ll~~~~----~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~ 483 (634)
+++.+.+ ..|++|||+ +|+|.+++.... ....+++..++.|+.||+.||.|||++|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5554443 388999999 579999996432 1123456888899999999999999999
Q ss_pred EEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCC-----------CCCchHHHHHHHHH
Q 006703 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-----------PSNEKSDVFSFGVI 552 (634)
Q Consensus 484 IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~-----------~~s~~sDVwSLGvl 552 (634)
|+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999999999999999986433 2345567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 553 LWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 553 L~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+|||++|+.||......+... .....+..+++.+.+||.+||..||++|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCSG------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccchh------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999997655432211 112234678999999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=344.40 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=207.1
Q ss_pred CCcceeecceeeccCcEEEEEEEE-----cCCcEEEEEEeeccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEW-----RNSDVAVKILIEQEF--HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~-----~~~~vAvK~~~~~~~--~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~ 430 (634)
....|...+.||+|+||.||+|++ .+..||+|++..... .......+.+|+.+++++ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 347899999999999999999998 345599999865432 112224566899999999 699999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
...++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999997433 4899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCC-cccCCCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhhcCcccC
Q 006703 511 RSKPNT-YISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRRLE 583 (634)
Q Consensus 511 ~~~~~~-~~~~~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~----~~~~~~~i~~~~~~~~ 583 (634)
+..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.... .......+ ....+.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~ 284 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPP 284 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCC
Confidence 764322 122334579999999999986 346899999999999999999999997533 22332222 234456
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRP-----SFPSIMET 616 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RP-----s~~~Il~~ 616 (634)
++..+++.+.+||.+||..||++|| |+.++++.
T Consensus 285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 7788999999999999999999999 99999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.98 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=203.4
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN------ 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~------ 432 (634)
..|...+.||+|+||.||+|.+.. ..||+|++...........++.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 678899999999999999999874 459999997765566666788999999999999999999999987654
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
++++|||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 588887642 3899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------ 579 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------ 579 (634)
.... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....
T Consensus 176 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 176 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 4432 345678999999999877 678999999999999999999999999887665444332100
Q ss_pred -----------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -----------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -----------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
........+++.+.+||.+||..||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011233567999999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.80 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=199.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc-EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------ 431 (634)
...+|...+.||+|+||.||+|++..+. +|+|++...... ..+|+.+++.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3467999999999999999999987544 888887654321 227999999999999999999984433
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEEecCCC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLS 510 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~DFGla 510 (634)
.+++||||++++.+..+.........+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 38899999987655444432222345899999999999999999999999 99999999999999 7999999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc---------
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--------- 580 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~--------- 580 (634)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 190 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8654332 23456789999999999765 489999999999999999999999998887655443321100
Q ss_pred ------c------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 ------R------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ------~------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. ..++..+++++.+||.+||..||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 0123458899999999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.30 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=207.7
Q ss_pred CCCCcceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC--CCCeeeeeceeecCCcE
Q 006703 357 SGPSTHVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 357 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~--h~nIv~l~~~~~~~~~~ 433 (634)
......|...+.||+|+||.||++.+.. ..||+|++............+.+|+.++++++ |+||+++++++...+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3445789999999999999999998764 44999999877666677788999999999997 59999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++|| +.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++. +.+||+|||++...
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 99999 55789999997543 4889999999999999999999999 999999999999964 89999999999865
Q ss_pred CCCc--ccCCCCCCCCcccCcccccC-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcC
Q 006703 514 PNTY--ISSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKG 579 (634)
Q Consensus 514 ~~~~--~~~~~~~gt~~y~APEvl~~-----------~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~ 579 (634)
.... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 4321 12235579999999999876 4678899999999999999999999987543 33333333334
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
....++...++.+.+++.+||..||++|||+.++++.
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 4556677789999999999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=364.65 Aligned_cols=259 Identities=31% Similarity=0.534 Sum_probs=219.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
....|...+.||+|+||.||+|.+... .+|+|++.... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 446788899999999999999988642 27888875432 34455789999999999999999999999854 568
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999997543 24889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCc-ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 514 PNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 514 ~~~~-~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+. ....+..+..+++.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 620 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCCHH
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHH
Confidence 4322 22234457789999999999999999999999999999997 999999988887776664 34456678889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+.+++.+||..||++|||+.+|++.|++++...
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.99 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=206.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEc---CCcEEEEEEeeccccHHHHHHHHHHHHHHHhC---CCCCeeeeeceee----
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT---- 428 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l---~h~nIv~l~~~~~---- 428 (634)
....|...+.||+|+||.||+|++. +..||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999984 33499999876543322223445666666655 8999999999986
Q ss_pred -cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEec
Q 006703 429 -EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 507 (634)
Q Consensus 429 -~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DF 507 (634)
.....++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecC
Confidence 5667999999997 599999875432 23889999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC--------
Q 006703 508 GLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-------- 579 (634)
Q Consensus 508 Gla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-------- 579 (634)
|++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+....
T Consensus 165 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 165 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred cccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 999865432 23456679999999999999999999999999999999999999999888766554442110
Q ss_pred -----------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -----------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -----------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+...+++.+.+|+.+||..||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001233568899999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.71 Aligned_cols=255 Identities=17% Similarity=0.173 Sum_probs=208.0
Q ss_pred CCcceeecceeeccCcEEEEEEE-----E--cCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC---CCCeeeeeceee
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAE-----W--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVT 428 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~-----~--~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~---h~nIv~l~~~~~ 428 (634)
....|...+.||+|+||+||+|. . .+..||+|++.... ..++..|+.+++.++ |+||+++++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 34789999999999999999994 2 24559999986543 235667888888886 899999999999
Q ss_pred cCCcEEEEEeecccCCHHHHhccC--CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC--------
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIP--DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-------- 498 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~--~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-------- 498 (634)
..+..++||||+++|+|.+++... .....+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC---
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999999632 12345999999999999999999999999 999999999999988
Q ss_pred ---CCcEEEEecCCCccCC--CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 006703 499 ---TYTVKVCDFGLSRSKP--NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS 573 (634)
Q Consensus 499 ---~~~ikL~DFGla~~~~--~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~ 573 (634)
++.+||+|||++.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 8999999999996432 12223456779999999999999999999999999999999999999996543211
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHhcCC
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR-PSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~R-Ps~~~Il~~L~~ll~~~~~ 626 (634)
............++.+.+++..||+.+|.+| |++.++.+.|++++.....
T Consensus 293 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 293 ---CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp ---EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred ---eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 0000111111357889999999999999999 7899999999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=343.70 Aligned_cols=247 Identities=23% Similarity=0.265 Sum_probs=204.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhC------CCCCeeeeeceeecC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL------RHPNIVLLMGAVTEP 430 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l------~h~nIv~l~~~~~~~ 430 (634)
...+|...+.||+|+||+||+|.+..+ .||||++... .....++.+|+++++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 346799999999999999999998754 4999998654 23335667788888776 577999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc--EEEEecC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFG 508 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~--ikL~DFG 508 (634)
...++||||+. ++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999996 589998875433 23899999999999999999999999 999999999999998887 9999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-------
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------- 581 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~------- 581 (634)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......
T Consensus 248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 99764432 34568999999999999999999999999999999999999999988876655433211000
Q ss_pred --------------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 006703 582 --------------------------------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFP 611 (634)
Q Consensus 582 --------------------------------------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~ 611 (634)
..++...++.+.+||.+||..||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 001123478899999999999999999999
Q ss_pred HHHH
Q 006703 612 SIME 615 (634)
Q Consensus 612 ~Il~ 615 (634)
++++
T Consensus 405 e~L~ 408 (429)
T 3kvw_A 405 QALR 408 (429)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.74 Aligned_cols=247 Identities=25% Similarity=0.314 Sum_probs=200.5
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-------
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------- 429 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~------- 429 (634)
...+|...+.||+|+||.||+|.+.. ..||+|++...... ..+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34689999999999999999999864 45999998654321 2379999999999999999999833
Q ss_pred -------------------------------CCcEEEEEeecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHH
Q 006703 430 -------------------------------PPNLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYL 477 (634)
Q Consensus 430 -------------------------------~~~~~lV~E~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yL 477 (634)
...+++||||+++ +|.+.+.. ......+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3448899999985 77777642 11223589999999999999999999
Q ss_pred HhCCCCEEeeccCCCcEEEc-CCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHH
Q 006703 478 HQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWE 555 (634)
Q Consensus 478 H~~g~~IvHrDIKP~NILld-~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~e 555 (634)
|++| |+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 158 H~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 158 HSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 9999 99999999999998 68899999999998654332 344667899999999988754 8999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhhcCc---------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 006703 556 LITLQKPWRNSTPSQVISAVGFKGR---------------------------RLEIPKNVNPMVAALIETCWAEEPEIRP 608 (634)
Q Consensus 556 Lltg~~Pf~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~s~~l~~Li~~cL~~dP~~RP 608 (634)
|++|+.||.+.+..+....+..... ...++..+++.+.+|+.+||..||.+||
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999999998887665544421100 1114556889999999999999999999
Q ss_pred CHHHHHH
Q 006703 609 SFPSIME 615 (634)
Q Consensus 609 s~~~Il~ 615 (634)
|+.++++
T Consensus 315 t~~e~l~ 321 (383)
T 3eb0_A 315 NPYEAMA 321 (383)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999984
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=331.73 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=204.4
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-----
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP----- 430 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~----- 430 (634)
.....|...+.||+|+||.||+|.+. +..||+|++.... ......++.+|+.++++++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 34578999999999999999999987 4459999986432 344456788999999999999999999987654
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
...+++|||+. ++|.+++... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 67999999997 5899888643 3899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcc----------cCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 006703 511 RSKPNTYI----------SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 579 (634)
Q Consensus 511 ~~~~~~~~----------~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~ 579 (634)
........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 76543211 1233578999999998764 678999999999999999999999999887655443321100
Q ss_pred cc------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 RR------------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ~~------------------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.. ......+++.+.+||.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 0112468899999999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.04 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=196.2
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec------CCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~------~~~ 432 (634)
..|...+.||+|+||.||+|++. +..||||++..... ...+|+.+++.++|+||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 56899999999999999999996 44599999865431 22379999999999999999998843 224
Q ss_pred EEEEEeecccCCHHHHhcc-CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC-CcEEEEecCCC
Q 006703 433 LSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLS 510 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~-~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~-~~ikL~DFGla 510 (634)
+++||||+++ +|.+++.. ......+++..++.++.||++||.|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 7799999986 56555532 122345899999999999999999999999 9999999999999954 67899999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-C---------
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G--------- 579 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~--------- 579 (634)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+... .
T Consensus 205 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8654322 23456789999999999765 6899999999999999999999999988765544333211 0
Q ss_pred -----cccC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 -----RRLE------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 -----~~~~------------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.... ++..+++++.+||.+||..||++|||+.++++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0001 23467899999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=332.70 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=192.7
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
.....|...+.||+|+||.||+|.+. +..||+|++..... .....++.+|+.++++++||||+++++++...+..++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34578899999999999999999874 55699998865432 2334678899999999999999999999999999999
Q ss_pred EEeecccCCHHHHhcc-----CCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 436 VTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~-----~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
||||+++++|.+++.. ......+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999999863 112345899999999999999999999999 999999999999999999999999988
Q ss_pred ccCCCCc-----ccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc----
Q 006703 511 RSKPNTY-----ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---- 580 (634)
Q Consensus 511 ~~~~~~~-----~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~---- 580 (634)
....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 6543211 11234579999999999876 5689999999999999999999999988776655443321111
Q ss_pred ----ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 ----RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 ----~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.......+++.+.+++.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 12233568899999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.40 Aligned_cols=250 Identities=22% Similarity=0.255 Sum_probs=205.2
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEc---CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCC------Ceeeeece
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP------NIVLLMGA 426 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~------nIv~l~~~ 426 (634)
......+|...+.||+|+||.||+|.+. +..||+|++... ......+.+|+.+++.++|+ +|++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 3344578999999999999999999873 345999998643 23446678899999888654 59999999
Q ss_pred eecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC--------
Q 006703 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-------- 498 (634)
Q Consensus 427 ~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-------- 498 (634)
+...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence 99999999999999 8899999875432 24889999999999999999999999 999999999999987
Q ss_pred -----------CCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Q 006703 499 -----------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 567 (634)
Q Consensus 499 -----------~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~ 567 (634)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||...+
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999864432 345679999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHhhcCcc------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCC
Q 006703 568 PSQVISAVGFKGRR------------------------------------------LEIPKNVNPMVAALIETCWAEEPE 605 (634)
Q Consensus 568 ~~~~~~~i~~~~~~------------------------------------------~~~~~~~s~~l~~Li~~cL~~dP~ 605 (634)
..+....+...... ...+...++.+.+||.+||..||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 76554333111000 011123467899999999999999
Q ss_pred CCCCHHHHHH
Q 006703 606 IRPSFPSIME 615 (634)
Q Consensus 606 ~RPs~~~Il~ 615 (634)
+|||+.++++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.10 Aligned_cols=247 Identities=22% Similarity=0.326 Sum_probs=198.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceee---------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--------- 428 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~--------- 428 (634)
..+|...+.||+|+||.||+|.+.. ..||+|++... .....+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 4789999999999999999999884 45999998654 3445678899999999999999999998873
Q ss_pred -----cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcE
Q 006703 429 -----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTV 502 (634)
Q Consensus 429 -----~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~i 502 (634)
.....++||||+. ++|.+++... .+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 5999998642 3889999999999999999999999 99999999999997 56799
Q ss_pred EEEecCCCccCCCCc---ccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 006703 503 KVCDFGLSRSKPNTY---ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 578 (634)
Q Consensus 503 kL~DFGla~~~~~~~---~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~ 578 (634)
||+|||++....... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654321 12234457999999998865 67899999999999999999999999988876655443211
Q ss_pred Cc----------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 579 GR----------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 579 ~~----------------------------~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.. ....+..+++.+.++|.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 10 01123468999999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=347.68 Aligned_cols=256 Identities=19% Similarity=0.279 Sum_probs=211.8
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC-CCeeeeeceeecCCcEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h-~nIv~l~~~~~~~~~~~lV 436 (634)
...|...+.||+|+||.||+|++. +..||||++...... .++.+|+++++.++| ++|..+..++......++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 467999999999999999999986 455999987655432 246789999999976 6666777777888889999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE---cCCCcEEEEecCCCccC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl---d~~~~ikL~DFGla~~~ 513 (634)
|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++| |+||||||+|||| +.++.+||+|||++...
T Consensus 82 me~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999 899999997433 24899999999999999999999999 9999999999999 68899999999999864
Q ss_pred CCCc-------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHh---hcCc
Q 006703 514 PNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVG---FKGR 580 (634)
Q Consensus 514 ~~~~-------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~---~~~~~~i~---~~~~ 580 (634)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 4322 122366799999999999999999999999999999999999999987554 22222221 1122
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 581 ~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
...++..+++++.+|+.+||..+|++||++.+|++.|++++...
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 22344678999999999999999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=334.95 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=198.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccc---------cHHHHHHHHHHHHHHHhCCCCCeeeeeceee
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEF---------HEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~---------~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~ 428 (634)
....|...+.||+|+||.||+|.+. +..||+|++..... .....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3477999999999999999999876 44599999865432 2334477899999999999999999999983
Q ss_pred -----cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEE
Q 006703 429 -----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 503 (634)
Q Consensus 429 -----~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ik 503 (634)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEE
Confidence 3446899999997 47877776432 34899999999999999999999999 99999999999999999999
Q ss_pred EEecCCCccCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-
Q 006703 504 VCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR- 581 (634)
Q Consensus 504 L~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~- 581 (634)
|+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+......
T Consensus 175 l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999997543322 3345678999999999877 67899999999999999999999999988876655544221100
Q ss_pred -----------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 -----------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 -----------------------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
...+...++.+.+||.+||..||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1123456889999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=327.37 Aligned_cols=243 Identities=21% Similarity=0.317 Sum_probs=199.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeec--CCcE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE--PPNL 433 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~--~~~~ 433 (634)
....|...+.||+|+||+||+|.+. +..||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 3478999999999999999999886 4459999986432 256789999999997 9999999999987 6679
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCcc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRS 512 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~ 512 (634)
+++|||+.+++|.+++. .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 99999999999999885 2888899999999999999999999 99999999999999776 899999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhh-------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGF------------- 577 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-~~~~~~~i~~------------- 577 (634)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.... ..+....+..
T Consensus 181 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 181 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 54332 3445679999999999977 668999999999999999999999995433 2222211100
Q ss_pred cC----------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 578 KG----------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 578 ~~----------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.. .....+..+++.+.+||.+||..||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000111237899999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=343.17 Aligned_cols=247 Identities=15% Similarity=0.084 Sum_probs=184.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccc-cHHHHHHHHHHH---HHHHhCCCCCeeeeec-------e
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREV---AIMKGLRHPNIVLLMG-------A 426 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~-~~~~~~~~~~El---~iL~~l~h~nIv~l~~-------~ 426 (634)
...|...+.||+|+||.||+|++..+ .||+|++..... .......+.+|+ .+|+. +||||++++. +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 45689999999999999999998744 499999987654 334456677785 45555 7999888653 3
Q ss_pred eecC-----------------CcEEEEEeecccCCHHHHhccCCCcccccHHHH------HHHHHHHHHHHHHHHhCCCC
Q 006703 427 VTEP-----------------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR------LNMAYDVAKGMNYLHQRRPP 483 (634)
Q Consensus 427 ~~~~-----------------~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~------~~i~~qIa~aL~yLH~~g~~ 483 (634)
+... ...++||||++ ++|.+++...+. .+++..+ +.++.||+.||.|||++|
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 3222 33899999998 799999975322 2344445 677899999999999999
Q ss_pred EEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCC
Q 006703 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQK 561 (634)
Q Consensus 484 IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~ 561 (634)
|+||||||+|||++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998654321 14556799999999987 678999999999999999999999
Q ss_pred CCCCCChHHHHHH-----HhhcCcc--cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 562 PWRNSTPSQVISA-----VGFKGRR--LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 562 Pf~~~~~~~~~~~-----i~~~~~~--~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
||....+...... ....... .+.+..+++.+.+||.+||..||++|||+.++++
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9987644211000 0000111 2223578999999999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=323.76 Aligned_cols=245 Identities=26% Similarity=0.434 Sum_probs=195.1
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec---------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--------- 429 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--------- 429 (634)
..|...+.||+|+||.||+|++. +..||+|++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 56888999999999999999986 445999998643 3445778899999999999999999998754
Q ss_pred ----CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 430 ----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 430 ----~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEe
Confidence 356899999999999999997543 34788899999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCC--------------cccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCC-hH
Q 006703 506 DFGLSRSKPNT--------------YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNST-PS 569 (634)
Q Consensus 506 DFGla~~~~~~--------------~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-~~ 569 (634)
|||++...... ........||+.|+|||++.+. .++.++||||||+++|+|++ ||.... ..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99998764321 1123455689999999999865 68999999999999999998 665322 22
Q ss_pred HHHHHHhhc--CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 570 QVISAVGFK--GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 570 ~~~~~i~~~--~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+....+... .....++...++.+.+++.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 333333211 1223345667889999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=325.87 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=189.6
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
....|...+.||+|+||.||+|.+. +..||+|++............+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467888999999999999999986 45699999987655444445555666678888999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
|||+ ++.+..+..... ..+++..++.++.||+.||.|||++ | |+|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 9999 556666654322 3489999999999999999999995 9 99999999999999999999999999876543
Q ss_pred CcccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhhcCcccCCC--CC
Q 006703 516 TYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIP--KN 587 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~--~~ 587 (634)
.. ......||+.|+|||++. +..++.++||||||+++|+|++|+.||.... ..+....+. ....+.++ ..
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 255 (318)
T 2dyl_A 178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPGHMG 255 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCSSSC
T ss_pred Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCccCC
Confidence 22 234557999999999994 5567899999999999999999999998744 333333332 23333333 46
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++.+.+++.+||..||.+|||+.++++
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 8999999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.14 Aligned_cols=248 Identities=21% Similarity=0.238 Sum_probs=197.4
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCC--------CCCeeeeecee
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR--------HPNIVLLMGAV 427 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~--------h~nIv~l~~~~ 427 (634)
....+|...+.||+|+||+||+|++..+ .||+|++... ......+.+|+.+++.++ |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3457899999999999999999988744 4999998643 334467889999999885 78899999998
Q ss_pred e----cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCC--
Q 006703 428 T----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTY-- 500 (634)
Q Consensus 428 ~----~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~-- 500 (634)
. .....++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++ | |+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLG-HHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEeccC-ccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchh
Confidence 7 5668999999995 566555543321 3489999999999999999999998 9 99999999999998765
Q ss_pred -----------------------------------------------cEEEEecCCCccCCCCcccCCCCCCCCcccCcc
Q 006703 501 -----------------------------------------------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 533 (634)
Q Consensus 501 -----------------------------------------------~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APE 533 (634)
.+||+|||++...... .....||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999865432 34567999999999
Q ss_pred cccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhh-cCc--------------------------
Q 006703 534 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP------SQVISAVGF-KGR-------------------------- 580 (634)
Q Consensus 534 vl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~------~~~~~~i~~-~~~-------------------------- 580 (634)
++.+..++.++|||||||++|+|++|+.||...+. ......+.. ...
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999999976542 111111100 000
Q ss_pred -------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -------------~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+...++.+.+||.+||..||++|||+.++++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00112334567899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=330.03 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=182.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHH-HHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~-iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
....|...+.||+|+||.||+|.++ +..||+|++..... .....++..|+. +++.++||||+++++++...+..++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 3478899999999999999999987 44599999876543 333345556665 6777899999999999999999999
Q ss_pred EEeecccCCHHHHhcc--CCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 436 VTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~--~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
||||+.+ +|.+++.. ......+++..++.++.|++.||.|||++ | |+||||||+||+++.++.+||+|||++..
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999986 88777752 11123589999999999999999999998 9 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccc----cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCC---
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVL----REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--- 585 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl----~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 585 (634)
..... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||..................+.++
T Consensus 176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3aln_A 176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence 54332 23344799999999998 56678999999999999999999999998754321111111112222222
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 586 -KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 586 -~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
..+++.+.+|+.+||..||++|||+.++++
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 468999999999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=333.60 Aligned_cols=249 Identities=20% Similarity=0.228 Sum_probs=188.9
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN------ 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~------ 432 (634)
..|...+.||+|+||.||+|++. +..||+|++....... ..+.++++.++.++||||+++++++.....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 57889999999999999999987 4459999886543222 345578888889999999999999855332
Q ss_pred -EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHH--hCCCCEEeeccCCCcEEEcC-CCcEEEEecC
Q 006703 433 -LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--QRRPPIVHRDLKSPNLLVDS-TYTVKVCDFG 508 (634)
Q Consensus 433 -~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH--~~g~~IvHrDIKP~NILld~-~~~ikL~DFG 508 (634)
.++||||++++.+..+.........+++..++.++.|++.||.||| ++| |+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 8899999987433333322223345889999999999999999999 888 999999999999996 8999999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-------
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------- 580 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~------- 580 (634)
++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 178 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 178 SAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 998654432 334567899999999987655 79999999999999999999999999887666554422100
Q ss_pred -----------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 581 -----------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 581 -----------------------~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+...++.+.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 01122336789999999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=324.88 Aligned_cols=250 Identities=20% Similarity=0.235 Sum_probs=202.0
Q ss_pred CCCCCcceeecceeeccCcEEEEEEEEcC---CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC------eeeeece
Q 006703 356 PSGPSTHVIDSSNFIKGSFGTVYHAEWRN---SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN------IVLLMGA 426 (634)
Q Consensus 356 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~---~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n------Iv~l~~~ 426 (634)
......+|...+.||+|+||+||+|.+.. ..||+|++... ......+.+|+.++++++|++ ++.++++
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 33445789999999999999999999863 34999998643 233466778999999886655 9999999
Q ss_pred eecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE----------
Q 006703 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---------- 496 (634)
Q Consensus 427 ~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl---------- 496 (634)
+......++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence 99999999999999 5566666654322 24899999999999999999999999 9999999999999
Q ss_pred ---------cCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Q 006703 497 ---------DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 567 (634)
Q Consensus 497 ---------d~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~ 567 (634)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999864332 345679999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHhhcCcc------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCC
Q 006703 568 PSQVISAVGFKGRR------------------------------------------LEIPKNVNPMVAALIETCWAEEPE 605 (634)
Q Consensus 568 ~~~~~~~i~~~~~~------------------------------------------~~~~~~~s~~l~~Li~~cL~~dP~ 605 (634)
..+....+...... .......++.+.+||.+||..||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 76544333211000 001112356899999999999999
Q ss_pred CCCCHHHHHH
Q 006703 606 IRPSFPSIME 615 (634)
Q Consensus 606 ~RPs~~~Il~ 615 (634)
+|||+.++++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.44 Aligned_cols=248 Identities=21% Similarity=0.362 Sum_probs=181.6
Q ss_pred cceee-cceeeccCcEEEEEEEEc----CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeecee--ecCCcE
Q 006703 361 THVID-SSNFIKGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV--TEPPNL 433 (634)
Q Consensus 361 ~~~~~-~~~LG~G~fG~Vy~a~~~----~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~--~~~~~~ 433 (634)
..|.. .++||+|+||+||+|+++ +..||+|++...... ..+.+|+.+|++++||||+++++++ ......
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34444 568999999999999976 345999998755433 3567999999999999999999999 457789
Q ss_pred EEEEeecccCCHHHHhccC------CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE----cCCCcEE
Q 006703 434 SIVTEYLSRGSLYKLLHIP------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVK 503 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~------~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl----d~~~~ik 503 (634)
++||||+.+ +|.+++... .....+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+|
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 999999975 777777421 11234899999999999999999999999 9999999999999 6778999
Q ss_pred EEecCCCccCCCCc---ccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChH---------H
Q 006703 504 VCDFGLSRSKPNTY---ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS---------Q 570 (634)
Q Consensus 504 L~DFGla~~~~~~~---~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~---------~ 570 (634)
|+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998654321 223456799999999999875 4899999999999999999999999765432 1
Q ss_pred HHHHH-hhcCccc-----------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 006703 571 VISAV-GFKGRRL-----------------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 614 (634)
Q Consensus 571 ~~~~i-~~~~~~~-----------------------------------~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il 614 (634)
....+ ....... ......++.+.+||.+||..||.+|||+.+++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111 0000000 00112367889999999999999999999998
Q ss_pred H
Q 006703 615 E 615 (634)
Q Consensus 615 ~ 615 (634)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.38 Aligned_cols=243 Identities=21% Similarity=0.351 Sum_probs=204.6
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccH----HHHHHHHHHHHHHHhCC--CCCeeeeeceeec
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLR--HPNIVLLMGAVTE 429 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~----~~~~~~~~El~iL~~l~--h~nIv~l~~~~~~ 429 (634)
....+|...+.||+|+||.||+|.+.. ..||+|++....... .....+.+|+.++++++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 445789999999999999999998864 449999987654321 11234668999999996 5999999999999
Q ss_pred CCcEEEEEeeccc-CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEEec
Q 006703 430 PPNLSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDF 507 (634)
Q Consensus 430 ~~~~~lV~E~~~g-gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~DF 507 (634)
.+..+++||++.+ ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 9999999999975 8999998753 24899999999999999999999999 99999999999999 7889999999
Q ss_pred CCCccCCCCcccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCC
Q 006703 508 GLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 586 (634)
Q Consensus 508 Gla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 586 (634)
|++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... . .......+.
T Consensus 195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~------~~~~~~~~~ 264 (320)
T 3a99_A 195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--I------IRGQVFFRQ 264 (320)
T ss_dssp TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H------HHCCCCCSS
T ss_pred ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--h------hcccccccc
Confidence 999876543 2345679999999999987776 6889999999999999999999975321 1 112334567
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 587 NVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+++.+.++|.+||..||++|||+.++++
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 88999999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.38 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=177.1
Q ss_pred Ccceeec-ceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec----CCc
Q 006703 360 STHVIDS-SNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPN 432 (634)
Q Consensus 360 ~~~~~~~-~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~----~~~ 432 (634)
...|... +.||+|+||.||+|.++ +..||+|++.... .. ..+....++.++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3667775 46999999999999988 5569999986532 11 1122334566799999999999865 455
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEEEEecCC
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL 509 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ikL~DFGl 509 (634)
.++||||+++++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+||+++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 8999999999999999975432 35899999999999999999999999 999999999999975 45699999999
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----hhc--CcccC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV----GFK--GRRLE 583 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i----~~~--~~~~~ 583 (634)
+...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||............ ... .....
T Consensus 178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 178 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9865432 234567899999999998888999999999999999999999999776654432111 111 11122
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 584 ~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
....+++.+.+||.+||..||.+|||+.++++ ..+++..
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~ 294 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQS 294 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHTG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Ccccccc
Confidence 23578999999999999999999999999998 3444443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.77 Aligned_cols=251 Identities=25% Similarity=0.228 Sum_probs=202.7
Q ss_pred CCCCCCcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CC-----Ceeeeece
Q 006703 355 NPSGPSTHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HP-----NIVLLMGA 426 (634)
Q Consensus 355 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~-----nIv~l~~~ 426 (634)
........|...+.||+|+||+||+|.+..+ .||||++... .....++.+|+++++.++ |+ +|++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3334457899999999999999999998744 4999998643 233456778888888874 44 49999999
Q ss_pred eecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh--CCCCEEeeccCCCcEEEc--CCCcE
Q 006703 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ--RRPPIVHRDLKSPNLLVD--STYTV 502 (634)
Q Consensus 427 ~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~--~g~~IvHrDIKP~NILld--~~~~i 502 (634)
+...+..++||||+.+ +|.+++..... ..+++..+..++.||+.||.|||. .| |+||||||+|||++ .++.+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCE
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcE
Confidence 9999999999999965 99999875432 238999999999999999999995 56 99999999999994 57889
Q ss_pred EEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc
Q 006703 503 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 582 (634)
Q Consensus 503 kL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~ 582 (634)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......+
T Consensus 201 kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp EECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999999875432 345689999999999999999999999999999999999999999988776655442211000
Q ss_pred C----------------CC------------------C---C-------------------------CcHHHHHHHHHhh
Q 006703 583 E----------------IP------------------K---N-------------------------VNPMVAALIETCW 600 (634)
Q Consensus 583 ~----------------~~------------------~---~-------------------------~s~~l~~Li~~cL 600 (634)
+ ++ . . ..+.+.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0 00 0 0 0147899999999
Q ss_pred hcCCCCCCCHHHHHH
Q 006703 601 AEEPEIRPSFPSIME 615 (634)
Q Consensus 601 ~~dP~~RPs~~~Il~ 615 (634)
..||++|||+.++++
T Consensus 358 ~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQ 372 (382)
T ss_dssp CSCTTTSCCHHHHTT
T ss_pred CCChhhCCCHHHHhc
Confidence 999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=325.27 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=196.9
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccH----HHHHHHHHHHHHHHhC----CCCCeeeeecee
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHE----DRFKEFLREVAIMKGL----RHPNIVLLMGAV 427 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~----~~~~~~~~El~iL~~l----~h~nIv~l~~~~ 427 (634)
.....|...+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.+++++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34577999999999999999999885 4459999987654322 1223456799999988 899999999999
Q ss_pred ecCCcEEEEEee-cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEE
Q 006703 428 TEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVC 505 (634)
Q Consensus 428 ~~~~~~~lV~E~-~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~ 505 (634)
...+..+++||+ +.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEE
Confidence 999999999999 78999999997533 4899999999999999999999999 99999999999999 88999999
Q ss_pred ecCCCccCCCCcccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCC
Q 006703 506 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 584 (634)
Q Consensus 506 DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 584 (634)
|||++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... . ......+
T Consensus 183 dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~------~~~~~~~ 252 (312)
T 2iwi_A 183 DFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--I------LEAELHF 252 (312)
T ss_dssp CCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H------HHTCCCC
T ss_pred EcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--H------hhhccCC
Confidence 99999875543 2345679999999999987766 4589999999999999999999975321 1 1233456
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+..+++.+.++|.+||..||++|||+.++++
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6789999999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.50 Aligned_cols=246 Identities=20% Similarity=0.297 Sum_probs=196.0
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-----------CCCeeeeece
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----------HPNIVLLMGA 426 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-----------h~nIv~l~~~ 426 (634)
...|...+.||+|+||+||+|++. +..||+|++.... .....+.+|+.++++++ |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 468999999999999999999986 4459999986432 33456778999998885 8999999999
Q ss_pred eecCC----cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeeccCCCcEEEc----
Q 006703 427 VTEPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVD---- 497 (634)
Q Consensus 427 ~~~~~----~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~-g~~IvHrDIKP~NILld---- 497 (634)
+.... ..+++|||+ +++|.+++..... ..+++..++.++.||+.||.|||++ | |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCC
Confidence 87544 789999999 8899999875332 2388999999999999999999998 9 99999999999995
Q ss_pred --CCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChH------
Q 006703 498 --STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS------ 569 (634)
Q Consensus 498 --~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~------ 569 (634)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3448999999999865432 34567999999999999999999999999999999999999999865421
Q ss_pred HHHHHHhh-cC---------------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 006703 570 QVISAVGF-KG---------------------------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPS 609 (634)
Q Consensus 570 ~~~~~i~~-~~---------------------------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs 609 (634)
+....+.. .. ....++..+++.+.+||.+||..||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11111100 00 011233455788999999999999999999
Q ss_pred HHHHHH
Q 006703 610 FPSIME 615 (634)
Q Consensus 610 ~~~Il~ 615 (634)
+.++++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=330.12 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=186.7
Q ss_pred CcceeecceeeccCcEEEEEE-EEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a-~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||+||.+ ...+..||||++.... ...+.+|+.+++++ +||||+++++++.+++..++||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 356777889999999999765 3446679999986542 24567899999876 8999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcc----cccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCC-------------C
Q 006703 438 EYLSRGSLYKLLHIPDARV----VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-------------Y 500 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~----~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~-------------~ 500 (634)
||+. ++|.+++....... ..++..++.++.||+.||.|||++| |+||||||+|||++.+ +
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCce
Confidence 9996 59999997543211 1133346789999999999999999 9999999999999754 4
Q ss_pred cEEEEecCCCccCCCCcc----cCCCCCCCCcccCcccccC-------CCCCchHHHHHHHHHHHHHHh-CCCCCCCCCh
Q 006703 501 TVKVCDFGLSRSKPNTYI----SSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 568 (634)
Q Consensus 501 ~ikL~DFGla~~~~~~~~----~~~~~~gt~~y~APEvl~~-------~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~ 568 (634)
.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 899999999986544321 1234579999999999976 568999999999999999999 9999977654
Q ss_pred HHHHHHHhhcCcccCC----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 569 SQVISAVGFKGRRLEI----PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 569 ~~~~~~i~~~~~~~~~----~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+..... ........ +..+++++.++|.+||..||.+|||+.++++
T Consensus 246 ~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHH-TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHhc-CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 4322111 11111111 1235688999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.48 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=190.3
Q ss_pred CcceeecceeeccCcEEE-EEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTV-YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~V-y~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||+| |++...++.||||++...... .+.+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 356888899999999995 555566778999998654432 234899999999 7999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-----CCcEEEEecCCCcc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSRS 512 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-----~~~ikL~DFGla~~ 512 (634)
||+. ++|.+++..... ...+..++.++.||+.||.|||++| |+||||||+|||++. ...+||+|||++..
T Consensus 98 E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp ECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred ECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9996 599999875442 2444456789999999999999999 999999999999953 34688999999986
Q ss_pred CCCCc---ccCCCCCCCCcccCccccc---CCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCccc-CC
Q 006703 513 KPNTY---ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRL-EI 584 (634)
Q Consensus 513 ~~~~~---~~~~~~~gt~~y~APEvl~---~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~-~~ 584 (634)
..... .......||+.|+|||++. +..++.++|||||||++|||++ |..||................... ..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCc
Confidence 54321 2234567999999999997 4567889999999999999999 899997766555443332211111 11
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 585 ~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+...+..+.+||.+||..||.+|||+.++++
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 2334667899999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.69 Aligned_cols=232 Identities=14% Similarity=0.120 Sum_probs=191.0
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
...+|...+.||+|+||.||+|.+. +..||+|++...... ......+.+|+.++++++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3467999999999999999999987 455999998766443 4556789999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||++|++|.+++... .....+..++.||+.||.|||++| |+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999999532 345568889999999999999999 9999999999999999999998553
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhhcCcc----cCCCCCCcH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS-AVGFKGRR----LEIPKNVNP 590 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~-~i~~~~~~----~~~~~~~s~ 590 (634)
|++ +++.++||||||+++|+|++|+.||...+..+... ........ ......+++
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence 223 36889999999999999999999998766432110 00000111 123367899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
.+.++|.+||..||++| |+.++++.|+++.....
T Consensus 235 ~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 235 QISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 99999999999999999 99999999999887544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=303.43 Aligned_cols=230 Identities=24% Similarity=0.373 Sum_probs=181.7
Q ss_pred cceeec-ceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHH-HhCCCCCeeeeeceeec----CCc
Q 006703 361 THVIDS-SNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIM-KGLRHPNIVLLMGAVTE----PPN 432 (634)
Q Consensus 361 ~~~~~~-~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL-~~l~h~nIv~l~~~~~~----~~~ 432 (634)
..|... +.||+|+||.||+|.+.. ..||+|++... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 445554 789999999999999864 45999998642 2455788887 55699999999999876 677
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEEEEecCC
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL 509 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ikL~DFGl 509 (634)
.++||||+++++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999975432 34899999999999999999999999 999999999999997 78999999998
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--CcccCCC--
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--GRRLEIP-- 585 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~-- 585 (634)
+.... +..++.++||||||+++|+|++|+.||............... ......+
T Consensus 167 a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 167 AKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp CEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred ccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 86432 234678999999999999999999999876554432211111 1112222
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 586 --KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 586 --~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
..+++.+.+++.+||..||.+|||+.++++ ..++++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~~ 263 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQS 263 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHTG
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhccc
Confidence 568999999999999999999999999998 3445443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=324.13 Aligned_cols=244 Identities=15% Similarity=0.124 Sum_probs=187.4
Q ss_pred CCCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCC-CCeeeee---------
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVLLM--------- 424 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h-~nIv~l~--------- 424 (634)
.....|...+.||+|+||.||+|.+. +..||||++..... .....+.+.+|+.+++.++| .|+....
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34456888899999999999999988 56699999874332 22335678899999999977 3221111
Q ss_pred ------------ceeec-----CCcEEEEEeecccCCHHHHhcc----CCCcccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 006703 425 ------------GAVTE-----PPNLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483 (634)
Q Consensus 425 ------------~~~~~-----~~~~~lV~E~~~ggsL~~ll~~----~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~ 483 (634)
.++.. ...++++|+++ +++|.+++.. ......+++..++.++.||++||.|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 11111 22467788876 6799998841 222345888899999999999999999999
Q ss_pred EEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccc----------cCCCCCchHHHHHHHHHH
Q 006703 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL----------REDPSNEKSDVFSFGVIL 553 (634)
Q Consensus 484 IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl----------~~~~~s~~sDVwSLGvlL 553 (634)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999998865433 345677 999999999 555678999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 006703 554 WELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 614 (634)
Q Consensus 554 ~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il 614 (634)
|||++|+.||...+..+....+ ......+++.+.+||.+||..||++|||+.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999876654322111 222346889999999999999999999976663
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=342.04 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=207.6
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec------CC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~------~~ 431 (634)
...|...+.||+|+||.||+|.+. +..||+|++... ........+.+|+.++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 367899999999999999999876 445999998654 345556789999999999999999999998765 67
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCc---EEEEecC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFG 508 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~---ikL~DFG 508 (634)
..++||||+++++|.+++........+++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 78999999999999999986555456888999999999999999999999 999999999999986654 9999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHH---------HHHhhc-
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI---------SAVGFK- 578 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~---------~~i~~~- 578 (634)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ......
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998754432 334568999999999999999999999999999999999999999765332110 000000
Q ss_pred --Cc------c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHHHHHhc
Q 006703 579 --GR------R----LEIPKNVNPMVAALIETCWAEEPEIRPSFPS-----IMETLQQFLMSS 624 (634)
Q Consensus 579 --~~------~----~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~-----Il~~L~~ll~~~ 624 (634)
.. . ..+...+++.+.+++.+||..||++|||+.+ +.+.++.++...
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00 0 1122346789999999999999999999988 667888887754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=341.77 Aligned_cols=243 Identities=20% Similarity=0.249 Sum_probs=197.7
Q ss_pred CCcceeecceeeccCcEEEEEEEEc---CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc---
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--- 432 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~---~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~--- 432 (634)
...+|...+.||+|+||.||+|.+. +..||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 3478999999999999999999986 3459999876543 34455678899999999999999999999987665
Q ss_pred --EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 433 --LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 433 --~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+||+|||++
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987753 3899999999999999999999999 9999999999999875 8999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
...... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||........ .........++
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~~ 295 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYD 295 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCHHHHHCH
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------cccccccccCH
Confidence 865433 4567999999999997764 8999999999999999999988865221100 00000012457
Q ss_pred HHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHh
Q 006703 591 MVAALIETCWAEEPEIRP-SFPSIMETLQQFLMS 623 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RP-s~~~Il~~L~~ll~~ 623 (634)
.+.++|.+||..||.+|| +++++...|..++..
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 899999999999999998 577788888777643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=315.31 Aligned_cols=237 Identities=18% Similarity=0.194 Sum_probs=183.2
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccc------cHHHHHHHHHHHHHHHhCC---------C--------
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEF------HEDRFKEFLREVAIMKGLR---------H-------- 417 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~------~~~~~~~~~~El~iL~~l~---------h-------- 417 (634)
..|...+.||+|+||+||+|++++..||||++..... .....+.+.+|+.+++.++ |
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 6788889999999999999999888899999986642 1223356778888888885 4
Q ss_pred ---------CCeeeeeceeec-------------CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHH
Q 006703 418 ---------PNIVLLMGAVTE-------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475 (634)
Q Consensus 418 ---------~nIv~l~~~~~~-------------~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~ 475 (634)
|||+++++++.. ....|+||||+++|++.+.+.. ..+++..++.++.||+.||.
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHH
Confidence 455555555543 7889999999999976665533 24899999999999999999
Q ss_pred HHH-hCCCCEEeeccCCCcEEEcCCC--------------------cEEEEecCCCccCCCCcccCCCCCCCCcccCccc
Q 006703 476 YLH-QRRPPIVHRDLKSPNLLVDSTY--------------------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 534 (634)
Q Consensus 476 yLH-~~g~~IvHrDIKP~NILld~~~--------------------~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEv 534 (634)
||| ++| |+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|||+
T Consensus 176 ~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGG
T ss_pred HHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhh
Confidence 999 899 99999999999999887 899999999986543 24479999999999
Q ss_pred ccCCCCCchHHHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHh-hcCccc----CCCCCCcHHHHHHHHHhhhcCCCCC
Q 006703 535 LREDPSNEKSDVFSFGVI-LWELITLQKPWRNSTP-SQVISAVG-FKGRRL----EIPKNVNPMVAALIETCWAEEPEIR 607 (634)
Q Consensus 535 l~~~~~s~~sDVwSLGvl-L~eLltg~~Pf~~~~~-~~~~~~i~-~~~~~~----~~~~~~s~~l~~Li~~cL~~dP~~R 607 (634)
+.+.. +.++||||||++ .+++++|..||..... ......+. ...... ..+..+++++.+||.+||..|
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 98877 899999998777 7778889999854221 11111111 111111 112357889999999999976
Q ss_pred CCHHHHH
Q 006703 608 PSFPSIM 614 (634)
Q Consensus 608 Ps~~~Il 614 (634)
|+.+++
T Consensus 324 -sa~e~l 329 (336)
T 2vuw_A 324 -SATDLL 329 (336)
T ss_dssp -SHHHHH
T ss_pred -CHHHHH
Confidence 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=284.92 Aligned_cols=184 Identities=14% Similarity=0.093 Sum_probs=130.8
Q ss_pred eeeccCcEEEEEEEE--cCCcEEEEEEeeccc--------cHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEEE
Q 006703 368 NFIKGSFGTVYHAEW--RNSDVAVKILIEQEF--------HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~~--------~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~lV 436 (634)
..+.|++|.+..++. .+..+++|++..... .+...++|.+|+.+|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 455677777766544 477799999976521 123346799999999999 799999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||++|++|.+++...+ .+++. +|+.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997554 35554 57899999999999999 999999999999999999999999999876554
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCC
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ 560 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~ 560 (634)
.....+.+||+.|+|||++.+. +..++|+||+|+++++|.++.
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 4445566799999999999765 567899999999987765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=259.24 Aligned_cols=187 Identities=17% Similarity=0.212 Sum_probs=147.8
Q ss_pred eeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccH------HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~------~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
++..+.||+|+||.||++...+..+++|+........ ...+++.+|++++++++||||+++..++...+..++|
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ----------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3556799999999999998888889999876543321 1235689999999999999999666666677788999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999874 4588999999999999999 999999999999998 9999999999876543
Q ss_pred ccc-------CCCCCCCCcccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCC
Q 006703 517 YIS-------SKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWR 564 (634)
Q Consensus 517 ~~~-------~~~~~gt~~y~APEvl~~--~~~s~~sDVwSLGvlL~eLltg~~Pf~ 564 (634)
... .....||+.|+|||++.. ..|+..+|+|+...-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 135579999999999977 567788899999999888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=200.93 Aligned_cols=145 Identities=17% Similarity=0.118 Sum_probs=114.2
Q ss_pred ceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccH----------------HHHHHHHHHHHHHHhCCCCCeeeee
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHE----------------DRFKEFLREVAIMKGLRHPNIVLLM 424 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~----------------~~~~~~~~El~iL~~l~h~nIv~l~ 424 (634)
.|...+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 3455689999999999999984 4459999986432211 23467889999999998 5 6666
Q ss_pred ceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEE
Q 006703 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 504 (634)
Q Consensus 425 ~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL 504 (634)
+++.. +..++||||++|++|.+ +... ....++.|++.||.|||++| |+||||||+|||++ ++.+||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~~---------~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRVE---------NPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCCS---------CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEE
T ss_pred eEEec-cceEEEEEecCCCcHHH-cchh---------hHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEE
Confidence 65543 56699999999999988 4321 23468999999999999999 99999999999999 999999
Q ss_pred EecCCCccCCCCcccCCCCCCCCcccCccccc
Q 006703 505 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 536 (634)
Q Consensus 505 ~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~ 536 (634)
+|||+++. +..++|||.+.
T Consensus 234 ~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE-------------TTSTTHHHHHH
T ss_pred EECCCCeE-------------CCCCCHHHHHH
Confidence 99999874 23468899873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=4e-18 Score=173.45 Aligned_cols=138 Identities=18% Similarity=0.159 Sum_probs=105.3
Q ss_pred ceeecceeeccCcEEEEEEEE--cCCc--EEEEEEeecccc----------------------HHHHHHHHHHHHHHHhC
Q 006703 362 HVIDSSNFIKGSFGTVYHAEW--RNSD--VAVKILIEQEFH----------------------EDRFKEFLREVAIMKGL 415 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~--~~~~--vAvK~~~~~~~~----------------------~~~~~~~~~El~iL~~l 415 (634)
.|...+.||+|+||.||+|.+ .+.. ||||+++..... ......+.+|+.+|+++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 456778999999999999988 5777 999997543211 01123578899999999
Q ss_pred CCCCe--eeeeceeecCCcEEEEEeeccc-C----CHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHH-hCCCCEEee
Q 006703 416 RHPNI--VLLMGAVTEPPNLSIVTEYLSR-G----SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHR 487 (634)
Q Consensus 416 ~h~nI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH-~~g~~IvHr 487 (634)
.|++| +.++.. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.| |+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 87754 344432 356899999943 3 67665431 234456789999999999999 999 9999
Q ss_pred ccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 488 DLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 488 DIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999988 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=9.7e-16 Score=164.25 Aligned_cols=137 Identities=15% Similarity=0.129 Sum_probs=98.0
Q ss_pred cceeecceeeccCcEEEEEEEEc-CCcEEEEEEeecccc----------------HHHH--H--HHHHHHHHHHhCCCCC
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFH----------------EDRF--K--EFLREVAIMKGLRHPN 419 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~----------------~~~~--~--~~~~El~iL~~l~h~n 419 (634)
.-|...+.||+|++|.||+|... +..||||+++..... .... . ....|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34778899999999999999875 556999997532110 0000 0 1235677777775444
Q ss_pred ee--eeeceeecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc
Q 006703 420 IV--LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 497 (634)
Q Consensus 420 Iv--~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld 497 (634)
+. ..++. ...+|||||++|++|.++.... ....++.||+.+|.+||+.| ||||||||.|||++
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKHG--LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe
Confidence 32 22221 1237999999999887764321 23467899999999999999 99999999999998
Q ss_pred CCC----------cEEEEecCCCcc
Q 006703 498 STY----------TVKVCDFGLSRS 512 (634)
Q Consensus 498 ~~~----------~ikL~DFGla~~ 512 (634)
.++ .+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 766 389999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=2.8e-11 Score=122.11 Aligned_cols=139 Identities=14% Similarity=0.016 Sum_probs=107.1
Q ss_pred eeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEeecc
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
|.....++.|+.+.||++...++.+++|+........ ...+.+|+.+++.+. +..++++++++.+....|+||||++
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 4455567778889999998777789999986532111 134778999999884 6778899999988889999999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR---------------------------------------- 481 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g---------------------------------------- 481 (634)
|.+|.+.+.. ......++.+++++|..||+..
T Consensus 94 G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 94 GVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp SEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred CeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9999876321 1123467889999999999810
Q ss_pred -----------------CCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 482 -----------------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 482 -----------------~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
+.++|+|++|.||+++.+..+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 238999999999999876666799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=7.7e-10 Score=117.13 Aligned_cols=143 Identities=15% Similarity=0.193 Sum_probs=106.1
Q ss_pred eecceeeccCcEEEEEEEEcCCcEEEEEEe--eccccHHHHHHHHHHHHHHHhCC--CCCeeeeeceeecC---CcEEEE
Q 006703 364 IDSSNFIKGSFGTVYHAEWRNSDVAVKILI--EQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEP---PNLSIV 436 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~--~~~~~~~~~~~~~~El~iL~~l~--h~nIv~l~~~~~~~---~~~~lV 436 (634)
...+.|+.|.++.||++...+..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. ...|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 345678899999999998887778888765 22211 12246778999999986 45578888888766 348999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR------------------------------------ 480 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~------------------------------------ 480 (634)
|||++|..+.+... ..++......++.++++.|..||+.
T Consensus 120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999987754211 1267778888999999999999973
Q ss_pred --------------------CCCEEeeccCCCcEEEcCCCc--EEEEecCCCcc
Q 006703 481 --------------------RPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRS 512 (634)
Q Consensus 481 --------------------g~~IvHrDIKP~NILld~~~~--ikL~DFGla~~ 512 (634)
.+.++|+|++|.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999987653 68999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.91 E-value=1.7e-09 Score=108.02 Aligned_cols=127 Identities=19% Similarity=0.146 Sum_probs=92.7
Q ss_pred eccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC--eeeeeceeecCCcEEEEEeecccCCHH
Q 006703 370 IKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAVTEPPNLSIVTEYLSRGSLY 446 (634)
Q Consensus 370 G~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~ 446 (634)
+.|..+.||++... +..+++|+..... ...+.+|+.+++.+.+.+ +++++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 35666999999765 3459999875431 134668888888885434 567888888888899999999998884
Q ss_pred HHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 006703 447 KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR--------------------------------------------- 481 (634)
Q Consensus 447 ~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g--------------------------------------------- 481 (634)
... .+ ...++.++++.|..||+..
T Consensus 104 --~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 --SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp --TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred --cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 221 11 1245677778888888643
Q ss_pred -----------CCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 482 -----------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 482 -----------~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+.++|+|++|.||+++.++.+.|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1299999999999998776677999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=8.6e-09 Score=106.51 Aligned_cols=185 Identities=18% Similarity=0.150 Sum_probs=120.4
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCC--eeeeeceeecCC---cEEEEEee
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPN--IVLLMGAVTEPP---NLSIVTEY 439 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~n--Iv~l~~~~~~~~---~~~lV~E~ 439 (634)
.+.++.|.+..||++. ..+++|+.... .....+.+|..+|+.+ .+.. +.+++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568899999999973 66888885432 3346688999999887 3332 445555443333 35889999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-------------------------------------- 481 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g-------------------------------------- 481 (634)
++|.+|..... ..++......++.++++.+..||+..
T Consensus 98 i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 98 IKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred cCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99988865322 12667777788888888888888611
Q ss_pred ------------------CCEEeeccCCCcEEEcC--CCcEEEEecCCCccCCCCcccCCCCCCCCcccCcccccC----
Q 006703 482 ------------------PPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE---- 537 (634)
Q Consensus 482 ------------------~~IvHrDIKP~NILld~--~~~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~---- 537 (634)
+.++|+|++|.||+++. ...+.|+||+.+....... ..........-..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHH
Confidence 24899999999999997 5568899999886532210 0000000000012221110
Q ss_pred -CCC---------CchHHHHHHHHHHHHHHhCCCCC
Q 006703 538 -DPS---------NEKSDVFSFGVILWELITLQKPW 563 (634)
Q Consensus 538 -~~~---------s~~sDVwSLGvlL~eLltg~~Pf 563 (634)
... ....+.|+++.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001 11258999999999999998876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.1e-06 Score=86.48 Aligned_cols=132 Identities=16% Similarity=0.146 Sum_probs=92.9
Q ss_pred eeccCcE-EEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEeecccCC
Q 006703 369 FIKGSFG-TVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGS 444 (634)
Q Consensus 369 LG~G~fG-~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~ggs 444 (634)
+..|..| .||+.... +..+++|+.... ....+.+|...|+.+. +--|.+++.++.+++..++|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 3445554 68987654 335888875432 2345778999888873 3347788888888899999999999988
Q ss_pred HHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 006703 445 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR------------------------------------------- 481 (634)
Q Consensus 445 L~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g------------------------------------------- 481 (634)
+.+..... ......+..++++.|..||...
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87765321 1122345666677777777321
Q ss_pred -------------CCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 482 -------------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 482 -------------~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0379999999999999877777999997753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=6e-06 Score=85.43 Aligned_cols=135 Identities=18% Similarity=0.133 Sum_probs=92.8
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCC---Ceeeeeceee-cCCcEEEEEeecc
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP---NIVLLMGAVT-EPPNLSIVTEYLS 441 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~---nIv~l~~~~~-~~~~~~lV~E~~~ 441 (634)
.+.++.|....||+. +..+++|+... ......+.+|..+|+.+.+. .|.+++.+.. .....+++||+++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788999999998 67789988422 23346788999999998642 3566666663 4556889999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR----------------------------------------- 480 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~----------------------------------------- 480 (634)
|.++....-. .++......++.++.+.|..||+.
T Consensus 97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9888663210 133444445555555555555532
Q ss_pred -----------------CCCEEeeccCCCcEEEcC---CCc-EEEEecCCCcc
Q 006703 481 -----------------RPPIVHRDLKSPNLLVDS---TYT-VKVCDFGLSRS 512 (634)
Q Consensus 481 -----------------g~~IvHrDIKP~NILld~---~~~-ikL~DFGla~~ 512 (634)
.+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123799999999999987 355 58999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=2.4e-05 Score=81.01 Aligned_cols=140 Identities=15% Similarity=0.094 Sum_probs=78.2
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC--CCCeeeeec------eeecCCcEEEEE
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMG------AVTEPPNLSIVT 437 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~--h~nIv~l~~------~~~~~~~~~lV~ 437 (634)
.+.|+.|..+.||++...+..+++|+.... .. ++..|+.+++.+. .-.+++++. +....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---EK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---HH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---HH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666778999999877767899987652 22 2224444444442 113344443 123456789999
Q ss_pred eecccCCHH-----------HH---hcc--CCC--c-------ccccHHH------------------------------
Q 006703 438 EYLSRGSLY-----------KL---LHI--PDA--R-------VVVDERL------------------------------ 462 (634)
Q Consensus 438 E~~~ggsL~-----------~l---l~~--~~~--~-------~~l~e~~------------------------------ 462 (634)
+|++|..+. .. ++. ... . ....+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 01 111 000 0 0001110
Q ss_pred -HHHHHHHHHHHHHHHHh-----------CCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 463 -RLNMAYDVAKGMNYLHQ-----------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 463 -~~~i~~qIa~aL~yLH~-----------~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
...+...+..++.+|+. ..+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112234445666653 22349999999999999878889999999765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=3.2e-05 Score=81.13 Aligned_cols=84 Identities=8% Similarity=-0.060 Sum_probs=54.5
Q ss_pred eeeccee-eccCcEEEEEEEEc--------CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCC-C--CCeeeeeceeec
Q 006703 363 VIDSSNF-IKGSFGTVYHAEWR--------NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-H--PNIVLLMGAVTE 429 (634)
Q Consensus 363 ~~~~~~L-G~G~fG~Vy~a~~~--------~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~-h--~nIv~l~~~~~~ 429 (634)
....+.| +.|....+|+.... +..+++|+...... .......+.+|..+++.+. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445677 78889999998765 45688887543220 0000123557888887773 2 356777777655
Q ss_pred C---CcEEEEEeecccCCHH
Q 006703 430 P---PNLSIVTEYLSRGSLY 446 (634)
Q Consensus 430 ~---~~~~lV~E~~~ggsL~ 446 (634)
. ...++||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3578999999987764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=8.2e-05 Score=79.42 Aligned_cols=77 Identities=14% Similarity=0.076 Sum_probs=48.3
Q ss_pred ecceeeccCcEEEEEEEE--cCCcEEEEEEeeccc--cH---HHHHHHHHHHHHHHhCCC--C-CeeeeeceeecCCcEE
Q 006703 365 DSSNFIKGSFGTVYHAEW--RNSDVAVKILIEQEF--HE---DRFKEFLREVAIMKGLRH--P-NIVLLMGAVTEPPNLS 434 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~--~~~~vAvK~~~~~~~--~~---~~~~~~~~El~iL~~l~h--~-nIv~l~~~~~~~~~~~ 434 (634)
..+.||.|.++.||++.. .+..+++|....... .. ....++..|.++++.+.. + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 456789999999999954 345699998653211 00 012345678888887732 3 34455543 345568
Q ss_pred EEEeecccC
Q 006703 435 IVTEYLSRG 443 (634)
Q Consensus 435 lV~E~~~gg 443 (634)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00023 Score=73.89 Aligned_cols=78 Identities=17% Similarity=0.145 Sum_probs=60.8
Q ss_pred eeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC---CCCeeeeeceeecCCcEEEEEee
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~---h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
....+.|+.|....+|+....+..+++|+.... ....+..|...|+.+. ...+++++.+.......++||||
T Consensus 38 i~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp CCEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 345667899999999999877777899986533 1345778888888773 36688888888877889999999
Q ss_pred cccCCH
Q 006703 440 LSRGSL 445 (634)
Q Consensus 440 ~~ggsL 445 (634)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00084 Score=65.67 Aligned_cols=144 Identities=17% Similarity=0.230 Sum_probs=98.3
Q ss_pred CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHH-hCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCC
Q 006703 443 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 521 (634)
Q Consensus 443 gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH-~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~ 521 (634)
.+|.++|...+. ++++.++|.++.|.+++|.-+- ++. -..+=+.|..|++..+|.+-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 478898875443 5999999999999999987762 222 11233456889999999887764 1110
Q ss_pred CCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 006703 522 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 601 (634)
Q Consensus 522 ~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~ 601 (634)
.....+.|||... ...+.+.=|||||+++|..+- .+.....+..+++.|..||..|..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD-------------------ygL~e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD-------------------YGLKENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT-------------------TTCCTTEEECCCHHHHHHHHHHTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh-------------------cCCCcccchhhCHHHHHHHHHHHh
Confidence 1233567888764 455788999999999999874 222333456789999999999986
Q ss_pred c-------------------------CCCCCCCHHHHHHHHHHHHHh
Q 006703 602 E-------------------------EPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 602 ~-------------------------dP~~RPs~~~Il~~L~~ll~~ 623 (634)
. .+..|+++.+|++.-+.-+++
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~ 202 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPT 202 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHHHHHTTSSS
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccC
Confidence 6 246889999999887765554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0004 Score=74.79 Aligned_cols=75 Identities=16% Similarity=0.176 Sum_probs=44.8
Q ss_pred CEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcccCCCCC--CCCcccCcccccCCC---CCchHHHHHHHHHHHHHH
Q 006703 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDP---SNEKSDVFSFGVILWELI 557 (634)
Q Consensus 483 ~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~~~~~~--gt~~y~APEvl~~~~---~s~~sDVwSLGvlL~eLl 557 (634)
.++|+|++|.|||++.++ ++|+||+.+...+... ...... -...|.+|+...... .....++..+...+|+.+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 499999999999998776 9999999886432110 000000 012355555443111 122345567777777777
Q ss_pred hC
Q 006703 558 TL 559 (634)
Q Consensus 558 tg 559 (634)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0012 Score=67.90 Aligned_cols=145 Identities=12% Similarity=0.152 Sum_probs=80.0
Q ss_pred eeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC--eeeeece------eecCCcEE
Q 006703 363 VIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGA------VTEPPNLS 434 (634)
Q Consensus 363 ~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n--Iv~l~~~------~~~~~~~~ 434 (634)
....+.|+.|....+|+....+..+++|+..... . ...+..|+.+++.+...+ +.+++.. ....+..+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ceEeeccCCCcccceEEEEeCCccEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 3455677888889999998777779999876521 1 123445666666663212 3344422 12235678
Q ss_pred EEEeecccCCHHH-----------H---hccC--C---Cc----ccccHHHHHH------------HHHHHHHHHHHHHh
Q 006703 435 IVTEYLSRGSLYK-----------L---LHIP--D---AR----VVVDERLRLN------------MAYDVAKGMNYLHQ 479 (634)
Q Consensus 435 lV~E~~~ggsL~~-----------l---l~~~--~---~~----~~l~e~~~~~------------i~~qIa~aL~yLH~ 479 (634)
++|+|++|..+.. . ++.. . .. ....+...+. +...+.+.+..++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999999865321 0 1110 0 00 0001111000 00123445555653
Q ss_pred C-----CCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 480 R-----RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 480 ~-----g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
. ...++|+|+++.||+++.+..+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2 1249999999999999887666899998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0016 Score=66.51 Aligned_cols=71 Identities=14% Similarity=0.236 Sum_probs=43.7
Q ss_pred cceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCe-eeeeceeecCCcEEEEEeec-ccC
Q 006703 366 SSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYL-SRG 443 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nI-v~l~~~~~~~~~~~lV~E~~-~gg 443 (634)
.+.|+.|....+|++ ..+++|+...... ......+|..+++.+...++ .+++.+ +...-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567888999999999 6688888654211 01112357777766632222 455543 344457899999 665
Q ss_pred CH
Q 006703 444 SL 445 (634)
Q Consensus 444 sL 445 (634)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.002 Score=66.66 Aligned_cols=30 Identities=37% Similarity=0.419 Sum_probs=26.4
Q ss_pred CEEeeccCCCcEEEcCC----CcEEEEecCCCcc
Q 006703 483 PIVHRDLKSPNLLVDST----YTVKVCDFGLSRS 512 (634)
Q Consensus 483 ~IvHrDIKP~NILld~~----~~ikL~DFGla~~ 512 (634)
.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999874 6899999998865
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0038 Score=64.09 Aligned_cols=103 Identities=15% Similarity=0.194 Sum_probs=71.5
Q ss_pred HHHHHHHHHhhccCCHHHHHHHHHHHHHhhcCCCCCCchhHhhhhHHHHHHHHHhhhCCeeeeeccccccccchhHHHHH
Q 006703 139 ELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFK 218 (634)
Q Consensus 139 ~l~~~~~~~~~~~~~~~~~~~~l~~~v~~~mg~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~g~~~~g~~rhra~lfk 218 (634)
++.+.|.++..+..+..+.+..|...|.+.+.=........ ......| .-+.|+|++-|.||-
T Consensus 127 ~i~~~A~~~~~~~~~~~~~~~ai~~~v~~~~~Y~~~~~~~~-----~~a~~~l------------~~~~G~C~d~A~l~v 189 (293)
T 3isr_A 127 KLQKLAYKEFGKIENVYSKVLAITDWIYNNVEYISGSTNSQ-----TSAFDTI------------TERAGVCRDFAHLGI 189 (293)
T ss_dssp GSHHHHHHHHTTCCSHHHHHHHHHHHHHHHSEECTTSCCTT-----CCHHHHH------------HHCEECHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCHHHHHHHHHHHHHhhcEEeccCCCCC-----CCHHHhh------------cCCcEehHHHHHHHH
Confidence 35666777777777777889999999988764111100000 0111222 225899999999999
Q ss_pred HHhhhcCCCceeeccccCC--CCCCCceEEEEecCCcceeeec
Q 006703 219 VLADLINLPCRIAKGCKYC--RRDDASSCLVQIGPDREYLVDL 259 (634)
Q Consensus 219 ~lad~~~~~~~l~~g~~~~--~~~~~~~~~v~~~~~~~~~vd~ 259 (634)
.||-.+|||||+|.|+... ..+.|+|+.|.+++ .=+.+|-
T Consensus 190 al~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl~g-gWv~~Dp 231 (293)
T 3isr_A 190 ALCRALSIPARYFTGYAFKLNPPDFHACFEAYIGG-NWIIFDA 231 (293)
T ss_dssp HHHHHTTCCEEEEEEEETTCSSCCEEEEEEEEETT-EEEEECT
T ss_pred HHHHHCCCCEEEEEEECCCCCCCCeEEEEEEEECC-cEEEEEC
Confidence 9999999999999997654 25789999999976 4344554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0071 Score=61.26 Aligned_cols=77 Identities=14% Similarity=0.075 Sum_probs=51.9
Q ss_pred ceeecceeeccCcEEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC---CCeeeeeceeecCCcEEEEE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h---~nIv~l~~~~~~~~~~~lV~ 437 (634)
.+...+.+|.|..+.||+.+.. ++.+++|+........ ...+..|...|+.+.. --+++++.+. .-+++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 4566788999999999999876 4568999754332211 1346688888888732 2344555542 237899
Q ss_pred eecccCC
Q 006703 438 EYLSRGS 444 (634)
Q Consensus 438 E~~~ggs 444 (634)
||+.++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9998654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0065 Score=65.71 Aligned_cols=74 Identities=16% Similarity=0.224 Sum_probs=48.4
Q ss_pred eecceeeccCcEEEEEEEEc---------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC-eeeeeceeecCCcE
Q 006703 364 IDSSNFIKGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNL 433 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n-Iv~l~~~~~~~~~~ 433 (634)
...+.|+.|....||++... +..+++|+...... ...+.+|..+++.+...+ .+++++.+.+
T Consensus 76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 34567888889999999875 24588888733211 133457888888874323 3566665543
Q ss_pred EEEEeecccCCH
Q 006703 434 SIVTEYLSRGSL 445 (634)
Q Consensus 434 ~lV~E~~~ggsL 445 (634)
.+|+||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.40 E-value=0.023 Score=58.22 Aligned_cols=74 Identities=11% Similarity=0.064 Sum_probs=45.2
Q ss_pred eeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC--CCeeeeece-----eecCCcEEEEEee
Q 006703 368 NFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGA-----VTEPPNLSIVTEY 439 (634)
Q Consensus 368 ~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h--~nIv~l~~~-----~~~~~~~~lV~E~ 439 (634)
.++ |....||++...+ ..+++|+........ ..+..|..+++.+.. -.+++++.. ...++..+++|++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 455 7788999987654 369999976432222 344567777766632 124444443 1224456789999
Q ss_pred cccCCH
Q 006703 440 LSRGSL 445 (634)
Q Consensus 440 ~~ggsL 445 (634)
++|..+
T Consensus 109 i~G~~~ 114 (328)
T 1zyl_A 109 VGGRQF 114 (328)
T ss_dssp CCCEEC
T ss_pred cCCCCC
Confidence 987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.011 Score=64.59 Aligned_cols=75 Identities=13% Similarity=0.050 Sum_probs=47.1
Q ss_pred eecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCe-eeeeceeecCCcEEEEEeec
Q 006703 364 IDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYL 440 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nI-v~l~~~~~~~~~~~lV~E~~ 440 (634)
...+.|+.|-...+|++...+ ..+++|+....... .-.-.+|..+++.+...++ +++++.+. + .+||||+
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 345678889899999998876 56888876332100 0011378888888854444 56676653 2 3599999
Q ss_pred ccCCH
Q 006703 441 SRGSL 445 (634)
Q Consensus 441 ~ggsL 445 (634)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0093 Score=63.46 Aligned_cols=139 Identities=14% Similarity=0.159 Sum_probs=77.6
Q ss_pred cceeeccCcEEEEEEEEcC---------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEE
Q 006703 366 SSNFIKGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~---------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~l 435 (634)
.+.|..|-...+|++...+ ..+++|+.-.. .. ......+|.++++.+. +.-..++++.+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 3456667778899987642 45788874221 11 1234558888888873 3223566666554 28
Q ss_pred EEeecccCCHHHH--------------h---ccCC---Ccccc-cHHHHHHHHHHHHH-------------------HHH
Q 006703 436 VTEYLSRGSLYKL--------------L---HIPD---ARVVV-DERLRLNMAYDVAK-------------------GMN 475 (634)
Q Consensus 436 V~E~~~ggsL~~l--------------l---~~~~---~~~~l-~e~~~~~i~~qIa~-------------------aL~ 475 (634)
||||++|.+|..- + +... .+... -+.++.++..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998665311 0 1111 11111 23444444433321 233
Q ss_pred HHH----hCC--CCEEeeccCCCcEEEcCC----CcEEEEecCCCc
Q 006703 476 YLH----QRR--PPIVHRDLKSPNLLVDST----YTVKVCDFGLSR 511 (634)
Q Consensus 476 yLH----~~g--~~IvHrDIKP~NILld~~----~~ikL~DFGla~ 511 (634)
.|. ..+ ..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 221 248999999999999876 789999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.016 Score=60.47 Aligned_cols=30 Identities=20% Similarity=0.360 Sum_probs=26.9
Q ss_pred CEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 483 ~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999999878899999987764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.92 E-value=0.02 Score=60.15 Aligned_cols=74 Identities=12% Similarity=0.216 Sum_probs=42.3
Q ss_pred ecceeeccCcEEEEEEEEcC----------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC-eeeeeceeecCCcE
Q 006703 365 DSSNFIKGSFGTVYHAEWRN----------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNL 433 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~----------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n-Iv~l~~~~~~~~~~ 433 (634)
..+.|+.|....+|++...+ ..+++|+..... . .......|..+++.+...+ ++++++... -
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-D--ELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-G--GTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-c--ceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 34567778888999998764 467788754321 1 1111246777777774223 446665442 3
Q ss_pred EEEEeecccCCH
Q 006703 434 SIVTEYLSRGSL 445 (634)
Q Consensus 434 ~lV~E~~~ggsL 445 (634)
+++|||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 789999987644
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=95.27 E-value=0.013 Score=59.77 Aligned_cols=50 Identities=18% Similarity=0.119 Sum_probs=43.1
Q ss_pred ccccccchhHHHHHHHhhhcCCCceeeccccCCCCCCCceEEEEecC-Ccceeeec
Q 006703 205 LSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGP-DREYLVDL 259 (634)
Q Consensus 205 ~~~g~~rhra~lfk~lad~~~~~~~l~~g~~~~~~~~~~~~~v~~~~-~~~~~vd~ 259 (634)
-+.|+|++=|.||-.||-.+|||+|+|-|+ +.|+|+.|-++. .+=..||-
T Consensus 138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~Gy-----~~HaW~Evy~~g~~gWv~~Dp 188 (295)
T 2f4m_A 138 TRCGRCGEWANCFTLCCRALGFEARYVWDY-----TDHVWTEVYSPSQQRWLHCDA 188 (295)
T ss_dssp HCEESHHHHHHHHHHHHHHTTCCEEEEEET-----TTEEEEEEEETTTTEEEEEET
T ss_pred cCCEeeHHHHHHHHHHHHHCCCCEEEEcCC-----CCEEEEEEEECCCCeEEEEeC
Confidence 468999999999999999999999999996 899999999976 34344555
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=94.52 E-value=0.085 Score=58.21 Aligned_cols=106 Identities=11% Similarity=0.143 Sum_probs=71.4
Q ss_pred HHHHHHHHHhhccCCHHHHHHHHHHHHHhhcCCCCCC-chhHhhhhHHHHHHHHHhhhCCeeeeeccccccccchhHHHH
Q 006703 139 ELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTST-EEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLF 217 (634)
Q Consensus 139 ~l~~~~~~~~~~~~~~~~~~~~l~~~v~~~mg~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~g~~~~g~~rhra~lf 217 (634)
++++.|.++..+..+..+-+..|...|.+.+.=.... +...+. -...+.-|+.. .|.|+-.|+||
T Consensus 229 ~i~~~a~~l~~~~~~~~ek~~~iy~~V~~~i~y~~~~~~~~g~~--~~~a~~vl~~~------------~G~C~d~a~Ll 294 (506)
T 3kd4_A 229 ESKTFAQFLTDKSGNEQEKVNIIRDHILNNLSTCPIPMAMTGYT--VRDIDTVLRSA------------YGTPLEIAQLL 294 (506)
T ss_dssp HHHHHHHHHHSSCSSHHHHHHHHHHHHHHHCEECCCCGGGGTTC--CCCHHHHHHHT------------EECHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHHHHhccEecceecccCCCC--CCCHHHHHHhC------------CcchHHHHHHH
Confidence 3556666777777888888888888888877421110 000000 01123334333 69999999999
Q ss_pred HHHhhhcCCCceeeccccC------CC--CCCCceEEEEecCCcceeeec
Q 006703 218 KVLADLINLPCRIAKGCKY------CR--RDDASSCLVQIGPDREYLVDL 259 (634)
Q Consensus 218 k~lad~~~~~~~l~~g~~~------~~--~~~~~~~~v~~~~~~~~~vd~ 259 (634)
.-||..+|||+|+|-+.-. ++ +-.|+++.|.++ +..|++|.
T Consensus 295 ~AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~~-g~~y~lDa 343 (506)
T 3kd4_A 295 NVMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATVD-GKDQYLSA 343 (506)
T ss_dssp HHHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEET-TEEEEESS
T ss_pred HHHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEEC-CEEEEEec
Confidence 9999999999999988621 22 237888888884 55699998
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.92 E-value=0.27 Score=52.93 Aligned_cols=75 Identities=11% Similarity=0.186 Sum_probs=46.4
Q ss_pred eecceeeccCcEEEEEEEEc---------CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcE
Q 006703 364 IDSSNFIKGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~---------~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~ 433 (634)
...+.|..|-...+|+.... +..+++++..... ...-...+|.++++.+. +.-..++++.+. -
T Consensus 73 ~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 73 IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 44556777888899999876 4568888753321 11111236777777773 222445555332 2
Q ss_pred EEEEeecccCCH
Q 006703 434 SIVTEYLSRGSL 445 (634)
Q Consensus 434 ~lV~E~~~ggsL 445 (634)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998764
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=90.89 E-value=0.21 Score=51.49 Aligned_cols=45 Identities=20% Similarity=0.206 Sum_probs=39.8
Q ss_pred cccccccchhHHHHHHHhhhcCCCceeeccccCCCCCCCceEEEEecCCc
Q 006703 204 SLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDR 253 (634)
Q Consensus 204 ~~~~g~~rhra~lfk~lad~~~~~~~l~~g~~~~~~~~~~~~~v~~~~~~ 253 (634)
.-+.|.|.|=|-||=.||-.+|+|+|+|-| ..+|+|+.|-.....
T Consensus 178 ~tr~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~~ 222 (335)
T 1x3z_A 178 ETRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLN 222 (335)
T ss_dssp HHCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTT
T ss_pred HhCCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCCC
Confidence 345899999999999999999999999977 578999999997643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.26 E-value=1 Score=47.77 Aligned_cols=28 Identities=25% Similarity=0.432 Sum_probs=24.3
Q ss_pred EEeeccCCCcEEE------cCCCcEEEEecCCCc
Q 006703 484 IVHRDLKSPNLLV------DSTYTVKVCDFGLSR 511 (634)
Q Consensus 484 IvHrDIKP~NILl------d~~~~ikL~DFGla~ 511 (634)
++|+|+.+.|||+ +.+..++++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 346689999999886
|
| >2q3z_A Transglutaminase 2; transglutaminase 2, tissue transglutaminase, TG2, transferas; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1kv3_A 3ly6_A* | Back alignment and structure |
|---|
Probab=88.85 E-value=0.14 Score=57.96 Aligned_cols=81 Identities=14% Similarity=0.156 Sum_probs=51.8
Q ss_pred ccCCHHHHHHHHHHHHHhhc------C---CCCCCchhHhhhhHHHHHHHHHhhhCCeeeeeccccccccchhHHHHHHH
Q 006703 150 DRITAEEAVHQLANLVCNHM------G---GTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVL 220 (634)
Q Consensus 150 ~~~~~~~~~~~l~~~v~~~m------g---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~g~~~~g~~rhra~lfk~l 220 (634)
...++-.++..|.+.|...- | |.-..+.. -..|......|...+...+. ..+.|.|++=|-+|=.+
T Consensus 213 ~r~dPv~v~r~lsa~vn~~~d~gvl~g~w~~~y~~g~~--p~~~~gs~~il~~~~~~~~~---~~k~G~C~dfA~~~~~l 287 (687)
T 2q3z_A 213 RRSSPVYVGRVGSGMVNCNDDQGVLLGRWDNNYGDGVS--PMSWIGSVDILRRWKNHGCQ---RVKYGQCWVFAAVACTV 287 (687)
T ss_dssp HTTCHHHHHHHHHHTTTCTTTTSSEEECCSSCCTTSCC--TTTCCBSHHHHHHHHHTTTC---CEEEECHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHHhhcccccceEeeccccCcCCCCC--CccccCchHHHHHHHhcCCC---ccceeehHHHHHHHHHH
Confidence 47788888888888776531 1 11111111 12343333333333221111 37899999999999999
Q ss_pred hhhcCCCceeecccc
Q 006703 221 ADLINLPCRIAKGCK 235 (634)
Q Consensus 221 ad~~~~~~~l~~g~~ 235 (634)
|-++|||||.|.|+.
T Consensus 288 lRalGIPAR~VsGy~ 302 (687)
T 2q3z_A 288 LRCLGIPTRVVTNYN 302 (687)
T ss_dssp HHHHTCCEEEEEEEE
T ss_pred HHhCCCCcEEEeecc
Confidence 999999999999985
|
| >1g0d_A Protein-glutamine gamma-glutamyltransferase; tissue transglutaminase,acyltransferase; 2.50A {Pagrus major} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 | Back alignment and structure |
|---|
Probab=86.38 E-value=0.38 Score=54.23 Aligned_cols=85 Identities=13% Similarity=0.101 Sum_probs=55.9
Q ss_pred hccCCHHHHHHHHHHHHHhhcCCCCCCch-------hHhhhhHHHHHHHHHhhhCCeeeeeccccccccchhHHHHHHHh
Q 006703 149 CDRITAEEAVHQLANLVCNHMGGTTSTEE-------EEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLA 221 (634)
Q Consensus 149 ~~~~~~~~~~~~l~~~v~~~mg~~~~~~~-------~~~~~~~~~~~~~l~~~~~~~~~~~g~~~~g~~rhra~lfk~la 221 (634)
....++-.++..|.+.|-..-...+..+. ...-..|......|+.-+.+..- .++.|.|+|=|-+|-.++
T Consensus 207 ~~r~dpv~v~r~lsa~vn~~dD~gvl~g~W~~~y~~g~~P~~w~gs~~il~~~~~~~~~---PV~~G~C~~fA~v~~t~l 283 (695)
T 1g0d_A 207 EHRSDPVYVGRTITAMVNSNGDRGVLTGRWEEPYTDGVAPYRWTGSVPILQQWSKAGVR---PVKYGQCWVFAAVACTVL 283 (695)
T ss_dssp HHTTCHHHHHHHHHHHHTTCTTTCSEEECCSSCCTTSCCGGGCSBSHHHHHHHHHTTSC---CEEEECHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHHhhccCcCceeecccccccCCCcCCcccCChHHHHHHHHHcCCC---cccceeeHHHHHHHHHHH
Confidence 34778999999999988765311111000 00013455454555443332222 368999999999999999
Q ss_pred hhcCCCceeeccccC
Q 006703 222 DLINLPCRIAKGCKY 236 (634)
Q Consensus 222 d~~~~~~~l~~g~~~ 236 (634)
-.+|||||+|.|+..
T Consensus 284 R~lGIPaR~Vtgy~s 298 (695)
T 1g0d_A 284 RCLGIPTRPITNFAS 298 (695)
T ss_dssp HHHTCCEEEEEEEEE
T ss_pred HhCCCCeeEEccccc
Confidence 999999999999754
|
| >1ex0_A Coagulation factor XIII A chain; transglutaminase, blood coagulation, mutant, W279F, oxyanion, transferase; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1evu_A 1fie_A 1f13_A 1ggt_A 1ggu_A 1ggy_A 1qrk_A | Back alignment and structure |
|---|
Probab=82.46 E-value=1 Score=51.01 Aligned_cols=76 Identities=17% Similarity=0.239 Sum_probs=53.1
Q ss_pred ccCCHHHHHHHHHHHHHhh--------------cCCCCCCchhHhhhhHHHHHHHHHhhhCCeeeeeccccccccchhHH
Q 006703 150 DRITAEEAVHQLANLVCNH--------------MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRAL 215 (634)
Q Consensus 150 ~~~~~~~~~~~l~~~v~~~--------------mg~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~g~~~~g~~rhra~ 215 (634)
...++-.++..|++.|-.. .+|... ..|......|+.-+.+. -.++.|.|.|=|-
T Consensus 251 ~r~dpv~v~r~lsa~vn~~dD~GVL~GnW~~~y~~g~~P-------~~~~gs~~il~~~~~~~----~PV~~G~C~~fA~ 319 (731)
T 1ex0_A 251 GRGNPIKVSRVGSAMVNAKDDEGVLVGSFDNIYAYGVPP-------SAWTGSVDILLEYRSSE----NPVRYGQCWVFAG 319 (731)
T ss_dssp GTTCHHHHHHHHHHHHBCSTTCSSEEECCSSCCTTSCCG-------GGCCBSHHHHHHHHHHT----SCEEEECHHHHHH
T ss_pred cCCCHHHHHHHHHHHhhcCCcCceeecccccccCCCcCC-------cccCChHHHHHHHHhcC----CccceeeehhHHH
Confidence 3678889999999888654 222221 34544444444333211 1368999999999
Q ss_pred HHHHHhhhcCCCceeeccccC
Q 006703 216 LFKVLADLINLPCRIAKGCKY 236 (634)
Q Consensus 216 lfk~lad~~~~~~~l~~g~~~ 236 (634)
+|-++.-++|||||+|.|+..
T Consensus 320 v~~~~lR~lGIPaRvVtgy~s 340 (731)
T 1ex0_A 320 VFNTFLRCLGIPARIVTNYFS 340 (731)
T ss_dssp HHHHHHHHHTCCEEEEEEEEE
T ss_pred HHHHHHHhCCCCeeEEccccc
Confidence 999999999999999999654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 634 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-77 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-69 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-69 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-67 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-66 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-65 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-62 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-54 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-50 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-49 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-47 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (629), Expect = 1e-77
Identities = 92/275 (33%), Positives = 147/275 (53%), Gaps = 21/275 (7%)
Query: 364 IDSSNFI------KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH 417
I GSFGTVY +W DVAVK+L + + F EV +++ RH
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 418 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 477
NI+L MG T P L+IVT++ SLY LHI + + + +++A A+GM+YL
Sbjct: 64 VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYL 120
Query: 478 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVL 535
H + I+HRDLKS N+ + TVK+ DFGL+ S+ + + +G+ WMAPEV+
Sbjct: 121 HAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 536 R---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL----EIPKNV 588
R ++P + +SDV++FG++L+EL+T Q P+ N I + +G ++ N
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
+ L+ C ++ + RP FP I+ +++ S
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 5e-71
Identities = 89/251 (35%), Positives = 130/251 (51%), Gaps = 13/251 (5%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
KG FG V ++R + VAVK + + FL E ++M LRH N+V L+G + E
Sbjct: 17 KGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEE 72
Query: 431 PN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
L IVTEY+++GSL L R V+ L + DV + M YL VHRDL
Sbjct: 73 KGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDL 129
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 549
+ N+LV KV DFGL++ +T T +W APE LRE + KSDV+SF
Sbjct: 130 AARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSF 186
Query: 550 GVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G++LWE+ + + P+ V+ V KG +++ P P V +++ CW + +RP
Sbjct: 187 GILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 245
Query: 609 SFPSIMETLQQ 619
SF + E L+
Sbjct: 246 SFLQLREQLEH 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 2e-69
Identities = 70/253 (27%), Positives = 116/253 (45%), Gaps = 9/253 (3%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GS+G ++ + K L E + + EV +++ L+HPNIV +
Sbjct: 14 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73
Query: 429 EPPN--LSIVTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQR---RP 482
+ N L IV EY G L ++ R +DE L + + + H+R
Sbjct: 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 133
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
++HRDLK N+ +D VK+ DFGL+R + +K GTP +M+PE + NE
Sbjct: 134 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE 193
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
KSD++S G +L+EL L P+ + ++ + +G+ IP + + +I
Sbjct: 194 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDELNEIITRMLNL 252
Query: 603 EPEIRPSFPSIME 615
+ RPS I+E
Sbjct: 253 KDYHRPSVEEILE 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 9e-69
Identities = 84/256 (32%), Positives = 133/256 (51%), Gaps = 9/256 (3%)
Query: 371 KGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
G FG V+ + ++ VAVK L + D FL E +MK L+H +V L VT+
Sbjct: 23 AGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P + I+TEY+ GSL L P + + L+MA +A+GM ++ +R +HRDL
Sbjct: 80 EP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDL 135
Query: 490 KSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
++ N+LV T + K+ DFGL+R + N Y + + A +W APE + KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
FG++L E++T + + + +G R+ P N + L+ CW E PE RP
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255
Query: 609 SFPSIMETLQQFLMSS 624
+F + L+ F ++
Sbjct: 256 TFDYLRSVLEDFFTAT 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 9e-69
Identities = 79/266 (29%), Positives = 136/266 (51%), Gaps = 15/266 (5%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G+FG+V +R VA+K+L +Q + +E +RE IM L +P IV L+G
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIG- 76
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
V + L +V E G L+K L R + + + V+ GM YL ++ VH
Sbjct: 77 VCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEK--NFVH 132
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
RDL + N+L+ + + K+ DFGLS+ + + Y + +W APE + + +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+S+GV +WE ++ QKP++ +V++ + +G+R+E P P + AL+ CW
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIY 251
Query: 603 EPEIRPSFPSIMETLQQFLMSSVCQP 628
+ E RP F ++ + ++ S +
Sbjct: 252 KWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 4e-68
Identities = 81/265 (30%), Positives = 129/265 (48%), Gaps = 15/265 (5%)
Query: 371 KGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 426
G+FGTV ++ VAVKIL + E L E +M+ L +P IV ++G
Sbjct: 17 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG- 75
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
+ E + +V E G L K L V ++ + + + V+ GM YL + VH
Sbjct: 76 ICEAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN--FVH 130
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
RDL + N+L+ + + K+ DFGLS+ + N Y + +W APE + + K
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 544 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
SDV+SFGV++WE + QKP+R S+V + + KG R+ P + L+ CW
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTY 249
Query: 603 EPEIRPSFPSIMETLQQFLMSSVCQ 627
+ E RP F ++ L+ + V +
Sbjct: 250 DVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 8e-68
Identities = 88/265 (33%), Positives = 132/265 (49%), Gaps = 17/265 (6%)
Query: 364 IDSSNFI------KGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 416
ID + G FG V + +WR DVA+K++ E ED EF+ E +M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 417 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 476
H +V L G T+ + I+TEY++ G L L R + L M DV + M Y
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEY 115
Query: 477 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 535
L + +HRDL + N LV+ VKV DFGLSR + Y SS + W PEVL
Sbjct: 116 LESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 536 REDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594
+ KSD+++FGV++WE+ +L K P+ T S+ + +G RL P + V
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYT 232
Query: 595 LIETCWAEEPEIRPSFPSIMETLQQ 619
++ +CW E+ + RP+F ++ +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 1e-67
Identities = 89/270 (32%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 363 VIDSSNFI------KGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL 415
VID S G FG V+ W N D VA+K + E E ++F+ E +M L
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKL 57
Query: 416 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475
HP +V L G E + +V E++ G L L L M DV +GM
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMA 115
Query: 476 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 534
YL + ++HRDL + N LV +KV DFG++R + Y SS +W +PEV
Sbjct: 116 YLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 535 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 593
+ KSDV+SFGV++WE+ + K P+ N + S+V+ + G RL P+ + V
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVY 232
Query: 594 ALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
++ CW E PE RP+F ++ L + S
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 3e-67
Identities = 76/253 (30%), Positives = 126/253 (49%), Gaps = 14/253 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA-- 426
+GSF TVY + VA L +++ + + F E ++KGL+HPNIV +
Sbjct: 19 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 78
Query: 427 --VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
V + +VTE ++ G+L L V+ ++ + + KG+ +LH R PPI
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135
Query: 485 VHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 543
+HRDLK N+ + T +VK+ D GL+ K ++ +K GTPE+MAPE+ E +E
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEE-KYDES 192
Query: 544 SDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
DV++FG+ + E+ T + P+ +Q+ V + K P V +IE C +
Sbjct: 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 252
Query: 603 EPEIRPSFPSIME 615
+ R S ++
Sbjct: 253 NKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-66
Identities = 66/253 (26%), Positives = 122/253 (48%), Gaps = 14/253 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+FG VY A+ + + A K++ + E+ ++++ E+ I+ HPNIV L+ A
Sbjct: 22 DGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
NL I+ E+ + G++ ++ + + E + +NYLH + I+HRD
Sbjct: 80 YENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRD 135
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----REDPSNEK 543
LK+ N+L +K+ DFG+S T + GTP WMAPEV+ ++ P + K
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 195
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAE 602
+DV+S G+ L E+ ++ P P +V+ + L P + ++ C +
Sbjct: 196 ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK 255
Query: 603 EPEIRPSFPSIME 615
+ R + +++
Sbjct: 256 NVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 7e-66
Identities = 90/275 (32%), Positives = 132/275 (48%), Gaps = 21/275 (7%)
Query: 361 THVIDSSNFI------KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRF-KEFLRE 408
T +I + GSFG V EW VAVK L + +F+RE
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 409 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 468
V M L H N++ L G V PP + +VTE GSL L ++ R A
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAV 118
Query: 469 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAG 525
VA+GM YL +R +HRDL + NLL+ + VK+ DFGL R+ P + Y+ +
Sbjct: 119 QVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEI 584
W APE L+ + SD + FGV LWE+ T + PW SQ++ + +G RL
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619
P++ + ++ CWA +PE RP+F ++ + L +
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 1e-65
Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 17/262 (6%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
G FG V + VA+K L + + E + ++FL E +IM HPN++ L G
Sbjct: 36 AGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEG 94
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
VT+ + I+TE++ GSL L D + + M +A GM YL V
Sbjct: 95 VVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMN--YV 150
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-----TYISSKTAAGTPEWMAPEVLREDPS 540
HRDL + N+LV+S KV DFGLSR + TY S+ W APE ++
Sbjct: 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210
Query: 541 NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 599
SDV+S+G+++WE+++ ++P+ + T VI+A+ + RL P + + L+ C
Sbjct: 211 TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDC 269
Query: 600 WAEEPEIRPSFPSIMETLQQFL 621
W ++ RP F I+ TL + +
Sbjct: 270 WQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-65
Identities = 86/292 (29%), Positives = 129/292 (44%), Gaps = 40/292 (13%)
Query: 364 IDSSNFI------KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVA 410
N G+FG V +A VAVK+L E+ +R + + E+
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSELK 92
Query: 411 IMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------------------- 450
+M L H NIV L+GA T + ++ EY G L L
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 451 -IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509
+ V+ L AY VAKGM +L + VHRDL + N+LV VK+CDFGL
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 510 SR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNS 566
+R + Y+ A +WMAPE L E KSDV+S+G++LWE+ +L P+
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 567 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 618
+ G +++ P + ++++CWA + RPSFP++ L
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-65
Identities = 70/248 (28%), Positives = 118/248 (47%), Gaps = 12/248 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
KG FG VY A + S +A+K+L + + + + REV I LRHPNI+ L G
Sbjct: 16 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 75
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ + ++ EY G++Y+ L DE+ ++A ++Y H +R ++HR
Sbjct: 76 HDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR--VIHR 130
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+K NLL+ S +K+ DFG S P++ T GT +++ PE++ +EK D++
Sbjct: 131 DIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLW 188
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
S GV+ +E + + P+ +T + + P V LI P R
Sbjct: 189 SLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQR 246
Query: 608 PSFPSIME 615
P ++E
Sbjct: 247 PMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 6e-65
Identities = 90/289 (31%), Positives = 140/289 (48%), Gaps = 31/289 (10%)
Query: 359 PSTH-VIDSSNFI------KGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLR 407
P+ + V+D ++ +G+FG V A + D A+K +++ +D ++F
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAG 59
Query: 408 EVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------------IPD 453
E+ ++ L HPNI+ L+GA L + EY G+L L
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119
Query: 454 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513
+ + L+ A DVA+GM+YL Q +HRDL + N+LV Y K+ DFGLSR
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG- 176
Query: 514 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVI 572
Y+ WMA E L SDV+S+GV+LWE+++L P+ T +++
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 573 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ +G RLE P N + V L+ CW E+P RPSF I+ +L + L
Sbjct: 237 EKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 2e-64
Identities = 93/281 (33%), Positives = 137/281 (48%), Gaps = 17/281 (6%)
Query: 355 NPSGPST--HVIDSSNFI------KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE 404
+PS P+ ++ ++ G +G VY W+ VAVK L E +E
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EE 59
Query: 405 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 464
FL+E A+MK ++HPN+V L+G T P I+TE+++ G+L L + R V + L
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLL 118
Query: 465 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP-NTYISSKTA 523
MA ++ M YL + +HRDL + N LV + VKV DFGLSR +TY + A
Sbjct: 119 YMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 583
+W APE L + + KSDV++FGV+LWE+ T + + K R+E
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 584 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
P+ V L+ CW P RPSF I + + S
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 6e-64
Identities = 65/248 (26%), Positives = 121/248 (48%), Gaps = 11/248 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+ GTVY A + VA++ + Q + + + + E+ +M+ ++PNIV + +
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L +V EYL+ GSL ++ +DE + + + + +LH + ++HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRD 141
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+KS N+L+ +VK+ DFG T GTP WMAPEV+ K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPEIR 607
G++ E+I + P+ N P + + + G L+ P+ ++ + + C + E R
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 608 PSFPSIME 615
S +++
Sbjct: 262 GSAKELLQ 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-63
Identities = 88/257 (34%), Positives = 132/257 (51%), Gaps = 11/257 (4%)
Query: 371 KGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
+G FG V+ W + VA+K L + FL+E +MK LRH +V L V+E
Sbjct: 27 QGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE 83
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
P + IVTEY+S+GSL L + + ++MA +A GM Y+ + VHRDL
Sbjct: 84 EP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN--YVHRDL 139
Query: 490 KSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
++ N+LV KV DFGL+R + N Y + + A +W APE KSDV+S
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 199
Query: 549 FGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
FG++L EL T + P+ +V+ V +G R+ P + L+ CW +EPE R
Sbjct: 200 FGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEER 258
Query: 608 PSFPSIMETLQQFLMSS 624
P+F + L+ + S+
Sbjct: 259 PTFEYLQAFLEDYFTST 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (533), Expect = 3e-63
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 15/251 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
GSFG VY A + VA+K + + +++++ ++EV ++ LRHPN + G
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+V EY + L + + E + + +G+ YLH ++HR
Sbjct: 85 LREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHR 139
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR---EDPSNEKS 544
D+K+ N+L+ VK+ DFG + + GTP WMAPEV+ E + K
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
DV+S G+ EL + P N + + + + +++C + P
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255
Query: 605 EIRPSFPSIME 615
+ RP+ +++
Sbjct: 256 QDRPTSEVLLK 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-62
Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 20/275 (7%)
Query: 364 IDSSNFI------KGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 411
I S G FG VY + S VA+K L + + E + +FL E I
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGI 62
Query: 412 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 471
M H NI+ L G +++ + I+TEY+ G+L K + + + M +A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIA 120
Query: 472 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT---AAGTPE 528
GM YL VHRDL + N+LV+S KV DFGLSR + ++ T
Sbjct: 121 AGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 529 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588
W APE + SDV+SFG+++WE++T + + + G RL P +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 589 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623
+ L+ CW +E RP F I+ L + + +
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 4e-62
Identities = 87/282 (30%), Positives = 130/282 (46%), Gaps = 35/282 (12%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+FG V+ A VAVK+L ++E D +F RE A+M +PNIV L
Sbjct: 23 EGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIVKL 81
Query: 424 MGAVTEPPNLSIVTEYLSRGSLYKLLH---------------------IPDARVVVDERL 462
+G + ++ EY++ G L + L +
Sbjct: 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141
Query: 463 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISS 520
+L +A VA GM YL +R+ VHRDL + N LV VK+ DFGLSR+ + Y +
Sbjct: 142 QLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 199
Query: 521 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKG 579
A WM PE + + +SDV+++GV+LWE+ + P+ +VI V G
Sbjct: 200 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DG 258
Query: 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
L P+N + L+ CW++ P RPSF SI LQ+
Sbjct: 259 NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 5e-62
Identities = 81/258 (31%), Positives = 127/258 (49%), Gaps = 14/258 (5%)
Query: 371 KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
+G FG V+ + + + VA+K R ++FL+E M+ HP+IV L+G
Sbjct: 17 EGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLIG 75
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+TE + I+ E + G L L + + D + AY ++ + YL +R V
Sbjct: 76 VITEN-PVWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR--FV 130
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 544
HRD+ + N+LV S VK+ DFGLSR + +TY + +WMAPE + S
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 545 DVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 603
DV+ FGV +WE++ P++ + VI + G RL +P N P + +L+ CWA +
Sbjct: 191 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPTLYSLMTKCWAYD 249
Query: 604 PEIRPSFPSIMETLQQFL 621
P RP F + L L
Sbjct: 250 PSRRPRFTELKAQLSTIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 86/275 (31%), Positives = 130/275 (47%), Gaps = 16/275 (5%)
Query: 358 GPSTHVIDSSNFI-KGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 411
GPS+ ++ + I +G FG VYH ++D AVK L + +FL E I
Sbjct: 23 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGII 81
Query: 412 MKGLRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 470
MK HPN++ L+G +V Y+ G L + V + + V
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG--FGLQV 139
Query: 471 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGT 526
AKGM +L VHRDL + N ++D +TVKV DFGL+R + ++ + A
Sbjct: 140 AKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 527 PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 586
+WMA E L+ KSDV+SFGV+LWEL+T P + I+ +GRRL P+
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 257
Query: 587 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ ++ CW + E+RPSF ++ +
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-61
Identities = 77/259 (29%), Positives = 125/259 (48%), Gaps = 14/259 (5%)
Query: 371 KGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
G+FGTVY W VA+K L E + KE L E +M + +P++ L+
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLL 77
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
G + ++T+ + G L L ++ + + + + LN +AKGMNYL RR +
Sbjct: 78 GICLTS-TVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--L 132
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
VHRDL + N+LV + VK+ DFGL++ ++ +WMA E +
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
+SDV+S+GV +WEL+T + P+ IS++ KG RL P V ++ CW
Sbjct: 193 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 252
Query: 603 EPEIRPSFPSIMETLQQFL 621
+ + RP F ++ +
Sbjct: 253 DADSRPKFRELIIEFSKMA 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-61
Identities = 79/280 (28%), Positives = 130/280 (46%), Gaps = 29/280 (10%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 422
G+FG V A VAVK+ ++ H + + E+ ++ L H NIV
Sbjct: 33 AGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLH---------------IPDARVVVDERLRLNMA 467
L+GA T ++TEY G L L + D + +D L+ +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 468 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAG 525
Y VAKGM +L + +HRDL + N+L+ K+CDFGL+R + Y+ A
Sbjct: 152 YQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 526 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEI 584
+WMAPE + +SDV+S+G+ LWEL +L P + +G R+
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269
Query: 585 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
P++ + +++TCW +P RP+F I++ +++ + S
Sbjct: 270 PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-60
Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 11/243 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+ G V+ + S +A K+ I E + +RE+ ++ P IV GA
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+SI E++ GSL ++L + E++ ++ V KG+ YL ++ I+HRD
Sbjct: 75 SDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRD 130
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 548
+K N+LV+S +K+CDFG+S ++ + + GT +M+PE L+ + +SD++S
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 549 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 608
G+ L E+ + P ++ F + P + + RP
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRP 246
Query: 609 SFP 611
Sbjct: 247 PMA 249
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-59
Identities = 72/251 (28%), Positives = 113/251 (45%), Gaps = 12/251 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++G V A R ++ VAVKI ++ + D + +E+ I K L H N+V G
Sbjct: 15 EGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 73
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
E + EY S G L+ + + + E + + G+ YLH I HRD
Sbjct: 74 EGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRD 128
Query: 489 LKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSD 545
+K NLL+D +K+ DFGL+ N GT ++APE+L+ E D
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 546 VFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 604
V+S G++L ++ + PW + S Q S K L K ++ AL+ E P
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENP 248
Query: 605 EIRPSFPSIME 615
R + P I +
Sbjct: 249 SARITIPDIKK 259
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-59
Identities = 84/293 (28%), Positives = 142/293 (48%), Gaps = 35/293 (11%)
Query: 364 IDSSNFI------KGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLRE 408
+ + +G+FG V AE D VAVK+L + + E + + E
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISE 68
Query: 409 VAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI-------------PDA 454
+ +MK + +H NI+ L+GA T+ L ++ EY S+G+L + L +
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 455 RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--S 512
+ + ++ AY VA+GM YL + +HRDL + N+LV +K+ DFGL+R
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI 572
+ Y + +WMAPE L + +SDV+SFGV+LWE+ TL P + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 573 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL-MSS 624
+ +G R++ P N + ++ CW P RP+F ++E L + + ++S
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-58
Identities = 77/289 (26%), Positives = 119/289 (41%), Gaps = 47/289 (16%)
Query: 371 KGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 430
KG FG V+ +WR +VAVKI +E +R E+ LRH NI+ + A +
Sbjct: 13 KGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 431 ----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ------R 480
L +V++Y GSL+ L+ R V + +A A G+ +LH
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGTPEWMAPEVLR 536
+P I HRDLKS N+LV T + D GL+ + I+ GT +MAPEVL
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 537 ED------PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---------------VISAV 575
+ S +++D+++ G++ WE+ Q + V
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 576 GFKGRRLEIPKNVNPM-----VAALIETCWAEEPEIRPSFPSIMETLQQ 619
+ R IP +A ++ CW R + I +TL Q
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-58
Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 27/288 (9%)
Query: 364 IDSSNFI------KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVA 410
+ +GSFG VY + VA+K + E +R EFL E +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEAS 75
Query: 411 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD-------ARVVVDERLR 463
+MK ++V L+G V++ ++ E ++RG L L
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 464 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSK 521
+ MA ++A GM YL+ VHRDL + N +V +TVK+ DFG++R + + Y
Sbjct: 136 IQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 522 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGR 580
WM+PE L++ SDV+SFGV+LWE+ TL + P++ + QV+ V +G
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGG 252
Query: 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 628
L+ P N M+ L+ CW P++RPSF I+ ++++ + +
Sbjct: 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-56
Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 12/249 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
+GSF TV A + A+KIL E++ RE +M L HP V L
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 77
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ L Y G L K + + DE ++ + YLH I+HR
Sbjct: 78 QDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH--GKGIIHR 132
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
DLK N+L++ +++ DFG ++ S + + + GT ++++PE+L E + + SD
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSD 192
Query: 546 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 605
+++ G I+++L+ P+R + + + P+ P L+E +
Sbjct: 193 LWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVEKLLVLDAT 250
Query: 606 IRPSFPSIM 614
R +
Sbjct: 251 KRLGCEEME 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 191 bits (486), Expect = 5e-56
Identities = 63/264 (23%), Positives = 115/264 (43%), Gaps = 17/264 (6%)
Query: 362 HVIDSSNFIK----GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL 415
HV+D + + G+FG V+ R + A K ++ HE + +E+ M L
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVL 80
Query: 416 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475
RHP +V L A + + ++ E++S G L++ + D + E + V KG+
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 476 YLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 533
++H+ VH DLK N++ + + +K+ DFGL+ + S K GT E+ APE
Sbjct: 139 HMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPE 195
Query: 534 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPM 591
V P +D++S GV+ + L++ P+ + + V + ++
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 592 VAALIETCWAEEPEIRPSFPSIME 615
I +P R + +E
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-56
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 26/278 (9%)
Query: 371 KGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 423
+G+FG V A+ D VAVK+L E H + ++ H N+V L
Sbjct: 23 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82
Query: 424 MGAVTEPPN-LSIVTEYLSRGSLYKLLH-------------IPDARVVVDERLRLNMAYD 469
+GA T+P L ++ E+ G+L L + + + ++
Sbjct: 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 142
Query: 470 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP 527
VAKGM +L R+ +HRDL + N+L+ VK+CDFGL+R K Y+ A
Sbjct: 143 VAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200
Query: 528 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPK 586
+WMAPE + + +SDV+SFGV+LWE+ +L P+ + +G R+ P
Sbjct: 201 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 260
Query: 587 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
P + + CW EP RP+F ++E L L ++
Sbjct: 261 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 189 bits (481), Expect = 3e-55
Identities = 58/251 (23%), Positives = 113/251 (45%), Gaps = 13/251 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+FG V+ + + K I + D+ E++IM L HP ++ L A
Sbjct: 39 SGAFGVVHRCVEKATGRVFVAKF-INTPYPLDK-YTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ + ++ E+LS G L+ + D + + E +N +G+ ++H+ IVH D
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEHS--IVHLD 152
Query: 489 LKSPNLLVDSTY--TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
+K N++ ++ +VK+ DFGL+ I T T E+ APE++ +P +D+
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVDREPVGFYTDM 211
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIETCWAEEP 604
++ GV+ + L++ P+ + + V + +V+P I+ +EP
Sbjct: 212 WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEP 271
Query: 605 EIRPSFPSIME 615
R + +E
Sbjct: 272 RKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 5e-55
Identities = 68/252 (26%), Positives = 119/252 (47%), Gaps = 14/252 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+F V AE + + VA+K I ++ E + E+A++ ++HPNIV L
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 77
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+L ++ + +S G L+ + + ER + + V + YLH IVHRD
Sbjct: 78 SGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD--LGIVHRD 132
Query: 489 LKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 545
LK NLL D + + DFGLS+ + + S TA GTP ++APEVL + P ++ D
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKPYSKAVD 191
Query: 546 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEE 603
+S GVI + L+ P+ + +++ + + P +++ I ++
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKD 251
Query: 604 PEIRPSFPSIME 615
PE R + ++
Sbjct: 252 PEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-54
Identities = 50/251 (19%), Positives = 115/251 (45%), Gaps = 14/251 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G FG V+ +S K + + + K +E++I+ RH NI+ L +
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHLHESFE 71
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L ++ E++S +++ ++ + ++ER ++ + V + + +LH I H D
Sbjct: 72 SMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFD 127
Query: 489 LKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
++ N++ + + T+K+ +FG +R + + PE+ APEV + D + +D+
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDM 186
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIETCWAEEP 604
+S G +++ L++ P+ T Q+I + E K ++ ++ +E
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKER 246
Query: 605 EIRPSFPSIME 615
+ R + ++
Sbjct: 247 KSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 11/246 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIM-KGLRHPNIVLLMGA 426
KGSFG V+ AE++ ++ A+K L + +D + + E ++ HP + +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 71
Query: 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 486
NL V EYL+ G L + + D A ++ G+ +LH + IV+
Sbjct: 72 FQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG--IVY 126
Query: 487 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 546
RDLK N+L+D +K+ DFG+ + + T GTP+++APE+L N D
Sbjct: 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 186
Query: 547 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEI 606
+SFGV+L+E++ Q P+ ++ ++ + P+ + L+ + EPE
Sbjct: 187 WSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLFVREPEK 244
Query: 607 RPSFPS 612
R
Sbjct: 245 RLGVRG 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 179 bits (456), Expect = 2e-52
Identities = 59/271 (21%), Positives = 116/271 (42%), Gaps = 26/271 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-------IEQEFHEDRFKEFLREVAIMKGLR-HPNI 420
+G V + + AVKI+ E ++ + L+EV I++ + HPNI
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 421 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
+ L +V + + +G L+ L +V + E+ + + + + LH+
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKL 129
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
IVHRDLK N+L+D +K+ DFG S + GTP ++APE++ +
Sbjct: 130 N--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMN 186
Query: 541 ------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV 592
++ D++S GVI++ L+ P+ + ++ + + P + + V
Sbjct: 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246
Query: 593 AALIETCWAEEPEIRPSFPSIMET--LQQFL 621
L+ +P+ R + + QQ++
Sbjct: 247 KDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 176 bits (448), Expect = 5e-51
Identities = 58/254 (22%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAV 427
GSFG V+ R++ A+K+L ++ + E E ++ + HP I+ + G
Sbjct: 14 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 73
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ + ++ +Y+ +L + + A +V + YLH I++R
Sbjct: 74 QDAQQIFMIMDYIEG---GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--SKDIIYR 128
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DLK N+L+D +K+ DFG ++ P+ T GTP+++APEV+ P N+ D +
Sbjct: 129 DLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYNKSIDWW 185
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
SFG++++E++ P+ +S + + L P N V L+ + R
Sbjct: 186 SFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRLITRDLSQR 243
Query: 608 PSFPSIMETLQQFL 621
++ +
Sbjct: 244 L--GNLQNGTEDVK 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 173 bits (439), Expect = 4e-50
Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 17/251 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMGAV 427
G V+ A VAVK+L + F F RE L HP IV +
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76
Query: 428 TEPPNLS----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
IV EY+ +L ++H + + + + D + +N+ HQ
Sbjct: 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG-- 131
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPS 540
I+HRD+K N+++ +T VKV DFG++R N+ + GT ++++PE R D
Sbjct: 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 191
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMVAALIET 598
+ +SDV+S G +L+E++T + P+ +P V + + ++ + A++
Sbjct: 192 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251
Query: 599 CWAEEPEIRPS 609
A+ PE R
Sbjct: 252 ALAKNPENRYQ 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 63/254 (24%), Positives = 115/254 (45%), Gaps = 12/254 (4%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 427
KG+FG V + + A+KIL E +D + E +++ RHP + L A
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
L V EY + G L+ L V E ++ + YLH +V+R
Sbjct: 75 QTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH--SRDVVYR 129
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
D+K NL++D +K+ DFGL + + + KT GTPE++APEVL ++ D +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
GV+++E++ + P+ N ++ + + P+ ++P +L+ ++P+ R
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 608 PSFPSIMETLQQFL 621
++ +
Sbjct: 248 LG--GGPSDAKEVM 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 173 bits (439), Expect = 4e-49
Identities = 60/247 (24%), Positives = 107/247 (43%), Gaps = 15/247 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
+G FG VY ++ A+K L I+ + E ++++ P IV +
Sbjct: 14 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
A P LS + + ++ G L+ L V E A ++ G+ ++H R +
Sbjct: 74 YAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF--V 128
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEK 543
V+RDLK N+L+D V++ D GL+ + GT +MAPEVL++ +
Sbjct: 129 VYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSS 186
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQVIS-AVGFKGRRLEIPKNVNPMVAALIETCWAE 602
+D FS G +L++L+ P+R +E+P + +P + +L+E
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246
Query: 603 EPEIRPS 609
+ R
Sbjct: 247 DVNRRLG 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 61/277 (22%), Positives = 116/277 (41%), Gaps = 25/277 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 424
G F V +++ A K + + ++ REV+I+K ++HPN++ L
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 425 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
++ ++ E ++ G L+ + + E + G+ YLH I
Sbjct: 80 EVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHSL--QI 134
Query: 485 VHRDLKSPNLLVDS----TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
H DLK N+++ +K+ DFGL+ K GTPE++APE++ +P
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPL 193
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIET 598
++D++S GVI + L++ P+ T + ++ V E N + + I
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 599 CWAEEPEIRPSFPSIME-------TLQQFLMSSVCQP 628
++P+ R + ++ QQ L S+ P
Sbjct: 254 LLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 1e-47
Identities = 45/272 (16%), Positives = 92/272 (33%), Gaps = 26/272 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
GSFG +Y + VA+K+ + H + E I K ++ + +
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ +++ L SL L + + + L +A + + Y+H + +HRD
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHSKN--FIHRD 128
Query: 489 LKSPNLLVDST---YTVKVCDFGLSR-------SKPNTYISSKTAAGTPEWMAPEVLRED 538
+K N L+ V + DFGL++ + Y +K GT + +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 539 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------GFKGRRLEIPKNVNPMV 592
+ + D+ S G +L PW+ + + K
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 593 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624
A + C + + +P + + + +
Sbjct: 249 ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 62/261 (23%), Positives = 105/261 (40%), Gaps = 27/261 (10%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIM-KGLRHPNIVLLMGA- 426
G G V + + A+K+L + REV + + + P+IV ++
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 427 ---VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
L IV E L G L+ + + ER + + + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHSIN-- 131
Query: 484 IVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
I HRD+K NLL S +K+ DFG ++ + S T TP ++APEVL +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKY 190
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI------PKNVNPMVAA 594
++ D++S GVI++ L+ P+ ++ + + + R + V+ V
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 595 LIETCWAEEPEIRPSFPSIME 615
LI EP R + M
Sbjct: 251 LIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 9e-47
Identities = 53/255 (20%), Positives = 99/255 (38%), Gaps = 24/255 (9%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLR--HPNIVL 422
G FG+VY + + VA+K + I EV ++K + ++
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 423 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
L+ P + ++ E L R + E L + + V + + + H
Sbjct: 74 LLDWFERPDSFVLILERPEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCHNC-- 129
Query: 483 PIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-S 540
++HRD+K N+L+D + +K+ DFG +T GT + PE +R
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYH 187
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 600
+ V+S G++L++++ P+ + ++ + V+ LI C
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--------GQVFFRQRVSSECQHLIRWCL 239
Query: 601 AEEPEIRPSFPSIME 615
A P RP+F I
Sbjct: 240 ALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (403), Expect = 7e-45
Identities = 41/271 (15%), Positives = 88/271 (32%), Gaps = 28/271 (10%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+GSFG ++ ++ VA+K + + E K L + +
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
+ +++ L SL LL + + V A + + +H++ +V+RD
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKS--LVYRD 126
Query: 489 LKSPNLLVDSTYT-----VKVCDFGLSR-------SKPNTYISSKTAAGTPEWMAPEVLR 536
+K N L+ + + V DFG+ + + Y K +GT +M+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 537 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV------ISAVGFKGRRLEIPKNVNP 590
+ + D+ + G + + PW+ + I E+
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246
Query: 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ + P + + + L
Sbjct: 247 EFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 37/277 (13%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 425
+G F TVY A +N++ VA+K + E + + LRE+ +++ L HPNI+ L+
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67
Query: 426 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
A N+S+V +++ + I D +V+ +G+ YLHQ I+
Sbjct: 68 AFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--WIL 122
Query: 486 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKS 544
HRDLK NLL+D +K+ DFGL++S + + T + APE+L
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 545 DVFSFGVILWELITLQKPWRNSTPSQVISAV-------------------------GFKG 579
D+++ G IL EL+ + ++ + F G
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 580 RRL-EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
L I + LI+ + P R + ++
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 3e-44
Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 15/254 (5%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAV 427
GSFG V + + S A+KIL +Q+ + + E L E I++ + P +V L +
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110
Query: 428 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 487
+ NL +V EY++ G ++ L E A + YLH +++R
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYR 165
Query: 488 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 547
DLK NLL+D ++V DFG ++ T GTPE +APE++ N+ D +
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 607
+ GV+++E+ P+ P Q+ + ++ P + + + L+ + R
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKR 280
Query: 608 PSFPSIMETLQQFL 621
F ++ +
Sbjct: 281 --FGNLKNGVNDIK 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-44
Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 41/281 (14%)
Query: 371 KGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLM 424
+G++G V+ A + VA+K + Q E +REVA+++ L HPN+V L
Sbjct: 17 EGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 76
Query: 425 GAVTEPPN-----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 479
T L++V E++ + L +P+ V +M + + +G+++LH
Sbjct: 77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV--PTETIKDMMFQLLRGLDFLHS 134
Query: 480 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 539
R +VHRDLK N+LV S+ +K+ DFGL+R + ++ + T + APEVL +
Sbjct: 135 HR--VVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSS 191
Query: 540 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------------------------ 575
D++S G I E+ + +R S+ + +
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251
Query: 576 -GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
+ +++ + L+ C P R S S +
Sbjct: 252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 2e-43
Identities = 57/274 (20%), Positives = 106/274 (38%), Gaps = 34/274 (12%)
Query: 371 KGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 429
+G++G VY A+ + A+K + ++ E +RE++I+K L+H NIV L +
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 489
L +V E+L + L ++ + + G+ Y H RR ++HRDL
Sbjct: 72 KKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDL 126
Query: 490 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFS 548
K NLL++ +K+ DFGL+R+ T + AP+VL + D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 549 FGVILWELITLQKPWRNSTPSQVISAV---------------------------GFKGRR 581
G I E++ + + + + +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246
Query: 582 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
K ++ L+ +P R + +E
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 5e-43
Identities = 54/275 (19%), Positives = 111/275 (40%), Gaps = 34/275 (12%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++G VY A + + VA+K + E +RE++++K L HPNIV L+ +
Sbjct: 12 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L +V E+L + + + + + + +G+ + H ++HRD
Sbjct: 72 TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH--RVLHRD 127
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVF 547
LK NLL+++ +K+ DFGL+R+ + T + APE+L + D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAV---------------------------GFKGR 580
S G I E++T + + + + + +
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 581 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
++ ++ +L+ +P R S + +
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 59/299 (19%), Positives = 95/299 (31%), Gaps = 45/299 (15%)
Query: 354 QNPSGPSTHVIDSSNFI-KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVA 410
Q P P + I GSFG VY A+ +S VA+K +++ + + RE+
Sbjct: 12 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQ 65
Query: 411 IMKGLRHPNIVLLMGAVTEP------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 464
IM+ L H NIV L L++V +Y+ H A+ +
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 465 NMAYDVAKGMNYLHQRRPPIVHRDLK-SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 523
Y + + + Y+H I HRD+K LL T +K+CDFG ++ +
Sbjct: 126 LYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 524 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-------- 575
+ DV+S G +L EL+ Q + + + +
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 576 -------------------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
P AL P R +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 59/284 (20%), Positives = 107/284 (37%), Gaps = 46/284 (16%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++G V A + VA+K + E H+ + LRE+ I+ RH NI+ + +
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIR 76
Query: 429 EPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 484
P + +L LYKLL + Y + +G+ Y+H +
Sbjct: 77 APTIEQMKDVYLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN--V 130
Query: 485 VHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVL-REDPS 540
+HRDLK NLL+++T +K+CDFGL+R + T + APE++
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 541 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------------------------- 575
+ D++S G IL E+++ + + ++ +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 576 ----GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
K + N + L++ P R +
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 63/295 (21%), Positives = 127/295 (43%), Gaps = 25/295 (8%)
Query: 345 VTADRDLQMQNPSGPSTHV-IDSSNFIK----GSFGTVYHAE-----WRNSDVAVKILIE 394
+T +L+ N +G + V I++ +K G++G V+ A+K+L +
Sbjct: 3 LTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 62
Query: 395 QEFHEDR--FKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 451
+ + E +++ +R P +V L A L ++ +Y++ G L+ L
Sbjct: 63 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS- 121
Query: 452 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511
R E ++ + +LH+ I++RD+K N+L+DS V + DFGLS+
Sbjct: 122 --QRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 177
Query: 512 S-KPNTYISSKTAAGTPEWMAPEVLREDPS--NEKSDVFSFGVILWELITLQKPWRNSTP 568
+ + GT E+MAP+++R S ++ D +S GV+++EL+T P+
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237
Query: 569 SQVISAV--GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621
+ + P+ ++ + LI+ ++P+ R +
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG--CGPRDADEIK 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 1e-38
Identities = 58/276 (21%), Positives = 107/276 (38%), Gaps = 36/276 (13%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G++GTV+ A+ R + VA+K + + E LRE+ ++K L+H NIV L +
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH 71
Query: 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 488
L++V E+ + + +D + + + + KG+ + H R ++HRD
Sbjct: 72 SDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRD 126
Query: 489 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVF 547
LK NLL++ +K+ +FGL+R+ T + P+VL + D++
Sbjct: 127 LKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186
Query: 548 SFGVILWELITLQKPWRNSTPSQVISAVGFKG---------------------------- 579
S G I EL +P F+
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246
Query: 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
+ + +N L++ P R S ++
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 54/290 (18%), Positives = 108/290 (37%), Gaps = 50/290 (17%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
+G+FG V+ A R + VA+K ++ + E LRE+ I++ L+H N+V L+
Sbjct: 20 QGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79
Query: 429 EPP--------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
++ +V ++ + + V + + G+ Y+H+
Sbjct: 80 TKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGTPEWMAPEVLR 536
+ I+HRD+K+ N+L+ +K+ DFGL+R +K + T + PE+L
Sbjct: 137 K--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194
Query: 537 EDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-------------------- 575
+ D++ G I+ E+ T + +T ++ +
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254
Query: 576 ----------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
K + +P LI+ +P R +
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 62/283 (21%), Positives = 105/283 (37%), Gaps = 48/283 (16%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G V A + VA+K L E K RE+ ++K +RH N++ L+ T
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87
Query: 429 EPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
L +V ++ + H + E + Y + KG+ Y+H
Sbjct: 88 PDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHAAGI 142
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSN 541
HRDLK NL V+ +K+ DFGL+R + T + APEV+
Sbjct: 143 I--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMRYT 197
Query: 542 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------------------ 577
+ D++S G I+ E+IT + ++ S + +
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 578 -----KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615
K I N +P+ L+E + E R + +
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 58/270 (21%), Positives = 107/270 (39%), Gaps = 18/270 (6%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G+ G V A D VA+K L ++ K RE+ +MK + H NI+ L+ T
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 429 EPP------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 482
++ +V E + + D + Y + G+ +LH
Sbjct: 87 PQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHSAGI 140
Query: 483 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 542
+HRDLK N++V S T+K+ DFGL+R+ +++ + T + APEV+ E
Sbjct: 141 --IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGYKE 197
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 602
D++S G I+ E++ + + + V + P+ + + +
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-IEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 603 EPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 632
+FP + S + ++Q
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQ 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-31
Identities = 61/282 (21%), Positives = 111/282 (39%), Gaps = 46/282 (16%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G++G+V A + VAVK L K RE+ ++K ++H N++ L+ T
Sbjct: 28 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87
Query: 429 EPPNLS-----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 483
+L + +L L ++ + + + Y + +G+ Y+H
Sbjct: 88 PARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 484 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDPSNE 542
I+HRDLK NL V+ +K+ DFGL+R + T + APE+ L N+
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQ 198
Query: 543 KSDVFSFGVILWELITLQKPWRNSTPSQVI---------------------SAVGFKGRR 581
D++S G I+ EL+T + + + + SA +
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 582 LEIPK--------NVNPMVAALIETCWAEEPEIRPSFPSIME 615
++PK NP+ L+E + + R + +
Sbjct: 259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (302), Expect = 1e-30
Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAV 427
+G + V+ A ++ V VKIL + K+ RE+ I++ LR PNI+ L V
Sbjct: 45 RGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIV 99
Query: 428 TEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 485
+P + ++V E+++ +L + + Y++ K ++Y H I+
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG--IM 151
Query: 486 HRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEK 543
HRD+K N+++D +++ D+GL+ + + + PE+L + +
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYS 210
Query: 544 SDVFSFGVILWELITLQKPWRNSTPSQ 570
D++S G +L +I ++P+ + +
Sbjct: 211 LDMWSLGCMLASMIFRKEPFFHGHDNY 237
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 1e-24
Identities = 42/215 (19%), Positives = 87/215 (40%), Gaps = 28/215 (13%)
Query: 371 KGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 428
G F TV+ A+ ++ VA+KI+ + + + + E+ +++ + +
Sbjct: 23 WGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDSMGA 79
Query: 429 E-------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 475
P + +V + G L + ++ + G++
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 476 YLHQRRPPIVHRDLKSPNLLVDS------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 529
Y+H+R I+H D+K N+L++ +K+ D G + Y +S T E+
Sbjct: 140 YMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI---QTREY 195
Query: 530 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 564
+PEVL P +D++S +++ELIT +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 1e-16
Identities = 29/181 (16%), Positives = 49/181 (27%), Gaps = 33/181 (18%)
Query: 371 KGSFGTVYHAEWRNS-DVAVKIL--------IEQEFHEDRFKEFLREVAIMKGLRHPNIV 421
+G V++ + VK +E + F +
Sbjct: 10 EGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69
Query: 422 LLMGAVTEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 480
L G L++ Y ++ L V + + + + + R
Sbjct: 70 KLQG-------LAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 481 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 540
IVH DL N+LV + + DF S E E+L D
Sbjct: 123 --GIVHGDLSQYNVLVSE-EGIWIIDFPQSVE-------------VGEEGWREILERDVR 166
Query: 541 N 541
N
Sbjct: 167 N 167
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 634 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.9 | |
| d2q3za4 | 316 | Transglutaminase catalytic domain {Human (Homo sap | 89.72 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 88.62 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=415.09 Aligned_cols=258 Identities=35% Similarity=0.596 Sum_probs=216.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..+|...+.||+|+||+||+|++++ .||||++..........+.|.+|+.++++++||||+++++++.. +.+++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 4678888999999999999998654 59999998776666677889999999999999999999998754 568999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--c
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--Y 517 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~--~ 517 (634)
+++|+|.+++..... .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 85 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 85 CEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999975433 4899999999999999999999999 999999999999999999999999999865432 2
Q ss_pred ccCCCCCCCCcccCcccccCC---CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-cc---cCCCCCCcH
Q 006703 518 ISSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RR---LEIPKNVNP 590 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~---~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~-~~---~~~~~~~s~ 590 (634)
.......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+............ .. ...+..+++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 234566799999999999643 47999999999999999999999999877655444332222 22 245678899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
++.+|+.+||..||++|||+.+|++.|+.+.++
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 999999999999999999999999999998874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=413.16 Aligned_cols=246 Identities=28% Similarity=0.498 Sum_probs=219.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeecccc-HHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~-~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||+||+|+++.+ .||+|++...... ......+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5688999999999999999998744 4999998765432 223467889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|......
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997443 4899999999999999999999999 999999999999999999999999999875543
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+. ...+.+|..+++++.+||.
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHH
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHH
Confidence 2345679999999999999999999999999999999999999999988888777663 4456678889999999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~ 615 (634)
+||..||++|||+.++++
T Consensus 237 ~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHccCCHhHCcCHHHHHc
Confidence 999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=415.50 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=210.1
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--CCcEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~--~~~~~lV 436 (634)
..|...+.||+|+||+||+|+++. ..||+|++..........+.+.+|++++++++||||+++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 578899999999999999999874 459999998877777777889999999999999999999999865 4568999
Q ss_pred EeecccCCHHHHhccC-CCcccccHHHHHHHHHHHHHHHHHHHhCC---CCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 437 TEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRR---PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~-~~~~~l~e~~~~~i~~qIa~aL~yLH~~g---~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
|||+++|+|.+++... ..+..+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998632 12345999999999999999999999864 2499999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHH
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 592 (634)
............||+.|+|||++.+..+++++|||||||++|||++|+.||...+..+....+.. ...+.++..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHH
Confidence 65544445677899999999999999999999999999999999999999999888887777643 33446778899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||.+||..||++|||+.++++
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHh
Confidence 99999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=415.22 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=219.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
+..+|...+.||+|+||+||+|+++ +..||+|++....... .+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 3467999999999999999999977 4559999987654332 35688999999999999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||++||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 mEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 9999999999988643 3899999999999999999999999 999999999999999999999999999876555
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-CcccCCCCCCcHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~L 595 (634)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ......+..+++.+++|
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 44556778999999999999999999999999999999999999999998877766555333 23345567899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~ 615 (634)
|.+||..||++|||+.++++
T Consensus 250 i~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-50 Score=414.25 Aligned_cols=258 Identities=32% Similarity=0.530 Sum_probs=215.8
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc-----EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~-----vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+.||+|+||+||+|+++.++ ||||.+.... .....++|.+|+.+|++++|||||++++++..++.+++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888899999999999999986432 7777765443 44555789999999999999999999999999999999
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++|+|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 105 v~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999887543 34899999999999999999999999 99999999999999999999999999986543
Q ss_pred Ccc-----cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCc
Q 006703 516 TYI-----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 589 (634)
Q Consensus 516 ~~~-----~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 589 (634)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+....+. ...+++.+..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccch
Confidence 211 1223457899999999999999999999999999999998 899999999888877764 445666788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 590 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 590 ~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+.+.+|+.+||..||++|||+.+|++.|++++++.
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 99999999999999999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=404.52 Aligned_cols=255 Identities=32% Similarity=0.576 Sum_probs=214.0
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..|...+.||+|+||+||+|++.++ .||||++....... ++|.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4688899999999999999998754 49999987654433 5688999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-c
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-I 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~-~ 518 (634)
+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred cCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999987543 34889999999999999999999999 9999999999999999999999999998654432 2
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+. ...++..|..+++++.+|+.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 236 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMN 236 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHH
Confidence 2345678999999999999999999999999999999999 577777777777766664 34566677889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+||..||++|||+.+|++.|++++++
T Consensus 237 ~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=406.27 Aligned_cols=251 Identities=31% Similarity=0.508 Sum_probs=215.1
Q ss_pred cceeeccCcEEEEEEEEcCC----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEeecc
Q 006703 366 SSNFIKGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 441 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 441 (634)
.++||+|+||+||+|.++++ .||||++..........+++.+|+++|++++||||+++++++.. +..++||||++
T Consensus 12 ~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 35799999999999987542 39999997665556666789999999999999999999999865 46789999999
Q ss_pred cCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc---c
Q 006703 442 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY---I 518 (634)
Q Consensus 442 ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~---~ 518 (634)
+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999997543 4899999999999999999999999 9999999999999999999999999998643321 2
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+. ...+++.|..+++++.+|+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHH
Confidence 2344578999999999999999999999999999999998 899999988887776664 45677888999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+||+.||++|||+.+|++.|+++..+
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999999999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=404.05 Aligned_cols=249 Identities=30% Similarity=0.486 Sum_probs=211.9
Q ss_pred cce-eecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec----CCcE
Q 006703 361 THV-IDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNL 433 (634)
Q Consensus 361 ~~~-~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~----~~~~ 433 (634)
.+| ...++||+|+||+||+|+++.+ .||+|++..........+.+.+|+++|++++||||+++++++.+ ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 5567899999999999998855 49999998777666777889999999999999999999999854 4568
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc-CCCcEEEEecCCCcc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRS 512 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld-~~~~ikL~DFGla~~ 512 (634)
|+||||+++|+|.+++.... .+++..+..++.||++||+|||+++++|+||||||+|||++ .++.+||+|||+|+.
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999999999997543 48999999999999999999999887799999999999997 578999999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCcccCCCCCCcHH
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.... ......||+.|+|||++.+ +++.++|||||||++|||++|+.||..... .+....+........++...+++
T Consensus 165 ~~~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 165 KRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp CCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ccCC--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 4433 2346789999999999875 599999999999999999999999987554 44444444333444566778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+||.+||..||++|||+.++++
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCCHhHCcCHHHHhC
Confidence 999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=404.52 Aligned_cols=263 Identities=29% Similarity=0.492 Sum_probs=224.7
Q ss_pred cceeecc-eeeccCcEEEEEEEEcCC----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSS-NFIKGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~-~LG~G~fG~Vy~a~~~~~----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~l 435 (634)
..+...+ +||+|+||+||+|.++.. .||||++.... .....++|.+|+++|++++|||||++++++.. +.+|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 4566666 499999999999977532 38999986543 44556789999999999999999999999875 46899
Q ss_pred EEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCC
Q 006703 436 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~ 515 (634)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 vmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999985433 34899999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 516 TY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 516 ~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
.. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+. ...+++.|..++++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPE 240 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHH
Confidence 21 22335568999999999999999999999999999999998 899999988877766664 45667888999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 630 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~ 630 (634)
+.+||.+||..||++|||+.+|++.|+.+..+...+..+
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~ 279 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccch
Confidence 999999999999999999999999999988875555443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=403.24 Aligned_cols=258 Identities=33% Similarity=0.579 Sum_probs=221.9
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
+...|...+.||+|+||+||+|++++. .||||++....... +.|.+|+.++++++|||||++++++.+ +..++||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 346888999999999999999998754 59999987654333 568899999999999999999998765 5679999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++|+|.+++..... ..+++..++.|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 87 Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999998764332 34899999999999999999999999 9999999999999999999999999998765432
Q ss_pred -ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 -~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......||+.|+|||++.+..++.++|||||||++|||+|| .+||......+....+. ...++..|..+++++.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHHHHHH
Confidence 234456789999999999999999999999999999999995 55566666666666653 456677788999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+.+||+.||++|||+.+|++.|++++.++
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 99999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=410.91 Aligned_cols=257 Identities=35% Similarity=0.572 Sum_probs=220.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||+||+|.++.+ .||||++...... .+++.+|+.+|++++|||||++++++.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 36788899999999999999998744 4999998655433 356889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++|+|.+++..... ..+++..++.++.||++||.|||++| |+||||||+|||++.++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999865432 35899999999999999999999999 9999999999999999999999999998754432
Q ss_pred -ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 518 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 518 -~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......||+.|+|||++.+..++.++|||||||++|||++|..|| ...+..+....+ ....++..+..+++.+.+|
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~l 248 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYEL 248 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHH
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchHHHHHH
Confidence 2233445889999999999999999999999999999999976655 455555544443 4556777888999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 596 IETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+.+||..||++|||+.+|++.|+.+++.
T Consensus 249 i~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999988664
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=405.83 Aligned_cols=249 Identities=28% Similarity=0.342 Sum_probs=208.0
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||+||+|+++. ..||+|++...... +..+++.+|+.+|++++||||+++++++.+++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 578899999999999999999874 45999998765432 234678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC--
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-- 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~-- 516 (634)
|+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999986443 4999999999999999999999999 999999999999999999999999999864322
Q ss_pred cccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhhcCcccCCCCCCcHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .................+++++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 222456789999999999988876 678999999999999999999997755432 222232222233334578999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
|+.+||..||++|||+.++++
T Consensus 239 li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=412.21 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=216.1
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||+||+|+++.+ .||+|++..... ...+.+.+|+++|++++||||+++++++.+++.+++||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 35688899999999999999998754 499999876532 23467889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+++|+|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|.......
T Consensus 89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999999976432 24899999999999999999999999 9999999999999999999999999997654433
Q ss_pred ccCCCCCCCCcccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc-ccCCCCCCcHH
Q 006703 518 ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPM 591 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~-----~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~ 591 (634)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+..... ....+..++++
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 3345678999999999984 45678999999999999999999999999888877766643322 23445678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 592 VAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+.+||.+||..||++|||+.++++
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=409.18 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=216.5
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||+||+|+++. ..||||++..... .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 569999999999999999999874 4599999876543 2334467889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC-
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~- 516 (634)
||++||+|.+++...+ .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987443 4999999999999999999999999 999999999999999999999999999865432
Q ss_pred -cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 006703 517 -YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 595 (634)
Q Consensus 517 -~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 595 (634)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+. ...+.+|..+++.+++|
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDL 240 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHHH
Confidence 223345689999999999999999999999999999999999999999998888777763 34566788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 006703 596 IETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 596 i~~cL~~dP~~RPs~~~Il~ 615 (634)
|.+||..||++|||+.|++.
T Consensus 241 i~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHccCCHhHCcCHHHHcC
Confidence 99999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=399.26 Aligned_cols=258 Identities=32% Similarity=0.547 Sum_probs=215.4
Q ss_pred cceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..|...+.||+|+||.||+|.++.+ .||||++.... ......+|.+|+.++++++|||||++++++.+....+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4588889999999999999987743 38999986543 3444567999999999999999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
++|||+.++++.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999998876443 24899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc---ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 515 NTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 515 ~~~---~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
... .......||+.|+|||++.+..++.++|||||||++|||+++ .+|+......+....+. ...+++.+..+++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhhHH
Confidence 322 123345689999999999999999999999999999999996 55556666666665553 4566778888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
.+.+||.+||..||++|||+.+|++.|++++++.
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 9999999999999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=407.08 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=216.4
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||+||+|++..++ ||||++..... .....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 56889999999999999999987544 99999976654 3455677999999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
|||.+|+|..++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|.....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999997766533 24899999999999999999999999 99999999999999999999999999986543
Q ss_pred ccCCCCCCCCcccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~---~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+.........+..+++++.+
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 346689999999999864 457899999999999999999999999988888777765544444456678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
||.+||..||++|||+.++++
T Consensus 246 li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCcCChhHCcCHHHHHh
Confidence 999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=395.20 Aligned_cols=251 Identities=32% Similarity=0.557 Sum_probs=222.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..|...++||+|+||+||+|+++++ .||||+++...... ++|.+|+.++++++||||+++++++.+++.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4677888999999999999999755 59999998765543 4688999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc-
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI- 518 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~- 518 (634)
+++|+|..++.... ..+++..+++++.|+++||.|||++| |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp CTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred cCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999976443 34889999999999999999999999 99999999999999999999999999986543322
Q ss_pred cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 519 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......||+.|+|||++.+..++.++||||||+++|||+| |+.||...+..+....+. ...++..|...++++.+||.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHH
Confidence 3345678999999999999999999999999999999998 899999999888877774 45567788899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHH
Q 006703 598 TCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 598 ~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
+||+.||++|||+.+|++.|.+
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=411.46 Aligned_cols=257 Identities=32% Similarity=0.495 Sum_probs=218.5
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-------cEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~ 431 (634)
...|...+.||+|+||+||+|++.+. .||+|++.... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 46788999999999999999988643 38888876543 233446788999999998 8999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCCC--------------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDA--------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 491 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~--------------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP 491 (634)
.+++|||||++|+|.++++.... ...+++..++.++.||++||.|||+++ |+||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp 192 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAA 192 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCch
Confidence 99999999999999999964421 134889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCccCCCCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCh
Q 006703 492 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 568 (634)
Q Consensus 492 ~NILld~~~~ikL~DFGla~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~ 568 (634)
+|||++.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999997643322 12235568999999999999999999999999999999998 8999998777
Q ss_pred HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 006703 569 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 619 (634)
Q Consensus 569 ~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ 619 (634)
.+....+.....++..|..+++++.+||.+||+.||++|||+.+|++.|..
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 666666656667778889999999999999999999999999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=407.28 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=201.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||+||+|+++. ..||||++....... ....+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4669999999999999999999874 449999997665433 2356889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc---CCCcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld---~~~~ikL~DFGla~~~~ 514 (634)
|||+||+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||+. .++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999997543 4999999999999999999999999 99999999999995 57899999999998654
Q ss_pred CCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc--CCCCCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l 592 (634)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+....... +.+..+++++
T Consensus 162 ~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 162 PGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 332 3456789999999999999999999999999999999999999999988888777765443332 3446799999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006703 593 AALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.+||.+||..||++|||+.++++
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHhc
Confidence 99999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=409.10 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=222.1
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||.||+|+++. ..||+|++.+... .....+++.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 568999999999999999999874 4599999976543 2334577889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||++||+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999987543 4899999999999999999999999 9999999999999999999999999998765544
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+. ...+.+|..+++++.+||.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHH
Confidence 45567789999999999999999999999999999999999999999999888777664 3456778899999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHH
Q 006703 598 TCWAEEPEIRPS-----FPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RPs-----~~~Il~ 615 (634)
+||.+||.+||+ +.++++
T Consensus 238 ~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred hhccCCchhhcccccccHHHHHc
Confidence 999999999994 888887
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=408.68 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=207.4
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
...|...+.||+|+||+||+|+++.+ .||+|++.... ......++.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46789999999999999999998754 49999987653 3344567899999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
||++||+|.+++.+.. .+++..+..++.||+.||.|||+ +| |+||||||+|||++.++.+||+|||+|......
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999997543 48999999999999999999997 48 999999999999999999999999999864332
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--------------------
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-------------------- 576 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~-------------------- 576 (634)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+......
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2346789999999999999999999999999999999999999997765432211000
Q ss_pred ---------------------hcCcccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 577 ---------------------FKGRRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 577 ---------------------~~~~~~~~~-~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.....+..+ ..+++++.+|+.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001111122 246889999999999999999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=394.11 Aligned_cols=259 Identities=31% Similarity=0.546 Sum_probs=213.2
Q ss_pred CCcceeecceeeccCcEEEEEEEEcCCc-----EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-----vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
+..+|...+.||+|+||.||+|.+.... ||||.+... ......+.+.+|+.++++++||||+++++++.+ +.+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 3467899999999999999999886432 667766433 244556789999999999999999999999864 678
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
++||||+++|+|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+|+..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999999876443 34899999999999999999999999 999999999999999999999999999865
Q ss_pred CCC-cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 514 PNT-YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 514 ~~~-~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+. ...+++++..+++.
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 237 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 432 223445678999999999999999999999999999999998 899999998888877764 45566788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+.+||.+||+.||++|||+.+|++.|+++++..
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=396.17 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=217.9
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccH----HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~----~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~ 433 (634)
...|...+.||+|+||+||+|+++. ..||||++....... ...+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3679999999999999999999874 459999997654322 1246788999999999999999999999999999
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC----cEEEEecCC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL 509 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~----~ikL~DFGl 509 (634)
|+|||||++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997543 4999999999999999999999999 99999999999998766 599999999
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCCC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKN 587 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~ 587 (634)
|....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...... ...+..
T Consensus 164 a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 164 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp CEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred hhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence 98765432 345678999999999999999999999999999999999999999999888877776443322 223467
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+++.+.+||.+||..||++|||+.++++
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-47 Score=404.31 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=216.4
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...+.||+|+||.||+|+++.+ .||||++.... ....+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5789999999999999999998744 59999987553 3344678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc--CCCcEEEEecCCCccCCCC
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld--~~~~ikL~DFGla~~~~~~ 516 (634)
|++||+|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 104 ~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999986433 34999999999999999999999999 99999999999996 4678999999999875443
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc--CCCCCCcHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l~~ 594 (634)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....... .....+++++++
T Consensus 180 ~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp S-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred c-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 3345689999999999999999999999999999999999999999998888877775443322 233568999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
||.+||..||++|||+.++++
T Consensus 259 li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=393.92 Aligned_cols=260 Identities=33% Similarity=0.542 Sum_probs=216.6
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..+|...+.||+|+||+||+|+++++ .||||++....... +.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 36799999999999999999998865 49999987554433 568899999999999999999999865 56789999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc-
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY- 517 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~- 517 (634)
|+++|+|..++..... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999988864322 24899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
.......||+.|+|||++.+..++.++||||||+++|||++| .+|+......+....+. ...+++.+..+++++++||
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLM 247 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHHHHHHH
Confidence 233446789999999999999999999999999999999996 45556666666666554 4556678889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHhcCCC
Q 006703 597 ETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 627 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~ 627 (634)
.+||..||++|||+++|++.|++++.+...+
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 9999999999999999999999988765443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-47 Score=398.51 Aligned_cols=245 Identities=24% Similarity=0.421 Sum_probs=218.2
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||+||+|+++. ..||||++..... .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 568899999999999999999874 4599999876543 2233567889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.|++|..++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999887544 3788899999999999999999999 999999999999999999999999999876543
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ....+|..+++++.+++.
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence 3467899999999999999999999999999999999999999999998888777643 345677889999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHH
Q 006703 598 TCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RP-----s~~~Il~ 615 (634)
+||..||.+|+ |++++++
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhhhCHHhccccchhhHHHHHc
Confidence 99999999996 8999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-47 Score=402.49 Aligned_cols=248 Identities=22% Similarity=0.341 Sum_probs=216.8
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||.||+|+++. ..||||++..... .....+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999874 4599999876532 234678899999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc--CCCcEEEEecCCCccCCCC
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld--~~~~ikL~DFGla~~~~~~ 516 (634)
||+||+|.+++.... ..+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+|......
T Consensus 107 ~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 107 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred cCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999998876443 34999999999999999999999999 99999999999998 5789999999999876543
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc--cCCCCCCcHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMVAA 594 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l~~ 594 (634)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...... ...+..+++++.+
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred C-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 234567999999999999999999999999999999999999999999988877776543332 2344679999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 006703 595 LIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~ 615 (634)
||.+||..||++|||+.++++
T Consensus 262 li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.4e-47 Score=387.75 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=214.8
Q ss_pred CCcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC----
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP---- 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~---- 431 (634)
...+|...+.||+|+||+||+|++. ++.||||++..... +.....++.+|++++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 4567999999999999999999987 44599999976654 3455678999999999999999999999986544
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
.+|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.++..+|+|||.+.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred eEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhh
Confidence 3899999999999999886443 4899999999999999999999999 9999999999999999999999999886
Q ss_pred cCCCC---cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc--CCCC
Q 006703 512 SKPNT---YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPK 586 (634)
Q Consensus 512 ~~~~~---~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~ 586 (634)
..... ........||+.|+|||++.+..+++++|||||||++|||+||+.||.+.+..+....+......+ ....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 54322 223456679999999999999999999999999999999999999999998887766654433322 3456
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q 006703 587 NVNPMVAALIETCWAEEPEIRP-SFPSIMETLQQFL 621 (634)
Q Consensus 587 ~~s~~l~~Li~~cL~~dP~~RP-s~~~Il~~L~~ll 621 (634)
.+++++.++|.+||..||.+|| |++++++.|.++.
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 7899999999999999999998 8999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=392.11 Aligned_cols=262 Identities=30% Similarity=0.542 Sum_probs=213.3
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC-------cEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec-C
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE-P 430 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~-~ 430 (634)
..+|...+.||+|+||.||+|++.+. .||||++.... .....+.+.+|..++.++ +|+||+.+++++.. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 36789999999999999999987642 38999986544 334456788888888777 68999999998765 4
Q ss_pred CcEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 497 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld 497 (634)
..+++|||||++|+|.++++.... +..+++..++.++.||++||.|||+++ |+||||||+||||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~ 168 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS 168 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeEC
Confidence 568999999999999999964321 235889999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Q 006703 498 STYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISA 574 (634)
Q Consensus 498 ~~~~ikL~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~ 574 (634)
.++.+||+|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||++| ..||......+....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999864432 2233456799999999999999999999999999999999986 568877766555555
Q ss_pred HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 575 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 575 i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
......++..|..+++++.+++.+||..||++|||+.+|++.|++++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 44566677888899999999999999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=389.24 Aligned_cols=252 Identities=35% Similarity=0.620 Sum_probs=214.7
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-CCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-~~~~~lV~E~ 439 (634)
.+|...+.||+|+||.||+|+++++.||||+++... ..+.+.+|++++++++||||+++++++.+ .+.+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 567888999999999999999999999999986543 23568899999999999999999998855 4568999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999999996432 224899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 006703 520 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 598 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~ 598 (634)
.....+|+.|+|||++.+..+++++||||||+++|||+| |+.||...+..+....+. ...+++++..+++++.+||.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHHHHHH
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHH
Confidence 345578999999999999999999999999999999998 788998888887777763 456778889999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 599 CWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 599 cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
||..||++|||+.+|++.|+++...
T Consensus 236 cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999998664
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=390.40 Aligned_cols=255 Identities=34% Similarity=0.550 Sum_probs=213.0
Q ss_pred cceeecceeeccCcEEEEEEEEcCC-----cEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
.+|...+.||+|+||.||+|++... .||||++..... .....++|.+|+.+|++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5688899999999999999987532 389998876543 34456789999999999999999999999976 4678
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||++++++.+++.... ..+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876433 34899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCcc---cCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcH
Q 006703 515 NTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 590 (634)
Q Consensus 515 ~~~~---~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 590 (634)
.... ......||..|+|||++.+..++.++||||||+++|||+| |+.||.+.+..+....+.....+++.+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 3321 2334567889999999999999999999999999999998 89999999999988888777777888889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 006703 591 MVAALIETCWAEEPEIRPSFPSIMETLQQF 620 (634)
Q Consensus 591 ~l~~Li~~cL~~dP~~RPs~~~Il~~L~~l 620 (634)
.+.+|+.+||..||++|||+.+|++.|++.
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-47 Score=394.55 Aligned_cols=259 Identities=34% Similarity=0.561 Sum_probs=223.3
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 431 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~ 431 (634)
+...|...+.||+|+||+||+|++++ +.||||++.... .....++|.+|+.+|++++||||+++++++....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 45789999999999999999999864 349999986543 4455678999999999999999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCC---------------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccC
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPD---------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 490 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~---------------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIK 490 (634)
..+++|||+++|+|.+++.... ....+++..++.|+.|++.||+|||+++ |+|||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlK 167 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLA 167 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEc
Confidence 9999999999999999985322 1234888999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCC-CCCCCCC
Q 006703 491 SPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNST 567 (634)
Q Consensus 491 P~NILld~~~~ikL~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~-~Pf~~~~ 567 (634)
|+|||++.++.+||+|||+|+..... ........||+.|+|||.+.+..++.++|||||||++|||++|. .||...+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 99999999999999999999754332 22234567899999999999999999999999999999999985 6888888
Q ss_pred hHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 006703 568 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 621 (634)
Q Consensus 568 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll 621 (634)
..+....+. ....+..|..+++++.+|+.+||..||++|||+.+|++.|+++.
T Consensus 248 ~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 888877764 44567788899999999999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=393.73 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=215.2
Q ss_pred cceeecceeeccCcEEEEEEEEcCC------cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..|...+.||+|+||+||+|.+..+ .||+|.+.... .....+++.+|+.++++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 5689999999999999999988644 37788775432 233456799999999999999999999999864 567
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+++||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8889999999998886543 34899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc--ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhcCcccCCCCCCcHH
Q 006703 515 NTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 591 (634)
Q Consensus 515 ~~~--~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 591 (634)
... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+. ...+++.|..+++.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 241 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTID 241 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHH
Confidence 322 22334568999999999999999999999999999999998 799999888777665553 45667788899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 592 VAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 592 l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
+.+|+.+||..||++|||+.+|++.|.++.+.
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999988764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-46 Score=399.70 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=218.5
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~-~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..|...+.||+|+||.||+|+++ +..||||++..... .....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 67999999999999999999987 44599999875543 2234567889999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 517 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~ 517 (634)
||+.+|+|..++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999986543 4899999999999999999999999 999999999999999999999999999876443
Q ss_pred ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 006703 518 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 597 (634)
Q Consensus 518 ~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li~ 597 (634)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ..+..+..+++++.+||.
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHHH
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHHH
Confidence 3467899999999999999999999999999999999999999999988887777743 345667889999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHH
Q 006703 598 TCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 598 ~cL~~dP~~RP-----s~~~Il~ 615 (634)
+||..||.+|+ |+.++++
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhhhCHHhccccccccHHHHHc
Confidence 99999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=396.95 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=217.2
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccc-cHHHHHHHHHHHHHHH-hCCCCCeeeeeceeecCCcEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMK-GLRHPNIVLLMGAVTEPPNLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~-~~~~~~~~~~El~iL~-~l~h~nIv~l~~~~~~~~~~~lV 436 (634)
..|...+.||+|+||+||+|+++.++ ||||++.+... .....+.+..|..++. .++||||+++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999997544 99999976532 2223355667777665 68999999999999999999999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 516 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~ 516 (634)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997443 4899999999999999999999999 999999999999999999999999999876555
Q ss_pred cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 006703 517 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 596 (634)
Q Consensus 517 ~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Li 596 (634)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+. ...+.+|..+++++.+||
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLL 234 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 555566789999999999999999999999999999999999999999999888877774 345677888999999999
Q ss_pred HHhhhcCCCCCCCHH-HHHH
Q 006703 597 ETCWAEEPEIRPSFP-SIME 615 (634)
Q Consensus 597 ~~cL~~dP~~RPs~~-~Il~ 615 (634)
.+||..||++|||+. ++++
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGG
T ss_pred HHhcccCCCCCcCHHHHHHh
Confidence 999999999999995 6753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=390.12 Aligned_cols=259 Identities=33% Similarity=0.588 Sum_probs=220.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc----EEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCCcEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 435 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~----vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~~~~l 435 (634)
..|...+.||+|+||.||+|++++++ ||||.+.... .....+.+.+|+++|+++ +||||+++++++.+++.+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 67778899999999999999987553 6677765433 333456799999999999 79999999999999999999
Q ss_pred EEeecccCCHHHHhccC-------------CCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcE
Q 006703 436 VTEYLSRGSLYKLLHIP-------------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 502 (634)
Q Consensus 436 V~E~~~ggsL~~ll~~~-------------~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~i 502 (634)
||||+++|+|.++++.. .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCCce
Confidence 99999999999999654 22345899999999999999999999999 9999999999999999999
Q ss_pred EEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCcc
Q 006703 503 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 581 (634)
Q Consensus 503 kL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~ 581 (634)
||+|||+++..... .......||..|+|||.+.+..++.++||||||+++|||++| .+||...+..++...+. ...+
T Consensus 167 kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~~~~ 244 (309)
T d1fvra_ 167 KIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYR 244 (309)
T ss_dssp EECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTCC
T ss_pred EEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-hcCC
Confidence 99999999764432 233456789999999999999999999999999999999996 46788888888777764 4566
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 582 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 582 ~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
+..+..+++++.+||.+||+.||++|||+.+|++.|+++++..
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 7788899999999999999999999999999999999999753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=385.90 Aligned_cols=262 Identities=31% Similarity=0.578 Sum_probs=223.0
Q ss_pred CCCcceeecceeeccCcEEEEEEEEcCC---------cEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeecee
Q 006703 358 GPSTHVIDSSNFIKGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 427 (634)
Q Consensus 358 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~---------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~ 427 (634)
.+..+|...+.||+|+||.||+|+..+. .||||++.... ......++.+|...+.++ +||||+++++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3457899999999999999999987543 38999986554 444557788999999888 899999999999
Q ss_pred ecCCcEEEEEeecccCCHHHHhccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcE
Q 006703 428 TEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 494 (634)
Q Consensus 428 ~~~~~~~lV~E~~~ggsL~~ll~~~~~-------------~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NI 494 (634)
.++...++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~Ni 166 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 166 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccce
Confidence 999999999999999999999964431 235899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 006703 495 LVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQV 571 (634)
Q Consensus 495 Lld~~~~ikL~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~ 571 (634)
|++.++.+||+|||++...... ........||+.|+|||.+.+..+++++||||||+++|||++ |+.||...+..+.
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 9999999999999999864332 223455678999999999999999999999999999999998 7999998888877
Q ss_pred HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 006703 572 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 623 (634)
Q Consensus 572 ~~~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~ 623 (634)
...+. ...++..|..+++.+.+||.+||+.||.+|||+.+|++.|++++..
T Consensus 247 ~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 FKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 66664 4567788889999999999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.7e-46 Score=380.73 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=215.2
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeecccc-------HHHHHHHHHHHHHHHhCC-CCCeeeeeceeecC
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFH-------EDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEP 430 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~-------~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~ 430 (634)
.+|...+.||+|+||+||+|++.. ..||||++...... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 578899999999999999999864 44999999765432 223356889999999996 99999999999999
Q ss_pred CcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCC
Q 006703 431 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 510 (634)
Q Consensus 431 ~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla 510 (634)
+..||||||+++|+|.+++.... .+++..+..++.||++||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997433 4999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCcccCcccccC------CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccC-
Q 006703 511 RSKPNTYISSKTAAGTPEWMAPEVLRE------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE- 583 (634)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~APEvl~~------~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~- 583 (634)
+...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+......+.
T Consensus 158 ~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 158 CQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 8765432 3456789999999999853 3468899999999999999999999999998887766654433322
Q ss_pred -CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 584 -IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 584 -~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....+++++.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 33478999999999999999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=387.68 Aligned_cols=263 Identities=30% Similarity=0.504 Sum_probs=227.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeecCC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~~~ 431 (634)
..+|...+.||+|+||.||+|++.+ ..||||++.... .......+.+|+.+++++ +|||||++++++.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 4688889999999999999998753 239999987654 344456799999999999 6999999999999999
Q ss_pred cEEEEEeecccCCHHHHhccCC---------------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEE
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPD---------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 496 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~---------------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILl 496 (634)
..+++|||+++|+|.++++... ....+++..+..++.||++||.|||+++ |+||||||+||++
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL 178 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccccccc
Confidence 9999999999999999996432 2235889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006703 497 DSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 573 (634)
Q Consensus 497 d~~~~ikL~DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLlt-g~~Pf~~~~~~~~~~ 573 (634)
+.++.+||+|||+++..... ........||+.|+|||++.+..++.++||||||+++|||+| |.+||...+..+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999875432 223445678999999999999999999999999999999998 666777777766666
Q ss_pred HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcC
Q 006703 574 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 625 (634)
Q Consensus 574 ~i~~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~ 625 (634)
.+.....++..+..+++.+.+||.+||+.||++|||+.+|++.|++++..+.
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~ 310 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence 6656677778888899999999999999999999999999999999988643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=385.75 Aligned_cols=246 Identities=25% Similarity=0.294 Sum_probs=203.1
Q ss_pred ecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccH---HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 365 DSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHE---DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~---~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
..+.||+|+||+||+|+++. +.||||++....... ...+.+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 35789999999999999864 459999986554322 2235688999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+.++++..+.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|.........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9998777665433 34888999999999999999999999 999999999999999999999999999876665555
Q ss_pred CCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-----------------
Q 006703 520 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------------- 581 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------------- 581 (634)
....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 5677899999999998654 5799999999999999999999999998887766554221000
Q ss_pred ----c-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ----L-----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ----~-----~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+ .....+++.+.+|+.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 011356889999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=383.96 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=213.1
Q ss_pred cceeeccCcEEEEEEEEcCC-----cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec-CCcEEEEEee
Q 006703 366 SSNFIKGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIVTEY 439 (634)
Q Consensus 366 ~~~LG~G~fG~Vy~a~~~~~-----~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-~~~~~lV~E~ 439 (634)
.++||+|+||+||+|.+..+ .||||++... ......++|.+|+++|++++||||+++++++.. +...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 57899999999999988643 2889988643 345566889999999999999999999999765 5679999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCc--
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-- 517 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~-- 517 (634)
+++++|.+++..... .+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred eecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999875443 4778889999999999999999999 9999999999999999999999999998644322
Q ss_pred --ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhhcCcccCCCCCCcHHHHH
Q 006703 518 --ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAA 594 (634)
Q Consensus 518 --~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~ 594 (634)
.......||+.|+|||.+.+..++.++||||||+++|||++|..||.... ..+....+ ....++..|..+++.+.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCcccCcHHHHH
Confidence 12234568999999999999999999999999999999999877765533 33333333 345677788899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCC
Q 006703 595 LIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 626 (634)
Q Consensus 595 Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~ 626 (634)
||.+||..||++|||+.+|++.|+++++.-..
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 99999999999999999999999999886433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=388.35 Aligned_cols=248 Identities=20% Similarity=0.322 Sum_probs=215.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~ 437 (634)
..+|...+.||+|+||+||+|.++.+ .||+|++..... ....+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 46799999999999999999998754 499999976542 2345789999999999999999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC--CCcEEEEecCCCccCCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPN 515 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~--~~~ikL~DFGla~~~~~ 515 (634)
|||+|++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ...+||+|||++.....
T Consensus 81 E~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999997543 24899999999999999999999999 999999999999984 45899999999987543
Q ss_pred CcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc--CCCCCCcHHHH
Q 006703 516 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVA 593 (634)
Q Consensus 516 ~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l~ 593 (634)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... ..+..+++++.
T Consensus 157 ~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 32 2345678999999999999999999999999999999999999999999888877774333222 22247899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 006703 594 ALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 594 ~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
+||.+||..||.+|||+.++++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-45 Score=392.63 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=208.4
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccH----HHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~----~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~ 434 (634)
..|...+.||+|+||.||+|+++. ..||||++....... ....+..+|+.+++.++||||+++++++.+++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 568899999999999999999874 459999987554322 22233345577888889999999999999999999
Q ss_pred EEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCC
Q 006703 435 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 514 (634)
Q Consensus 435 lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~ 514 (634)
+||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997543 4889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hhcCcccCCCCCCcHHH
Q 006703 515 NTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GFKGRRLEIPKNVNPMV 592 (634)
Q Consensus 515 ~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~s~~l 592 (634)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ........++..+++++
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 3456789999999999964 56899999999999999999999999875543322211 12345566778899999
Q ss_pred HHHHHHhhhcCCCCCCC-----HHHHHH
Q 006703 593 AALIETCWAEEPEIRPS-----FPSIME 615 (634)
Q Consensus 593 ~~Li~~cL~~dP~~RPs-----~~~Il~ 615 (634)
.+||.+||..||++||| ++++++
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 99999999999999999 788876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=385.59 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=213.6
Q ss_pred cceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
..|...+.||+|+||+||+|++. ++.||+|++...........++.+|+++|++++||||+++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 46888999999999999999987 4459999997665444445788999999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
|+.++.+ .++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~-~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHH-HHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCchh-hhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9976544 4443222 234999999999999999999999999 99999999999999999999999999987665555
Q ss_pred cCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCc----------------c
Q 006703 519 SSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 581 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~----------------~ 581 (634)
......||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+....+..... .
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 5667789999999999877664 8899999999999999999999998887766554321100 0
Q ss_pred cC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 006703 582 LE-----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 633 (634)
Q Consensus 582 ~~-----------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~~~~~~~~~p 633 (634)
.. ....+++++.+|+.+||..||++|||+.|+++. .+++ ...+|+|+-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~-~~~~p~p~~~ 297 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQ-DVTKPVPHLR 297 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGT-TCCCCCCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--Hhhc-cCCCCCCCCC
Confidence 00 112567899999999999999999999999884 3333 3456666543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=384.33 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=199.6
Q ss_pred cceeec-ceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhC-CCCCeeeeeceeec----CCc
Q 006703 361 THVIDS-SNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE----PPN 432 (634)
Q Consensus 361 ~~~~~~-~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l-~h~nIv~l~~~~~~----~~~ 432 (634)
..|... +.||+|+||+||+|++.. ..||||++... ..+.+|+.++.++ +||||++++++|.+ +..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 467665 469999999999999874 45999998643 3456899887654 89999999999865 467
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC---CCcEEEEecCC
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL 509 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~---~~~ikL~DFGl 509 (634)
+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 9999999999999999975432 34999999999999999999999999 999999999999975 56799999999
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--CcccCCC--
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--GRRLEIP-- 585 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~-- 585 (634)
|+...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+... .....+|
T Consensus 161 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 98654432 345678999999999999999999999999999999999999999876655443333221 1222233
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 586 --KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 586 --~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
..+++++.+||.+||..||++|||+.++++.
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2578999999999999999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.5e-45 Score=375.75 Aligned_cols=250 Identities=23% Similarity=0.281 Sum_probs=207.9
Q ss_pred cceeecceeeccCcEEEEEEEEcC-CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 439 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~-~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E~ 439 (634)
.+|...++||+|+||+||+|+++. ..||||++..........+++.+|+.+|++++||||+++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 478899999999999999999874 4599999977655555557889999999999999999999999999999999999
Q ss_pred cccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCccc
Q 006703 440 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 519 (634)
Q Consensus 440 ~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~~ 519 (634)
+.++.+..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+.........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 9887777666533 34999999999999999999999999 999999999999999999999999999876555555
Q ss_pred CCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-------------------
Q 006703 520 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------- 579 (634)
Q Consensus 520 ~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------------- 579 (634)
.....+++.|+|||++.+. .++.++|||||||++|||++|+.||...+..+....+....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 5667799999999998765 46899999999999999999999999888776655432100
Q ss_pred --------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 --------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 --------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
........+++.+.+|+.+||..||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001233567899999999999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=379.54 Aligned_cols=259 Identities=32% Similarity=0.560 Sum_probs=224.4
Q ss_pred CcceeecceeeccCcEEEEEEEEcC-------CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCc
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 432 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~-------~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~ 432 (634)
..+|...+.||+|+||+||+|.+++ +.||||++.... .......+.+|+.++++++||||+++++++..+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 4688889999999999999998753 459999987543 34455679999999999999999999999999999
Q ss_pred EEEEEeecccCCHHHHhccCC-------CcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEE
Q 006703 433 LSIVTEYLSRGSLYKLLHIPD-------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 505 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~-------~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~ 505 (634)
.++||||+++|+|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+|||++.++++||+
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEEC
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEEe
Confidence 999999999999999985321 2234688899999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCC--cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhhcCccc
Q 006703 506 DFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRL 582 (634)
Q Consensus 506 DFGla~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~ 582 (634)
|||+|+..... ........||+.|+|||.+.+..++.++||||||+++|||+|| ..||.+.+..+....+. ...++
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-EGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-TTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hCCCC
Confidence 99999864332 2223455689999999999999999999999999999999998 68898888888877664 45567
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 006703 583 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 622 (634)
Q Consensus 583 ~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~ 622 (634)
..|..+++.+.+++.+||+.||++|||+.+|++.|++.++
T Consensus 255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 7788999999999999999999999999999999887654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=375.95 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=205.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcCC---cEEEEEEeeccccHHHHHHHHHHHHHHHhC---CCCCeeeeeceee-----
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRNS---DVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT----- 428 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~~---~vAvK~~~~~~~~~~~~~~~~~El~iL~~l---~h~nIv~l~~~~~----- 428 (634)
..+|...+.||+|+||+||+|++..+ .||||++............+.+|+.+|+.+ +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999998532 389999976644433333455676666555 8999999999984
Q ss_pred cCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 429 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 429 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
.....+++|||+.++++........ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchh
Confidence 3356899999999877765544332 34899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC---------
Q 006703 509 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------- 579 (634)
Q Consensus 509 la~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~--------- 579 (634)
++...... .......||+.|+|||++.+.+++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 162 ~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 98865433 24467789999999999999999999999999999999999999999988877655542110
Q ss_pred ----------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 580 ----------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 580 ----------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
....++..+++.+.+||.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 011234567899999999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=376.64 Aligned_cols=241 Identities=21% Similarity=0.363 Sum_probs=203.2
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccH----HHHHHHHHHHHHHHhCC--CCCeeeeeceeecCC
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPP 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~----~~~~~~~~El~iL~~l~--h~nIv~l~~~~~~~~ 431 (634)
..+|...+.||+|+||+||+|++.. ..||||++....... ....++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4679999999999999999999874 459999987653321 11234668999999986 899999999999999
Q ss_pred cEEEEEeeccc-CCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-CCcEEEEecCC
Q 006703 432 NLSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGL 509 (634)
Q Consensus 432 ~~~lV~E~~~g-gsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-~~~ikL~DFGl 509 (634)
..++||||+.+ +++.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 99999999975 57888876433 4899999999999999999999999 999999999999985 57999999999
Q ss_pred CccCCCCcccCCCCCCCCcccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcccCCCCCC
Q 006703 510 SRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 588 (634)
Q Consensus 510 a~~~~~~~~~~~~~~gt~~y~APEvl~~~~~-s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 588 (634)
|...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+ + + ......++..+
T Consensus 158 a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i--~~~~~~~~~~~ 227 (273)
T d1xwsa_ 158 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----I--IRGQVFFRQRV 227 (273)
T ss_dssp CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----H--HHCCCCCSSCC
T ss_pred ceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----H--hhcccCCCCCC
Confidence 9865443 2346789999999999987765 677999999999999999999997632 1 1 12334567789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 589 NPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 589 s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
++++.+||.+||..||++|||+.++++
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 999999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=371.56 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=202.1
Q ss_pred cceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC----cEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLSIV 436 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~----~~~lV 436 (634)
.+|+..+.||+|+||.||+|++++..||||++..... .......|+..+.+++||||+++++++.+.+ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 5688889999999999999999999999999864431 1122234566667789999999999997554 58999
Q ss_pred EeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh--------CCCCEEeeccCCCcEEEcCCCcEEEEecC
Q 006703 437 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ--------RRPPIVHRDLKSPNLLVDSTYTVKVCDFG 508 (634)
Q Consensus 437 ~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~--------~g~~IvHrDIKP~NILld~~~~ikL~DFG 508 (634)
|||+++|+|.+++++. .+++..++.++.|++.||.|||+ +| |+||||||+||||+.++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999754 38899999999999999999997 46 9999999999999999999999999
Q ss_pred CCccCCCCc----ccCCCCCCCCcccCcccccCCC------CCchHHHHHHHHHHHHHHhCCCCCCCC------------
Q 006703 509 LSRSKPNTY----ISSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITLQKPWRNS------------ 566 (634)
Q Consensus 509 la~~~~~~~----~~~~~~~gt~~y~APEvl~~~~------~s~~sDVwSLGvlL~eLltg~~Pf~~~------------ 566 (634)
++....... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 998643321 1234567999999999987653 467899999999999999998776321
Q ss_pred ---ChHHHHHHHhhcCcccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 567 ---TPSQVISAVGFKGRRLEIPKN-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 567 ---~~~~~~~~i~~~~~~~~~~~~-----~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
..............++.++.. ....+.+|+.+||..||++|||+.+|++.|+++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 223333334333444544433 2356999999999999999999999999999988754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=369.51 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=204.0
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 431 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~------ 431 (634)
..+|...++||+|+||+||+|.++ +..||||++..........+++.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999987 445999999876666667788999999999999999999999997654
Q ss_pred cEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 432 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 432 ~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
.+|+||||+ +.+|..+.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccccccccee
Confidence 579999999 66888877533 3999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc------------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------ 578 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~------------ 578 (634)
..... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 170 QADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp ECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 75443 3567899999999998765 4689999999999999999999999988766554332110
Q ss_pred -----------------CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 579 -----------------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 579 -----------------~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.........+++.+.+||.+||..||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00112335678999999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=359.32 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=212.0
Q ss_pred cceeecceeeccCcEEEEEEEEcCCc--EEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCCcEEEEEe
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 438 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~~--vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~~~~lV~E 438 (634)
.+|...++||+|+||+||+|++..++ ||||+++..........++.+|+.+|+.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46899999999999999999987544 9999998776666667889999999999999999999999999999999999
Q ss_pred ecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccCCCCcc
Q 006703 439 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 518 (634)
Q Consensus 439 ~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~~~~~~ 518 (634)
++.+++|..++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988876443 4889999999999999999999999 99999999999999999999999999987665554
Q ss_pred cCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhhc------------------
Q 006703 519 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFK------------------ 578 (634)
Q Consensus 519 ~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~-~~~~~~~~~i~~~------------------ 578 (634)
......+++.|+|||++.+.. +++++|||||||++|||++|+.||.. .+..+....+...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 555667889999999987665 59999999999999999999998654 4444444333110
Q ss_pred ---------CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 579 ---------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 579 ---------~~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.........+++.+.+|+.+||..||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111233467889999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=369.99 Aligned_cols=246 Identities=24% Similarity=0.283 Sum_probs=199.5
Q ss_pred cceeecceeeccCcEEEEEEEEcCC--cEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec------CCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~~--~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~------~~~ 432 (634)
..|...+.||+|+||+||+|+++.+ .||||++..... ...+|+.+|++++|+||++++++|.. ..+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 4688899999999999999999744 499999876532 22379999999999999999999843 345
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSR 511 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~ 511 (634)
+++||||++++.+..+.........+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++.
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence 8999999987655555443333345999999999999999999999999 99999999999999765 89999999998
Q ss_pred cCCCCcccCCCCCCCCcccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc------------
Q 006703 512 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------ 578 (634)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~APEvl~~-~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~------------ 578 (634)
...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+...
T Consensus 172 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 172 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp ECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 654332 3456789999999999865 46899999999999999999999999888776654443210
Q ss_pred ---Ccc------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 579 ---GRR------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 579 ---~~~------------~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
... ......+++++.+|+.+||..||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0122457899999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=361.94 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=201.0
Q ss_pred CcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec--------
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-------- 429 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~-------- 429 (634)
..+|...++||+|+||+||+|+++. +.||||++...........++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4789999999999999999999874 459999987665555555678899999999999999999998754
Q ss_pred CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCC
Q 006703 430 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 509 (634)
Q Consensus 430 ~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGl 509 (634)
....+++|||+.++.+..+.... ..+++..++.++.||++||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecce
Confidence 34689999999887766554322 34889999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCC----cccCCCCCCCCcccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCccc--
Q 006703 510 SRSKPNT----YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL-- 582 (634)
Q Consensus 510 a~~~~~~----~~~~~~~~gt~~y~APEvl~~~-~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~~-- 582 (634)
+...... ........||+.|+|||++.+. .+++++|||||||++|||++|+.||.+.+.......+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9754422 1223445799999999998765 57999999999999999999999999888776655442211100
Q ss_pred CCC----------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 583 EIP----------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 583 ~~~----------------------------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
... ...++.+.+||.+||..||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 012567889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=365.53 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=200.6
Q ss_pred CcceeecceeeccCcEEEEEEEEc--CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecCC----cE
Q 006703 360 STHVIDSSNFIKGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NL 433 (634)
Q Consensus 360 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~~----~~ 433 (634)
..+|...++||+|+||+||+|.++ ++.||||++.... .....+++.+|+.+|++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 467999999999999999999987 4559999987554 3445578899999999999999999999986543 23
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++++++.+++|.+++... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 4444556689999999643 3899999999999999999999999 999999999999999999999999999754
Q ss_pred CCC---cccCCCCCCCCcccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC----------
Q 006703 514 PNT---YISSKTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------- 579 (634)
Q Consensus 514 ~~~---~~~~~~~~gt~~y~APEvl~-~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~---------- 579 (634)
... ........||+.|+|||++. +..++.++||||+||++|+|++|+.||...+..+.........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 332 12245667999999999984 4567899999999999999999999998887655443321100
Q ss_pred --------------cc-----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 580 --------------RR-----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 580 --------------~~-----~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
.. ......+++++.+|+.+||..||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01224678899999999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-42 Score=355.85 Aligned_cols=255 Identities=19% Similarity=0.244 Sum_probs=204.0
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC-eeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n-Iv~l~~~~~~~~~~~lV~ 437 (634)
++|...+.||+|+||.||+|++.. ..||||++...... .++..|+++++.++|+| |+.+..++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 579999999999999999999874 45999998754322 34678999999997665 556666678888899999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEc---CCCcEEEEecCCCccCC
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP 514 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld---~~~~ikL~DFGla~~~~ 514 (634)
||+. ++|...+.... ..+++..+..++.|++.||+|||++| |+||||||+|||++ .+..+||+|||+|+...
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp ECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9994 56666665333 24899999999999999999999999 99999999999986 45579999999998653
Q ss_pred CCc-------ccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------hcCcc
Q 006703 515 NTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG------FKGRR 581 (634)
Q Consensus 515 ~~~-------~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~------~~~~~ 581 (634)
... .......||+.|+|||++.+..+++++|||||||++|||++|+.||...........+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 321 12345679999999999999999999999999999999999999998766544322221 11222
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 582 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 582 ~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
...+..+|+++.+++.+||+.||++||++.+|.+.|+++....
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 3345678999999999999999999999999999999987653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-41 Score=351.90 Aligned_cols=255 Identities=18% Similarity=0.214 Sum_probs=211.1
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCC-CCeeeeeceeecCCcEEEEE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIVT 437 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h-~nIv~l~~~~~~~~~~~lV~ 437 (634)
.+|...+.||+|+||+||+|++.. +.||||++...... ..+.+|++.++.+.| +||+.+++++..+...++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 678999999999999999999874 44999988654322 345688899999965 89999999999999999999
Q ss_pred eecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcC-----CCcEEEEecCCCcc
Q 006703 438 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSRS 512 (634)
Q Consensus 438 E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~-----~~~ikL~DFGla~~ 512 (634)
||+ +++|.+++..... .+++..+..++.|++.||+|||++| |+||||||+|||++. .+.+||+|||+|+.
T Consensus 81 e~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 999 6799998875443 4899999999999999999999999 999999999999964 57899999999986
Q ss_pred CCCC-------cccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhh---cC
Q 006703 513 KPNT-------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGF---KG 579 (634)
Q Consensus 513 ~~~~-------~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~---~~~~~~i~~---~~ 579 (634)
.... ........||+.|+|||++.+..++.++||||||+++|||++|..||.+... .+....+.. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 4321 1123456799999999999999999999999999999999999999975443 222222211 12
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 006703 580 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 624 (634)
Q Consensus 580 ~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~L~~ll~~~ 624 (634)
....++..+|+++.+++..|+..+|++||+++.+.+.|+++++..
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 223345678999999999999999999999999999999988754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=363.46 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=208.3
Q ss_pred cceeecceeeccCcEEEEEEEEc-----CCcEEEEEEeeccc--cHHHHHHHHHHHHHHHhCCC-CCeeeeeceeecCCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~-----~~~vAvK~~~~~~~--~~~~~~~~~~El~iL~~l~h-~nIv~l~~~~~~~~~ 432 (634)
..|...+.||+|+||+||+|+.. ++.||||++..... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 66999999999999999999873 34599999865533 22233567799999999976 899999999999999
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
.+++|||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999987544 3778899999999999999999999 99999999999999999999999999976
Q ss_pred CCC-CcccCCCCCCCCcccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--hcCcccCCCCC
Q 006703 513 KPN-TYISSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKN 587 (634)
Q Consensus 513 ~~~-~~~~~~~~~gt~~y~APEvl~~~~--~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~ 587 (634)
... .........|++.|+|||.+.+.. ++.++|||||||+||+|++|+.||......+....+. .....+.++..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 543 222345667999999999997654 5889999999999999999999997765443332222 12345567788
Q ss_pred CcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 006703 588 VNPMVAALIETCWAEEPEIRP-----SFPSIME 615 (634)
Q Consensus 588 ~s~~l~~Li~~cL~~dP~~RP-----s~~~Il~ 615 (634)
+++++.+|+.+||..||++|| |++|+++
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 999999999999999999999 5888886
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.5e-41 Score=351.21 Aligned_cols=243 Identities=21% Similarity=0.309 Sum_probs=197.4
Q ss_pred CCcceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeec--CCcE
Q 006703 359 PSTHVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE--PPNL 433 (634)
Q Consensus 359 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~--~~~~ 433 (634)
...+|...++||+|+||+||+|+++. +.||||++.... .+++.+|+.+|++++ ||||+++++++.. ...+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 34789999999999999999999874 449999986432 256789999999995 9999999999864 4569
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCC-cEEEEecCCCcc
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRS 512 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~-~ikL~DFGla~~ 512 (634)
++||||+.+++|..+.+ .+++..+..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+|..
T Consensus 108 ~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred eEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeeccccccee
Confidence 99999999999977642 3899999999999999999999999 99999999999998654 699999999986
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhh-------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGF------------- 577 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~-~~~~i~~------------- 577 (634)
..... ......+|+.|+|||++.+.. ++.++||||+||++++|++|+.||....... ....+..
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred ccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 54332 345678999999999987654 6999999999999999999999997655322 1111100
Q ss_pred c--C--------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 578 K--G--------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 578 ~--~--------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
. . ........+++++.+||.+||..||++|||++++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 000111346889999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=360.49 Aligned_cols=246 Identities=23% Similarity=0.309 Sum_probs=203.1
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeecC-----CcE
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNL 433 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~~-----~~~ 433 (634)
.+|...+.||+|+||+||+|++.. +.||||++..........+++.+|+.+|++++||||+++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 569999999999999999999874 4499999987766666677899999999999999999999998533 334
Q ss_pred EEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCccC
Q 006703 434 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 513 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~~ 513 (634)
+++++++.+++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||++...
T Consensus 98 ~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhccc
Confidence 5667777899999999643 3999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCcccCCCCCCCCcccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcCcc-----------
Q 006703 514 PNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------- 581 (634)
Q Consensus 514 ~~~~~~~~~~~gt~~y~APEvl~~~~-~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------- 581 (634)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 172 ~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 172 DD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp TG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred Cc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 33 345678999999999977765 589999999999999999999999988776555444211100
Q ss_pred ----------cC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006703 582 ----------LE--------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 615 (634)
Q Consensus 582 ----------~~--------~~~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~ 615 (634)
.. ....+++++.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 11357899999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=360.10 Aligned_cols=247 Identities=24% Similarity=0.293 Sum_probs=195.0
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCCeeeeeceeec------CCc
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPN 432 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~nIv~l~~~~~~------~~~ 432 (634)
.+|...++||+|+||+||+|+++. ..||||++...........++.+|+.+|++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 569999999999999999999884 459999998777677777889999999999999999999999953 467
Q ss_pred EEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEecCCCcc
Q 006703 433 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 512 (634)
Q Consensus 433 ~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~DFGla~~ 512 (634)
+|+||||+.++++.. +. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhc
Confidence 999999997765544 43 23899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcC-------------
Q 006703 513 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------- 579 (634)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~~~~~i~~~~------------- 579 (634)
.... .......+|+.|+|||++.+..+++++||||+||++++|++|+.||.+.+.......+....
T Consensus 169 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 5443 23456679999999999999999999999999999999999999998877655443321100
Q ss_pred -------ccc--------------CCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006703 580 -------RRL--------------EIP------KNVNPMVAALIETCWAEEPEIRPSFPSIMET 616 (634)
Q Consensus 580 -------~~~--------------~~~------~~~s~~l~~Li~~cL~~dP~~RPs~~~Il~~ 616 (634)
... ..+ ...++.+.+|+.+||..||++|||++++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000 1235678999999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-36 Score=319.34 Aligned_cols=247 Identities=19% Similarity=0.279 Sum_probs=185.6
Q ss_pred cceeecceeeccCcEEEEEEEEcC--CcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-----------CCCeeeeecee
Q 006703 361 THVIDSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----------HPNIVLLMGAV 427 (634)
Q Consensus 361 ~~~~~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-----------h~nIv~l~~~~ 427 (634)
.+|...++||+|+||+||+|+++. ..||||+++.... ..+.+.+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 469999999999999999999874 4499999875432 2355678888888774 57899999887
Q ss_pred ec--CCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeeccCCCcEEEcCCC----
Q 006703 428 TE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTY---- 500 (634)
Q Consensus 428 ~~--~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~-~g~~IvHrDIKP~NILld~~~---- 500 (634)
.. ....+++++++..+..............+++..++.++.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 54 34566677766554433333222333458899999999999999999998 88 99999999999998654
Q ss_pred --cEEEEecCCCccCCCCcccCCCCCCCCcccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCCChHH------HH
Q 006703 501 --TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ------VI 572 (634)
Q Consensus 501 --~ikL~DFGla~~~~~~~~~~~~~~gt~~y~APEvl~~~~~s~~sDVwSLGvlL~eLltg~~Pf~~~~~~~------~~ 572 (634)
.++++|||.+..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||....... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999986443 2356789999999999999999999999999999999999999997543211 11
Q ss_pred HH-HhhcC---------------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 006703 573 SA-VGFKG---------------------------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPS 612 (634)
Q Consensus 573 ~~-i~~~~---------------------------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~RPs~~~ 612 (634)
.. +...+ .....+...++++.+|+.+||..||.+|||+.+
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00 00000 001112234678999999999999999999999
Q ss_pred HHH
Q 006703 613 IME 615 (634)
Q Consensus 613 Il~ 615 (634)
+|+
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=5.3e-22 Score=190.57 Aligned_cols=165 Identities=15% Similarity=0.090 Sum_probs=118.1
Q ss_pred eecceeeccCcEEEEEEEEc-CCcEEEEEEeecccc----------------HHHHHHHHHHHHHHHhCCCCCeeeeece
Q 006703 364 IDSSNFIKGSFGTVYHAEWR-NSDVAVKILIEQEFH----------------EDRFKEFLREVAIMKGLRHPNIVLLMGA 426 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~-~~~vAvK~~~~~~~~----------------~~~~~~~~~El~iL~~l~h~nIv~l~~~ 426 (634)
...++||+|+||+||+|++. +..||||+++..... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999875 456999987532110 1112345678999999999999988865
Q ss_pred eecCCcEEEEEeecccCCHHHHhccCCCcccccHHHHHHHHHHHHHHHHHHHhCCCCEEeeccCCCcEEEcCCCcEEEEe
Q 006703 427 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 506 (634)
Q Consensus 427 ~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g~~IvHrDIKP~NILld~~~~ikL~D 506 (634)
.. .+++|||+++..+.. +++..+..++.|++++|.|||++| |+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEE
Confidence 32 379999998866543 333445678999999999999999 9999999999999865 489999
Q ss_pred cCCCccCCCCcccCCCCCCCCcccCcc-----cccCCCCCchHHHHHHHHHH
Q 006703 507 FGLSRSKPNTYISSKTAAGTPEWMAPE-----VLREDPSNEKSDVFSFGVIL 553 (634)
Q Consensus 507 FGla~~~~~~~~~~~~~~gt~~y~APE-----vl~~~~~s~~sDVwSLGvlL 553 (634)
||+|.....+.. ..|.... .+..+.++.++|+||+.-.+
T Consensus 146 FG~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999876432210 1111110 12235567788999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=8.1e-07 Score=86.61 Aligned_cols=130 Identities=15% Similarity=0.034 Sum_probs=89.5
Q ss_pred cCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcEEEEEeecccCCHHHHhc
Q 006703 372 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 450 (634)
Q Consensus 372 G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~ 450 (634)
++.+.||+....+..+++|+........ ...+.+|...++.+. +--+.+++.+...++..++||++++|.++.....
T Consensus 25 ~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 25 MSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 4457899998777778888875443211 123557888877763 3336778888888889999999999988866542
Q ss_pred cCCCcccccHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 006703 451 IPDARVVVDERLRLNMAYDVAKGMNYLHQRR------------------------------------------------- 481 (634)
Q Consensus 451 ~~~~~~~l~e~~~~~i~~qIa~aL~yLH~~g------------------------------------------------- 481 (634)
... ....++.++++.+..||+..
T Consensus 103 ~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 103 DEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp TCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 111 12234555556666666321
Q ss_pred --------CCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 482 --------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 482 --------~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
+.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 037999999999999987666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=2.9e-05 Score=74.82 Aligned_cols=74 Identities=16% Similarity=0.117 Sum_probs=49.8
Q ss_pred eeccCc-EEEEEEEEcCCc-EEEEEEeeccccHHHHHHHHHHHHHHHhCC--CCCeeeeeceeecCCcEEEEEeecccCC
Q 006703 369 FIKGSF-GTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPNLSIVTEYLSRGS 444 (634)
Q Consensus 369 LG~G~f-G~Vy~a~~~~~~-vAvK~~~~~~~~~~~~~~~~~El~iL~~l~--h~nIv~l~~~~~~~~~~~lV~E~~~ggs 444 (634)
+..|.. +.||+....+.. +++|....... ..+..|...++.+. .-.+.+++.+..+++..+++|++++|.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 344443 679999876554 77787544322 23456777777663 3336678888888888999999998876
Q ss_pred HHH
Q 006703 445 LYK 447 (634)
Q Consensus 445 L~~ 447 (634)
+.+
T Consensus 93 ~~~ 95 (255)
T d1nd4a_ 93 LLS 95 (255)
T ss_dssp TTT
T ss_pred ccc
Confidence 543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.03 E-value=0.00057 Score=70.57 Aligned_cols=78 Identities=13% Similarity=0.061 Sum_probs=46.8
Q ss_pred ecceeeccCcEEEEEEEEcC--CcEEEEEEeecc-cc----HHHHHHHHHHHHHHHhC-CC--CCeeeeeceeecCCcEE
Q 006703 365 DSSNFIKGSFGTVYHAEWRN--SDVAVKILIEQE-FH----EDRFKEFLREVAIMKGL-RH--PNIVLLMGAVTEPPNLS 434 (634)
Q Consensus 365 ~~~~LG~G~fG~Vy~a~~~~--~~vAvK~~~~~~-~~----~~~~~~~~~El~iL~~l-~h--~nIv~l~~~~~~~~~~~ 434 (634)
..+.||.|....||++.... ..+++|...... .. +-...+...|...|+.+ .+ ..+++++.+ ++...+
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 45578999999999997653 358888653211 00 00112344677777766 22 345566543 455668
Q ss_pred EEEeecccCC
Q 006703 435 IVTEYLSRGS 444 (634)
Q Consensus 435 lV~E~~~ggs 444 (634)
++||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.41 E-value=0.02 Score=58.27 Aligned_cols=74 Identities=18% Similarity=0.247 Sum_probs=47.2
Q ss_pred eecceeeccCcEEEEEEEEcCC---------cEEEEEEeeccccHHHHHHHHHHHHHHHhCC-CCCeeeeeceeecCCcE
Q 006703 364 IDSSNFIKGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNL 433 (634)
Q Consensus 364 ~~~~~LG~G~fG~Vy~a~~~~~---------~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~-h~nIv~l~~~~~~~~~~ 433 (634)
...+.|+.|-.=.+|++...+. .+.+++.-... .. -...+|..+++.+. +.-.+++++++.+
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE---SHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred eEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 3445777788889999987532 25555543221 11 23447888888874 4334577777653
Q ss_pred EEEEeecccCCH
Q 006703 434 SIVTEYLSRGSL 445 (634)
Q Consensus 434 ~lV~E~~~ggsL 445 (634)
.+|+||++|..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 689999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.11 E-value=0.05 Score=53.70 Aligned_cols=67 Identities=12% Similarity=0.106 Sum_probs=41.3
Q ss_pred EEEEEEEEc-CCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCCC--eeeeec-----eeecCCcEEEEEeecccCC
Q 006703 375 GTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMG-----AVTEPPNLSIVTEYLSRGS 444 (634)
Q Consensus 375 G~Vy~a~~~-~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~n--Iv~l~~-----~~~~~~~~~lV~E~~~ggs 444 (634)
-.||+++.. ++.+++|+.+...... +++..|+..+..|...+ ++..+. .+......+.+++++.|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 579999875 5569999976554333 34557777777763222 122211 1234556888999997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.90 E-value=0.048 Score=53.23 Aligned_cols=146 Identities=10% Similarity=0.031 Sum_probs=73.6
Q ss_pred ceeecceeeccCcEEEEEEEEcCCcEEEEEEeeccccHHHHHHHHHHHHHHHhCCCC--Ceeeeece------eecCCcE
Q 006703 362 HVIDSSNFIKGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGA------VTEPPNL 433 (634)
Q Consensus 362 ~~~~~~~LG~G~fG~Vy~a~~~~~~vAvK~~~~~~~~~~~~~~~~~El~iL~~l~h~--nIv~l~~~------~~~~~~~ 433 (634)
.+...+.|..|.--+.|+.+..+..+++|+..... .. ..+..|+.++..+... .+...+.. .......
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC-CH---HHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 34555667778888999999888889999975432 11 2233455566555221 12221111 1223345
Q ss_pred EEEEeecccCCHHHHh--------------c----c---CCCcc-----------------cccHHHHHHHHHHHHHHHH
Q 006703 434 SIVTEYLSRGSLYKLL--------------H----I---PDARV-----------------VVDERLRLNMAYDVAKGMN 475 (634)
Q Consensus 434 ~lV~E~~~ggsL~~ll--------------~----~---~~~~~-----------------~l~e~~~~~i~~qIa~aL~ 475 (634)
..++.++.+......- + . ..... ..........+..+...+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 5666666553322110 0 0 00000 0000111122222333333
Q ss_pred HHHhCC--CCEEeeccCCCcEEEcCCCcEEEEecCCCc
Q 006703 476 YLHQRR--PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 511 (634)
Q Consensus 476 yLH~~g--~~IvHrDIKP~NILld~~~~ikL~DFGla~ 511 (634)
..+..+ .++||+|+.++||+++++...-|.||+.+.
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 322211 149999999999999988777899999875
|
| >d2q3za4 d.3.1.4 (A:146-461) Transglutaminase catalytic domain {Human (Homo sapiens), tissue isozyme [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Transglutaminase catalytic domain species: Human (Homo sapiens), tissue isozyme [TaxId: 9606]
Probab=89.72 E-value=0.056 Score=52.32 Aligned_cols=82 Identities=12% Similarity=0.103 Sum_probs=60.8
Q ss_pred hhccCCHHHHHHHHHHHHHhhcC---------CCCCCchhHhhhhHHHHHHHHHhhhCCeeeeeccccccccchhHHHHH
Q 006703 148 LCDRITAEEAVHQLANLVCNHMG---------GTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFK 218 (634)
Q Consensus 148 ~~~~~~~~~~~~~l~~~v~~~mg---------~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~g~~~~g~~rhra~lfk 218 (634)
++...++-.|+..|+++|...=- |.-.++ ..-..|..+...|++-+.+..-| ++.|-|.|=|-.+-
T Consensus 66 ~~~R~dPv~V~Rv~samvns~dd~GVL~G~Ws~~y~~G--~~P~~W~GSv~IL~q~~~~~~~p---VkyGqCwvFA~v~~ 140 (316)
T d2q3za4 66 CSRRSSPVYVGRVGSGMVNCNDDQGVLLGRWDNNYGDG--VSPMSWIGSVDILRRWKNHGCQR---VKYGQCWVFAAVAC 140 (316)
T ss_dssp HHHTTCHHHHHHHHHHTTTCTTTTSSEEECCSSCCTTS--CCTTTCCBSHHHHHHHHHTTTCC---EEEECHHHHHHHHH
T ss_pred hhhcCCchhhhhhhhhhhccCCCCceeecccccccCCC--cCCCCCCCcHHHHHHHHHcCCcc---cccchhHHHHHHHH
Confidence 44478887888888777763321 111111 12256888888998887766555 79999999999999
Q ss_pred HHhhhcCCCceeeccc
Q 006703 219 VLADLINLPCRIAKGC 234 (634)
Q Consensus 219 ~lad~~~~~~~l~~g~ 234 (634)
+++-.+|||||+|.|+
T Consensus 141 tvlR~lGIPaRvVT~f 156 (316)
T d2q3za4 141 TVLRCLGIPTRVVTNY 156 (316)
T ss_dssp HHHHHHTCCEEEEEEE
T ss_pred HHHHhcCCCceEeccc
Confidence 9999999999999994
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.62 E-value=0.15 Score=49.34 Aligned_cols=53 Identities=15% Similarity=0.139 Sum_probs=43.7
Q ss_pred eccccccccchhHHHHHHHhhhcCCCceeeccccCCCCCCCceEEEEecCCcce-eeec
Q 006703 202 IGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREY-LVDL 259 (634)
Q Consensus 202 ~g~~~~g~~rhra~lfk~lad~~~~~~~l~~g~~~~~~~~~~~~~v~~~~~~~~-~vd~ 259 (634)
+=.-+.|.|.|=|.||-.+|-.+|+|+|.|.|. .+|+|+.|-.+...+. -||-
T Consensus 135 ll~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~~-----~~H~W~Ev~~~~~~rWv~vDp 188 (287)
T d2f4ma1 135 LLETRCGRCGEWANCFTLCCRALGFEARYVWDY-----TDHVWTEVYSPSQQRWLHCDA 188 (287)
T ss_dssp HHHHCEESHHHHHHHHHHHHHHTTCCEEEEEET-----TTEEEEEEEETTTTEEEEEET
T ss_pred HHHhcCccHHHHHHHHHHHHHHcCCCeEEEecC-----CcceeEEEEecCCCcEEEecC
Confidence 345678999999999999999999999999984 4799999999775433 3554
|